data_2kz4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kz4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -115.18 -32.56 5.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.671 0.788 . . . . 0.0 111.592 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.39 -168.21 1.33 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.999 1.32 . . . . 0.0 109.242 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' HG23 ' A' ' 79' ' ' THR . 50.4 mtm180 -138.55 147.71 43.39 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.472 0.709 . . . . 0.0 110.135 171.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 75' ' ' ILE . 32.9 pt -125.98 153.45 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.644 1.178 . . . . 0.0 109.794 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -115.63 124.17 50.24 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.03 111.45 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 124.013 0.82 . . . . 0.0 109.933 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -99.22 95.36 7.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.175 0.988 . . . . 0.0 108.44 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.573 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 5.7 p -82.9 145.29 29.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.199 -1.818 . . . . 0.0 107.622 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -96.32 107.87 20.29 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.851 0.751 . . . . 0.0 109.015 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -85.28 104.24 14.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.199 1.0 . . . . 0.0 109.958 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 53.5 mt-30 -100.56 85.47 2.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 108.671 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -94.4 120.65 34.97 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.639 0.776 . . . . 0.0 109.669 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -71.91 170.56 13.48 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 122.849 0.459 . . . . 0.0 110.497 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 15.5 t70 -112.02 161.74 16.14 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.417 0.687 . . . . 0.0 109.564 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -70.86 13.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.486 1.114 . . . . 0.0 112.904 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -140.38 -34.33 0.53 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.97 0.56 Allowed Glycine 0 C--N 1.355 1.591 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.786 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 30.6 mt-10 -114.06 157.3 22.72 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.98 104.98 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.87 89.81 6.87 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 40.3 mt-10 -81.0 118.36 22.4 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.69 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.77 158.29 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 107.597 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -106.92 101.05 10.51 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.573 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 10.0 pt-20 -73.19 94.43 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.44 121.67 13.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.536 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.71 -111.0 2.55 Favored Glycine 0 C--N 1.344 0.972 0 C-N-CA 121.448 -0.406 . . . . 0.0 113.304 -154.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -98.56 130.82 45.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 51.1 m -105.75 97.58 7.38 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.68 171.61 7.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -59.78 124.43 20.13 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.753 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' A' ' 10' ' ' ILE . . . -140.29 170.97 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.696 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 t -133.29 101.44 5.18 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.416 HG11 HG12 ' A' ' 61' ' ' ILE . 31.7 t -93.91 95.54 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.755 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.68 122.29 41.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.489 ' HG2' HG22 ' A' ' 59' ' ' VAL . 87.6 mtp -67.93 156.54 36.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.655 0.264 . . . . 0.0 110.4 174.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.15 160.89 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.998 0.919 . . . . 0.0 111.511 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -93.08 178.52 5.72 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 160.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -65.57 -20.26 66.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.476 0.31 . . . . 0.0 110.81 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.592 ' HB2' ' HZ1' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -52.36 -60.84 2.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.187 . . . . 0.0 112.417 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.53 -18.37 57.04 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.69 -59.07 2.95 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.158 0.504 . . . . 0.0 109.928 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.2 mt -51.21 -38.59 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.998 1.319 . . . . 0.0 111.6 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -64.96 -46.27 82.24 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.404 0.682 . . . . 0.0 111.335 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 27.3 t -80.42 -4.68 54.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.927 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.55 -87.84 1.13 Allowed Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.63 11.01 1.85 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.414 0.686 . . . . 0.0 111.013 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 44.5 tt0 -76.92 -51.88 10.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 58' ' ' THR . 65.8 mt -91.77 163.42 14.07 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 160.68 37.24 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.3 113.7 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -6.32 20.61 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.42 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.416 HG22 HD13 ' A' ' 90' ' ' ILE . 42.1 m -55.72 131.46 46.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.198 0.599 . . . . 0.0 110.248 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.489 HG22 ' HG2' ' A' ' 41' ' ' MET . 61.8 t -96.23 113.92 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.291 0.637 . . . . 0.0 110.019 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -88.16 143.25 27.16 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.65 HD11 HG22 ' A' ' 75' ' ' ILE . 82.1 mt -139.95 108.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -99.39 116.84 32.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.665 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 10' ' ' ILE . 46.7 pt -128.98 160.28 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -57.3 157.69 6.17 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.724 0.238 . . . . 0.0 110.89 165.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -57.39 112.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.295 0.638 . . . . 0.0 111.395 -171.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HD3' HD13 ' A' ' 69' ' ' ILE . 26.6 ttt85 -139.22 103.7 4.82 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.504 0.722 . . . . 0.0 109.377 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -80.53 11.02 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.495 1.118 . . . . 0.0 112.006 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.02 -24.57 22.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.186 0.994 . . . . 0.0 109.916 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 104' ' ' ILE . 20.5 mm -69.55 131.63 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -120.48 161.15 21.75 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.71 -24.56 64.5 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.297 0.639 . . . . 0.0 111.858 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 p -81.33 -7.67 59.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.473 0.709 . . . . 0.0 111.74 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -78.5 157.97 28.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -116.49 148.98 40.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.671 0.788 . . . . 0.0 108.98 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 HD11 ' A' ' 61' ' ' ILE . 45.2 mm -112.48 117.19 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.816 0.446 . . . . 0.0 109.996 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 34.5 ttpt -104.86 125.66 51.12 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -78.32 103.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 110.042 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -67.69 -22.96 65.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.681 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 9' ' ' ARG . 11.7 t -171.5 135.28 0.9 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.887 0.875 . . . . 0.0 109.88 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.95 -159.29 28.09 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.478 -0.624 . . . . 0.0 112.956 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.64 -17.15 29.94 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.109 2.539 . . . . 0.0 112.23 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.72 36.73 4.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.419 1.087 . . . . 0.0 109.454 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.05 98.51 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.781 0.832 . . . . 0.0 111.596 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.83 -20.26 7.27 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.825 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.12 137.15 36.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.931 0.892 . . . . 0.0 110.818 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 12.1 t -104.15 106.91 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 156.7 21.67 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.976 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -117.52 144.14 45.38 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.0 mt -82.38 123.23 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 58' ' ' THR . 26.2 pt -105.24 139.22 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.578 0.751 . . . . 0.0 109.968 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -108.46 2.53 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.894 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.436 ' O ' HD22 ' A' ' 105' ' ' LEU . 12.5 pt20 -153.6 141.07 13.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.568 0.747 . . . . 0.0 109.855 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.62 102.11 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.273 1.982 . . . . 0.0 111.101 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.32 116.49 64.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.062 0.945 . . . . 0.0 109.434 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.87 136.58 33.05 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.628 2.219 . . . . 0.0 112.106 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.5 139.42 31.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.255 0.622 . . . . 0.0 110.775 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.88 80.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.108 0.963 . . . . 0.0 112.247 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.07 -3.46 58.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.221 0.609 . . . . 0.0 111.288 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? 66.51 22.37 10.63 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.438 1.095 . . . . 0.0 111.942 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.1 p -85.57 -13.28 49.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.266 0.626 . . . . 0.0 110.996 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -163.42 -172.15 2.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.928 0.491 . . . . 0.0 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -140.46 124.5 17.45 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -88.1 95.59 10.2 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 21.4 mm -87.06 120.48 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 92' ' ' GLN . 0.4 OUTLIER -108.98 142.25 39.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.485 ' SG ' HD12 ' A' ' 61' ' ' ILE . 72.2 m -150.93 172.93 14.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.754 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -143.95 158.47 43.68 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.73 127.09 30.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.441 0.463 . . . . 0.0 111.073 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.784 -177.487 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.484 0.183 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.18 -14.14 6.59 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.185 0.994 . . . . 0.0 112.319 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -102.15 -179.2 3.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.957 1.303 . . . . 0.0 109.268 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.427 ' HB3' HG21 ' A' ' 34' ' ' THR . 45.2 mtm180 -135.59 146.86 48.39 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.076 0.55 . . . . 0.0 109.98 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -138.92 144.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.944 0.898 . . . . 0.0 109.527 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -98.57 127.37 44.47 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.8 mm -80.64 106.97 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.452 0.701 . . . . 0.0 110.678 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' TRP . 27.9 mp0 -79.9 96.59 6.41 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.472 0.653 . . . . 0.0 109.93 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -81.25 136.22 35.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.708 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 27' ' ' GLU . 57.8 tp -78.42 98.97 6.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.07 0.462 . . . . 0.0 109.782 -173.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -74.92 93.93 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.027 0.931 . . . . 0.0 110.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 46.4 mt-30 -91.76 83.65 5.31 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -90.31 125.53 35.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.24 0.616 . . . . 0.0 110.404 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -78.22 152.06 32.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.671 0.389 . . . . 0.0 110.277 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 31.1 t70 -99.97 164.11 12.14 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.4 -10.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.472 1.109 . . . . 0.0 113.092 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -120.65 -6.45 9.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.455 -0.778 . . . . 0.0 109.496 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.17 48.04 1.64 Allowed Glycine 0 C--N 1.36 1.897 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 165.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 5.1 mp0 -106.14 148.15 28.18 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.53 100.83 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.64 101.25 13.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 0.0 108.65 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HB3' HD12 ' A' ' 15' ' ' LEU . 50.1 mt-10 -85.19 118.79 24.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.501 0.72 . . . . 0.0 110.202 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 ' O ' HD11 ' A' ' 15' ' ' LEU . 36.5 p -134.95 174.8 10.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . 85.0 m95 -117.5 107.83 14.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.0 146.43 23.94 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.9 141.39 53.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.911 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.96 -107.0 3.17 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -127.51 148.78 50.32 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.6 m -102.79 97.49 7.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.161 0.584 . . . . 0.0 109.465 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -113.01 171.99 7.21 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.251 0.62 . . . . 0.0 111.941 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -62.65 123.77 19.26 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.937 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -135.61 172.03 13.6 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.488 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 t -129.91 99.34 5.07 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 61' ' ' ILE . 21.8 t -88.7 92.44 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.4 0.619 . . . . 0.0 109.446 -174.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -96.03 106.07 18.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.741 0.816 . . . . 0.0 110.244 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.46 121.75 19.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 58' ' ' THR . 5.5 m -67.38 135.44 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -91.53 -177.03 4.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.461 0.705 . . . . 0.0 111.36 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 p -61.79 -41.21 97.43 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.495 0.718 . . . . 0.0 111.269 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -54.58 -43.58 72.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.118 0.967 . . . . 0.0 110.693 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.93 -52.23 66.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.648 0.593 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.77 -55.22 21.07 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.821 0.849 . . . . 0.0 112.712 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.034 0.934 . . . . 0.0 111.516 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.7 m -66.25 -41.05 90.52 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.452 0.701 . . . . 0.0 112.161 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 93.9 p -87.52 -5.24 58.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.106 0.562 . . . . 0.0 111.755 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.65 -71.95 1.5 Allowed Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.18 11.35 0.28 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.882 0.873 . . . . 0.0 110.897 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.1 tt0 -80.29 -27.2 38.58 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.087 0.555 . . . . 0.0 110.984 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -115.03 44.67 1.75 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.45 132.11 46.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.87 126.31 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 124.364 1.04 . . . . 0.0 110.85 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.58 -12.42 13.69 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -163.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.468 ' HB ' HG23 ' A' ' 42' ' ' VAL . 31.3 m -82.17 149.32 28.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.07 129.53 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -100.01 135.81 40.88 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 75' ' ' ILE . 71.1 mt -134.46 109.38 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.971 0.908 . . . . 0.0 109.002 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 30.0 m95 -90.95 116.79 29.02 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 37' ' ' ALA . 43.4 pt -121.32 163.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.67 138.73 58.04 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 164.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 2.6 t80 -53.04 126.58 21.06 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.36 1.064 . . . . 0.0 109.82 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -140.79 134.62 30.47 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.818 0.699 . . . . 0.0 109.252 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -82.16 1.79 34.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 111.581 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.16 -20.78 20.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.874 0.869 . . . . 0.0 111.201 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.466 HG21 HD12 ' A' ' 104' ' ' ILE . 23.4 mm -72.16 123.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.668 0.387 . . . . 0.0 110.481 -170.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -133.41 170.88 14.83 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 109.138 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.62 65.45 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.294 0.638 . . . . 0.0 111.433 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -94.19 39.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.819 0.848 . . . . 0.0 110.374 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 m -130.47 150.5 51.66 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 78.1 mtm180 -117.16 162.95 17.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 61' ' ' ILE . 32.2 mm -127.58 97.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.68 118.09 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.873 0.469 . . . . 0.0 110.443 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 t -69.07 -36.56 77.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.76 0.824 . . . . 0.0 110.738 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' HB2' ' A' ' 9' ' ' ARG . 9.0 t -167.51 135.59 2.46 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.897 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.91 -158.33 27.83 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.861 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.76 -29.21 51.1 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.811 2.341 . . . . 0.0 112.062 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 39' ' ' VAL . 66.6 mt -115.86 32.16 6.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 0.0 110.559 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.46 114.2 2.12 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.467 0.707 . . . . 0.0 111.349 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.59 -30.68 6.54 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.683 0.615 . . . . 0.0 112.69 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -72.7 142.64 48.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.405 0.682 . . . . 0.0 110.864 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.57 97.75 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-O 122.494 1.14 . . . . 0.0 109.985 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.9 114.66 21.83 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.701 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.508 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.07 135.56 34.79 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.135 0.974 . . . . 0.0 109.433 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.61 116.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.2 pt -98.88 132.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.294 0.637 . . . . 0.0 109.508 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.98 -120.88 5.58 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -171.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' HD23 ' A' ' 105' ' ' LEU . 11.3 pt20 -147.25 147.59 29.13 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.056 0.943 . . . . 0.0 108.485 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.89 141.84 96.14 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.87 2.38 . . . . 0.0 112.718 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.86 108.92 53.12 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.65 156.17 62.72 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.356 2.037 . . . . 0.0 112.004 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.54 154.59 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.442 0.697 . . . . 0.0 112.34 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.21 91.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.927 0.891 . . . . 0.0 111.126 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.43 -8.44 54.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.19 0.596 . . . . 0.0 111.235 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.79 21.05 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.227 1.411 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -79.77 -3.11 46.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 18.6 ptp180 -167.17 -176.1 3.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.068 0.947 . . . . 0.0 109.141 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.478 HD13 HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -132.18 117.27 18.05 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.66 111.8 21.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.536 HG23 ' SG ' ' A' ' 106' ' ' CYS . 21.9 mm -95.26 135.37 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -112.45 128.35 56.3 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 174.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' A' ' 104' ' ' ILE . 76.3 m -147.11 175.1 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.605 -168.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -139.64 158.02 44.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -52.53 151.93 3.92 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.015 0.526 . . . . 0.0 111.535 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.816 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.268 -175.485 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -80.01 -43.62 21.62 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.934 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' THR . 53.5 m-20 -104.41 -161.15 0.8 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.688 1.595 . . . . 0.0 110.872 -170.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 53.9 ttt180 -159.0 137.06 10.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.116 0.966 . . . . 0.0 109.557 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -132.42 168.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 124.428 1.091 . . . . 0.0 110.446 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.9 m -115.92 138.91 50.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.798 1.239 . . . . 0.0 108.101 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.12 101.58 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.024 0.53 . . . . 0.0 110.495 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.515 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 19.6 mp0 -75.51 100.97 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.707 0.803 . . . . 0.0 110.265 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.8 p -79.06 147.95 32.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.107 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 27' ' ' GLU . 60.5 tp -98.03 107.63 20.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 3.0 ttmp? -99.07 120.57 39.69 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.588 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 89.2 mt-30 -82.57 93.7 7.36 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.406 ' HG1' ' HG2' ' A' ' 16' ' ' LYS . 31.6 m -92.05 114.36 26.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.582 0.753 . . . . 0.0 109.401 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttp85 -72.72 158.29 35.88 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -110.7 169.84 8.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 109.351 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.6 -8.42 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 124.331 1.052 . . . . 0.0 112.839 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 p -99.25 -9.27 23.87 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.612 0.72 . . . . 0.0 109.084 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.39 19.8 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.339 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.29 140.55 31.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.355 0.662 . . . . 0.0 109.421 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 17' ' ' GLN . 40.0 mm -89.32 101.43 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.45 104.97 17.48 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 42.9 mt-10 -80.19 112.4 17.47 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -128.58 144.52 51.17 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.231 1.013 . . . . 0.0 110.609 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -103.28 100.22 10.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -98.0 135.3 39.9 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.689 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.06 142.98 55.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 -110.19 3.18 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -117.53 141.83 47.89 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 109.545 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.443 HG22 ' HG2' ' A' ' 9' ' ' ARG . 11.2 m -101.8 102.5 13.13 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.087 0.955 . . . . 0.0 109.531 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' H ' HD21 ' A' ' 35' ' ' LEU . 1.7 pt? -114.16 171.03 7.85 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.276 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -70.8 132.77 45.81 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.214 1.005 . . . . 0.0 111.945 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -135.8 -179.47 5.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.375 1.07 . . . . 0.0 110.867 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -139.06 102.29 4.49 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.92 106.27 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.396 1.078 . . . . 0.0 110.064 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -116.52 108.85 16.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 110.53 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 84.2 mtp -68.64 125.53 26.84 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.25 138.05 19.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 C-N-CA 123.766 0.826 . . . . 0.0 111.03 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -97.14 -177.86 3.99 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.469 ' HG ' HD11 ' A' ' 56' ' ' ILE . 13.9 m -58.66 -35.71 72.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.939 0.896 . . . . 0.0 111.794 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -52.62 -61.21 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.939 0.896 . . . . 0.0 112.233 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.49 -23.99 42.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.676 0.39 . . . . 0.0 111.578 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.38 18.22 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 120.954 0.407 . . . . 0.0 111.383 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.27 -37.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.03 0.932 . . . . 0.0 111.067 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -46.78 87.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.729 0.812 . . . . 0.0 111.115 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 79.4 p -82.38 -13.65 56.51 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.273 0.629 . . . . 0.0 111.348 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.24 -86.89 1.17 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.23 -1.59 5.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.817 0.847 . . . . 0.0 111.153 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.0 tt0 -65.58 -63.07 1.18 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.462 0.705 . . . . 0.0 109.774 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.29 138.15 31.69 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 165.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.2 144.69 51.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD11 ' HG ' ' A' ' 44' ' ' SER . 10.4 mt -62.81 113.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 118.113 0.415 . . . . 0.0 110.398 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.18 -10.75 14.89 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 123.04 0.352 . . . . 0.0 112.898 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -63.81 146.93 53.02 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.8 t -119.63 123.69 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.263 0.625 . . . . 0.0 110.63 -169.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -103.78 130.44 51.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.5 HG22 HG23 ' A' ' 75' ' ' ILE . 86.4 mt -134.2 113.04 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.393 0.677 . . . . 0.0 109.209 -166.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -102.05 115.27 30.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.619 0.768 . . . . 0.0 109.79 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 47.4 pt -121.32 163.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -60.51 157.08 14.87 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' N ' ' HA ' ' A' ' 101' ' ' ARG . 70.8 t80 -64.16 101.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.571 -172.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -119.9 118.83 31.77 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.8 -2.69 40.79 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.997 0.919 . . . . 0.0 110.932 -174.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -92.66 -21.12 20.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.288 0.635 . . . . 0.0 110.949 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.04 134.48 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.158 0.583 . . . . 0.0 110.632 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -131.0 171.68 12.94 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.2 67.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.567 0.747 . . . . 0.0 111.076 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.7 p -86.36 45.47 1.24 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.87 1.268 . . . . 0.0 110.554 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.0 m -141.49 122.65 14.72 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.412 1.085 . . . . 0.0 108.213 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -94.56 133.09 38.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.5 HG23 HG22 ' A' ' 61' ' ' ILE . 22.7 mm -95.99 94.0 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.867 0.867 . . . . 0.0 109.932 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HE2' ' NE2' ' A' ' 13' ' ' GLN . 40.1 ttpt -94.6 111.62 23.38 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG21 HD23 ' A' ' 87' ' ' LEU . 49.8 t -70.65 128.75 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 110.477 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -93.23 -29.63 15.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.924 0.89 . . . . 0.0 110.364 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 9' ' ' ARG . 54.4 m -151.93 110.49 3.79 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.467 -166.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.74 29.73 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.556 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -16.18 45.72 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 HD13 ' A' ' 87' ' ' LEU . 83.6 mt -127.36 34.33 4.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.217 1.007 . . . . 0.0 110.147 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.72 93.48 0.11 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.337 0.655 . . . . 0.0 111.131 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.58 -13.56 4.81 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.792 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 62.1 ttm-85 -95.55 149.36 21.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.17 0.988 . . . . 0.0 110.563 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.9 p -108.21 101.1 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 122.326 1.06 . . . . 0.0 109.737 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 77' ' ' VAL . 2.1 mm? -86.53 131.18 34.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.031 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.412 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -103.78 143.66 32.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.434 0.694 . . . . 0.0 109.256 -174.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.52 108.37 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 107' ' ' ARG . 25.7 pt -87.19 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 122.254 1.026 . . . . 0.0 110.559 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.43 -149.07 19.83 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -124.45 141.38 37.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.5 134.66 65.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.329 2.686 . . . . 0.0 112.629 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.51 107.15 49.46 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.318 1.047 . . . . 0.0 109.446 -170.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.22 152.01 72.09 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.672 2.248 . . . . 0.0 111.832 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -81.1 178.19 8.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.388 0.275 . . . . 0.0 110.643 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.24 70.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.102 0.961 . . . . 0.0 112.889 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.21 37.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.016 0.526 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 57.64 33.24 23.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 0.0 110.391 -172.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.0 t -92.15 -7.64 47.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.117 0.967 . . . . 0.0 110.162 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.44 ' HA ' ' N ' ' A' ' 65' ' ' TYR . 9.1 ptp180 -161.34 167.86 25.01 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.543 0.687 . . . . 0.0 111.384 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.05 109.34 16.33 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.437 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -79.93 107.6 12.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.472 HG21 ' SG ' ' A' ' 106' ' ' CYS . 24.6 mm -97.67 112.44 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -82.37 135.06 35.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 104' ' ' ILE . 78.7 m -148.99 175.41 11.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.197 0.999 . . . . 0.0 108.755 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.444 ' HB2' HD12 ' A' ' 90' ' ' ILE . 61.5 ttt85 -149.95 161.48 42.22 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.621 ' HG2' ' HD3' ' A' ' 85' ' ' ARG . 1.8 tm-20 -45.45 125.73 5.96 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.795 0.838 . . . . 0.0 110.384 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.06 0 O-C-N 123.552 0.533 . . . . 0.0 113.686 -167.128 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -93.8 -27.51 16.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.03 0.932 . . . . 0.0 112.345 -163.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.85 171.8 8.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.061 0.944 . . . . 0.0 109.026 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.536 ' HB2' HG23 ' A' ' 79' ' ' THR . 98.2 mtt180 -136.84 138.0 40.32 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 77' ' ' VAL . 47.8 pt -140.97 176.86 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.248 1.019 . . . . 0.0 109.751 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -140.12 136.5 33.61 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.361 0.664 . . . . 0.0 109.406 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.0 mm -73.12 125.89 32.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.268 0.627 . . . . 0.0 109.549 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -97.62 116.53 30.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -89.76 135.57 33.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.096 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 27' ' ' GLU . 2.9 tm? -92.91 99.9 12.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -85.93 107.92 17.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.361 0.664 . . . . 0.0 110.015 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -77.43 110.49 12.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -120.45 121.4 38.41 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HG2' ' H ' ' A' ' 20' ' ' ASP . 21.8 ttp180 -77.01 172.35 13.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.322 0.51 . . . . 0.0 111.209 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 16.9 t70 -108.12 161.22 15.17 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.8 tt -67.77 -6.26 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 123.792 0.837 . . . . 0.0 113.056 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -105.46 -18.92 13.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.45 54.69 0.93 Allowed Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.737 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -112.15 147.24 36.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.581 1.152 . . . . 0.0 107.942 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.7 mm -90.07 101.15 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.863 0.756 . . . . 0.0 109.731 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.45 97.85 11.43 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB3' HD21 ' A' ' 15' ' ' LEU . 43.8 mt-10 -83.46 131.75 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.443 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.9 p -132.89 161.4 34.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.109 0.964 . . . . 0.0 109.982 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -118.21 118.59 32.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.485 0.714 . . . . 0.0 109.729 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.89 151.35 25.88 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.105 0.962 . . . . 0.0 109.25 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.83 135.25 38.89 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.36 -110.34 3.06 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -113.28 132.76 55.42 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.0 m -76.45 141.66 41.27 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.97 0.908 . . . . 0.0 108.985 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.88 146.42 27.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.234 0.54 . . . . 0.0 111.682 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -71.06 124.23 23.93 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.437 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -136.81 172.45 12.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.775 0.83 . . . . 0.0 111.288 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -130.84 105.55 7.85 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 61' ' ' ILE . 60.8 t -91.64 91.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 0.0 109.373 -173.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -115.4 119.91 37.81 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.506 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -66.32 152.69 44.45 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.05 149.74 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.894 0.478 . . . . 0.0 111.039 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -88.15 176.61 7.19 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -57.47 -35.96 70.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.078 0.551 . . . . 0.0 110.446 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.05 -39.25 59.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.704 1.202 . . . . 0.0 112.133 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -66.16 -49.74 66.36 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.383 0.427 . . . . 0.0 111.198 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.5 97.66 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.981 0.801 . . . . 0.0 110.8 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.5 mt -63.22 -43.83 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.645 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 t -75.76 -13.66 60.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.428 0.691 . . . . 0.0 111.781 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.526 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 45.6 m -111.18 -2.38 15.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.676 0.79 . . . . 0.0 111.736 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.13 -74.5 1.85 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.6 5.33 0.8 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.884 0.874 . . . . 0.0 111.21 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 35.8 tt0 -70.73 -68.54 0.42 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.126 0.571 . . . . 0.0 110.342 -177.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.16 142.5 45.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 164.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.67 153.18 39.73 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.53 0.732 . . . . 0.0 109.539 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.85 115.39 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.07 -5.54 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.766 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.522 HG23 HD13 ' A' ' 90' ' ' ILE . 98.6 m -70.49 119.39 14.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.506 HG22 ' HG2' ' A' ' 41' ' ' MET . 51.0 t -84.68 118.1 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -98.75 143.33 29.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.557 HD11 HG23 ' A' ' 75' ' ' ILE . 66.5 mt -138.54 109.97 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -97.56 115.55 28.07 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 69' ' ' ILE . 49.4 pt -121.2 158.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -56.33 140.76 44.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.191 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -49.32 118.8 2.91 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.615 1.166 . . . . 0.0 111.629 -171.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -143.34 117.76 9.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.154 0.582 . . . . 0.0 109.967 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.42 2.59 27.93 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.597 1.159 . . . . 0.0 112.204 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.36 -17.32 24.82 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.852 0.861 . . . . 0.0 110.998 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 104' ' ' ILE . 26.9 mm -67.52 138.98 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.039 0.536 . . . . 0.0 110.31 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -145.7 169.63 18.1 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.081 0.952 . . . . 0.0 108.709 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . . . -63.6 -26.97 68.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.088 0.555 . . . . 0.0 112.037 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.5 p -97.9 48.01 1.01 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.16 0.981 . . . . 0.0 110.656 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -131.29 156.53 45.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -126.76 159.25 34.32 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.289 0.566 . . . . 0.0 109.989 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.557 HG23 HD11 ' A' ' 61' ' ' ILE . 48.4 mm -112.41 98.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.053 . . . . 0.0 109.224 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -90.45 113.57 25.54 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 10' ' ' ILE . 64.9 t -77.0 112.23 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 110.629 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.7 t -72.8 -30.02 63.74 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.969 0.907 . . . . 0.0 111.227 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 9' ' ' ARG . 15.0 t -165.71 139.55 4.51 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.978 0.911 . . . . 0.0 109.285 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.7 -163.4 30.38 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-O 118.95 -0.917 . . . . 0.0 111.67 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.74 -25.91 28.21 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.377 2.051 . . . . 0.0 111.452 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -114.5 33.93 5.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.195 0.998 . . . . 0.0 109.724 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.3 109.16 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.702 0.801 . . . . 0.0 111.452 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.37 -21.32 10.02 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.415 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -80.62 165.87 21.63 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.387 0.675 . . . . 0.0 111.153 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.17 102.05 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 122.351 1.072 . . . . 0.0 109.414 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 120.86 24.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.674 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.49 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -82.75 134.76 35.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.223 1.009 . . . . 0.0 108.288 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.518 HG12 ' SG ' ' A' ' 106' ' ' CYS . 66.1 mt -82.19 95.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -172.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.522 HD13 HG23 ' A' ' 58' ' ' THR . 21.7 pt -80.53 62.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 122.3 1.048 . . . . 0.0 111.14 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.54 -158.85 27.83 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.513 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 92.5 mt-30 -126.59 145.44 53.22 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 109.365 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 134.47 57.88 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 113.504 -173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -106.56 108.92 62.7 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.1 142.7 56.95 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.668 2.246 . . . . 0.0 112.269 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.24 150.56 48.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 111.374 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.99 70.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.529 1.132 . . . . 0.0 112.369 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.66 -8.97 45.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.878 0.471 . . . . 0.0 110.973 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 62.54 20.28 11.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.705 1.202 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.8 t -89.41 -0.17 57.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.344 0.258 . . . . 0.0 110.813 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.64 -174.89 2.94 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 123.65 0.78 . . . . 0.0 109.949 171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.26 124.62 26.21 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.62 117.33 28.42 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.533 HD12 HG22 ' A' ' 69' ' ' ILE . 15.3 mm -108.76 140.55 26.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.572 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.3 pt? -112.14 128.97 56.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.518 ' SG ' HG12 ' A' ' 89' ' ' ILE . 56.2 m -150.74 -178.96 6.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -171.09 175.68 4.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.34 1.056 . . . . 0.0 108.642 163.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -57.67 172.04 0.41 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.691 0.796 . . . . 0.0 111.066 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.097 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -176.45 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -117.09 -44.17 2.81 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.398 1.079 . . . . 0.0 110.284 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -101.07 -175.48 2.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.049 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -131.94 147.73 52.48 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.79 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' THR . 13.7 pt -138.97 145.29 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.622 1.169 . . . . 0.0 109.266 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -108.62 137.95 45.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 109.021 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.06 114.15 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.889 0.476 . . . . 0.0 110.284 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.1 mp0 -89.79 103.79 16.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 p -79.41 159.03 27.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.481 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 27' ' ' GLU . 49.5 tp -114.84 110.28 19.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.082 0.553 . . . . 0.0 109.997 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -93.99 101.94 14.01 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.952 0.901 . . . . 0.0 109.417 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -79.81 125.42 29.67 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -137.11 150.55 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 108.718 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -99.33 166.24 11.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.55 0.34 . . . . 0.0 110.121 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 8.7 t70 -110.59 162.89 14.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.642 1.177 . . . . 0.0 108.592 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tt -59.25 -12.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 125.013 1.325 . . . . 0.0 113.805 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -112.52 -34.61 5.8 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.49 48.04 0.15 Allowed Glycine 0 C--N 1.354 1.559 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.708 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 23.7 mm-40 -96.12 154.21 17.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.423 0.689 . . . . 0.0 109.258 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -107.05 102.93 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.81 101.72 13.06 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.575 1.15 . . . . 0.0 109.106 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HB3' HD12 ' A' ' 15' ' ' LEU . 47.5 mt-10 -88.2 107.39 18.76 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -116.14 144.6 43.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.638 0.775 . . . . 0.0 110.231 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 74' ' ' ARG . 85.4 m95 -114.22 113.62 24.88 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.133 0.973 . . . . 0.0 109.424 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.02 123.82 47.34 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.36 128.88 38.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.267 1.427 . . . . 0.0 109.364 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.47 -126.4 3.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -165.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.91 135.03 43.01 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.918 0.887 . . . . 0.0 110.717 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 16.6 m -99.1 105.77 17.9 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.369 0.668 . . . . 0.0 110.85 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -108.82 170.72 7.86 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.588 0.708 . . . . 0.0 111.721 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -71.81 127.54 32.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.279 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.436 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -138.74 176.35 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.306 1.043 . . . . 0.0 111.106 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -136.7 110.29 8.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.022 0.929 . . . . 0.0 108.511 162.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.87 106.28 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.392 0.677 . . . . 0.0 110.538 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -112.91 103.92 11.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.009 0.923 . . . . 0.0 109.48 173.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.526 ' SD ' HD22 ' A' ' 82' ' ' LEU . 92.5 mtp -66.53 130.52 43.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.04 142.51 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.015 0.436 . . . . 0.0 110.737 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -98.22 -173.02 2.47 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 124.03 0.932 . . . . 0.0 110.457 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -53.42 -29.92 37.64 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.264 1.025 . . . . 0.0 112.839 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -49.99 -51.12 44.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.63 0.772 . . . . 0.0 112.053 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -67.12 -40.43 86.83 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.653 0.596 . . . . 0.0 111.634 -174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.79 72.18 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.293 0.637 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.68 -42.45 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.832 0.853 . . . . 0.0 111.403 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.4 t -68.77 -30.25 68.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.216 0.607 . . . . 0.0 111.383 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 97.1 p -91.84 -9.34 43.75 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.417 0.687 . . . . 0.0 111.163 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.5 -72.09 2.8 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.37 10.19 0.5 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.704 0.802 . . . . 0.0 110.88 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 47.3 mt-10 -78.45 -30.91 47.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.91 0.484 . . . . 0.0 111.084 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.56 170.34 8.25 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.074 0.95 . . . . 0.0 109.252 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.07 149.54 35.25 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.803 0.841 . . . . 0.0 109.682 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mt -63.23 144.6 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.53 0.732 . . . . 0.0 110.364 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.98 -12.03 70.58 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.135 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 90' ' ' ILE . 47.1 m -61.05 116.7 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.223 0.609 . . . . 0.0 109.358 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 87' ' ' LEU . 46.4 t -76.69 103.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.883 -171.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -92.58 137.44 32.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -141.4 109.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.824 0.85 . . . . 0.0 108.777 -167.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -92.65 124.11 36.43 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.35 0.66 . . . . 0.0 109.579 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 44.9 pt -130.25 167.39 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.623 0.769 . . . . 0.0 110.16 -175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -53.25 151.08 5.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.735 0.647 . . . . 0.0 111.451 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.434 ' HE1' ' HD2' ' A' ' 99' ' ' ARG . 61.5 t80 -60.38 107.91 0.73 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -129.64 119.16 23.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.3 -2.89 30.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.927 1.291 . . . . 0.0 112.31 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.05 -21.31 19.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.885 0.874 . . . . 0.0 111.396 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.62 132.21 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.65 0.38 . . . . 0.0 110.554 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.438 HD21 ' H ' ' A' ' 72' ' ' THR . 5.0 t30 -143.18 161.88 37.08 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.01 -27.78 68.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.3 0.64 . . . . 0.0 111.897 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.438 ' H ' HD21 ' A' ' 70' ' ' ASN . 35.3 p -79.2 14.32 1.53 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.183 0.993 . . . . 0.0 112.364 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -111.42 167.65 10.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.505 0.722 . . . . 0.0 109.077 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 51.0 mtm180 -122.46 150.28 42.72 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 mm -113.17 99.92 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.498 1.119 . . . . 0.0 109.019 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.3 ttpt -89.44 120.28 30.63 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.072 -0.393 . . . . 0.0 110.172 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 87' ' ' LEU . 53.4 t -76.79 120.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.966 0.412 . . . . 0.0 109.902 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.0 m -84.81 -29.94 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.343 1.057 . . . . 0.0 111.522 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.9 p -141.27 126.77 18.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.85 0.86 . . . . 0.0 109.556 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.92 -158.19 25.08 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.503 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.62 -13.38 29.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.246 2.631 . . . . 0.0 112.441 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.526 HD22 ' SD ' ' A' ' 41' ' ' MET . 70.9 mt -120.77 25.77 9.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.838 . . . . 0.0 110.149 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.34 112.48 2.44 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.342 0.657 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.01 2.54 51.86 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.501 0.501 . . . . 0.0 113.175 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -105.53 139.55 39.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.574 0.75 . . . . 0.0 109.475 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -104.93 102.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 122.313 1.054 . . . . 0.0 109.722 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 59' ' ' VAL . 1.5 mm? -82.73 133.14 35.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.198 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.419 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -100.44 143.6 30.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.195 0.598 . . . . 0.0 109.561 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.3 mt -80.48 143.62 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 58' ' ' THR . 2.2 pt -122.19 104.38 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.813 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.3 -105.98 2.48 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.847 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.1 150.17 29.05 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.684 0.794 . . . . 0.0 109.884 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.64 12.23 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 121.903 1.736 . . . . 0.0 111.008 167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -89.14 113.8 57.68 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -76.55 129.13 10.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.17 1.913 . . . . 0.0 110.699 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.625 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 21.9 t70 -52.69 150.37 5.24 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.342 1.057 . . . . 0.0 112.198 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.76 -43.92 77.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.926 0.891 . . . . 0.0 112.001 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.57 0.12 56.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.549 0.739 . . . . 0.0 111.251 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 38.7 mmt180 61.88 26.04 15.72 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.088 1.355 . . . . 0.0 112.138 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.8 p -79.79 -12.2 59.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.625 ' HG2' ' HB2' ' A' ' 96' ' ' ASP . 13.3 ptp180 -165.67 175.9 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.69 121.81 37.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.944 0.898 . . . . 0.0 108.766 165.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.33 102.99 12.36 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.26 142.88 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -123.61 138.05 54.62 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.09 176.44 10.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.073 -167.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 159.24 42.8 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -45.79 122.76 3.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.976 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.142 -172.714 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD13 ' HG3' ' A' ' 64' ' ' ARG . 27.2 mt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.884 0.373 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -97.56 -21.2 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.504 0.721 . . . . 0.0 111.468 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.3 -174.68 2.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.145 0.978 . . . . 0.0 110.052 -173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -139.01 150.92 46.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.385 0.674 . . . . 0.0 110.077 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' THR . 44.6 pt -139.33 168.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.178 . . . . 0.0 109.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -128.81 138.91 52.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.677 0.791 . . . . 0.0 109.013 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -89.71 92.35 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.359 0.6 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -71.66 99.13 2.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.82 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 p -84.27 139.45 32.32 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.57 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 28' ' ' THR . 64.1 tp -78.18 105.58 9.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.144 0.577 . . . . 0.0 109.737 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -90.51 117.95 29.6 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.804 0.841 . . . . 0.0 111.087 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.98 94.34 5.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -90.92 111.49 22.95 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.346 0.659 . . . . 0.0 109.576 -173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.7 ttt-85 -87.79 152.85 21.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.052 0.453 . . . . 0.0 111.443 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -107.65 164.04 12.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.963 0.905 . . . . 0.0 108.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.4 tt -72.2 -1.26 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 C-N-CA 124.121 0.969 . . . . 0.0 113.239 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -98.45 -14.24 20.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.981 0.896 . . . . 0.0 109.33 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.97 40.98 5.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.805 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 46.5 mt-10 -96.79 149.58 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.622 0.769 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -108.49 107.4 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.47 103.79 15.77 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.38 126.5 31.25 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 109.631 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 15' ' ' LEU . 37.7 p -139.53 -176.17 4.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.599 1.56 . . . . 0.0 108.469 -168.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -128.05 115.09 17.93 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.906 -0.496 . . . . 0.0 109.665 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.62 145.34 26.95 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.79 136.81 37.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.966 0.507 . . . . 0.0 109.634 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.86 -109.45 3.34 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -108.11 134.38 51.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 88.3 m -97.96 102.91 14.79 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.04 168.75 9.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.576 0.751 . . . . 0.0 112.264 -173.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.0 122.26 19.01 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.359 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.96 13.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.442 0.697 . . . . 0.0 112.368 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 2.1 m -131.74 94.61 3.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.384 1.074 . . . . 0.0 108.226 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 77' ' ' VAL . 2.8 p -91.2 94.27 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.698 0.761 . . . . 0.0 109.67 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -113.6 119.85 38.91 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.724 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 82' ' ' LEU . 54.1 mtp -76.62 150.63 36.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.937 0.495 . . . . 0.0 109.737 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -83.7 136.41 22.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.146 0.579 . . . . 0.0 109.576 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.57 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 39.5 t -90.3 -178.85 5.48 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.964 0.906 . . . . 0.0 109.535 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -60.53 -33.57 72.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.423 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 18.4 ptpt -53.93 -40.24 66.56 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.619 1.167 . . . . 0.0 111.461 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -70.28 -43.37 70.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.012 0.925 . . . . 0.0 110.44 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.39 -32.12 72.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.895 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.8 mt -73.16 -45.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.249 0.62 . . . . 0.0 110.553 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.3 m -63.45 -36.95 85.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.78 0.832 . . . . 0.0 111.856 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.7 p -86.51 -48.37 8.44 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.034 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.22 -64.68 0.31 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.98 -5.57 0.79 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.872 0.869 . . . . 0.0 111.568 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.0 tt0 -71.98 -68.94 0.42 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.006 0.522 . . . . 0.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -77.09 119.52 20.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.91 39.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.98 117.97 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.08 -11.17 14.88 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 116.856 -0.156 . . . . 0.0 113.048 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.1 m -68.29 146.91 52.87 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.93 116.41 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.271 0.628 . . . . 0.0 110.096 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -87.63 126.39 34.92 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 75' ' ' ILE . 44.8 mt -123.48 104.95 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 11.9 m0 -90.56 117.91 29.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.723 0.809 . . . . 0.0 109.722 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 pt -130.29 161.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 108.324 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HG3' HD13 ' A' ' 6' ' ' LEU . 64.1 mtm180 -60.92 141.13 57.48 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.883 0.765 . . . . 0.0 110.826 167.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.24 130.99 36.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.052 1.341 . . . . 0.0 111.135 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.41 147.15 25.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.19 0.596 . . . . 0.0 111.238 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -83.2 1.02 42.78 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.603 1.161 . . . . 0.0 111.884 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.67 -26.78 19.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.877 0.471 . . . . 0.0 111.216 -165.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.512 HG21 HD13 ' A' ' 104' ' ' ILE . 6.3 mm -75.65 132.03 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.73 167.37 16.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.91 63.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.082 0.553 . . . . 0.0 111.635 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.1 p -84.95 3.11 39.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.791 0.836 . . . . 0.0 111.547 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 m -93.95 159.79 15.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.57 0.748 . . . . 0.0 109.646 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -132.12 165.0 25.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 0.0 109.01 170.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG22 HD12 ' A' ' 61' ' ' ILE . 43.7 mm -115.97 99.22 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.487 0.715 . . . . 0.0 110.621 -173.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -91.93 110.11 21.46 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.44 HG22 HG21 ' A' ' 39' ' ' VAL . 95.7 t -72.84 117.94 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.678 0.791 . . . . 0.0 111.106 -172.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.3 m -77.44 -21.73 52.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.358 1.063 . . . . 0.0 112.158 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -167.71 132.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.729 0.811 . . . . 0.0 109.34 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.44 -163.72 30.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.928 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.42 -16.07 17.37 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.134 2.556 . . . . 0.0 112.102 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.664 HD12 HD12 ' A' ' 87' ' ' LEU . 82.7 mt -119.26 28.93 7.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.341 1.056 . . . . 0.0 109.795 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.81 115.23 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.425 0.69 . . . . 0.0 110.542 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.63 38.96 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.811 0.694 . . . . 0.0 112.946 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -107.68 143.82 35.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.862 0.865 . . . . 0.0 109.853 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.12 88.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 122.481 1.134 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.664 HD12 HD12 ' A' ' 82' ' ' LEU . 2.6 mm? -62.57 132.41 52.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.033 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -95.13 130.69 41.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.275 1.03 . . . . 0.0 109.357 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.91 129.92 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.49 HG23 ' HD2' ' A' ' 107' ' ' ARG . 1.5 pt -97.18 111.55 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 0.0 109.215 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.46 -94.05 1.9 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.987 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -166.92 155.11 9.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.316 1.046 . . . . 0.0 109.325 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -58.35 123.44 13.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.755 2.303 . . . . 0.0 111.831 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.12 111.71 65.26 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 123.916 0.887 . . . . 0.0 109.789 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.08 155.9 63.79 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.229 2.62 . . . . 0.0 113.691 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.86 155.2 41.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 110.914 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.88 84.23 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.344 0.657 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.29 59.28 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.948 0.499 . . . . 0.0 110.899 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 61.29 23.85 14.03 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.285 1.434 . . . . 0.0 112.236 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 t -85.87 -6.51 59.07 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.796 0.438 . . . . 0.0 111.401 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.59 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 5.5 ppt_? -161.27 162.54 31.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.583 0.753 . . . . 0.0 109.614 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.56 118.21 32.5 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.59 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 37.8 tt0 -90.27 105.27 17.7 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.7 mm -88.74 97.69 7.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD22 ' H ' ' A' ' 105' ' ' LEU . 2.6 pt? -81.19 136.84 35.9 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 77.1 m -151.75 -175.5 5.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.068 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.49 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -153.53 160.09 42.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.44 0.696 . . . . 0.0 109.196 165.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 138.49 57.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.544 0.737 . . . . 0.0 110.322 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.073 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.851 -171.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -103.58 -7.62 20.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.734 0.814 . . . . 0.0 112.33 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -102.64 -176.92 3.24 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 55.6 mtm180 -133.74 150.78 51.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.579 0.752 . . . . 0.0 109.42 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 34' ' ' THR . 12.4 pt -136.4 157.18 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 31' ' ' ASP . 26.0 m -116.55 124.82 50.82 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.8 mm -72.31 93.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.674 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 2.3 tp-100 -71.58 100.17 2.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -83.71 140.55 32.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.603 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 27' ' ' GLU . 42.5 tp -101.6 98.92 9.16 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 110.018 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -83.66 105.91 14.95 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 109.237 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -74.99 90.82 2.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.5 m -89.68 112.31 23.53 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 109.938 -171.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -72.65 153.45 41.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.843 0.354 . . . . 0.0 110.431 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HB2' HD11 ' A' ' 26' ' ' LEU . 19.3 t70 -113.89 164.65 13.48 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.3 5.95 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.853 0.861 . . . . 0.0 112.392 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -101.54 -14.96 17.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.707 0.803 . . . . 0.0 109.033 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.79 33.91 8.09 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.371 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.59 166.95 10.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.613 0.765 . . . . 0.0 110.537 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.2 mm -114.14 105.36 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.708 0.803 . . . . 0.0 109.21 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' A' ' 20' ' ' ASP . 5.9 mp -98.27 96.05 7.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.849 1.26 . . . . 0.0 107.697 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.585 ' HB3' HD12 ' A' ' 15' ' ' LEU . 44.9 mt-10 -79.03 118.66 21.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.512 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -126.75 149.13 49.78 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.753 1.221 . . . . 0.0 110.251 -172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.425 ' CE2' HD13 ' A' ' 15' ' ' LEU . 92.7 m95 -107.62 109.5 21.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.867 0.867 . . . . 0.0 109.49 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.3 140.07 39.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.091 0.957 . . . . 0.0 108.567 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB2' HG23 ' A' ' 11' ' ' THR . 5.5 p-10 -71.54 128.99 37.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.28 -119.66 4.56 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.784 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.47 116.59 28.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.448 0.699 . . . . 0.0 109.423 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 26.8 m -90.26 94.53 9.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -103.96 162.83 12.81 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.244 0.545 . . . . 0.0 111.604 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -63.26 126.31 27.0 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.794 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 10' ' ' ILE . . . -134.71 165.53 25.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.364 1.066 . . . . 0.0 111.709 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -121.66 98.91 6.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.13 91.63 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.282 0.633 . . . . 0.0 110.125 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -95.54 107.49 19.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.445 0.698 . . . . 0.0 110.34 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.23 130.71 41.45 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.538 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 13.8 m -70.21 151.13 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -95.38 -177.32 4.06 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.653 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -61.29 -41.0 96.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.641 0.776 . . . . 0.0 110.778 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.17 -34.4 68.42 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.225 1.01 . . . . 0.0 112.314 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 5.8 mm-40 -62.3 -39.41 92.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.263 0.625 . . . . 0.0 111.169 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.98 67.12 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.512 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.77 -33.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.106 0.962 . . . . 0.0 111.939 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -87.65 -48.55 7.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.513 0.725 . . . . 0.0 110.704 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 15.8 m -84.49 -22.65 30.16 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.86 -102.19 1.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.242 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.24 -5.02 57.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.431 0.692 . . . . 0.0 111.816 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 34.7 tt0 -82.91 -62.64 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.632 0.373 . . . . 0.0 110.465 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.606 HD22 HG22 ' A' ' 58' ' ' THR . 47.1 mt -110.08 147.94 32.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.493 0.717 . . . . 0.0 109.228 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.97 168.92 18.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.476 1.11 . . . . 0.0 110.252 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.4 116.12 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.81 -9.76 14.21 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 123.072 0.368 . . . . 0.0 112.43 -167.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.606 HG22 HD22 ' A' ' 54' ' ' LEU . 88.2 m -80.56 161.98 24.51 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.299 1.04 . . . . 0.0 109.281 172.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.97 126.41 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.116 0.966 . . . . 0.0 109.117 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -95.46 134.36 38.38 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.18 109.35 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -94.15 127.22 39.84 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 pt -132.83 168.04 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.627 0.371 . . . . 0.0 110.677 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -49.14 131.71 19.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.815 0.446 . . . . 0.0 110.15 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 69.0 t80 -51.55 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.519 1.528 . . . . 0.0 111.697 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 104.58 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 109.464 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.76 7.73 9.68 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.055 0.942 . . . . 0.0 111.729 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.84 -18.91 21.5 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.189 0.996 . . . . 0.0 111.138 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.568 HG21 HD12 ' A' ' 104' ' ' ILE . 39.2 mm -68.7 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 122.878 0.471 . . . . 0.0 109.897 -177.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -142.33 172.68 12.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.107 0.963 . . . . 0.0 108.587 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -30.1 65.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.082 0.953 . . . . 0.0 112.99 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 p -90.55 23.26 3.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.543 0.737 . . . . 0.0 112.324 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -112.74 162.34 15.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.674 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 99.8 mtt180 -122.88 159.34 28.41 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.61 93.25 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.95 0.9 . . . . 0.0 109.134 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.6 ttpt -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 HD21 ' A' ' 87' ' ' LEU . 83.9 t -67.36 122.03 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 122.917 0.487 . . . . 0.0 110.517 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 44.0 t -82.33 -39.64 22.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.937 0.895 . . . . 0.0 109.932 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.3 p -143.92 137.2 27.65 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.739 0.816 . . . . 0.0 109.887 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.41 -161.6 25.0 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.977 0.798 . . . . 0.0 111.485 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.04 -17.98 40.59 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.186 2.591 . . . . 0.0 112.522 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -116.4 27.5 9.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.866 0.866 . . . . 0.0 110.223 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.14 95.08 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.661 0.785 . . . . 0.0 111.586 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.99 -18.33 5.6 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.072 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -86.85 143.8 27.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.713 0.805 . . . . 0.0 110.201 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.0 p -100.94 117.69 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 0.0 109.316 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.0 mm? -87.63 142.95 27.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 108.318 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -107.69 139.59 42.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.923 0.889 . . . . 0.0 109.047 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.9 mt -81.14 99.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 107' ' ' ARG . 23.6 pt -74.26 94.34 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.945 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.29 12.64 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.595 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -128.35 142.97 46.42 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.267 1.027 . . . . 0.0 109.309 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.54 155.53 69.84 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.025 2.483 . . . . 0.0 112.601 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -116.88 107.41 46.15 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -62.76 141.1 83.85 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -69.03 145.49 53.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.88 67.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.606 1.163 . . . . 0.0 112.357 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.62 54.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.763 0.425 . . . . 0.0 111.586 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 65.42 14.4 9.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.47 1.108 . . . . 0.0 112.67 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -89.8 -2.81 58.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.872 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -168.57 178.04 4.93 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.629 0.772 . . . . 0.0 110.91 171.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.44 121.53 32.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -83.72 112.25 19.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.568 HD12 HG21 ' A' ' 69' ' ' ILE . 22.1 mm -98.11 142.29 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.482 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.3 pt? -117.82 133.76 55.61 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 81.2 m -150.06 161.74 41.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.582 -171.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.405 ' HB2' HD13 ' A' ' 90' ' ' ILE . 56.5 ttp180 -144.95 139.85 27.84 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.554 ' HA ' HD11 ' A' ' 87' ' ' LEU . 27.7 tt0 -48.78 143.29 5.42 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.517 1.136 . . . . 0.0 113.397 -168.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.018 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.775 -173.124 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 38' ' ' SER . 6.4 mp . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -123.62 -29.26 3.76 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.165 0.986 . . . . 0.0 111.548 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -99.89 -172.82 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.341 1.456 . . . . 0.0 110.247 -173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.511 ' HB2' HG22 ' A' ' 79' ' ' THR . 53.4 mtm180 -139.62 146.35 39.66 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 110.409 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.83 149.79 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.419 1.088 . . . . 0.0 109.048 178.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -107.58 126.13 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.18 111.32 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.361 0.665 . . . . 0.0 110.229 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 76.4 mt-30 -95.06 96.7 9.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.513 0.725 . . . . 0.0 109.718 172.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -82.07 150.25 27.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.109 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 27' ' ' GLU . 51.3 tp -89.3 98.31 11.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.8 0.727 . . . . 0.0 109.517 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -85.34 101.59 12.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.611 0.764 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -86.73 86.13 7.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -91.95 126.04 36.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.066 0.946 . . . . 0.0 110.611 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.6 ttp180 -79.19 148.14 32.38 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.693 0.282 . . . . 0.0 110.98 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.43 165.76 12.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.226 1.01 . . . . 0.0 108.887 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.41 -11.09 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 C-N-CA 124.225 1.01 . . . . 0.0 113.239 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -105.0 -7.07 19.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.57 -0.706 . . . . 0.0 109.33 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 50.56 3.67 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.078 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 45.6 mt-10 -108.55 138.38 44.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 108.894 173.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 mm -87.94 99.56 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.89 109.26 17.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.61 0.764 . . . . 0.0 109.776 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB3' HD12 ' A' ' 15' ' ' LEU . 45.2 mt-10 -80.0 111.3 16.21 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.3 p -132.69 154.27 50.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.043 . . . . 0.0 108.59 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -103.04 105.24 15.51 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 16.5 pt-20 -84.56 139.81 31.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.958 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -84.94 138.32 32.57 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.16 -108.77 2.8 Favored Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -174.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -118.05 142.39 47.45 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.952 0.406 . . . . 0.0 110.465 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 9' ' ' ARG . 16.2 m -96.14 96.69 8.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 108.57 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.01 176.28 5.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.154 0.582 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -71.83 134.91 46.41 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.361 1.064 . . . . 0.0 111.056 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -142.84 168.04 20.66 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.112 0.965 . . . . 0.0 110.829 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 23.1 t -123.15 98.69 6.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.63 90.95 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.27 97.52 11.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.716 0.806 . . . . 0.0 109.495 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.85 106.04 11.58 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 46' ' ' GLU . 3.3 m -74.86 138.19 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.358 0.599 . . . . 0.0 111.645 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.4 m -97.36 -174.01 2.81 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 124.456 1.103 . . . . 0.0 109.757 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.555 ' HA ' HG12 ' A' ' 56' ' ' ILE . 13.2 p -53.8 -43.64 69.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.17 0.988 . . . . 0.0 112.764 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.32 -46.38 83.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.079 0.551 . . . . 0.0 111.456 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 53.1 mm-40 -61.96 -43.26 99.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.12 0.568 . . . . 0.0 111.859 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.46 91.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.505 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.1 -31.05 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.636 0.774 . . . . 0.0 110.505 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.0 m -71.05 -25.92 62.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.482 0.713 . . . . 0.0 110.628 172.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 26.8 t -92.24 -10.65 37.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.151 0.981 . . . . 0.0 110.552 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 -80.14 1.73 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.33 12.11 0.55 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.977 0.911 . . . . 0.0 110.757 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 35.7 tt0 -75.65 -55.01 6.06 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.577 HD22 HG23 ' A' ' 58' ' ' THR . 80.3 mt -86.96 166.82 14.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.986 0.514 . . . . 0.0 109.659 168.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.18 160.73 31.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.097 0.959 . . . . 0.0 109.208 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.555 HG12 ' HA ' ' A' ' 44' ' ' SER . 49.6 mt -69.88 104.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.26 3.63 18.99 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.348 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.577 HG23 HD22 ' A' ' 54' ' ' LEU . 32.2 m -68.44 119.37 12.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.444 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -84.05 97.46 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.371 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -87.99 125.31 34.47 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 75' ' ' ILE . 86.2 mt -128.72 109.71 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 0.0 109.362 -165.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -97.13 113.5 25.08 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 123.561 0.744 . . . . 0.0 109.71 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HD3' ' A' ' 66' ' ' ARG . 41.5 pt -120.58 163.35 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -58.77 149.78 25.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.299 0.5 . . . . 0.0 112.057 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.02 124.87 22.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.348 -170.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.525 ' HD3' HD12 ' A' ' 63' ' ' ILE . 10.2 ptm180 -153.46 133.51 13.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.485 0.714 . . . . 0.0 109.759 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -83.64 10.27 9.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.827 0.851 . . . . 0.0 111.061 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -91.25 -27.28 18.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.58 1.152 . . . . 0.0 111.552 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 104' ' ' ILE . 19.0 mm -74.75 137.86 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.923 0.392 . . . . 0.0 110.294 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -137.44 164.73 27.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.025 0.93 . . . . 0.0 108.867 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.77 66.06 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.757 0.823 . . . . 0.0 111.914 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.5 p -86.83 28.78 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.712 0.805 . . . . 0.0 111.636 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -126.63 134.61 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -100.31 148.8 24.27 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 61' ' ' ILE . 43.2 mm -110.04 108.79 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.692 0.797 . . . . 0.0 109.328 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -100.43 112.93 25.33 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.27 104.49 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.947 0.499 . . . . 0.0 109.744 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.67 -26.39 63.42 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.576 0.75 . . . . 0.0 111.694 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.8 t -162.95 135.04 5.27 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.38 -154.53 25.92 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.315 -0.714 . . . . 0.0 112.346 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 -20.27 33.47 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.228 2.619 . . . . 0.0 112.31 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 85' ' ' ARG . 84.1 mt -128.23 38.33 4.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.755 0.822 . . . . 0.0 109.995 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.43 97.87 0.15 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.57 -34.93 1.92 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.872 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.403 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 75.4 mtt85 -68.57 138.17 54.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.44 0.696 . . . . 0.0 112.195 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.91 86.9 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.643 1.211 . . . . 0.0 108.019 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.61 149.43 43.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.803 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -108.99 139.21 44.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.513 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.91 105.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 58' ' ' THR . 19.6 pt -77.83 74.08 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 122.1 0.952 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.72 -141.16 13.79 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -127.16 138.39 32.62 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.76 0.824 . . . . 0.0 109.046 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.22 142.12 79.12 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.568 2.845 . . . . 0.0 112.53 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.79 119.67 29.93 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.52 155.18 59.8 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.589 2.192 . . . . 0.0 112.163 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.65 151.42 46.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.189 0.596 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -41.02 88.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.403 1.081 . . . . 0.0 111.802 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 -3.92 57.18 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.427 0.691 . . . . 0.0 111.891 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 63.61 15.9 9.26 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.905 1.282 . . . . 0.0 113.114 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -82.06 -7.48 59.62 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.951 0.405 . . . . 0.0 111.172 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 4.6 ppt_? -162.7 169.69 19.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.722 0.809 . . . . 0.0 109.11 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.28 131.33 56.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 33.3 tt0 -100.28 114.77 28.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.187 0.518 . . . . 0.0 109.902 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 69' ' ' ILE . 15.4 mm -93.97 136.44 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 105' ' ' LEU . 1.9 pt? -109.48 130.64 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 82.7 m -147.36 171.21 15.81 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.891 0.877 . . . . 0.0 108.66 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HB2' HD12 ' A' ' 90' ' ' ILE . 64.1 ttt180 -158.47 160.52 36.85 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.598 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.0 146.38 54.21 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.641 1.176 . . . . 0.0 110.278 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 170.51 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -105.55 -33.3 8.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.422 0.689 . . . . 0.0 110.138 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -96.23 -174.13 2.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.594 1.158 . . . . 0.0 110.116 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HG2' HG22 ' A' ' 34' ' ' THR . 53.8 ttp180 -154.1 123.38 6.5 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -116.18 159.07 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.632 0.773 . . . . 0.0 110.142 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -109.67 146.02 35.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.368 0.667 . . . . 0.0 109.329 168.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -101.26 107.2 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.486 1.114 . . . . 0.0 110.08 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -77.69 95.41 4.61 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.403 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 8.7 p -80.15 152.08 29.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.505 0.722 . . . . 0.0 109.82 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 27' ' ' GLU . 27.9 tp -92.41 97.59 10.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.323 0.583 . . . . 0.0 110.992 -171.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -76.83 95.19 4.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.095 0.958 . . . . 0.0 109.644 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.4 104.86 14.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.8 m -111.83 116.23 30.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 -169.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -85.96 140.17 30.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 122.607 0.363 . . . . 0.0 110.791 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -99.81 178.39 4.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 109.613 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tt -50.45 -46.68 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.357 1.063 . . . . 0.0 113.298 -172.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -105.85 12.79 30.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.89 23.58 7.37 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -77.94 119.57 21.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.15 87.33 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.66 92.62 0.87 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.685 0.794 . . . . 0.0 109.565 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' HD13 ' A' ' 15' ' ' LEU . 50.2 mt-10 -79.76 94.17 5.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -101.44 143.86 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.48 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -94.02 93.39 7.83 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 15.7 pt-20 -77.7 112.4 14.49 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.11 103.93 0.33 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.964 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.41 2.07 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.683 -160.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -106.76 146.72 30.51 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.603 0.761 . . . . 0.0 111.254 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 9' ' ' ARG . 4.6 m -106.76 140.59 39.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.626 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.82 158.18 40.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.432 0.693 . . . . 0.0 110.684 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -61.43 149.04 39.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.106 0.962 . . . . 0.0 112.041 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 10' ' ' ILE . . . -155.29 169.47 24.12 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.368 0.667 . . . . 0.0 111.385 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 14.7 t -128.58 91.37 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.95 96.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.407 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -107.52 99.37 8.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.499 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.466 ' SD ' HD22 ' A' ' 82' ' ' LEU . 48.7 mtp -73.11 142.03 47.52 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.84 159.71 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.522 0.729 . . . . 0.0 112.518 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.633 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.2 m -93.31 -178.46 4.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.13 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.413 ' HA ' HG12 ' A' ' 56' ' ' ILE . 34.9 p -72.23 -20.99 61.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.065 0.546 . . . . 0.0 111.56 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.633 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 20.6 ptmt -53.56 -41.7 66.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.352 1.061 . . . . 0.0 113.193 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -31.71 49.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.457 0.703 . . . . 0.0 110.868 -172.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.99 85.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.672 0.789 . . . . 0.0 110.357 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.72 -34.67 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -68.85 -49.42 58.51 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.84 0.856 . . . . 0.0 111.304 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 23.7 m -93.64 1.17 56.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.65 -79.01 1.44 Allowed Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.31 -17.67 2.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.02 0.928 . . . . 0.0 111.241 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 33.3 tt0 -57.37 -50.31 73.36 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.293 0.637 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.9 mt -103.0 158.14 16.49 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.899 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.19 153.41 25.68 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.232 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 44' ' ' SER . 31.0 mt -65.4 128.05 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.2 -8.42 18.32 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.213 0.321 . . . . 0.0 112.77 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 90' ' ' ILE . 40.8 m -68.93 139.49 55.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.308 0.643 . . . . 0.0 109.309 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -124.68 103.24 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -81.64 98.93 8.6 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.67 106.29 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 9.1 m0 -88.32 113.37 23.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.742 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.96 -171.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.78 0.832 . . . . 0.0 108.899 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -86.94 158.46 19.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.491 0.316 . . . . 0.0 110.456 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 70.1 t80 -60.66 97.44 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.522 1.129 . . . . 0.0 112.039 -172.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -120.77 104.81 10.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 109.501 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -68.92 -0.4 5.52 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.04 -20.57 21.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.603 0.761 . . . . 0.0 110.834 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.465 HG23 HD13 ' A' ' 104' ' ' ILE . 48.0 mm -66.18 128.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.45 164.9 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.7 1.2 . . . . 0.0 108.56 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.23 65.4 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.451 0.7 . . . . 0.0 111.22 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.1 p -87.4 40.19 0.91 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.166 0.986 . . . . 0.0 110.877 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -141.72 145.81 35.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.115 0.966 . . . . 0.0 108.861 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -108.8 138.7 44.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 104' ' ' ILE . 22.3 mm -107.33 90.75 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 33.7 ttmt -83.71 115.85 22.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.526 HG23 HD23 ' A' ' 87' ' ' LEU . 97.4 t -72.85 99.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 m -71.04 -26.46 63.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 111.566 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -155.49 140.73 17.57 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.942 0.897 . . . . 0.0 108.733 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.65 -154.68 26.08 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.313 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.62 -37.5 21.67 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.704 2.269 . . . . 0.0 111.369 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.601 HD13 HD13 ' A' ' 87' ' ' LEU . 89.0 mt -103.89 42.12 1.22 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.476 1.11 . . . . 0.0 109.74 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.63 101.48 0.25 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.863 0.865 . . . . 0.0 111.602 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.88 -19.13 11.3 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.412 1.006 . . . . 0.0 112.307 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HD2' HD21 ' A' ' 82' ' ' LEU . 92.7 mtt180 -83.13 141.16 32.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.478 0.711 . . . . 0.0 111.241 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 51.4 t -103.0 106.99 21.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 124.834 1.254 . . . . 0.0 108.408 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.601 HD13 HD13 ' A' ' 82' ' ' LEU . 2.6 mm? -90.07 128.73 36.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.527 0.731 . . . . 0.0 109.167 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.82 119.0 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.282 0.633 . . . . 0.0 110.059 -173.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 106' ' ' CYS . 45.6 mt -56.36 134.31 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.417 0.687 . . . . 0.0 111.26 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.63 HG21 ' HE ' ' A' ' 107' ' ' ARG . 11.5 pt -112.1 96.34 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.724 175.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.27 -84.76 0.37 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.126 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -170.33 158.83 6.15 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.212 1.005 . . . . 0.0 109.523 -172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 57.8 Cg_endo -69.62 125.07 11.79 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.23 1.953 . . . . 0.0 111.57 171.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -103.93 109.47 62.35 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.063 0.945 . . . . 0.0 109.508 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.29 150.5 53.01 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.693 2.262 . . . . 0.0 111.04 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.73 175.11 7.5 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.3 67.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.385 0.674 . . . . 0.0 112.508 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.89 -13.55 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.369 0.668 . . . . 0.0 112.528 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.52 26.07 15.87 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.391 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 t -82.25 -25.5 34.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.299 0.639 . . . . 0.0 110.012 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -138.83 168.59 19.48 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 15.4 tp -128.54 108.22 10.35 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.95 109.78 18.41 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.524 HG22 HG13 ' A' ' 75' ' ' ILE . 13.1 mm -90.09 102.88 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.4 pt? -81.12 105.13 12.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.182 0.991 . . . . 0.0 108.362 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 61.5 m -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.921 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.63 ' HE ' HG21 ' A' ' 90' ' ' ILE . 21.4 ttp85 -146.39 140.65 26.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.67 118.92 8.3 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 111.096 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.431 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 176.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 54.3 mt . . . . . 0 CA--C 1.552 1.03 0 CA-C-O 121.786 0.803 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -91.25 -26.95 18.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.922 1.289 . . . . 0.0 110.896 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.22 -172.64 2.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.609 1.564 . . . . 0.0 109.719 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.494 ' HG2' HG22 ' A' ' 34' ' ' THR . 14.6 ttp180 -155.77 138.75 15.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.879 0.872 . . . . 0.0 108.776 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.01 144.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.387 0.675 . . . . 0.0 111.122 -173.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -92.0 120.93 33.1 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.524 1.13 . . . . 0.0 109.902 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.43 95.52 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -73.59 99.26 3.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 109.928 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.556 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 21.4 p -79.87 146.42 32.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.603 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 27' ' ' GLU . 54.5 tp -92.86 106.77 18.68 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.75 0.42 . . . . 0.0 110.333 -172.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -94.69 101.87 13.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.52 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 48.6 mt-30 -77.56 93.95 4.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.58 0.752 . . . . 0.0 109.164 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.2 m -92.78 123.52 36.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.347 1.059 . . . . 0.0 110.404 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -74.59 163.13 28.09 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.031 0.532 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.28 165.0 12.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.465 1.106 . . . . 0.0 108.502 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.2 -15.84 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -95.84 -6.69 38.84 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.1 6.39 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.077 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.08 136.28 53.17 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.132 0.973 . . . . 0.0 108.827 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.35 120.22 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.4 123.9 51.31 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.06 0.944 . . . . 0.0 109.707 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HB3' HD12 ' A' ' 15' ' ' LEU . 3.5 mp0 -81.57 116.92 21.56 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.781 0.833 . . . . 0.0 110.118 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 p -130.92 153.04 49.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.109 0.964 . . . . 0.0 108.806 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -110.4 108.86 19.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.503 0.721 . . . . 0.0 109.491 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 4.4 pt-20 -93.03 133.8 35.81 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.7 127.46 31.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.15 -113.75 3.8 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -99.61 124.93 45.28 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.427 0.691 . . . . 0.0 109.847 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 10.1 m -101.04 94.88 6.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -117.04 168.51 10.19 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.206 0.602 . . . . 0.0 111.773 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 35.7 m95 -64.19 136.36 57.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.916 0.886 . . . . 0.0 112.573 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -139.24 165.97 25.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.295 1.038 . . . . 0.0 111.672 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 22.5 t -120.42 92.12 3.7 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 166.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -90.72 98.19 8.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.016 0.926 . . . . 0.0 108.951 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -119.07 116.04 25.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.546 0.738 . . . . 0.0 109.408 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.507 ' HG2' HG23 ' A' ' 59' ' ' VAL . 81.9 mtp -65.9 130.7 44.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 22.3 m -70.54 146.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 111.021 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t -84.53 174.78 9.74 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.405 ' HA ' HG12 ' A' ' 56' ' ' ILE . 42.6 p -60.73 -25.92 66.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -26.1 68.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.628 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 16.3 mm-40 -68.2 -41.46 81.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.156 0.582 . . . . 0.0 110.719 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.15 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.907 0.754 . . . . 0.0 110.86 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -64.86 -40.31 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.366 0.666 . . . . 0.0 110.521 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.0 m -66.48 -49.74 65.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.687 0.795 . . . . 0.0 111.943 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 76.6 p -91.42 -19.48 22.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.462 0.705 . . . . 0.0 112.39 -171.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.34 2.22 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.56 -15.04 1.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.426 0.691 . . . . 0.0 112.036 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 24.4 mm-40 -59.82 -43.75 94.36 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.2 0.6 . . . . 0.0 111.297 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.94 149.33 29.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.55 167.46 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.814 0.846 . . . . 0.0 109.644 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 44' ' ' SER . 26.4 mt -76.28 114.22 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 4.76 59.73 Favored Glycine 0 N--CA 1.467 0.706 0 CA-C-O 119.625 -0.542 . . . . 0.0 112.95 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.465 HG23 HD13 ' A' ' 90' ' ' ILE . 18.3 m -56.54 113.74 1.74 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.293 0.568 . . . . 0.0 109.753 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 41' ' ' MET . 49.3 t -73.18 107.25 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.189 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -90.98 134.02 34.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 80.7 mt -133.35 108.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -168.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 32.5 m0 -91.25 124.3 35.36 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 123.528 0.731 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.35 163.84 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -52.21 149.71 5.16 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.746 0.418 . . . . 0.0 111.627 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -56.83 108.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.017 0.823 . . . . 0.0 109.968 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.464 ' HD3' HD13 ' A' ' 69' ' ' ILE . 46.9 ttt85 -135.96 116.69 14.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -168.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -84.44 9.05 14.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.625 1.17 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 20.9 t70 -92.85 -19.57 21.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.245 1.418 . . . . 0.0 110.495 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.464 HD13 ' HD3' ' A' ' 66' ' ' ARG . 13.2 mm -84.32 139.94 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.483 0.713 . . . . 0.0 109.577 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -130.65 166.48 20.6 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.76 -23.71 66.79 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.411 0.684 . . . . 0.0 111.437 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -85.44 41.93 0.92 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.191 0.996 . . . . 0.0 110.433 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 m -131.72 147.57 52.51 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 123.778 0.831 . . . . 0.0 109.081 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -115.17 120.99 41.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 104' ' ' ILE . 18.2 mm -88.4 91.28 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.32 1.048 . . . . 0.0 109.507 -173.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -91.18 120.18 31.9 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG22 HD21 ' A' ' 87' ' ' LEU . 88.7 t -71.38 122.28 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.824 0.345 . . . . 0.0 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -89.44 -30.53 18.25 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 109.583 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 m -143.57 110.51 5.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.065 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.68 -170.08 30.52 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.82 -0.434 . . . . 0.0 113.736 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.26 -29.0 26.98 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.839 2.359 . . . . 0.0 111.735 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.3 mt -98.26 22.14 9.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.656 0.782 . . . . 0.0 111.018 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.14 124.32 19.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.005 0.522 . . . . 0.0 110.715 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.08 34.17 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.111 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -88.88 143.24 27.01 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.439 0.695 . . . . 0.0 110.744 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -105.99 100.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 122.194 0.997 . . . . 0.0 109.54 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 ' HG ' HG11 ' A' ' 59' ' ' VAL . 2.1 mm? -83.24 113.08 20.43 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.953 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.473 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.8 139.8 32.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 109.094 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.477 HD13 HD12 ' A' ' 75' ' ' ILE . 63.1 mt -78.53 108.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 58' ' ' THR . 18.5 pt -92.16 61.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 122.152 0.977 . . . . 0.0 110.133 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.92 -122.03 1.12 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.426 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -150.88 143.82 16.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.976 0.91 . . . . 0.0 109.139 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 111.97 1.12 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 110.499 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.47 117.43 36.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.128 0.971 . . . . 0.0 108.845 -167.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.56 158.57 49.12 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.574 2.183 . . . . 0.0 112.367 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.1 -174.54 4.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.837 0.455 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.08 -48.01 66.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.487 0.715 . . . . 0.0 111.705 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.97 58.86 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.598 0.759 . . . . 0.0 112.798 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 71.39 14.33 6.44 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -85.05 -1.72 57.16 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.315 1.046 . . . . 0.0 112.236 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -163.41 161.32 24.3 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.812 0.815 . . . . 0.0 110.129 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.74 109.21 21.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -90.67 108.87 20.09 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 0.0 109.666 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.53 HG22 HG13 ' A' ' 75' ' ' ILE . 9.3 mm -88.45 145.38 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.52 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.1 pt? -120.48 132.93 55.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.2 m -153.76 175.64 13.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.34 0.656 . . . . 0.0 111.017 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.6 166.62 22.22 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 108.497 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -73.22 156.16 38.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 167.4 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.551 0.983 0 CA-C-O 120.591 0.234 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -129.44 -30.06 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.663 0.785 . . . . 0.0 111.839 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -109.96 -166.91 1.13 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.045 1.738 . . . . 0.0 109.858 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 79' ' ' THR . 25.1 ttm180 -152.78 140.92 20.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.939 0.896 . . . . 0.0 109.166 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.613 HD12 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.15 156.78 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.804 0.842 . . . . 0.0 110.014 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -103.37 123.14 46.27 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.484 1.114 . . . . 0.0 108.992 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.19 108.95 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -85.83 111.41 20.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.71 0.767 . . . . 0.0 110.308 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -84.75 142.7 29.64 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.782 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 27' ' ' GLU . 50.1 tp -97.85 113.88 25.8 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.748 0.819 . . . . 0.0 109.634 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 5.6 ttpm? -99.77 113.19 25.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.797 0.839 . . . . 0.0 109.657 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -86.56 103.35 14.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.799 0.84 . . . . 0.0 109.402 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 m -93.9 165.16 12.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -114.1 165.95 12.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.859 0.754 . . . . 0.0 109.835 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB2' HD13 ' A' ' 26' ' ' LEU . 18.3 t70 -108.72 161.8 14.76 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.52 -14.21 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -103.25 -10.16 18.97 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.66 15.42 20.76 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.238 -0.892 . . . . 0.0 115.32 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.78 145.35 24.65 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.534 1.167 . . . . 0.0 109.485 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.51 122.48 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.312 0.645 . . . . 0.0 111.15 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 20' ' ' ASP . 5.3 mp -96.84 108.48 21.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.339 1.056 . . . . 0.0 108.565 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' HB3' HD13 ' A' ' 15' ' ' LEU . 44.4 mt-10 -80.96 107.1 13.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.371 0.669 . . . . 0.0 109.605 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -114.68 146.49 40.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.755 0.822 . . . . 0.0 110.2 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -111.18 106.23 15.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.698 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -106.1 143.86 33.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.78 137.94 48.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.821 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.26 -116.67 3.77 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -99.08 137.35 37.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 m -108.82 96.73 6.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.767 0.827 . . . . 0.0 108.855 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.59 175.24 5.57 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.38 0.609 . . . . 0.0 111.276 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -70.69 135.42 48.29 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.477 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -136.5 173.75 11.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.336 1.054 . . . . 0.0 111.074 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.2 m -130.38 96.25 4.1 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 160.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 61' ' ' ILE . 2.6 p -94.41 102.36 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -173.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.27 122.58 44.36 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.779 0.831 . . . . 0.0 109.123 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.517 ' SD ' HD21 ' A' ' 82' ' ' LEU . 72.1 mtp -72.22 145.93 47.64 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.1 134.51 30.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -83.45 176.33 9.15 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 123.53 0.732 . . . . 0.0 109.776 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p -60.13 -31.12 69.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -56.56 -49.67 74.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.671 0.788 . . . . 0.0 111.012 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.58 -44.07 91.83 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.845 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.98 -45.68 90.01 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 124.281 0.988 . . . . 0.0 112.438 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.93 -46.85 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.332 0.653 . . . . 0.0 111.217 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.5 m -65.6 -29.09 69.63 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.642 0.777 . . . . 0.0 112.216 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 89.8 p -90.6 -17.42 26.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.521 0.728 . . . . 0.0 111.996 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.02 -79.21 1.72 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.74 12.09 2.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.292 0.637 . . . . 0.0 111.05 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.4 tp10 -77.87 -53.55 7.35 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.51 HD21 HG23 ' A' ' 58' ' ' THR . 81.1 mt -106.49 147.22 29.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.862 0.865 . . . . 0.0 108.808 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.28 158.75 41.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.1 mt -62.63 120.39 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.64 -11.12 13.99 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 123.383 0.427 . . . . 0.0 112.59 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.51 HG23 HD21 ' A' ' 54' ' ' LEU . 25.4 m -71.88 140.21 49.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 166.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 38.7 t -122.67 122.28 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.494 0.718 . . . . 0.0 110.482 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -93.81 135.89 34.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 75' ' ' ILE . 66.1 mt -132.6 107.98 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.77 116.02 28.29 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.257 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.23 159.06 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -55.69 136.64 50.58 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 168.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 56.0 t80 -48.17 114.66 0.98 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.568 1.547 . . . . 0.0 113.212 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -138.23 119.61 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.78 0.832 . . . . 0.0 109.231 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HZ2' ' HB2' ' A' ' 67' ' ' LYS . 9.6 mtmp? -79.84 7.57 8.49 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.8 0.44 . . . . 0.0 110.992 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.34 -22.89 20.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.337 0.655 . . . . 0.0 110.183 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.91 130.81 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.71 162.67 23.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.708 0.803 . . . . 0.0 109.171 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.96 -15.64 63.54 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.302 0.641 . . . . 0.0 112.052 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.2 p -83.16 2.82 33.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.563 0.745 . . . . 0.0 111.649 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -101.31 137.74 39.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -106.17 134.77 48.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 61' ' ' ILE . 30.3 mm -94.07 102.63 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 123.041 0.536 . . . . 0.0 110.077 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.4 ttpt -103.78 112.72 25.8 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.62 120.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.24 0.616 . . . . 0.0 111.594 -173.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -79.45 -31.9 42.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.696 1.199 . . . . 0.0 111.749 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 9' ' ' ARG . 11.7 t -160.51 142.79 12.84 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.14 -160.63 24.42 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.832 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.49 -27.36 46.59 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.911 2.407 . . . . 0.0 112.639 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD21 ' SD ' ' A' ' 41' ' ' MET . 54.9 mt -115.77 31.64 6.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.723 0.809 . . . . 0.0 111.156 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.02 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.494 0.718 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.58 -19.0 4.83 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.082 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HD2' HD23 ' A' ' 82' ' ' LEU . 91.4 mtt-85 -86.51 142.69 28.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.291 0.637 . . . . 0.0 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.441 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 4.5 p -107.25 95.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.026 0.917 . . . . 0.0 108.995 172.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 108' ' ' GLU . 1.2 mm? -77.33 128.38 34.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.433 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -99.7 141.5 32.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.744 . . . . 0.0 109.17 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.62 122.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 pt -100.02 86.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.12 -94.18 0.54 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -159.15 145.83 12.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.964 0.905 . . . . 0.0 110.041 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.39 114.89 3.06 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.835 2.357 . . . . 0.0 111.128 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.94 108.76 48.16 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.876 0.87 . . . . 0.0 109.346 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.1 143.93 55.77 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.057 2.505 . . . . 0.0 112.331 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.41 168.9 19.24 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.194 0.452 . . . . 0.0 110.723 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.91 -27.5 65.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.005 0.922 . . . . 0.0 112.877 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.4 -7.25 42.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 62.13 29.78 17.63 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.447 1.099 . . . . 0.0 111.491 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 p -90.55 -17.98 26.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.881 0.873 . . . . 0.0 111.434 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -158.78 171.15 20.61 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.616 0.722 . . . . 0.0 110.78 -168.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.57 113.07 17.58 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.78 96.25 5.56 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.584 HG23 ' SG ' ' A' ' 106' ' ' CYS . 22.8 mm -88.71 97.16 6.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.6 HD21 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -79.01 130.51 35.61 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.584 ' SG ' HG23 ' A' ' 104' ' ' ILE . 84.7 m -147.78 173.14 13.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.376 1.07 . . . . 0.0 108.875 -170.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -138.41 153.71 48.88 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.523 ' HA ' HD11 ' A' ' 87' ' ' LEU . 38.3 tt0 -44.33 125.73 4.79 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.724 0.81 . . . . 0.0 112.848 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 86' ' ' VAL . . . . . . . . 0 C--N 1.347 1.187 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.472 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 37' ' ' ALA . 43.7 mt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -123.08 -28.63 4.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.388 0.675 . . . . 0.0 111.775 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -101.82 -174.18 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HB2' HG21 ' A' ' 79' ' ' THR . 94.2 mtt180 -136.38 142.22 43.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.68 0.792 . . . . 0.0 109.601 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 pt -133.71 166.01 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 108.779 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -132.81 134.93 45.32 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 73' ' ' SER . 51.4 mm -81.91 116.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.674 0.609 . . . . 0.0 109.666 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -89.98 104.26 16.84 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.39 139.37 34.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.927 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 27' ' ' GLU . 57.4 tp -89.51 98.62 11.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.226 0.467 . . . . 0.0 109.902 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.2 99.31 6.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 110.312 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.509 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 51.5 mt-30 -96.56 79.37 3.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -98.58 126.08 44.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.043 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.64 162.32 27.84 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.185 0.994 . . . . 0.0 111.482 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 11.3 t70 -113.65 164.35 13.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.733 0.813 . . . . 0.0 109.835 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.49 -14.62 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.669 0.788 . . . . 0.0 112.859 172.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 p -100.53 -20.15 15.85 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.91 39.97 3.22 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.007 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mm-40 -97.44 146.72 24.93 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.813 0.845 . . . . 0.0 108.921 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.8 100.32 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.38 92.13 7.48 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 15' ' ' LEU . 38.5 mt-10 -82.63 106.29 14.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.987 0.915 . . . . 0.0 109.046 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -126.05 165.48 18.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.447 1.099 . . . . 0.0 109.474 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.69 102.73 10.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.28 121.59 29.94 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.787 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.51 126.28 26.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.839 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.55 -112.77 3.6 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -120.53 133.72 55.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.143 0.577 . . . . 0.0 109.944 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.6 m -85.31 107.45 17.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.53 0.732 . . . . 0.0 109.693 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.1 pt? -108.06 164.53 12.2 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 0.0 110.863 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -75.86 130.4 38.49 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.608 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HA ' HD22 ' A' ' 6' ' ' LEU . . . -147.24 -176.51 5.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.816 0.846 . . . . 0.0 111.268 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -134.27 104.33 6.12 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.475 HG12 HG21 ' A' ' 77' ' ' VAL . 2.3 p -105.61 114.42 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 109.186 -172.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -136.14 153.62 51.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.167 1.387 . . . . 0.0 109.521 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.63 ' SD ' HD23 ' A' ' 82' ' ' LEU . 76.6 mtp -85.17 136.33 33.58 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 58' ' ' THR . 20.2 m -68.45 137.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -97.22 -173.94 2.81 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.86 0.864 . . . . 0.0 110.865 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 p -54.48 -34.44 61.58 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.268 1.027 . . . . 0.0 112.182 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -51.76 -52.62 47.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.856 0.863 . . . . 0.0 110.902 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.42 -41.58 76.16 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.447 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.93 78.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.619 . . . . 0.0 112.353 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.23 -33.75 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.678 0.791 . . . . 0.0 110.795 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 t -71.91 -44.34 63.85 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.331 0.652 . . . . 0.0 111.552 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 73.6 p -104.33 0.28 29.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.29 0.636 . . . . 0.0 112.479 -174.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.77 -70.39 2.93 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.04 -2.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.09 0.556 . . . . 0.0 112.206 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 38.0 tt0 -65.07 -50.94 64.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.108 0.563 . . . . 0.0 110.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.06 60.79 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.47 156.63 26.48 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.82 122.83 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -171.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.38 -13.04 16.04 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.695 0.665 . . . . 0.0 112.031 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 42' ' ' VAL . 87.3 m -79.65 139.46 37.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.493 HG11 ' HG ' ' A' ' 87' ' ' LEU . 42.8 t -110.67 116.5 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.46 0.704 . . . . 0.0 110.914 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -83.67 128.42 34.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.628 1.171 . . . . 0.0 110.408 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.5 HD12 ' SG ' ' A' ' 106' ' ' CYS . 51.3 mt -135.19 110.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -98.98 131.69 44.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.109 0.564 . . . . 0.0 110.438 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.29 161.04 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -63.75 151.04 43.19 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 164.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -53.49 118.64 4.03 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.034 0.934 . . . . 0.0 111.157 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.438 HH11 HD11 ' A' ' 35' ' ' LEU . 56.4 ttt180 -136.86 128.08 28.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.75 1.83 40.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.275 1.03 . . . . 0.0 112.457 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.89 -21.76 19.65 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.489 0.716 . . . . 0.0 111.31 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.5 mm -81.0 131.36 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 110.249 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -131.66 158.65 40.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.092 0.957 . . . . 0.0 109.747 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 92' ' ' GLN . . . -66.99 -25.82 66.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.047 0.939 . . . . 0.0 112.312 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -84.13 8.9 14.08 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.795 0.838 . . . . 0.0 111.758 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.436 ' HB3' HG23 ' A' ' 12' ' ' ILE . 22.8 m -111.5 120.02 40.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.607 0.763 . . . . 0.0 109.177 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -83.1 136.88 34.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.78 0.432 . . . . 0.0 110.41 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 61' ' ' ILE . 33.1 mm -96.36 101.8 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 0.0 110.114 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 29.9 ttpt -90.31 120.0 31.08 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.241 0.616 . . . . 0.0 109.982 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 39' ' ' VAL . 2.7 p -73.55 115.62 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.347 0.659 . . . . 0.0 110.805 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -81.3 -24.8 36.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.865 0.866 . . . . 0.0 111.814 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' HB2' ' A' ' 9' ' ' ARG . 10.6 t -168.24 137.86 2.48 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.857 0.863 . . . . 0.0 108.725 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.37 -165.96 29.53 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.462 -174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.15 -9.02 22.93 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 123.388 2.725 . . . . 0.0 112.656 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.63 HD23 ' SD ' ' A' ' 41' ' ' MET . 79.9 mt -119.08 6.66 11.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.169 0.988 . . . . 0.0 111.2 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -42.5 115.04 0.65 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.846 1.258 . . . . 0.0 113.58 -165.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.02 25.22 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.48 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -94.77 172.58 8.08 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.207 0.504 . . . . 0.0 110.593 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 42.5 t -124.08 114.08 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.307 0.643 . . . . 0.0 109.645 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -90.25 140.84 29.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.0 143.71 32.22 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.52 130.61 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 107' ' ' ARG . 29.7 pt -102.5 128.23 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 122.881 0.472 . . . . 0.0 109.82 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.02 -93.34 1.18 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.936 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 12.2 pt20 -161.51 156.35 19.97 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.399 1.08 . . . . 0.0 108.878 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.1 109.87 2.28 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.871 1.714 . . . . 0.0 110.274 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.4 113.31 38.21 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.32 1.048 . . . . 0.0 108.949 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.58 144.55 32.02 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.335 2.023 . . . . 0.0 111.665 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -60.76 149.57 35.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.415 0.686 . . . . 0.0 112.09 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.04 -28.77 65.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.032 0.933 . . . . 0.0 110.978 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.69 -5.46 45.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.591 0.756 . . . . 0.0 111.368 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? 61.31 18.72 9.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.837 1.255 . . . . 0.0 113.377 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -81.28 -10.49 59.57 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.361 0.528 . . . . 0.0 111.28 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -155.6 -179.13 7.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.349 0.595 . . . . 0.0 110.853 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.436 HD12 HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -137.64 112.22 8.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.0 97.78 2.92 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 HG23 ' SG ' ' A' ' 106' ' ' CYS . 20.0 mm -85.31 86.96 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -79.11 136.03 37.02 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 61' ' ' ILE . 62.9 m -146.41 170.25 17.21 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 90' ' ' ILE . 37.2 ttp180 -142.16 144.49 33.47 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 172.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -41.6 118.95 1.16 Allowed 'General case' 0 C--N 1.362 1.11 0 O-C-N 124.43 1.081 . . . . 0.0 110.998 -177.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.214 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.927 -165.352 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.241 0.639 0 CA-C-O 121.854 0.835 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.09 -22.55 45.1 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.651 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -103.6 -175.39 2.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.573 1.149 . . . . 0.0 110.283 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.504 ' HB3' HG22 ' A' ' 34' ' ' THR . 51.6 mtm180 -141.38 148.25 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 109.399 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -140.79 145.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.891 0.876 . . . . 0.0 108.687 177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 m -96.23 122.85 39.54 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.551 0.614 . . . . 0.0 109.976 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.7 mm -75.54 103.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.575 0.75 . . . . 0.0 109.892 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.415 ' NE2' ' HB2' ' A' ' 76' ' ' LYS . 78.5 mt-30 -85.55 95.72 9.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.511 0.672 . . . . 0.0 109.882 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 9.4 p -79.09 150.09 31.91 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.661 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.7 tp -88.35 105.0 17.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -170.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -89.73 96.61 10.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.037 0.935 . . . . 0.0 109.807 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 45.9 mt-30 -84.4 97.44 9.5 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -106.14 117.7 34.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.614 0.766 . . . . 0.0 109.336 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -72.07 162.48 29.4 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 120.629 0.252 . . . . 0.0 110.506 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.88 163.6 15.32 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.801 0.84 . . . . 0.0 109.361 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.6 -21.38 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.95 0.9 . . . . 0.0 113.018 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -93.85 -13.36 27.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.85 40.31 4.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.157 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.27 137.86 42.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 109.603 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -90.75 96.42 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.96 96.14 8.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' A' ' 15' ' ' LEU . 49.4 mt-10 -79.97 111.58 16.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -125.58 169.15 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.857 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 73' ' ' SER . 79.6 m95 -119.97 109.41 15.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 7.4 pt-20 -84.31 115.11 22.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.5 135.79 55.6 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.202 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.57 -119.84 3.14 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.803 -168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -99.8 125.21 45.68 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -170.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 3.7 m -88.04 93.29 9.44 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -110.89 170.41 8.11 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -64.38 120.65 12.64 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.2 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 10' ' ' ILE . . . -141.87 176.53 8.86 Favored 'General case' 0 C--O 1.209 -1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 111.979 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 m -135.38 108.41 7.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 61' ' ' ILE . 2.0 p -108.16 109.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.958 0.903 . . . . 0.0 110.837 -172.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.05 138.66 49.7 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 0.0 109.044 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.499 ' SD ' HD22 ' A' ' 82' ' ' LEU . 77.1 mtp -75.45 145.34 41.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.32 130.8 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 O-C-N 123.691 0.619 . . . . 0.0 109.68 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 m -87.94 -175.93 5.29 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 123.4 0.68 . . . . 0.0 110.706 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.8 p -59.9 -33.91 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.791 0.837 . . . . 0.0 111.502 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.86 -47.52 67.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.806 0.843 . . . . 0.0 111.106 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.21 -45.22 81.53 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.114 0.884 . . . . 0.0 111.165 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -51.97 66.4 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.922 0.764 . . . . 0.0 111.217 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.23 -38.23 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.141 0.977 . . . . 0.0 111.581 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 t -77.09 -28.57 54.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.99 0.516 . . . . 0.0 111.556 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 50.7 m -94.79 -9.86 33.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 0.0 111.894 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.94 -74.62 2.27 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.25 2.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.767 0.827 . . . . 0.0 111.047 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 1.9 tm-20 -63.95 -61.15 2.46 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.81 142.01 30.1 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.08 151.34 45.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.36 0.664 . . . . 0.0 109.557 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.85 119.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.834 0.854 . . . . 0.0 110.765 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.28 -12.64 16.46 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.281 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.447 HG22 HD13 ' A' ' 90' ' ' ILE . 86.3 m -73.47 154.14 40.06 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 164.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 22.0 t -132.2 115.41 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -87.45 132.2 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.504 HG23 HG23 ' A' ' 75' ' ' ILE . 41.8 mt -138.86 109.0 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.781 0.832 . . . . 0.0 109.037 -170.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CE3' ' HD2' ' A' ' 101' ' ' ARG . 62.0 m95 -95.0 122.97 38.2 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.8 pt -116.62 165.32 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -54.25 140.17 33.72 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 164.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HE1' ' HB3' ' A' ' 95' ' ' PRO . 51.8 t80 -54.6 129.51 36.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.007 1.323 . . . . 0.0 111.745 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.4 mtt85 -150.96 129.32 12.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.788 0.835 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -81.79 -13.9 57.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.252 1.021 . . . . 0.0 111.02 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.05 -21.47 22.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.765 0.426 . . . . 0.0 110.747 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.08 128.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.663 0.385 . . . . 0.0 110.199 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.679 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 67.2 t30 -140.73 168.09 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.387 1.075 . . . . 0.0 109.235 -177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.62 -7.66 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.9 p -86.08 19.99 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.345 1.058 . . . . 0.0 112.274 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.439 ' HA ' ' HZ3' ' A' ' 29' ' ' TRP . 72.5 m -130.09 172.77 11.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.609 0.764 . . . . 0.0 110.777 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -119.92 140.66 50.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.899 0.88 . . . . 0.0 108.952 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.504 HG23 HG23 ' A' ' 61' ' ' ILE . 50.1 mm -98.08 105.49 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.601 0.76 . . . . 0.0 109.617 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 88.2 tttt -90.44 131.09 36.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG21 HD21 ' A' ' 87' ' ' LEU . 67.8 t -83.9 123.09 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.785 0.434 . . . . 0.0 110.579 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -85.64 -38.9 17.87 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.466 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 p -146.76 128.41 15.17 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.32 -169.69 29.62 Favored Glycine 0 N--CA 1.469 0.895 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.244 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.42 -1.24 10.75 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.017 2.478 . . . . 0.0 112.855 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.499 HD22 ' SD ' ' A' ' 41' ' ' MET . 89.4 mt -130.03 32.98 4.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.004 0.922 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.83 104.95 0.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.59 0.756 . . . . 0.0 111.685 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.32 -18.36 12.14 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.959 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.15 158.31 20.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 110.954 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.8 p -124.96 98.6 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.552 1.168 . . . . 0.0 110.189 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.5 mm? -82.54 148.77 27.88 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.294 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -110.76 141.07 44.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.051 0.94 . . . . 0.0 108.508 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.71 98.69 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 58' ' ' THR . 39.2 pt -80.86 146.57 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.098 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.12 -105.45 2.06 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.755 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -161.8 144.94 9.19 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 123.519 0.728 . . . . 0.0 109.897 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 62.8 Cg_endo -69.7 125.74 12.53 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.196 1.931 . . . . 0.0 110.678 173.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 111.7 54.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HA ' HD21 ' A' ' 102' ' ' LEU . 74.4 Cg_exo -53.83 142.59 62.63 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.205 2.603 . . . . 0.0 113.559 175.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 18.1 t70 -51.74 156.09 1.51 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.929 0.892 . . . . 0.0 112.639 173.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.16 77.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.326 1.05 . . . . 0.0 112.013 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.97 -6.58 35.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.313 0.645 . . . . 0.0 111.491 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 25.57 15.27 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.783 1.233 . . . . 0.0 112.249 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.9 p -83.28 -4.73 58.72 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.327 0.584 . . . . 0.0 111.334 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 17.3 ptt180 -169.12 -176.46 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.661 1.584 . . . . 0.0 107.894 -168.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -137.16 118.16 14.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -173.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.69 108.51 14.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 mm -100.17 153.15 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -133.63 146.61 51.07 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 71.3 m -150.21 171.99 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.281 -168.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -160.62 158.19 28.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -44.16 151.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.469 1.108 . . . . 0.0 112.776 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.899 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.753 -175.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 34.9 mt . . . . . 0 C--O 1.239 0.509 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -116.03 1.74 13.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.564 0.746 . . . . 0.0 112.429 -170.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -113.88 -172.59 2.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.939 1.296 . . . . 0.0 109.231 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 50.1 mtm180 -140.57 156.21 46.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.168 0.987 . . . . 0.0 109.234 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.574 HD12 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.35 135.39 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.3 m -90.02 113.58 25.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.116 0.966 . . . . 0.0 109.654 173.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mm -74.06 105.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.845 1.258 . . . . 0.0 109.982 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.467 HE21 ' HB2' ' A' ' 76' ' ' LYS . 65.9 mt-30 -72.76 102.32 3.33 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 174.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -83.03 133.64 35.08 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.624 -1.625 . . . . 0.0 108.294 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 27' ' ' GLU . 57.3 tp -82.04 96.77 7.85 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -80.82 102.23 9.88 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -81.79 100.97 9.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.298 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -92.39 178.95 5.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -130.11 164.95 23.29 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.605 -0.684 . . . . 0.0 109.448 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 18.5 t70 -107.02 160.22 15.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.142 0.977 . . . . 0.0 108.754 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.5 tt -55.57 -15.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -98.71 -2.84 37.23 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.71 53.99 3.6 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.39 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 15.0 pt-20 -130.62 142.35 50.45 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.65 109.96 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 122.884 0.473 . . . . 0.0 110.998 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -96.26 93.0 6.64 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HB3' HD12 ' A' ' 15' ' ' LEU . 48.5 mt-10 -80.86 131.68 35.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.921 0.488 . . . . 0.0 110.302 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.4 p -138.95 159.81 41.26 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.306 1.042 . . . . 0.0 110.137 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -111.62 120.41 41.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.261 0.624 . . . . 0.0 109.886 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.15 164.14 23.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.725 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.07 138.65 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.114 0.884 . . . . 0.0 108.797 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.56 -107.4 2.42 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -110.07 129.4 55.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.91 0.884 . . . . 0.0 109.131 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 21.4 m -106.5 96.16 6.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.646 0.378 . . . . 0.0 110.183 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.74 172.01 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 122.883 0.473 . . . . 0.0 112.254 -174.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -67.19 129.97 41.62 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.574 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -144.56 172.55 12.81 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 123.769 0.828 . . . . 0.0 111.423 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 6' ' ' LEU . 72.1 m -128.17 109.68 11.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 61' ' ' ILE . 2.9 p -100.86 98.0 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.831 0.852 . . . . 0.0 109.611 -172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -112.4 115.24 28.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.827 0.851 . . . . 0.0 110.748 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 69.7 mtp -62.39 133.81 55.58 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.636 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 6.0 m -68.02 153.5 8.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.417 0.448 . . . . 0.0 110.262 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -84.28 171.76 12.44 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.949 0.5 . . . . 0.0 110.458 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -60.18 -27.13 66.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.167 0.587 . . . . 0.0 110.669 173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -47.85 -46.15 30.9 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.378 1.471 . . . . 0.0 111.897 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.636 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 33.9 mm-40 -67.2 -39.76 86.39 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.504 0.502 . . . . 0.0 111.465 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -51.63 57.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.981 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.57 -52.61 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.344 1.058 . . . . 0.0 112.155 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -71.69 -26.47 62.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.439 0.695 . . . . 0.0 112.486 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 43.0 m -92.7 -7.71 45.97 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.912 0.485 . . . . 0.0 111.411 175.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.53 0.72 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 123.494 0.496 . . . . 0.0 111.894 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.71 -5.93 7.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.791 0.836 . . . . 0.0 111.123 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 12.1 tp10 -66.56 -51.46 56.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.488 0.715 . . . . 0.0 110.669 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.83 155.95 19.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.87 0.868 . . . . 0.0 108.982 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.28 177.63 7.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.758 0.823 . . . . 0.0 110.546 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.73 136.68 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.88 43.91 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -170.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.0 m -70.75 145.13 50.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.044 0.937 . . . . 0.0 109.322 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 45.2 t -126.24 129.81 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.424 1.09 . . . . 0.0 109.214 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.3 140.37 37.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 75' ' ' ILE . 56.1 mt -137.1 143.37 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -170.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -129.22 127.32 41.04 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 ' HB1' ' A' ' 37' ' ' ALA . 42.9 pt -126.95 157.89 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.572 1.149 . . . . 0.0 107.931 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -60.28 145.46 47.44 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.448 . . . . 0.0 110.482 168.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.506 ' HA ' HD13 ' A' ' 102' ' ' LEU . 39.5 t80 -57.09 125.12 21.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.676 0.79 . . . . 0.0 110.242 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 32.7 ttt180 -153.29 122.08 6.43 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 123.613 0.571 . . . . 0.0 110.79 -172.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -71.56 -3.16 19.85 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.174 1.389 . . . . 0.0 112.431 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 4.3 t70 -89.92 -23.35 21.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.353 1.061 . . . . 0.0 110.369 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.411 HD13 ' HD3' ' A' ' 66' ' ' ARG . 20.8 mm -87.65 130.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.527 -175.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.697 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 66.3 t30 -145.3 167.95 21.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 109.594 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.26 65.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.165 0.986 . . . . 0.0 111.947 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.8 p -72.16 0.03 10.75 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.343 1.057 . . . . 0.0 112.334 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.9 t -101.14 161.34 13.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.855 0.862 . . . . 0.0 109.565 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 52.9 mtp180 -113.88 147.48 38.38 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 61' ' ' ILE . 49.3 mm -95.6 102.56 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.491 0.316 . . . . 0.0 110.393 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HG3' HG22 ' A' ' 86' ' ' VAL . 58.3 tttm -94.94 102.96 14.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG21 HD21 ' A' ' 87' ' ' LEU . 70.2 t -69.41 124.28 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 120.74 0.305 . . . . 0.0 111.095 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 42.2 t -80.97 -40.11 24.92 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.991 0.917 . . . . 0.0 110.79 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.0 p -146.33 132.64 19.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 108.747 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.0 -170.44 27.91 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 123.517 0.51 . . . . 0.0 112.531 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.03 -17.65 59.85 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.137 2.558 . . . . 0.0 112.059 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.482 HD21 ' SD ' ' A' ' 41' ' ' MET . 29.9 mt -114.25 23.94 12.4 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.742 1.217 . . . . 0.0 110.088 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.85 108.48 1.2 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.892 . . . . 0.0 111.487 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.28 -31.42 5.45 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 123.979 0.8 . . . . 0.0 111.938 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.476 HH12 ' HG3' ' A' ' 108' ' ' GLU . 36.3 mtm180 -89.08 170.71 10.41 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.573 0.749 . . . . 0.0 112.761 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.485 HG22 ' HG3' ' A' ' 76' ' ' LYS . 37.5 t -122.54 104.88 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.454 1.101 . . . . 0.0 110.106 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 77' ' ' VAL . 2.2 mm? -86.63 140.93 29.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.601 170.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.47 141.95 39.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.404 1.082 . . . . 0.0 109.072 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.8 mt -81.11 107.14 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.423 HD13 ' HB2' ' A' ' 107' ' ' ARG . 32.0 pt -90.92 41.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.414 0.686 . . . . 0.0 111.302 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.5 -134.97 2.5 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 112.001 -0.439 . . . . 0.0 112.001 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -134.65 136.52 25.62 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.903 1.281 . . . . 0.0 108.708 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.697 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 73.9 Cg_endo -69.62 111.24 2.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.158 1.905 . . . . 0.0 110.765 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 107.66 60.17 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -173.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 51.4 Cg_exo -56.03 150.61 46.41 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.539 2.826 . . . . 0.0 112.882 172.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.8 173.34 9.26 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.81 -32.45 69.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.48 0.712 . . . . 0.0 112.36 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.47 -9.33 44.91 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 62.48 30.09 17.16 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.176 0.99 . . . . 0.0 111.302 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.2 p -101.38 -12.88 18.27 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.824 0.849 . . . . 0.0 112.204 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.66 143.08 3.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -171.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.528 HD23 ' HB2' ' A' ' 93' ' ' PRO . 9.6 mp -101.64 139.57 37.12 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.958 0.903 . . . . 0.0 110.069 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.66 109.99 19.56 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 164.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.5 mm -95.92 104.57 15.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 105' ' ' LEU . 2.7 pt? -83.3 137.52 33.95 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 104' ' ' ILE . 73.7 m -149.57 175.05 11.87 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.099 0.96 . . . . 0.0 108.888 -173.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.423 ' HB2' HD13 ' A' ' 90' ' ' ILE . 57.5 ttt180 -156.65 159.97 38.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.476 ' HG3' HH12 ' A' ' 85' ' ' ARG . 0.4 OUTLIER -61.34 101.0 0.15 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.037 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.981 -165.663 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 36' ' ' TRP . 8.1 mp . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.407 0.622 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -121.64 -13.67 8.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.86 1.264 . . . . 0.0 111.366 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.47 -170.74 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.444 1.497 . . . . 0.0 110.09 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HB3' HG21 ' A' ' 34' ' ' THR . 46.2 mtm180 -136.5 142.75 43.53 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 109.904 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -136.15 143.5 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.344 1.058 . . . . 0.0 109.155 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -101.83 118.85 37.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.033 0.933 . . . . 0.0 108.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.32 92.14 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 123.95 0.781 . . . . 0.0 109.634 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 35.1 tt0 -83.79 93.77 8.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.904 0.859 . . . . 0.0 109.645 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.525 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 21.5 p -80.07 154.09 28.34 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.288 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 27' ' ' GLU . 67.2 tp -83.5 108.77 16.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.181 0.592 . . . . 0.0 109.948 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 45.9 tttp -84.67 94.24 8.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.384 0.674 . . . . 0.0 110.224 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 42.8 mt-30 -87.45 108.64 19.11 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -130.09 129.37 43.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.782 0.833 . . . . 0.0 109.173 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -73.49 148.47 43.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 122.75 0.42 . . . . 0.0 110.086 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.33 169.28 8.99 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.02 -14.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 p -91.85 -10.84 38.26 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.777 0.798 . . . . 0.0 109.344 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.32 44.29 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.742 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.21 132.59 38.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.0 mm -76.44 94.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.82 109.2 15.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HB3' HD13 ' A' ' 15' ' ' LEU . 45.6 mt-10 -84.11 96.17 8.84 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.82 0.819 . . . . 0.0 109.303 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 15' ' ' LEU . 67.1 p -110.92 -177.99 3.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.08 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -128.53 115.5 18.23 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.947 -0.471 . . . . 0.0 110.536 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 8.7 pt-20 -97.95 109.89 22.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 13' ' ' GLN . 6.4 p-10 -63.75 135.2 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.9 -112.22 3.23 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 120.089 -0.284 . . . . 0.0 113.127 -163.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -102.66 135.28 44.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.091 0.557 . . . . 0.0 109.68 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.4 m -100.98 99.11 9.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.58 -179.68 3.94 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.192 0.52 . . . . 0.0 110.62 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.587 ' HB2' HD21 ' A' ' 6' ' ' LEU . 27.4 m95 -73.85 146.3 44.23 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.341 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -157.67 166.46 32.76 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.909 0.884 . . . . 0.0 112.824 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 t -110.42 95.92 5.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 77' ' ' VAL . 3.5 p -96.7 90.49 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.971 0.891 . . . . 0.0 109.054 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.18 127.55 55.98 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.52 ' HG2' HG23 ' A' ' 59' ' ' VAL . 72.0 mtp -67.16 137.77 56.52 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.27 159.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.597 0.759 . . . . 0.0 111.857 -173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 m -82.5 168.61 17.23 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.396 0.678 . . . . 0.0 110.345 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.3 p -63.56 -21.56 66.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.513 0.725 . . . . 0.0 111.773 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.28 14.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.694 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.23 -46.25 91.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 111.372 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.36 61.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.61 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.62 -47.39 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.891 0.876 . . . . 0.0 111.896 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -75.69 -32.59 60.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.872 0.869 . . . . 0.0 111.14 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.0 t -74.55 -45.6 44.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.866 0.467 . . . . 0.0 111.285 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.73 -75.86 0.22 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.613 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.81 13.64 0.91 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.011 0.525 . . . . 0.0 112.352 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.76 -63.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.67 149.94 31.08 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.06 20.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.443 0.697 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mt -78.29 156.79 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.965 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.93 -10.2 68.15 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 HG21 HD11 ' A' ' 90' ' ' ILE . 86.8 m -65.2 152.21 44.21 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.536 1.134 . . . . 0.0 109.784 171.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.52 HG23 ' HG2' ' A' ' 41' ' ' MET . 41.9 t -125.46 125.9 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.954 0.901 . . . . 0.0 109.438 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -96.97 133.24 41.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 109.265 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 67.7 mt -133.21 107.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.536 0.734 . . . . 0.0 109.177 -169.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -95.35 119.89 34.63 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.621 0.768 . . . . 0.0 110.743 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.21 166.11 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.892 0.877 . . . . 0.0 108.733 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.44 ' H ' HD23 ' A' ' 6' ' ' LEU . 31.5 mmm180 -56.72 157.47 5.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.789 0.435 . . . . 0.0 110.612 166.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.85 95.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 69' ' ' ILE . 28.7 ttt85 -110.16 116.72 32.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.346 -177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -78.71 1.17 23.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.763 1.225 . . . . 0.0 111.679 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -92.51 -19.43 21.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.425 1.09 . . . . 0.0 110.535 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.463 HD11 ' HD3' ' A' ' 66' ' ' ARG . 16.6 mm -79.91 134.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.957 0.503 . . . . 0.0 110.582 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -129.42 166.12 20.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.99 67.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.033 0.533 . . . . 0.0 110.955 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.1 p -82.58 19.43 1.29 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.654 0.781 . . . . 0.0 111.824 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -107.37 142.32 37.36 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.787 0.835 . . . . 0.0 108.842 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -107.58 133.35 52.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 61' ' ' ILE . 37.7 mm -94.49 91.7 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.112 0.482 . . . . 0.0 110.139 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 26.8 ttpp -86.99 106.3 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 87' ' ' LEU . 99.1 t -78.8 130.35 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.116 0.566 . . . . 0.0 111.281 -169.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.5 m -89.81 -19.67 24.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.977 0.911 . . . . 0.0 113.048 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.6 p -135.0 -177.13 4.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.172 0.589 . . . . 0.0 110.92 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.12 -151.59 51.97 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.956 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.83 -12.89 13.29 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.177 2.585 . . . . 0.0 113.349 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.07 23.35 13.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.577 0.751 . . . . 0.0 110.737 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.7 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.406 0.682 . . . . 0.0 110.734 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.16 6.89 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.727 0.679 . . . . 0.0 112.13 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -71.06 139.36 50.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.059 0.544 . . . . 0.0 110.193 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.2 p -104.89 90.65 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.497 1.142 . . . . 0.0 108.927 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.1 mm? -70.76 149.26 47.07 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.861 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -122.11 137.93 54.64 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.27 95.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -173.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 58' ' ' THR . 25.3 pt -80.63 63.72 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 122.333 1.063 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.18 -118.27 0.82 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' H ' HD22 ' A' ' 105' ' ' LEU . 9.9 pt20 -162.74 142.43 7.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.64 0.776 . . . . 0.0 109.42 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.84 116.06 3.1 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.989 2.46 . . . . 0.0 110.751 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.94 108.15 38.96 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.809 0.843 . . . . 0.0 109.767 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.05 135.82 19.48 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.359 2.04 . . . . 0.0 110.129 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.0 174.07 9.12 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.57 62.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.652 0.781 . . . . 0.0 113.031 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.45 27.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.492 0.317 . . . . 0.0 111.258 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 62.06 30.49 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.232 1.013 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.1 t -86.13 -16.2 38.68 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.843 0.857 . . . . 0.0 110.933 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -152.12 166.45 31.63 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.675 0.75 . . . . 0.0 110.349 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 107.8 12.84 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -87.09 101.5 13.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.302 0.641 . . . . 0.0 109.448 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.5 mm -83.92 145.72 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.97 0.908 . . . . 0.0 108.788 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.4 pt? -122.78 143.07 50.07 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 72.2 m -151.53 176.09 11.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.705 0.802 . . . . 0.0 110.64 -170.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -161.11 155.35 22.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.373 0.669 . . . . 0.0 109.448 167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.34 144.89 28.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.183 0.993 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.04 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.023 173.411 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 121.403 0.62 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -98.96 -36.92 9.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.785 1.234 . . . . 0.0 112.369 -171.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -96.6 -167.6 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.775 1.23 . . . . 0.0 108.861 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 34' ' ' THR . 49.3 mtm180 -148.91 146.46 27.9 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 0.0 110.418 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.3 151.27 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.841 0.856 . . . . 0.0 109.044 175.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -102.45 122.95 45.33 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.8 116.96 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.792 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -83.36 99.94 10.36 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.441 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 2.4 p -82.28 141.28 33.06 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.989 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.3 tp -110.27 113.77 26.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.513 0.725 . . . . 0.0 109.386 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 3.2 ttmp? -102.35 114.46 28.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.722 0.409 . . . . 0.0 110.212 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 41.8 mt-30 -75.51 90.3 2.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -91.54 110.23 21.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 109.703 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -71.24 158.59 36.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.534 0.334 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.92 164.41 13.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.428 0.691 . . . . 0.0 109.703 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.81 -11.23 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 125.068 1.347 . . . . 0.0 112.982 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 p -104.67 -23.99 13.01 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.84 44.67 1.74 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.94 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -106.41 149.91 26.55 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.33 101.69 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.906 0.483 . . . . 0.0 110.025 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.93 90.96 7.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.991 0.916 . . . . 0.0 108.96 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.553 ' HB3' HD11 ' A' ' 15' ' ' LEU . 42.4 mt-10 -79.34 121.04 24.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -137.98 141.85 40.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.587 1.155 . . . . 0.0 109.824 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -101.5 103.55 14.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.078 0.951 . . . . 0.0 109.088 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 7.6 pt-20 -88.44 125.73 34.88 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.247 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.83 113.36 7.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.706 1.202 . . . . 0.0 108.397 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.35 -109.45 2.86 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.319 -157.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -117.09 139.0 51.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.394 0.678 . . . . 0.0 110.215 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.7 m -101.45 98.44 8.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 109.74 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.457 HD11 HD12 ' A' ' 63' ' ' ILE . 1.3 pt? -106.69 163.73 12.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.952 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -59.49 123.31 16.43 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.113 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HB2' HD11 ' A' ' 10' ' ' ILE . . . -136.83 176.44 8.7 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.203 1.001 . . . . 0.0 110.933 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -136.94 107.55 6.54 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG11 HG23 ' A' ' 77' ' ' VAL . 66.5 t -105.29 131.6 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.65 0.78 . . . . 0.0 109.307 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.29 159.58 44.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 167.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.435 ' SD ' HG22 ' A' ' 59' ' ' VAL . 19.8 mmt -67.76 148.22 51.55 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.19 145.23 13.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 O-C-N 123.746 0.654 . . . . 0.0 110.151 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 47.4 t -74.35 163.27 28.0 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.955 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 p -61.21 -31.5 71.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.501 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 16.9 ptpt -62.17 -33.5 74.64 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.469 0.707 . . . . 0.0 111.492 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.75 -50.84 14.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.558 0.743 . . . . 0.0 110.258 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.95 40.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.437 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.2 mt -66.43 -27.32 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.773 0.829 . . . . 0.0 111.982 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -59.24 -49.36 78.14 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.787 0.435 . . . . 0.0 110.572 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 83.9 p -79.78 -12.29 59.79 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.151 0.58 . . . . 0.0 111.564 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -77.5 2.04 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.89 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.103 0.561 . . . . 0.0 111.847 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 32.6 mt-10 -78.36 -69.54 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.94 141.91 31.81 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -139.75 156.91 46.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.96 0.504 . . . . 0.0 110.212 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.59 125.55 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.07 -12.58 12.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -163.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 m -77.77 154.61 31.8 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 156.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.435 HG22 ' SD ' ' A' ' 41' ' ' MET . 40.5 t -124.53 128.04 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.841 0.857 . . . . 0.0 111.033 -170.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -98.2 128.86 44.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.335 0.654 . . . . 0.0 109.519 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.551 HD12 HG22 ' A' ' 75' ' ' ILE . 65.7 mt -135.0 143.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.141 0.976 . . . . 0.0 108.494 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.415 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 60.1 m95 -134.92 121.67 20.86 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 35' ' ' LEU . 44.6 pt -121.41 168.75 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.414 0.686 . . . . 0.0 109.977 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -47.42 146.75 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.595 0.758 . . . . 0.0 112.748 165.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -67.35 108.95 2.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.358 0.663 . . . . 0.0 110.287 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.407 ' NE ' HD12 ' A' ' 35' ' ' LEU . 9.9 ptp180 -149.21 125.63 10.91 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.059 0.544 . . . . 0.0 110.327 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -84.09 12.35 6.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.394 1.078 . . . . 0.0 111.408 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.28 -18.31 28.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.405 1.082 . . . . 0.0 110.004 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.4 HG13 HD13 ' A' ' 63' ' ' ILE . 21.6 mm -74.55 138.69 20.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 159.68 34.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 92' ' ' GLN . . . -66.14 -20.67 66.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.594 0.358 . . . . 0.0 111.808 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -92.06 28.23 1.93 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -107.34 161.74 14.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 86' ' ' VAL . 51.3 mtp180 -125.04 128.55 48.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.551 HG22 HD12 ' A' ' 61' ' ' ILE . 44.5 mm -88.4 96.52 6.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.721 0.808 . . . . 0.0 109.454 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -94.76 109.39 21.35 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.444 HG21 HD23 ' A' ' 87' ' ' LEU . 61.5 t -74.99 124.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.381 0.672 . . . . 0.0 110.789 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 t -83.52 -25.66 30.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.71 0.804 . . . . 0.0 111.342 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.1 t -163.37 132.53 4.02 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.59 -163.7 30.43 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.93 -14.24 29.36 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.778 2.319 . . . . 0.0 112.028 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.1 mt -123.06 32.28 5.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.285 1.034 . . . . 0.0 110.01 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.73 25.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.45 0.7 . . . . 0.0 110.659 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.62 12.29 72.63 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.588 0.555 . . . . 0.0 113.085 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -119.9 148.18 43.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.348 0.659 . . . . 0.0 109.44 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.517 HG23 HH21 ' A' ' 74' ' ' ARG . 5.1 p -111.17 97.9 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 122.624 1.202 . . . . 0.0 110.93 -173.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD23 HG21 ' A' ' 77' ' ' VAL . 1.8 mm? -86.38 142.43 28.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.387 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.59 143.32 32.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.363 1.065 . . . . 0.0 108.763 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.29 129.62 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 pt -113.07 132.73 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.893 0.877 . . . . 0.0 109.27 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.76 -84.38 1.41 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 pt20 -169.34 158.13 7.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.683 0.793 . . . . 0.0 110.512 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.24 148.87 27.51 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.05 1.833 . . . . 0.0 110.334 159.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.18 125.05 5.08 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 152.55 40.12 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.443 2.096 . . . . 0.0 112.194 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.73 178.02 3.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 122.289 -0.257 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.87 -36.42 83.25 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.767 0.827 . . . . 0.0 112.523 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.76 -13.29 34.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.119 0.568 . . . . 0.0 111.958 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 62.45 34.47 15.43 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.628 1.171 . . . . 0.0 111.408 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -98.33 0.33 45.31 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.747 0.819 . . . . 0.0 110.817 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 5.4 ptp180 -169.51 -177.77 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.95 0.9 . . . . 0.0 109.242 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.07 112.64 16.09 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.91 119.6 17.37 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.532 HG22 ' SG ' ' A' ' 106' ' ' CYS . 25.8 mm -109.8 118.83 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.45 ' H ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -98.65 133.47 42.95 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.532 ' SG ' HG22 ' A' ' 104' ' ' ILE . 85.3 m -144.98 173.68 11.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.036 -170.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -150.03 162.89 39.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -45.59 143.79 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.044 0.537 . . . . 0.0 111.099 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.255 0 O-C-N 123.136 0.273 . . . . 0.0 113.14 -171.014 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -83.22 -39.55 20.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.061 0.944 . . . . 0.0 112.218 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.63 -171.35 1.82 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.557 1.543 . . . . 0.0 109.905 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -143.85 147.35 33.94 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.616 1.166 . . . . 0.0 110.214 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.04 154.7 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.421 1.089 . . . . 0.0 109.576 177.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -108.56 125.37 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.197 0.999 . . . . 0.0 108.47 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.53 125.92 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 123.395 0.435 . . . . 0.0 110.373 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -88.07 100.28 12.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.096 0.958 . . . . 0.0 108.68 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.525 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 22.9 p -83.63 143.84 29.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.818 172.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.578 HD13 ' HB3' ' A' ' 27' ' ' GLU . 57.7 tp -90.7 107.7 19.34 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.672 0.389 . . . . 0.0 110.627 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.53 97.06 8.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.545 0.738 . . . . 0.0 109.375 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.23 90.75 2.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -89.94 161.14 16.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.213 1.005 . . . . 0.0 109.389 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -125.97 154.54 42.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.13 -0.356 . . . . 0.0 110.577 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -104.64 160.06 15.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.78 1.232 . . . . 0.0 108.64 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.31 -11.37 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -108.7 -0.51 20.03 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.682 0.753 . . . . 0.0 109.261 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 28.58 9.09 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.249 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -92.75 134.78 34.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.1 mm -91.07 118.14 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.83 17.51 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB3' HD13 ' A' ' 15' ' ' LEU . 1.9 mp0 -78.78 114.94 18.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -130.22 152.48 49.6 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.128 0.971 . . . . 0.0 108.385 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -106.59 103.86 13.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 6.4 pt-20 -87.34 128.71 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.09 145.56 55.2 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -106.93 2.56 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -115.2 135.21 54.42 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.073 0.949 . . . . 0.0 108.683 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.4 m -94.26 95.8 9.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -111.34 169.49 8.76 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.45 0.643 . . . . 0.0 111.447 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -71.12 130.37 41.32 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.739 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 10' ' ' ILE . . . -136.84 176.72 8.46 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.495 175.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 55.4 m -130.58 98.99 4.82 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.61 102.6 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.497 0.719 . . . . 0.0 109.07 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.15 106.42 14.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.054 0.942 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.697 ' SD ' HG21 ' A' ' 59' ' ' VAL . 86.6 mmm -60.19 117.94 5.76 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 m -70.63 155.58 7.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 121.118 0.485 . . . . 0.0 110.668 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.503 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t -85.22 176.98 8.02 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.458 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.73 -28.73 66.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.055 0.942 . . . . 0.0 111.909 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 20.4 ptmt -49.33 -42.75 42.61 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.798 1.239 . . . . 0.0 113.463 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.52 -41.16 93.45 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.295 0.638 . . . . 0.0 111.052 -176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.19 74.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.758 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.1 mt -60.51 -43.31 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.68 0.792 . . . . 0.0 111.26 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.5 m -69.72 -33.8 72.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.391 0.676 . . . . 0.0 111.994 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 77.8 p -82.09 -30.25 31.34 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.635 0.374 . . . . 0.0 111.046 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.82 -66.03 0.24 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.044 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 15.04 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.299 1.04 . . . . 0.0 110.59 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.1 tt0 -86.13 -53.75 4.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.601 0.76 . . . . 0.0 109.584 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.53 160.8 20.42 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.88 154.82 40.48 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.751 0.82 . . . . 0.0 110.153 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.83 108.28 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.52 10.92 20.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.497 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.9 m -64.71 122.18 16.26 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.697 HG21 ' SD ' ' A' ' 41' ' ' MET . 24.8 t -86.95 105.6 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.778 0.831 . . . . 0.0 110.026 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -90.74 133.37 35.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 75' ' ' ILE . 79.6 mt -135.79 117.46 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.134 0.974 . . . . 0.0 108.895 -169.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 79.3 m95 -102.73 119.12 38.27 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 122.888 0.475 . . . . 0.0 109.909 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 pt -124.22 155.76 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -59.17 163.64 3.61 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.25 0.477 . . . . 0.0 111.396 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.462 ' HA ' HD12 ' A' ' 102' ' ' LEU . 42.5 t80 -55.8 100.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.755 0.822 . . . . 0.0 111.203 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -118.93 106.28 12.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -68.03 -24.08 65.06 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.389 1.076 . . . . 0.0 113.28 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.25 -18.64 23.14 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.624 0.769 . . . . 0.0 112.325 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -67.18 132.63 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -154.17 173.6 15.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -26.39 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.505 0.722 . . . . 0.0 112.329 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.7 p -80.09 9.91 4.99 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.282 1.033 . . . . 0.0 113.341 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.0 p -117.55 156.94 27.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.257 0.623 . . . . 0.0 109.503 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -112.95 155.0 25.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 61' ' ' ILE . 21.3 mm -116.82 103.21 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.26 0.624 . . . . 0.0 109.864 -177.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.2 ttpt -94.15 109.5 21.28 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.491 HG22 HD22 ' A' ' 87' ' ' LEU . 95.8 t -73.23 126.85 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 O-C-N 123.622 0.576 . . . . 0.0 110.516 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.4 m -79.67 -25.17 41.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.292 1.037 . . . . 0.0 113.287 -171.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -152.53 178.47 9.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.71 -146.64 30.07 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.42 -0.655 . . . . 0.0 113.052 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.64 -22.47 13.69 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.262 2.642 . . . . 0.0 113.289 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.624 HD13 ' SD ' ' A' ' 41' ' ' MET . 92.5 mt -115.71 31.29 6.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.881 0.473 . . . . 0.0 110.927 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.72 94.71 0.31 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.476 0.71 . . . . 0.0 110.895 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.0 -17.81 8.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.739 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -79.23 129.57 34.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.374 0.67 . . . . 0.0 109.722 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -102.36 80.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 122.648 1.214 . . . . 0.0 109.152 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 77' ' ' VAL . 2.0 mm? -65.78 153.52 41.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.184 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -120.43 139.1 53.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.438 HG12 ' SG ' ' A' ' 106' ' ' CYS . 62.7 mt -80.78 104.07 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -172.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 pt -83.1 16.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.002 0.921 . . . . 0.0 112.36 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.57 -141.85 3.23 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -128.89 134.81 26.73 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.546 ' HB2' HD22 ' A' ' 102' ' ' LEU . 67.1 Cg_endo -68.36 146.13 67.85 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.905 2.403 . . . . 0.0 111.52 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 120.41 5.01 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 40.3 Cg_endo -66.65 157.43 60.94 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.555 . . . . 0.0 113.743 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.56 179.73 3.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.25 69.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.872 0.869 . . . . 0.0 112.623 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.6 -11.26 29.74 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.36 0.664 . . . . 0.0 112.463 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.2 20.02 8.97 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.958 0.903 . . . . 0.0 111.938 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -74.82 -18.02 60.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.411 0.684 . . . . 0.0 111.842 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.18 153.27 5.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.618 0.767 . . . . 0.0 110.764 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 93' ' ' PRO . 8.1 mp -102.82 133.95 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.131 0.973 . . . . 0.0 109.718 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.37 116.54 23.76 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 12.4 mm -98.95 131.81 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 173.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -106.77 136.83 45.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.438 ' SG ' HG12 ' A' ' 89' ' ' ILE . 83.9 m -148.73 172.92 13.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.4 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -163.6 154.38 16.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -74.19 131.17 41.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 179.725 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -136.13 -28.91 1.03 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.22 0.608 . . . . 0.0 112.438 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 79' ' ' THR . 70.0 m-20 -107.14 -171.26 1.85 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.45 1.5 . . . . 0.0 110.419 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -141.11 147.14 38.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.315 1.046 . . . . 0.0 108.975 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.88 155.61 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.233 0.613 . . . . 0.0 109.791 173.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 m -113.18 124.99 53.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.364 0.666 . . . . 0.0 109.628 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.53 108.86 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.637 1.175 . . . . 0.0 110.596 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.6 mp0 -80.74 98.3 7.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.045 0.926 . . . . 0.0 108.979 172.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.439 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 5.0 m -79.8 145.23 32.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.987 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 27' ' ' GLU . 50.2 tp -97.38 99.79 11.22 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.92 -0.487 . . . . 0.0 109.817 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HG2' ' HG1' ' A' ' 18' ' ' THR . 64.3 tttp -83.44 105.66 14.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.218 0.607 . . . . 0.0 109.876 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.571 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 50.3 mt-30 -88.31 89.06 7.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.55 ' HG1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m -94.04 135.12 35.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.099 0.96 . . . . 0.0 110.0 -173.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 4.7 ttp180 -74.47 148.41 41.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB2' HD11 ' A' ' 26' ' ' LEU . 20.5 t70 -96.58 163.81 12.87 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.12 -11.05 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -99.24 -4.2 32.5 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.446 -0.784 . . . . 0.0 109.643 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.73 44.51 6.79 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.821 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.6 mt-10 -103.37 173.58 6.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.719 0.807 . . . . 0.0 109.736 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.61 103.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.341 0.656 . . . . 0.0 109.308 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 20' ' ' ASP . 8.8 mp -94.61 108.94 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.833 1.253 . . . . 0.0 109.31 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 41.9 mt-10 -79.88 117.0 20.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 p -131.91 157.4 44.08 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.359 1.063 . . . . 0.0 109.422 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -103.83 101.5 11.32 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.439 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 6.3 pt-20 -83.37 123.01 29.23 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.32 115.43 10.47 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.66 -119.77 4.32 Favored Glycine 0 N--CA 1.474 1.192 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.876 -160.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.97 159.76 28.61 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.554 0.742 . . . . 0.0 110.478 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 47.0 m -138.07 95.97 3.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 169.79 8.58 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.933 -174.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -67.85 131.42 45.49 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.425 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -140.82 178.28 7.45 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.99 0.916 . . . . 0.0 111.363 176.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -140.73 105.18 4.87 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.84 114.63 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -133.01 124.59 27.97 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 73.3 mtp -67.78 134.56 51.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.19 152.3 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.552 0.341 . . . . 0.0 110.203 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t -97.91 -175.43 3.15 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 56' ' ' ILE . 14.2 p -55.93 -30.55 61.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.284 1.033 . . . . 0.0 112.936 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -50.14 -48.17 53.79 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.648 1.179 . . . . 0.0 112.716 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.16 -36.65 72.1 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.05 96.57 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.004 0.815 . . . . 0.0 110.519 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.48 -46.78 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.433 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -71.67 -24.15 61.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.417 0.687 . . . . 0.0 112.399 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 31.8 m -101.84 -5.4 24.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.218 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.07 -90.07 0.79 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.019 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.99 -11.68 10.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 110.803 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 10.0 tp10 -64.43 -59.82 3.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 110.288 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 58' ' ' THR . 61.2 mt -93.88 162.07 14.06 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.92 166.19 25.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 110.315 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 44' ' ' SER . 59.6 mt -71.12 111.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.12 -10.38 17.72 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-O 120.218 -0.212 . . . . 0.0 112.626 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.651 HG21 HD23 ' A' ' 54' ' ' LEU . 24.5 m -61.6 137.75 58.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.304 0.642 . . . . 0.0 109.53 169.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.9 t -105.33 127.46 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 109.867 -177.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -109.32 144.32 37.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.41 0.624 . . . . 0.0 109.909 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 75' ' ' ILE . 41.0 mt -135.69 107.35 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -167.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -96.06 114.4 26.11 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 37' ' ' ALA . 44.5 pt -116.37 155.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.492 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 1.6 tmt_? -55.83 143.98 29.42 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 57.0 t80 -45.16 124.68 4.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 111.666 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.411 ' H ' HD21 ' A' ' 102' ' ' LEU . 5.7 tpm_? -151.26 116.01 5.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.51 0.724 . . . . 0.0 109.54 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.412 ' HE3' ' HE2' ' A' ' 65' ' ' TYR . 91.0 mttt -84.8 8.59 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.194 0.998 . . . . 0.0 111.577 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.98 -24.11 17.78 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.511 1.124 . . . . 0.0 111.567 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.88 126.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.716 0.406 . . . . 0.0 111.287 -170.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.89 157.96 30.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.84 -13.53 60.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.428 0.691 . . . . 0.0 112.68 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 p -77.05 -24.14 51.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.804 0.441 . . . . 0.0 110.964 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -73.19 155.21 39.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.316 0.647 . . . . 0.0 110.627 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 75.9 mtm180 -113.5 162.81 15.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 172.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.4 mp -112.17 126.97 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.052 1.341 . . . . 0.0 108.177 171.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -118.86 116.14 25.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.45 110.25 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 123.556 0.535 . . . . 0.0 110.998 -170.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 10' ' ' ILE . 31.8 t -70.5 -27.2 64.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.593 1.157 . . . . 0.0 111.265 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.426 ' O ' ' HB3' ' A' ' 8' ' ' ASP . 12.8 t -166.45 137.96 3.56 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.59 -162.45 30.73 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 119.771 -0.46 . . . . 0.0 112.294 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.33 -14.17 18.45 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.11 2.54 . . . . 0.0 111.765 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -124.81 32.86 5.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.441 1.096 . . . . 0.0 109.162 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.32 102.22 0.21 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.739 0.815 . . . . 0.0 111.507 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.85 0.24 15.09 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 119.859 -0.411 . . . . 0.0 113.147 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -106.64 160.47 15.43 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.582 0.753 . . . . 0.0 110.077 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.25 100.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.947 1.356 . . . . 0.0 111.168 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.93 124.5 34.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.269 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -97.6 142.32 29.55 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.324 1.05 . . . . 0.0 108.334 177.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.07 117.45 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.26 71.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 121.98 0.895 . . . . 0.0 109.852 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.53 -114.24 0.63 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.174 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' H ' HD23 ' A' ' 105' ' ' LEU . 12.5 pt20 -166.81 142.79 3.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.73 0.812 . . . . 0.0 109.438 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HB2' HD11 ' A' ' 102' ' ' LEU . 37.1 Cg_endo -60.28 120.74 8.68 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.791 2.328 . . . . 0.0 112.145 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.93 108.62 55.47 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.336 1.055 . . . . 0.0 108.965 -170.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 153.73 53.62 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.797 2.331 . . . . 0.0 113.082 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 6.8 p-10 -84.33 172.45 11.79 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 0.0 110.462 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.13 75.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.893 0.877 . . . . 0.0 112.249 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.04 -9.35 59.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.931 0.492 . . . . 0.0 111.65 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 25.2 mmt180 60.58 28.64 18.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.132 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -101.16 -5.44 25.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.845 0.858 . . . . 0.0 110.739 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.03 155.58 25.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.312 0.577 . . . . 0.0 110.903 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 93' ' ' PRO . 3.3 mm? -108.83 113.07 25.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -77.07 107.06 9.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.493 HG23 ' SG ' ' A' ' 106' ' ' CYS . 20.1 mm -96.55 134.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.578 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.9 pt? -111.25 130.6 55.61 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' A' ' 104' ' ' ILE . 71.9 m -153.77 176.68 11.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -167.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ptm85 -160.27 163.58 33.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.9 145.49 45.65 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.294 0.371 . . . . 0.0 110.874 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.262 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.496 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 1.7 mm? . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -97.9 -41.96 7.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.401 1.081 . . . . 0.0 111.276 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -102.61 -167.17 1.36 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.295 1.438 . . . . 0.0 110.238 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -146.38 150.8 36.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.857 1.263 . . . . 0.0 109.055 171.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.93 145.36 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.332 0.653 . . . . 0.0 109.698 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 31' ' ' ASP . 3.2 m -90.61 124.6 35.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 167.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.8 mm -71.14 107.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -78.84 95.35 5.36 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.624 1.202 . . . . 0.0 108.26 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -81.58 142.54 32.71 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.455 -2.157 . . . . 0.0 109.641 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 27' ' ' GLU . 37.5 tp -98.5 104.49 16.53 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -96.25 123.9 40.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -102.85 102.41 12.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -110.82 121.18 44.7 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.377 1.071 . . . . 0.0 109.164 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -69.11 164.93 21.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.311 0.644 . . . . 0.0 110.979 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -113.51 165.71 12.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.43 3.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 C-N-CA 124.563 1.145 . . . . 0.0 113.616 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.1 p -100.72 -11.76 19.68 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.14 -0.975 . . . . 0.0 109.765 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.7 30.4 15.5 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.859 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -104.82 135.32 46.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.83 0.852 . . . . 0.0 108.908 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.76 112.5 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.101 0.41 . . . . 0.0 110.013 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.06 117.22 30.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HB3' HD13 ' A' ' 15' ' ' LEU . 47.5 mt-10 -84.52 118.63 24.43 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.422 0.689 . . . . 0.0 109.311 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.1 p -129.82 151.21 50.65 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 0.0 109.933 -175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -110.31 104.17 12.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.679 0.792 . . . . 0.0 110.193 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.57 152.83 20.12 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.857 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HB2' HG22 ' A' ' 11' ' ' THR . 5.2 p-10 -85.26 131.8 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.7 -113.71 3.86 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -170.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -112.09 135.27 52.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.508 0.723 . . . . 0.0 109.722 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.3 m -98.74 106.64 18.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.474 0.709 . . . . 0.0 110.194 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 HD12 ' A' ' 63' ' ' ILE . 1.1 pt? -111.31 165.29 12.07 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.697 0.76 . . . . 0.0 112.242 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.524 ' HD1' ' HD2' ' A' ' 64' ' ' ARG . 51.6 m95 -56.98 122.45 12.33 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.324 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.567 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -133.04 176.64 8.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.238 1.015 . . . . 0.0 111.982 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.2 t -145.78 101.2 3.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 162.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 61' ' ' ILE . 53.1 t -96.29 113.09 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.672 0.789 . . . . 0.0 109.281 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -134.53 130.32 36.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.145 0.578 . . . . 0.0 109.874 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.676 ' SD ' HG23 ' A' ' 59' ' ' VAL . 77.9 mmm -62.74 131.28 48.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.681 . . . . 0.0 109.447 170.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 60' ' ' ARG . 8.0 m -71.13 152.36 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.269 0.356 . . . . 0.0 110.12 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.513 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.9 m -77.54 168.65 19.64 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.0 p -61.04 -20.82 63.0 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.447 0.699 . . . . 0.0 111.812 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 14.6 ptmm? -51.32 -35.63 38.96 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.163 1.385 . . . . 0.0 112.413 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -70.73 -41.26 72.09 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.416 0.447 . . . . 0.0 110.558 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.16 93.59 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.664 0.786 . . . . 0.0 110.415 175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.93 -43.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.221 1.008 . . . . 0.0 110.827 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 t -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.977 0.911 . . . . 0.0 111.121 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.583 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 81.8 p -89.6 -4.74 57.69 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.392 0.677 . . . . 0.0 111.229 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.37 -68.38 3.32 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.217 0.437 . . . . 0.0 112.064 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.54 16.97 0.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.794 0.838 . . . . 0.0 110.564 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.5 tp10 -79.25 -67.27 0.77 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.82 152.44 40.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.77 27.66 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.626 0.771 . . . . 0.0 109.882 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 mt -73.03 129.61 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.99 -9.55 15.76 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 106' ' ' CYS . 55.1 m -70.66 142.61 51.57 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.717 0.807 . . . . 0.0 109.027 169.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.676 HG23 ' SD ' ' A' ' 41' ' ' MET . 26.9 t -122.07 129.85 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.776 0.831 . . . . 0.0 109.612 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.495 ' HB2' HG12 ' A' ' 42' ' ' VAL . 8.5 ttt85 -103.64 126.22 50.64 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.573 HD12 HG21 ' A' ' 75' ' ' ILE . 30.4 mt -129.95 106.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.898 0.879 . . . . 0.0 108.756 -167.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -97.43 111.99 24.01 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.61 HD12 HD11 ' A' ' 35' ' ' LEU . 42.8 pt -122.19 153.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HD2' ' HD1' ' A' ' 36' ' ' TRP . 5.7 ptm180 -56.35 153.91 9.02 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 120.73 0.3 . . . . 0.0 111.399 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.69 134.35 55.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.366 0.666 . . . . 0.0 110.269 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -158.63 136.28 10.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.716 0.635 . . . . 0.0 110.066 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -83.3 -5.36 59.11 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.742 0.817 . . . . 0.0 112.486 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.49 -19.65 21.03 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.835 0.854 . . . . 0.0 111.204 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.5 mm -69.71 121.56 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.918 0.487 . . . . 0.0 110.259 -172.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.71 162.41 32.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 109.6 -172.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.34 69.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.708 0.803 . . . . 0.0 112.325 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -74.03 -17.56 60.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 0.0 111.779 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -96.76 105.08 17.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.006 0.922 . . . . 0.0 110.087 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -72.77 162.47 29.44 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.966 0.412 . . . . 0.0 111.441 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 61' ' ' ILE . 44.1 mm -106.23 102.97 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.707 0.803 . . . . 0.0 110.19 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -96.77 112.66 24.32 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.36 119.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.683 0.393 . . . . 0.0 111.605 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -77.7 -25.76 49.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.708 0.803 . . . . 0.0 111.998 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -168.39 135.36 2.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.579 0.751 . . . . 0.0 109.397 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.97 -164.91 28.19 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.616 -0.546 . . . . 0.0 112.228 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.78 -6.52 17.61 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.098 2.532 . . . . 0.0 112.593 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 87' ' ' LEU . 78.1 mt -130.37 26.92 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.226 1.01 . . . . 0.0 110.019 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 105.73 0.6 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.66 0.784 . . . . 0.0 111.552 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.89 -40.13 2.09 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.87 139.46 41.69 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.528 0.731 . . . . 0.0 110.364 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 t -106.59 110.77 32.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.385 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 82' ' ' LEU . 1.4 mm? -74.65 150.96 39.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.886 0.874 . . . . 0.0 110.365 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.47 ' OD1' ' HA3' ' A' ' 109' ' ' GLY . 9.0 m120 -114.09 135.81 53.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.393 1.077 . . . . 0.0 108.494 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.407 HG12 ' SG ' ' A' ' 106' ' ' CYS . 61.8 mt -82.54 121.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -172.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.451 HG22 ' HD2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -77.87 121.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.76 -87.61 0.36 Allowed Glycine 0 C--N 1.345 1.062 0 O-C-N 123.91 0.756 . . . . 0.0 112.735 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -166.37 150.13 6.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.858 1.263 . . . . 0.0 108.951 -175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.37 157.64 58.58 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.526 2.151 . . . . 0.0 112.159 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.25 109.55 19.61 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.316 0.647 . . . . 0.0 110.142 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.55 133.81 50.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.774 2.316 . . . . 0.0 110.496 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' O ' ' HD2' ' A' ' 99' ' ' ARG . 5.1 p-10 -64.95 173.99 2.1 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.707 0.403 . . . . 0.0 111.164 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.29 -35.6 67.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.032 0.933 . . . . 0.0 112.943 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.61 -13.24 40.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 112.105 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 96' ' ' ASP . 3.7 mpt_? 60.88 29.15 18.83 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.429 1.092 . . . . 0.0 110.767 -175.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -93.59 -0.86 56.03 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.985 0.914 . . . . 0.0 110.39 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 8.4 ptp85 -163.57 169.35 18.79 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.737 0.815 . . . . 0.0 110.092 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.23 109.23 19.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.83 1.252 . . . . 0.0 107.644 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.62 110.86 20.12 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 14.3 mm -98.42 116.17 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -89.27 134.79 33.91 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 104' ' ' ILE . 99.1 m -151.58 -179.38 7.36 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 109.494 -173.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -149.37 152.25 35.46 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 166.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.1 107.19 0.7 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.096 0.474 . . . . 0.0 111.365 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' ' OD1' ' A' ' 88' ' ' ASN . . . . . . . . 0 C--N 1.348 1.206 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.565 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 31.9 mt . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.999 0.428 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -100.13 -24.99 14.43 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.946 0.898 . . . . 0.0 111.784 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -108.01 -173.31 2.25 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.951 1.3 . . . . 0.0 109.626 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HG2' HG23 ' A' ' 34' ' ' THR . 51.0 ttp180 -148.09 131.86 16.98 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.584 HD13 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -129.99 153.32 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.6 0.76 . . . . 0.0 110.554 -175.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -103.04 124.64 48.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.221 1.008 . . . . 0.0 110.091 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.29 116.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 123.623 0.577 . . . . 0.0 109.946 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.693 1.197 . . . . 0.0 109.103 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -80.21 140.33 36.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.534 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 27' ' ' GLU . 33.2 tp -91.99 97.6 11.05 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -88.66 108.26 19.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.849 0.859 . . . . 0.0 109.56 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.578 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 48.4 mt-30 -91.58 101.31 13.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -109.58 122.3 47.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.667 0.787 . . . . 0.0 109.398 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -78.53 157.87 28.72 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.734 0.302 . . . . 0.0 110.294 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 22.7 t70 -103.51 168.73 8.97 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.617 0.767 . . . . 0.0 109.189 -172.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.48 -4.59 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 124.413 1.085 . . . . 0.0 112.666 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -110.98 -31.02 7.27 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.57 31.09 1.71 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.184 -1.371 . . . . 0.0 114.623 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 48.3 mm-40 -79.91 144.54 33.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 mm -95.89 101.77 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.6 90.93 6.86 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 44.3 mt-10 -79.68 105.56 11.07 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.9 p -123.93 155.11 38.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.334 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -109.45 96.71 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.48 130.63 35.59 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.21 127.53 32.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.48 -110.4 3.39 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -168.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.449 ' CD2' ' HB3' ' A' ' 35' ' ' LEU . 86.4 t60 -105.44 132.45 51.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 9' ' ' ARG . 36.5 m -104.58 95.17 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 2.4 pt? -108.44 170.1 8.23 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.591 0.71 . . . . 0.0 112.26 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 50.5 m95 -69.93 133.03 46.86 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.665 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.584 ' HB1' HD13 ' A' ' 10' ' ' ILE . . . -138.49 168.56 19.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.791 0.836 . . . . 0.0 112.175 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.9 t -120.98 94.06 4.22 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 162.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 61' ' ' ILE . 3.7 p -94.58 90.46 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 122.325 1.06 . . . . 0.0 108.978 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.3 118.51 36.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.444 -172.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.447 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.3 mtp -67.62 141.51 56.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.63 155.03 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.914 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.431 ' HB2' ' HG2' ' A' ' 46' ' ' GLU . 18.0 m -76.13 163.46 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.091 0.556 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -62.43 -35.64 79.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.316 0.647 . . . . 0.0 110.465 176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.25 -28.54 69.42 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.621 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 15.4 mm-40 -71.81 -41.42 68.27 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.371 0.419 . . . . 0.0 110.207 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.23 -52.34 65.7 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 124.184 0.928 . . . . 0.0 111.184 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.29 -48.24 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.272 1.029 . . . . 0.0 111.953 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.26 -30.62 65.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.558 0.743 . . . . 0.0 111.728 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 11.1 t -90.22 -8.59 50.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.587 0.755 . . . . 0.0 110.578 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.42 -102.36 1.18 Allowed Glycine 0 C--N 1.352 1.452 0 O-C-N 123.587 0.555 . . . . 0.0 112.787 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.09 -5.55 17.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.927 0.891 . . . . 0.0 111.789 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 10.3 tp10 -74.55 -75.42 0.16 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.754 0.422 . . . . 0.0 109.973 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.67 HD22 HG21 ' A' ' 58' ' ' THR . 64.7 mt -83.33 147.73 27.76 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.28 165.53 25.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.203 1.001 . . . . 0.0 109.048 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.13 117.06 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.66 -10.67 14.12 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.526 0.517 . . . . 0.0 112.101 -168.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.67 HG21 HD22 ' A' ' 54' ' ' LEU . 93.7 m -74.53 139.37 43.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.447 HG22 ' HG2' ' A' ' 41' ' ' MET . 44.7 t -126.29 132.47 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.592 0.757 . . . . 0.0 110.599 -173.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -99.65 141.06 32.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 50.9 mt -134.57 107.9 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -102.73 112.75 25.67 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.511 HG23 ' HB1' ' A' ' 37' ' ' ALA . 39.3 pt -123.93 166.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.147 0.579 . . . . 0.0 109.748 -173.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 21.5 mmt180 -53.07 137.99 32.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.273 0.488 . . . . 0.0 111.415 164.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HE1' ' HE3' ' A' ' 67' ' ' LYS . 28.3 t80 -55.87 116.69 3.1 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.175 0.99 . . . . 0.0 109.167 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -140.02 121.06 14.66 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HE3' ' HE1' ' A' ' 65' ' ' TYR . 32.7 mmtp -69.18 -10.1 56.11 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.825 1.25 . . . . 0.0 112.431 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.78 -19.23 22.8 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.619 0.767 . . . . 0.0 110.976 -173.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.8 119.93 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -116.88 168.59 10.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.989 0.916 . . . . 0.0 108.961 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.01 -24.67 66.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.786 . . . . 0.0 110.992 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -90.78 13.54 16.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.698 0.799 . . . . 0.0 111.67 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 100.33 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.929 0.892 . . . . 0.0 109.266 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HD2' ' ND2' ' A' ' 88' ' ' ASN . 49.1 mtm180 -72.23 165.5 24.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.685 0.755 . . . . 0.0 111.035 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.546 HG22 ' HB ' ' A' ' 10' ' ' ILE . 2.1 mp -115.6 130.28 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -125.32 113.87 18.16 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 82' ' ' LEU . 62.0 t -68.31 115.9 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.361 0.413 . . . . 0.0 111.626 -169.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.142 0.977 . . . . 0.0 111.813 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 9' ' ' ARG . 10.0 t -166.68 129.05 1.81 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.786 0.835 . . . . 0.0 109.499 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.67 -165.9 31.15 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.46 -0.633 . . . . 0.0 111.952 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.02 -15.01 35.97 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.829 2.352 . . . . 0.0 112.304 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.486 HD12 HD11 ' A' ' 87' ' ' LEU . 96.7 mt -122.78 35.01 4.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.061 0.945 . . . . 0.0 110.486 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.88 111.83 1.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.044 0.538 . . . . 0.0 110.42 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.82 -17.64 41.73 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.506 0.504 . . . . 0.0 113.229 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -83.96 132.3 34.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.81 0.844 . . . . 0.0 109.611 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.25 101.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 122.078 0.942 . . . . 0.0 110.54 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.486 HD11 HD12 ' A' ' 82' ' ' LEU . 1.2 mm? -81.57 124.41 29.5 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.327 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.425 ' ND2' ' HD2' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -99.7 141.51 32.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.529 1.132 . . . . 0.0 109.036 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.43 HG12 ' SG ' ' A' ' 106' ' ' CYS . 39.4 mt -78.19 128.63 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.1 68.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 122.0 0.905 . . . . 0.0 109.605 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.19 -122.88 1.53 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.691 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -140.6 146.5 45.06 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 108.679 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.29 102.11 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.181 1.92 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.74 112.74 34.41 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.908 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.92 137.21 44.12 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.435 2.09 . . . . 0.0 111.667 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 34.9 t70 -58.73 144.54 43.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.82 0.448 . . . . 0.0 111.494 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.04 63.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.025 0.93 . . . . 0.0 112.103 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.66 -5.18 46.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.202 0.601 . . . . 0.0 111.015 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.01 22.73 12.96 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 124.619 1.168 . . . . 0.0 112.107 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 75.1 p -85.83 -10.44 55.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.142 0.577 . . . . 0.0 110.766 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.474 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 7.8 ptp180 -163.71 -177.53 5.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.737 0.815 . . . . 0.0 110.742 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.58 115.84 18.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -82.29 102.31 11.1 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.547 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.7 mm -98.72 125.98 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.469 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.2 pt? -103.6 134.32 47.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.524 ' SG ' HD13 ' A' ' 61' ' ' ILE . 70.9 m -152.92 177.88 10.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.738 0.815 . . . . 0.0 110.217 -170.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -143.92 162.33 36.41 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.011 1.325 . . . . 0.0 107.974 169.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.01 122.01 12.67 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA3' ' ND2' ' A' ' 88' ' ' ASN . . . . . . . . 0 C--N 1.34 0.775 0 O-C-N 123.676 0.61 . . . . 0.0 113.807 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -64.83 105.62 1.04 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.896 0.379 . . . . 0.0 110.355 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -73.16 -10.43 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 124.217 1.007 . . . . 0.0 111.213 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.22 51.55 3.6 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 123.33 0.49 . . . . 0.0 113.009 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.86 170.29 16.47 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.811 0.844 . . . . 0.0 109.729 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -77.07 113.75 15.13 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.482 0.713 . . . . 0.0 109.731 -170.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -115.18 -32.56 5.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.671 0.788 . . . . 0.0 111.592 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.39 -168.21 1.33 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.999 1.32 . . . . 0.0 109.242 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HB2' HG23 ' A' ' 79' ' ' THR . 50.4 mtm180 -138.55 147.71 43.39 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.472 0.709 . . . . 0.0 110.135 171.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.509 ' HB ' HG23 ' A' ' 75' ' ' ILE . 32.9 pt -125.98 153.45 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.644 1.178 . . . . 0.0 109.794 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -115.63 124.17 50.24 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.03 111.45 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 124.013 0.82 . . . . 0.0 109.933 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -99.22 95.36 7.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.175 0.988 . . . . 0.0 108.44 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.573 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 5.7 p -82.9 145.29 29.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.199 -1.818 . . . . 0.0 107.622 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 tp -96.32 107.87 20.29 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.851 0.751 . . . . 0.0 109.015 -170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -85.28 104.24 14.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.199 1.0 . . . . 0.0 109.958 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 53.5 mt-30 -100.56 85.47 2.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 108.671 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -94.4 120.65 34.97 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.639 0.776 . . . . 0.0 109.669 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -71.91 170.56 13.48 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 122.849 0.459 . . . . 0.0 110.497 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 15.5 t70 -112.02 161.74 16.14 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.417 0.687 . . . . 0.0 109.564 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -70.86 13.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.486 1.114 . . . . 0.0 112.904 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -140.38 -34.33 0.53 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.97 0.56 Allowed Glycine 0 C--N 1.355 1.591 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.786 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 30.6 mt-10 -114.06 157.3 22.72 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.98 104.98 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.87 89.81 6.87 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 40.3 mt-10 -81.0 118.36 22.4 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.69 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.77 158.29 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 107.597 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -106.92 101.05 10.51 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.573 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 10.0 pt-20 -73.19 94.43 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.44 121.67 13.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.536 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.71 -111.0 2.55 Favored Glycine 0 C--N 1.344 0.972 0 C-N-CA 121.448 -0.406 . . . . 0.0 113.304 -154.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -98.56 130.82 45.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 51.1 m -105.75 97.58 7.38 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.68 171.61 7.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -59.78 124.43 20.13 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.753 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' A' ' 10' ' ' ILE . . . -140.29 170.97 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.696 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 t -133.29 101.44 5.18 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.416 HG11 HG12 ' A' ' 61' ' ' ILE . 31.7 t -93.91 95.54 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.755 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.68 122.29 41.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.489 ' HG2' HG22 ' A' ' 59' ' ' VAL . 87.6 mtp -67.93 156.54 36.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.655 0.264 . . . . 0.0 110.4 174.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.15 160.89 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.998 0.919 . . . . 0.0 111.511 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -93.08 178.52 5.72 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 160.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -65.57 -20.26 66.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.476 0.31 . . . . 0.0 110.81 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.592 ' HB2' ' HZ1' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -52.36 -60.84 2.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.187 . . . . 0.0 112.417 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.53 -18.37 57.04 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.69 -59.07 2.95 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.158 0.504 . . . . 0.0 109.928 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.2 mt -51.21 -38.59 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.998 1.319 . . . . 0.0 111.6 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -64.96 -46.27 82.24 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.404 0.682 . . . . 0.0 111.335 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 27.3 t -80.42 -4.68 54.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.927 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.55 -87.84 1.13 Allowed Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.63 11.01 1.85 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.414 0.686 . . . . 0.0 111.013 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 44.5 tt0 -76.92 -51.88 10.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 58' ' ' THR . 65.8 mt -91.77 163.42 14.07 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 160.68 37.24 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.3 113.7 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -6.32 20.61 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.42 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.416 HG22 HD13 ' A' ' 90' ' ' ILE . 42.1 m -55.72 131.46 46.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.198 0.599 . . . . 0.0 110.248 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.489 HG22 ' HG2' ' A' ' 41' ' ' MET . 61.8 t -96.23 113.92 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.291 0.637 . . . . 0.0 110.019 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -88.16 143.25 27.16 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.65 HD11 HG22 ' A' ' 75' ' ' ILE . 82.1 mt -139.95 108.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -99.39 116.84 32.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.665 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 10' ' ' ILE . 46.7 pt -128.98 160.28 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -57.3 157.69 6.17 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.724 0.238 . . . . 0.0 110.89 165.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -57.39 112.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.295 0.638 . . . . 0.0 111.395 -171.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HD3' HD13 ' A' ' 69' ' ' ILE . 26.6 ttt85 -139.22 103.7 4.82 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.504 0.722 . . . . 0.0 109.377 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -80.53 11.02 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.495 1.118 . . . . 0.0 112.006 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.02 -24.57 22.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.186 0.994 . . . . 0.0 109.916 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 104' ' ' ILE . 20.5 mm -69.55 131.63 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -120.48 161.15 21.75 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.71 -24.56 64.5 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.297 0.639 . . . . 0.0 111.858 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 p -81.33 -7.67 59.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.473 0.709 . . . . 0.0 111.74 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -78.5 157.97 28.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -116.49 148.98 40.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.671 0.788 . . . . 0.0 108.98 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 HD11 ' A' ' 61' ' ' ILE . 45.2 mm -112.48 117.19 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.816 0.446 . . . . 0.0 109.996 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 34.5 ttpt -104.86 125.66 51.12 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -78.32 103.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 110.042 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -67.69 -22.96 65.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.681 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 9' ' ' ARG . 11.7 t -171.5 135.28 0.9 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.887 0.875 . . . . 0.0 109.88 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.95 -159.29 28.09 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.478 -0.624 . . . . 0.0 112.956 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.64 -17.15 29.94 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.109 2.539 . . . . 0.0 112.23 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.72 36.73 4.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.419 1.087 . . . . 0.0 109.454 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.05 98.51 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.781 0.832 . . . . 0.0 111.596 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.83 -20.26 7.27 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.825 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.12 137.15 36.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.931 0.892 . . . . 0.0 110.818 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 12.1 t -104.15 106.91 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 156.7 21.67 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.976 173.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -117.52 144.14 45.38 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.0 mt -82.38 123.23 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 58' ' ' THR . 26.2 pt -105.24 139.22 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.578 0.751 . . . . 0.0 109.968 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -108.46 2.53 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.894 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.436 ' O ' HD22 ' A' ' 105' ' ' LEU . 12.5 pt20 -153.6 141.07 13.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.568 0.747 . . . . 0.0 109.855 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.62 102.11 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.273 1.982 . . . . 0.0 111.101 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.32 116.49 64.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.062 0.945 . . . . 0.0 109.434 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.87 136.58 33.05 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.628 2.219 . . . . 0.0 112.106 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.5 139.42 31.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.255 0.622 . . . . 0.0 110.775 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.88 80.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.108 0.963 . . . . 0.0 112.247 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.07 -3.46 58.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.221 0.609 . . . . 0.0 111.288 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? 66.51 22.37 10.63 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.438 1.095 . . . . 0.0 111.942 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.1 p -85.57 -13.28 49.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.266 0.626 . . . . 0.0 110.996 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -163.42 -172.15 2.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.928 0.491 . . . . 0.0 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD13 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -140.46 124.5 17.45 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -88.1 95.59 10.2 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 21.4 mm -87.06 120.48 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 92' ' ' GLN . 0.4 OUTLIER -108.98 142.25 39.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.485 ' SG ' HD12 ' A' ' 61' ' ' ILE . 72.2 m -150.93 172.93 14.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.754 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -143.95 158.47 43.68 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.73 127.09 30.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.441 0.463 . . . . 0.0 111.073 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.05 54.86 4.3 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.784 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.3 96.33 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.641 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.95 -1.9 56.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.887 0.875 . . . . 0.0 111.889 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--O 1.25 1.093 0 C-N-CA 123.171 0.589 . . . . 0.0 109.763 179.001 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -140.01 141.92 36.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.079 0.952 . . . . 0.0 109.324 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -30.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.854 0.862 . . . . 0.0 112.354 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.63 49.99 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -72.06 138.77 48.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.978 0.911 . . . . 0.0 110.858 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -81.14 105.33 12.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.807 0.443 . . . . 0.0 110.895 -168.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.18 -14.14 6.59 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.185 0.994 . . . . 0.0 112.319 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -102.15 -179.2 3.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.957 1.303 . . . . 0.0 109.268 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.427 ' HB3' HG21 ' A' ' 34' ' ' THR . 45.2 mtm180 -135.59 146.86 48.39 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.076 0.55 . . . . 0.0 109.98 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -138.92 144.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.944 0.898 . . . . 0.0 109.527 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -98.57 127.37 44.47 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.8 mm -80.64 106.97 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.452 0.701 . . . . 0.0 110.678 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' TRP . 27.9 mp0 -79.9 96.59 6.41 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.472 0.653 . . . . 0.0 109.93 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -81.25 136.22 35.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.708 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 27' ' ' GLU . 57.8 tp -78.42 98.97 6.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.07 0.462 . . . . 0.0 109.782 -173.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -74.92 93.93 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.027 0.931 . . . . 0.0 110.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 46.4 mt-30 -91.76 83.65 5.31 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -90.31 125.53 35.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.24 0.616 . . . . 0.0 110.404 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -78.22 152.06 32.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.671 0.389 . . . . 0.0 110.277 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 31.1 t70 -99.97 164.11 12.14 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.4 -10.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.472 1.109 . . . . 0.0 113.092 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -120.65 -6.45 9.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.455 -0.778 . . . . 0.0 109.496 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.17 48.04 1.64 Allowed Glycine 0 C--N 1.36 1.897 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 165.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 5.1 mp0 -106.14 148.15 28.18 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.53 100.83 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.64 101.25 13.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 0.0 108.65 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HB3' HD12 ' A' ' 15' ' ' LEU . 50.1 mt-10 -85.19 118.79 24.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.501 0.72 . . . . 0.0 110.202 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 ' O ' HD11 ' A' ' 15' ' ' LEU . 36.5 p -134.95 174.8 10.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . 85.0 m95 -117.5 107.83 14.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.0 146.43 23.94 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.9 141.39 53.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.911 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.96 -107.0 3.17 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -127.51 148.78 50.32 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.6 m -102.79 97.49 7.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.161 0.584 . . . . 0.0 109.465 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -113.01 171.99 7.21 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.251 0.62 . . . . 0.0 111.941 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -62.65 123.77 19.26 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.937 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -135.61 172.03 13.6 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.488 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 t -129.91 99.34 5.07 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 61' ' ' ILE . 21.8 t -88.7 92.44 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.4 0.619 . . . . 0.0 109.446 -174.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -96.03 106.07 18.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.741 0.816 . . . . 0.0 110.244 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.46 121.75 19.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 58' ' ' THR . 5.5 m -67.38 135.44 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -91.53 -177.03 4.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.461 0.705 . . . . 0.0 111.36 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 p -61.79 -41.21 97.43 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.495 0.718 . . . . 0.0 111.269 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -54.58 -43.58 72.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.118 0.967 . . . . 0.0 110.693 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.93 -52.23 66.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.648 0.593 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.77 -55.22 21.07 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.821 0.849 . . . . 0.0 112.712 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.034 0.934 . . . . 0.0 111.516 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.7 m -66.25 -41.05 90.52 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.452 0.701 . . . . 0.0 112.161 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 93.9 p -87.52 -5.24 58.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.106 0.562 . . . . 0.0 111.755 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.65 -71.95 1.5 Allowed Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.18 11.35 0.28 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.882 0.873 . . . . 0.0 110.897 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.1 tt0 -80.29 -27.2 38.58 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.087 0.555 . . . . 0.0 110.984 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -115.03 44.67 1.75 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.45 132.11 46.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.87 126.31 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 124.364 1.04 . . . . 0.0 110.85 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.58 -12.42 13.69 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -163.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.468 ' HB ' HG23 ' A' ' 42' ' ' VAL . 31.3 m -82.17 149.32 28.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.07 129.53 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -100.01 135.81 40.88 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 75' ' ' ILE . 71.1 mt -134.46 109.38 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.971 0.908 . . . . 0.0 109.002 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 30.0 m95 -90.95 116.79 29.02 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 37' ' ' ALA . 43.4 pt -121.32 163.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.67 138.73 58.04 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 164.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 2.6 t80 -53.04 126.58 21.06 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.36 1.064 . . . . 0.0 109.82 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -140.79 134.62 30.47 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.818 0.699 . . . . 0.0 109.252 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -82.16 1.79 34.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 111.581 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.16 -20.78 20.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.874 0.869 . . . . 0.0 111.201 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.466 HG21 HD12 ' A' ' 104' ' ' ILE . 23.4 mm -72.16 123.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.668 0.387 . . . . 0.0 110.481 -170.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -133.41 170.88 14.83 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 109.138 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.62 65.45 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.294 0.638 . . . . 0.0 111.433 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -94.19 39.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.819 0.848 . . . . 0.0 110.374 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 m -130.47 150.5 51.66 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.439 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 78.1 mtm180 -117.16 162.95 17.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.517 HG21 HG21 ' A' ' 61' ' ' ILE . 32.2 mm -127.58 97.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -73.68 118.09 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.873 0.469 . . . . 0.0 110.443 -174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 t -69.07 -36.56 77.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.76 0.824 . . . . 0.0 110.738 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' HB2' ' A' ' 9' ' ' ARG . 9.0 t -167.51 135.59 2.46 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.897 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.91 -158.33 27.83 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.861 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.76 -29.21 51.1 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.811 2.341 . . . . 0.0 112.062 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD11 HG11 ' A' ' 39' ' ' VAL . 66.6 mt -115.86 32.16 6.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 0.0 110.559 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.46 114.2 2.12 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.467 0.707 . . . . 0.0 111.349 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.59 -30.68 6.54 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.683 0.615 . . . . 0.0 112.69 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -72.7 142.64 48.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.405 0.682 . . . . 0.0 110.864 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.57 97.75 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-O 122.494 1.14 . . . . 0.0 109.985 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.9 114.66 21.83 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.701 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.508 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.07 135.56 34.79 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.135 0.974 . . . . 0.0 109.433 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.61 116.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.2 pt -98.88 132.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.294 0.637 . . . . 0.0 109.508 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.98 -120.88 5.58 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -171.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.4 ' O ' HD23 ' A' ' 105' ' ' LEU . 11.3 pt20 -147.25 147.59 29.13 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.056 0.943 . . . . 0.0 108.485 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.89 141.84 96.14 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.87 2.38 . . . . 0.0 112.718 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.86 108.92 53.12 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.65 156.17 62.72 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.356 2.037 . . . . 0.0 112.004 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.54 154.59 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.442 0.697 . . . . 0.0 112.34 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.21 91.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.927 0.891 . . . . 0.0 111.126 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.43 -8.44 54.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.19 0.596 . . . . 0.0 111.235 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.79 21.05 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.227 1.411 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -79.77 -3.11 46.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 18.6 ptp180 -167.17 -176.1 3.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.068 0.947 . . . . 0.0 109.141 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.478 HD13 HD11 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -132.18 117.27 18.05 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.66 111.8 21.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.536 HG23 ' SG ' ' A' ' 106' ' ' CYS . 21.9 mm -95.26 135.37 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -112.45 128.35 56.3 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 174.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' A' ' 104' ' ' ILE . 76.3 m -147.11 175.1 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.605 -168.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -139.64 158.02 44.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -52.53 151.93 3.92 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.015 0.526 . . . . 0.0 111.535 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 43.64 3.26 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.268 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.42 80.02 4.83 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.12 -11.82 61.13 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.085 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 C-N-CA 124.629 1.171 . . . . 0.0 108.157 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -93.22 106.22 18.21 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.466 0.706 . . . . 0.0 109.365 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.5 mt -87.02 72.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.757 0.823 . . . . 0.0 110.962 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.79 53.41 0.61 Allowed Glycine 0 N--CA 1.467 0.748 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.69 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.15 132.15 27.99 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.59 0.756 . . . . 0.0 110.82 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.02 89.84 3.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.732 0.645 . . . . 0.0 109.336 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -80.01 -43.62 21.62 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.934 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 79' ' ' THR . 53.5 m-20 -104.41 -161.15 0.8 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.688 1.595 . . . . 0.0 110.872 -170.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 53.9 ttt180 -159.0 137.06 10.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.116 0.966 . . . . 0.0 109.557 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -132.42 168.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 124.428 1.091 . . . . 0.0 110.446 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.9 m -115.92 138.91 50.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.798 1.239 . . . . 0.0 108.101 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.12 101.58 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.024 0.53 . . . . 0.0 110.495 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.515 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 19.6 mp0 -75.51 100.97 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.707 0.803 . . . . 0.0 110.265 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.8 p -79.06 147.95 32.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.107 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 27' ' ' GLU . 60.5 tp -98.03 107.63 20.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 3.0 ttmp? -99.07 120.57 39.69 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.588 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 89.2 mt-30 -82.57 93.7 7.36 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.406 ' HG1' ' HG2' ' A' ' 16' ' ' LYS . 31.6 m -92.05 114.36 26.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.582 0.753 . . . . 0.0 109.401 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttp85 -72.72 158.29 35.88 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -110.7 169.84 8.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 109.351 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.6 -8.42 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 124.331 1.052 . . . . 0.0 112.839 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 p -99.25 -9.27 23.87 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.612 0.72 . . . . 0.0 109.084 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.39 19.8 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.339 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.29 140.55 31.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.355 0.662 . . . . 0.0 109.421 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.511 HG21 ' HB3' ' A' ' 17' ' ' GLN . 40.0 mm -89.32 101.43 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.45 104.97 17.48 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 42.9 mt-10 -80.19 112.4 17.47 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -128.58 144.52 51.17 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.231 1.013 . . . . 0.0 110.609 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -103.28 100.22 10.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -98.0 135.3 39.9 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.689 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.06 142.98 55.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 -110.19 3.18 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -117.53 141.83 47.89 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 109.545 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.443 HG22 ' HG2' ' A' ' 9' ' ' ARG . 11.2 m -101.8 102.5 13.13 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.087 0.955 . . . . 0.0 109.531 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' H ' HD21 ' A' ' 35' ' ' LEU . 1.7 pt? -114.16 171.03 7.85 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.276 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -70.8 132.77 45.81 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.214 1.005 . . . . 0.0 111.945 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.627 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -135.8 -179.47 5.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.375 1.07 . . . . 0.0 110.867 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -139.06 102.29 4.49 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.92 106.27 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.396 1.078 . . . . 0.0 110.064 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -116.52 108.85 16.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 110.53 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 84.2 mtp -68.64 125.53 26.84 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.25 138.05 19.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 C-N-CA 123.766 0.826 . . . . 0.0 111.03 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -97.14 -177.86 3.99 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.469 ' HG ' HD11 ' A' ' 56' ' ' ILE . 13.9 m -58.66 -35.71 72.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.939 0.896 . . . . 0.0 111.794 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -52.62 -61.21 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.939 0.896 . . . . 0.0 112.233 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.49 -23.99 42.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.676 0.39 . . . . 0.0 111.578 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.38 18.22 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 120.954 0.407 . . . . 0.0 111.383 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.27 -37.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.03 0.932 . . . . 0.0 111.067 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -46.78 87.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.729 0.812 . . . . 0.0 111.115 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 79.4 p -82.38 -13.65 56.51 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.273 0.629 . . . . 0.0 111.348 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.24 -86.89 1.17 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.23 -1.59 5.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.817 0.847 . . . . 0.0 111.153 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.0 tt0 -65.58 -63.07 1.18 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.462 0.705 . . . . 0.0 109.774 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.29 138.15 31.69 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 165.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.2 144.69 51.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD11 ' HG ' ' A' ' 44' ' ' SER . 10.4 mt -62.81 113.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 118.113 0.415 . . . . 0.0 110.398 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.18 -10.75 14.89 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 123.04 0.352 . . . . 0.0 112.898 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -63.81 146.93 53.02 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.8 t -119.63 123.69 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.263 0.625 . . . . 0.0 110.63 -169.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -103.78 130.44 51.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.5 HG22 HG23 ' A' ' 75' ' ' ILE . 86.4 mt -134.2 113.04 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.393 0.677 . . . . 0.0 109.209 -166.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -102.05 115.27 30.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.619 0.768 . . . . 0.0 109.79 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 47.4 pt -121.32 163.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -60.51 157.08 14.87 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' N ' ' HA ' ' A' ' 101' ' ' ARG . 70.8 t80 -64.16 101.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.571 -172.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -119.9 118.83 31.77 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.8 -2.69 40.79 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.997 0.919 . . . . 0.0 110.932 -174.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -92.66 -21.12 20.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.288 0.635 . . . . 0.0 110.949 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.04 134.48 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.158 0.583 . . . . 0.0 110.632 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -131.0 171.68 12.94 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.2 67.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.567 0.747 . . . . 0.0 111.076 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.7 p -86.36 45.47 1.24 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.87 1.268 . . . . 0.0 110.554 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.0 m -141.49 122.65 14.72 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.412 1.085 . . . . 0.0 108.213 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -94.56 133.09 38.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.5 HG23 HG22 ' A' ' 61' ' ' ILE . 22.7 mm -95.99 94.0 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.867 0.867 . . . . 0.0 109.932 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HE2' ' NE2' ' A' ' 13' ' ' GLN . 40.1 ttpt -94.6 111.62 23.38 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG21 HD23 ' A' ' 87' ' ' LEU . 49.8 t -70.65 128.75 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 110.477 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -93.23 -29.63 15.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.924 0.89 . . . . 0.0 110.364 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' A' ' 9' ' ' ARG . 54.4 m -151.93 110.49 3.79 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.467 -166.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.74 29.73 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.556 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -16.18 45.72 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 HD13 ' A' ' 87' ' ' LEU . 83.6 mt -127.36 34.33 4.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.217 1.007 . . . . 0.0 110.147 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.72 93.48 0.11 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.337 0.655 . . . . 0.0 111.131 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.58 -13.56 4.81 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.792 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 62.1 ttm-85 -95.55 149.36 21.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.17 0.988 . . . . 0.0 110.563 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.9 p -108.21 101.1 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 122.326 1.06 . . . . 0.0 109.737 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.522 HD23 HG21 ' A' ' 77' ' ' VAL . 2.1 mm? -86.53 131.18 34.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.031 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.412 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -103.78 143.66 32.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.434 0.694 . . . . 0.0 109.256 -174.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.52 108.37 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 107' ' ' ARG . 25.7 pt -87.19 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 122.254 1.026 . . . . 0.0 110.559 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.43 -149.07 19.83 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -124.45 141.38 37.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.5 134.66 65.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.329 2.686 . . . . 0.0 112.629 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.51 107.15 49.46 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.318 1.047 . . . . 0.0 109.446 -170.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.22 152.01 72.09 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.672 2.248 . . . . 0.0 111.832 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -81.1 178.19 8.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.388 0.275 . . . . 0.0 110.643 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.24 70.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.102 0.961 . . . . 0.0 112.889 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.21 37.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.016 0.526 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 57.64 33.24 23.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 0.0 110.391 -172.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.0 t -92.15 -7.64 47.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.117 0.967 . . . . 0.0 110.162 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.44 ' HA ' ' N ' ' A' ' 65' ' ' TYR . 9.1 ptp180 -161.34 167.86 25.01 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.543 0.687 . . . . 0.0 111.384 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.05 109.34 16.33 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.437 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -79.93 107.6 12.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.472 HG21 ' SG ' ' A' ' 106' ' ' CYS . 24.6 mm -97.67 112.44 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -82.37 135.06 35.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.472 ' SG ' HG21 ' A' ' 104' ' ' ILE . 78.7 m -148.99 175.41 11.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.197 0.999 . . . . 0.0 108.755 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.444 ' HB2' HD12 ' A' ' 90' ' ' ILE . 61.5 ttt85 -149.95 161.48 42.22 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.621 ' HG2' ' HD3' ' A' ' 85' ' ' ARG . 1.8 tm-20 -45.45 125.73 5.96 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.795 0.838 . . . . 0.0 110.384 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.32 36.73 3.44 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.552 0.533 . . . . 0.0 113.686 -167.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.32 39.12 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.715 1.206 . . . . 0.0 112.451 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -77.23 89.3 3.69 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.788 0.835 . . . . 0.0 110.573 -172.569 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -72.6 115.86 12.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.363 0.665 . . . . 0.0 109.981 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -75.07 -25.77 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.047 0.539 . . . . 0.0 110.014 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.38 30.3 1.92 Allowed Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 114.181 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.448 ' HB2' HD21 ' A' ' 6' ' ' LEU . 60.3 mtp180 -71.23 -48.6 50.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 5' ' ' ARG . 2.5 mm? -92.38 98.94 11.8 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.499 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -93.8 -27.51 16.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.03 0.932 . . . . 0.0 112.345 -163.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.85 171.8 8.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.061 0.944 . . . . 0.0 109.026 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.536 ' HB2' HG23 ' A' ' 79' ' ' THR . 98.2 mtt180 -136.84 138.0 40.32 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 77' ' ' VAL . 47.8 pt -140.97 176.86 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.248 1.019 . . . . 0.0 109.751 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -140.12 136.5 33.61 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.361 0.664 . . . . 0.0 109.406 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.0 mm -73.12 125.89 32.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.268 0.627 . . . . 0.0 109.549 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -97.62 116.53 30.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -89.76 135.57 33.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.096 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 27' ' ' GLU . 2.9 tm? -92.91 99.9 12.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -85.93 107.92 17.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.361 0.664 . . . . 0.0 110.015 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -77.43 110.49 12.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -120.45 121.4 38.41 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HG2' ' H ' ' A' ' 20' ' ' ASP . 21.8 ttp180 -77.01 172.35 13.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.322 0.51 . . . . 0.0 111.209 -172.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 16.9 t70 -108.12 161.22 15.17 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.8 tt -67.77 -6.26 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 123.792 0.837 . . . . 0.0 113.056 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -105.46 -18.92 13.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.45 54.69 0.93 Allowed Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.737 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -112.15 147.24 36.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.581 1.152 . . . . 0.0 107.942 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.7 mm -90.07 101.15 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.863 0.756 . . . . 0.0 109.731 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.45 97.85 11.43 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB3' HD21 ' A' ' 15' ' ' LEU . 43.8 mt-10 -83.46 131.75 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.443 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.9 p -132.89 161.4 34.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.109 0.964 . . . . 0.0 109.982 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -118.21 118.59 32.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.485 0.714 . . . . 0.0 109.729 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.89 151.35 25.88 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.105 0.962 . . . . 0.0 109.25 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.83 135.25 38.89 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.36 -110.34 3.06 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -113.28 132.76 55.42 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.0 m -76.45 141.66 41.27 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.97 0.908 . . . . 0.0 108.985 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.88 146.42 27.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.234 0.54 . . . . 0.0 111.682 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -71.06 124.23 23.93 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.437 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -136.81 172.45 12.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.775 0.83 . . . . 0.0 111.288 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -130.84 105.55 7.85 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 61' ' ' ILE . 60.8 t -91.64 91.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 0.0 109.373 -173.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -115.4 119.91 37.81 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.506 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -66.32 152.69 44.45 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.05 149.74 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.894 0.478 . . . . 0.0 111.039 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -88.15 176.61 7.19 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -57.47 -35.96 70.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.078 0.551 . . . . 0.0 110.446 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.05 -39.25 59.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.704 1.202 . . . . 0.0 112.133 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -66.16 -49.74 66.36 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.383 0.427 . . . . 0.0 111.198 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.5 97.66 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.981 0.801 . . . . 0.0 110.8 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.5 mt -63.22 -43.83 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.645 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 t -75.76 -13.66 60.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.428 0.691 . . . . 0.0 111.781 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.526 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 45.6 m -111.18 -2.38 15.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.676 0.79 . . . . 0.0 111.736 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.13 -74.5 1.85 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.6 5.33 0.8 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.884 0.874 . . . . 0.0 111.21 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 35.8 tt0 -70.73 -68.54 0.42 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.126 0.571 . . . . 0.0 110.342 -177.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.16 142.5 45.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 164.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.67 153.18 39.73 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.53 0.732 . . . . 0.0 109.539 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.85 115.39 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.07 -5.54 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.766 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.522 HG23 HD13 ' A' ' 90' ' ' ILE . 98.6 m -70.49 119.39 14.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.506 HG22 ' HG2' ' A' ' 41' ' ' MET . 51.0 t -84.68 118.1 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -98.75 143.33 29.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.557 HD11 HG23 ' A' ' 75' ' ' ILE . 66.5 mt -138.54 109.97 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -97.56 115.55 28.07 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 69' ' ' ILE . 49.4 pt -121.2 158.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -56.33 140.76 44.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.191 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -49.32 118.8 2.91 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.615 1.166 . . . . 0.0 111.629 -171.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -143.34 117.76 9.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.154 0.582 . . . . 0.0 109.967 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.42 2.59 27.93 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.597 1.159 . . . . 0.0 112.204 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.36 -17.32 24.82 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.852 0.861 . . . . 0.0 110.998 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.533 HG22 HD12 ' A' ' 104' ' ' ILE . 26.9 mm -67.52 138.98 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.039 0.536 . . . . 0.0 110.31 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -145.7 169.63 18.1 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.081 0.952 . . . . 0.0 108.709 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . . . -63.6 -26.97 68.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.088 0.555 . . . . 0.0 112.037 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.5 p -97.9 48.01 1.01 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.16 0.981 . . . . 0.0 110.656 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -131.29 156.53 45.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -126.76 159.25 34.32 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.289 0.566 . . . . 0.0 109.989 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.557 HG23 HD11 ' A' ' 61' ' ' ILE . 48.4 mm -112.41 98.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.053 . . . . 0.0 109.224 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -90.45 113.57 25.54 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 10' ' ' ILE . 64.9 t -77.0 112.23 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 110.629 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.7 t -72.8 -30.02 63.74 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.969 0.907 . . . . 0.0 111.227 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 9' ' ' ARG . 15.0 t -165.71 139.55 4.51 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.978 0.911 . . . . 0.0 109.285 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.7 -163.4 30.38 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-O 118.95 -0.917 . . . . 0.0 111.67 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.74 -25.91 28.21 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.377 2.051 . . . . 0.0 111.452 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -114.5 33.93 5.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.195 0.998 . . . . 0.0 109.724 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.3 109.16 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.702 0.801 . . . . 0.0 111.452 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.37 -21.32 10.02 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.415 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -80.62 165.87 21.63 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.387 0.675 . . . . 0.0 111.153 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.17 102.05 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 122.351 1.072 . . . . 0.0 109.414 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 120.86 24.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.674 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.49 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -82.75 134.76 35.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.223 1.009 . . . . 0.0 108.288 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.518 HG12 ' SG ' ' A' ' 106' ' ' CYS . 66.1 mt -82.19 95.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -172.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.522 HD13 HG23 ' A' ' 58' ' ' THR . 21.7 pt -80.53 62.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 122.3 1.048 . . . . 0.0 111.14 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.54 -158.85 27.83 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.513 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 92.5 mt-30 -126.59 145.44 53.22 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 109.365 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 134.47 57.88 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 113.504 -173.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -106.56 108.92 62.7 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.1 142.7 56.95 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.668 2.246 . . . . 0.0 112.269 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.24 150.56 48.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 111.374 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.99 70.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.529 1.132 . . . . 0.0 112.369 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.66 -8.97 45.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.878 0.471 . . . . 0.0 110.973 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 62.54 20.28 11.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.705 1.202 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.8 t -89.41 -0.17 57.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.344 0.258 . . . . 0.0 110.813 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.64 -174.89 2.94 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 123.65 0.78 . . . . 0.0 109.949 171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.26 124.62 26.21 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.62 117.33 28.42 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.533 HD12 HG22 ' A' ' 69' ' ' ILE . 15.3 mm -108.76 140.55 26.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.572 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.3 pt? -112.14 128.97 56.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.518 ' SG ' HG12 ' A' ' 89' ' ' ILE . 56.2 m -150.74 -178.96 6.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -171.09 175.68 4.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.34 1.056 . . . . 0.0 108.642 163.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -57.67 172.04 0.41 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.691 0.796 . . . . 0.0 111.066 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.23 44.17 3.31 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.9 83.71 7.67 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 124.368 1.067 . . . . 0.0 110.092 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 3.36 52.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.053 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.434 1.093 . . . . 0.0 109.783 -177.529 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -72.64 156.81 38.58 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 122.547 0.339 . . . . 0.0 110.113 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.65 46.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.07 30.37 7.74 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.433 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.97 -81.8 0.64 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.434 0.694 . . . . 0.0 109.569 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 140.53 38.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.682 . . . . 0.0 110.407 -173.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -117.09 -44.17 2.81 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.398 1.079 . . . . 0.0 110.284 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -101.07 -175.48 2.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.049 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -131.94 147.73 52.48 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.79 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' THR . 13.7 pt -138.97 145.29 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.622 1.169 . . . . 0.0 109.266 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -108.62 137.95 45.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 109.021 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.06 114.15 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.889 0.476 . . . . 0.0 110.284 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.578 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.1 mp0 -89.79 103.79 16.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 p -79.41 159.03 27.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.481 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.575 HD12 ' HB3' ' A' ' 27' ' ' GLU . 49.5 tp -114.84 110.28 19.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.082 0.553 . . . . 0.0 109.997 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -93.99 101.94 14.01 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.952 0.901 . . . . 0.0 109.417 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -79.81 125.42 29.67 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -137.11 150.55 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 108.718 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -99.33 166.24 11.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.55 0.34 . . . . 0.0 110.121 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 8.7 t70 -110.59 162.89 14.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.642 1.177 . . . . 0.0 108.592 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tt -59.25 -12.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 125.013 1.325 . . . . 0.0 113.805 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -112.52 -34.61 5.8 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.49 48.04 0.15 Allowed Glycine 0 C--N 1.354 1.559 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.708 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 23.7 mm-40 -96.12 154.21 17.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.423 0.689 . . . . 0.0 109.258 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -107.05 102.93 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.81 101.72 13.06 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.575 1.15 . . . . 0.0 109.106 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HB3' HD12 ' A' ' 15' ' ' LEU . 47.5 mt-10 -88.2 107.39 18.76 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -116.14 144.6 43.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.638 0.775 . . . . 0.0 110.231 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 74' ' ' ARG . 85.4 m95 -114.22 113.62 24.88 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.133 0.973 . . . . 0.0 109.424 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.02 123.82 47.34 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.36 128.88 38.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.267 1.427 . . . . 0.0 109.364 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.47 -126.4 3.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -165.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.91 135.03 43.01 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.918 0.887 . . . . 0.0 110.717 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 16.6 m -99.1 105.77 17.9 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.369 0.668 . . . . 0.0 110.85 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -108.82 170.72 7.86 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.588 0.708 . . . . 0.0 111.721 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -71.81 127.54 32.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.279 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.436 ' HB3' HG21 ' A' ' 63' ' ' ILE . . . -138.74 176.35 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.306 1.043 . . . . 0.0 111.106 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -136.7 110.29 8.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.022 0.929 . . . . 0.0 108.511 162.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.87 106.28 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.392 0.677 . . . . 0.0 110.538 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -112.91 103.92 11.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.009 0.923 . . . . 0.0 109.48 173.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.526 ' SD ' HD22 ' A' ' 82' ' ' LEU . 92.5 mtp -66.53 130.52 43.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.04 142.51 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.015 0.436 . . . . 0.0 110.737 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -98.22 -173.02 2.47 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 124.03 0.932 . . . . 0.0 110.457 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -53.42 -29.92 37.64 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.264 1.025 . . . . 0.0 112.839 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -49.99 -51.12 44.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.63 0.772 . . . . 0.0 112.053 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -67.12 -40.43 86.83 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.653 0.596 . . . . 0.0 111.634 -174.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.79 72.18 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.293 0.637 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.68 -42.45 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.832 0.853 . . . . 0.0 111.403 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.4 t -68.77 -30.25 68.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.216 0.607 . . . . 0.0 111.383 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 97.1 p -91.84 -9.34 43.75 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.417 0.687 . . . . 0.0 111.163 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.5 -72.09 2.8 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.37 10.19 0.5 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.704 0.802 . . . . 0.0 110.88 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 47.3 mt-10 -78.45 -30.91 47.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.91 0.484 . . . . 0.0 111.084 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.56 170.34 8.25 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.074 0.95 . . . . 0.0 109.252 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.07 149.54 35.25 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.803 0.841 . . . . 0.0 109.682 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mt -63.23 144.6 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.53 0.732 . . . . 0.0 110.364 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.98 -12.03 70.58 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.135 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 90' ' ' ILE . 47.1 m -61.05 116.7 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.223 0.609 . . . . 0.0 109.358 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 87' ' ' LEU . 46.4 t -76.69 103.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.883 -171.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -92.58 137.44 32.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -141.4 109.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.824 0.85 . . . . 0.0 108.777 -167.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -92.65 124.11 36.43 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.35 0.66 . . . . 0.0 109.579 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 44.9 pt -130.25 167.39 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.623 0.769 . . . . 0.0 110.16 -175.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -53.25 151.08 5.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.735 0.647 . . . . 0.0 111.451 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.434 ' HE1' ' HD2' ' A' ' 99' ' ' ARG . 61.5 t80 -60.38 107.91 0.73 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -129.64 119.16 23.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.3 -2.89 30.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.927 1.291 . . . . 0.0 112.31 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.05 -21.31 19.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.885 0.874 . . . . 0.0 111.396 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.0 mm -72.62 132.21 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.65 0.38 . . . . 0.0 110.554 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.438 HD21 ' H ' ' A' ' 72' ' ' THR . 5.0 t30 -143.18 161.88 37.08 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.01 -27.78 68.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.3 0.64 . . . . 0.0 111.897 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.438 ' H ' HD21 ' A' ' 70' ' ' ASN . 35.3 p -79.2 14.32 1.53 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.183 0.993 . . . . 0.0 112.364 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -111.42 167.65 10.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.505 0.722 . . . . 0.0 109.077 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 51.0 mtm180 -122.46 150.28 42.72 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 mm -113.17 99.92 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.498 1.119 . . . . 0.0 109.019 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.3 ttpt -89.44 120.28 30.63 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.072 -0.393 . . . . 0.0 110.172 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 87' ' ' LEU . 53.4 t -76.79 120.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.966 0.412 . . . . 0.0 109.902 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.0 m -84.81 -29.94 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.343 1.057 . . . . 0.0 111.522 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.9 p -141.27 126.77 18.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.85 0.86 . . . . 0.0 109.556 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.92 -158.19 25.08 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.503 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.62 -13.38 29.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.246 2.631 . . . . 0.0 112.441 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.526 HD22 ' SD ' ' A' ' 41' ' ' MET . 70.9 mt -120.77 25.77 9.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.838 . . . . 0.0 110.149 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.34 112.48 2.44 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.342 0.657 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.01 2.54 51.86 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.501 0.501 . . . . 0.0 113.175 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -105.53 139.55 39.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.574 0.75 . . . . 0.0 109.475 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -104.93 102.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 122.313 1.054 . . . . 0.0 109.722 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 59' ' ' VAL . 1.5 mm? -82.73 133.14 35.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.198 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.419 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -100.44 143.6 30.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.195 0.598 . . . . 0.0 109.561 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.3 mt -80.48 143.62 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 58' ' ' THR . 2.2 pt -122.19 104.38 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.813 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.3 -105.98 2.48 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.847 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.1 150.17 29.05 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.684 0.794 . . . . 0.0 109.884 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.02 123.64 12.23 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 121.903 1.736 . . . . 0.0 111.008 167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -89.14 113.8 57.68 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -76.55 129.13 10.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.17 1.913 . . . . 0.0 110.699 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.625 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 21.9 t70 -52.69 150.37 5.24 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.342 1.057 . . . . 0.0 112.198 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.76 -43.92 77.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.926 0.891 . . . . 0.0 112.001 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.57 0.12 56.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.549 0.739 . . . . 0.0 111.251 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 38.7 mmt180 61.88 26.04 15.72 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.088 1.355 . . . . 0.0 112.138 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.8 p -79.79 -12.2 59.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.625 ' HG2' ' HB2' ' A' ' 96' ' ' ASP . 13.3 ptp180 -165.67 175.9 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.69 121.81 37.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.944 0.898 . . . . 0.0 108.766 165.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.33 102.99 12.36 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mm -87.26 142.88 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -123.61 138.05 54.62 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.09 176.44 10.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.073 -167.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 159.24 42.8 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -45.79 122.76 3.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.97 50.63 3.72 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.142 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.06 119.87 22.81 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -67.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.059 0.849 . . . . 0.0 108.864 177.552 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.329 0.109 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.07 108.36 19.82 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.507 HG13 ' HG2' ' A' ' 64' ' ' ARG . 40.2 mm -89.04 87.06 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.94 51.44 4.57 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.859 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -126.53 -37.61 2.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.672 1.189 . . . . 0.0 109.891 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD13 ' HG3' ' A' ' 64' ' ' ARG . 27.2 mt -72.29 84.27 1.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.497 -163.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -97.56 -21.2 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.504 0.721 . . . . 0.0 111.468 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.3 -174.68 2.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.145 0.978 . . . . 0.0 110.052 -173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -139.01 150.92 46.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.385 0.674 . . . . 0.0 110.077 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' THR . 44.6 pt -139.33 168.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.178 . . . . 0.0 109.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -128.81 138.91 52.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.677 0.791 . . . . 0.0 109.013 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -89.71 92.35 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.359 0.6 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -71.66 99.13 2.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.82 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 p -84.27 139.45 32.32 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.57 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 28' ' ' THR . 64.1 tp -78.18 105.58 9.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.144 0.577 . . . . 0.0 109.737 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -90.51 117.95 29.6 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.804 0.841 . . . . 0.0 111.087 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.98 94.34 5.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -90.92 111.49 22.95 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.346 0.659 . . . . 0.0 109.576 -173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.7 ttt-85 -87.79 152.85 21.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.052 0.453 . . . . 0.0 111.443 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -107.65 164.04 12.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.963 0.905 . . . . 0.0 108.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.4 tt -72.2 -1.26 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 C-N-CA 124.121 0.969 . . . . 0.0 113.239 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -98.45 -14.24 20.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.981 0.896 . . . . 0.0 109.33 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.97 40.98 5.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.805 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 46.5 mt-10 -96.79 149.58 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.622 0.769 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -108.49 107.4 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.47 103.79 15.77 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -80.38 126.5 31.25 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 109.631 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 15' ' ' LEU . 37.7 p -139.53 -176.17 4.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.599 1.56 . . . . 0.0 108.469 -168.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -128.05 115.09 17.93 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.906 -0.496 . . . . 0.0 109.665 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.62 145.34 26.95 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.79 136.81 37.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.966 0.507 . . . . 0.0 109.634 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.86 -109.45 3.34 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -108.11 134.38 51.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 88.3 m -97.96 102.91 14.79 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.04 168.75 9.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.576 0.751 . . . . 0.0 112.264 -173.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.0 122.26 19.01 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.359 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.96 13.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.442 0.697 . . . . 0.0 112.368 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 2.1 m -131.74 94.61 3.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.384 1.074 . . . . 0.0 108.226 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG21 HG22 ' A' ' 77' ' ' VAL . 2.8 p -91.2 94.27 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.698 0.761 . . . . 0.0 109.67 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -113.6 119.85 38.91 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.724 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 82' ' ' LEU . 54.1 mtp -76.62 150.63 36.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.937 0.495 . . . . 0.0 109.737 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -83.7 136.41 22.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.146 0.579 . . . . 0.0 109.576 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.57 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 39.5 t -90.3 -178.85 5.48 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.964 0.906 . . . . 0.0 109.535 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -60.53 -33.57 72.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.423 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.57 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 18.4 ptpt -53.93 -40.24 66.56 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.619 1.167 . . . . 0.0 111.461 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -70.28 -43.37 70.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.012 0.925 . . . . 0.0 110.44 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.39 -32.12 72.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.895 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.8 mt -73.16 -45.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.249 0.62 . . . . 0.0 110.553 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.3 m -63.45 -36.95 85.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.78 0.832 . . . . 0.0 111.856 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.7 p -86.51 -48.37 8.44 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.034 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.22 -64.68 0.31 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.98 -5.57 0.79 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.872 0.869 . . . . 0.0 111.568 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.0 tt0 -71.98 -68.94 0.42 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.006 0.522 . . . . 0.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -77.09 119.52 20.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.91 39.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.98 117.97 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.08 -11.17 14.88 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 116.856 -0.156 . . . . 0.0 113.048 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.1 m -68.29 146.91 52.87 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.93 116.41 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.271 0.628 . . . . 0.0 110.096 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -87.63 126.39 34.92 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 75' ' ' ILE . 44.8 mt -123.48 104.95 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 11.9 m0 -90.56 117.91 29.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.723 0.809 . . . . 0.0 109.722 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 pt -130.29 161.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 108.324 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.507 ' HG2' HG13 ' A' ' 3' ' ' ILE . 64.1 mtm180 -60.92 141.13 57.48 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.883 0.765 . . . . 0.0 110.826 167.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.24 130.99 36.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.052 1.341 . . . . 0.0 111.135 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.41 147.15 25.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.19 0.596 . . . . 0.0 111.238 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -83.2 1.02 42.78 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.603 1.161 . . . . 0.0 111.884 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.67 -26.78 19.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.877 0.471 . . . . 0.0 111.216 -165.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.512 HG21 HD13 ' A' ' 104' ' ' ILE . 6.3 mm -75.65 132.03 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.73 167.37 16.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.91 63.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.082 0.553 . . . . 0.0 111.635 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.1 p -84.95 3.11 39.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.791 0.836 . . . . 0.0 111.547 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 m -93.95 159.79 15.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.57 0.748 . . . . 0.0 109.646 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -132.12 165.0 25.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 0.0 109.01 170.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG22 HD12 ' A' ' 61' ' ' ILE . 43.7 mm -115.97 99.22 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.487 0.715 . . . . 0.0 110.621 -173.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -91.93 110.11 21.46 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.44 HG22 HG21 ' A' ' 39' ' ' VAL . 95.7 t -72.84 117.94 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.678 0.791 . . . . 0.0 111.106 -172.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.3 m -77.44 -21.73 52.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.358 1.063 . . . . 0.0 112.158 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -167.71 132.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.729 0.811 . . . . 0.0 109.34 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.44 -163.72 30.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.928 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.42 -16.07 17.37 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.134 2.556 . . . . 0.0 112.102 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.664 HD12 HD12 ' A' ' 87' ' ' LEU . 82.7 mt -119.26 28.93 7.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.341 1.056 . . . . 0.0 109.795 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.81 115.23 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.425 0.69 . . . . 0.0 110.542 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.63 38.96 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.811 0.694 . . . . 0.0 112.946 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -107.68 143.82 35.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.862 0.865 . . . . 0.0 109.853 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.12 88.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 122.481 1.134 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.664 HD12 HD12 ' A' ' 82' ' ' LEU . 2.6 mm? -62.57 132.41 52.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.033 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -95.13 130.69 41.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.275 1.03 . . . . 0.0 109.357 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.91 129.92 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.49 HG23 ' HD2' ' A' ' 107' ' ' ARG . 1.5 pt -97.18 111.55 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 0.0 109.215 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.46 -94.05 1.9 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.987 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -166.92 155.11 9.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.316 1.046 . . . . 0.0 109.325 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -58.35 123.44 13.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.755 2.303 . . . . 0.0 111.831 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.12 111.71 65.26 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 123.916 0.887 . . . . 0.0 109.789 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.08 155.9 63.79 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.229 2.62 . . . . 0.0 113.691 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.86 155.2 41.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 110.914 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.88 84.23 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.344 0.657 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.29 59.28 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.948 0.499 . . . . 0.0 110.899 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 61.29 23.85 14.03 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.285 1.434 . . . . 0.0 112.236 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 t -85.87 -6.51 59.07 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.796 0.438 . . . . 0.0 111.401 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.59 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 5.5 ppt_? -161.27 162.54 31.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.583 0.753 . . . . 0.0 109.614 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.56 118.21 32.5 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.59 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 37.8 tt0 -90.27 105.27 17.7 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.7 mm -88.74 97.69 7.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD22 ' H ' ' A' ' 105' ' ' LEU . 2.6 pt? -81.19 136.84 35.9 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 77.1 m -151.75 -175.5 5.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.068 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.49 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -153.53 160.09 42.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.44 0.696 . . . . 0.0 109.196 165.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 138.49 57.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.544 0.737 . . . . 0.0 110.322 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.62 29.87 5.59 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.851 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 99.16 1.63 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.44 94.74 0.12 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.946 0.898 . . . . 0.0 110.895 -171.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 124.241 1.017 . . . . 0.0 108.58 -173.269 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -74.93 100.27 4.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.132 0.573 . . . . 0.0 111.271 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.9 mt -126.5 -29.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.167 0.987 . . . . 0.0 108.866 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.32 24.63 2.5 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -168.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HB2' HD21 ' A' ' 6' ' ' LEU . 37.4 mmt180 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 167.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 5' ' ' ARG . 0.7 OUTLIER -99.09 85.64 3.28 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.752 -170.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -103.58 -7.62 20.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.734 0.814 . . . . 0.0 112.33 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -102.64 -176.92 3.24 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 55.6 mtm180 -133.74 150.78 51.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.579 0.752 . . . . 0.0 109.42 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 34' ' ' THR . 12.4 pt -136.4 157.18 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 31' ' ' ASP . 26.0 m -116.55 124.82 50.82 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.8 mm -72.31 93.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.674 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 2.3 tp-100 -71.58 100.17 2.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -83.71 140.55 32.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.603 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 27' ' ' GLU . 42.5 tp -101.6 98.92 9.16 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 110.018 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -83.66 105.91 14.95 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 109.237 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -74.99 90.82 2.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.5 m -89.68 112.31 23.53 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 109.938 -171.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -72.65 153.45 41.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.843 0.354 . . . . 0.0 110.431 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HB2' HD11 ' A' ' 26' ' ' LEU . 19.3 t70 -113.89 164.65 13.48 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.3 5.95 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.853 0.861 . . . . 0.0 112.392 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -101.54 -14.96 17.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.707 0.803 . . . . 0.0 109.033 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.79 33.91 8.09 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.371 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.59 166.95 10.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.613 0.765 . . . . 0.0 110.537 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.2 mm -114.14 105.36 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.708 0.803 . . . . 0.0 109.21 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' A' ' 20' ' ' ASP . 5.9 mp -98.27 96.05 7.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.849 1.26 . . . . 0.0 107.697 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.585 ' HB3' HD12 ' A' ' 15' ' ' LEU . 44.9 mt-10 -79.03 118.66 21.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.512 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -126.75 149.13 49.78 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.753 1.221 . . . . 0.0 110.251 -172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.425 ' CE2' HD13 ' A' ' 15' ' ' LEU . 92.7 m95 -107.62 109.5 21.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.867 0.867 . . . . 0.0 109.49 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.3 140.07 39.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.091 0.957 . . . . 0.0 108.567 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB2' HG23 ' A' ' 11' ' ' THR . 5.5 p-10 -71.54 128.99 37.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.28 -119.66 4.56 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.784 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.47 116.59 28.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.448 0.699 . . . . 0.0 109.423 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 26.8 m -90.26 94.53 9.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -103.96 162.83 12.81 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.244 0.545 . . . . 0.0 111.604 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -63.26 126.31 27.0 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.794 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.496 ' HB3' HG12 ' A' ' 10' ' ' ILE . . . -134.71 165.53 25.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.364 1.066 . . . . 0.0 111.709 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -121.66 98.91 6.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.13 91.63 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.282 0.633 . . . . 0.0 110.125 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -95.54 107.49 19.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.445 0.698 . . . . 0.0 110.34 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.23 130.71 41.45 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.538 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 13.8 m -70.21 151.13 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -95.38 -177.32 4.06 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.653 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -61.29 -41.0 96.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.641 0.776 . . . . 0.0 110.778 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.17 -34.4 68.42 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.225 1.01 . . . . 0.0 112.314 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 5.8 mm-40 -62.3 -39.41 92.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.263 0.625 . . . . 0.0 111.169 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.98 67.12 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.512 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.77 -33.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.106 0.962 . . . . 0.0 111.939 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -87.65 -48.55 7.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.513 0.725 . . . . 0.0 110.704 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 15.8 m -84.49 -22.65 30.16 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.86 -102.19 1.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.242 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.24 -5.02 57.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.431 0.692 . . . . 0.0 111.816 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 34.7 tt0 -82.91 -62.64 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.632 0.373 . . . . 0.0 110.465 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.606 HD22 HG22 ' A' ' 58' ' ' THR . 47.1 mt -110.08 147.94 32.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.493 0.717 . . . . 0.0 109.228 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.97 168.92 18.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.476 1.11 . . . . 0.0 110.252 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.4 116.12 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.81 -9.76 14.21 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 123.072 0.368 . . . . 0.0 112.43 -167.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.606 HG22 HD22 ' A' ' 54' ' ' LEU . 88.2 m -80.56 161.98 24.51 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.299 1.04 . . . . 0.0 109.281 172.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.97 126.41 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.116 0.966 . . . . 0.0 109.117 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -95.46 134.36 38.38 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.18 109.35 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -94.15 127.22 39.84 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 pt -132.83 168.04 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.627 0.371 . . . . 0.0 110.677 -173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -49.14 131.71 19.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.815 0.446 . . . . 0.0 110.15 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 69.0 t80 -51.55 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.519 1.528 . . . . 0.0 111.697 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 104.58 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 109.464 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.76 7.73 9.68 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.055 0.942 . . . . 0.0 111.729 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.84 -18.91 21.5 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.189 0.996 . . . . 0.0 111.138 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.568 HG21 HD12 ' A' ' 104' ' ' ILE . 39.2 mm -68.7 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 122.878 0.471 . . . . 0.0 109.897 -177.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -142.33 172.68 12.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.107 0.963 . . . . 0.0 108.587 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -30.1 65.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.082 0.953 . . . . 0.0 112.99 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 p -90.55 23.26 3.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.543 0.737 . . . . 0.0 112.324 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -112.74 162.34 15.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.674 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 99.8 mtt180 -122.88 159.34 28.41 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.61 93.25 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.95 0.9 . . . . 0.0 109.134 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.6 ttpt -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 HD21 ' A' ' 87' ' ' LEU . 83.9 t -67.36 122.03 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 122.917 0.487 . . . . 0.0 110.517 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 44.0 t -82.33 -39.64 22.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.937 0.895 . . . . 0.0 109.932 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.3 p -143.92 137.2 27.65 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.739 0.816 . . . . 0.0 109.887 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.41 -161.6 25.0 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.977 0.798 . . . . 0.0 111.485 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.04 -17.98 40.59 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.186 2.591 . . . . 0.0 112.522 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -116.4 27.5 9.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.866 0.866 . . . . 0.0 110.223 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.14 95.08 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.661 0.785 . . . . 0.0 111.586 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.99 -18.33 5.6 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.072 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -86.85 143.8 27.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.713 0.805 . . . . 0.0 110.201 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.0 p -100.94 117.69 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 0.0 109.316 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.0 mm? -87.63 142.95 27.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 108.318 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -107.69 139.59 42.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.923 0.889 . . . . 0.0 109.047 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.9 mt -81.14 99.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 107' ' ' ARG . 23.6 pt -74.26 94.34 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.945 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.29 12.64 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.595 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -128.35 142.97 46.42 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.267 1.027 . . . . 0.0 109.309 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.54 155.53 69.84 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.025 2.483 . . . . 0.0 112.601 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -116.88 107.41 46.15 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -62.76 141.1 83.85 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.534 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -69.03 145.49 53.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.88 67.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.606 1.163 . . . . 0.0 112.357 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.62 54.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.763 0.425 . . . . 0.0 111.586 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 65.42 14.4 9.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.47 1.108 . . . . 0.0 112.67 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -89.8 -2.81 58.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.872 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -168.57 178.04 4.93 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.629 0.772 . . . . 0.0 110.91 171.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.44 121.53 32.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -83.72 112.25 19.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.568 HD12 HG21 ' A' ' 69' ' ' ILE . 22.1 mm -98.11 142.29 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.482 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.3 pt? -117.82 133.76 55.61 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 81.2 m -150.06 161.74 41.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.582 -171.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.405 ' HB2' HD13 ' A' ' 90' ' ' ILE . 56.5 ttp180 -144.95 139.85 27.84 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' HA ' HD11 ' A' ' 87' ' ' LEU . 27.7 tt0 -48.78 143.29 5.42 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.517 1.136 . . . . 0.0 113.397 -168.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.26 53.9 4.45 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.775 -173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.34 69.02 2.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.949 0.899 . . . . 0.0 108.779 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.94 93.56 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.736 1.214 . . . . 0.0 111.284 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 tptt . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -176.134 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.2 mtp . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.589 ' HB3' ' HZ3' ' A' ' 62' ' ' TRP . 4.2 m-20 -95.97 122.2 38.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.516 1.126 . . . . 0.0 110.855 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.95 11.38 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.584 0.754 . . . . 0.0 111.349 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.76 57.83 4.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.928 0.775 . . . . 0.0 111.678 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -66.04 142.36 57.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.142 1.377 . . . . 0.0 111.47 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 38' ' ' SER . 6.4 mp -70.49 117.68 12.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.005 0.922 . . . . 0.0 110.301 -172.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -123.62 -29.26 3.76 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.165 0.986 . . . . 0.0 111.548 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -99.89 -172.82 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.341 1.456 . . . . 0.0 110.247 -173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.511 ' HB2' HG22 ' A' ' 79' ' ' THR . 53.4 mtm180 -139.62 146.35 39.66 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 110.409 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.83 149.79 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.419 1.088 . . . . 0.0 109.048 178.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -107.58 126.13 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.18 111.32 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.361 0.665 . . . . 0.0 110.229 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 76.4 mt-30 -95.06 96.7 9.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.513 0.725 . . . . 0.0 109.718 172.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -82.07 150.25 27.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.109 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' HB3' ' A' ' 27' ' ' GLU . 51.3 tp -89.3 98.31 11.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.8 0.727 . . . . 0.0 109.517 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -85.34 101.59 12.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.611 0.764 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -86.73 86.13 7.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -91.95 126.04 36.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.066 0.946 . . . . 0.0 110.611 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.6 ttp180 -79.19 148.14 32.38 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.693 0.282 . . . . 0.0 110.98 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.43 165.76 12.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.226 1.01 . . . . 0.0 108.887 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.41 -11.09 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 C-N-CA 124.225 1.01 . . . . 0.0 113.239 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -105.0 -7.07 19.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.57 -0.706 . . . . 0.0 109.33 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 50.56 3.67 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.078 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 45.6 mt-10 -108.55 138.38 44.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 108.894 173.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 mm -87.94 99.56 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.89 109.26 17.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.61 0.764 . . . . 0.0 109.776 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.559 ' HB3' HD12 ' A' ' 15' ' ' LEU . 45.2 mt-10 -80.0 111.3 16.21 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.3 p -132.69 154.27 50.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.043 . . . . 0.0 108.59 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -103.04 105.24 15.51 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 16.5 pt-20 -84.56 139.81 31.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.958 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -84.94 138.32 32.57 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.16 -108.77 2.8 Favored Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -174.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -118.05 142.39 47.45 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.952 0.406 . . . . 0.0 110.465 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 9' ' ' ARG . 16.2 m -96.14 96.69 8.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 108.57 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.01 176.28 5.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.154 0.582 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -71.83 134.91 46.41 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.361 1.064 . . . . 0.0 111.056 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.598 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -142.84 168.04 20.66 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.112 0.965 . . . . 0.0 110.829 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 23.1 t -123.15 98.69 6.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.63 90.95 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.27 97.52 11.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.716 0.806 . . . . 0.0 109.495 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.85 106.04 11.58 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 46' ' ' GLU . 3.3 m -74.86 138.19 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.358 0.599 . . . . 0.0 111.645 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.4 m -97.36 -174.01 2.81 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 124.456 1.103 . . . . 0.0 109.757 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.555 ' HA ' HG12 ' A' ' 56' ' ' ILE . 13.2 p -53.8 -43.64 69.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.17 0.988 . . . . 0.0 112.764 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.32 -46.38 83.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.079 0.551 . . . . 0.0 111.456 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 53.1 mm-40 -61.96 -43.26 99.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.12 0.568 . . . . 0.0 111.859 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.46 91.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.505 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.1 -31.05 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.636 0.774 . . . . 0.0 110.505 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.0 m -71.05 -25.92 62.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.482 0.713 . . . . 0.0 110.628 172.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 26.8 t -92.24 -10.65 37.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.151 0.981 . . . . 0.0 110.552 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 -80.14 1.73 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.33 12.11 0.55 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.977 0.911 . . . . 0.0 110.757 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 35.7 tt0 -75.65 -55.01 6.06 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.577 HD22 HG23 ' A' ' 58' ' ' THR . 80.3 mt -86.96 166.82 14.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.986 0.514 . . . . 0.0 109.659 168.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.18 160.73 31.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.097 0.959 . . . . 0.0 109.208 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.555 HG12 ' HA ' ' A' ' 44' ' ' SER . 49.6 mt -69.88 104.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.26 3.63 18.99 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.348 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.577 HG23 HD22 ' A' ' 54' ' ' LEU . 32.2 m -68.44 119.37 12.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.444 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -84.05 97.46 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.371 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -87.99 125.31 34.47 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 75' ' ' ILE . 86.2 mt -128.72 109.71 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 0.0 109.362 -165.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.589 ' HZ3' ' HB3' ' A' ' 2' ' ' ASN . 15.1 m0 -97.13 113.5 25.08 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 123.561 0.744 . . . . 0.0 109.71 -175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HD3' ' A' ' 66' ' ' ARG . 41.5 pt -120.58 163.35 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -58.77 149.78 25.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.299 0.5 . . . . 0.0 112.057 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.02 124.87 22.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.348 -170.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.525 ' HD3' HD12 ' A' ' 63' ' ' ILE . 10.2 ptm180 -153.46 133.51 13.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.485 0.714 . . . . 0.0 109.759 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -83.64 10.27 9.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.827 0.851 . . . . 0.0 111.061 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -91.25 -27.28 18.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.58 1.152 . . . . 0.0 111.552 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 104' ' ' ILE . 19.0 mm -74.75 137.86 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.923 0.392 . . . . 0.0 110.294 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -137.44 164.73 27.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.025 0.93 . . . . 0.0 108.867 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.77 66.06 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.757 0.823 . . . . 0.0 111.914 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.5 p -86.83 28.78 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.712 0.805 . . . . 0.0 111.636 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -126.63 134.61 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -100.31 148.8 24.27 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 61' ' ' ILE . 43.2 mm -110.04 108.79 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.692 0.797 . . . . 0.0 109.328 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -100.43 112.93 25.33 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.27 104.49 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.947 0.499 . . . . 0.0 109.744 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.67 -26.39 63.42 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.576 0.75 . . . . 0.0 111.694 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.511 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.8 t -162.95 135.04 5.27 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.38 -154.53 25.92 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.315 -0.714 . . . . 0.0 112.346 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 -20.27 33.47 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.228 2.619 . . . . 0.0 112.31 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 85' ' ' ARG . 84.1 mt -128.23 38.33 4.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.755 0.822 . . . . 0.0 109.995 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.43 97.87 0.15 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.57 -34.93 1.92 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.872 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.403 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 75.4 mtt85 -68.57 138.17 54.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.44 0.696 . . . . 0.0 112.195 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.91 86.9 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.643 1.211 . . . . 0.0 108.019 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.61 149.43 43.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.803 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -108.99 139.21 44.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.513 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.91 105.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.436 HD11 HG21 ' A' ' 58' ' ' THR . 19.6 pt -77.83 74.08 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 122.1 0.952 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.72 -141.16 13.79 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -127.16 138.39 32.62 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.76 0.824 . . . . 0.0 109.046 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.22 142.12 79.12 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.568 2.845 . . . . 0.0 112.53 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.79 119.67 29.93 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.52 155.18 59.8 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.589 2.192 . . . . 0.0 112.163 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.65 151.42 46.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.189 0.596 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -41.02 88.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.403 1.081 . . . . 0.0 111.802 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 -3.92 57.18 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.427 0.691 . . . . 0.0 111.891 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 63.61 15.9 9.26 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.905 1.282 . . . . 0.0 113.114 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -82.06 -7.48 59.62 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.951 0.405 . . . . 0.0 111.172 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 4.6 ppt_? -162.7 169.69 19.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.722 0.809 . . . . 0.0 109.11 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.28 131.33 56.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 33.3 tt0 -100.28 114.77 28.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.187 0.518 . . . . 0.0 109.902 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 69' ' ' ILE . 15.4 mm -93.97 136.44 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.555 ' H ' HD22 ' A' ' 105' ' ' LEU . 1.9 pt? -109.48 130.64 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 82.7 m -147.36 171.21 15.81 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.891 0.877 . . . . 0.0 108.66 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HB2' HD12 ' A' ' 90' ' ' ILE . 64.1 ttt180 -158.47 160.52 36.85 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.598 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.0 146.38 54.21 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.641 1.176 . . . . 0.0 110.278 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.05 48.61 3.47 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 51.39 -95.47 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.736 1.615 . . . . 0.0 112.287 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -168.57 26.1 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.976 1.31 . . . . 0.0 108.467 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.777 1.231 . . . . 0.0 109.448 -173.386 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -74.23 122.74 23.31 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.404 HG21 ' N ' ' A' ' 4' ' ' GLY . 40.1 mt -129.5 170.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.124 1.369 . . . . 0.0 107.329 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' HG21 ' A' ' 3' ' ' ILE . . . -74.67 56.67 2.56 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 123.419 0.533 . . . . 0.0 112.959 174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -82.21 -25.26 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.922 1.289 . . . . 0.0 109.833 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt -70.28 97.74 1.28 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.606 0.762 . . . . 0.0 109.531 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -105.55 -33.3 8.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.422 0.689 . . . . 0.0 110.138 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -96.23 -174.13 2.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.594 1.158 . . . . 0.0 110.116 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HG2' HG22 ' A' ' 34' ' ' THR . 53.8 ttp180 -154.1 123.38 6.5 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -116.18 159.07 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.632 0.773 . . . . 0.0 110.142 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -109.67 146.02 35.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.368 0.667 . . . . 0.0 109.329 168.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -101.26 107.2 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.486 1.114 . . . . 0.0 110.08 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -77.69 95.41 4.61 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.403 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 8.7 p -80.15 152.08 29.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.505 0.722 . . . . 0.0 109.82 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 27' ' ' GLU . 27.9 tp -92.41 97.59 10.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.323 0.583 . . . . 0.0 110.992 -171.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -76.83 95.19 4.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.095 0.958 . . . . 0.0 109.644 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.4 104.86 14.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.8 m -111.83 116.23 30.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 -169.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -85.96 140.17 30.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 122.607 0.363 . . . . 0.0 110.791 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -99.81 178.39 4.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 109.613 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tt -50.45 -46.68 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.357 1.063 . . . . 0.0 113.298 -172.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -105.85 12.79 30.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.89 23.58 7.37 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -77.94 119.57 21.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.15 87.33 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.66 92.62 0.87 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.685 0.794 . . . . 0.0 109.565 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' HD13 ' A' ' 15' ' ' LEU . 50.2 mt-10 -79.76 94.17 5.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -101.44 143.86 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.48 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -94.02 93.39 7.83 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 15.7 pt-20 -77.7 112.4 14.49 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.11 103.93 0.33 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.964 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.41 2.07 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.683 -160.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -106.76 146.72 30.51 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.603 0.761 . . . . 0.0 111.254 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 9' ' ' ARG . 4.6 m -106.76 140.59 39.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.626 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.82 158.18 40.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.432 0.693 . . . . 0.0 110.684 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -61.43 149.04 39.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.106 0.962 . . . . 0.0 112.041 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 10' ' ' ILE . . . -155.29 169.47 24.12 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.368 0.667 . . . . 0.0 111.385 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 14.7 t -128.58 91.37 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.95 96.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.407 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -107.52 99.37 8.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.499 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.466 ' SD ' HD22 ' A' ' 82' ' ' LEU . 48.7 mtp -73.11 142.03 47.52 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.84 159.71 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.522 0.729 . . . . 0.0 112.518 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.633 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.2 m -93.31 -178.46 4.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.13 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.413 ' HA ' HG12 ' A' ' 56' ' ' ILE . 34.9 p -72.23 -20.99 61.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.065 0.546 . . . . 0.0 111.56 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.633 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 20.6 ptmt -53.56 -41.7 66.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.352 1.061 . . . . 0.0 113.193 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -31.71 49.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.457 0.703 . . . . 0.0 110.868 -172.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.99 85.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.672 0.789 . . . . 0.0 110.357 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.72 -34.67 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -68.85 -49.42 58.51 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.84 0.856 . . . . 0.0 111.304 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 23.7 m -93.64 1.17 56.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.65 -79.01 1.44 Allowed Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.31 -17.67 2.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.02 0.928 . . . . 0.0 111.241 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 33.3 tt0 -57.37 -50.31 73.36 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.293 0.637 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.9 mt -103.0 158.14 16.49 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.899 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.19 153.41 25.68 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.232 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 44' ' ' SER . 31.0 mt -65.4 128.05 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.2 -8.42 18.32 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.213 0.321 . . . . 0.0 112.77 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 90' ' ' ILE . 40.8 m -68.93 139.49 55.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.308 0.643 . . . . 0.0 109.309 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -124.68 103.24 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -81.64 98.93 8.6 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.67 106.29 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 9.1 m0 -88.32 113.37 23.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.742 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.96 -171.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.78 0.832 . . . . 0.0 108.899 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -86.94 158.46 19.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.491 0.316 . . . . 0.0 110.456 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 70.1 t80 -60.66 97.44 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.522 1.129 . . . . 0.0 112.039 -172.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -120.77 104.81 10.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 109.501 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -68.92 -0.4 5.52 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.04 -20.57 21.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.603 0.761 . . . . 0.0 110.834 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.465 HG23 HD13 ' A' ' 104' ' ' ILE . 48.0 mm -66.18 128.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.45 164.9 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.7 1.2 . . . . 0.0 108.56 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.23 65.4 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.451 0.7 . . . . 0.0 111.22 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.1 p -87.4 40.19 0.91 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.166 0.986 . . . . 0.0 110.877 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -141.72 145.81 35.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.115 0.966 . . . . 0.0 108.861 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -108.8 138.7 44.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.524 HG13 HG22 ' A' ' 104' ' ' ILE . 22.3 mm -107.33 90.75 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 33.7 ttmt -83.71 115.85 22.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.526 HG23 HD23 ' A' ' 87' ' ' LEU . 97.4 t -72.85 99.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 m -71.04 -26.46 63.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 111.566 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -155.49 140.73 17.57 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.942 0.897 . . . . 0.0 108.733 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.65 -154.68 26.08 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.313 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.62 -37.5 21.67 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.704 2.269 . . . . 0.0 111.369 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.601 HD13 HD13 ' A' ' 87' ' ' LEU . 89.0 mt -103.89 42.12 1.22 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.476 1.11 . . . . 0.0 109.74 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.63 101.48 0.25 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.863 0.865 . . . . 0.0 111.602 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.88 -19.13 11.3 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.412 1.006 . . . . 0.0 112.307 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HD2' HD21 ' A' ' 82' ' ' LEU . 92.7 mtt180 -83.13 141.16 32.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.478 0.711 . . . . 0.0 111.241 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 51.4 t -103.0 106.99 21.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 124.834 1.254 . . . . 0.0 108.408 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.601 HD13 HD13 ' A' ' 82' ' ' LEU . 2.6 mm? -90.07 128.73 36.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.527 0.731 . . . . 0.0 109.167 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.82 119.0 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.282 0.633 . . . . 0.0 110.059 -173.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 106' ' ' CYS . 45.6 mt -56.36 134.31 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.417 0.687 . . . . 0.0 111.26 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.63 HG21 ' HE ' ' A' ' 107' ' ' ARG . 11.5 pt -112.1 96.34 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.724 175.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.27 -84.76 0.37 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.126 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -170.33 158.83 6.15 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.212 1.005 . . . . 0.0 109.523 -172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 57.8 Cg_endo -69.62 125.07 11.79 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.23 1.953 . . . . 0.0 111.57 171.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -103.93 109.47 62.35 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.063 0.945 . . . . 0.0 109.508 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.29 150.5 53.01 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.693 2.262 . . . . 0.0 111.04 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.73 175.11 7.5 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.3 67.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.385 0.674 . . . . 0.0 112.508 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.89 -13.55 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.369 0.668 . . . . 0.0 112.528 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.52 26.07 15.87 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.391 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 t -82.25 -25.5 34.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.299 0.639 . . . . 0.0 110.012 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -138.83 168.59 19.48 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 15.4 tp -128.54 108.22 10.35 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.95 109.78 18.41 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.524 HG22 HG13 ' A' ' 75' ' ' ILE . 13.1 mm -90.09 102.88 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.586 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.4 pt? -81.12 105.13 12.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.182 0.991 . . . . 0.0 108.362 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 61.5 m -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.921 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.63 ' HE ' HG21 ' A' ' 90' ' ' ILE . 21.4 ttp85 -146.39 140.65 26.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.67 118.92 8.3 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 111.096 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.78 41.84 3.05 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.02 29.06 1.21 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.386 1.474 . . . . 0.0 108.356 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.89 76.81 1.64 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.458 1.503 . . . . 0.0 110.718 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? . . . . . 0 C--O 1.251 1.181 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.24 112.67 21.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.374 0.669 . . . . 0.0 109.537 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 mm -75.89 149.47 6.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.22 59.32 2.33 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 123.376 0.512 . . . . 0.0 112.588 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.59 -36.5 74.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.034 1.333 . . . . 0.0 111.579 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 54.3 mt -69.57 80.01 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.231 0.957 . . . . 0.0 110.574 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -91.25 -26.95 18.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.922 1.289 . . . . 0.0 110.896 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.22 -172.64 2.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.609 1.564 . . . . 0.0 109.719 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.494 ' HG2' HG22 ' A' ' 34' ' ' THR . 14.6 ttp180 -155.77 138.75 15.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.879 0.872 . . . . 0.0 108.776 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.01 144.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.387 0.675 . . . . 0.0 111.122 -173.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -92.0 120.93 33.1 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.524 1.13 . . . . 0.0 109.902 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.43 95.52 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -73.59 99.26 3.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 109.928 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.556 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 21.4 p -79.87 146.42 32.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.603 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 27' ' ' GLU . 54.5 tp -92.86 106.77 18.68 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.75 0.42 . . . . 0.0 110.333 -172.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -94.69 101.87 13.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.52 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 48.6 mt-30 -77.56 93.95 4.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.58 0.752 . . . . 0.0 109.164 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.2 m -92.78 123.52 36.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.347 1.059 . . . . 0.0 110.404 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -74.59 163.13 28.09 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.031 0.532 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.28 165.0 12.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.465 1.106 . . . . 0.0 108.502 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.2 -15.84 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -95.84 -6.69 38.84 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.1 6.39 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.077 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.08 136.28 53.17 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.132 0.973 . . . . 0.0 108.827 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.35 120.22 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.4 123.9 51.31 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.06 0.944 . . . . 0.0 109.707 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HB3' HD12 ' A' ' 15' ' ' LEU . 3.5 mp0 -81.57 116.92 21.56 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.781 0.833 . . . . 0.0 110.118 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 p -130.92 153.04 49.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.109 0.964 . . . . 0.0 108.806 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -110.4 108.86 19.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.503 0.721 . . . . 0.0 109.491 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 4.4 pt-20 -93.03 133.8 35.81 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.7 127.46 31.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.15 -113.75 3.8 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -99.61 124.93 45.28 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.427 0.691 . . . . 0.0 109.847 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 10.1 m -101.04 94.88 6.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -117.04 168.51 10.19 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.206 0.602 . . . . 0.0 111.773 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 35.7 m95 -64.19 136.36 57.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.916 0.886 . . . . 0.0 112.573 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.596 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -139.24 165.97 25.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.295 1.038 . . . . 0.0 111.672 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 22.5 t -120.42 92.12 3.7 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 166.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -90.72 98.19 8.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.016 0.926 . . . . 0.0 108.951 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -119.07 116.04 25.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.546 0.738 . . . . 0.0 109.408 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.507 ' HG2' HG23 ' A' ' 59' ' ' VAL . 81.9 mtp -65.9 130.7 44.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.628 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 22.3 m -70.54 146.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 111.021 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t -84.53 174.78 9.74 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.405 ' HA ' HG12 ' A' ' 56' ' ' ILE . 42.6 p -60.73 -25.92 66.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -26.1 68.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.628 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 16.3 mm-40 -68.2 -41.46 81.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.156 0.582 . . . . 0.0 110.719 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.15 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.907 0.754 . . . . 0.0 110.86 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -64.86 -40.31 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.366 0.666 . . . . 0.0 110.521 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.0 m -66.48 -49.74 65.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.687 0.795 . . . . 0.0 111.943 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.602 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 76.6 p -91.42 -19.48 22.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.462 0.705 . . . . 0.0 112.39 -171.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.34 2.22 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.56 -15.04 1.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.426 0.691 . . . . 0.0 112.036 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 24.4 mm-40 -59.82 -43.75 94.36 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.2 0.6 . . . . 0.0 111.297 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.94 149.33 29.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.55 167.46 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.814 0.846 . . . . 0.0 109.644 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 44' ' ' SER . 26.4 mt -76.28 114.22 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 4.76 59.73 Favored Glycine 0 N--CA 1.467 0.706 0 CA-C-O 119.625 -0.542 . . . . 0.0 112.95 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.465 HG23 HD13 ' A' ' 90' ' ' ILE . 18.3 m -56.54 113.74 1.74 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.293 0.568 . . . . 0.0 109.753 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 41' ' ' MET . 49.3 t -73.18 107.25 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.189 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -90.98 134.02 34.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 80.7 mt -133.35 108.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -168.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 32.5 m0 -91.25 124.3 35.36 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 123.528 0.731 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.35 163.84 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -52.21 149.71 5.16 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.746 0.418 . . . . 0.0 111.627 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -56.83 108.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.017 0.823 . . . . 0.0 109.968 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.464 ' HD3' HD13 ' A' ' 69' ' ' ILE . 46.9 ttt85 -135.96 116.69 14.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -168.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -84.44 9.05 14.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.625 1.17 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 20.9 t70 -92.85 -19.57 21.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.245 1.418 . . . . 0.0 110.495 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.464 HD13 ' HD3' ' A' ' 66' ' ' ARG . 13.2 mm -84.32 139.94 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.483 0.713 . . . . 0.0 109.577 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -130.65 166.48 20.6 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.76 -23.71 66.79 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.411 0.684 . . . . 0.0 111.437 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -85.44 41.93 0.92 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.191 0.996 . . . . 0.0 110.433 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 m -131.72 147.57 52.51 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 123.778 0.831 . . . . 0.0 109.081 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -115.17 120.99 41.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 104' ' ' ILE . 18.2 mm -88.4 91.28 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.32 1.048 . . . . 0.0 109.507 -173.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -91.18 120.18 31.9 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG22 HD21 ' A' ' 87' ' ' LEU . 88.7 t -71.38 122.28 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.824 0.345 . . . . 0.0 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -89.44 -30.53 18.25 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 109.583 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 m -143.57 110.51 5.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.065 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.68 -170.08 30.52 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.82 -0.434 . . . . 0.0 113.736 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.26 -29.0 26.98 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.839 2.359 . . . . 0.0 111.735 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.3 mt -98.26 22.14 9.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.656 0.782 . . . . 0.0 111.018 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.14 124.32 19.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.005 0.522 . . . . 0.0 110.715 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.08 34.17 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.111 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -88.88 143.24 27.01 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.439 0.695 . . . . 0.0 110.744 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -105.99 100.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 122.194 0.997 . . . . 0.0 109.54 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 ' HG ' HG11 ' A' ' 59' ' ' VAL . 2.1 mm? -83.24 113.08 20.43 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.953 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.473 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.8 139.8 32.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 109.094 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.477 HD13 HD12 ' A' ' 75' ' ' ILE . 63.1 mt -78.53 108.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 58' ' ' THR . 18.5 pt -92.16 61.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 122.152 0.977 . . . . 0.0 110.133 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.92 -122.03 1.12 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.426 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -150.88 143.82 16.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.976 0.91 . . . . 0.0 109.139 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 111.97 1.12 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 110.499 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.47 117.43 36.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.128 0.971 . . . . 0.0 108.845 -167.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.56 158.57 49.12 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.574 2.183 . . . . 0.0 112.367 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.1 -174.54 4.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.837 0.455 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.08 -48.01 66.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.487 0.715 . . . . 0.0 111.705 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.97 58.86 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.598 0.759 . . . . 0.0 112.798 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 71.39 14.33 6.44 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -85.05 -1.72 57.16 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.315 1.046 . . . . 0.0 112.236 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -163.41 161.32 24.3 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.812 0.815 . . . . 0.0 110.129 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.74 109.21 21.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -90.67 108.87 20.09 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 0.0 109.666 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.53 HG22 HG13 ' A' ' 75' ' ' ILE . 9.3 mm -88.45 145.38 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.52 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.1 pt? -120.48 132.93 55.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 60.2 m -153.76 175.64 13.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.34 0.656 . . . . 0.0 111.017 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.6 166.62 22.22 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 108.497 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 54.3 mp0 -73.22 156.16 38.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 173.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.63 28.3 16.47 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -172.54 34.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.788 1.235 . . . . 0.0 109.281 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -60.95 -16.71 45.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.969 1.308 . . . . 0.0 112.456 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.505 1.122 . . . . 0.0 110.678 175.35 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -142.64 126.04 16.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.461 0.704 . . . . 0.0 109.412 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG22 ' H ' ' A' ' 5' ' ' ARG . 63.3 mt -63.16 129.89 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.99 22.34 8.34 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.576 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.593 ' H ' HG22 ' A' ' 3' ' ' ILE . 10.3 mpt_? 59.39 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.071 1.748 . . . . 0.0 113.472 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.91 164.3 26.33 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.085 1.354 . . . . 0.0 111.567 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -129.44 -30.06 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.663 0.785 . . . . 0.0 111.839 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -109.96 -166.91 1.13 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.045 1.738 . . . . 0.0 109.858 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 79' ' ' THR . 25.1 ttm180 -152.78 140.92 20.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.939 0.896 . . . . 0.0 109.166 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.613 HD12 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.15 156.78 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.804 0.842 . . . . 0.0 110.014 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -103.37 123.14 46.27 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.484 1.114 . . . . 0.0 108.992 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.19 108.95 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -85.83 111.41 20.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.71 0.767 . . . . 0.0 110.308 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -84.75 142.7 29.64 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.782 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.541 HD13 ' HB3' ' A' ' 27' ' ' GLU . 50.1 tp -97.85 113.88 25.8 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.748 0.819 . . . . 0.0 109.634 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HZ3' ' HB3' ' A' ' 16' ' ' LYS . 5.6 ttpm? -99.77 113.19 25.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.797 0.839 . . . . 0.0 109.657 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -86.56 103.35 14.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.799 0.84 . . . . 0.0 109.402 173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 m -93.9 165.16 12.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -114.1 165.95 12.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.859 0.754 . . . . 0.0 109.835 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB2' HD13 ' A' ' 26' ' ' LEU . 18.3 t70 -108.72 161.8 14.76 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.52 -14.21 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -103.25 -10.16 18.97 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.66 15.42 20.76 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.238 -0.892 . . . . 0.0 115.32 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.78 145.35 24.65 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.534 1.167 . . . . 0.0 109.485 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.51 122.48 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.312 0.645 . . . . 0.0 111.15 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 20' ' ' ASP . 5.3 mp -96.84 108.48 21.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.339 1.056 . . . . 0.0 108.565 175.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' HB3' HD13 ' A' ' 15' ' ' LEU . 44.4 mt-10 -80.96 107.1 13.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.371 0.669 . . . . 0.0 109.605 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -114.68 146.49 40.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.755 0.822 . . . . 0.0 110.2 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -111.18 106.23 15.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.698 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -106.1 143.86 33.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.78 137.94 48.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.821 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.26 -116.67 3.77 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -99.08 137.35 37.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.1 m -108.82 96.73 6.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.767 0.827 . . . . 0.0 108.855 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.59 175.24 5.57 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.38 0.609 . . . . 0.0 111.276 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -70.69 135.42 48.29 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.477 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -136.5 173.75 11.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.336 1.054 . . . . 0.0 111.074 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.2 m -130.38 96.25 4.1 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 160.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 61' ' ' ILE . 2.6 p -94.41 102.36 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -173.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.27 122.58 44.36 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.779 0.831 . . . . 0.0 109.123 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.517 ' SD ' HD21 ' A' ' 82' ' ' LEU . 72.1 mtp -72.22 145.93 47.64 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.1 134.51 30.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -83.45 176.33 9.15 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 123.53 0.732 . . . . 0.0 109.776 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p -60.13 -31.12 69.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -56.56 -49.67 74.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.671 0.788 . . . . 0.0 111.012 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.58 -44.07 91.83 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.845 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.98 -45.68 90.01 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 124.281 0.988 . . . . 0.0 112.438 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.93 -46.85 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.332 0.653 . . . . 0.0 111.217 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.5 m -65.6 -29.09 69.63 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.642 0.777 . . . . 0.0 112.216 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 89.8 p -90.6 -17.42 26.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.521 0.728 . . . . 0.0 111.996 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.02 -79.21 1.72 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.74 12.09 2.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.292 0.637 . . . . 0.0 111.05 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.4 tp10 -77.87 -53.55 7.35 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.51 HD21 HG23 ' A' ' 58' ' ' THR . 81.1 mt -106.49 147.22 29.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.862 0.865 . . . . 0.0 108.808 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.28 158.75 41.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.1 mt -62.63 120.39 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.64 -11.12 13.99 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 123.383 0.427 . . . . 0.0 112.59 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.51 HG23 HD21 ' A' ' 54' ' ' LEU . 25.4 m -71.88 140.21 49.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 166.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 38.7 t -122.67 122.28 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.494 0.718 . . . . 0.0 110.482 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -93.81 135.89 34.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 75' ' ' ILE . 66.1 mt -132.6 107.98 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.77 116.02 28.29 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.257 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.23 159.06 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -55.69 136.64 50.58 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 168.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 56.0 t80 -48.17 114.66 0.98 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.568 1.547 . . . . 0.0 113.212 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -138.23 119.61 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.78 0.832 . . . . 0.0 109.231 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HZ2' ' HB2' ' A' ' 67' ' ' LYS . 9.6 mtmp? -79.84 7.57 8.49 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.8 0.44 . . . . 0.0 110.992 172.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.34 -22.89 20.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.337 0.655 . . . . 0.0 110.183 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.91 130.81 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.71 162.67 23.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.708 0.803 . . . . 0.0 109.171 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.96 -15.64 63.54 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.302 0.641 . . . . 0.0 112.052 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.2 p -83.16 2.82 33.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.563 0.745 . . . . 0.0 111.649 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -101.31 137.74 39.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -106.17 134.77 48.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 61' ' ' ILE . 30.3 mm -94.07 102.63 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 123.041 0.536 . . . . 0.0 110.077 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.4 ttpt -103.78 112.72 25.8 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.62 120.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.24 0.616 . . . . 0.0 111.594 -173.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -79.45 -31.9 42.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.696 1.199 . . . . 0.0 111.749 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 9' ' ' ARG . 11.7 t -160.51 142.79 12.84 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.14 -160.63 24.42 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.832 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.49 -27.36 46.59 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.911 2.407 . . . . 0.0 112.639 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD21 ' SD ' ' A' ' 41' ' ' MET . 54.9 mt -115.77 31.64 6.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.723 0.809 . . . . 0.0 111.156 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.02 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.494 0.718 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.58 -19.0 4.83 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.082 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HD2' HD23 ' A' ' 82' ' ' LEU . 91.4 mtt-85 -86.51 142.69 28.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.291 0.637 . . . . 0.0 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.441 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 4.5 p -107.25 95.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.026 0.917 . . . . 0.0 108.995 172.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 108' ' ' GLU . 1.2 mm? -77.33 128.38 34.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.433 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -99.7 141.5 32.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.744 . . . . 0.0 109.17 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.62 122.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 pt -100.02 86.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.12 -94.18 0.54 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -159.15 145.83 12.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.964 0.905 . . . . 0.0 110.041 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.39 114.89 3.06 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.835 2.357 . . . . 0.0 111.128 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.94 108.76 48.16 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.876 0.87 . . . . 0.0 109.346 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.1 143.93 55.77 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.057 2.505 . . . . 0.0 112.331 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.41 168.9 19.24 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.194 0.452 . . . . 0.0 110.723 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.91 -27.5 65.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.005 0.922 . . . . 0.0 112.877 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.4 -7.25 42.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 62.13 29.78 17.63 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.447 1.099 . . . . 0.0 111.491 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 p -90.55 -17.98 26.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.881 0.873 . . . . 0.0 111.434 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -158.78 171.15 20.61 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.616 0.722 . . . . 0.0 110.78 -168.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.57 113.07 17.58 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.78 96.25 5.56 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.584 HG23 ' SG ' ' A' ' 106' ' ' CYS . 22.8 mm -88.71 97.16 6.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.6 HD21 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -79.01 130.51 35.61 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.077 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.584 ' SG ' HG23 ' A' ' 104' ' ' ILE . 84.7 m -147.78 173.14 13.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.376 1.07 . . . . 0.0 108.875 -170.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -138.41 153.71 48.88 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.523 ' HA ' HD11 ' A' ' 87' ' ' LEU . 38.3 tt0 -44.33 125.73 4.79 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.724 0.81 . . . . 0.0 112.848 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 86' ' ' VAL . . . -89.87 52.0 3.56 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.472 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.54 142.22 48.53 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.109 0.964 . . . . 0.0 108.885 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.44 -28.7 61.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.669 0.388 . . . . 0.0 110.532 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.1 tttm . . . . . 0 C--O 1.249 1.054 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.736 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.31 150.29 35.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.303 1.041 . . . . 0.0 109.016 174.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.13 34.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 124.001 0.921 . . . . 0.0 112.174 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.04 50.29 4.38 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.296 0.474 . . . . 0.0 114.047 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -146.18 170.92 15.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.178 0.991 . . . . 0.0 109.064 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 37' ' ' ALA . 43.7 mt -115.67 117.89 31.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.186 0.594 . . . . 0.0 109.733 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -123.08 -28.63 4.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.388 0.675 . . . . 0.0 111.775 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -101.82 -174.18 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HB2' HG21 ' A' ' 79' ' ' THR . 94.2 mtt180 -136.38 142.22 43.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.68 0.792 . . . . 0.0 109.601 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 pt -133.71 166.01 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 108.779 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -132.81 134.93 45.32 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.436 HG23 ' HB3' ' A' ' 73' ' ' SER . 51.4 mm -81.91 116.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.674 0.609 . . . . 0.0 109.666 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -89.98 104.26 16.84 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.39 139.37 34.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.927 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' HB3' ' A' ' 27' ' ' GLU . 57.4 tp -89.51 98.62 11.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.226 0.467 . . . . 0.0 109.902 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.2 99.31 6.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 110.312 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.509 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 51.5 mt-30 -96.56 79.37 3.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -98.58 126.08 44.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.043 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -76.64 162.32 27.84 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.185 0.994 . . . . 0.0 111.482 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 11.3 t70 -113.65 164.35 13.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.733 0.813 . . . . 0.0 109.835 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.49 -14.62 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.669 0.788 . . . . 0.0 112.859 172.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 p -100.53 -20.15 15.85 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.91 39.97 3.22 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.007 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mm-40 -97.44 146.72 24.93 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.813 0.845 . . . . 0.0 108.921 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.8 100.32 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.38 92.13 7.48 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 15' ' ' LEU . 38.5 mt-10 -82.63 106.29 14.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.987 0.915 . . . . 0.0 109.046 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -126.05 165.48 18.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.447 1.099 . . . . 0.0 109.474 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.69 102.73 10.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.28 121.59 29.94 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.787 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.51 126.28 26.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.839 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.55 -112.77 3.6 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -120.53 133.72 55.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.143 0.577 . . . . 0.0 109.944 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.6 m -85.31 107.45 17.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.53 0.732 . . . . 0.0 109.693 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.1 pt? -108.06 164.53 12.2 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 0.0 110.863 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -75.86 130.4 38.49 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.608 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HA ' HD22 ' A' ' 6' ' ' LEU . . . -147.24 -176.51 5.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.816 0.846 . . . . 0.0 111.268 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -134.27 104.33 6.12 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG12 HG21 ' A' ' 77' ' ' VAL . 2.3 p -105.61 114.42 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 109.186 -172.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -136.14 153.62 51.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.167 1.387 . . . . 0.0 109.521 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.63 ' SD ' HD23 ' A' ' 82' ' ' LEU . 76.6 mtp -85.17 136.33 33.58 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 58' ' ' THR . 20.2 m -68.45 137.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -97.22 -173.94 2.81 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.86 0.864 . . . . 0.0 110.865 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 p -54.48 -34.44 61.58 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.268 1.027 . . . . 0.0 112.182 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -51.76 -52.62 47.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.856 0.863 . . . . 0.0 110.902 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.42 -41.58 76.16 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.447 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.93 78.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.619 . . . . 0.0 112.353 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.23 -33.75 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.678 0.791 . . . . 0.0 110.795 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 t -71.91 -44.34 63.85 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.331 0.652 . . . . 0.0 111.552 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 73.6 p -104.33 0.28 29.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.29 0.636 . . . . 0.0 112.479 -174.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.77 -70.39 2.93 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.04 -2.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.09 0.556 . . . . 0.0 112.206 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 38.0 tt0 -65.07 -50.94 64.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.108 0.563 . . . . 0.0 110.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.06 60.79 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.47 156.63 26.48 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.82 122.83 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -171.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.38 -13.04 16.04 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.695 0.665 . . . . 0.0 112.031 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 42' ' ' VAL . 87.3 m -79.65 139.46 37.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.493 HG11 ' HG ' ' A' ' 87' ' ' LEU . 42.8 t -110.67 116.5 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.46 0.704 . . . . 0.0 110.914 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -83.67 128.42 34.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.628 1.171 . . . . 0.0 110.408 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.5 HD12 ' SG ' ' A' ' 106' ' ' CYS . 51.3 mt -135.19 110.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -98.98 131.69 44.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.109 0.564 . . . . 0.0 110.438 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.29 161.04 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -63.75 151.04 43.19 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 164.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -53.49 118.64 4.03 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.034 0.934 . . . . 0.0 111.157 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.438 HH11 HD11 ' A' ' 35' ' ' LEU . 56.4 ttt180 -136.86 128.08 28.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.75 1.83 40.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.275 1.03 . . . . 0.0 112.457 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.89 -21.76 19.65 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.489 0.716 . . . . 0.0 111.31 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.5 mm -81.0 131.36 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 110.249 -170.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -131.66 158.65 40.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.092 0.957 . . . . 0.0 109.747 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 92' ' ' GLN . . . -66.99 -25.82 66.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.047 0.939 . . . . 0.0 112.312 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -84.13 8.9 14.08 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.795 0.838 . . . . 0.0 111.758 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.436 ' HB3' HG23 ' A' ' 12' ' ' ILE . 22.8 m -111.5 120.02 40.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.607 0.763 . . . . 0.0 109.177 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -83.1 136.88 34.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.78 0.432 . . . . 0.0 110.41 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 61' ' ' ILE . 33.1 mm -96.36 101.8 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 0.0 110.114 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 29.9 ttpt -90.31 120.0 31.08 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.241 0.616 . . . . 0.0 109.982 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 39' ' ' VAL . 2.7 p -73.55 115.62 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.347 0.659 . . . . 0.0 110.805 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -81.3 -24.8 36.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.865 0.866 . . . . 0.0 111.814 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.447 HG21 ' HB2' ' A' ' 9' ' ' ARG . 10.6 t -168.24 137.86 2.48 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.857 0.863 . . . . 0.0 108.725 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.37 -165.96 29.53 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.462 -174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.15 -9.02 22.93 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 123.388 2.725 . . . . 0.0 112.656 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD23 ' SD ' ' A' ' 41' ' ' MET . 79.9 mt -119.08 6.66 11.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.169 0.988 . . . . 0.0 111.2 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -42.5 115.04 0.65 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.846 1.258 . . . . 0.0 113.58 -165.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.02 25.22 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.48 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -94.77 172.58 8.08 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.207 0.504 . . . . 0.0 110.593 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 42.5 t -124.08 114.08 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.307 0.643 . . . . 0.0 109.645 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.595 HD13 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -90.25 140.84 29.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.0 143.71 32.22 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.52 130.61 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 107' ' ' ARG . 29.7 pt -102.5 128.23 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 122.881 0.472 . . . . 0.0 109.82 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.02 -93.34 1.18 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.936 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.452 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 12.2 pt20 -161.51 156.35 19.97 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.399 1.08 . . . . 0.0 108.878 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.1 109.87 2.28 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.871 1.714 . . . . 0.0 110.274 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.4 113.31 38.21 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.32 1.048 . . . . 0.0 108.949 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.58 144.55 32.02 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.335 2.023 . . . . 0.0 111.665 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -60.76 149.57 35.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.415 0.686 . . . . 0.0 112.09 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.04 -28.77 65.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.032 0.933 . . . . 0.0 110.978 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.69 -5.46 45.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.591 0.756 . . . . 0.0 111.368 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? 61.31 18.72 9.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.837 1.255 . . . . 0.0 113.377 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -81.28 -10.49 59.57 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.361 0.528 . . . . 0.0 111.28 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -155.6 -179.13 7.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.349 0.595 . . . . 0.0 110.853 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.436 HD12 HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -137.64 112.22 8.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.0 97.78 2.92 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 HG23 ' SG ' ' A' ' 106' ' ' CYS . 20.0 mm -85.31 86.96 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -79.11 136.03 37.02 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 61' ' ' ILE . 62.9 m -146.41 170.25 17.21 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 90' ' ' ILE . 37.2 ttp180 -142.16 144.49 33.47 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 172.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -41.6 118.95 1.16 Allowed 'General case' 0 C--N 1.362 1.11 0 O-C-N 124.43 1.081 . . . . 0.0 110.998 -177.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.44 51.01 3.32 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.927 -165.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.45 89.9 0.52 Allowed 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.107 0.563 . . . . 0.0 109.656 171.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.537 ' HG3' ' HG2' ' A' ' 112' ' ' LYS . 9.3 pt-20 -71.83 -31.66 66.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.537 ' HG2' ' HG3' ' A' ' 111' ' ' GLU . 24.3 pttm . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.85 0.86 . . . . 0.0 109.223 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -148.6 -168.63 3.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.436 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.8 mm -75.33 89.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.49 50.89 3.59 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.798 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -68.68 138.21 54.77 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.045 0.938 . . . . 0.0 110.298 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.87 81.31 7.16 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.854 0.835 . . . . 0.0 108.783 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.09 -22.55 45.1 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.651 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -103.6 -175.39 2.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.573 1.149 . . . . 0.0 110.283 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.504 ' HB3' HG22 ' A' ' 34' ' ' THR . 51.6 mtm180 -141.38 148.25 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 109.399 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -140.79 145.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.891 0.876 . . . . 0.0 108.687 177.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 m -96.23 122.85 39.54 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.551 0.614 . . . . 0.0 109.976 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.7 mm -75.54 103.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.575 0.75 . . . . 0.0 109.892 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.415 ' NE2' ' HB2' ' A' ' 76' ' ' LYS . 78.5 mt-30 -85.55 95.72 9.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.511 0.672 . . . . 0.0 109.882 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 9.4 p -79.09 150.09 31.91 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.661 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.7 tp -88.35 105.0 17.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -170.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -89.73 96.61 10.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.037 0.935 . . . . 0.0 109.807 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 45.9 mt-30 -84.4 97.44 9.5 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -106.14 117.7 34.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.614 0.766 . . . . 0.0 109.336 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -72.07 162.48 29.4 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 120.629 0.252 . . . . 0.0 110.506 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.88 163.6 15.32 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.801 0.84 . . . . 0.0 109.361 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.6 -21.38 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.95 0.9 . . . . 0.0 113.018 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -93.85 -13.36 27.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.85 40.31 4.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.157 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.27 137.86 42.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 109.603 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -90.75 96.42 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.96 96.14 8.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' A' ' 15' ' ' LEU . 49.4 mt-10 -79.97 111.58 16.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -125.58 169.15 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.857 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 73' ' ' SER . 79.6 m95 -119.97 109.41 15.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 7.4 pt-20 -84.31 115.11 22.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.5 135.79 55.6 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.202 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.57 -119.84 3.14 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.803 -168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -99.8 125.21 45.68 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -170.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 3.7 m -88.04 93.29 9.44 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -110.89 170.41 8.11 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -64.38 120.65 12.64 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.2 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 10' ' ' ILE . . . -141.87 176.53 8.86 Favored 'General case' 0 C--O 1.209 -1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 111.979 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 m -135.38 108.41 7.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 61' ' ' ILE . 2.0 p -108.16 109.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.958 0.903 . . . . 0.0 110.837 -172.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.05 138.66 49.7 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 0.0 109.044 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.499 ' SD ' HD22 ' A' ' 82' ' ' LEU . 77.1 mtp -75.45 145.34 41.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.32 130.8 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 O-C-N 123.691 0.619 . . . . 0.0 109.68 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 m -87.94 -175.93 5.29 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 123.4 0.68 . . . . 0.0 110.706 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.8 p -59.9 -33.91 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.791 0.837 . . . . 0.0 111.502 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.86 -47.52 67.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.806 0.843 . . . . 0.0 111.106 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.21 -45.22 81.53 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.114 0.884 . . . . 0.0 111.165 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -51.97 66.4 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.922 0.764 . . . . 0.0 111.217 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.23 -38.23 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.141 0.977 . . . . 0.0 111.581 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 t -77.09 -28.57 54.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.99 0.516 . . . . 0.0 111.556 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.426 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 50.7 m -94.79 -9.86 33.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 0.0 111.894 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.94 -74.62 2.27 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.25 2.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.767 0.827 . . . . 0.0 111.047 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 1.9 tm-20 -63.95 -61.15 2.46 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.81 142.01 30.1 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.08 151.34 45.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.36 0.664 . . . . 0.0 109.557 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.85 119.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.834 0.854 . . . . 0.0 110.765 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.28 -12.64 16.46 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.281 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 HG22 HD13 ' A' ' 90' ' ' ILE . 86.3 m -73.47 154.14 40.06 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 164.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 22.0 t -132.2 115.41 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -87.45 132.2 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.504 HG23 HG23 ' A' ' 75' ' ' ILE . 41.8 mt -138.86 109.0 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.781 0.832 . . . . 0.0 109.037 -170.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CE3' ' HD2' ' A' ' 101' ' ' ARG . 62.0 m95 -95.0 122.97 38.2 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.8 pt -116.62 165.32 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -54.25 140.17 33.72 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 164.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.407 ' HE1' ' HB3' ' A' ' 95' ' ' PRO . 51.8 t80 -54.6 129.51 36.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.007 1.323 . . . . 0.0 111.745 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.4 mtt85 -150.96 129.32 12.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.788 0.835 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -81.79 -13.9 57.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.252 1.021 . . . . 0.0 111.02 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.05 -21.47 22.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.765 0.426 . . . . 0.0 110.747 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.08 128.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.663 0.385 . . . . 0.0 110.199 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.679 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 67.2 t30 -140.73 168.09 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.387 1.075 . . . . 0.0 109.235 -177.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.62 -7.66 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.9 p -86.08 19.99 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.345 1.058 . . . . 0.0 112.274 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.439 ' HA ' ' HZ3' ' A' ' 29' ' ' TRP . 72.5 m -130.09 172.77 11.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.609 0.764 . . . . 0.0 110.777 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -119.92 140.66 50.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.899 0.88 . . . . 0.0 108.952 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.504 HG23 HG23 ' A' ' 61' ' ' ILE . 50.1 mm -98.08 105.49 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.601 0.76 . . . . 0.0 109.617 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 88.2 tttt -90.44 131.09 36.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG21 HD21 ' A' ' 87' ' ' LEU . 67.8 t -83.9 123.09 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.785 0.434 . . . . 0.0 110.579 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -85.64 -38.9 17.87 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.466 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 p -146.76 128.41 15.17 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.32 -169.69 29.62 Favored Glycine 0 N--CA 1.469 0.895 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.244 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.42 -1.24 10.75 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.017 2.478 . . . . 0.0 112.855 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.499 HD22 ' SD ' ' A' ' 41' ' ' MET . 89.4 mt -130.03 32.98 4.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.004 0.922 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.83 104.95 0.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.59 0.756 . . . . 0.0 111.685 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.32 -18.36 12.14 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.959 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.15 158.31 20.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 110.954 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.8 p -124.96 98.6 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.552 1.168 . . . . 0.0 110.189 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.5 mm? -82.54 148.77 27.88 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.294 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -110.76 141.07 44.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.051 0.94 . . . . 0.0 108.508 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.71 98.69 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.49 HG23 ' HZ2' ' A' ' 112' ' ' LYS . 39.2 pt -80.86 146.57 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.098 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.12 -105.45 2.06 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.755 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -161.8 144.94 9.19 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 123.519 0.728 . . . . 0.0 109.897 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 62.8 Cg_endo -69.7 125.74 12.53 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.196 1.931 . . . . 0.0 110.678 173.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 111.7 54.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.428 ' HA ' HD21 ' A' ' 102' ' ' LEU . 74.4 Cg_exo -53.83 142.59 62.63 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.205 2.603 . . . . 0.0 113.559 175.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 18.1 t70 -51.74 156.09 1.51 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.929 0.892 . . . . 0.0 112.639 173.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.16 77.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.326 1.05 . . . . 0.0 112.013 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.97 -6.58 35.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.313 0.645 . . . . 0.0 111.491 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 25.57 15.27 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.783 1.233 . . . . 0.0 112.249 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.9 p -83.28 -4.73 58.72 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.327 0.584 . . . . 0.0 111.334 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 17.3 ptt180 -169.12 -176.46 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.661 1.584 . . . . 0.0 107.894 -168.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 95' ' ' PRO . 0.1 OUTLIER -137.16 118.16 14.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -173.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.69 108.51 14.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 mm -100.17 153.15 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -133.63 146.61 51.07 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 170.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 71.3 m -150.21 171.99 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.281 -168.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -160.62 158.19 28.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -44.16 151.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.469 1.108 . . . . 0.0 112.776 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.98 42.57 3.11 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.753 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.96 166.73 10.61 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.785 1.234 . . . . 0.0 108.843 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 64.77 14.47 9.17 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.282 1.033 . . . . 0.0 112.555 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HZ2' HG23 ' A' ' 90' ' ' ILE . 36.8 ttmt . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.878 0.871 . . . . 0.0 108.786 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -141.3 106.63 5.02 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mt 73.79 -29.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 126.319 1.848 . . . . 0.0 112.086 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.79 55.44 5.01 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 121.926 -0.484 . . . . 0.0 113.053 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -81.6 -16.68 50.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.444 1.098 . . . . 0.0 109.775 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 34.9 mt -91.38 117.84 30.02 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.932 1.293 . . . . 0.0 110.329 -165.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -116.03 1.74 13.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.564 0.746 . . . . 0.0 112.429 -170.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -113.88 -172.59 2.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.939 1.296 . . . . 0.0 109.231 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 50.1 mtm180 -140.57 156.21 46.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.168 0.987 . . . . 0.0 109.234 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.574 HD12 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.35 135.39 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.3 m -90.02 113.58 25.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.116 0.966 . . . . 0.0 109.654 173.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mm -74.06 105.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.845 1.258 . . . . 0.0 109.982 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.467 HE21 ' HB2' ' A' ' 76' ' ' LYS . 65.9 mt-30 -72.76 102.32 3.33 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 174.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -83.03 133.64 35.08 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.624 -1.625 . . . . 0.0 108.294 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HB3' ' A' ' 27' ' ' GLU . 57.3 tp -82.04 96.77 7.85 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -80.82 102.23 9.88 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -81.79 100.97 9.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.298 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -92.39 178.95 5.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -130.11 164.95 23.29 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.605 -0.684 . . . . 0.0 109.448 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 18.5 t70 -107.02 160.22 15.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.142 0.977 . . . . 0.0 108.754 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.5 tt -55.57 -15.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -98.71 -2.84 37.23 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.71 53.99 3.6 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.39 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 15.0 pt-20 -130.62 142.35 50.45 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.65 109.96 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 122.884 0.473 . . . . 0.0 110.998 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -96.26 93.0 6.64 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HB3' HD12 ' A' ' 15' ' ' LEU . 48.5 mt-10 -80.86 131.68 35.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.921 0.488 . . . . 0.0 110.302 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.4 p -138.95 159.81 41.26 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.306 1.042 . . . . 0.0 110.137 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -111.62 120.41 41.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.261 0.624 . . . . 0.0 109.886 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.15 164.14 23.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.725 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.07 138.65 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.114 0.884 . . . . 0.0 108.797 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.56 -107.4 2.42 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -110.07 129.4 55.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.91 0.884 . . . . 0.0 109.131 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 21.4 m -106.5 96.16 6.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.646 0.378 . . . . 0.0 110.183 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.74 172.01 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 122.883 0.473 . . . . 0.0 112.254 -174.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -67.19 129.97 41.62 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.574 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -144.56 172.55 12.81 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 123.769 0.828 . . . . 0.0 111.423 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 6' ' ' LEU . 72.1 m -128.17 109.68 11.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.506 HG23 HG12 ' A' ' 61' ' ' ILE . 2.9 p -100.86 98.0 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.831 0.852 . . . . 0.0 109.611 -172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -112.4 115.24 28.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.827 0.851 . . . . 0.0 110.748 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 69.7 mtp -62.39 133.81 55.58 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.636 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 6.0 m -68.02 153.5 8.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.417 0.448 . . . . 0.0 110.262 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -84.28 171.76 12.44 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.949 0.5 . . . . 0.0 110.458 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -60.18 -27.13 66.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.167 0.587 . . . . 0.0 110.669 173.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -47.85 -46.15 30.9 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.378 1.471 . . . . 0.0 111.897 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.636 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 33.9 mm-40 -67.2 -39.76 86.39 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.504 0.502 . . . . 0.0 111.465 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -51.63 57.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.981 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.57 -52.61 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.344 1.058 . . . . 0.0 112.155 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -71.69 -26.47 62.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.439 0.695 . . . . 0.0 112.486 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 43.0 m -92.7 -7.71 45.97 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.912 0.485 . . . . 0.0 111.411 175.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.53 0.72 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 123.494 0.496 . . . . 0.0 111.894 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.71 -5.93 7.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.791 0.836 . . . . 0.0 111.123 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 12.1 tp10 -66.56 -51.46 56.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.488 0.715 . . . . 0.0 110.669 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.83 155.95 19.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.87 0.868 . . . . 0.0 108.982 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.28 177.63 7.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.758 0.823 . . . . 0.0 110.546 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.73 136.68 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.88 43.91 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -170.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.0 m -70.75 145.13 50.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.044 0.937 . . . . 0.0 109.322 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 45.2 t -126.24 129.81 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.424 1.09 . . . . 0.0 109.214 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.3 140.37 37.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 75' ' ' ILE . 56.1 mt -137.1 143.37 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -170.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -129.22 127.32 41.04 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG23 ' HB1' ' A' ' 37' ' ' ALA . 42.9 pt -126.95 157.89 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.572 1.149 . . . . 0.0 107.931 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -60.28 145.46 47.44 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.448 . . . . 0.0 110.482 168.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.506 ' HA ' HD13 ' A' ' 102' ' ' LEU . 39.5 t80 -57.09 125.12 21.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.676 0.79 . . . . 0.0 110.242 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 32.7 ttt180 -153.29 122.08 6.43 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 123.613 0.571 . . . . 0.0 110.79 -172.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -71.56 -3.16 19.85 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.174 1.389 . . . . 0.0 112.431 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 4.3 t70 -89.92 -23.35 21.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.353 1.061 . . . . 0.0 110.369 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.411 HD13 ' HD3' ' A' ' 66' ' ' ARG . 20.8 mm -87.65 130.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.527 -175.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.697 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 66.3 t30 -145.3 167.95 21.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 109.594 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.26 65.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.165 0.986 . . . . 0.0 111.947 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.8 p -72.16 0.03 10.75 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.343 1.057 . . . . 0.0 112.334 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.9 t -101.14 161.34 13.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.855 0.862 . . . . 0.0 109.565 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 52.9 mtp180 -113.88 147.48 38.38 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 61' ' ' ILE . 49.3 mm -95.6 102.56 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.491 0.316 . . . . 0.0 110.393 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HG3' HG22 ' A' ' 86' ' ' VAL . 58.3 tttm -94.94 102.96 14.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG21 HD21 ' A' ' 87' ' ' LEU . 70.2 t -69.41 124.28 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 120.74 0.305 . . . . 0.0 111.095 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 42.2 t -80.97 -40.11 24.92 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.991 0.917 . . . . 0.0 110.79 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.0 p -146.33 132.64 19.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 108.747 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.0 -170.44 27.91 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 123.517 0.51 . . . . 0.0 112.531 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.03 -17.65 59.85 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.137 2.558 . . . . 0.0 112.059 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.482 HD21 ' SD ' ' A' ' 41' ' ' MET . 29.9 mt -114.25 23.94 12.4 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.742 1.217 . . . . 0.0 110.088 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.85 108.48 1.2 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.892 . . . . 0.0 111.487 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.28 -31.42 5.45 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 123.979 0.8 . . . . 0.0 111.938 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.476 HH12 ' HG3' ' A' ' 108' ' ' GLU . 36.3 mtm180 -89.08 170.71 10.41 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.573 0.749 . . . . 0.0 112.761 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.485 HG22 ' HG3' ' A' ' 76' ' ' LYS . 37.5 t -122.54 104.88 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.454 1.101 . . . . 0.0 110.106 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 77' ' ' VAL . 2.2 mm? -86.63 140.93 29.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.601 170.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.47 141.95 39.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.404 1.082 . . . . 0.0 109.072 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.8 mt -81.11 107.14 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -173.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.423 HD13 ' HB2' ' A' ' 107' ' ' ARG . 32.0 pt -90.92 41.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.414 0.686 . . . . 0.0 111.302 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.5 -134.97 2.5 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 112.001 -0.439 . . . . 0.0 112.001 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -134.65 136.52 25.62 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.903 1.281 . . . . 0.0 108.708 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.697 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 73.9 Cg_endo -69.62 111.24 2.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.158 1.905 . . . . 0.0 110.765 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 107.66 60.17 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -173.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 51.4 Cg_exo -56.03 150.61 46.41 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.539 2.826 . . . . 0.0 112.882 172.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.8 173.34 9.26 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.81 -32.45 69.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.48 0.712 . . . . 0.0 112.36 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.47 -9.33 44.91 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 62.48 30.09 17.16 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.176 0.99 . . . . 0.0 111.302 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.2 p -101.38 -12.88 18.27 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.824 0.849 . . . . 0.0 112.204 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.66 143.08 3.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -171.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.528 HD23 ' HB2' ' A' ' 93' ' ' PRO . 9.6 mp -101.64 139.57 37.12 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.958 0.903 . . . . 0.0 110.069 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.66 109.99 19.56 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 164.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.5 mm -95.92 104.57 15.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 105' ' ' LEU . 2.7 pt? -83.3 137.52 33.95 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.437 ' SG ' HG22 ' A' ' 104' ' ' ILE . 73.7 m -149.57 175.05 11.87 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.099 0.96 . . . . 0.0 108.888 -173.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.423 ' HB2' HD13 ' A' ' 90' ' ' ILE . 57.5 ttt180 -156.65 159.97 38.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.476 ' HG3' HH12 ' A' ' 85' ' ' ARG . 0.4 OUTLIER -61.34 101.0 0.15 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.41 52.49 1.35 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.981 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.55 74.37 0.44 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.264 1.025 . . . . 0.0 111.53 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -76.91 -20.2 56.49 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.587 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 9.3 mptt . . . . . 0 C--O 1.258 1.53 0 C-N-CA 124.651 1.18 . . . . 0.0 108.402 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 121.068 0.461 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -160.49 156.04 25.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.106 1.362 . . . . 0.0 108.05 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.402 HG12 ' NH1' ' A' ' 64' ' ' ARG . 2.9 mp -69.74 96.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.58 56.19 4.89 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.254 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -130.06 -61.44 0.98 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.557 0.743 . . . . 0.0 109.146 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 36' ' ' TRP . 8.1 mp -69.18 90.8 0.49 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.395 0.678 . . . . 0.0 111.355 -169.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -121.64 -13.67 8.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.86 1.264 . . . . 0.0 111.366 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.47 -170.74 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.444 1.497 . . . . 0.0 110.09 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.469 ' HB3' HG21 ' A' ' 34' ' ' THR . 46.2 mtm180 -136.5 142.75 43.53 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 109.904 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -136.15 143.5 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.344 1.058 . . . . 0.0 109.155 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -101.83 118.85 37.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.033 0.933 . . . . 0.0 108.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.32 92.14 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 123.95 0.781 . . . . 0.0 109.634 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 35.1 tt0 -83.79 93.77 8.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.904 0.859 . . . . 0.0 109.645 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.525 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 21.5 p -80.07 154.09 28.34 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.288 -176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 27' ' ' GLU . 67.2 tp -83.5 108.77 16.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.181 0.592 . . . . 0.0 109.948 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 45.9 tttp -84.67 94.24 8.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.384 0.674 . . . . 0.0 110.224 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 42.8 mt-30 -87.45 108.64 19.11 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -130.09 129.37 43.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.782 0.833 . . . . 0.0 109.173 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -73.49 148.47 43.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 122.75 0.42 . . . . 0.0 110.086 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.33 169.28 8.99 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.02 -14.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 p -91.85 -10.84 38.26 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.777 0.798 . . . . 0.0 109.344 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.32 44.29 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.742 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.21 132.59 38.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.0 mm -76.44 94.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.82 109.2 15.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.492 ' HB3' HD13 ' A' ' 15' ' ' LEU . 45.6 mt-10 -84.11 96.17 8.84 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.82 0.819 . . . . 0.0 109.303 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 15' ' ' LEU . 67.1 p -110.92 -177.99 3.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.08 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -128.53 115.5 18.23 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.947 -0.471 . . . . 0.0 110.536 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 8.7 pt-20 -97.95 109.89 22.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 13' ' ' GLN . 6.4 p-10 -63.75 135.2 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.9 -112.22 3.23 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 120.089 -0.284 . . . . 0.0 113.127 -163.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -102.66 135.28 44.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.091 0.557 . . . . 0.0 109.68 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.4 m -100.98 99.11 9.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.58 -179.68 3.94 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.192 0.52 . . . . 0.0 110.62 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.587 ' HB2' HD21 ' A' ' 6' ' ' LEU . 27.4 m95 -73.85 146.3 44.23 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.341 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -157.67 166.46 32.76 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.909 0.884 . . . . 0.0 112.824 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 t -110.42 95.92 5.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.477 HG22 HG21 ' A' ' 77' ' ' VAL . 3.5 p -96.7 90.49 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.971 0.891 . . . . 0.0 109.054 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.18 127.55 55.98 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.52 ' HG2' HG23 ' A' ' 59' ' ' VAL . 72.0 mtp -67.16 137.77 56.52 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.27 159.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.597 0.759 . . . . 0.0 111.857 -173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 m -82.5 168.61 17.23 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.396 0.678 . . . . 0.0 110.345 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.3 p -63.56 -21.56 66.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.513 0.725 . . . . 0.0 111.773 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.28 14.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.694 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.23 -46.25 91.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 111.372 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.36 61.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.61 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.62 -47.39 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.891 0.876 . . . . 0.0 111.896 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -75.69 -32.59 60.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.872 0.869 . . . . 0.0 111.14 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.0 t -74.55 -45.6 44.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.866 0.467 . . . . 0.0 111.285 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.73 -75.86 0.22 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.613 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.81 13.64 0.91 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.011 0.525 . . . . 0.0 112.352 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.76 -63.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.67 149.94 31.08 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.06 20.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.443 0.697 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mt -78.29 156.79 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.965 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.93 -10.2 68.15 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 HG21 HD11 ' A' ' 90' ' ' ILE . 86.8 m -65.2 152.21 44.21 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.536 1.134 . . . . 0.0 109.784 171.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.52 HG23 ' HG2' ' A' ' 41' ' ' MET . 41.9 t -125.46 125.9 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.954 0.901 . . . . 0.0 109.438 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -96.97 133.24 41.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 109.265 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 67.7 mt -133.21 107.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.536 0.734 . . . . 0.0 109.177 -169.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -95.35 119.89 34.63 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.621 0.768 . . . . 0.0 110.743 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.21 166.11 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.892 0.877 . . . . 0.0 108.733 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.44 ' H ' HD23 ' A' ' 6' ' ' LEU . 31.5 mmm180 -56.72 157.47 5.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.789 0.435 . . . . 0.0 110.612 166.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.85 95.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HD3' HD11 ' A' ' 69' ' ' ILE . 28.7 ttt85 -110.16 116.72 32.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.346 -177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -78.71 1.17 23.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.763 1.225 . . . . 0.0 111.679 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -92.51 -19.43 21.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.425 1.09 . . . . 0.0 110.535 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.463 HD11 ' HD3' ' A' ' 66' ' ' ARG . 16.6 mm -79.91 134.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.957 0.503 . . . . 0.0 110.582 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -129.42 166.12 20.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.99 67.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.033 0.533 . . . . 0.0 110.955 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.1 p -82.58 19.43 1.29 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.654 0.781 . . . . 0.0 111.824 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -107.37 142.32 37.36 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.787 0.835 . . . . 0.0 108.842 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -107.58 133.35 52.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 61' ' ' ILE . 37.7 mm -94.49 91.7 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.112 0.482 . . . . 0.0 110.139 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 26.8 ttpp -86.99 106.3 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 87' ' ' LEU . 99.1 t -78.8 130.35 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.116 0.566 . . . . 0.0 111.281 -169.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.5 m -89.81 -19.67 24.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.977 0.911 . . . . 0.0 113.048 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.6 p -135.0 -177.13 4.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.172 0.589 . . . . 0.0 110.92 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.12 -151.59 51.97 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.956 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.83 -12.89 13.29 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.177 2.585 . . . . 0.0 113.349 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.07 23.35 13.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.577 0.751 . . . . 0.0 110.737 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.7 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.406 0.682 . . . . 0.0 110.734 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.16 6.89 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.727 0.679 . . . . 0.0 112.13 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -71.06 139.36 50.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.059 0.544 . . . . 0.0 110.193 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.2 p -104.89 90.65 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.497 1.142 . . . . 0.0 108.927 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.1 mm? -70.76 149.26 47.07 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.861 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -122.11 137.93 54.64 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.27 95.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -173.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 58' ' ' THR . 25.3 pt -80.63 63.72 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 122.333 1.063 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.18 -118.27 0.82 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' H ' HD22 ' A' ' 105' ' ' LEU . 9.9 pt20 -162.74 142.43 7.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.64 0.776 . . . . 0.0 109.42 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.84 116.06 3.1 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.989 2.46 . . . . 0.0 110.751 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.94 108.15 38.96 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.809 0.843 . . . . 0.0 109.767 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.05 135.82 19.48 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.359 2.04 . . . . 0.0 110.129 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.0 174.07 9.12 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.57 62.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.652 0.781 . . . . 0.0 113.031 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.45 27.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.492 0.317 . . . . 0.0 111.258 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 62.06 30.49 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.232 1.013 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.1 t -86.13 -16.2 38.68 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.843 0.857 . . . . 0.0 110.933 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -152.12 166.45 31.63 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.675 0.75 . . . . 0.0 110.349 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 107.8 12.84 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -87.09 101.5 13.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.302 0.641 . . . . 0.0 109.448 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.5 mm -83.92 145.72 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.97 0.908 . . . . 0.0 108.788 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.4 pt? -122.78 143.07 50.07 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 72.2 m -151.53 176.09 11.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.705 0.802 . . . . 0.0 110.64 -170.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -161.11 155.35 22.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.373 0.669 . . . . 0.0 109.448 167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.34 144.89 28.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.183 0.993 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.92 35.77 3.7 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.023 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.69 91.89 0.36 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.967 1.307 . . . . 0.0 109.153 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -104.65 0.14 28.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.123 0.969 . . . . 0.0 111.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.056 0.942 . . . . 0.0 111.511 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -83.02 77.47 9.73 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.558 HG13 ' HG2' ' A' ' 5' ' ' ARG . 19.8 pt -97.68 157.6 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.729 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.22 25.65 6.06 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 114.05 0.38 . . . . 0.0 114.05 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.558 ' HG2' HG13 ' A' ' 3' ' ' ILE . 12.2 ptm180 -60.28 143.62 52.37 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.85 0.86 . . . . 0.0 110.683 176.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.59 96.05 1.15 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.056 0.847 . . . . 0.0 110.628 -169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -98.96 -36.92 9.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.785 1.234 . . . . 0.0 112.369 -171.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -96.6 -167.6 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.775 1.23 . . . . 0.0 108.861 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB3' HG21 ' A' ' 34' ' ' THR . 49.3 mtm180 -148.91 146.46 27.9 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 0.0 110.418 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.3 151.27 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.841 0.856 . . . . 0.0 109.044 175.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -102.45 122.95 45.33 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.8 116.96 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.792 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -83.36 99.94 10.36 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.441 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 2.4 p -82.28 141.28 33.06 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.989 173.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.3 tp -110.27 113.77 26.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.513 0.725 . . . . 0.0 109.386 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 3.2 ttmp? -102.35 114.46 28.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.722 0.409 . . . . 0.0 110.212 174.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.505 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 41.8 mt-30 -75.51 90.3 2.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -91.54 110.23 21.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 109.703 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -71.24 158.59 36.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.534 0.334 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.92 164.41 13.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.428 0.691 . . . . 0.0 109.703 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.81 -11.23 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 125.068 1.347 . . . . 0.0 112.982 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 p -104.67 -23.99 13.01 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.84 44.67 1.74 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.94 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -106.41 149.91 26.55 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.33 101.69 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.906 0.483 . . . . 0.0 110.025 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.93 90.96 7.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.991 0.916 . . . . 0.0 108.96 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.553 ' HB3' HD11 ' A' ' 15' ' ' LEU . 42.4 mt-10 -79.34 121.04 24.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -137.98 141.85 40.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.587 1.155 . . . . 0.0 109.824 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -101.5 103.55 14.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.078 0.951 . . . . 0.0 109.088 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 7.6 pt-20 -88.44 125.73 34.88 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.247 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.83 113.36 7.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.706 1.202 . . . . 0.0 108.397 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.35 -109.45 2.86 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.319 -157.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -117.09 139.0 51.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.394 0.678 . . . . 0.0 110.215 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.7 m -101.45 98.44 8.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 109.74 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.457 HD11 HD12 ' A' ' 63' ' ' ILE . 1.3 pt? -106.69 163.73 12.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.952 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -59.49 123.31 16.43 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.113 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HB2' HD11 ' A' ' 10' ' ' ILE . . . -136.83 176.44 8.7 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.203 1.001 . . . . 0.0 110.933 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -136.94 107.55 6.54 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG11 HG23 ' A' ' 77' ' ' VAL . 66.5 t -105.29 131.6 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.65 0.78 . . . . 0.0 109.307 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.29 159.58 44.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 167.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.435 ' SD ' HG22 ' A' ' 59' ' ' VAL . 19.8 mmt -67.76 148.22 51.55 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.19 145.23 13.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 O-C-N 123.746 0.654 . . . . 0.0 110.151 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 47.4 t -74.35 163.27 28.0 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.955 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 p -61.21 -31.5 71.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.501 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 16.9 ptpt -62.17 -33.5 74.64 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.469 0.707 . . . . 0.0 111.492 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.75 -50.84 14.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.558 0.743 . . . . 0.0 110.258 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.95 40.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.437 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.2 mt -66.43 -27.32 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.773 0.829 . . . . 0.0 111.982 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -59.24 -49.36 78.14 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.787 0.435 . . . . 0.0 110.572 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.528 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 83.9 p -79.78 -12.29 59.79 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.151 0.58 . . . . 0.0 111.564 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -77.5 2.04 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.89 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.103 0.561 . . . . 0.0 111.847 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 32.6 mt-10 -78.36 -69.54 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.94 141.91 31.81 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -139.75 156.91 46.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.96 0.504 . . . . 0.0 110.212 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.59 125.55 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.07 -12.58 12.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -163.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 m -77.77 154.61 31.8 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 156.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.435 HG22 ' SD ' ' A' ' 41' ' ' MET . 40.5 t -124.53 128.04 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.841 0.857 . . . . 0.0 111.033 -170.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -98.2 128.86 44.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.335 0.654 . . . . 0.0 109.519 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.551 HD12 HG22 ' A' ' 75' ' ' ILE . 65.7 mt -135.0 143.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.141 0.976 . . . . 0.0 108.494 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.415 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 60.1 m95 -134.92 121.67 20.86 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 35' ' ' LEU . 44.6 pt -121.41 168.75 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.414 0.686 . . . . 0.0 109.977 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -47.42 146.75 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.595 0.758 . . . . 0.0 112.748 165.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -67.35 108.95 2.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.358 0.663 . . . . 0.0 110.287 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.407 ' NE ' HD12 ' A' ' 35' ' ' LEU . 9.9 ptp180 -149.21 125.63 10.91 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.059 0.544 . . . . 0.0 110.327 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -84.09 12.35 6.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.394 1.078 . . . . 0.0 111.408 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.28 -18.31 28.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.405 1.082 . . . . 0.0 110.004 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.4 HG13 HD13 ' A' ' 63' ' ' ILE . 21.6 mm -74.55 138.69 20.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 159.68 34.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 92' ' ' GLN . . . -66.14 -20.67 66.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.594 0.358 . . . . 0.0 111.808 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -92.06 28.23 1.93 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -107.34 161.74 14.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.517 HH21 HG23 ' A' ' 86' ' ' VAL . 51.3 mtp180 -125.04 128.55 48.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.551 HG22 HD12 ' A' ' 61' ' ' ILE . 44.5 mm -88.4 96.52 6.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.721 0.808 . . . . 0.0 109.454 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -94.76 109.39 21.35 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.444 HG21 HD23 ' A' ' 87' ' ' LEU . 61.5 t -74.99 124.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.381 0.672 . . . . 0.0 110.789 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 t -83.52 -25.66 30.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.71 0.804 . . . . 0.0 111.342 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.1 t -163.37 132.53 4.02 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.59 -163.7 30.43 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.93 -14.24 29.36 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.778 2.319 . . . . 0.0 112.028 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.1 mt -123.06 32.28 5.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.285 1.034 . . . . 0.0 110.01 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.73 25.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.45 0.7 . . . . 0.0 110.659 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.62 12.29 72.63 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.588 0.555 . . . . 0.0 113.085 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -119.9 148.18 43.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.348 0.659 . . . . 0.0 109.44 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.517 HG23 HH21 ' A' ' 74' ' ' ARG . 5.1 p -111.17 97.9 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 122.624 1.202 . . . . 0.0 110.93 -173.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD23 HG21 ' A' ' 77' ' ' VAL . 1.8 mm? -86.38 142.43 28.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.387 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.59 143.32 32.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.363 1.065 . . . . 0.0 108.763 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.29 129.62 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 pt -113.07 132.73 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.893 0.877 . . . . 0.0 109.27 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.76 -84.38 1.41 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 pt20 -169.34 158.13 7.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.683 0.793 . . . . 0.0 110.512 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.24 148.87 27.51 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.05 1.833 . . . . 0.0 110.334 159.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.18 125.05 5.08 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 152.55 40.12 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.443 2.096 . . . . 0.0 112.194 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.73 178.02 3.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 122.289 -0.257 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.87 -36.42 83.25 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.767 0.827 . . . . 0.0 112.523 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.76 -13.29 34.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.119 0.568 . . . . 0.0 111.958 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 62.45 34.47 15.43 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.628 1.171 . . . . 0.0 111.408 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -98.33 0.33 45.31 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.747 0.819 . . . . 0.0 110.817 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 5.4 ptp180 -169.51 -177.77 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.95 0.9 . . . . 0.0 109.242 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.07 112.64 16.09 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.91 119.6 17.37 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.532 HG22 ' SG ' ' A' ' 106' ' ' CYS . 25.8 mm -109.8 118.83 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.45 ' H ' HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -98.65 133.47 42.95 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.532 ' SG ' HG22 ' A' ' 104' ' ' ILE . 85.3 m -144.98 173.68 11.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.036 -170.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -150.03 162.89 39.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -45.59 143.79 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.044 0.537 . . . . 0.0 111.099 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.22 51.12 4.2 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.136 0.273 . . . . 0.0 113.14 -171.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.23 89.23 3.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.49 71.28 6.06 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.983 0.913 . . . . 0.0 109.26 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--O 1.247 0.932 0 C-N-CA 124.9 1.28 . . . . 0.0 108.617 -175.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -68.58 109.61 3.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.229 0.612 . . . . 0.0 109.511 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.462 ' H ' HD11 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -85.75 -15.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 177.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.61 37.58 3.47 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.239 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -76.6 -16.6 59.54 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.969 0.508 . . . . 0.0 110.666 172.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.7 104.25 16.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.335 1.054 . . . . 0.0 109.578 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -83.22 -39.55 20.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.061 0.944 . . . . 0.0 112.218 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.63 -171.35 1.82 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.557 1.543 . . . . 0.0 109.905 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -143.85 147.35 33.94 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.616 1.166 . . . . 0.0 110.214 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.648 HD11 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.04 154.7 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.421 1.089 . . . . 0.0 109.576 177.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -108.56 125.37 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.197 0.999 . . . . 0.0 108.47 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.53 125.92 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 123.395 0.435 . . . . 0.0 110.373 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -88.07 100.28 12.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.096 0.958 . . . . 0.0 108.68 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.525 ' HG1' ' HG3' ' A' ' 30' ' ' GLU . 22.9 p -83.63 143.84 29.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.818 172.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.578 HD13 ' HB3' ' A' ' 27' ' ' GLU . 57.7 tp -90.7 107.7 19.34 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.672 0.389 . . . . 0.0 110.627 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.53 97.06 8.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.545 0.738 . . . . 0.0 109.375 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.23 90.75 2.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -89.94 161.14 16.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.213 1.005 . . . . 0.0 109.389 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -125.97 154.54 42.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.13 -0.356 . . . . 0.0 110.577 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -104.64 160.06 15.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.78 1.232 . . . . 0.0 108.64 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.31 -11.37 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -108.7 -0.51 20.03 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.682 0.753 . . . . 0.0 109.261 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 28.58 9.09 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.249 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -92.75 134.78 34.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.1 mm -91.07 118.14 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.83 17.51 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HB3' HD13 ' A' ' 15' ' ' LEU . 1.9 mp0 -78.78 114.94 18.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 p -130.22 152.48 49.6 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.128 0.971 . . . . 0.0 108.385 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -106.59 103.86 13.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.525 ' HG3' ' HG1' ' A' ' 14' ' ' THR . 6.4 pt-20 -87.34 128.71 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.09 145.56 55.2 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -106.93 2.56 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -115.2 135.21 54.42 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.073 0.949 . . . . 0.0 108.683 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.4 m -94.26 95.8 9.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -111.34 169.49 8.76 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.45 0.643 . . . . 0.0 111.447 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -71.12 130.37 41.32 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.739 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 10' ' ' ILE . . . -136.84 176.72 8.46 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.495 175.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 55.4 m -130.58 98.99 4.82 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.61 102.6 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.497 0.719 . . . . 0.0 109.07 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.15 106.42 14.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.054 0.942 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.697 ' SD ' HG21 ' A' ' 59' ' ' VAL . 86.6 mmm -60.19 117.94 5.76 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 m -70.63 155.58 7.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 121.118 0.485 . . . . 0.0 110.668 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.503 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t -85.22 176.98 8.02 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.458 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.73 -28.73 66.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.055 0.942 . . . . 0.0 111.909 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 20.4 ptmt -49.33 -42.75 42.61 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.798 1.239 . . . . 0.0 113.463 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.52 -41.16 93.45 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.295 0.638 . . . . 0.0 111.052 -176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.19 74.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.758 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.1 mt -60.51 -43.31 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.68 0.792 . . . . 0.0 111.26 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.5 m -69.72 -33.8 72.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.391 0.676 . . . . 0.0 111.994 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 77.8 p -82.09 -30.25 31.34 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.635 0.374 . . . . 0.0 111.046 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.82 -66.03 0.24 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.044 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 15.04 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.299 1.04 . . . . 0.0 110.59 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.1 tt0 -86.13 -53.75 4.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.601 0.76 . . . . 0.0 109.584 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.53 160.8 20.42 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 167.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.88 154.82 40.48 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.751 0.82 . . . . 0.0 110.153 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.83 108.28 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.52 10.92 20.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.497 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.9 m -64.71 122.18 16.26 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.697 HG21 ' SD ' ' A' ' 41' ' ' MET . 24.8 t -86.95 105.6 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.778 0.831 . . . . 0.0 110.026 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -90.74 133.37 35.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 75' ' ' ILE . 79.6 mt -135.79 117.46 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.134 0.974 . . . . 0.0 108.895 -169.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 79.3 m95 -102.73 119.12 38.27 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 122.888 0.475 . . . . 0.0 109.909 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 pt -124.22 155.76 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -59.17 163.64 3.61 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.25 0.477 . . . . 0.0 111.396 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.462 ' HA ' HD12 ' A' ' 102' ' ' LEU . 42.5 t80 -55.8 100.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.755 0.822 . . . . 0.0 111.203 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -118.93 106.28 12.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -68.03 -24.08 65.06 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.389 1.076 . . . . 0.0 113.28 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.25 -18.64 23.14 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.624 0.769 . . . . 0.0 112.325 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -67.18 132.63 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -154.17 173.6 15.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -26.39 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.505 0.722 . . . . 0.0 112.329 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.7 p -80.09 9.91 4.99 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.282 1.033 . . . . 0.0 113.341 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.0 p -117.55 156.94 27.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.257 0.623 . . . . 0.0 109.503 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -112.95 155.0 25.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 171.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 61' ' ' ILE . 21.3 mm -116.82 103.21 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.26 0.624 . . . . 0.0 109.864 -177.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.2 ttpt -94.15 109.5 21.28 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.491 HG22 HD22 ' A' ' 87' ' ' LEU . 95.8 t -73.23 126.85 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 O-C-N 123.622 0.576 . . . . 0.0 110.516 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.4 m -79.67 -25.17 41.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.292 1.037 . . . . 0.0 113.287 -171.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -152.53 178.47 9.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.71 -146.64 30.07 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.42 -0.655 . . . . 0.0 113.052 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.64 -22.47 13.69 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.262 2.642 . . . . 0.0 113.289 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.624 HD13 ' SD ' ' A' ' 41' ' ' MET . 92.5 mt -115.71 31.29 6.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.881 0.473 . . . . 0.0 110.927 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.72 94.71 0.31 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.476 0.71 . . . . 0.0 110.895 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.0 -17.81 8.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.739 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -79.23 129.57 34.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.374 0.67 . . . . 0.0 109.722 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -102.36 80.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 122.648 1.214 . . . . 0.0 109.152 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 77' ' ' VAL . 2.0 mm? -65.78 153.52 41.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.184 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -120.43 139.1 53.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.438 HG12 ' SG ' ' A' ' 106' ' ' CYS . 62.7 mt -80.78 104.07 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -172.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.0 pt -83.1 16.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.002 0.921 . . . . 0.0 112.36 -174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.57 -141.85 3.23 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -128.89 134.81 26.73 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.546 ' HB2' HD22 ' A' ' 102' ' ' LEU . 67.1 Cg_endo -68.36 146.13 67.85 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.905 2.403 . . . . 0.0 111.52 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 120.41 5.01 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 40.3 Cg_endo -66.65 157.43 60.94 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.555 . . . . 0.0 113.743 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.56 179.73 3.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.25 69.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.872 0.869 . . . . 0.0 112.623 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.6 -11.26 29.74 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.36 0.664 . . . . 0.0 112.463 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.2 20.02 8.97 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.958 0.903 . . . . 0.0 111.938 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -74.82 -18.02 60.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.411 0.684 . . . . 0.0 111.842 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.18 153.27 5.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.618 0.767 . . . . 0.0 110.764 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 93' ' ' PRO . 8.1 mp -102.82 133.95 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.131 0.973 . . . . 0.0 109.718 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.37 116.54 23.76 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 12.4 mm -98.95 131.81 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 173.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -106.77 136.83 45.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.438 ' SG ' HG12 ' A' ' 89' ' ' ILE . 83.9 m -148.73 172.92 13.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.4 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -163.6 154.38 16.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -74.19 131.17 41.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.92 28.32 7.33 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.27 111.13 0.02 OUTLIER 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.401 1.48 . . . . 0.0 111.734 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.76 83.76 0.07 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.923 -168.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.53 147.43 23.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.867 0.467 . . . . 0.0 109.872 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.45 153.5 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 108.775 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.5 49.29 3.82 Favored Glycine 0 C--N 1.348 1.241 0 C-N-CA 123.184 0.421 . . . . 0.0 112.914 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 163.82 12.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.868 0.867 . . . . 0.0 110.594 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -123.29 169.1 11.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.909 0.884 . . . . 0.0 109.968 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -136.13 -28.91 1.03 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.22 0.608 . . . . 0.0 112.438 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 79' ' ' THR . 70.0 m-20 -107.14 -171.26 1.85 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.45 1.5 . . . . 0.0 110.419 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -141.11 147.14 38.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.315 1.046 . . . . 0.0 108.975 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.632 HD12 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.88 155.61 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.233 0.613 . . . . 0.0 109.791 173.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 m -113.18 124.99 53.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.364 0.666 . . . . 0.0 109.628 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.53 108.86 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.637 1.175 . . . . 0.0 110.596 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.6 mp0 -80.74 98.3 7.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.045 0.926 . . . . 0.0 108.979 172.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.439 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 5.0 m -79.8 145.23 32.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.987 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 27' ' ' GLU . 50.2 tp -97.38 99.79 11.22 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.92 -0.487 . . . . 0.0 109.817 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HG2' ' HG1' ' A' ' 18' ' ' THR . 64.3 tttp -83.44 105.66 14.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.218 0.607 . . . . 0.0 109.876 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.571 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 50.3 mt-30 -88.31 89.06 7.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.55 ' HG1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m -94.04 135.12 35.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.099 0.96 . . . . 0.0 110.0 -173.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 4.7 ttp180 -74.47 148.41 41.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HB2' HD11 ' A' ' 26' ' ' LEU . 20.5 t70 -96.58 163.81 12.87 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.12 -11.05 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -99.24 -4.2 32.5 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.446 -0.784 . . . . 0.0 109.643 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.73 44.51 6.79 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.821 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.6 mt-10 -103.37 173.58 6.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.719 0.807 . . . . 0.0 109.736 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.61 103.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.341 0.656 . . . . 0.0 109.308 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 20' ' ' ASP . 8.8 mp -94.61 108.94 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.833 1.253 . . . . 0.0 109.31 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 41.9 mt-10 -79.88 117.0 20.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 p -131.91 157.4 44.08 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.359 1.063 . . . . 0.0 109.422 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -103.83 101.5 11.32 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.439 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 6.3 pt-20 -83.37 123.01 29.23 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.32 115.43 10.47 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.66 -119.77 4.32 Favored Glycine 0 N--CA 1.474 1.192 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.876 -160.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.97 159.76 28.61 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.554 0.742 . . . . 0.0 110.478 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 47.0 m -138.07 95.97 3.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 169.79 8.58 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.933 -174.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -67.85 131.42 45.49 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.425 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 10' ' ' ILE . . . -140.82 178.28 7.45 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.99 0.916 . . . . 0.0 111.363 176.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -140.73 105.18 4.87 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.84 114.63 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -133.01 124.59 27.97 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.509 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 73.3 mtp -67.78 134.56 51.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.19 152.3 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.552 0.341 . . . . 0.0 110.203 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t -97.91 -175.43 3.15 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 56' ' ' ILE . 14.2 p -55.93 -30.55 61.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.284 1.033 . . . . 0.0 112.936 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -50.14 -48.17 53.79 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.648 1.179 . . . . 0.0 112.716 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.16 -36.65 72.1 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.05 96.57 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.004 0.815 . . . . 0.0 110.519 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.48 -46.78 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.433 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -71.67 -24.15 61.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.417 0.687 . . . . 0.0 112.399 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 31.8 m -101.84 -5.4 24.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.218 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.07 -90.07 0.79 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.019 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.99 -11.68 10.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 110.803 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 10.0 tp10 -64.43 -59.82 3.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 110.288 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 58' ' ' THR . 61.2 mt -93.88 162.07 14.06 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.92 166.19 25.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 110.315 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 44' ' ' SER . 59.6 mt -71.12 111.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.12 -10.38 17.72 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-O 120.218 -0.212 . . . . 0.0 112.626 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.651 HG21 HD23 ' A' ' 54' ' ' LEU . 24.5 m -61.6 137.75 58.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.304 0.642 . . . . 0.0 109.53 169.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.9 t -105.33 127.46 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 109.867 -177.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -109.32 144.32 37.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.41 0.624 . . . . 0.0 109.909 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 75' ' ' ILE . 41.0 mt -135.69 107.35 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -167.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -96.06 114.4 26.11 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 37' ' ' ALA . 44.5 pt -116.37 155.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.492 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 1.6 tmt_? -55.83 143.98 29.42 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 57.0 t80 -45.16 124.68 4.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 111.666 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.411 ' H ' HD21 ' A' ' 102' ' ' LEU . 5.7 tpm_? -151.26 116.01 5.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.51 0.724 . . . . 0.0 109.54 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.412 ' HE3' ' HE2' ' A' ' 65' ' ' TYR . 91.0 mttt -84.8 8.59 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.194 0.998 . . . . 0.0 111.577 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.98 -24.11 17.78 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.511 1.124 . . . . 0.0 111.567 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.88 126.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.716 0.406 . . . . 0.0 111.287 -170.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.89 157.96 30.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.84 -13.53 60.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.428 0.691 . . . . 0.0 112.68 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 p -77.05 -24.14 51.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.804 0.441 . . . . 0.0 110.964 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -73.19 155.21 39.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.316 0.647 . . . . 0.0 110.627 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.423 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 75.9 mtm180 -113.5 162.81 15.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 172.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.4 mp -112.17 126.97 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.052 1.341 . . . . 0.0 108.177 171.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -118.86 116.14 25.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.45 110.25 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 123.556 0.535 . . . . 0.0 110.998 -170.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 10' ' ' ILE . 31.8 t -70.5 -27.2 64.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.593 1.157 . . . . 0.0 111.265 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.426 ' O ' ' HB3' ' A' ' 8' ' ' ASP . 12.8 t -166.45 137.96 3.56 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.59 -162.45 30.73 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 119.771 -0.46 . . . . 0.0 112.294 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.33 -14.17 18.45 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.11 2.54 . . . . 0.0 111.765 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -124.81 32.86 5.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.441 1.096 . . . . 0.0 109.162 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.32 102.22 0.21 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.739 0.815 . . . . 0.0 111.507 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.85 0.24 15.09 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 119.859 -0.411 . . . . 0.0 113.147 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -106.64 160.47 15.43 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.582 0.753 . . . . 0.0 110.077 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.25 100.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.947 1.356 . . . . 0.0 111.168 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.93 124.5 34.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.269 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -97.6 142.32 29.55 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.324 1.05 . . . . 0.0 108.334 177.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.07 117.45 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.26 71.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 121.98 0.895 . . . . 0.0 109.852 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.53 -114.24 0.63 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.174 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' H ' HD23 ' A' ' 105' ' ' LEU . 12.5 pt20 -166.81 142.79 3.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.73 0.812 . . . . 0.0 109.438 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HB2' HD11 ' A' ' 102' ' ' LEU . 37.1 Cg_endo -60.28 120.74 8.68 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.791 2.328 . . . . 0.0 112.145 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.93 108.62 55.47 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.336 1.055 . . . . 0.0 108.965 -170.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 153.73 53.62 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.797 2.331 . . . . 0.0 113.082 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 6.8 p-10 -84.33 172.45 11.79 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 0.0 110.462 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.13 75.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.893 0.877 . . . . 0.0 112.249 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.04 -9.35 59.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.931 0.492 . . . . 0.0 111.65 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 25.2 mmt180 60.58 28.64 18.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.132 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -101.16 -5.44 25.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.845 0.858 . . . . 0.0 110.739 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.03 155.58 25.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.312 0.577 . . . . 0.0 110.903 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 93' ' ' PRO . 3.3 mm? -108.83 113.07 25.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -77.07 107.06 9.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.493 HG23 ' SG ' ' A' ' 106' ' ' CYS . 20.1 mm -96.55 134.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.578 HD21 ' H ' ' A' ' 105' ' ' LEU . 1.9 pt? -111.25 130.6 55.61 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' A' ' 104' ' ' ILE . 71.9 m -153.77 176.68 11.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -167.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ptm85 -160.27 163.58 33.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.9 145.49 45.65 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.294 0.371 . . . . 0.0 110.874 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.92 51.38 4.29 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.39 102.58 5.19 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.13 0.972 . . . . 0.0 110.318 -175.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.39 79.27 0.38 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 110.952 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.198 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -71.31 99.17 1.89 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.085 0.554 . . . . 0.0 109.743 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mt 70.81 2.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 125.193 1.397 . . . . 0.0 111.29 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.11 55.15 3.63 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -149.73 154.88 39.24 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.731 1.213 . . . . 0.0 108.474 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 1.7 mm? -77.75 95.76 4.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 -170.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -97.9 -41.96 7.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.401 1.081 . . . . 0.0 111.276 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -102.61 -167.17 1.36 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.295 1.438 . . . . 0.0 110.238 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -146.38 150.8 36.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.857 1.263 . . . . 0.0 109.055 171.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.93 145.36 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.332 0.653 . . . . 0.0 109.698 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 31' ' ' ASP . 3.2 m -90.61 124.6 35.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 167.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.8 mm -71.14 107.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -78.84 95.35 5.36 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.624 1.202 . . . . 0.0 108.26 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -81.58 142.54 32.71 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.455 -2.157 . . . . 0.0 109.641 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 27' ' ' GLU . 37.5 tp -98.5 104.49 16.53 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -96.25 123.9 40.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -102.85 102.41 12.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -110.82 121.18 44.7 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.377 1.071 . . . . 0.0 109.164 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -69.11 164.93 21.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.311 0.644 . . . . 0.0 110.979 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -113.51 165.71 12.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.43 3.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 C-N-CA 124.563 1.145 . . . . 0.0 113.616 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.1 p -100.72 -11.76 19.68 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.14 -0.975 . . . . 0.0 109.765 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.7 30.4 15.5 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.859 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -104.82 135.32 46.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.83 0.852 . . . . 0.0 108.908 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.76 112.5 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.101 0.41 . . . . 0.0 110.013 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.06 117.22 30.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HB3' HD13 ' A' ' 15' ' ' LEU . 47.5 mt-10 -84.52 118.63 24.43 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.422 0.689 . . . . 0.0 109.311 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.1 p -129.82 151.21 50.65 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 0.0 109.933 -175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -110.31 104.17 12.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.679 0.792 . . . . 0.0 110.193 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -91.57 152.83 20.12 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.857 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.42 ' HB2' HG22 ' A' ' 11' ' ' THR . 5.2 p-10 -85.26 131.8 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.7 -113.71 3.86 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -170.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -112.09 135.27 52.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.508 0.723 . . . . 0.0 109.722 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.3 m -98.74 106.64 18.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.474 0.709 . . . . 0.0 110.194 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 HD12 ' A' ' 63' ' ' ILE . 1.1 pt? -111.31 165.29 12.07 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.697 0.76 . . . . 0.0 112.242 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.524 ' HD1' ' HD2' ' A' ' 64' ' ' ARG . 51.6 m95 -56.98 122.45 12.33 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.324 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.567 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -133.04 176.64 8.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.238 1.015 . . . . 0.0 111.982 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.2 t -145.78 101.2 3.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 162.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG23 HG22 ' A' ' 61' ' ' ILE . 53.1 t -96.29 113.09 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.672 0.789 . . . . 0.0 109.281 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -134.53 130.32 36.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.145 0.578 . . . . 0.0 109.874 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.676 ' SD ' HG23 ' A' ' 59' ' ' VAL . 77.9 mmm -62.74 131.28 48.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.681 . . . . 0.0 109.447 170.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 60' ' ' ARG . 8.0 m -71.13 152.36 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.269 0.356 . . . . 0.0 110.12 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.513 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.9 m -77.54 168.65 19.64 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.0 p -61.04 -20.82 63.0 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.447 0.699 . . . . 0.0 111.812 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 14.6 ptmm? -51.32 -35.63 38.96 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.163 1.385 . . . . 0.0 112.413 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -70.73 -41.26 72.09 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.416 0.447 . . . . 0.0 110.558 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.16 93.59 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.664 0.786 . . . . 0.0 110.415 175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.93 -43.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.221 1.008 . . . . 0.0 110.827 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 t -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.977 0.911 . . . . 0.0 111.121 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.583 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 81.8 p -89.6 -4.74 57.69 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.392 0.677 . . . . 0.0 111.229 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.37 -68.38 3.32 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.217 0.437 . . . . 0.0 112.064 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.54 16.97 0.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.794 0.838 . . . . 0.0 110.564 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.5 tp10 -79.25 -67.27 0.77 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.82 152.44 40.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.77 27.66 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.626 0.771 . . . . 0.0 109.882 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 mt -73.03 129.61 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.99 -9.55 15.76 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 106' ' ' CYS . 55.1 m -70.66 142.61 51.57 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.717 0.807 . . . . 0.0 109.027 169.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.676 HG23 ' SD ' ' A' ' 41' ' ' MET . 26.9 t -122.07 129.85 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.776 0.831 . . . . 0.0 109.612 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.495 ' HB2' HG12 ' A' ' 42' ' ' VAL . 8.5 ttt85 -103.64 126.22 50.64 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.573 HD12 HG21 ' A' ' 75' ' ' ILE . 30.4 mt -129.95 106.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.898 0.879 . . . . 0.0 108.756 -167.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -97.43 111.99 24.01 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.61 HD12 HD11 ' A' ' 35' ' ' LEU . 42.8 pt -122.19 153.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' HD2' ' HD1' ' A' ' 36' ' ' TRP . 5.7 ptm180 -56.35 153.91 9.02 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 120.73 0.3 . . . . 0.0 111.399 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.69 134.35 55.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.366 0.666 . . . . 0.0 110.269 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -158.63 136.28 10.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.716 0.635 . . . . 0.0 110.066 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -83.3 -5.36 59.11 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.742 0.817 . . . . 0.0 112.486 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.49 -19.65 21.03 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.835 0.854 . . . . 0.0 111.204 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.5 mm -69.71 121.56 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.918 0.487 . . . . 0.0 110.259 -172.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.71 162.41 32.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 109.6 -172.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.05 -27.34 69.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.708 0.803 . . . . 0.0 112.325 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -74.03 -17.56 60.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 0.0 111.779 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -96.76 105.08 17.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.006 0.922 . . . . 0.0 110.087 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -72.77 162.47 29.44 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.966 0.412 . . . . 0.0 111.441 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 61' ' ' ILE . 44.1 mm -106.23 102.97 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.707 0.803 . . . . 0.0 110.19 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -96.77 112.66 24.32 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.36 119.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.683 0.393 . . . . 0.0 111.605 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -77.7 -25.76 49.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.708 0.803 . . . . 0.0 111.998 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -168.39 135.36 2.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.579 0.751 . . . . 0.0 109.397 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.97 -164.91 28.19 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.616 -0.546 . . . . 0.0 112.228 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.78 -6.52 17.61 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.098 2.532 . . . . 0.0 112.593 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 87' ' ' LEU . 78.1 mt -130.37 26.92 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.226 1.01 . . . . 0.0 110.019 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 105.73 0.6 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.66 0.784 . . . . 0.0 111.552 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.89 -40.13 2.09 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.87 139.46 41.69 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.528 0.731 . . . . 0.0 110.364 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 t -106.59 110.77 32.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.385 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 82' ' ' LEU . 1.4 mm? -74.65 150.96 39.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.886 0.874 . . . . 0.0 110.365 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.47 ' OD1' ' HA3' ' A' ' 109' ' ' GLY . 9.0 m120 -114.09 135.81 53.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.393 1.077 . . . . 0.0 108.494 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.407 HG12 ' SG ' ' A' ' 106' ' ' CYS . 61.8 mt -82.54 121.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -172.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.451 HG22 ' HD2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -77.87 121.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.76 -87.61 0.36 Allowed Glycine 0 C--N 1.345 1.062 0 O-C-N 123.91 0.756 . . . . 0.0 112.735 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -166.37 150.13 6.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.858 1.263 . . . . 0.0 108.951 -175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.37 157.64 58.58 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.526 2.151 . . . . 0.0 112.159 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.25 109.55 19.61 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.316 0.647 . . . . 0.0 110.142 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.55 133.81 50.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.774 2.316 . . . . 0.0 110.496 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' O ' ' HD2' ' A' ' 99' ' ' ARG . 5.1 p-10 -64.95 173.99 2.1 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.707 0.403 . . . . 0.0 111.164 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.29 -35.6 67.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.032 0.933 . . . . 0.0 112.943 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.61 -13.24 40.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 112.105 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 96' ' ' ASP . 3.7 mpt_? 60.88 29.15 18.83 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.429 1.092 . . . . 0.0 110.767 -175.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -93.59 -0.86 56.03 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.985 0.914 . . . . 0.0 110.39 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 8.4 ptp85 -163.57 169.35 18.79 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.737 0.815 . . . . 0.0 110.092 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.23 109.23 19.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.83 1.252 . . . . 0.0 107.644 169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.62 110.86 20.12 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 14.3 mm -98.42 116.17 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -89.27 134.79 33.91 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.505 ' SG ' HG21 ' A' ' 104' ' ' ILE . 99.1 m -151.58 -179.38 7.36 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 109.494 -173.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -149.37 152.25 35.46 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 166.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.1 107.19 0.7 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.096 0.474 . . . . 0.0 111.365 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' ' OD1' ' A' ' 88' ' ' ASN . . . -93.46 35.35 4.16 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.565 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.01 35.98 1.64 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.414 1.086 . . . . 0.0 108.616 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.99 -34.25 61.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.498 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.26 175.389 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -83.79 103.85 13.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.23 140.09 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.591 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.14 39.16 2.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.13 0.269 . . . . 0.0 113.545 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -73.44 146.25 45.15 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.982 0.913 . . . . 0.0 109.802 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 31.9 mt -81.55 93.45 6.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.52 -163.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -100.13 -24.99 14.43 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.946 0.898 . . . . 0.0 111.784 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -108.01 -173.31 2.25 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.951 1.3 . . . . 0.0 109.626 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HG2' HG23 ' A' ' 34' ' ' THR . 51.0 ttp180 -148.09 131.86 16.98 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.584 HD13 ' HB1' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -129.99 153.32 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.6 0.76 . . . . 0.0 110.554 -175.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -103.04 124.64 48.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.221 1.008 . . . . 0.0 110.091 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.29 116.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 123.623 0.577 . . . . 0.0 109.946 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.693 1.197 . . . . 0.0 109.103 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -80.21 140.33 36.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.534 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 27' ' ' GLU . 33.2 tp -91.99 97.6 11.05 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -88.66 108.26 19.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.849 0.859 . . . . 0.0 109.56 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.578 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 48.4 mt-30 -91.58 101.31 13.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -109.58 122.3 47.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.667 0.787 . . . . 0.0 109.398 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -78.53 157.87 28.72 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.734 0.302 . . . . 0.0 110.294 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 22.7 t70 -103.51 168.73 8.97 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.617 0.767 . . . . 0.0 109.189 -172.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.48 -4.59 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 124.413 1.085 . . . . 0.0 112.666 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -110.98 -31.02 7.27 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.57 31.09 1.71 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.184 -1.371 . . . . 0.0 114.623 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 48.3 mm-40 -79.91 144.54 33.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 mm -95.89 101.77 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.6 90.93 6.86 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 44.3 mt-10 -79.68 105.56 11.07 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.9 p -123.93 155.11 38.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.334 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -109.45 96.71 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.48 130.63 35.59 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.21 127.53 32.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.48 -110.4 3.39 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -168.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.449 ' CD2' ' HB3' ' A' ' 35' ' ' LEU . 86.4 t60 -105.44 132.45 51.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 9' ' ' ARG . 36.5 m -104.58 95.17 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.449 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 2.4 pt? -108.44 170.1 8.23 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.591 0.71 . . . . 0.0 112.26 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 50.5 m95 -69.93 133.03 46.86 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.665 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.584 ' HB1' HD13 ' A' ' 10' ' ' ILE . . . -138.49 168.56 19.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.791 0.836 . . . . 0.0 112.175 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.9 t -120.98 94.06 4.22 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 162.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 61' ' ' ILE . 3.7 p -94.58 90.46 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 122.325 1.06 . . . . 0.0 108.978 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.3 118.51 36.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.444 -172.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.447 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.3 mtp -67.62 141.51 56.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.63 155.03 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.914 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.431 ' HB2' ' HG2' ' A' ' 46' ' ' GLU . 18.0 m -76.13 163.46 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.091 0.556 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -62.43 -35.64 79.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.316 0.647 . . . . 0.0 110.465 176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.25 -28.54 69.42 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.621 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 15.4 mm-40 -71.81 -41.42 68.27 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.371 0.419 . . . . 0.0 110.207 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.23 -52.34 65.7 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 124.184 0.928 . . . . 0.0 111.184 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.29 -48.24 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.272 1.029 . . . . 0.0 111.953 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.26 -30.62 65.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.558 0.743 . . . . 0.0 111.728 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 11.1 t -90.22 -8.59 50.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.587 0.755 . . . . 0.0 110.578 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.42 -102.36 1.18 Allowed Glycine 0 C--N 1.352 1.452 0 O-C-N 123.587 0.555 . . . . 0.0 112.787 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.09 -5.55 17.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.927 0.891 . . . . 0.0 111.789 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 10.3 tp10 -74.55 -75.42 0.16 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.754 0.422 . . . . 0.0 109.973 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.67 HD22 HG21 ' A' ' 58' ' ' THR . 64.7 mt -83.33 147.73 27.76 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.28 165.53 25.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.203 1.001 . . . . 0.0 109.048 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.13 117.06 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.66 -10.67 14.12 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.526 0.517 . . . . 0.0 112.101 -168.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.67 HG21 HD22 ' A' ' 54' ' ' LEU . 93.7 m -74.53 139.37 43.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.447 HG22 ' HG2' ' A' ' 41' ' ' MET . 44.7 t -126.29 132.47 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.592 0.757 . . . . 0.0 110.599 -173.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -99.65 141.06 32.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 50.9 mt -134.57 107.9 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -102.73 112.75 25.67 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 HG23 ' HB1' ' A' ' 37' ' ' ALA . 39.3 pt -123.93 166.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.147 0.579 . . . . 0.0 109.748 -173.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 21.5 mmt180 -53.07 137.99 32.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.273 0.488 . . . . 0.0 111.415 164.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HE1' ' HE3' ' A' ' 67' ' ' LYS . 28.3 t80 -55.87 116.69 3.1 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.175 0.99 . . . . 0.0 109.167 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -140.02 121.06 14.66 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HE3' ' HE1' ' A' ' 65' ' ' TYR . 32.7 mmtp -69.18 -10.1 56.11 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.825 1.25 . . . . 0.0 112.431 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.78 -19.23 22.8 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.619 0.767 . . . . 0.0 110.976 -173.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.8 119.93 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -116.88 168.59 10.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.989 0.916 . . . . 0.0 108.961 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.01 -24.67 66.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.786 . . . . 0.0 110.992 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -90.78 13.54 16.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.698 0.799 . . . . 0.0 111.67 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 100.33 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.929 0.892 . . . . 0.0 109.266 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HD2' ' ND2' ' A' ' 88' ' ' ASN . 49.1 mtm180 -72.23 165.5 24.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.685 0.755 . . . . 0.0 111.035 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.546 HG22 ' HB ' ' A' ' 10' ' ' ILE . 2.1 mp -115.6 130.28 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -125.32 113.87 18.16 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 82' ' ' LEU . 62.0 t -68.31 115.9 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.361 0.413 . . . . 0.0 111.626 -169.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.142 0.977 . . . . 0.0 111.813 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 9' ' ' ARG . 10.0 t -166.68 129.05 1.81 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.786 0.835 . . . . 0.0 109.499 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.67 -165.9 31.15 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.46 -0.633 . . . . 0.0 111.952 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.02 -15.01 35.97 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.829 2.352 . . . . 0.0 112.304 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.486 HD12 HD11 ' A' ' 87' ' ' LEU . 96.7 mt -122.78 35.01 4.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.061 0.945 . . . . 0.0 110.486 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.88 111.83 1.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.044 0.538 . . . . 0.0 110.42 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.82 -17.64 41.73 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.506 0.504 . . . . 0.0 113.229 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -83.96 132.3 34.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.81 0.844 . . . . 0.0 109.611 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.25 101.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 122.078 0.942 . . . . 0.0 110.54 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.486 HD11 HD12 ' A' ' 82' ' ' LEU . 1.2 mm? -81.57 124.41 29.5 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.327 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.425 ' ND2' ' HD2' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -99.7 141.51 32.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.529 1.132 . . . . 0.0 109.036 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.43 HG12 ' SG ' ' A' ' 106' ' ' CYS . 39.4 mt -78.19 128.63 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.1 68.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 122.0 0.905 . . . . 0.0 109.605 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.19 -122.88 1.53 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.691 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -140.6 146.5 45.06 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 108.679 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.29 102.11 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.181 1.92 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.74 112.74 34.41 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.908 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.92 137.21 44.12 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.435 2.09 . . . . 0.0 111.667 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.474 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 34.9 t70 -58.73 144.54 43.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.82 0.448 . . . . 0.0 111.494 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.04 63.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.025 0.93 . . . . 0.0 112.103 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.66 -5.18 46.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.202 0.601 . . . . 0.0 111.015 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.01 22.73 12.96 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 124.619 1.168 . . . . 0.0 112.107 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 75.1 p -85.83 -10.44 55.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.142 0.577 . . . . 0.0 110.766 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.474 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 7.8 ptp180 -163.71 -177.53 5.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.737 0.815 . . . . 0.0 110.742 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.58 115.84 18.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -82.29 102.31 11.1 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.547 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.7 mm -98.72 125.98 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.469 HD21 ' H ' ' A' ' 105' ' ' LEU . 2.2 pt? -103.6 134.32 47.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' SG ' HD13 ' A' ' 61' ' ' ILE . 70.9 m -152.92 177.88 10.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.738 0.815 . . . . 0.0 110.217 -170.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -143.92 162.33 36.41 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.011 1.325 . . . . 0.0 107.974 169.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.01 122.01 12.67 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.422 ' HA3' ' ND2' ' A' ' 88' ' ' ASN . . . -89.07 44.28 3.1 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.676 0.61 . . . . 0.0 113.807 -171.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 47.76 54.94 9.15 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.882 1.273 . . . . 0.0 113.126 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.05 56.06 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.782 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 123.62 0.768 . . . . 0.0 109.207 169.6 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -115.18 -32.56 5.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.671 0.788 . . . . 0.0 111.592 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.39 -168.21 1.33 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.999 1.32 . . . . 0.0 109.242 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HB2' HG22 ' A' ' 79' ' ' THR . 50.4 mtm180 -138.55 147.71 43.39 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.472 0.709 . . . . 0.0 110.135 171.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 75' ' ' ILE . 32.9 pt -125.98 153.45 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.644 1.178 . . . . 0.0 109.794 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -115.63 124.17 50.24 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 69' ' ' ILE . 26.5 mm -83.03 111.45 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 124.013 0.82 . . . . 0.0 109.933 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -99.22 95.36 7.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.175 0.988 . . . . 0.0 108.44 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' HG3' ' A' ' 30' ' ' GLU . 5.7 p -82.9 145.29 29.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.199 -1.818 . . . . 0.0 107.622 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' THR . 58.2 tp -96.32 107.87 20.29 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.851 0.751 . . . . 0.0 109.015 -170.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -85.28 104.24 14.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.199 1.0 . . . . 0.0 109.958 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 53.5 mt-30 -100.56 85.47 2.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 108.671 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -94.4 120.65 34.97 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.639 0.776 . . . . 0.0 109.669 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -71.91 170.56 13.48 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 122.849 0.459 . . . . 0.0 110.497 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 15.5 t70 -112.02 161.74 16.14 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.417 0.687 . . . . 0.0 109.564 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -70.86 13.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.486 1.114 . . . . 0.0 112.904 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -140.38 -34.33 0.53 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.97 0.56 Allowed Glycine 0 C--N 1.355 1.591 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.786 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 30.6 mt-10 -114.06 157.3 22.72 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.98 104.98 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.87 89.81 6.87 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 40.3 mt-10 -81.0 118.36 22.4 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.69 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.404 ' O ' HD12 ' A' ' 15' ' ' LEU . 21.5 p -141.77 158.29 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 107.597 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -106.92 101.05 10.51 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 10.0 pt-20 -73.19 94.43 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.44 121.67 13.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.536 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.71 -111.0 2.55 Favored Glycine 0 C--N 1.344 0.972 0 C-N-CA 121.448 -0.406 . . . . 0.0 113.304 -154.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -98.56 130.82 45.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 51.1 m -105.75 97.58 7.38 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.68 171.61 7.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -59.78 124.43 20.13 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.753 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -140.29 170.97 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.696 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 t -133.29 101.44 5.18 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 61' ' ' ILE . 31.7 t -93.91 95.54 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.755 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -119.68 122.29 41.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' VAL . 87.6 mtp -67.93 156.54 36.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.655 0.264 . . . . 0.0 110.4 174.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.15 160.89 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.998 0.919 . . . . 0.0 111.511 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -93.08 178.52 5.72 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 160.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -65.57 -20.26 66.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.476 0.31 . . . . 0.0 110.81 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -60.84 2.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.187 . . . . 0.0 112.417 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.53 -18.37 57.04 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.69 -59.07 2.95 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.158 0.504 . . . . 0.0 109.928 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.2 mt -51.21 -38.59 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.998 1.319 . . . . 0.0 111.6 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -64.96 -46.27 82.24 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.404 0.682 . . . . 0.0 111.335 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 27.3 t -80.42 -4.68 54.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.927 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.55 -87.84 1.13 Allowed Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.63 11.01 1.85 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.414 0.686 . . . . 0.0 111.013 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 44.5 tt0 -76.92 -51.88 10.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 58' ' ' THR . 65.8 mt -91.77 163.42 14.07 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 160.68 37.24 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.3 113.7 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -6.32 20.61 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.42 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 54' ' ' LEU . 42.1 m -55.72 131.46 46.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.198 0.599 . . . . 0.0 110.248 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG22 ' HG2' ' A' ' 41' ' ' MET . 61.8 t -96.23 113.92 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.291 0.637 . . . . 0.0 110.019 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -88.16 143.25 27.16 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.718 HD13 HG21 ' A' ' 75' ' ' ILE . 82.1 mt -139.95 108.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -99.39 116.84 32.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.665 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 10' ' ' ILE . 46.7 pt -128.98 160.28 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -57.3 157.69 6.17 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.724 0.238 . . . . 0.0 110.89 165.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -57.39 112.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.295 0.638 . . . . 0.0 111.395 -171.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HD3' HD11 ' A' ' 69' ' ' ILE . 26.6 ttt85 -139.22 103.7 4.82 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.504 0.722 . . . . 0.0 109.377 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -80.53 11.02 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.495 1.118 . . . . 0.0 112.006 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.02 -24.57 22.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.186 0.994 . . . . 0.0 109.916 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.481 HG21 HD12 ' A' ' 104' ' ' ILE . 20.5 mm -69.55 131.63 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -120.48 161.15 21.75 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.71 -24.56 64.5 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.297 0.639 . . . . 0.0 111.858 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 p -81.33 -7.67 59.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.473 0.709 . . . . 0.0 111.74 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -78.5 157.97 28.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -116.49 148.98 40.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.671 0.788 . . . . 0.0 108.98 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.718 HG21 HD13 ' A' ' 61' ' ' ILE . 45.2 mm -112.48 117.19 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.816 0.446 . . . . 0.0 109.996 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 34.5 ttpt -104.86 125.66 51.12 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -78.32 103.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 110.042 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -67.69 -22.96 65.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.681 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 9' ' ' ARG . 11.7 t -171.5 135.28 0.9 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.887 0.875 . . . . 0.0 109.88 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.95 -159.29 28.09 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.478 -0.624 . . . . 0.0 112.956 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.64 -17.15 29.94 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.109 2.539 . . . . 0.0 112.23 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.72 36.73 4.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.419 1.087 . . . . 0.0 109.454 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.05 98.51 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.781 0.832 . . . . 0.0 111.596 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.83 -20.26 7.27 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.825 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.12 137.15 36.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.931 0.892 . . . . 0.0 110.818 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 12.1 t -104.15 106.91 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.482 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -84.42 156.7 21.67 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.976 173.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -117.52 144.14 45.38 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.0 mt -82.38 123.23 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 58' ' ' THR . 26.2 pt -105.24 139.22 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.578 0.751 . . . . 0.0 109.968 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -108.46 2.53 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.894 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' O ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -153.6 141.07 13.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.568 0.747 . . . . 0.0 109.855 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.62 102.11 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.273 1.982 . . . . 0.0 111.101 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.32 116.49 64.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.062 0.945 . . . . 0.0 109.434 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.87 136.58 33.05 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.628 2.219 . . . . 0.0 112.106 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.5 139.42 31.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.255 0.622 . . . . 0.0 110.775 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.88 80.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.108 0.963 . . . . 0.0 112.247 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.07 -3.46 58.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.221 0.609 . . . . 0.0 111.288 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? 66.51 22.37 10.63 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.438 1.095 . . . . 0.0 111.942 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.1 p -85.57 -13.28 49.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.266 0.626 . . . . 0.0 110.996 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -163.42 -172.15 2.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.928 0.491 . . . . 0.0 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -140.46 124.5 17.45 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -88.1 95.59 10.2 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 21.4 mm -87.06 120.48 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -108.98 142.25 39.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 61' ' ' ILE . 72.2 m -150.93 172.93 14.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.754 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -143.95 158.47 43.68 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.73 127.09 30.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.441 0.463 . . . . 0.0 111.073 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.784 -177.487 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.484 0.183 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.18 -14.14 6.59 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.185 0.994 . . . . 0.0 112.319 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -102.15 -179.2 3.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.957 1.303 . . . . 0.0 109.268 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HB3' HG22 ' A' ' 34' ' ' THR . 45.2 mtm180 -135.59 146.86 48.39 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.076 0.55 . . . . 0.0 109.98 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.92 144.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.944 0.898 . . . . 0.0 109.527 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -98.57 127.37 44.47 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.8 mm -80.64 106.97 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.452 0.701 . . . . 0.0 110.678 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' TRP . 27.9 mp0 -79.9 96.59 6.41 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.472 0.653 . . . . 0.0 109.93 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -81.25 136.22 35.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.708 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.8 tp -78.42 98.97 6.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.07 0.462 . . . . 0.0 109.782 -173.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -74.92 93.93 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.027 0.931 . . . . 0.0 110.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.453 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 46.4 mt-30 -91.76 83.65 5.31 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -90.31 125.53 35.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.24 0.616 . . . . 0.0 110.404 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 42.1 ttp180 -78.22 152.06 32.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.671 0.389 . . . . 0.0 110.277 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 31.1 t70 -99.97 164.11 12.14 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.4 -10.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.472 1.109 . . . . 0.0 113.092 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -120.65 -6.45 9.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.455 -0.778 . . . . 0.0 109.496 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.17 48.04 1.64 Allowed Glycine 0 C--N 1.36 1.897 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 165.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 5.1 mp0 -106.14 148.15 28.18 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.53 100.83 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.64 101.25 13.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 0.0 108.65 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.1 mt-10 -85.19 118.79 24.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.501 0.72 . . . . 0.0 110.202 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 15' ' ' LEU . 36.5 p -134.95 174.8 10.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . 85.0 m95 -117.5 107.83 14.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.0 146.43 23.94 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.9 141.39 53.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.911 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.96 -107.0 3.17 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -127.51 148.78 50.32 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.6 m -102.79 97.49 7.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.161 0.584 . . . . 0.0 109.465 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.3 pt? -113.01 171.99 7.21 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.251 0.62 . . . . 0.0 111.941 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -62.65 123.77 19.26 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.937 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.721 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.61 172.03 13.6 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.488 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 t -129.91 99.34 5.07 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.527 HG13 HG12 ' A' ' 61' ' ' ILE . 21.8 t -88.7 92.44 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.4 0.619 . . . . 0.0 109.446 -174.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -96.03 106.07 18.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.741 0.816 . . . . 0.0 110.244 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.46 121.75 19.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG21 ' HB ' ' A' ' 58' ' ' THR . 5.5 m -67.38 135.44 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -91.53 -177.03 4.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.461 0.705 . . . . 0.0 111.36 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 p -61.79 -41.21 97.43 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.495 0.718 . . . . 0.0 111.269 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -54.58 -43.58 72.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.118 0.967 . . . . 0.0 110.693 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.93 -52.23 66.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.648 0.593 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.77 -55.22 21.07 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.821 0.849 . . . . 0.0 112.712 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.034 0.934 . . . . 0.0 111.516 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.7 m -66.25 -41.05 90.52 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.452 0.701 . . . . 0.0 112.161 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 93.9 p -87.52 -5.24 58.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.106 0.562 . . . . 0.0 111.755 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.65 -71.95 1.5 Allowed Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.18 11.35 0.28 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.882 0.873 . . . . 0.0 110.897 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.1 tt0 -80.29 -27.2 38.58 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.087 0.555 . . . . 0.0 110.984 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -115.03 44.67 1.75 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.45 132.11 46.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.87 126.31 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 124.364 1.04 . . . . 0.0 110.85 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.58 -12.42 13.69 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -163.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.45 ' HB ' HG21 ' A' ' 42' ' ' VAL . 31.3 m -82.17 149.32 28.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.07 129.53 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -100.01 135.81 40.88 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 75' ' ' ILE . 71.1 mt -134.46 109.38 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.971 0.908 . . . . 0.0 109.002 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -90.95 116.79 29.02 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 37' ' ' ALA . 43.4 pt -121.32 163.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.67 138.73 58.04 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 164.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 2.6 t80 -53.04 126.58 21.06 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.36 1.064 . . . . 0.0 109.82 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -140.79 134.62 30.47 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.818 0.699 . . . . 0.0 109.252 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -82.16 1.79 34.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 111.581 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.16 -20.78 20.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.874 0.869 . . . . 0.0 111.201 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 104' ' ' ILE . 23.4 mm -72.16 123.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.668 0.387 . . . . 0.0 110.481 -170.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -133.41 170.88 14.83 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 109.138 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.62 65.45 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.294 0.638 . . . . 0.0 111.433 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -94.19 39.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.819 0.848 . . . . 0.0 110.374 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 m -130.47 150.5 51.66 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 78.1 mtm180 -117.16 162.95 17.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 61' ' ' ILE . 32.2 mm -127.58 97.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 HG11 ' A' ' 39' ' ' VAL . 22.9 t -73.68 118.09 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.873 0.469 . . . . 0.0 110.443 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 t -69.07 -36.56 77.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.76 0.824 . . . . 0.0 110.738 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 9' ' ' ARG . 9.0 t -167.51 135.59 2.46 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.897 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.91 -158.33 27.83 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.861 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.76 -29.21 51.1 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.811 2.341 . . . . 0.0 112.062 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 39' ' ' VAL . 66.6 mt -115.86 32.16 6.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 0.0 110.559 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.46 114.2 2.12 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.467 0.707 . . . . 0.0 111.349 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.59 -30.68 6.54 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.683 0.615 . . . . 0.0 112.69 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -72.7 142.64 48.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.405 0.682 . . . . 0.0 110.864 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.57 97.75 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-O 122.494 1.14 . . . . 0.0 109.985 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.9 114.66 21.83 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.701 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.07 135.56 34.79 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.135 0.974 . . . . 0.0 109.433 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.61 116.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.2 pt -98.88 132.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.294 0.637 . . . . 0.0 109.508 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.98 -120.88 5.58 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -171.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.418 ' O ' HD21 ' A' ' 105' ' ' LEU . 11.3 pt20 -147.25 147.59 29.13 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.056 0.943 . . . . 0.0 108.485 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.89 141.84 96.14 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.87 2.38 . . . . 0.0 112.718 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.86 108.92 53.12 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.65 156.17 62.72 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.356 2.037 . . . . 0.0 112.004 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 27.2 t70 -59.54 154.59 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.442 0.697 . . . . 0.0 112.34 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.21 91.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.927 0.891 . . . . 0.0 111.126 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.43 -8.44 54.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.19 0.596 . . . . 0.0 111.235 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.79 21.05 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.227 1.411 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -79.77 -3.11 46.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 18.6 ptp180 -167.17 -176.1 3.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.068 0.947 . . . . 0.0 109.141 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -132.18 117.27 18.05 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.66 111.8 21.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.56 HG22 ' SG ' ' A' ' 106' ' ' CYS . 21.9 mm -95.26 135.37 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -112.45 128.35 56.3 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 174.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.56 ' SG ' HG22 ' A' ' 104' ' ' ILE . 76.3 m -147.11 175.1 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.605 -168.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -139.64 158.02 44.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -52.53 151.93 3.92 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.015 0.526 . . . . 0.0 111.535 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.816 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.268 -175.485 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -80.01 -43.62 21.62 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.934 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' THR . 53.5 m-20 -104.41 -161.15 0.8 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.688 1.595 . . . . 0.0 110.872 -170.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 53.9 ttt180 -159.0 137.06 10.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.116 0.966 . . . . 0.0 109.557 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -132.42 168.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 124.428 1.091 . . . . 0.0 110.446 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.9 m -115.92 138.91 50.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.798 1.239 . . . . 0.0 108.101 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.12 101.58 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.024 0.53 . . . . 0.0 110.495 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.51 100.97 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.707 0.803 . . . . 0.0 110.265 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.8 p -79.06 147.95 32.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.107 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 27' ' ' GLU . 60.5 tp -98.03 107.63 20.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -99.07 120.57 39.69 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.599 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 89.2 mt-30 -82.57 93.7 7.36 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -92.05 114.36 26.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.582 0.753 . . . . 0.0 109.401 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 23.6 ttp85 -72.72 158.29 35.88 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -110.7 169.84 8.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 109.351 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.6 -8.42 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 124.331 1.052 . . . . 0.0 112.839 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 p -99.25 -9.27 23.87 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.612 0.72 . . . . 0.0 109.084 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.39 19.8 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.339 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 42.5 mt-10 -97.29 140.55 31.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.355 0.662 . . . . 0.0 109.421 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' GLN . 40.0 mm -89.32 101.43 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.45 104.97 17.48 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 42.9 mt-10 -80.19 112.4 17.47 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -128.58 144.52 51.17 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.231 1.013 . . . . 0.0 110.609 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -103.28 100.22 10.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -98.0 135.3 39.9 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.689 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.06 142.98 55.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 -110.19 3.18 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -117.53 141.83 47.89 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 109.545 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 9' ' ' ARG . 11.2 m -101.8 102.5 13.13 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.087 0.955 . . . . 0.0 109.531 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.7 pt? -114.16 171.03 7.85 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.276 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -70.8 132.77 45.81 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.214 1.005 . . . . 0.0 111.945 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.8 -179.47 5.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.375 1.07 . . . . 0.0 110.867 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -139.06 102.29 4.49 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.92 106.27 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.396 1.078 . . . . 0.0 110.064 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -116.52 108.85 16.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 110.53 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 84.2 mtp -68.64 125.53 26.84 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.25 138.05 19.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 C-N-CA 123.766 0.826 . . . . 0.0 111.03 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -97.14 -177.86 3.99 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.66 -35.71 72.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.939 0.896 . . . . 0.0 111.794 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -52.62 -61.21 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.939 0.896 . . . . 0.0 112.233 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.49 -23.99 42.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.676 0.39 . . . . 0.0 111.578 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.38 18.22 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 120.954 0.407 . . . . 0.0 111.383 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.27 -37.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.03 0.932 . . . . 0.0 111.067 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -46.78 87.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.729 0.812 . . . . 0.0 111.115 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 79.4 p -82.38 -13.65 56.51 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.273 0.629 . . . . 0.0 111.348 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.24 -86.89 1.17 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.23 -1.59 5.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.817 0.847 . . . . 0.0 111.153 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.0 tt0 -65.58 -63.07 1.18 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.462 0.705 . . . . 0.0 109.774 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.29 138.15 31.69 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 165.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.2 144.69 51.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.4 mt -62.81 113.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 118.113 0.415 . . . . 0.0 110.398 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.18 -10.75 14.89 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 123.04 0.352 . . . . 0.0 112.898 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -63.81 146.93 53.02 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.8 t -119.63 123.69 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.263 0.625 . . . . 0.0 110.63 -169.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -103.78 130.44 51.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 75' ' ' ILE . 86.4 mt -134.2 113.04 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.393 0.677 . . . . 0.0 109.209 -166.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -102.05 115.27 30.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.619 0.768 . . . . 0.0 109.79 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 47.4 pt -121.32 163.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -60.51 157.08 14.87 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.444 ' N ' ' HA ' ' A' ' 101' ' ' ARG . 70.8 t80 -64.16 101.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.571 -172.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -119.9 118.83 31.77 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.8 -2.69 40.79 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.997 0.919 . . . . 0.0 110.932 -174.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -92.66 -21.12 20.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.288 0.635 . . . . 0.0 110.949 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.04 134.48 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.158 0.583 . . . . 0.0 110.632 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -131.0 171.68 12.94 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.2 67.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.567 0.747 . . . . 0.0 111.076 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.7 p -86.36 45.47 1.24 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.87 1.268 . . . . 0.0 110.554 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.0 m -141.49 122.65 14.72 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.412 1.085 . . . . 0.0 108.213 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -94.56 133.09 38.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 61' ' ' ILE . 22.7 mm -95.99 94.0 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.867 0.867 . . . . 0.0 109.932 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 40.1 ttpt -94.6 111.62 23.38 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 87' ' ' LEU . 49.8 t -70.65 128.75 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 110.477 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -93.23 -29.63 15.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.924 0.89 . . . . 0.0 110.364 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 9' ' ' ARG . 54.4 m -151.93 110.49 3.79 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.467 -166.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.74 29.73 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.556 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -16.18 45.72 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 87' ' ' LEU . 83.6 mt -127.36 34.33 4.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.217 1.007 . . . . 0.0 110.147 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.72 93.48 0.11 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.337 0.655 . . . . 0.0 111.131 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.58 -13.56 4.81 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.792 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.627 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 62.1 ttm-85 -95.55 149.36 21.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.17 0.988 . . . . 0.0 110.563 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.9 p -108.21 101.1 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 122.326 1.06 . . . . 0.0 109.737 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -86.53 131.18 34.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.031 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -103.78 143.66 32.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.434 0.694 . . . . 0.0 109.256 -174.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.52 108.37 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 107' ' ' ARG . 25.7 pt -87.19 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 122.254 1.026 . . . . 0.0 110.559 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.43 -149.07 19.83 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -124.45 141.38 37.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.5 134.66 65.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.329 2.686 . . . . 0.0 112.629 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.51 107.15 49.46 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.318 1.047 . . . . 0.0 109.446 -170.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.22 152.01 72.09 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.672 2.248 . . . . 0.0 111.832 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -81.1 178.19 8.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.388 0.275 . . . . 0.0 110.643 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.24 70.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.102 0.961 . . . . 0.0 112.889 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.21 37.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.016 0.526 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 57.64 33.24 23.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 0.0 110.391 -172.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.0 t -92.15 -7.64 47.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.117 0.967 . . . . 0.0 110.162 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HA ' ' N ' ' A' ' 65' ' ' TYR . 9.1 ptp180 -161.34 167.86 25.01 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.543 0.687 . . . . 0.0 111.384 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.05 109.34 16.33 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.437 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -79.93 107.6 12.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.501 HG22 ' SG ' ' A' ' 106' ' ' CYS . 24.6 mm -97.67 112.44 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -82.37 135.06 35.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.501 ' SG ' HG22 ' A' ' 104' ' ' ILE . 78.7 m -148.99 175.41 11.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.197 0.999 . . . . 0.0 108.755 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 90' ' ' ILE . 61.5 ttt85 -149.95 161.48 42.22 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' ' HD3' ' A' ' 85' ' ' ARG . 1.8 tm-20 -45.45 125.73 5.96 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.795 0.838 . . . . 0.0 110.384 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.06 0 O-C-N 123.552 0.533 . . . . 0.0 113.686 -167.128 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -93.8 -27.51 16.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.03 0.932 . . . . 0.0 112.345 -163.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.85 171.8 8.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.061 0.944 . . . . 0.0 109.026 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HB2' HG22 ' A' ' 79' ' ' THR . 98.2 mtt180 -136.84 138.0 40.32 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 77' ' ' VAL . 47.8 pt -140.97 176.86 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.248 1.019 . . . . 0.0 109.751 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -140.12 136.5 33.61 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.361 0.664 . . . . 0.0 109.406 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.0 mm -73.12 125.89 32.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.268 0.627 . . . . 0.0 109.549 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -97.62 116.53 30.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -89.76 135.57 33.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.096 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' ' 27' ' ' GLU . 2.9 tm? -92.91 99.9 12.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -85.93 107.92 17.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.361 0.664 . . . . 0.0 110.015 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -77.43 110.49 12.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -120.45 121.4 38.41 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -77.01 172.35 13.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.322 0.51 . . . . 0.0 111.209 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.9 t70 -108.12 161.22 15.17 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.8 tt -67.77 -6.26 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 123.792 0.837 . . . . 0.0 113.056 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -105.46 -18.92 13.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.45 54.69 0.93 Allowed Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.737 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 25.9 mt-10 -112.15 147.24 36.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.581 1.152 . . . . 0.0 107.942 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.7 mm -90.07 101.15 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.863 0.756 . . . . 0.0 109.731 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.45 97.85 11.43 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.617 ' HB3' HD21 ' A' ' 15' ' ' LEU . 43.8 mt-10 -83.46 131.75 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.443 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.9 p -132.89 161.4 34.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.109 0.964 . . . . 0.0 109.982 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -118.21 118.59 32.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.485 0.714 . . . . 0.0 109.729 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.89 151.35 25.88 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.105 0.962 . . . . 0.0 109.25 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.83 135.25 38.89 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.36 -110.34 3.06 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -113.28 132.76 55.42 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.0 m -76.45 141.66 41.27 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.97 0.908 . . . . 0.0 108.985 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.88 146.42 27.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.234 0.54 . . . . 0.0 111.682 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -71.06 124.23 23.93 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.437 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -136.81 172.45 12.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.775 0.83 . . . . 0.0 111.288 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -130.84 105.55 7.85 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 61' ' ' ILE . 60.8 t -91.64 91.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 0.0 109.373 -173.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -115.4 119.91 37.81 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.518 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -66.32 152.69 44.45 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.05 149.74 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.894 0.478 . . . . 0.0 111.039 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -88.15 176.61 7.19 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -57.47 -35.96 70.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.078 0.551 . . . . 0.0 110.446 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.05 -39.25 59.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.704 1.202 . . . . 0.0 112.133 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -66.16 -49.74 66.36 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.383 0.427 . . . . 0.0 111.198 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.5 97.66 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.981 0.801 . . . . 0.0 110.8 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.5 mt -63.22 -43.83 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.645 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 t -75.76 -13.66 60.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.428 0.691 . . . . 0.0 111.781 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 45.6 m -111.18 -2.38 15.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.676 0.79 . . . . 0.0 111.736 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.13 -74.5 1.85 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.6 5.33 0.8 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.884 0.874 . . . . 0.0 111.21 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 35.8 tt0 -70.73 -68.54 0.42 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.126 0.571 . . . . 0.0 110.342 -177.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.16 142.5 45.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 164.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.67 153.18 39.73 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.53 0.732 . . . . 0.0 109.539 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.85 115.39 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.07 -5.54 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.766 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 90' ' ' ILE . 98.6 m -70.49 119.39 14.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 41' ' ' MET . 51.0 t -84.68 118.1 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -98.75 143.33 29.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 75' ' ' ILE . 66.5 mt -138.54 109.97 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -97.56 115.55 28.07 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 ' HB2' ' A' ' 37' ' ' ALA . 49.4 pt -121.2 158.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -56.33 140.76 44.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.191 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -49.32 118.8 2.91 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.615 1.166 . . . . 0.0 111.629 -171.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -143.34 117.76 9.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.154 0.582 . . . . 0.0 109.967 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.42 2.59 27.93 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.597 1.159 . . . . 0.0 112.204 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.36 -17.32 24.82 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.852 0.861 . . . . 0.0 110.998 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.6 HG21 HD12 ' A' ' 104' ' ' ILE . 26.9 mm -67.52 138.98 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.039 0.536 . . . . 0.0 110.31 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -145.7 169.63 18.1 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.081 0.952 . . . . 0.0 108.709 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . . . -63.6 -26.97 68.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.088 0.555 . . . . 0.0 112.037 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.5 p -97.9 48.01 1.01 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.16 0.981 . . . . 0.0 110.656 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -131.29 156.53 45.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -126.76 159.25 34.32 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.289 0.566 . . . . 0.0 109.989 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.604 HG21 HD13 ' A' ' 61' ' ' ILE . 48.4 mm -112.41 98.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.053 . . . . 0.0 109.224 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -90.45 113.57 25.54 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.525 ' HA ' HG22 ' A' ' 10' ' ' ILE . 64.9 t -77.0 112.23 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 110.629 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.7 t -72.8 -30.02 63.74 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.969 0.907 . . . . 0.0 111.227 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 9' ' ' ARG . 15.0 t -165.71 139.55 4.51 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.978 0.911 . . . . 0.0 109.285 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.7 -163.4 30.38 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-O 118.95 -0.917 . . . . 0.0 111.67 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.74 -25.91 28.21 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.377 2.051 . . . . 0.0 111.452 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -114.5 33.93 5.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.195 0.998 . . . . 0.0 109.724 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.3 109.16 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.702 0.801 . . . . 0.0 111.452 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.37 -21.32 10.02 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.415 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -80.62 165.87 21.63 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.387 0.675 . . . . 0.0 111.153 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.17 102.05 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 122.351 1.072 . . . . 0.0 109.414 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 120.86 24.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.674 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.75 134.76 35.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.223 1.009 . . . . 0.0 108.288 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' A' ' 106' ' ' CYS . 66.1 mt -82.19 95.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -172.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 58' ' ' THR . 21.7 pt -80.53 62.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 122.3 1.048 . . . . 0.0 111.14 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.54 -158.85 27.83 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 92.5 mt-30 -126.59 145.44 53.22 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 109.365 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 134.47 57.88 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 113.504 -173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -106.56 108.92 62.7 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.1 142.7 56.95 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.668 2.246 . . . . 0.0 112.269 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.24 150.56 48.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 111.374 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.99 70.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.529 1.132 . . . . 0.0 112.369 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.66 -8.97 45.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.878 0.471 . . . . 0.0 110.973 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 62.54 20.28 11.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.705 1.202 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.8 t -89.41 -0.17 57.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.344 0.258 . . . . 0.0 110.813 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.64 -174.89 2.94 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 123.65 0.78 . . . . 0.0 109.949 171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.26 124.62 26.21 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.62 117.33 28.42 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 HG21 ' A' ' 69' ' ' ILE . 15.3 mm -108.76 140.55 26.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -112.14 128.97 56.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' A' ' 89' ' ' ILE . 56.2 m -150.74 -178.96 6.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -171.09 175.68 4.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.34 1.056 . . . . 0.0 108.642 163.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -57.67 172.04 0.41 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.691 0.796 . . . . 0.0 111.066 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.097 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -176.45 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -117.09 -44.17 2.81 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.398 1.079 . . . . 0.0 110.284 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -101.07 -175.48 2.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.049 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -131.94 147.73 52.48 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.79 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' THR . 13.7 pt -138.97 145.29 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.622 1.169 . . . . 0.0 109.266 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -108.62 137.95 45.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 109.021 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.06 114.15 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.889 0.476 . . . . 0.0 110.284 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.584 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.1 mp0 -89.79 103.79 16.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 p -79.41 159.03 27.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.481 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.5 tp -114.84 110.28 19.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.082 0.553 . . . . 0.0 109.997 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -93.99 101.94 14.01 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.952 0.901 . . . . 0.0 109.417 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -79.81 125.42 29.67 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -137.11 150.55 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 108.718 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 37.9 ttp180 -99.33 166.24 11.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.55 0.34 . . . . 0.0 110.121 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 8.7 t70 -110.59 162.89 14.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.642 1.177 . . . . 0.0 108.592 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tt -59.25 -12.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 125.013 1.325 . . . . 0.0 113.805 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -112.52 -34.61 5.8 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.49 48.04 0.15 Allowed Glycine 0 C--N 1.354 1.559 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.708 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.506 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 23.7 mm-40 -96.12 154.21 17.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.423 0.689 . . . . 0.0 109.258 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -107.05 102.93 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.81 101.72 13.06 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.575 1.15 . . . . 0.0 109.106 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -88.2 107.39 18.76 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -116.14 144.6 43.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.638 0.775 . . . . 0.0 110.231 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.42 ' CZ3' ' HG3' ' A' ' 74' ' ' ARG . 85.4 m95 -114.22 113.62 24.88 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.133 0.973 . . . . 0.0 109.424 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.02 123.82 47.34 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.36 128.88 38.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.267 1.427 . . . . 0.0 109.364 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.47 -126.4 3.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -165.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.91 135.03 43.01 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.918 0.887 . . . . 0.0 110.717 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 16.6 m -99.1 105.77 17.9 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.369 0.668 . . . . 0.0 110.85 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -108.82 170.72 7.86 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.588 0.708 . . . . 0.0 111.721 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -71.81 127.54 32.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.279 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -138.74 176.35 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.306 1.043 . . . . 0.0 111.106 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -136.7 110.29 8.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.022 0.929 . . . . 0.0 108.511 162.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.87 106.28 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.392 0.677 . . . . 0.0 110.538 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.91 103.92 11.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.009 0.923 . . . . 0.0 109.48 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.536 ' SD ' HD21 ' A' ' 82' ' ' LEU . 92.5 mtp -66.53 130.52 43.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.04 142.51 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.015 0.436 . . . . 0.0 110.737 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -98.22 -173.02 2.47 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 124.03 0.932 . . . . 0.0 110.457 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -53.42 -29.92 37.64 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.264 1.025 . . . . 0.0 112.839 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -49.99 -51.12 44.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.63 0.772 . . . . 0.0 112.053 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -67.12 -40.43 86.83 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.653 0.596 . . . . 0.0 111.634 -174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.79 72.18 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.293 0.637 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.68 -42.45 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.832 0.853 . . . . 0.0 111.403 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.4 t -68.77 -30.25 68.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.216 0.607 . . . . 0.0 111.383 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 97.1 p -91.84 -9.34 43.75 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.417 0.687 . . . . 0.0 111.163 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.5 -72.09 2.8 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.37 10.19 0.5 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.704 0.802 . . . . 0.0 110.88 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 47.3 mt-10 -78.45 -30.91 47.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.91 0.484 . . . . 0.0 111.084 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.56 170.34 8.25 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.074 0.95 . . . . 0.0 109.252 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.07 149.54 35.25 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.803 0.841 . . . . 0.0 109.682 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mt -63.23 144.6 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.53 0.732 . . . . 0.0 110.364 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.98 -12.03 70.58 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.135 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.511 HG23 HD11 ' A' ' 90' ' ' ILE . 47.1 m -61.05 116.7 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.223 0.609 . . . . 0.0 109.358 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.554 HG11 ' HG ' ' A' ' 87' ' ' LEU . 46.4 t -76.69 103.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.883 -171.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -92.58 137.44 32.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -141.4 109.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.824 0.85 . . . . 0.0 108.777 -167.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -92.65 124.11 36.43 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.35 0.66 . . . . 0.0 109.579 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.9 pt -130.25 167.39 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.623 0.769 . . . . 0.0 110.16 -175.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -53.25 151.08 5.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.735 0.647 . . . . 0.0 111.451 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.466 ' HE1' ' HD2' ' A' ' 99' ' ' ARG . 61.5 t80 -60.38 107.91 0.73 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -129.64 119.16 23.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.3 -2.89 30.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.927 1.291 . . . . 0.0 112.31 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.05 -21.31 19.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.885 0.874 . . . . 0.0 111.396 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 HD12 ' A' ' 104' ' ' ILE . 29.0 mm -72.62 132.21 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.65 0.38 . . . . 0.0 110.554 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -143.18 161.88 37.08 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.01 -27.78 68.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.3 0.64 . . . . 0.0 111.897 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -79.2 14.32 1.53 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.183 0.993 . . . . 0.0 112.364 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -111.42 167.65 10.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.505 0.722 . . . . 0.0 109.077 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 51.0 mtm180 -122.46 150.28 42.72 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 mm -113.17 99.92 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.498 1.119 . . . . 0.0 109.019 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.3 ttpt -89.44 120.28 30.63 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.072 -0.393 . . . . 0.0 110.172 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 87' ' ' LEU . 53.4 t -76.79 120.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.966 0.412 . . . . 0.0 109.902 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.0 m -84.81 -29.94 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.343 1.057 . . . . 0.0 111.522 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.9 p -141.27 126.77 18.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.85 0.86 . . . . 0.0 109.556 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.92 -158.19 25.08 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.503 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.62 -13.38 29.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.246 2.631 . . . . 0.0 112.441 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.536 HD21 ' SD ' ' A' ' 41' ' ' MET . 70.9 mt -120.77 25.77 9.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.838 . . . . 0.0 110.149 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.34 112.48 2.44 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.342 0.657 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.01 2.54 51.86 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.501 0.501 . . . . 0.0 113.175 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -105.53 139.55 39.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.574 0.75 . . . . 0.0 109.475 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -104.93 102.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 122.313 1.054 . . . . 0.0 109.722 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' HG11 ' A' ' 59' ' ' VAL . 1.5 mm? -82.73 133.14 35.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.198 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.44 143.6 30.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.195 0.598 . . . . 0.0 109.561 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.3 mt -80.48 143.62 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 HG23 ' A' ' 58' ' ' THR . 2.2 pt -122.19 104.38 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.813 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.3 -105.98 2.48 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.847 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.1 150.17 29.05 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.684 0.794 . . . . 0.0 109.884 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HB2' HD23 ' A' ' 102' ' ' LEU . 33.6 Cg_endo -64.02 123.64 12.23 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 121.903 1.736 . . . . 0.0 111.008 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -89.14 113.8 57.68 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -76.55 129.13 10.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.17 1.913 . . . . 0.0 110.699 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.671 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 21.9 t70 -52.69 150.37 5.24 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.342 1.057 . . . . 0.0 112.198 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.76 -43.92 77.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.926 0.891 . . . . 0.0 112.001 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.57 0.12 56.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.549 0.739 . . . . 0.0 111.251 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 38.7 mmt180 61.88 26.04 15.72 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.088 1.355 . . . . 0.0 112.138 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.8 p -79.79 -12.2 59.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 96' ' ' ASP . 13.3 ptp180 -165.67 175.9 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 93' ' ' PRO . 6.5 mp -122.69 121.81 37.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.944 0.898 . . . . 0.0 108.766 165.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.33 102.99 12.36 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 69' ' ' ILE . 8.6 mm -87.26 142.88 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -123.61 138.05 54.62 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.09 176.44 10.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.073 -167.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 159.24 42.8 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -45.79 122.76 3.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.976 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.142 -172.714 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 64' ' ' ARG . 27.2 mt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.884 0.373 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -97.56 -21.2 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.504 0.721 . . . . 0.0 111.468 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.3 -174.68 2.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.145 0.978 . . . . 0.0 110.052 -173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -139.01 150.92 46.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.385 0.674 . . . . 0.0 110.077 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 34' ' ' THR . 44.6 pt -139.33 168.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.178 . . . . 0.0 109.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -128.81 138.91 52.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.677 0.791 . . . . 0.0 109.013 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -89.71 92.35 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.359 0.6 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -71.66 99.13 2.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.82 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 p -84.27 139.45 32.32 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.57 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 28' ' ' THR . 64.1 tp -78.18 105.58 9.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.144 0.577 . . . . 0.0 109.737 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -90.51 117.95 29.6 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.804 0.841 . . . . 0.0 111.087 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.98 94.34 5.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -90.92 111.49 22.95 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.346 0.659 . . . . 0.0 109.576 -173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.7 ttt-85 -87.79 152.85 21.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.052 0.453 . . . . 0.0 111.443 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -107.65 164.04 12.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.963 0.905 . . . . 0.0 108.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.4 tt -72.2 -1.26 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 C-N-CA 124.121 0.969 . . . . 0.0 113.239 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -98.45 -14.24 20.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.981 0.896 . . . . 0.0 109.33 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.97 40.98 5.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.805 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 46.5 mt-10 -96.79 149.58 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.622 0.769 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -108.49 107.4 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.47 103.79 15.77 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.2 mt-10 -80.38 126.5 31.25 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 109.631 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.433 ' O ' HD12 ' A' ' 15' ' ' LEU . 37.7 p -139.53 -176.17 4.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.599 1.56 . . . . 0.0 108.469 -168.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -128.05 115.09 17.93 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.906 -0.496 . . . . 0.0 109.665 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.62 145.34 26.95 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.79 136.81 37.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.966 0.507 . . . . 0.0 109.634 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.86 -109.45 3.34 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -108.11 134.38 51.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 88.3 m -97.96 102.91 14.79 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.04 168.75 9.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.576 0.751 . . . . 0.0 112.264 -173.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.0 122.26 19.01 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.359 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.96 13.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.442 0.697 . . . . 0.0 112.368 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 2.1 m -131.74 94.61 3.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.384 1.074 . . . . 0.0 108.226 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 77' ' ' VAL . 2.8 p -91.2 94.27 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.698 0.761 . . . . 0.0 109.67 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -113.6 119.85 38.91 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.724 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.539 ' SD ' HD21 ' A' ' 82' ' ' LEU . 54.1 mtp -76.62 150.63 36.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.937 0.495 . . . . 0.0 109.737 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -83.7 136.41 22.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.146 0.579 . . . . 0.0 109.576 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 39.5 t -90.3 -178.85 5.48 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.964 0.906 . . . . 0.0 109.535 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -60.53 -33.57 72.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.423 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 18.4 ptpt -53.93 -40.24 66.56 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.619 1.167 . . . . 0.0 111.461 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -70.28 -43.37 70.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.012 0.925 . . . . 0.0 110.44 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.39 -32.12 72.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.895 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.8 mt -73.16 -45.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.249 0.62 . . . . 0.0 110.553 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.3 m -63.45 -36.95 85.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.78 0.832 . . . . 0.0 111.856 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.7 p -86.51 -48.37 8.44 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.034 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.22 -64.68 0.31 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.98 -5.57 0.79 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.872 0.869 . . . . 0.0 111.568 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.0 tt0 -71.98 -68.94 0.42 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.006 0.522 . . . . 0.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -77.09 119.52 20.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.91 39.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.98 117.97 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.08 -11.17 14.88 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 116.856 -0.156 . . . . 0.0 113.048 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 90' ' ' ILE . 89.1 m -68.29 146.91 52.87 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.93 116.41 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.271 0.628 . . . . 0.0 110.096 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -87.63 126.39 34.92 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 75' ' ' ILE . 44.8 mt -123.48 104.95 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 11.9 m0 -90.56 117.91 29.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.723 0.809 . . . . 0.0 109.722 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 pt -130.29 161.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 108.324 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HG3' HD11 ' A' ' 6' ' ' LEU . 64.1 mtm180 -60.92 141.13 57.48 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.883 0.765 . . . . 0.0 110.826 167.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.24 130.99 36.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.052 1.341 . . . . 0.0 111.135 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.41 147.15 25.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.19 0.596 . . . . 0.0 111.238 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -83.2 1.02 42.78 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.603 1.161 . . . . 0.0 111.884 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.67 -26.78 19.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.877 0.471 . . . . 0.0 111.216 -165.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 104' ' ' ILE . 6.3 mm -75.65 132.03 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.73 167.37 16.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.91 63.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.082 0.553 . . . . 0.0 111.635 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.1 p -84.95 3.11 39.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.791 0.836 . . . . 0.0 111.547 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 m -93.95 159.79 15.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.57 0.748 . . . . 0.0 109.646 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -132.12 165.0 25.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 0.0 109.01 170.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.646 HG21 HD13 ' A' ' 61' ' ' ILE . 43.7 mm -115.97 99.22 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.487 0.715 . . . . 0.0 110.621 -173.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -91.93 110.11 21.46 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 39' ' ' VAL . 95.7 t -72.84 117.94 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.678 0.791 . . . . 0.0 111.106 -172.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.3 m -77.44 -21.73 52.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.358 1.063 . . . . 0.0 112.158 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -167.71 132.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.729 0.811 . . . . 0.0 109.34 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.44 -163.72 30.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.928 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.42 -16.07 17.37 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.134 2.556 . . . . 0.0 112.102 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 87' ' ' LEU . 82.7 mt -119.26 28.93 7.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.341 1.056 . . . . 0.0 109.795 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.81 115.23 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.425 0.69 . . . . 0.0 110.542 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.63 38.96 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.811 0.694 . . . . 0.0 112.946 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -107.68 143.82 35.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.862 0.865 . . . . 0.0 109.853 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.12 88.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 122.481 1.134 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 82' ' ' LEU . 2.6 mm? -62.57 132.41 52.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.033 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -95.13 130.69 41.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.275 1.03 . . . . 0.0 109.357 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.91 129.92 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.489 HG23 ' HD2' ' A' ' 107' ' ' ARG . 1.5 pt -97.18 111.55 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 0.0 109.215 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.46 -94.05 1.9 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.987 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -166.92 155.11 9.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.316 1.046 . . . . 0.0 109.325 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -58.35 123.44 13.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.755 2.303 . . . . 0.0 111.831 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.12 111.71 65.26 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 123.916 0.887 . . . . 0.0 109.789 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.08 155.9 63.79 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.229 2.62 . . . . 0.0 113.691 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.86 155.2 41.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 110.914 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.88 84.23 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.344 0.657 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.29 59.28 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.948 0.499 . . . . 0.0 110.899 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 61.29 23.85 14.03 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.285 1.434 . . . . 0.0 112.236 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 t -85.87 -6.51 59.07 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.796 0.438 . . . . 0.0 111.401 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.599 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 5.5 ppt_? -161.27 162.54 31.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.583 0.753 . . . . 0.0 109.614 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.56 118.21 32.5 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.599 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 37.8 tt0 -90.27 105.27 17.7 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 69' ' ' ILE . 13.7 mm -88.74 97.69 7.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -81.19 136.84 35.9 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 77.1 m -151.75 -175.5 5.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.068 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.489 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -153.53 160.09 42.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.44 0.696 . . . . 0.0 109.196 165.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 138.49 57.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.544 0.737 . . . . 0.0 110.322 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.073 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.851 -171.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -103.58 -7.62 20.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.734 0.814 . . . . 0.0 112.33 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -102.64 -176.92 3.24 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 55.6 mtm180 -133.74 150.78 51.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.579 0.752 . . . . 0.0 109.42 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' THR . 12.4 pt -136.4 157.18 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 31' ' ' ASP . 26.0 m -116.55 124.82 50.82 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.8 mm -72.31 93.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 2.3 tp-100 -71.58 100.17 2.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -83.71 140.55 32.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.603 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB3' ' A' ' 27' ' ' GLU . 42.5 tp -101.6 98.92 9.16 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 110.018 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -83.66 105.91 14.95 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 109.237 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -74.99 90.82 2.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.5 m -89.68 112.31 23.53 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 109.938 -171.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.7 ttp180 -72.65 153.45 41.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.843 0.354 . . . . 0.0 110.431 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 26' ' ' LEU . 19.3 t70 -113.89 164.65 13.48 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.3 5.95 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.853 0.861 . . . . 0.0 112.392 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -101.54 -14.96 17.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.707 0.803 . . . . 0.0 109.033 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.79 33.91 8.09 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.371 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 47.9 mt-10 -102.59 166.95 10.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.613 0.765 . . . . 0.0 110.537 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.2 mm -114.14 105.36 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.708 0.803 . . . . 0.0 109.21 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 20' ' ' ASP . 5.9 mp -98.27 96.05 7.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.849 1.26 . . . . 0.0 107.697 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.668 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.9 mt-10 -79.03 118.66 21.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.512 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -126.75 149.13 49.78 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.753 1.221 . . . . 0.0 110.251 -172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.442 ' CE2' HD13 ' A' ' 15' ' ' LEU . 92.7 m95 -107.62 109.5 21.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.867 0.867 . . . . 0.0 109.49 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.3 140.07 39.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.091 0.957 . . . . 0.0 108.567 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.5 p-10 -71.54 128.99 37.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.28 -119.66 4.56 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.784 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.47 116.59 28.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.448 0.699 . . . . 0.0 109.423 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 26.8 m -90.26 94.53 9.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -103.96 162.83 12.81 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.244 0.545 . . . . 0.0 111.604 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -63.26 126.31 27.0 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.794 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -134.71 165.53 25.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.364 1.066 . . . . 0.0 111.709 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -121.66 98.91 6.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.13 91.63 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.282 0.633 . . . . 0.0 110.125 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.54 107.49 19.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.445 0.698 . . . . 0.0 110.34 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.23 130.71 41.45 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 13.8 m -70.21 151.13 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -95.38 -177.32 4.06 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.653 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -61.29 -41.0 96.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.641 0.776 . . . . 0.0 110.778 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.17 -34.4 68.42 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.225 1.01 . . . . 0.0 112.314 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 5.8 mm-40 -62.3 -39.41 92.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.263 0.625 . . . . 0.0 111.169 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.98 67.12 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.512 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.77 -33.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.106 0.962 . . . . 0.0 111.939 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -87.65 -48.55 7.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.513 0.725 . . . . 0.0 110.704 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 15.8 m -84.49 -22.65 30.16 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.86 -102.19 1.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.242 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.24 -5.02 57.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.431 0.692 . . . . 0.0 111.816 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 34.7 tt0 -82.91 -62.64 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.632 0.373 . . . . 0.0 110.465 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 58' ' ' THR . 47.1 mt -110.08 147.94 32.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.493 0.717 . . . . 0.0 109.228 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.97 168.92 18.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.476 1.11 . . . . 0.0 110.252 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.4 116.12 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.81 -9.76 14.21 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 123.072 0.368 . . . . 0.0 112.43 -167.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.623 HG21 HD22 ' A' ' 54' ' ' LEU . 88.2 m -80.56 161.98 24.51 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.299 1.04 . . . . 0.0 109.281 172.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.97 126.41 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.116 0.966 . . . . 0.0 109.117 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -95.46 134.36 38.38 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.18 109.35 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -94.15 127.22 39.84 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 10' ' ' ILE . 49.7 pt -132.83 168.04 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.627 0.371 . . . . 0.0 110.677 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -49.14 131.71 19.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.815 0.446 . . . . 0.0 110.15 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.54 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 69.0 t80 -51.55 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.519 1.528 . . . . 0.0 111.697 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 104.58 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 109.464 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.76 7.73 9.68 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.055 0.942 . . . . 0.0 111.729 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.84 -18.91 21.5 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.189 0.996 . . . . 0.0 111.138 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.615 HG21 HD12 ' A' ' 104' ' ' ILE . 39.2 mm -68.7 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 122.878 0.471 . . . . 0.0 109.897 -177.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -142.33 172.68 12.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.107 0.963 . . . . 0.0 108.587 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -30.1 65.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.082 0.953 . . . . 0.0 112.99 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 p -90.55 23.26 3.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.543 0.737 . . . . 0.0 112.324 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -112.74 162.34 15.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.685 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 99.8 mtt180 -122.88 159.34 28.41 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.61 93.25 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.95 0.9 . . . . 0.0 109.134 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.6 ttpt -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.549 HG23 HD23 ' A' ' 87' ' ' LEU . 83.9 t -67.36 122.03 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 122.917 0.487 . . . . 0.0 110.517 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 44.0 t -82.33 -39.64 22.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.937 0.895 . . . . 0.0 109.932 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.3 p -143.92 137.2 27.65 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.739 0.816 . . . . 0.0 109.887 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.41 -161.6 25.0 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.977 0.798 . . . . 0.0 111.485 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.04 -17.98 40.59 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.186 2.591 . . . . 0.0 112.522 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -116.4 27.5 9.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.866 0.866 . . . . 0.0 110.223 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.14 95.08 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.661 0.785 . . . . 0.0 111.586 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.99 -18.33 5.6 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.072 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -86.85 143.8 27.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.713 0.805 . . . . 0.0 110.201 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.0 p -100.94 117.69 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 0.0 109.316 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.0 mm? -87.63 142.95 27.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 108.318 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -107.69 139.59 42.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.923 0.889 . . . . 0.0 109.047 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.9 mt -81.14 99.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 107' ' ' ARG . 23.6 pt -74.26 94.34 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.945 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.29 12.64 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.595 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -128.35 142.97 46.42 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.267 1.027 . . . . 0.0 109.309 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.54 155.53 69.84 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.025 2.483 . . . . 0.0 112.601 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -116.88 107.41 46.15 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -62.76 141.1 83.85 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -69.03 145.49 53.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.88 67.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.606 1.163 . . . . 0.0 112.357 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.62 54.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.763 0.425 . . . . 0.0 111.586 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 65.42 14.4 9.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.47 1.108 . . . . 0.0 112.67 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.415 HG23 ' HD2' ' A' ' 101' ' ' ARG . 13.5 t -89.8 -2.81 58.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.872 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -168.57 178.04 4.93 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.629 0.772 . . . . 0.0 110.91 171.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.44 121.53 32.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -83.72 112.25 19.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 69' ' ' ILE . 22.1 mm -98.11 142.29 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -117.82 133.76 55.61 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 81.2 m -150.06 161.74 41.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.582 -171.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.408 ' HB2' HD13 ' A' ' 90' ' ' ILE . 56.5 ttp180 -144.95 139.85 27.84 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' LEU . 27.7 tt0 -48.78 143.29 5.42 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.517 1.136 . . . . 0.0 113.397 -168.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.018 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.775 -173.124 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 38' ' ' SER . 6.4 mp . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -123.62 -29.26 3.76 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.165 0.986 . . . . 0.0 111.548 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -99.89 -172.82 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.341 1.456 . . . . 0.0 110.247 -173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB2' HG22 ' A' ' 79' ' ' THR . 53.4 mtm180 -139.62 146.35 39.66 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 110.409 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.83 149.79 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.419 1.088 . . . . 0.0 109.048 178.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -107.58 126.13 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.18 111.32 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.361 0.665 . . . . 0.0 110.229 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 76.4 mt-30 -95.06 96.7 9.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.513 0.725 . . . . 0.0 109.718 172.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -82.07 150.25 27.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.109 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 27' ' ' GLU . 51.3 tp -89.3 98.31 11.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.8 0.727 . . . . 0.0 109.517 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -85.34 101.59 12.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.611 0.764 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -86.73 86.13 7.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -91.95 126.04 36.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.066 0.946 . . . . 0.0 110.611 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.6 ttp180 -79.19 148.14 32.38 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.693 0.282 . . . . 0.0 110.98 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.43 165.76 12.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.226 1.01 . . . . 0.0 108.887 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.41 -11.09 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 C-N-CA 124.225 1.01 . . . . 0.0 113.239 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -105.0 -7.07 19.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.57 -0.706 . . . . 0.0 109.33 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 50.56 3.67 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.078 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 45.6 mt-10 -108.55 138.38 44.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 108.894 173.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 mm -87.94 99.56 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.89 109.26 17.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.61 0.764 . . . . 0.0 109.776 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.2 mt-10 -80.0 111.3 16.21 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.3 p -132.69 154.27 50.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.043 . . . . 0.0 108.59 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -103.04 105.24 15.51 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 16.5 pt-20 -84.56 139.81 31.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.958 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -84.94 138.32 32.57 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.16 -108.77 2.8 Favored Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -174.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -118.05 142.39 47.45 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.952 0.406 . . . . 0.0 110.465 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 9' ' ' ARG . 16.2 m -96.14 96.69 8.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 108.57 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -105.01 176.28 5.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.154 0.582 . . . . 0.0 111.472 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -71.83 134.91 46.41 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.361 1.064 . . . . 0.0 111.056 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -142.84 168.04 20.66 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.112 0.965 . . . . 0.0 110.829 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 23.1 t -123.15 98.69 6.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.63 90.95 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.27 97.52 11.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.716 0.806 . . . . 0.0 109.495 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.85 106.04 11.58 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 46' ' ' GLU . 3.3 m -74.86 138.19 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.358 0.599 . . . . 0.0 111.645 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.4 m -97.36 -174.01 2.81 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 124.456 1.103 . . . . 0.0 109.757 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 56' ' ' ILE . 13.2 p -53.8 -43.64 69.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.17 0.988 . . . . 0.0 112.764 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.32 -46.38 83.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.079 0.551 . . . . 0.0 111.456 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 53.1 mm-40 -61.96 -43.26 99.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.12 0.568 . . . . 0.0 111.859 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.46 91.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.505 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.1 -31.05 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.636 0.774 . . . . 0.0 110.505 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.0 m -71.05 -25.92 62.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.482 0.713 . . . . 0.0 110.628 172.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 26.8 t -92.24 -10.65 37.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.151 0.981 . . . . 0.0 110.552 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 -80.14 1.73 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.33 12.11 0.55 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.977 0.911 . . . . 0.0 110.757 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 35.7 tt0 -75.65 -55.01 6.06 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 58' ' ' THR . 80.3 mt -86.96 166.82 14.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.986 0.514 . . . . 0.0 109.659 168.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.18 160.73 31.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.097 0.959 . . . . 0.0 109.208 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' SER . 49.6 mt -69.88 104.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.26 3.63 18.99 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.348 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 54' ' ' LEU . 32.2 m -68.44 119.37 12.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.444 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -84.05 97.46 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.371 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -87.99 125.31 34.47 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 75' ' ' ILE . 86.2 mt -128.72 109.71 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 0.0 109.362 -165.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -97.13 113.5 25.08 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 123.561 0.744 . . . . 0.0 109.71 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' A' ' 66' ' ' ARG . 41.5 pt -120.58 163.35 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -58.77 149.78 25.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.299 0.5 . . . . 0.0 112.057 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.02 124.87 22.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.348 -170.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.571 ' HD3' HD12 ' A' ' 63' ' ' ILE . 10.2 ptm180 -153.46 133.51 13.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.485 0.714 . . . . 0.0 109.759 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -83.64 10.27 9.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.827 0.851 . . . . 0.0 111.061 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -91.25 -27.28 18.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.58 1.152 . . . . 0.0 111.552 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 104' ' ' ILE . 19.0 mm -74.75 137.86 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.923 0.392 . . . . 0.0 110.294 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -137.44 164.73 27.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.025 0.93 . . . . 0.0 108.867 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.77 66.06 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.757 0.823 . . . . 0.0 111.914 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.5 p -86.83 28.78 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.712 0.805 . . . . 0.0 111.636 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -126.63 134.61 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -100.31 148.8 24.27 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.47 HG21 HD13 ' A' ' 61' ' ' ILE . 43.2 mm -110.04 108.79 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.692 0.797 . . . . 0.0 109.328 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -100.43 112.93 25.33 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.27 104.49 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.947 0.499 . . . . 0.0 109.744 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.67 -26.39 63.42 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.576 0.75 . . . . 0.0 111.694 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.8 t -162.95 135.04 5.27 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.38 -154.53 25.92 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.315 -0.714 . . . . 0.0 112.346 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 -20.27 33.47 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.228 2.619 . . . . 0.0 112.31 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 85' ' ' ARG . 84.1 mt -128.23 38.33 4.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.755 0.822 . . . . 0.0 109.995 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.43 97.87 0.15 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.57 -34.93 1.92 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.872 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 75.4 mtt85 -68.57 138.17 54.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.44 0.696 . . . . 0.0 112.195 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.91 86.9 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.643 1.211 . . . . 0.0 108.019 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.61 149.43 43.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.803 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.99 139.21 44.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.513 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.91 105.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HG23 ' A' ' 58' ' ' THR . 19.6 pt -77.83 74.08 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 122.1 0.952 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.72 -141.16 13.79 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -127.16 138.39 32.62 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.76 0.824 . . . . 0.0 109.046 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.22 142.12 79.12 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.568 2.845 . . . . 0.0 112.53 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.79 119.67 29.93 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.52 155.18 59.8 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.589 2.192 . . . . 0.0 112.163 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.65 151.42 46.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.189 0.596 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -41.02 88.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.403 1.081 . . . . 0.0 111.802 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 -3.92 57.18 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.427 0.691 . . . . 0.0 111.891 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 63.61 15.9 9.26 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.905 1.282 . . . . 0.0 113.114 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -82.06 -7.48 59.62 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.951 0.405 . . . . 0.0 111.172 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 4.6 ppt_? -162.7 169.69 19.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.722 0.809 . . . . 0.0 109.11 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.28 131.33 56.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 33.3 tt0 -100.28 114.77 28.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.187 0.518 . . . . 0.0 109.902 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 69' ' ' ILE . 15.4 mm -93.97 136.44 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -109.48 130.64 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.418 ' SG ' HG22 ' A' ' 104' ' ' ILE . 82.7 m -147.36 171.21 15.81 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.891 0.877 . . . . 0.0 108.66 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.447 ' HB2' HD13 ' A' ' 90' ' ' ILE . 64.1 ttt180 -158.47 160.52 36.85 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.598 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.0 146.38 54.21 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.641 1.176 . . . . 0.0 110.278 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 170.51 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -105.55 -33.3 8.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.422 0.689 . . . . 0.0 110.138 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -96.23 -174.13 2.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.594 1.158 . . . . 0.0 110.116 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' THR . 53.8 ttp180 -154.1 123.38 6.5 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -116.18 159.07 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.632 0.773 . . . . 0.0 110.142 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -109.67 146.02 35.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.368 0.667 . . . . 0.0 109.329 168.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -101.26 107.2 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.486 1.114 . . . . 0.0 110.08 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -77.69 95.41 4.61 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 p -80.15 152.08 29.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.505 0.722 . . . . 0.0 109.82 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 27' ' ' GLU . 27.9 tp -92.41 97.59 10.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.323 0.583 . . . . 0.0 110.992 -171.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -76.83 95.19 4.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.095 0.958 . . . . 0.0 109.644 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.4 104.86 14.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.8 m -111.83 116.23 30.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 -169.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -85.96 140.17 30.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 122.607 0.363 . . . . 0.0 110.791 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -99.81 178.39 4.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 109.613 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tt -50.45 -46.68 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.357 1.063 . . . . 0.0 113.298 -172.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -105.85 12.79 30.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.89 23.58 7.37 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -77.94 119.57 21.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.15 87.33 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.66 92.62 0.87 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.685 0.794 . . . . 0.0 109.565 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.593 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.2 mt-10 -79.76 94.17 5.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -101.44 143.86 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.48 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -94.02 93.39 7.83 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.7 112.4 14.49 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.11 103.93 0.33 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.964 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.41 2.07 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.683 -160.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -106.76 146.72 30.51 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.603 0.761 . . . . 0.0 111.254 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.476 HG22 ' HG2' ' A' ' 9' ' ' ARG . 4.6 m -106.76 140.59 39.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.626 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.82 158.18 40.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.432 0.693 . . . . 0.0 110.684 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -61.43 149.04 39.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.106 0.962 . . . . 0.0 112.041 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -155.29 169.47 24.12 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.368 0.667 . . . . 0.0 111.385 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 14.7 t -128.58 91.37 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.95 96.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.407 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -107.52 99.37 8.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.499 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 82' ' ' LEU . 48.7 mtp -73.11 142.03 47.52 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.84 159.71 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.522 0.729 . . . . 0.0 112.518 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.64 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.2 m -93.31 -178.46 4.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.13 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . 34.9 p -72.23 -20.99 61.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.065 0.546 . . . . 0.0 111.56 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 20.6 ptmt -53.56 -41.7 66.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.352 1.061 . . . . 0.0 113.193 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -31.71 49.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.457 0.703 . . . . 0.0 110.868 -172.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.99 85.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.672 0.789 . . . . 0.0 110.357 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.72 -34.67 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -68.85 -49.42 58.51 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.84 0.856 . . . . 0.0 111.304 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 23.7 m -93.64 1.17 56.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.65 -79.01 1.44 Allowed Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.31 -17.67 2.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.02 0.928 . . . . 0.0 111.241 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 33.3 tt0 -57.37 -50.31 73.36 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.293 0.637 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.9 mt -103.0 158.14 16.49 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.899 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.19 153.41 25.68 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.232 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 44' ' ' SER . 31.0 mt -65.4 128.05 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.2 -8.42 18.32 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.213 0.321 . . . . 0.0 112.77 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 40.8 m -68.93 139.49 55.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.308 0.643 . . . . 0.0 109.309 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -124.68 103.24 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -81.64 98.93 8.6 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.67 106.29 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.512 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 9.1 m0 -88.32 113.37 23.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.742 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.96 -171.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.78 0.832 . . . . 0.0 108.899 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -86.94 158.46 19.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.491 0.316 . . . . 0.0 110.456 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 70.1 t80 -60.66 97.44 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.522 1.129 . . . . 0.0 112.039 -172.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -120.77 104.81 10.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 109.501 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -68.92 -0.4 5.52 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.04 -20.57 21.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.603 0.761 . . . . 0.0 110.834 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.49 HG21 HD12 ' A' ' 104' ' ' ILE . 48.0 mm -66.18 128.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -127.45 164.9 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.7 1.2 . . . . 0.0 108.56 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.23 65.4 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.451 0.7 . . . . 0.0 111.22 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.1 p -87.4 40.19 0.91 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.166 0.986 . . . . 0.0 110.877 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -141.72 145.81 35.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.115 0.966 . . . . 0.0 108.861 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -108.8 138.7 44.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 104' ' ' ILE . 22.3 mm -107.33 90.75 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 33.7 ttmt -83.71 115.85 22.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 97.4 t -72.85 99.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 m -71.04 -26.46 63.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 111.566 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -155.49 140.73 17.57 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.942 0.897 . . . . 0.0 108.733 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.65 -154.68 26.08 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.313 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.62 -37.5 21.67 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.704 2.269 . . . . 0.0 111.369 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 87' ' ' LEU . 89.0 mt -103.89 42.12 1.22 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.476 1.11 . . . . 0.0 109.74 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.63 101.48 0.25 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.863 0.865 . . . . 0.0 111.602 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.88 -19.13 11.3 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.412 1.006 . . . . 0.0 112.307 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 82' ' ' LEU . 92.7 mtt180 -83.13 141.16 32.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.478 0.711 . . . . 0.0 111.241 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 51.4 t -103.0 106.99 21.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 124.834 1.254 . . . . 0.0 108.408 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.6 mm? -90.07 128.73 36.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.527 0.731 . . . . 0.0 109.167 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.9 OUTLIER -97.82 119.0 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.282 0.633 . . . . 0.0 110.059 -173.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' CYS . 45.6 mt -56.36 134.31 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.417 0.687 . . . . 0.0 111.26 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' HE ' ' A' ' 107' ' ' ARG . 11.5 pt -112.1 96.34 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.724 175.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.27 -84.76 0.37 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.126 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -170.33 158.83 6.15 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.212 1.005 . . . . 0.0 109.523 -172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 57.8 Cg_endo -69.62 125.07 11.79 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.23 1.953 . . . . 0.0 111.57 171.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -103.93 109.47 62.35 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.063 0.945 . . . . 0.0 109.508 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.29 150.5 53.01 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.693 2.262 . . . . 0.0 111.04 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.73 175.11 7.5 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.3 67.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.385 0.674 . . . . 0.0 112.508 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.89 -13.55 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.369 0.668 . . . . 0.0 112.528 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.52 26.07 15.87 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.391 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 t -82.25 -25.5 34.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.299 0.639 . . . . 0.0 110.012 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -138.83 168.59 19.48 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 15.4 tp -128.54 108.22 10.35 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.95 109.78 18.41 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.549 HG21 HG13 ' A' ' 75' ' ' ILE . 13.1 mm -90.09 102.88 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.684 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.4 pt? -81.12 105.13 12.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.182 0.991 . . . . 0.0 108.362 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 61.5 m -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.921 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.675 ' HE ' HG21 ' A' ' 90' ' ' ILE . 21.4 ttp85 -146.39 140.65 26.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.67 118.92 8.3 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 111.096 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.431 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 176.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 54.3 mt . . . . . 0 CA--C 1.552 1.03 0 CA-C-O 121.786 0.803 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -91.25 -26.95 18.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.922 1.289 . . . . 0.0 110.896 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.22 -172.64 2.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.609 1.564 . . . . 0.0 109.719 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HG2' HG22 ' A' ' 34' ' ' THR . 14.6 ttp180 -155.77 138.75 15.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.879 0.872 . . . . 0.0 108.776 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.01 144.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.387 0.675 . . . . 0.0 111.122 -173.166 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -92.0 120.93 33.1 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.524 1.13 . . . . 0.0 109.902 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.43 95.52 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -73.59 99.26 3.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 109.928 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 p -79.87 146.42 32.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.603 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.5 tp -92.86 106.77 18.68 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.75 0.42 . . . . 0.0 110.333 -172.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -94.69 101.87 13.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.52 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 48.6 mt-30 -77.56 93.95 4.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.58 0.752 . . . . 0.0 109.164 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.2 m -92.78 123.52 36.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.347 1.059 . . . . 0.0 110.404 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -74.59 163.13 28.09 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.031 0.532 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.28 165.0 12.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.465 1.106 . . . . 0.0 108.502 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.2 -15.84 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -95.84 -6.69 38.84 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.1 6.39 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.077 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.08 136.28 53.17 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.132 0.973 . . . . 0.0 108.827 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.35 120.22 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.4 123.9 51.31 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.06 0.944 . . . . 0.0 109.707 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.645 ' HB3' HD11 ' A' ' 15' ' ' LEU . 3.5 mp0 -81.57 116.92 21.56 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.781 0.833 . . . . 0.0 110.118 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 p -130.92 153.04 49.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.109 0.964 . . . . 0.0 108.806 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -110.4 108.86 19.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.503 0.721 . . . . 0.0 109.491 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.03 133.8 35.81 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.7 127.46 31.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.15 -113.75 3.8 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -99.61 124.93 45.28 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.427 0.691 . . . . 0.0 109.847 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 10.1 m -101.04 94.88 6.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -117.04 168.51 10.19 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.206 0.602 . . . . 0.0 111.773 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 35.7 m95 -64.19 136.36 57.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.916 0.886 . . . . 0.0 112.573 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -139.24 165.97 25.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.295 1.038 . . . . 0.0 111.672 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 22.5 t -120.42 92.12 3.7 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 166.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -90.72 98.19 8.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.016 0.926 . . . . 0.0 108.951 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.07 116.04 25.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.546 0.738 . . . . 0.0 109.408 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.532 ' HG2' HG22 ' A' ' 59' ' ' VAL . 81.9 mtp -65.9 130.7 44.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.644 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 22.3 m -70.54 146.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 111.021 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t -84.53 174.78 9.74 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.6 p -60.73 -25.92 66.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -26.1 68.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.644 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 16.3 mm-40 -68.2 -41.46 81.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.156 0.582 . . . . 0.0 110.719 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.15 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.907 0.754 . . . . 0.0 110.86 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -64.86 -40.31 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.366 0.666 . . . . 0.0 110.521 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.0 m -66.48 -49.74 65.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.687 0.795 . . . . 0.0 111.943 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 76.6 p -91.42 -19.48 22.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.462 0.705 . . . . 0.0 112.39 -171.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.34 2.22 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.56 -15.04 1.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.426 0.691 . . . . 0.0 112.036 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 24.4 mm-40 -59.82 -43.75 94.36 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.2 0.6 . . . . 0.0 111.297 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.94 149.33 29.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.55 167.46 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.814 0.846 . . . . 0.0 109.644 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 mt -76.28 114.22 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 4.76 59.73 Favored Glycine 0 N--CA 1.467 0.706 0 CA-C-O 119.625 -0.542 . . . . 0.0 112.95 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.525 HG23 HD11 ' A' ' 90' ' ' ILE . 18.3 m -56.54 113.74 1.74 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.293 0.568 . . . . 0.0 109.753 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 41' ' ' MET . 49.3 t -73.18 107.25 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.189 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -90.98 134.02 34.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 80.7 mt -133.35 108.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -168.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 32.5 m0 -91.25 124.3 35.36 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 123.528 0.731 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.35 163.84 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -52.21 149.71 5.16 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.746 0.418 . . . . 0.0 111.627 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -56.83 108.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.017 0.823 . . . . 0.0 109.968 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 46.9 ttt85 -135.96 116.69 14.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -168.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -84.44 9.05 14.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.625 1.17 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 20.9 t70 -92.85 -19.57 21.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.245 1.418 . . . . 0.0 110.495 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 13.2 mm -84.32 139.94 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.483 0.713 . . . . 0.0 109.577 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -130.65 166.48 20.6 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.76 -23.71 66.79 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.411 0.684 . . . . 0.0 111.437 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -85.44 41.93 0.92 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.191 0.996 . . . . 0.0 110.433 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 m -131.72 147.57 52.51 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 123.778 0.831 . . . . 0.0 109.081 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -115.17 120.99 41.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 104' ' ' ILE . 18.2 mm -88.4 91.28 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.32 1.048 . . . . 0.0 109.507 -173.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -91.18 120.18 31.9 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 87' ' ' LEU . 88.7 t -71.38 122.28 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.824 0.345 . . . . 0.0 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -89.44 -30.53 18.25 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 109.583 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 m -143.57 110.51 5.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.065 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.68 -170.08 30.52 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.82 -0.434 . . . . 0.0 113.736 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.26 -29.0 26.98 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.839 2.359 . . . . 0.0 111.735 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.3 mt -98.26 22.14 9.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.656 0.782 . . . . 0.0 111.018 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.14 124.32 19.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.005 0.522 . . . . 0.0 110.715 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.08 34.17 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.111 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -88.88 143.24 27.01 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.439 0.695 . . . . 0.0 110.744 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -105.99 100.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 122.194 0.997 . . . . 0.0 109.54 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -83.24 113.08 20.43 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.953 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.8 139.8 32.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 109.094 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 75' ' ' ILE . 63.1 mt -78.53 108.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.525 HD11 HG23 ' A' ' 58' ' ' THR . 18.5 pt -92.16 61.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 122.152 0.977 . . . . 0.0 110.133 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.92 -122.03 1.12 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.426 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -150.88 143.82 16.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.976 0.91 . . . . 0.0 109.139 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 111.97 1.12 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 110.499 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.47 117.43 36.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.128 0.971 . . . . 0.0 108.845 -167.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.56 158.57 49.12 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.574 2.183 . . . . 0.0 112.367 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.1 -174.54 4.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.837 0.455 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.08 -48.01 66.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.487 0.715 . . . . 0.0 111.705 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.97 58.86 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.598 0.759 . . . . 0.0 112.798 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 71.39 14.33 6.44 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -85.05 -1.72 57.16 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.315 1.046 . . . . 0.0 112.236 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -163.41 161.32 24.3 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.812 0.815 . . . . 0.0 110.129 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.74 109.21 21.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -90.67 108.87 20.09 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 0.0 109.666 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 75' ' ' ILE . 9.3 mm -88.45 145.38 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -120.48 132.93 55.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 60.2 m -153.76 175.64 13.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.34 0.656 . . . . 0.0 111.017 -169.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.6 166.62 22.22 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 108.497 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -73.22 156.16 38.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 167.4 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.551 0.983 0 CA-C-O 120.591 0.234 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -129.44 -30.06 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.663 0.785 . . . . 0.0 111.839 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -109.96 -166.91 1.13 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.045 1.738 . . . . 0.0 109.858 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 79' ' ' THR . 25.1 ttm180 -152.78 140.92 20.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.939 0.896 . . . . 0.0 109.166 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.15 156.78 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.804 0.842 . . . . 0.0 110.014 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -103.37 123.14 46.27 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.484 1.114 . . . . 0.0 108.992 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.19 108.95 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -85.83 111.41 20.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.71 0.767 . . . . 0.0 110.308 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -84.75 142.7 29.64 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.782 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.1 tp -97.85 113.88 25.8 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.748 0.819 . . . . 0.0 109.634 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' NZ ' ' HB3' ' A' ' 16' ' ' LYS . 5.6 ttpm? -99.77 113.19 25.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.797 0.839 . . . . 0.0 109.657 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.4 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.3 mt-30 -86.56 103.35 14.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.799 0.84 . . . . 0.0 109.402 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 m -93.9 165.16 12.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -114.1 165.95 12.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.859 0.754 . . . . 0.0 109.835 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -108.72 161.8 14.76 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.52 -14.21 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -103.25 -10.16 18.97 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.66 15.42 20.76 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.238 -0.892 . . . . 0.0 115.32 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.78 145.35 24.65 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.534 1.167 . . . . 0.0 109.485 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.51 122.48 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.312 0.645 . . . . 0.0 111.15 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.84 108.48 21.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.339 1.056 . . . . 0.0 108.565 175.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.4 mt-10 -80.96 107.1 13.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.371 0.669 . . . . 0.0 109.605 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -114.68 146.49 40.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.755 0.822 . . . . 0.0 110.2 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -111.18 106.23 15.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.698 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -106.1 143.86 33.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.78 137.94 48.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.821 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.26 -116.67 3.77 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -99.08 137.35 37.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.1 m -108.82 96.73 6.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.767 0.827 . . . . 0.0 108.855 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.59 175.24 5.57 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.38 0.609 . . . . 0.0 111.276 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -70.69 135.42 48.29 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.477 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.5 173.75 11.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.336 1.054 . . . . 0.0 111.074 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.2 m -130.38 96.25 4.1 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 160.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 61' ' ' ILE . 2.6 p -94.41 102.36 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -173.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -117.27 122.58 44.36 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.779 0.831 . . . . 0.0 109.123 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 82' ' ' LEU . 72.1 mtp -72.22 145.93 47.64 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.1 134.51 30.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -83.45 176.33 9.15 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 123.53 0.732 . . . . 0.0 109.776 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p -60.13 -31.12 69.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -56.56 -49.67 74.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.671 0.788 . . . . 0.0 111.012 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.58 -44.07 91.83 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.845 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.98 -45.68 90.01 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 124.281 0.988 . . . . 0.0 112.438 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.93 -46.85 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.332 0.653 . . . . 0.0 111.217 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.5 m -65.6 -29.09 69.63 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.642 0.777 . . . . 0.0 112.216 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 89.8 p -90.6 -17.42 26.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.521 0.728 . . . . 0.0 111.996 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.02 -79.21 1.72 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.74 12.09 2.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.292 0.637 . . . . 0.0 111.05 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.4 tp10 -77.87 -53.55 7.35 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 58' ' ' THR . 81.1 mt -106.49 147.22 29.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.862 0.865 . . . . 0.0 108.808 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.28 158.75 41.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.1 mt -62.63 120.39 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.64 -11.12 13.99 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 123.383 0.427 . . . . 0.0 112.59 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 54' ' ' LEU . 25.4 m -71.88 140.21 49.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 166.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 38.7 t -122.67 122.28 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.494 0.718 . . . . 0.0 110.482 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -93.81 135.89 34.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 75' ' ' ILE . 66.1 mt -132.6 107.98 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.77 116.02 28.29 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.257 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.23 159.06 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -55.69 136.64 50.58 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 168.261 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HB3' ' NH1' ' A' ' 64' ' ' ARG . 56.0 t80 -48.17 114.66 0.98 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.568 1.547 . . . . 0.0 113.212 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -138.23 119.61 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.78 0.832 . . . . 0.0 109.231 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -79.84 7.57 8.49 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.8 0.44 . . . . 0.0 110.992 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.34 -22.89 20.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.337 0.655 . . . . 0.0 110.183 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.91 130.81 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.71 162.67 23.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.708 0.803 . . . . 0.0 109.171 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.96 -15.64 63.54 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.302 0.641 . . . . 0.0 112.052 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.2 p -83.16 2.82 33.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.563 0.745 . . . . 0.0 111.649 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -101.31 137.74 39.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -106.17 134.77 48.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 61' ' ' ILE . 30.3 mm -94.07 102.63 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 123.041 0.536 . . . . 0.0 110.077 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.4 ttpt -103.78 112.72 25.8 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.62 120.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.24 0.616 . . . . 0.0 111.594 -173.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -79.45 -31.9 42.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.696 1.199 . . . . 0.0 111.749 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 9' ' ' ARG . 11.7 t -160.51 142.79 12.84 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.14 -160.63 24.42 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.832 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.49 -27.36 46.59 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.911 2.407 . . . . 0.0 112.639 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 41' ' ' MET . 54.9 mt -115.77 31.64 6.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.723 0.809 . . . . 0.0 111.156 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.02 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.494 0.718 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.58 -19.0 4.83 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.082 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HD2' HD22 ' A' ' 82' ' ' LEU . 91.4 mtt-85 -86.51 142.69 28.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.291 0.637 . . . . 0.0 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 4.5 p -107.25 95.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.026 0.917 . . . . 0.0 108.995 172.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 108' ' ' GLU . 1.2 mm? -77.33 128.38 34.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.433 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -99.7 141.5 32.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.744 . . . . 0.0 109.17 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.62 122.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 pt -100.02 86.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.12 -94.18 0.54 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -159.15 145.83 12.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.964 0.905 . . . . 0.0 110.041 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.39 114.89 3.06 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.835 2.357 . . . . 0.0 111.128 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.94 108.76 48.16 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.876 0.87 . . . . 0.0 109.346 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.1 143.93 55.77 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.057 2.505 . . . . 0.0 112.331 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.41 168.9 19.24 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.194 0.452 . . . . 0.0 110.723 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.91 -27.5 65.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.005 0.922 . . . . 0.0 112.877 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.4 -7.25 42.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 62.13 29.78 17.63 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.447 1.099 . . . . 0.0 111.491 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 p -90.55 -17.98 26.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.881 0.873 . . . . 0.0 111.434 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -158.78 171.15 20.61 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.616 0.722 . . . . 0.0 110.78 -168.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.57 113.07 17.58 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.78 96.25 5.56 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.589 HG22 ' SG ' ' A' ' 106' ' ' CYS . 22.8 mm -88.71 97.16 6.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.702 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -79.01 130.51 35.61 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.077 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 104' ' ' ILE . 84.7 m -147.78 173.14 13.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.376 1.07 . . . . 0.0 108.875 -170.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -138.41 153.71 48.88 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 87' ' ' LEU . 38.3 tt0 -44.33 125.73 4.79 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.724 0.81 . . . . 0.0 112.848 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 86' ' ' VAL . . . . . . . . 0 C--N 1.347 1.187 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.472 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 37' ' ' ALA . 43.7 mt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -123.08 -28.63 4.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.388 0.675 . . . . 0.0 111.775 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -101.82 -174.18 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB2' HG22 ' A' ' 79' ' ' THR . 94.2 mtt180 -136.38 142.22 43.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.68 0.792 . . . . 0.0 109.601 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' THR . 49.3 pt -133.71 166.01 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 108.779 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -132.81 134.93 45.32 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 73' ' ' SER . 51.4 mm -81.91 116.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.674 0.609 . . . . 0.0 109.666 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -89.98 104.26 16.84 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.39 139.37 34.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.927 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.4 tp -89.51 98.62 11.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.226 0.467 . . . . 0.0 109.902 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.2 99.31 6.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 110.312 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 51.5 mt-30 -96.56 79.37 3.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -98.58 126.08 44.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.043 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 28.7 ttp180 -76.64 162.32 27.84 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.185 0.994 . . . . 0.0 111.482 -175.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 11.3 t70 -113.65 164.35 13.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.733 0.813 . . . . 0.0 109.835 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.49 -14.62 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.669 0.788 . . . . 0.0 112.859 172.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 p -100.53 -20.15 15.85 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.91 39.97 3.22 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.007 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mm-40 -97.44 146.72 24.93 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.813 0.845 . . . . 0.0 108.921 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.8 100.32 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.38 92.13 7.48 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB3' HD11 ' A' ' 15' ' ' LEU . 38.5 mt-10 -82.63 106.29 14.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.987 0.915 . . . . 0.0 109.046 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -126.05 165.48 18.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.447 1.099 . . . . 0.0 109.474 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.69 102.73 10.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.28 121.59 29.94 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.787 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.51 126.28 26.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.839 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.55 -112.77 3.6 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -120.53 133.72 55.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.143 0.577 . . . . 0.0 109.944 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 33.6 m -85.31 107.45 17.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.53 0.732 . . . . 0.0 109.693 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.1 pt? -108.06 164.53 12.2 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 0.0 110.863 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -75.86 130.4 38.49 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.608 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.456 ' HA ' HD22 ' A' ' 6' ' ' LEU . . . -147.24 -176.51 5.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.816 0.846 . . . . 0.0 111.268 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -134.27 104.33 6.12 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.536 HG11 HG23 ' A' ' 77' ' ' VAL . 2.3 p -105.61 114.42 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 109.186 -172.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -136.14 153.62 51.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.167 1.387 . . . . 0.0 109.521 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 82' ' ' LEU . 76.6 mtp -85.17 136.33 33.58 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 58' ' ' THR . 20.2 m -68.45 137.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -97.22 -173.94 2.81 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.86 0.864 . . . . 0.0 110.865 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 p -54.48 -34.44 61.58 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.268 1.027 . . . . 0.0 112.182 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -51.76 -52.62 47.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.856 0.863 . . . . 0.0 110.902 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.42 -41.58 76.16 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.447 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.93 78.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.619 . . . . 0.0 112.353 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.23 -33.75 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.678 0.791 . . . . 0.0 110.795 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 t -71.91 -44.34 63.85 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.331 0.652 . . . . 0.0 111.552 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 73.6 p -104.33 0.28 29.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.29 0.636 . . . . 0.0 112.479 -174.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.77 -70.39 2.93 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.04 -2.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.09 0.556 . . . . 0.0 112.206 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 38.0 tt0 -65.07 -50.94 64.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.108 0.563 . . . . 0.0 110.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.06 60.79 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.47 156.63 26.48 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.82 122.83 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -171.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.38 -13.04 16.04 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.695 0.665 . . . . 0.0 112.031 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 87.3 m -79.65 139.46 37.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.51 HG11 ' HG ' ' A' ' 87' ' ' LEU . 42.8 t -110.67 116.5 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.46 0.704 . . . . 0.0 110.914 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -83.67 128.42 34.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.628 1.171 . . . . 0.0 110.408 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' SG ' ' A' ' 106' ' ' CYS . 51.3 mt -135.19 110.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -98.98 131.69 44.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.109 0.564 . . . . 0.0 110.438 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.29 161.04 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -63.75 151.04 43.19 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 164.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -53.49 118.64 4.03 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.034 0.934 . . . . 0.0 111.157 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 HD13 ' A' ' 35' ' ' LEU . 56.4 ttt180 -136.86 128.08 28.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.75 1.83 40.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.275 1.03 . . . . 0.0 112.457 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.89 -21.76 19.65 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.489 0.716 . . . . 0.0 111.31 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 104' ' ' ILE . 25.5 mm -81.0 131.36 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 110.249 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -131.66 158.65 40.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.092 0.957 . . . . 0.0 109.747 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.99 -25.82 66.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.047 0.939 . . . . 0.0 112.312 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -84.13 8.9 14.08 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.795 0.838 . . . . 0.0 111.758 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 12' ' ' ILE . 22.8 m -111.5 120.02 40.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.607 0.763 . . . . 0.0 109.177 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -83.1 136.88 34.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.78 0.432 . . . . 0.0 110.41 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 61' ' ' ILE . 33.1 mm -96.36 101.8 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 0.0 110.114 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 29.9 ttpt -90.31 120.0 31.08 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.241 0.616 . . . . 0.0 109.982 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.536 HG23 HG11 ' A' ' 39' ' ' VAL . 2.7 p -73.55 115.62 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.347 0.659 . . . . 0.0 110.805 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -81.3 -24.8 36.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.865 0.866 . . . . 0.0 111.814 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 9' ' ' ARG . 10.6 t -168.24 137.86 2.48 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.857 0.863 . . . . 0.0 108.725 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.37 -165.96 29.53 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.462 -174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.15 -9.02 22.93 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 123.388 2.725 . . . . 0.0 112.656 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 41' ' ' MET . 79.9 mt -119.08 6.66 11.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.169 0.988 . . . . 0.0 111.2 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -42.5 115.04 0.65 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.846 1.258 . . . . 0.0 113.58 -165.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.02 25.22 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.48 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -94.77 172.58 8.08 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.207 0.504 . . . . 0.0 110.593 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 42.5 t -124.08 114.08 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.307 0.643 . . . . 0.0 109.645 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.612 HD11 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -90.25 140.84 29.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -103.0 143.71 32.22 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.52 130.61 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 107' ' ' ARG . 29.7 pt -102.5 128.23 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 122.881 0.472 . . . . 0.0 109.82 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.02 -93.34 1.18 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.936 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 12.2 pt20 -161.51 156.35 19.97 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.399 1.08 . . . . 0.0 108.878 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.1 109.87 2.28 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.871 1.714 . . . . 0.0 110.274 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.4 113.31 38.21 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.32 1.048 . . . . 0.0 108.949 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.58 144.55 32.02 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.335 2.023 . . . . 0.0 111.665 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -60.76 149.57 35.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.415 0.686 . . . . 0.0 112.09 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.04 -28.77 65.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.032 0.933 . . . . 0.0 110.978 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.69 -5.46 45.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.591 0.756 . . . . 0.0 111.368 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? 61.31 18.72 9.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.837 1.255 . . . . 0.0 113.377 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -81.28 -10.49 59.57 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.361 0.528 . . . . 0.0 111.28 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -155.6 -179.13 7.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.349 0.595 . . . . 0.0 110.853 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -137.64 112.22 8.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.0 97.78 2.92 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.0 mm -85.31 86.96 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -79.11 136.03 37.02 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.529 ' SG ' HD12 ' A' ' 61' ' ' ILE . 62.9 m -146.41 170.25 17.21 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' HB2' HD13 ' A' ' 90' ' ' ILE . 37.2 ttp180 -142.16 144.49 33.47 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 172.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -41.6 118.95 1.16 Allowed 'General case' 0 C--N 1.362 1.11 0 O-C-N 124.43 1.081 . . . . 0.0 110.998 -177.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.214 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.927 -165.352 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.241 0.639 0 CA-C-O 121.854 0.835 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.09 -22.55 45.1 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.651 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -103.6 -175.39 2.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.573 1.149 . . . . 0.0 110.283 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 34' ' ' THR . 51.6 mtm180 -141.38 148.25 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 109.399 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -140.79 145.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.891 0.876 . . . . 0.0 108.687 177.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 m -96.23 122.85 39.54 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.551 0.614 . . . . 0.0 109.976 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.7 mm -75.54 103.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.575 0.75 . . . . 0.0 109.892 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -85.55 95.72 9.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.511 0.672 . . . . 0.0 109.882 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -79.09 150.09 31.91 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.7 tp -88.35 105.0 17.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -170.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -89.73 96.61 10.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.037 0.935 . . . . 0.0 109.807 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 45.9 mt-30 -84.4 97.44 9.5 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -106.14 117.7 34.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.614 0.766 . . . . 0.0 109.336 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -72.07 162.48 29.4 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 120.629 0.252 . . . . 0.0 110.506 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.88 163.6 15.32 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.801 0.84 . . . . 0.0 109.361 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.6 -21.38 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.95 0.9 . . . . 0.0 113.018 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -93.85 -13.36 27.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.85 40.31 4.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.157 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.27 137.86 42.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 109.603 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -90.75 96.42 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.96 96.14 8.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 15' ' ' LEU . 49.4 mt-10 -79.97 111.58 16.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -125.58 169.15 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.857 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.443 ' HZ3' ' HA ' ' A' ' 73' ' ' SER . 79.6 m95 -119.97 109.41 15.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.31 115.11 22.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.5 135.79 55.6 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.202 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.57 -119.84 3.14 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.803 -168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -99.8 125.21 45.68 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -170.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 3.7 m -88.04 93.29 9.44 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -110.89 170.41 8.11 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -64.38 120.65 12.64 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.2 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -141.87 176.53 8.86 Favored 'General case' 0 C--O 1.209 -1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 111.979 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 m -135.38 108.41 7.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.579 HG23 HG12 ' A' ' 61' ' ' ILE . 2.0 p -108.16 109.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.958 0.903 . . . . 0.0 110.837 -172.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.05 138.66 49.7 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 0.0 109.044 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.509 ' SD ' HD21 ' A' ' 82' ' ' LEU . 77.1 mtp -75.45 145.34 41.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.32 130.8 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 O-C-N 123.691 0.619 . . . . 0.0 109.68 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 m -87.94 -175.93 5.29 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 123.4 0.68 . . . . 0.0 110.706 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.8 p -59.9 -33.91 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.791 0.837 . . . . 0.0 111.502 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.86 -47.52 67.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.806 0.843 . . . . 0.0 111.106 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.21 -45.22 81.53 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.114 0.884 . . . . 0.0 111.165 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -51.97 66.4 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.922 0.764 . . . . 0.0 111.217 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.23 -38.23 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.141 0.977 . . . . 0.0 111.581 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 t -77.09 -28.57 54.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.99 0.516 . . . . 0.0 111.556 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 50.7 m -94.79 -9.86 33.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 0.0 111.894 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.94 -74.62 2.27 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.25 2.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.767 0.827 . . . . 0.0 111.047 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 1.9 tm-20 -63.95 -61.15 2.46 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.81 142.01 30.1 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.08 151.34 45.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.36 0.664 . . . . 0.0 109.557 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.85 119.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.834 0.854 . . . . 0.0 110.765 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.28 -12.64 16.46 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.281 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.478 HG23 HD11 ' A' ' 90' ' ' ILE . 86.3 m -73.47 154.14 40.06 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 164.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 41' ' ' MET . 22.0 t -132.2 115.41 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -87.45 132.2 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 39' ' ' VAL . 41.8 mt -138.86 109.0 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.781 0.832 . . . . 0.0 109.037 -170.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -95.0 122.97 38.2 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.8 pt -116.62 165.32 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 66' ' ' ARG . 24.8 mmm180 -54.25 140.17 33.72 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 164.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 95' ' ' PRO . 51.8 t80 -54.6 129.51 36.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.007 1.323 . . . . 0.0 111.745 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 64' ' ' ARG . 50.4 mtt85 -150.96 129.32 12.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.788 0.835 . . . . 0.0 110.688 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -81.79 -13.9 57.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.252 1.021 . . . . 0.0 111.02 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.05 -21.47 22.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.765 0.426 . . . . 0.0 110.747 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.08 128.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.663 0.385 . . . . 0.0 110.199 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.686 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 67.2 t30 -140.73 168.09 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.387 1.075 . . . . 0.0 109.235 -177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.62 -7.66 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.9 p -86.08 19.99 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.345 1.058 . . . . 0.0 112.274 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.443 ' HA ' ' HZ3' ' A' ' 29' ' ' TRP . 72.5 m -130.09 172.77 11.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.609 0.764 . . . . 0.0 110.777 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -119.92 140.66 50.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.899 0.88 . . . . 0.0 108.952 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.523 HG21 HG21 ' A' ' 61' ' ' ILE . 50.1 mm -98.08 105.49 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.601 0.76 . . . . 0.0 109.617 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 88.2 tttt -90.44 131.09 36.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.456 HG23 HD23 ' A' ' 87' ' ' LEU . 67.8 t -83.9 123.09 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.785 0.434 . . . . 0.0 110.579 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -85.64 -38.9 17.87 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.466 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 p -146.76 128.41 15.17 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.32 -169.69 29.62 Favored Glycine 0 N--CA 1.469 0.895 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.244 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.42 -1.24 10.75 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.017 2.478 . . . . 0.0 112.855 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' SD ' ' A' ' 41' ' ' MET . 89.4 mt -130.03 32.98 4.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.004 0.922 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.83 104.95 0.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.59 0.756 . . . . 0.0 111.685 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.32 -18.36 12.14 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.959 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.15 158.31 20.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 110.954 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.8 p -124.96 98.6 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.552 1.168 . . . . 0.0 110.189 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.5 mm? -82.54 148.77 27.88 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.294 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -110.76 141.07 44.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.051 0.94 . . . . 0.0 108.508 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.71 98.69 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 58' ' ' THR . 39.2 pt -80.86 146.57 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.098 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.12 -105.45 2.06 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.755 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -161.8 144.94 9.19 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 123.519 0.728 . . . . 0.0 109.897 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.686 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 62.8 Cg_endo -69.7 125.74 12.53 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.196 1.931 . . . . 0.0 110.678 173.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 111.7 54.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HB3' ' HE1' ' A' ' 65' ' ' TYR . 74.4 Cg_exo -53.83 142.59 62.63 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.205 2.603 . . . . 0.0 113.559 175.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.535 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 18.1 t70 -51.74 156.09 1.51 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.929 0.892 . . . . 0.0 112.639 173.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.16 77.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.326 1.05 . . . . 0.0 112.013 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.97 -6.58 35.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.313 0.645 . . . . 0.0 111.491 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 25.57 15.27 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.783 1.233 . . . . 0.0 112.249 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.9 p -83.28 -4.73 58.72 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.327 0.584 . . . . 0.0 111.334 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 17.3 ptt180 -169.12 -176.46 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.661 1.584 . . . . 0.0 107.894 -168.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.16 118.16 14.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.69 108.51 14.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 mm -100.17 153.15 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -133.63 146.61 51.07 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 170.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 71.3 m -150.21 171.99 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.281 -168.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -160.62 158.19 28.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -44.16 151.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.469 1.108 . . . . 0.0 112.776 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.899 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.753 -175.585 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 34.9 mt . . . . . 0 C--O 1.239 0.509 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -116.03 1.74 13.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.564 0.746 . . . . 0.0 112.429 -170.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -113.88 -172.59 2.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.939 1.296 . . . . 0.0 109.231 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 50.1 mtm180 -140.57 156.21 46.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.168 0.987 . . . . 0.0 109.234 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.35 135.39 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.3 m -90.02 113.58 25.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.116 0.966 . . . . 0.0 109.654 173.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mm -74.06 105.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.845 1.258 . . . . 0.0 109.982 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.564 HE21 ' HB2' ' A' ' 76' ' ' LYS . 65.9 mt-30 -72.76 102.32 3.33 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 174.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -83.03 133.64 35.08 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.624 -1.625 . . . . 0.0 108.294 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.3 tp -82.04 96.77 7.85 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -80.82 102.23 9.88 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -81.79 100.97 9.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.298 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -92.39 178.95 5.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -130.11 164.95 23.29 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.605 -0.684 . . . . 0.0 109.448 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 18.5 t70 -107.02 160.22 15.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.142 0.977 . . . . 0.0 108.754 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.5 tt -55.57 -15.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -98.71 -2.84 37.23 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.71 53.99 3.6 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.39 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 15.0 pt-20 -130.62 142.35 50.45 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.65 109.96 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 122.884 0.473 . . . . 0.0 110.998 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -96.26 93.0 6.64 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HB3' HD11 ' A' ' 15' ' ' LEU . 48.5 mt-10 -80.86 131.68 35.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.921 0.488 . . . . 0.0 110.302 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.4 p -138.95 159.81 41.26 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.306 1.042 . . . . 0.0 110.137 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -111.62 120.41 41.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.261 0.624 . . . . 0.0 109.886 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.15 164.14 23.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.725 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.07 138.65 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.114 0.884 . . . . 0.0 108.797 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.56 -107.4 2.42 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -110.07 129.4 55.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.91 0.884 . . . . 0.0 109.131 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 21.4 m -106.5 96.16 6.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.646 0.378 . . . . 0.0 110.183 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.74 172.01 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 122.883 0.473 . . . . 0.0 112.254 -174.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -67.19 129.97 41.62 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -144.56 172.55 12.81 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 123.769 0.828 . . . . 0.0 111.423 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 6' ' ' LEU . 72.1 m -128.17 109.68 11.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.507 HG23 HG12 ' A' ' 61' ' ' ILE . 2.9 p -100.86 98.0 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.831 0.852 . . . . 0.0 109.611 -172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -112.4 115.24 28.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.827 0.851 . . . . 0.0 110.748 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 69.7 mtp -62.39 133.81 55.58 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 6.0 m -68.02 153.5 8.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.417 0.448 . . . . 0.0 110.262 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -84.28 171.76 12.44 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.949 0.5 . . . . 0.0 110.458 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -60.18 -27.13 66.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.167 0.587 . . . . 0.0 110.669 173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -47.85 -46.15 30.9 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.378 1.471 . . . . 0.0 111.897 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 33.9 mm-40 -67.2 -39.76 86.39 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.504 0.502 . . . . 0.0 111.465 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -51.63 57.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.981 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.57 -52.61 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.344 1.058 . . . . 0.0 112.155 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -71.69 -26.47 62.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.439 0.695 . . . . 0.0 112.486 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 43.0 m -92.7 -7.71 45.97 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.912 0.485 . . . . 0.0 111.411 175.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.53 0.72 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 123.494 0.496 . . . . 0.0 111.894 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.71 -5.93 7.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.791 0.836 . . . . 0.0 111.123 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 12.1 tp10 -66.56 -51.46 56.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.488 0.715 . . . . 0.0 110.669 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.83 155.95 19.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.87 0.868 . . . . 0.0 108.982 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.28 177.63 7.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.758 0.823 . . . . 0.0 110.546 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.73 136.68 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.88 43.91 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -170.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.0 m -70.75 145.13 50.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.044 0.937 . . . . 0.0 109.322 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 45.2 t -126.24 129.81 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.424 1.09 . . . . 0.0 109.214 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.3 140.37 37.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.643 HD13 HG21 ' A' ' 75' ' ' ILE . 56.1 mt -137.1 143.37 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -170.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -129.22 127.32 41.04 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 37' ' ' ALA . 42.9 pt -126.95 157.89 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.572 1.149 . . . . 0.0 107.931 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -60.28 145.46 47.44 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.448 . . . . 0.0 110.482 168.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.523 ' HA ' HD13 ' A' ' 102' ' ' LEU . 39.5 t80 -57.09 125.12 21.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.676 0.79 . . . . 0.0 110.242 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 32.7 ttt180 -153.29 122.08 6.43 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 123.613 0.571 . . . . 0.0 110.79 -172.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -71.56 -3.16 19.85 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.174 1.389 . . . . 0.0 112.431 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 4.3 t70 -89.92 -23.35 21.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.353 1.061 . . . . 0.0 110.369 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.447 HD11 ' HD3' ' A' ' 66' ' ' ARG . 20.8 mm -87.65 130.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.527 -175.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.707 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 66.3 t30 -145.3 167.95 21.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 109.594 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.26 65.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.165 0.986 . . . . 0.0 111.947 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.8 p -72.16 0.03 10.75 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.343 1.057 . . . . 0.0 112.334 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.9 t -101.14 161.34 13.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.855 0.862 . . . . 0.0 109.565 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 52.9 mtp180 -113.88 147.48 38.38 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.643 HG21 HD13 ' A' ' 61' ' ' ILE . 49.3 mm -95.6 102.56 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.491 0.316 . . . . 0.0 110.393 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HB2' HE21 ' A' ' 13' ' ' GLN . 58.3 tttm -94.94 102.96 14.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG23 HD23 ' A' ' 87' ' ' LEU . 70.2 t -69.41 124.28 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 120.74 0.305 . . . . 0.0 111.095 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 42.2 t -80.97 -40.11 24.92 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.991 0.917 . . . . 0.0 110.79 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.0 p -146.33 132.64 19.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 108.747 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.0 -170.44 27.91 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 123.517 0.51 . . . . 0.0 112.531 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.03 -17.65 59.85 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.137 2.558 . . . . 0.0 112.059 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 41' ' ' MET . 29.9 mt -114.25 23.94 12.4 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.742 1.217 . . . . 0.0 110.088 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.85 108.48 1.2 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.892 . . . . 0.0 111.487 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.28 -31.42 5.45 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 123.979 0.8 . . . . 0.0 111.938 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.492 HH12 ' HG3' ' A' ' 108' ' ' GLU . 36.3 mtm180 -89.08 170.71 10.41 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.573 0.749 . . . . 0.0 112.761 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 76' ' ' LYS . 37.5 t -122.54 104.88 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.454 1.101 . . . . 0.0 110.106 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 77' ' ' VAL . 2.2 mm? -86.63 140.93 29.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.601 170.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.47 141.95 39.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.404 1.082 . . . . 0.0 109.072 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 106' ' ' CYS . 51.8 mt -81.11 107.14 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -173.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 107' ' ' ARG . 32.0 pt -90.92 41.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.414 0.686 . . . . 0.0 111.302 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.5 -134.97 2.5 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 112.001 -0.439 . . . . 0.0 112.001 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -134.65 136.52 25.62 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.903 1.281 . . . . 0.0 108.708 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.707 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 73.9 Cg_endo -69.62 111.24 2.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.158 1.905 . . . . 0.0 110.765 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 107.66 60.17 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -173.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 51.4 Cg_exo -56.03 150.61 46.41 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.539 2.826 . . . . 0.0 112.882 172.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.8 173.34 9.26 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.81 -32.45 69.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.48 0.712 . . . . 0.0 112.36 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.47 -9.33 44.91 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 62.48 30.09 17.16 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.176 0.99 . . . . 0.0 111.302 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.2 p -101.38 -12.88 18.27 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.824 0.849 . . . . 0.0 112.204 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.66 143.08 3.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -171.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.546 HD23 ' HB2' ' A' ' 93' ' ' PRO . 9.6 mp -101.64 139.57 37.12 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.958 0.903 . . . . 0.0 110.069 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.66 109.99 19.56 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 164.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.5 mm -95.92 104.57 15.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.7 pt? -83.3 137.52 33.95 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 104' ' ' ILE . 73.7 m -149.57 175.05 11.87 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.099 0.96 . . . . 0.0 108.888 -173.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.464 ' HB2' HD13 ' A' ' 90' ' ' ILE . 57.5 ttt180 -156.65 159.97 38.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HG3' HH12 ' A' ' 85' ' ' ARG . 0.4 OUTLIER -61.34 101.0 0.15 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.037 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.981 -165.663 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 36' ' ' TRP . 8.1 mp . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.407 0.622 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -121.64 -13.67 8.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.86 1.264 . . . . 0.0 111.366 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.47 -170.74 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.444 1.497 . . . . 0.0 110.09 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.459 ' HB3' HG22 ' A' ' 34' ' ' THR . 46.2 mtm180 -136.5 142.75 43.53 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 109.904 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -136.15 143.5 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.344 1.058 . . . . 0.0 109.155 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -101.83 118.85 37.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.033 0.933 . . . . 0.0 108.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.32 92.14 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 123.95 0.781 . . . . 0.0 109.634 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 35.1 tt0 -83.79 93.77 8.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.904 0.859 . . . . 0.0 109.645 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -80.07 154.09 28.34 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.288 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' GLU . 67.2 tp -83.5 108.77 16.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.181 0.592 . . . . 0.0 109.948 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 45.9 tttp -84.67 94.24 8.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.384 0.674 . . . . 0.0 110.224 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.415 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 42.9 mt-30 -87.45 108.64 19.11 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -130.09 129.37 43.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.782 0.833 . . . . 0.0 109.173 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -73.49 148.47 43.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 122.75 0.42 . . . . 0.0 110.086 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.33 169.28 8.99 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.02 -14.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 p -91.85 -10.84 38.26 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.777 0.798 . . . . 0.0 109.344 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.32 44.29 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.742 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.21 132.59 38.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.0 mm -76.44 94.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.82 109.2 15.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.6 mt-10 -84.11 96.17 8.84 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.82 0.819 . . . . 0.0 109.303 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' HD12 ' A' ' 15' ' ' LEU . 67.1 p -110.92 -177.99 3.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.08 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -128.53 115.5 18.23 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.947 -0.471 . . . . 0.0 110.536 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 16' ' ' LYS . 8.7 pt-20 -97.95 109.89 22.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 13' ' ' GLN . 6.4 p-10 -63.75 135.2 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.9 -112.22 3.23 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 120.089 -0.284 . . . . 0.0 113.127 -163.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -102.66 135.28 44.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.091 0.557 . . . . 0.0 109.68 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.4 m -100.98 99.11 9.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.58 -179.68 3.94 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.192 0.52 . . . . 0.0 110.62 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.562 ' HB2' HD23 ' A' ' 6' ' ' LEU . 27.4 m95 -73.85 146.3 44.23 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.341 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -157.67 166.46 32.76 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.909 0.884 . . . . 0.0 112.824 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 t -110.42 95.92 5.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.586 HG21 HG21 ' A' ' 77' ' ' VAL . 3.5 p -96.7 90.49 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.971 0.891 . . . . 0.0 109.054 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -112.18 127.55 55.98 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.533 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.0 mtp -67.16 137.77 56.52 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.27 159.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.597 0.759 . . . . 0.0 111.857 -173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 m -82.5 168.61 17.23 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.396 0.678 . . . . 0.0 110.345 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.3 p -63.56 -21.56 66.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.513 0.725 . . . . 0.0 111.773 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.28 14.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.694 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.23 -46.25 91.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 111.372 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.36 61.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.61 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.62 -47.39 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.891 0.876 . . . . 0.0 111.896 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -75.69 -32.59 60.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.872 0.869 . . . . 0.0 111.14 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.0 t -74.55 -45.6 44.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.866 0.467 . . . . 0.0 111.285 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.73 -75.86 0.22 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.613 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.81 13.64 0.91 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.011 0.525 . . . . 0.0 112.352 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.76 -63.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.67 149.94 31.08 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.06 20.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.443 0.697 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mt -78.29 156.79 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.965 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.93 -10.2 68.15 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.445 HG23 HD11 ' A' ' 90' ' ' ILE . 86.8 m -65.2 152.21 44.21 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.536 1.134 . . . . 0.0 109.784 171.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 41' ' ' MET . 41.9 t -125.46 125.9 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.954 0.901 . . . . 0.0 109.438 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD3' ' HE1' ' A' ' 62' ' ' TRP . 21.7 ttm-85 -96.97 133.24 41.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 109.265 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 75' ' ' ILE . 67.7 mt -133.21 107.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.536 0.734 . . . . 0.0 109.177 -169.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.413 ' HE1' ' HD3' ' A' ' 60' ' ' ARG . 11.1 m0 -95.35 119.89 34.63 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.621 0.768 . . . . 0.0 110.743 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.21 166.11 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.892 0.877 . . . . 0.0 108.733 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' HD21 ' A' ' 6' ' ' LEU . 31.5 mmm180 -56.72 157.47 5.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.789 0.435 . . . . 0.0 110.612 166.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.85 95.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 28.7 ttt85 -110.16 116.72 32.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.346 -177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -78.71 1.17 23.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.763 1.225 . . . . 0.0 111.679 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -92.51 -19.43 21.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.425 1.09 . . . . 0.0 110.535 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 16.6 mm -79.91 134.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.957 0.503 . . . . 0.0 110.582 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -129.42 166.12 20.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.99 67.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.033 0.533 . . . . 0.0 110.955 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.1 p -82.58 19.43 1.29 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.654 0.781 . . . . 0.0 111.824 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -107.37 142.32 37.36 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.787 0.835 . . . . 0.0 108.842 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -107.58 133.35 52.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 61' ' ' ILE . 37.7 mm -94.49 91.7 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.112 0.482 . . . . 0.0 110.139 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 26.8 ttpp -86.99 106.3 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 99.1 t -78.8 130.35 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.116 0.566 . . . . 0.0 111.281 -169.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.5 m -89.81 -19.67 24.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.977 0.911 . . . . 0.0 113.048 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.6 p -135.0 -177.13 4.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.172 0.589 . . . . 0.0 110.92 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.12 -151.59 51.97 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.956 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.83 -12.89 13.29 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.177 2.585 . . . . 0.0 113.349 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.07 23.35 13.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.577 0.751 . . . . 0.0 110.737 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.7 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.406 0.682 . . . . 0.0 110.734 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.16 6.89 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.727 0.679 . . . . 0.0 112.13 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -71.06 139.36 50.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.059 0.544 . . . . 0.0 110.193 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.2 p -104.89 90.65 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.497 1.142 . . . . 0.0 108.927 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -70.76 149.26 47.07 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.861 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -122.11 137.93 54.64 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.27 95.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -173.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 58' ' ' THR . 25.3 pt -80.63 63.72 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 122.333 1.063 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.18 -118.27 0.82 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.434 ' H ' HD21 ' A' ' 105' ' ' LEU . 9.9 pt20 -162.74 142.43 7.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.64 0.776 . . . . 0.0 109.42 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.84 116.06 3.1 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.989 2.46 . . . . 0.0 110.751 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.94 108.15 38.96 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.809 0.843 . . . . 0.0 109.767 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.05 135.82 19.48 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.359 2.04 . . . . 0.0 110.129 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.0 174.07 9.12 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.57 62.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.652 0.781 . . . . 0.0 113.031 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.45 27.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.492 0.317 . . . . 0.0 111.258 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 62.06 30.49 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.232 1.013 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.1 t -86.13 -16.2 38.68 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.843 0.857 . . . . 0.0 110.933 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -152.12 166.45 31.63 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.675 0.75 . . . . 0.0 110.349 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 107.8 12.84 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -87.09 101.5 13.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.302 0.641 . . . . 0.0 109.448 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.5 mm -83.92 145.72 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.97 0.908 . . . . 0.0 108.788 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.4 pt? -122.78 143.07 50.07 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 72.2 m -151.53 176.09 11.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.705 0.802 . . . . 0.0 110.64 -170.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -161.11 155.35 22.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.373 0.669 . . . . 0.0 109.448 167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.34 144.89 28.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.183 0.993 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.04 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.023 173.411 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 121.403 0.62 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -98.96 -36.92 9.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.785 1.234 . . . . 0.0 112.369 -171.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -96.6 -167.6 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.775 1.23 . . . . 0.0 108.861 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' HB3' HG22 ' A' ' 34' ' ' THR . 49.3 mtm180 -148.91 146.46 27.9 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 0.0 110.418 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.3 151.27 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.841 0.856 . . . . 0.0 109.044 175.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -102.45 122.95 45.33 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.8 116.96 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.792 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -83.36 99.94 10.36 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 p -82.28 141.28 33.06 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.989 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.3 tp -110.27 113.77 26.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.513 0.725 . . . . 0.0 109.386 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -102.35 114.46 28.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.722 0.409 . . . . 0.0 110.212 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 41.8 mt-30 -75.51 90.3 2.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -91.54 110.23 21.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 109.703 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -71.24 158.59 36.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.534 0.334 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.92 164.41 13.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.428 0.691 . . . . 0.0 109.703 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.81 -11.23 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 125.068 1.347 . . . . 0.0 112.982 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 p -104.67 -23.99 13.01 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.84 44.67 1.74 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.94 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -106.41 149.91 26.55 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.33 101.69 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.906 0.483 . . . . 0.0 110.025 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.93 90.96 7.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.991 0.916 . . . . 0.0 108.96 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.588 ' HB3' HD11 ' A' ' 15' ' ' LEU . 42.4 mt-10 -79.34 121.04 24.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -137.98 141.85 40.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.587 1.155 . . . . 0.0 109.824 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -101.5 103.55 14.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.078 0.951 . . . . 0.0 109.088 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.44 125.73 34.88 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.247 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.83 113.36 7.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.706 1.202 . . . . 0.0 108.397 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.35 -109.45 2.86 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.319 -157.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -117.09 139.0 51.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.394 0.678 . . . . 0.0 110.215 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.7 m -101.45 98.44 8.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 109.74 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 63' ' ' ILE . 1.3 pt? -106.69 163.73 12.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.952 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -59.49 123.31 16.43 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.113 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.83 176.44 8.7 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.203 1.001 . . . . 0.0 110.933 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -136.94 107.55 6.54 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 77' ' ' VAL . 66.5 t -105.29 131.6 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.65 0.78 . . . . 0.0 109.307 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -151.29 159.58 44.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.453 ' SD ' HG22 ' A' ' 59' ' ' VAL . 19.8 mmt -67.76 148.22 51.55 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.19 145.23 13.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 O-C-N 123.746 0.654 . . . . 0.0 110.151 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 47.4 t -74.35 163.27 28.0 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.955 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 p -61.21 -31.5 71.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.501 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 16.9 ptpt -62.17 -33.5 74.64 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.469 0.707 . . . . 0.0 111.492 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.75 -50.84 14.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.558 0.743 . . . . 0.0 110.258 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.95 40.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.437 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.2 mt -66.43 -27.32 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.773 0.829 . . . . 0.0 111.982 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -59.24 -49.36 78.14 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.787 0.435 . . . . 0.0 110.572 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 83.9 p -79.78 -12.29 59.79 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.151 0.58 . . . . 0.0 111.564 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -77.5 2.04 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.89 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.103 0.561 . . . . 0.0 111.847 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 32.6 mt-10 -78.36 -69.54 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.94 141.91 31.81 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -139.75 156.91 46.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.96 0.504 . . . . 0.0 110.212 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.59 125.55 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.07 -12.58 12.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -163.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 m -77.77 154.61 31.8 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 156.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG22 ' SD ' ' A' ' 41' ' ' MET . 40.5 t -124.53 128.04 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.841 0.857 . . . . 0.0 111.033 -170.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -98.2 128.86 44.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.335 0.654 . . . . 0.0 109.519 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.619 HD13 HG21 ' A' ' 75' ' ' ILE . 65.7 mt -135.0 143.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.141 0.976 . . . . 0.0 108.494 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 60.1 m95 -134.92 121.67 20.86 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 35' ' ' LEU . 44.6 pt -121.41 168.75 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.414 0.686 . . . . 0.0 109.977 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -47.42 146.75 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.595 0.758 . . . . 0.0 112.748 165.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -67.35 108.95 2.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.358 0.663 . . . . 0.0 110.287 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' HD13 ' A' ' 35' ' ' LEU . 9.9 ptp180 -149.21 125.63 10.91 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.059 0.544 . . . . 0.0 110.327 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -84.09 12.35 6.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.394 1.078 . . . . 0.0 111.408 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.28 -18.31 28.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.405 1.082 . . . . 0.0 110.004 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.417 HG13 HD11 ' A' ' 63' ' ' ILE . 21.6 mm -74.55 138.69 20.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 159.68 34.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.14 -20.67 66.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.594 0.358 . . . . 0.0 111.808 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -92.06 28.23 1.93 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -107.34 161.74 14.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.553 HH21 HG21 ' A' ' 86' ' ' VAL . 51.3 mtp180 -125.04 128.55 48.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.619 HG21 HD13 ' A' ' 61' ' ' ILE . 44.5 mm -88.4 96.52 6.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.721 0.808 . . . . 0.0 109.454 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -94.76 109.39 21.35 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.484 HG23 HD23 ' A' ' 87' ' ' LEU . 61.5 t -74.99 124.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.381 0.672 . . . . 0.0 110.789 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 t -83.52 -25.66 30.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.71 0.804 . . . . 0.0 111.342 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.1 t -163.37 132.53 4.02 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.59 -163.7 30.43 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.93 -14.24 29.36 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.778 2.319 . . . . 0.0 112.028 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.1 mt -123.06 32.28 5.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.285 1.034 . . . . 0.0 110.01 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.73 25.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.45 0.7 . . . . 0.0 110.659 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.62 12.29 72.63 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.588 0.555 . . . . 0.0 113.085 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -119.9 148.18 43.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.348 0.659 . . . . 0.0 109.44 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.553 HG21 HH21 ' A' ' 74' ' ' ARG . 5.1 p -111.17 97.9 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 122.624 1.202 . . . . 0.0 110.93 -173.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD23 HG23 ' A' ' 77' ' ' VAL . 1.8 mm? -86.38 142.43 28.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.387 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -103.59 143.32 32.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.363 1.065 . . . . 0.0 108.763 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.29 129.62 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 pt -113.07 132.73 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.893 0.877 . . . . 0.0 109.27 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.76 -84.38 1.41 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 29.6 pt20 -169.34 158.13 7.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.683 0.793 . . . . 0.0 110.512 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.24 148.87 27.51 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.05 1.833 . . . . 0.0 110.334 159.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.18 125.05 5.08 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 152.55 40.12 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.443 2.096 . . . . 0.0 112.194 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.73 178.02 3.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 122.289 -0.257 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.87 -36.42 83.25 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.767 0.827 . . . . 0.0 112.523 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.76 -13.29 34.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.119 0.568 . . . . 0.0 111.958 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 62.45 34.47 15.43 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.628 1.171 . . . . 0.0 111.408 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -98.33 0.33 45.31 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.747 0.819 . . . . 0.0 110.817 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 5.4 ptp180 -169.51 -177.77 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.95 0.9 . . . . 0.0 109.242 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.07 112.64 16.09 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.91 119.6 17.37 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.547 HG22 ' SG ' ' A' ' 106' ' ' CYS . 25.8 mm -109.8 118.83 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -98.65 133.47 42.95 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.178 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 104' ' ' ILE . 85.3 m -144.98 173.68 11.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.036 -170.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -150.03 162.89 39.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -45.59 143.79 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.044 0.537 . . . . 0.0 111.099 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.255 0 O-C-N 123.136 0.273 . . . . 0.0 113.14 -171.014 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -83.22 -39.55 20.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.061 0.944 . . . . 0.0 112.218 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.63 -171.35 1.82 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.557 1.543 . . . . 0.0 109.905 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -143.85 147.35 33.94 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.616 1.166 . . . . 0.0 110.214 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.04 154.7 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.421 1.089 . . . . 0.0 109.576 177.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -108.56 125.37 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.197 0.999 . . . . 0.0 108.47 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.53 125.92 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 123.395 0.435 . . . . 0.0 110.373 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 19.3 mp0 -88.07 100.28 12.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.096 0.958 . . . . 0.0 108.68 170.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -83.63 143.84 29.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.818 172.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.7 tp -90.7 107.7 19.34 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.672 0.389 . . . . 0.0 110.627 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.53 97.06 8.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.545 0.738 . . . . 0.0 109.375 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.23 90.75 2.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -89.94 161.14 16.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.213 1.005 . . . . 0.0 109.389 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -125.97 154.54 42.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.13 -0.356 . . . . 0.0 110.577 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.8 t70 -104.64 160.06 15.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.78 1.232 . . . . 0.0 108.64 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.31 -11.37 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -108.7 -0.51 20.03 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.682 0.753 . . . . 0.0 109.261 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 28.58 9.09 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.249 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 10.3 mm-40 -92.75 134.78 34.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.1 mm -91.07 118.14 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.83 17.51 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' HD11 ' A' ' 15' ' ' LEU . 1.9 mp0 -78.78 114.94 18.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.8 p -130.22 152.48 49.6 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.128 0.971 . . . . 0.0 108.385 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -106.59 103.86 13.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -87.34 128.71 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.09 145.56 55.2 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -106.93 2.56 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -115.2 135.21 54.42 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.073 0.949 . . . . 0.0 108.683 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.4 m -94.26 95.8 9.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.1 pt? -111.34 169.49 8.76 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.45 0.643 . . . . 0.0 111.447 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -71.12 130.37 41.32 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.739 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.703 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.84 176.72 8.46 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.495 175.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 55.4 m -130.58 98.99 4.82 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.61 102.6 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.497 0.719 . . . . 0.0 109.07 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.15 106.42 14.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.054 0.942 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' HG22 ' A' ' 59' ' ' VAL . 86.6 mmm -60.19 117.94 5.76 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 m -70.63 155.58 7.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 121.118 0.485 . . . . 0.0 110.668 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t -85.22 176.98 8.02 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.458 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.73 -28.73 66.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.055 0.942 . . . . 0.0 111.909 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 20.4 ptmt -49.33 -42.75 42.61 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.798 1.239 . . . . 0.0 113.463 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.52 -41.16 93.45 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.295 0.638 . . . . 0.0 111.052 -176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.19 74.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.758 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.1 mt -60.51 -43.31 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.68 0.792 . . . . 0.0 111.26 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.5 m -69.72 -33.8 72.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.391 0.676 . . . . 0.0 111.994 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 77.8 p -82.09 -30.25 31.34 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.635 0.374 . . . . 0.0 111.046 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.82 -66.03 0.24 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.044 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 15.04 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.299 1.04 . . . . 0.0 110.59 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.1 tt0 -86.13 -53.75 4.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.601 0.76 . . . . 0.0 109.584 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 58' ' ' THR . 94.4 mt -84.53 160.8 20.42 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 167.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.88 154.82 40.48 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.751 0.82 . . . . 0.0 110.153 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.83 108.28 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.52 10.92 20.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.497 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.402 HG21 HD22 ' A' ' 54' ' ' LEU . 37.9 m -64.71 122.18 16.26 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.702 HG22 ' SD ' ' A' ' 41' ' ' MET . 24.8 t -86.95 105.6 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.778 0.831 . . . . 0.0 110.026 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -90.74 133.37 35.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.576 HD13 HG21 ' A' ' 75' ' ' ILE . 79.6 mt -135.79 117.46 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.134 0.974 . . . . 0.0 108.895 -169.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 79.3 m95 -102.73 119.12 38.27 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 122.888 0.475 . . . . 0.0 109.909 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 pt -124.22 155.76 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -59.17 163.64 3.61 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.25 0.477 . . . . 0.0 111.396 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.494 ' HA ' HD13 ' A' ' 102' ' ' LEU . 42.5 t80 -55.8 100.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.755 0.822 . . . . 0.0 111.203 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -118.93 106.28 12.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -68.03 -24.08 65.06 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.389 1.076 . . . . 0.0 113.28 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.25 -18.64 23.14 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.624 0.769 . . . . 0.0 112.325 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -67.18 132.63 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -154.17 173.6 15.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -26.39 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.505 0.722 . . . . 0.0 112.329 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.7 p -80.09 9.91 4.99 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.282 1.033 . . . . 0.0 113.341 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.0 p -117.55 156.94 27.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.257 0.623 . . . . 0.0 109.503 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 74.5 mtp180 -112.95 155.0 25.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 171.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.576 HG21 HD13 ' A' ' 61' ' ' ILE . 21.3 mm -116.82 103.21 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.26 0.624 . . . . 0.0 109.864 -177.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.2 ttpt -94.15 109.5 21.28 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 HD23 ' A' ' 87' ' ' LEU . 95.8 t -73.23 126.85 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 O-C-N 123.622 0.576 . . . . 0.0 110.516 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.4 m -79.67 -25.17 41.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.292 1.037 . . . . 0.0 113.287 -171.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -152.53 178.47 9.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.71 -146.64 30.07 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.42 -0.655 . . . . 0.0 113.052 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.64 -22.47 13.69 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.262 2.642 . . . . 0.0 113.289 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.639 HD11 ' SD ' ' A' ' 41' ' ' MET . 92.5 mt -115.71 31.29 6.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.881 0.473 . . . . 0.0 110.927 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.72 94.71 0.31 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.476 0.71 . . . . 0.0 110.895 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.0 -17.81 8.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.739 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -79.23 129.57 34.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.374 0.67 . . . . 0.0 109.722 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -102.36 80.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 122.648 1.214 . . . . 0.0 109.152 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 77' ' ' VAL . 2.0 mm? -65.78 153.52 41.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.184 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -120.43 139.1 53.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 106' ' ' CYS . 62.7 mt -80.78 104.07 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -172.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 107' ' ' ARG . 40.0 pt -83.1 16.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.002 0.921 . . . . 0.0 112.36 -174.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.57 -141.85 3.23 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -128.89 134.81 26.73 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.575 ' HB2' HD23 ' A' ' 102' ' ' LEU . 67.1 Cg_endo -68.36 146.13 67.85 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.905 2.403 . . . . 0.0 111.52 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 120.41 5.01 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 40.3 Cg_endo -66.65 157.43 60.94 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.555 . . . . 0.0 113.743 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.56 179.73 3.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.25 69.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.872 0.869 . . . . 0.0 112.623 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.6 -11.26 29.74 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.36 0.664 . . . . 0.0 112.463 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.2 20.02 8.97 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.958 0.903 . . . . 0.0 111.938 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -74.82 -18.02 60.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.411 0.684 . . . . 0.0 111.842 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.18 153.27 5.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.618 0.767 . . . . 0.0 110.764 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 93' ' ' PRO . 8.1 mp -102.82 133.95 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.131 0.973 . . . . 0.0 109.718 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.37 116.54 23.76 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 12.4 mm -98.95 131.81 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 173.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -106.77 136.83 45.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 89' ' ' ILE . 83.9 m -148.73 172.92 13.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.4 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HB3' HG21 ' A' ' 90' ' ' ILE . 72.3 ttt-85 -163.6 154.38 16.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -74.19 131.17 41.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 179.725 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -136.13 -28.91 1.03 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.22 0.608 . . . . 0.0 112.438 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' THR . 70.0 m-20 -107.14 -171.26 1.85 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.45 1.5 . . . . 0.0 110.419 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -141.11 147.14 38.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.315 1.046 . . . . 0.0 108.975 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.88 155.61 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.233 0.613 . . . . 0.0 109.791 173.367 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 m -113.18 124.99 53.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.364 0.666 . . . . 0.0 109.628 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.53 108.86 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.637 1.175 . . . . 0.0 110.596 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.6 mp0 -80.74 98.3 7.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.045 0.926 . . . . 0.0 108.979 172.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 5.0 m -79.8 145.23 32.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.987 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.2 tp -97.38 99.79 11.22 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.92 -0.487 . . . . 0.0 109.817 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -83.44 105.66 14.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.218 0.607 . . . . 0.0 109.876 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 50.3 mt-30 -88.31 89.06 7.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.5 m -94.04 135.12 35.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.099 0.96 . . . . 0.0 110.0 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 4.7 ttp180 -74.47 148.41 41.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . 20.5 t70 -96.58 163.81 12.87 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.12 -11.05 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -99.24 -4.2 32.5 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.446 -0.784 . . . . 0.0 109.643 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.73 44.51 6.79 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.821 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.6 mt-10 -103.37 173.58 6.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.719 0.807 . . . . 0.0 109.736 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.61 103.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.341 0.656 . . . . 0.0 109.308 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 20' ' ' ASP . 8.8 mp -94.61 108.94 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.833 1.253 . . . . 0.0 109.31 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 41.9 mt-10 -79.88 117.0 20.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 p -131.91 157.4 44.08 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.359 1.063 . . . . 0.0 109.422 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -103.83 101.5 11.32 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 6.3 pt-20 -83.37 123.01 29.23 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.32 115.43 10.47 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.66 -119.77 4.32 Favored Glycine 0 N--CA 1.474 1.192 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.876 -160.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.97 159.76 28.61 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.554 0.742 . . . . 0.0 110.478 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 47.0 m -138.07 95.97 3.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 169.79 8.58 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.933 -174.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -67.85 131.42 45.49 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.425 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -140.82 178.28 7.45 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.99 0.916 . . . . 0.0 111.363 176.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -140.73 105.18 4.87 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.84 114.63 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -133.01 124.59 27.97 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.523 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -67.78 134.56 51.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.19 152.3 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.552 0.341 . . . . 0.0 110.203 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t -97.91 -175.43 3.15 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 56' ' ' ILE . 14.2 p -55.93 -30.55 61.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.284 1.033 . . . . 0.0 112.936 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -50.14 -48.17 53.79 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.648 1.179 . . . . 0.0 112.716 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.16 -36.65 72.1 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.05 96.57 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.004 0.815 . . . . 0.0 110.519 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.48 -46.78 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.433 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -71.67 -24.15 61.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.417 0.687 . . . . 0.0 112.399 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 31.8 m -101.84 -5.4 24.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.218 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.07 -90.07 0.79 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.019 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.99 -11.68 10.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 110.803 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 10.0 tp10 -64.43 -59.82 3.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 110.288 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.677 HD22 HG21 ' A' ' 58' ' ' THR . 61.2 mt -93.88 162.07 14.06 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.92 166.19 25.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 110.315 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 44' ' ' SER . 59.6 mt -71.12 111.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.12 -10.38 17.72 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-O 120.218 -0.212 . . . . 0.0 112.626 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.677 HG21 HD22 ' A' ' 54' ' ' LEU . 24.5 m -61.6 137.75 58.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.304 0.642 . . . . 0.0 109.53 169.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 41' ' ' MET . 48.9 t -105.33 127.46 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 109.867 -177.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -109.32 144.32 37.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.41 0.624 . . . . 0.0 109.909 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 75' ' ' ILE . 41.0 mt -135.69 107.35 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -167.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -96.06 114.4 26.11 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.5 pt -116.37 155.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 1.6 tmt_? -55.83 143.98 29.42 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.501 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 57.0 t80 -45.16 124.68 4.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 111.666 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.477 ' H ' HD23 ' A' ' 102' ' ' LEU . 5.7 tpm_? -151.26 116.01 5.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.51 0.724 . . . . 0.0 109.54 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HE3' ' HE2' ' A' ' 65' ' ' TYR . 91.0 mttt -84.8 8.59 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.194 0.998 . . . . 0.0 111.577 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.98 -24.11 17.78 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.511 1.124 . . . . 0.0 111.567 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.88 126.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.716 0.406 . . . . 0.0 111.287 -170.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.89 157.96 30.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.84 -13.53 60.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.428 0.691 . . . . 0.0 112.68 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 p -77.05 -24.14 51.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.804 0.441 . . . . 0.0 110.964 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -73.19 155.21 39.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.316 0.647 . . . . 0.0 110.627 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 75.9 mtm180 -113.5 162.81 15.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 172.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.633 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.4 mp -112.17 126.97 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.052 1.341 . . . . 0.0 108.177 171.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -118.86 116.14 25.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.45 110.25 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 123.556 0.535 . . . . 0.0 110.998 -170.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.467 ' H ' ' HA ' ' A' ' 10' ' ' ILE . 31.8 t -70.5 -27.2 64.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.593 1.157 . . . . 0.0 111.265 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' ASP . 12.8 t -166.45 137.96 3.56 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.59 -162.45 30.73 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 119.771 -0.46 . . . . 0.0 112.294 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.33 -14.17 18.45 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.11 2.54 . . . . 0.0 111.765 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -124.81 32.86 5.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.441 1.096 . . . . 0.0 109.162 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.32 102.22 0.21 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.739 0.815 . . . . 0.0 111.507 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.85 0.24 15.09 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 119.859 -0.411 . . . . 0.0 113.147 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -106.64 160.47 15.43 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.582 0.753 . . . . 0.0 110.077 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.25 100.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.947 1.356 . . . . 0.0 111.168 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.93 124.5 34.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.269 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.6 142.32 29.55 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.324 1.05 . . . . 0.0 108.334 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.07 117.45 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.26 71.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 121.98 0.895 . . . . 0.0 109.852 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.53 -114.24 0.63 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.174 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.549 ' H ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -166.81 142.79 3.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.73 0.812 . . . . 0.0 109.438 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 102' ' ' LEU . 37.1 Cg_endo -60.28 120.74 8.68 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.791 2.328 . . . . 0.0 112.145 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.93 108.62 55.47 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.336 1.055 . . . . 0.0 108.965 -170.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 153.73 53.62 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.797 2.331 . . . . 0.0 113.082 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 6.8 p-10 -84.33 172.45 11.79 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 0.0 110.462 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.13 75.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.893 0.877 . . . . 0.0 112.249 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.04 -9.35 59.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.931 0.492 . . . . 0.0 111.65 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 25.2 mmt180 60.58 28.64 18.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.132 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -101.16 -5.44 25.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.845 0.858 . . . . 0.0 110.739 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.03 155.58 25.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.312 0.577 . . . . 0.0 110.903 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 93' ' ' PRO . 3.3 mm? -108.83 113.07 25.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -77.07 107.06 9.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.51 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.1 mm -96.55 134.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -111.25 130.6 55.61 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.51 ' SG ' HG22 ' A' ' 104' ' ' ILE . 71.9 m -153.77 176.68 11.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -167.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ptm85 -160.27 163.58 33.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.9 145.49 45.65 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.294 0.371 . . . . 0.0 110.874 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.262 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.496 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 1.7 mm? . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -97.9 -41.96 7.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.401 1.081 . . . . 0.0 111.276 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -102.61 -167.17 1.36 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.295 1.438 . . . . 0.0 110.238 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -146.38 150.8 36.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.857 1.263 . . . . 0.0 109.055 171.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.93 145.36 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.332 0.653 . . . . 0.0 109.698 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 31' ' ' ASP . 3.2 m -90.61 124.6 35.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 167.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.8 mm -71.14 107.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 35.4 tt0 -78.84 95.35 5.36 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.624 1.202 . . . . 0.0 108.26 176.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 27.8 m -81.58 142.54 32.71 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.455 -2.157 . . . . 0.0 109.641 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 27' ' ' GLU . 37.5 tp -98.5 104.49 16.53 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -96.25 123.9 40.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -102.85 102.41 12.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -110.82 121.18 44.7 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.377 1.071 . . . . 0.0 109.164 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -69.11 164.93 21.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.311 0.644 . . . . 0.0 110.979 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -113.51 165.71 12.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.43 3.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 C-N-CA 124.563 1.145 . . . . 0.0 113.616 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.1 p -100.72 -11.76 19.68 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.14 -0.975 . . . . 0.0 109.765 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.7 30.4 15.5 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.859 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -104.82 135.32 46.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.83 0.852 . . . . 0.0 108.908 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.76 112.5 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.101 0.41 . . . . 0.0 110.013 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.06 117.22 30.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -84.52 118.63 24.43 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.422 0.689 . . . . 0.0 109.311 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.1 p -129.82 151.21 50.65 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 0.0 109.933 -175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -110.31 104.17 12.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.679 0.792 . . . . 0.0 110.193 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 10.7 pt-20 -91.57 152.83 20.12 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.857 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.2 p-10 -85.26 131.8 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.7 -113.71 3.86 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -170.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -112.09 135.27 52.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.508 0.723 . . . . 0.0 109.722 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.3 m -98.74 106.64 18.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.474 0.709 . . . . 0.0 110.194 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.623 HD11 HD12 ' A' ' 63' ' ' ILE . 1.1 pt? -111.31 165.29 12.07 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.697 0.76 . . . . 0.0 112.242 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.541 ' HD1' ' HD2' ' A' ' 64' ' ' ARG . 51.6 m95 -56.98 122.45 12.33 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.324 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -133.04 176.64 8.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.238 1.015 . . . . 0.0 111.982 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.2 t -145.78 101.2 3.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 162.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 61' ' ' ILE . 53.1 t -96.29 113.09 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.672 0.789 . . . . 0.0 109.281 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -134.53 130.32 36.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.145 0.578 . . . . 0.0 109.874 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.686 ' SD ' HG22 ' A' ' 59' ' ' VAL . 77.9 mmm -62.74 131.28 48.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.681 . . . . 0.0 109.447 170.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 60' ' ' ARG . 8.0 m -71.13 152.36 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.269 0.356 . . . . 0.0 110.12 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.9 m -77.54 168.65 19.64 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.0 p -61.04 -20.82 63.0 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.447 0.699 . . . . 0.0 111.812 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 14.6 ptmm? -51.32 -35.63 38.96 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.163 1.385 . . . . 0.0 112.413 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -70.73 -41.26 72.09 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.416 0.447 . . . . 0.0 110.558 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.16 93.59 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.664 0.786 . . . . 0.0 110.415 175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.93 -43.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.221 1.008 . . . . 0.0 110.827 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 t -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.977 0.911 . . . . 0.0 111.121 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 81.8 p -89.6 -4.74 57.69 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.392 0.677 . . . . 0.0 111.229 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.37 -68.38 3.32 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.217 0.437 . . . . 0.0 112.064 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.54 16.97 0.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.794 0.838 . . . . 0.0 110.564 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.5 tp10 -79.25 -67.27 0.77 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.82 152.44 40.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.77 27.66 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.626 0.771 . . . . 0.0 109.882 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 mt -73.03 129.61 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.99 -9.55 15.76 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 106' ' ' CYS . 55.1 m -70.66 142.61 51.57 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.717 0.807 . . . . 0.0 109.027 169.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.686 HG22 ' SD ' ' A' ' 41' ' ' MET . 26.9 t -122.07 129.85 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.776 0.831 . . . . 0.0 109.612 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 42' ' ' VAL . 8.5 ttt85 -103.64 126.22 50.64 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 75' ' ' ILE . 30.4 mt -129.95 106.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.898 0.879 . . . . 0.0 108.756 -167.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -97.43 111.99 24.01 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 35' ' ' LEU . 42.8 pt -122.19 153.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.541 ' HD2' ' HD1' ' A' ' 36' ' ' TRP . 5.7 ptm180 -56.35 153.91 9.02 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 120.73 0.3 . . . . 0.0 111.399 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.69 134.35 55.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.366 0.666 . . . . 0.0 110.269 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.412 ' H ' HD23 ' A' ' 102' ' ' LEU . 32.1 ttt180 -158.63 136.28 10.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.716 0.635 . . . . 0.0 110.066 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -83.3 -5.36 59.11 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.742 0.817 . . . . 0.0 112.486 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.49 -19.65 21.03 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.835 0.854 . . . . 0.0 111.204 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.5 mm -69.71 121.56 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.918 0.487 . . . . 0.0 110.259 -172.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.71 162.41 32.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 109.6 -172.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -64.05 -27.34 69.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.708 0.803 . . . . 0.0 112.325 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -74.03 -17.56 60.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 0.0 111.779 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -96.76 105.08 17.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.006 0.922 . . . . 0.0 110.087 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 82.5 mtp180 -72.77 162.47 29.44 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.966 0.412 . . . . 0.0 111.441 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 HD13 ' A' ' 61' ' ' ILE . 44.1 mm -106.23 102.97 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.707 0.803 . . . . 0.0 110.19 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -96.77 112.66 24.32 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.36 119.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.683 0.393 . . . . 0.0 111.605 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -77.7 -25.76 49.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.708 0.803 . . . . 0.0 111.998 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -168.39 135.36 2.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.579 0.751 . . . . 0.0 109.397 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.97 -164.91 28.19 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.616 -0.546 . . . . 0.0 112.228 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.78 -6.52 17.61 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.098 2.532 . . . . 0.0 112.593 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HD11 ' A' ' 87' ' ' LEU . 78.1 mt -130.37 26.92 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.226 1.01 . . . . 0.0 110.019 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 105.73 0.6 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.66 0.784 . . . . 0.0 111.552 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.89 -40.13 2.09 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.87 139.46 41.69 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.528 0.731 . . . . 0.0 110.364 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 t -106.59 110.77 32.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.385 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD13 ' A' ' 82' ' ' LEU . 1.4 mm? -74.65 150.96 39.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.886 0.874 . . . . 0.0 110.365 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.47 ' OD1' ' HA3' ' A' ' 109' ' ' GLY . 9.0 m120 -114.09 135.81 53.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.393 1.077 . . . . 0.0 108.494 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 106' ' ' CYS . 61.8 mt -82.54 121.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -172.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -77.87 121.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.519 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.76 -87.61 0.36 Allowed Glycine 0 C--N 1.345 1.062 0 O-C-N 123.91 0.756 . . . . 0.0 112.735 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 23.2 pt20 -166.37 150.13 6.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.858 1.263 . . . . 0.0 108.951 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.37 157.64 58.58 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.526 2.151 . . . . 0.0 112.159 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.25 109.55 19.61 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.316 0.647 . . . . 0.0 110.142 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.55 133.81 50.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.774 2.316 . . . . 0.0 110.496 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 99' ' ' ARG . 5.1 p-10 -64.95 173.99 2.1 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.707 0.403 . . . . 0.0 111.164 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.29 -35.6 67.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.032 0.933 . . . . 0.0 112.943 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.61 -13.24 40.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 112.105 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 96' ' ' ASP . 3.7 mpt_? 60.88 29.15 18.83 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.429 1.092 . . . . 0.0 110.767 -175.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -93.59 -0.86 56.03 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.985 0.914 . . . . 0.0 110.39 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 8.4 ptp85 -163.57 169.35 18.79 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.737 0.815 . . . . 0.0 110.092 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -110.23 109.23 19.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.83 1.252 . . . . 0.0 107.644 169.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.62 110.86 20.12 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.521 HG22 ' SG ' ' A' ' 106' ' ' CYS . 14.3 mm -98.42 116.17 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -89.27 134.79 33.91 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 104' ' ' ILE . 99.1 m -151.58 -179.38 7.36 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 109.494 -173.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -149.37 152.25 35.46 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 166.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.1 107.19 0.7 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.096 0.474 . . . . 0.0 111.365 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' ' OD1' ' A' ' 88' ' ' ASN . . . . . . . . 0 C--N 1.348 1.206 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.565 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 31.9 mt . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.999 0.428 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -100.13 -24.99 14.43 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.946 0.898 . . . . 0.0 111.784 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -108.01 -173.31 2.25 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.951 1.3 . . . . 0.0 109.626 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.54 ' HG2' HG22 ' A' ' 34' ' ' THR . 51.0 ttp180 -148.09 131.86 16.98 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -129.99 153.32 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.6 0.76 . . . . 0.0 110.554 -175.332 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -103.04 124.64 48.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.221 1.008 . . . . 0.0 110.091 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.29 116.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 123.623 0.577 . . . . 0.0 109.946 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.693 1.197 . . . . 0.0 109.103 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -80.21 140.33 36.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.534 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 27' ' ' GLU . 33.2 tp -91.99 97.6 11.05 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -88.66 108.26 19.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.849 0.859 . . . . 0.0 109.56 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 48.4 mt-30 -91.58 101.31 13.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -109.58 122.3 47.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.667 0.787 . . . . 0.0 109.398 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -78.53 157.87 28.72 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.734 0.302 . . . . 0.0 110.294 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 22.7 t70 -103.51 168.73 8.97 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.617 0.767 . . . . 0.0 109.189 -172.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.48 -4.59 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 124.413 1.085 . . . . 0.0 112.666 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -110.98 -31.02 7.27 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.57 31.09 1.71 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.184 -1.371 . . . . 0.0 114.623 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 48.3 mm-40 -79.91 144.54 33.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 mm -95.89 101.77 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.6 90.93 6.86 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 44.3 mt-10 -79.68 105.56 11.07 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.9 p -123.93 155.11 38.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.334 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -109.45 96.71 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.48 130.63 35.59 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.21 127.53 32.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.48 -110.4 3.39 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -168.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -105.44 132.45 51.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 9' ' ' ARG . 36.5 m -104.58 95.17 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -108.44 170.1 8.23 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.591 0.71 . . . . 0.0 112.26 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 50.5 m95 -69.93 133.03 46.86 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.665 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -138.49 168.56 19.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.791 0.836 . . . . 0.0 112.175 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.9 t -120.98 94.06 4.22 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 162.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HG12 ' A' ' 61' ' ' ILE . 3.7 p -94.58 90.46 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 122.325 1.06 . . . . 0.0 108.978 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.3 118.51 36.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.444 -172.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.445 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.3 mtp -67.62 141.51 56.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.63 155.03 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.914 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 46' ' ' GLU . 18.0 m -76.13 163.46 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.091 0.556 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -62.43 -35.64 79.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.316 0.647 . . . . 0.0 110.465 176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.25 -28.54 69.42 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.621 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 15.4 mm-40 -71.81 -41.42 68.27 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.371 0.419 . . . . 0.0 110.207 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.23 -52.34 65.7 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 124.184 0.928 . . . . 0.0 111.184 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.29 -48.24 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.272 1.029 . . . . 0.0 111.953 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.26 -30.62 65.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.558 0.743 . . . . 0.0 111.728 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 11.1 t -90.22 -8.59 50.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.587 0.755 . . . . 0.0 110.578 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.42 -102.36 1.18 Allowed Glycine 0 C--N 1.352 1.452 0 O-C-N 123.587 0.555 . . . . 0.0 112.787 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.09 -5.55 17.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.927 0.891 . . . . 0.0 111.789 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 10.3 tp10 -74.55 -75.42 0.16 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.754 0.422 . . . . 0.0 109.973 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 58' ' ' THR . 64.7 mt -83.33 147.73 27.76 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.28 165.53 25.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.203 1.001 . . . . 0.0 109.048 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.13 117.06 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.66 -10.67 14.12 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.526 0.517 . . . . 0.0 112.101 -168.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.687 HG21 HD22 ' A' ' 54' ' ' LEU . 93.7 m -74.53 139.37 43.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 41' ' ' MET . 44.7 t -126.29 132.47 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.592 0.757 . . . . 0.0 110.599 -173.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -99.65 141.06 32.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 50.9 mt -134.57 107.9 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -102.73 112.75 25.67 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 37' ' ' ALA . 39.3 pt -123.93 166.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.147 0.579 . . . . 0.0 109.748 -173.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 21.5 mmt180 -53.07 137.99 32.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.273 0.488 . . . . 0.0 111.415 164.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HE1' ' HE3' ' A' ' 67' ' ' LYS . 28.3 t80 -55.87 116.69 3.1 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.175 0.99 . . . . 0.0 109.167 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HD3' HD11 ' A' ' 69' ' ' ILE . 37.0 ttt180 -140.02 121.06 14.66 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HE3' ' HE1' ' A' ' 65' ' ' TYR . 32.7 mmtp -69.18 -10.1 56.11 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.825 1.25 . . . . 0.0 112.431 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.78 -19.23 22.8 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.619 0.767 . . . . 0.0 110.976 -173.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 66' ' ' ARG . 33.3 mm -69.8 119.93 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -116.88 168.59 10.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.989 0.916 . . . . 0.0 108.961 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.01 -24.67 66.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.786 . . . . 0.0 110.992 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -90.78 13.54 16.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.698 0.799 . . . . 0.0 111.67 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 100.33 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.929 0.892 . . . . 0.0 109.266 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -72.23 165.5 24.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.685 0.755 . . . . 0.0 111.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.1 mp -115.6 130.28 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -125.32 113.87 18.16 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 82' ' ' LEU . 62.0 t -68.31 115.9 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.361 0.413 . . . . 0.0 111.626 -169.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.142 0.977 . . . . 0.0 111.813 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' ' 9' ' ' ARG . 10.0 t -166.68 129.05 1.81 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.786 0.835 . . . . 0.0 109.499 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.67 -165.9 31.15 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.46 -0.633 . . . . 0.0 111.952 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.02 -15.01 35.97 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.829 2.352 . . . . 0.0 112.304 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 87' ' ' LEU . 96.7 mt -122.78 35.01 4.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.061 0.945 . . . . 0.0 110.486 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.88 111.83 1.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.044 0.538 . . . . 0.0 110.42 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.82 -17.64 41.73 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.506 0.504 . . . . 0.0 113.229 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -83.96 132.3 34.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.81 0.844 . . . . 0.0 109.611 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.25 101.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 122.078 0.942 . . . . 0.0 110.54 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 HD13 ' A' ' 82' ' ' LEU . 1.2 mm? -81.57 124.41 29.5 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.327 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.7 141.51 32.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.529 1.132 . . . . 0.0 109.036 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 106' ' ' CYS . 39.4 mt -78.19 128.63 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.1 68.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 122.0 0.905 . . . . 0.0 109.605 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.19 -122.88 1.53 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.691 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -140.6 146.5 45.06 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 108.679 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.29 102.11 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.181 1.92 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.74 112.74 34.41 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.908 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.92 137.21 44.12 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.435 2.09 . . . . 0.0 111.667 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.498 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 34.9 t70 -58.73 144.54 43.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.82 0.448 . . . . 0.0 111.494 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.04 63.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.025 0.93 . . . . 0.0 112.103 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.66 -5.18 46.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.202 0.601 . . . . 0.0 111.015 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.01 22.73 12.96 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 124.619 1.168 . . . . 0.0 112.107 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 75.1 p -85.83 -10.44 55.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.142 0.577 . . . . 0.0 110.766 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.498 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 7.8 ptp180 -163.71 -177.53 5.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.737 0.815 . . . . 0.0 110.742 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.58 115.84 18.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -82.29 102.31 11.1 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.547 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.7 mm -98.72 125.98 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.2 pt? -103.6 134.32 47.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 61' ' ' ILE . 70.9 m -152.92 177.88 10.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.738 0.815 . . . . 0.0 110.217 -170.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -143.92 162.33 36.41 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.011 1.325 . . . . 0.0 107.974 169.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.01 122.01 12.67 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.775 0 O-C-N 123.676 0.61 . . . . 0.0 113.807 -171.699 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -64.83 105.62 1.04 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.896 0.379 . . . . 0.0 110.355 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -73.16 -10.43 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 124.217 1.007 . . . . 0.0 111.213 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.22 51.55 3.6 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 123.33 0.49 . . . . 0.0 113.009 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.86 170.29 16.47 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.811 0.844 . . . . 0.0 109.729 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.1 mm? -77.07 113.75 15.13 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.482 0.713 . . . . 0.0 109.731 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -115.18 -32.56 5.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.671 0.788 . . . . 0.0 111.592 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.39 -168.21 1.33 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.999 1.32 . . . . 0.0 109.242 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HB2' HG22 ' A' ' 79' ' ' THR . 50.4 mtm180 -138.55 147.71 43.39 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.472 0.709 . . . . 0.0 110.135 171.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 75' ' ' ILE . 32.9 pt -125.98 153.45 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.644 1.178 . . . . 0.0 109.794 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -115.63 124.17 50.24 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 69' ' ' ILE . 26.5 mm -83.03 111.45 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 124.013 0.82 . . . . 0.0 109.933 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -99.22 95.36 7.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.175 0.988 . . . . 0.0 108.44 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' HG3' ' A' ' 30' ' ' GLU . 5.7 p -82.9 145.29 29.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.199 -1.818 . . . . 0.0 107.622 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' THR . 58.2 tp -96.32 107.87 20.29 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.851 0.751 . . . . 0.0 109.015 -170.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -85.28 104.24 14.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.199 1.0 . . . . 0.0 109.958 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 53.5 mt-30 -100.56 85.47 2.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 108.671 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -94.4 120.65 34.97 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.639 0.776 . . . . 0.0 109.669 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -71.91 170.56 13.48 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 122.849 0.459 . . . . 0.0 110.497 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 15.5 t70 -112.02 161.74 16.14 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.417 0.687 . . . . 0.0 109.564 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -70.86 13.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.486 1.114 . . . . 0.0 112.904 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -140.38 -34.33 0.53 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.97 0.56 Allowed Glycine 0 C--N 1.355 1.591 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.786 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 30.6 mt-10 -114.06 157.3 22.72 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.98 104.98 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.87 89.81 6.87 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 40.3 mt-10 -81.0 118.36 22.4 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.69 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.404 ' O ' HD12 ' A' ' 15' ' ' LEU . 21.5 p -141.77 158.29 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 107.597 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -106.92 101.05 10.51 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 10.0 pt-20 -73.19 94.43 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.44 121.67 13.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.536 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.71 -111.0 2.55 Favored Glycine 0 C--N 1.344 0.972 0 C-N-CA 121.448 -0.406 . . . . 0.0 113.304 -154.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -98.56 130.82 45.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 51.1 m -105.75 97.58 7.38 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.68 171.61 7.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -59.78 124.43 20.13 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.753 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -140.29 170.97 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.696 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 t -133.29 101.44 5.18 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 61' ' ' ILE . 31.7 t -93.91 95.54 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.755 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -119.68 122.29 41.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' VAL . 87.6 mtp -67.93 156.54 36.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.655 0.264 . . . . 0.0 110.4 174.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.15 160.89 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.998 0.919 . . . . 0.0 111.511 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -93.08 178.52 5.72 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 160.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -65.57 -20.26 66.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.476 0.31 . . . . 0.0 110.81 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -60.84 2.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.187 . . . . 0.0 112.417 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.53 -18.37 57.04 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.69 -59.07 2.95 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.158 0.504 . . . . 0.0 109.928 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.2 mt -51.21 -38.59 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.998 1.319 . . . . 0.0 111.6 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -64.96 -46.27 82.24 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.404 0.682 . . . . 0.0 111.335 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 27.3 t -80.42 -4.68 54.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.927 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.55 -87.84 1.13 Allowed Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.63 11.01 1.85 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.414 0.686 . . . . 0.0 111.013 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 44.5 tt0 -76.92 -51.88 10.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 58' ' ' THR . 65.8 mt -91.77 163.42 14.07 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 160.68 37.24 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.3 113.7 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -6.32 20.61 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.42 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 54' ' ' LEU . 42.1 m -55.72 131.46 46.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.198 0.599 . . . . 0.0 110.248 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG22 ' HG2' ' A' ' 41' ' ' MET . 61.8 t -96.23 113.92 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.291 0.637 . . . . 0.0 110.019 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -88.16 143.25 27.16 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.718 HD13 HG21 ' A' ' 75' ' ' ILE . 82.1 mt -139.95 108.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -99.39 116.84 32.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.665 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 10' ' ' ILE . 46.7 pt -128.98 160.28 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -57.3 157.69 6.17 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.724 0.238 . . . . 0.0 110.89 165.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -57.39 112.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.295 0.638 . . . . 0.0 111.395 -171.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HD3' HD11 ' A' ' 69' ' ' ILE . 26.6 ttt85 -139.22 103.7 4.82 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.504 0.722 . . . . 0.0 109.377 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -80.53 11.02 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.495 1.118 . . . . 0.0 112.006 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.02 -24.57 22.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.186 0.994 . . . . 0.0 109.916 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.481 HG21 HD12 ' A' ' 104' ' ' ILE . 20.5 mm -69.55 131.63 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -120.48 161.15 21.75 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.71 -24.56 64.5 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.297 0.639 . . . . 0.0 111.858 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 p -81.33 -7.67 59.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.473 0.709 . . . . 0.0 111.74 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -78.5 157.97 28.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -116.49 148.98 40.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.671 0.788 . . . . 0.0 108.98 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.718 HG21 HD13 ' A' ' 61' ' ' ILE . 45.2 mm -112.48 117.19 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.816 0.446 . . . . 0.0 109.996 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 34.5 ttpt -104.86 125.66 51.12 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -78.32 103.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 110.042 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -67.69 -22.96 65.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.681 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 9' ' ' ARG . 11.7 t -171.5 135.28 0.9 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.887 0.875 . . . . 0.0 109.88 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.95 -159.29 28.09 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.478 -0.624 . . . . 0.0 112.956 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.64 -17.15 29.94 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.109 2.539 . . . . 0.0 112.23 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.72 36.73 4.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.419 1.087 . . . . 0.0 109.454 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.05 98.51 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.781 0.832 . . . . 0.0 111.596 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.83 -20.26 7.27 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.825 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.12 137.15 36.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.931 0.892 . . . . 0.0 110.818 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 12.1 t -104.15 106.91 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.482 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -84.42 156.7 21.67 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.976 173.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -117.52 144.14 45.38 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.0 mt -82.38 123.23 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 58' ' ' THR . 26.2 pt -105.24 139.22 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.578 0.751 . . . . 0.0 109.968 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -108.46 2.53 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.894 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' O ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -153.6 141.07 13.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.568 0.747 . . . . 0.0 109.855 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.62 102.11 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.273 1.982 . . . . 0.0 111.101 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.32 116.49 64.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.062 0.945 . . . . 0.0 109.434 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.87 136.58 33.05 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.628 2.219 . . . . 0.0 112.106 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.5 139.42 31.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.255 0.622 . . . . 0.0 110.775 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.88 80.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.108 0.963 . . . . 0.0 112.247 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.07 -3.46 58.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.221 0.609 . . . . 0.0 111.288 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? 66.51 22.37 10.63 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.438 1.095 . . . . 0.0 111.942 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.1 p -85.57 -13.28 49.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.266 0.626 . . . . 0.0 110.996 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -163.42 -172.15 2.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.928 0.491 . . . . 0.0 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -140.46 124.5 17.45 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -88.1 95.59 10.2 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 21.4 mm -87.06 120.48 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -108.98 142.25 39.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 61' ' ' ILE . 72.2 m -150.93 172.93 14.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.754 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -143.95 158.47 43.68 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.73 127.09 30.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.441 0.463 . . . . 0.0 111.073 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.05 54.86 4.3 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.784 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.3 96.33 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.641 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.95 -1.9 56.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.887 0.875 . . . . 0.0 111.889 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--O 1.25 1.093 0 C-N-CA 123.171 0.589 . . . . 0.0 109.763 179.001 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -140.01 141.92 36.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.079 0.952 . . . . 0.0 109.324 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -30.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.854 0.862 . . . . 0.0 112.354 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.63 49.99 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -72.06 138.77 48.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.978 0.911 . . . . 0.0 110.858 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -81.14 105.33 12.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.807 0.443 . . . . 0.0 110.895 -168.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.18 -14.14 6.59 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.185 0.994 . . . . 0.0 112.319 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -102.15 -179.2 3.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.957 1.303 . . . . 0.0 109.268 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HB3' HG22 ' A' ' 34' ' ' THR . 45.2 mtm180 -135.59 146.86 48.39 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.076 0.55 . . . . 0.0 109.98 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.92 144.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.944 0.898 . . . . 0.0 109.527 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -98.57 127.37 44.47 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.8 mm -80.64 106.97 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.452 0.701 . . . . 0.0 110.678 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' TRP . 27.9 mp0 -79.9 96.59 6.41 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.472 0.653 . . . . 0.0 109.93 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -81.25 136.22 35.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.708 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.8 tp -78.42 98.97 6.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.07 0.462 . . . . 0.0 109.782 -173.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -74.92 93.93 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.027 0.931 . . . . 0.0 110.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.453 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 46.4 mt-30 -91.76 83.65 5.31 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -90.31 125.53 35.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.24 0.616 . . . . 0.0 110.404 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 42.1 ttp180 -78.22 152.06 32.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.671 0.389 . . . . 0.0 110.277 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 31.1 t70 -99.97 164.11 12.14 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.4 -10.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.472 1.109 . . . . 0.0 113.092 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -120.65 -6.45 9.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.455 -0.778 . . . . 0.0 109.496 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.17 48.04 1.64 Allowed Glycine 0 C--N 1.36 1.897 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 165.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 5.1 mp0 -106.14 148.15 28.18 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.53 100.83 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.64 101.25 13.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 0.0 108.65 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.1 mt-10 -85.19 118.79 24.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.501 0.72 . . . . 0.0 110.202 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 15' ' ' LEU . 36.5 p -134.95 174.8 10.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . 85.0 m95 -117.5 107.83 14.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.0 146.43 23.94 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.9 141.39 53.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.911 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.96 -107.0 3.17 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -127.51 148.78 50.32 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.6 m -102.79 97.49 7.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.161 0.584 . . . . 0.0 109.465 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.3 pt? -113.01 171.99 7.21 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.251 0.62 . . . . 0.0 111.941 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -62.65 123.77 19.26 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.937 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.721 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.61 172.03 13.6 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.488 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 t -129.91 99.34 5.07 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.527 HG13 HG12 ' A' ' 61' ' ' ILE . 21.8 t -88.7 92.44 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.4 0.619 . . . . 0.0 109.446 -174.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -96.03 106.07 18.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.741 0.816 . . . . 0.0 110.244 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.46 121.75 19.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG21 ' HB ' ' A' ' 58' ' ' THR . 5.5 m -67.38 135.44 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -91.53 -177.03 4.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.461 0.705 . . . . 0.0 111.36 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 p -61.79 -41.21 97.43 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.495 0.718 . . . . 0.0 111.269 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -54.58 -43.58 72.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.118 0.967 . . . . 0.0 110.693 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.93 -52.23 66.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.648 0.593 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.77 -55.22 21.07 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.821 0.849 . . . . 0.0 112.712 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.034 0.934 . . . . 0.0 111.516 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.7 m -66.25 -41.05 90.52 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.452 0.701 . . . . 0.0 112.161 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 93.9 p -87.52 -5.24 58.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.106 0.562 . . . . 0.0 111.755 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.65 -71.95 1.5 Allowed Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.18 11.35 0.28 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.882 0.873 . . . . 0.0 110.897 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.1 tt0 -80.29 -27.2 38.58 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.087 0.555 . . . . 0.0 110.984 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -115.03 44.67 1.75 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.45 132.11 46.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.87 126.31 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 124.364 1.04 . . . . 0.0 110.85 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.58 -12.42 13.69 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -163.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.45 ' HB ' HG21 ' A' ' 42' ' ' VAL . 31.3 m -82.17 149.32 28.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.07 129.53 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -100.01 135.81 40.88 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 75' ' ' ILE . 71.1 mt -134.46 109.38 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.971 0.908 . . . . 0.0 109.002 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -90.95 116.79 29.02 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 37' ' ' ALA . 43.4 pt -121.32 163.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.67 138.73 58.04 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 164.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 2.6 t80 -53.04 126.58 21.06 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.36 1.064 . . . . 0.0 109.82 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -140.79 134.62 30.47 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.818 0.699 . . . . 0.0 109.252 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -82.16 1.79 34.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 111.581 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.16 -20.78 20.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.874 0.869 . . . . 0.0 111.201 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 104' ' ' ILE . 23.4 mm -72.16 123.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.668 0.387 . . . . 0.0 110.481 -170.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -133.41 170.88 14.83 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 109.138 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.62 65.45 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.294 0.638 . . . . 0.0 111.433 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -94.19 39.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.819 0.848 . . . . 0.0 110.374 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 m -130.47 150.5 51.66 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 78.1 mtm180 -117.16 162.95 17.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 61' ' ' ILE . 32.2 mm -127.58 97.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 HG11 ' A' ' 39' ' ' VAL . 22.9 t -73.68 118.09 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.873 0.469 . . . . 0.0 110.443 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 t -69.07 -36.56 77.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.76 0.824 . . . . 0.0 110.738 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 9' ' ' ARG . 9.0 t -167.51 135.59 2.46 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.897 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.91 -158.33 27.83 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.861 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.76 -29.21 51.1 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.811 2.341 . . . . 0.0 112.062 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 39' ' ' VAL . 66.6 mt -115.86 32.16 6.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 0.0 110.559 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.46 114.2 2.12 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.467 0.707 . . . . 0.0 111.349 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.59 -30.68 6.54 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.683 0.615 . . . . 0.0 112.69 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -72.7 142.64 48.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.405 0.682 . . . . 0.0 110.864 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.57 97.75 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-O 122.494 1.14 . . . . 0.0 109.985 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.9 114.66 21.83 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.701 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.07 135.56 34.79 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.135 0.974 . . . . 0.0 109.433 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.61 116.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.2 pt -98.88 132.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.294 0.637 . . . . 0.0 109.508 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.98 -120.88 5.58 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -171.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.418 ' O ' HD21 ' A' ' 105' ' ' LEU . 11.3 pt20 -147.25 147.59 29.13 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.056 0.943 . . . . 0.0 108.485 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.89 141.84 96.14 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.87 2.38 . . . . 0.0 112.718 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.86 108.92 53.12 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.65 156.17 62.72 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.356 2.037 . . . . 0.0 112.004 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 27.2 t70 -59.54 154.59 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.442 0.697 . . . . 0.0 112.34 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.21 91.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.927 0.891 . . . . 0.0 111.126 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.43 -8.44 54.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.19 0.596 . . . . 0.0 111.235 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.79 21.05 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.227 1.411 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -79.77 -3.11 46.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 18.6 ptp180 -167.17 -176.1 3.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.068 0.947 . . . . 0.0 109.141 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -132.18 117.27 18.05 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.66 111.8 21.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.56 HG22 ' SG ' ' A' ' 106' ' ' CYS . 21.9 mm -95.26 135.37 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -112.45 128.35 56.3 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 174.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.56 ' SG ' HG22 ' A' ' 104' ' ' ILE . 76.3 m -147.11 175.1 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.605 -168.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -139.64 158.02 44.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -52.53 151.93 3.92 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.015 0.526 . . . . 0.0 111.535 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 43.64 3.26 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.268 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.42 80.02 4.83 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.12 -11.82 61.13 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.085 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 C-N-CA 124.629 1.171 . . . . 0.0 108.157 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -93.22 106.22 18.21 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.466 0.706 . . . . 0.0 109.365 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.5 mt -87.02 72.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.757 0.823 . . . . 0.0 110.962 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.79 53.41 0.61 Allowed Glycine 0 N--CA 1.467 0.748 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.69 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.15 132.15 27.99 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.59 0.756 . . . . 0.0 110.82 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.02 89.84 3.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.732 0.645 . . . . 0.0 109.336 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -80.01 -43.62 21.62 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.934 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' THR . 53.5 m-20 -104.41 -161.15 0.8 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.688 1.595 . . . . 0.0 110.872 -170.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 53.9 ttt180 -159.0 137.06 10.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.116 0.966 . . . . 0.0 109.557 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -132.42 168.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 124.428 1.091 . . . . 0.0 110.446 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.9 m -115.92 138.91 50.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.798 1.239 . . . . 0.0 108.101 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.12 101.58 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.024 0.53 . . . . 0.0 110.495 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.51 100.97 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.707 0.803 . . . . 0.0 110.265 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.8 p -79.06 147.95 32.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.107 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 27' ' ' GLU . 60.5 tp -98.03 107.63 20.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -99.07 120.57 39.69 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.599 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 89.2 mt-30 -82.57 93.7 7.36 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -92.05 114.36 26.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.582 0.753 . . . . 0.0 109.401 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 23.6 ttp85 -72.72 158.29 35.88 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -110.7 169.84 8.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 109.351 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.6 -8.42 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 124.331 1.052 . . . . 0.0 112.839 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 p -99.25 -9.27 23.87 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.612 0.72 . . . . 0.0 109.084 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.39 19.8 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.339 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 42.5 mt-10 -97.29 140.55 31.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.355 0.662 . . . . 0.0 109.421 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' GLN . 40.0 mm -89.32 101.43 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.45 104.97 17.48 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 42.9 mt-10 -80.19 112.4 17.47 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -128.58 144.52 51.17 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.231 1.013 . . . . 0.0 110.609 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -103.28 100.22 10.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -98.0 135.3 39.9 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.689 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.06 142.98 55.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 -110.19 3.18 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -117.53 141.83 47.89 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 109.545 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 9' ' ' ARG . 11.2 m -101.8 102.5 13.13 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.087 0.955 . . . . 0.0 109.531 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.7 pt? -114.16 171.03 7.85 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.276 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -70.8 132.77 45.81 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.214 1.005 . . . . 0.0 111.945 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.8 -179.47 5.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.375 1.07 . . . . 0.0 110.867 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -139.06 102.29 4.49 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.92 106.27 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.396 1.078 . . . . 0.0 110.064 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -116.52 108.85 16.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 110.53 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 84.2 mtp -68.64 125.53 26.84 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.25 138.05 19.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 C-N-CA 123.766 0.826 . . . . 0.0 111.03 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -97.14 -177.86 3.99 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.66 -35.71 72.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.939 0.896 . . . . 0.0 111.794 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -52.62 -61.21 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.939 0.896 . . . . 0.0 112.233 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.49 -23.99 42.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.676 0.39 . . . . 0.0 111.578 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.38 18.22 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 120.954 0.407 . . . . 0.0 111.383 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.27 -37.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.03 0.932 . . . . 0.0 111.067 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -46.78 87.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.729 0.812 . . . . 0.0 111.115 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 79.4 p -82.38 -13.65 56.51 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.273 0.629 . . . . 0.0 111.348 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.24 -86.89 1.17 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.23 -1.59 5.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.817 0.847 . . . . 0.0 111.153 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.0 tt0 -65.58 -63.07 1.18 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.462 0.705 . . . . 0.0 109.774 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.29 138.15 31.69 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 165.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.2 144.69 51.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.4 mt -62.81 113.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 118.113 0.415 . . . . 0.0 110.398 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.18 -10.75 14.89 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 123.04 0.352 . . . . 0.0 112.898 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -63.81 146.93 53.02 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.8 t -119.63 123.69 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.263 0.625 . . . . 0.0 110.63 -169.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -103.78 130.44 51.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 75' ' ' ILE . 86.4 mt -134.2 113.04 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.393 0.677 . . . . 0.0 109.209 -166.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -102.05 115.27 30.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.619 0.768 . . . . 0.0 109.79 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 47.4 pt -121.32 163.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -60.51 157.08 14.87 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.444 ' N ' ' HA ' ' A' ' 101' ' ' ARG . 70.8 t80 -64.16 101.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.571 -172.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -119.9 118.83 31.77 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.8 -2.69 40.79 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.997 0.919 . . . . 0.0 110.932 -174.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -92.66 -21.12 20.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.288 0.635 . . . . 0.0 110.949 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.04 134.48 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.158 0.583 . . . . 0.0 110.632 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -131.0 171.68 12.94 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.2 67.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.567 0.747 . . . . 0.0 111.076 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.7 p -86.36 45.47 1.24 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.87 1.268 . . . . 0.0 110.554 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.0 m -141.49 122.65 14.72 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.412 1.085 . . . . 0.0 108.213 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -94.56 133.09 38.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 61' ' ' ILE . 22.7 mm -95.99 94.0 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.867 0.867 . . . . 0.0 109.932 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 40.1 ttpt -94.6 111.62 23.38 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 87' ' ' LEU . 49.8 t -70.65 128.75 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 110.477 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -93.23 -29.63 15.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.924 0.89 . . . . 0.0 110.364 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 9' ' ' ARG . 54.4 m -151.93 110.49 3.79 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.467 -166.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.74 29.73 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.556 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -16.18 45.72 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 87' ' ' LEU . 83.6 mt -127.36 34.33 4.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.217 1.007 . . . . 0.0 110.147 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.72 93.48 0.11 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.337 0.655 . . . . 0.0 111.131 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.58 -13.56 4.81 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.792 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.627 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 62.1 ttm-85 -95.55 149.36 21.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.17 0.988 . . . . 0.0 110.563 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.9 p -108.21 101.1 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 122.326 1.06 . . . . 0.0 109.737 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -86.53 131.18 34.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.031 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -103.78 143.66 32.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.434 0.694 . . . . 0.0 109.256 -174.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.52 108.37 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 107' ' ' ARG . 25.7 pt -87.19 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 122.254 1.026 . . . . 0.0 110.559 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.43 -149.07 19.83 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -124.45 141.38 37.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.5 134.66 65.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.329 2.686 . . . . 0.0 112.629 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.51 107.15 49.46 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.318 1.047 . . . . 0.0 109.446 -170.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.22 152.01 72.09 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.672 2.248 . . . . 0.0 111.832 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -81.1 178.19 8.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.388 0.275 . . . . 0.0 110.643 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.24 70.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.102 0.961 . . . . 0.0 112.889 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.21 37.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.016 0.526 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 57.64 33.24 23.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 0.0 110.391 -172.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.0 t -92.15 -7.64 47.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.117 0.967 . . . . 0.0 110.162 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HA ' ' N ' ' A' ' 65' ' ' TYR . 9.1 ptp180 -161.34 167.86 25.01 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.543 0.687 . . . . 0.0 111.384 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.05 109.34 16.33 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.437 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -79.93 107.6 12.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.501 HG22 ' SG ' ' A' ' 106' ' ' CYS . 24.6 mm -97.67 112.44 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -82.37 135.06 35.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.501 ' SG ' HG22 ' A' ' 104' ' ' ILE . 78.7 m -148.99 175.41 11.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.197 0.999 . . . . 0.0 108.755 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 90' ' ' ILE . 61.5 ttt85 -149.95 161.48 42.22 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' ' HD3' ' A' ' 85' ' ' ARG . 1.8 tm-20 -45.45 125.73 5.96 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.795 0.838 . . . . 0.0 110.384 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.32 36.73 3.44 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.552 0.533 . . . . 0.0 113.686 -167.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.32 39.12 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.715 1.206 . . . . 0.0 112.451 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -77.23 89.3 3.69 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.788 0.835 . . . . 0.0 110.573 -172.569 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -72.6 115.86 12.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.363 0.665 . . . . 0.0 109.981 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -75.07 -25.77 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.047 0.539 . . . . 0.0 110.014 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.38 30.3 1.92 Allowed Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 114.181 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.467 ' HB2' HD22 ' A' ' 6' ' ' LEU . 60.3 mtp180 -71.23 -48.6 50.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 5' ' ' ARG . 2.5 mm? -92.38 98.94 11.8 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.499 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -93.8 -27.51 16.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.03 0.932 . . . . 0.0 112.345 -163.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.85 171.8 8.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.061 0.944 . . . . 0.0 109.026 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HB2' HG22 ' A' ' 79' ' ' THR . 98.2 mtt180 -136.84 138.0 40.32 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 77' ' ' VAL . 47.8 pt -140.97 176.86 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.248 1.019 . . . . 0.0 109.751 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -140.12 136.5 33.61 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.361 0.664 . . . . 0.0 109.406 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.0 mm -73.12 125.89 32.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.268 0.627 . . . . 0.0 109.549 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -97.62 116.53 30.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -89.76 135.57 33.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.096 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' ' 27' ' ' GLU . 2.9 tm? -92.91 99.9 12.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -85.93 107.92 17.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.361 0.664 . . . . 0.0 110.015 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -77.43 110.49 12.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -120.45 121.4 38.41 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -77.01 172.35 13.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.322 0.51 . . . . 0.0 111.209 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.9 t70 -108.12 161.22 15.17 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.8 tt -67.77 -6.26 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 123.792 0.837 . . . . 0.0 113.056 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -105.46 -18.92 13.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.45 54.69 0.93 Allowed Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.737 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 25.9 mt-10 -112.15 147.24 36.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.581 1.152 . . . . 0.0 107.942 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.7 mm -90.07 101.15 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.863 0.756 . . . . 0.0 109.731 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.45 97.85 11.43 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.617 ' HB3' HD21 ' A' ' 15' ' ' LEU . 43.8 mt-10 -83.46 131.75 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.443 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.9 p -132.89 161.4 34.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.109 0.964 . . . . 0.0 109.982 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -118.21 118.59 32.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.485 0.714 . . . . 0.0 109.729 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.89 151.35 25.88 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.105 0.962 . . . . 0.0 109.25 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.83 135.25 38.89 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.36 -110.34 3.06 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -113.28 132.76 55.42 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.0 m -76.45 141.66 41.27 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.97 0.908 . . . . 0.0 108.985 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.88 146.42 27.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.234 0.54 . . . . 0.0 111.682 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -71.06 124.23 23.93 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.437 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -136.81 172.45 12.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.775 0.83 . . . . 0.0 111.288 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -130.84 105.55 7.85 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 61' ' ' ILE . 60.8 t -91.64 91.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 0.0 109.373 -173.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -115.4 119.91 37.81 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.518 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -66.32 152.69 44.45 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.05 149.74 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.894 0.478 . . . . 0.0 111.039 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -88.15 176.61 7.19 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -57.47 -35.96 70.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.078 0.551 . . . . 0.0 110.446 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.05 -39.25 59.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.704 1.202 . . . . 0.0 112.133 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -66.16 -49.74 66.36 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.383 0.427 . . . . 0.0 111.198 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.5 97.66 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.981 0.801 . . . . 0.0 110.8 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.5 mt -63.22 -43.83 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.645 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 t -75.76 -13.66 60.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.428 0.691 . . . . 0.0 111.781 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 45.6 m -111.18 -2.38 15.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.676 0.79 . . . . 0.0 111.736 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.13 -74.5 1.85 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.6 5.33 0.8 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.884 0.874 . . . . 0.0 111.21 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 35.8 tt0 -70.73 -68.54 0.42 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.126 0.571 . . . . 0.0 110.342 -177.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.16 142.5 45.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 164.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.67 153.18 39.73 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.53 0.732 . . . . 0.0 109.539 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.85 115.39 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.07 -5.54 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.766 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 90' ' ' ILE . 98.6 m -70.49 119.39 14.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 41' ' ' MET . 51.0 t -84.68 118.1 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -98.75 143.33 29.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 75' ' ' ILE . 66.5 mt -138.54 109.97 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -97.56 115.55 28.07 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 ' HB2' ' A' ' 37' ' ' ALA . 49.4 pt -121.2 158.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -56.33 140.76 44.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.191 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -49.32 118.8 2.91 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.615 1.166 . . . . 0.0 111.629 -171.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -143.34 117.76 9.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.154 0.582 . . . . 0.0 109.967 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.42 2.59 27.93 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.597 1.159 . . . . 0.0 112.204 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.36 -17.32 24.82 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.852 0.861 . . . . 0.0 110.998 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.6 HG21 HD12 ' A' ' 104' ' ' ILE . 26.9 mm -67.52 138.98 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.039 0.536 . . . . 0.0 110.31 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -145.7 169.63 18.1 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.081 0.952 . . . . 0.0 108.709 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . . . -63.6 -26.97 68.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.088 0.555 . . . . 0.0 112.037 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.5 p -97.9 48.01 1.01 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.16 0.981 . . . . 0.0 110.656 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -131.29 156.53 45.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -126.76 159.25 34.32 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.289 0.566 . . . . 0.0 109.989 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.604 HG21 HD13 ' A' ' 61' ' ' ILE . 48.4 mm -112.41 98.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.053 . . . . 0.0 109.224 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -90.45 113.57 25.54 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.525 ' HA ' HG22 ' A' ' 10' ' ' ILE . 64.9 t -77.0 112.23 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 110.629 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.7 t -72.8 -30.02 63.74 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.969 0.907 . . . . 0.0 111.227 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 9' ' ' ARG . 15.0 t -165.71 139.55 4.51 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.978 0.911 . . . . 0.0 109.285 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.7 -163.4 30.38 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-O 118.95 -0.917 . . . . 0.0 111.67 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.74 -25.91 28.21 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.377 2.051 . . . . 0.0 111.452 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -114.5 33.93 5.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.195 0.998 . . . . 0.0 109.724 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.3 109.16 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.702 0.801 . . . . 0.0 111.452 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.37 -21.32 10.02 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.415 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -80.62 165.87 21.63 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.387 0.675 . . . . 0.0 111.153 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.17 102.05 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 122.351 1.072 . . . . 0.0 109.414 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 120.86 24.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.674 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.75 134.76 35.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.223 1.009 . . . . 0.0 108.288 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' A' ' 106' ' ' CYS . 66.1 mt -82.19 95.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -172.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 58' ' ' THR . 21.7 pt -80.53 62.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 122.3 1.048 . . . . 0.0 111.14 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.54 -158.85 27.83 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 92.5 mt-30 -126.59 145.44 53.22 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 109.365 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 134.47 57.88 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 113.504 -173.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -106.56 108.92 62.7 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.1 142.7 56.95 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.668 2.246 . . . . 0.0 112.269 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.24 150.56 48.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 111.374 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.99 70.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.529 1.132 . . . . 0.0 112.369 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.66 -8.97 45.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.878 0.471 . . . . 0.0 110.973 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 62.54 20.28 11.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.705 1.202 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.8 t -89.41 -0.17 57.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.344 0.258 . . . . 0.0 110.813 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.64 -174.89 2.94 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 123.65 0.78 . . . . 0.0 109.949 171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.26 124.62 26.21 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.62 117.33 28.42 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 HG21 ' A' ' 69' ' ' ILE . 15.3 mm -108.76 140.55 26.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -112.14 128.97 56.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' A' ' 89' ' ' ILE . 56.2 m -150.74 -178.96 6.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -171.09 175.68 4.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.34 1.056 . . . . 0.0 108.642 163.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -57.67 172.04 0.41 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.691 0.796 . . . . 0.0 111.066 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.23 44.17 3.31 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.9 83.71 7.67 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 124.368 1.067 . . . . 0.0 110.092 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 3.36 52.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.053 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.434 1.093 . . . . 0.0 109.783 -177.529 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -72.64 156.81 38.58 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 122.547 0.339 . . . . 0.0 110.113 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.65 46.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.07 30.37 7.74 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.433 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.97 -81.8 0.64 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.434 0.694 . . . . 0.0 109.569 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 140.53 38.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.682 . . . . 0.0 110.407 -173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -117.09 -44.17 2.81 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.398 1.079 . . . . 0.0 110.284 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -101.07 -175.48 2.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.049 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -131.94 147.73 52.48 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.79 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' THR . 13.7 pt -138.97 145.29 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.622 1.169 . . . . 0.0 109.266 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -108.62 137.95 45.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 109.021 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.06 114.15 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.889 0.476 . . . . 0.0 110.284 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.584 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.1 mp0 -89.79 103.79 16.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 p -79.41 159.03 27.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.481 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.5 tp -114.84 110.28 19.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.082 0.553 . . . . 0.0 109.997 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -93.99 101.94 14.01 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.952 0.901 . . . . 0.0 109.417 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -79.81 125.42 29.67 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -137.11 150.55 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 108.718 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 37.9 ttp180 -99.33 166.24 11.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.55 0.34 . . . . 0.0 110.121 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 8.7 t70 -110.59 162.89 14.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.642 1.177 . . . . 0.0 108.592 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tt -59.25 -12.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 125.013 1.325 . . . . 0.0 113.805 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -112.52 -34.61 5.8 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.49 48.04 0.15 Allowed Glycine 0 C--N 1.354 1.559 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.708 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.506 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 23.7 mm-40 -96.12 154.21 17.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.423 0.689 . . . . 0.0 109.258 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -107.05 102.93 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.81 101.72 13.06 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.575 1.15 . . . . 0.0 109.106 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -88.2 107.39 18.76 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -116.14 144.6 43.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.638 0.775 . . . . 0.0 110.231 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.42 ' CZ3' ' HG3' ' A' ' 74' ' ' ARG . 85.4 m95 -114.22 113.62 24.88 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.133 0.973 . . . . 0.0 109.424 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.02 123.82 47.34 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.36 128.88 38.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.267 1.427 . . . . 0.0 109.364 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.47 -126.4 3.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -165.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.91 135.03 43.01 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.918 0.887 . . . . 0.0 110.717 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 16.6 m -99.1 105.77 17.9 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.369 0.668 . . . . 0.0 110.85 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -108.82 170.72 7.86 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.588 0.708 . . . . 0.0 111.721 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -71.81 127.54 32.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.279 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -138.74 176.35 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.306 1.043 . . . . 0.0 111.106 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -136.7 110.29 8.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.022 0.929 . . . . 0.0 108.511 162.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.87 106.28 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.392 0.677 . . . . 0.0 110.538 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.91 103.92 11.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.009 0.923 . . . . 0.0 109.48 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.536 ' SD ' HD21 ' A' ' 82' ' ' LEU . 92.5 mtp -66.53 130.52 43.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.04 142.51 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.015 0.436 . . . . 0.0 110.737 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -98.22 -173.02 2.47 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 124.03 0.932 . . . . 0.0 110.457 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -53.42 -29.92 37.64 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.264 1.025 . . . . 0.0 112.839 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -49.99 -51.12 44.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.63 0.772 . . . . 0.0 112.053 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -67.12 -40.43 86.83 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.653 0.596 . . . . 0.0 111.634 -174.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.79 72.18 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.293 0.637 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.68 -42.45 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.832 0.853 . . . . 0.0 111.403 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.4 t -68.77 -30.25 68.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.216 0.607 . . . . 0.0 111.383 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 97.1 p -91.84 -9.34 43.75 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.417 0.687 . . . . 0.0 111.163 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.5 -72.09 2.8 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.37 10.19 0.5 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.704 0.802 . . . . 0.0 110.88 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 47.3 mt-10 -78.45 -30.91 47.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.91 0.484 . . . . 0.0 111.084 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.56 170.34 8.25 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.074 0.95 . . . . 0.0 109.252 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.07 149.54 35.25 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.803 0.841 . . . . 0.0 109.682 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mt -63.23 144.6 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.53 0.732 . . . . 0.0 110.364 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.98 -12.03 70.58 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.135 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.511 HG23 HD11 ' A' ' 90' ' ' ILE . 47.1 m -61.05 116.7 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.223 0.609 . . . . 0.0 109.358 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.554 HG11 ' HG ' ' A' ' 87' ' ' LEU . 46.4 t -76.69 103.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.883 -171.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -92.58 137.44 32.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -141.4 109.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.824 0.85 . . . . 0.0 108.777 -167.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -92.65 124.11 36.43 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.35 0.66 . . . . 0.0 109.579 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.9 pt -130.25 167.39 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.623 0.769 . . . . 0.0 110.16 -175.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -53.25 151.08 5.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.735 0.647 . . . . 0.0 111.451 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.466 ' HE1' ' HD2' ' A' ' 99' ' ' ARG . 61.5 t80 -60.38 107.91 0.73 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -129.64 119.16 23.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.3 -2.89 30.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.927 1.291 . . . . 0.0 112.31 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.05 -21.31 19.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.885 0.874 . . . . 0.0 111.396 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 HD12 ' A' ' 104' ' ' ILE . 29.0 mm -72.62 132.21 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.65 0.38 . . . . 0.0 110.554 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -143.18 161.88 37.08 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.01 -27.78 68.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.3 0.64 . . . . 0.0 111.897 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -79.2 14.32 1.53 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.183 0.993 . . . . 0.0 112.364 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -111.42 167.65 10.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.505 0.722 . . . . 0.0 109.077 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 51.0 mtm180 -122.46 150.28 42.72 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 mm -113.17 99.92 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.498 1.119 . . . . 0.0 109.019 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.3 ttpt -89.44 120.28 30.63 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.072 -0.393 . . . . 0.0 110.172 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 87' ' ' LEU . 53.4 t -76.79 120.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.966 0.412 . . . . 0.0 109.902 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.0 m -84.81 -29.94 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.343 1.057 . . . . 0.0 111.522 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.9 p -141.27 126.77 18.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.85 0.86 . . . . 0.0 109.556 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.92 -158.19 25.08 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.503 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.62 -13.38 29.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.246 2.631 . . . . 0.0 112.441 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.536 HD21 ' SD ' ' A' ' 41' ' ' MET . 70.9 mt -120.77 25.77 9.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.838 . . . . 0.0 110.149 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.34 112.48 2.44 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.342 0.657 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.01 2.54 51.86 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.501 0.501 . . . . 0.0 113.175 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -105.53 139.55 39.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.574 0.75 . . . . 0.0 109.475 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -104.93 102.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 122.313 1.054 . . . . 0.0 109.722 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' HG11 ' A' ' 59' ' ' VAL . 1.5 mm? -82.73 133.14 35.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.198 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -100.44 143.6 30.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.195 0.598 . . . . 0.0 109.561 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.3 mt -80.48 143.62 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 HG23 ' A' ' 58' ' ' THR . 2.2 pt -122.19 104.38 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.813 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.3 -105.98 2.48 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.847 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.1 150.17 29.05 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.684 0.794 . . . . 0.0 109.884 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HB2' HD23 ' A' ' 102' ' ' LEU . 33.6 Cg_endo -64.02 123.64 12.23 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 121.903 1.736 . . . . 0.0 111.008 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -89.14 113.8 57.68 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -76.55 129.13 10.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.17 1.913 . . . . 0.0 110.699 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.671 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 21.9 t70 -52.69 150.37 5.24 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.342 1.057 . . . . 0.0 112.198 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.76 -43.92 77.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.926 0.891 . . . . 0.0 112.001 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.57 0.12 56.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.549 0.739 . . . . 0.0 111.251 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 38.7 mmt180 61.88 26.04 15.72 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.088 1.355 . . . . 0.0 112.138 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.8 p -79.79 -12.2 59.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 96' ' ' ASP . 13.3 ptp180 -165.67 175.9 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 93' ' ' PRO . 6.5 mp -122.69 121.81 37.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.944 0.898 . . . . 0.0 108.766 165.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.33 102.99 12.36 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 69' ' ' ILE . 8.6 mm -87.26 142.88 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -123.61 138.05 54.62 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.09 176.44 10.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.073 -167.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 159.24 42.8 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -45.79 122.76 3.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.97 50.63 3.72 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.142 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.06 119.87 22.81 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -67.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.059 0.849 . . . . 0.0 108.864 177.552 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.329 0.109 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.07 108.36 19.82 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG13 ' HG2' ' A' ' 64' ' ' ARG . 40.2 mm -89.04 87.06 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.94 51.44 4.57 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.859 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -126.53 -37.61 2.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.672 1.189 . . . . 0.0 109.891 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 64' ' ' ARG . 27.2 mt -72.29 84.27 1.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.497 -163.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -97.56 -21.2 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.504 0.721 . . . . 0.0 111.468 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.3 -174.68 2.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.145 0.978 . . . . 0.0 110.052 -173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -139.01 150.92 46.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.385 0.674 . . . . 0.0 110.077 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 34' ' ' THR . 44.6 pt -139.33 168.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.178 . . . . 0.0 109.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -128.81 138.91 52.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.677 0.791 . . . . 0.0 109.013 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -89.71 92.35 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.359 0.6 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -71.66 99.13 2.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.82 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 p -84.27 139.45 32.32 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.57 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 28' ' ' THR . 64.1 tp -78.18 105.58 9.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.144 0.577 . . . . 0.0 109.737 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -90.51 117.95 29.6 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.804 0.841 . . . . 0.0 111.087 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.98 94.34 5.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -90.92 111.49 22.95 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.346 0.659 . . . . 0.0 109.576 -173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.7 ttt-85 -87.79 152.85 21.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.052 0.453 . . . . 0.0 111.443 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -107.65 164.04 12.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.963 0.905 . . . . 0.0 108.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.4 tt -72.2 -1.26 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 C-N-CA 124.121 0.969 . . . . 0.0 113.239 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -98.45 -14.24 20.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.981 0.896 . . . . 0.0 109.33 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.97 40.98 5.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.805 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 46.5 mt-10 -96.79 149.58 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.622 0.769 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -108.49 107.4 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.47 103.79 15.77 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.2 mt-10 -80.38 126.5 31.25 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 109.631 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.433 ' O ' HD12 ' A' ' 15' ' ' LEU . 37.7 p -139.53 -176.17 4.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.599 1.56 . . . . 0.0 108.469 -168.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -128.05 115.09 17.93 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.906 -0.496 . . . . 0.0 109.665 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.62 145.34 26.95 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.79 136.81 37.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.966 0.507 . . . . 0.0 109.634 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.86 -109.45 3.34 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -108.11 134.38 51.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 88.3 m -97.96 102.91 14.79 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.04 168.75 9.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.576 0.751 . . . . 0.0 112.264 -173.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.0 122.26 19.01 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.359 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.96 13.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.442 0.697 . . . . 0.0 112.368 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 2.1 m -131.74 94.61 3.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.384 1.074 . . . . 0.0 108.226 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 77' ' ' VAL . 2.8 p -91.2 94.27 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.698 0.761 . . . . 0.0 109.67 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -113.6 119.85 38.91 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.724 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.539 ' SD ' HD21 ' A' ' 82' ' ' LEU . 54.1 mtp -76.62 150.63 36.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.937 0.495 . . . . 0.0 109.737 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -83.7 136.41 22.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.146 0.579 . . . . 0.0 109.576 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 39.5 t -90.3 -178.85 5.48 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.964 0.906 . . . . 0.0 109.535 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -60.53 -33.57 72.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.423 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 18.4 ptpt -53.93 -40.24 66.56 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.619 1.167 . . . . 0.0 111.461 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -70.28 -43.37 70.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.012 0.925 . . . . 0.0 110.44 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.39 -32.12 72.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.895 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.8 mt -73.16 -45.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.249 0.62 . . . . 0.0 110.553 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.3 m -63.45 -36.95 85.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.78 0.832 . . . . 0.0 111.856 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.7 p -86.51 -48.37 8.44 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.034 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.22 -64.68 0.31 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.98 -5.57 0.79 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.872 0.869 . . . . 0.0 111.568 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.0 tt0 -71.98 -68.94 0.42 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.006 0.522 . . . . 0.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -77.09 119.52 20.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.91 39.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.98 117.97 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.08 -11.17 14.88 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 116.856 -0.156 . . . . 0.0 113.048 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 90' ' ' ILE . 89.1 m -68.29 146.91 52.87 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.93 116.41 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.271 0.628 . . . . 0.0 110.096 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -87.63 126.39 34.92 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 75' ' ' ILE . 44.8 mt -123.48 104.95 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 11.9 m0 -90.56 117.91 29.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.723 0.809 . . . . 0.0 109.722 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 pt -130.29 161.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 108.324 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.523 ' HG2' HG13 ' A' ' 3' ' ' ILE . 64.1 mtm180 -60.92 141.13 57.48 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.883 0.765 . . . . 0.0 110.826 167.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.24 130.99 36.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.052 1.341 . . . . 0.0 111.135 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.41 147.15 25.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.19 0.596 . . . . 0.0 111.238 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -83.2 1.02 42.78 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.603 1.161 . . . . 0.0 111.884 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.67 -26.78 19.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.877 0.471 . . . . 0.0 111.216 -165.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 104' ' ' ILE . 6.3 mm -75.65 132.03 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.73 167.37 16.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.91 63.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.082 0.553 . . . . 0.0 111.635 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.1 p -84.95 3.11 39.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.791 0.836 . . . . 0.0 111.547 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 m -93.95 159.79 15.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.57 0.748 . . . . 0.0 109.646 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -132.12 165.0 25.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 0.0 109.01 170.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.646 HG21 HD13 ' A' ' 61' ' ' ILE . 43.7 mm -115.97 99.22 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.487 0.715 . . . . 0.0 110.621 -173.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -91.93 110.11 21.46 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 39' ' ' VAL . 95.7 t -72.84 117.94 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.678 0.791 . . . . 0.0 111.106 -172.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.3 m -77.44 -21.73 52.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.358 1.063 . . . . 0.0 112.158 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -167.71 132.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.729 0.811 . . . . 0.0 109.34 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.44 -163.72 30.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.928 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.42 -16.07 17.37 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.134 2.556 . . . . 0.0 112.102 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 87' ' ' LEU . 82.7 mt -119.26 28.93 7.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.341 1.056 . . . . 0.0 109.795 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.81 115.23 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.425 0.69 . . . . 0.0 110.542 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.63 38.96 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.811 0.694 . . . . 0.0 112.946 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -107.68 143.82 35.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.862 0.865 . . . . 0.0 109.853 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.12 88.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 122.481 1.134 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 82' ' ' LEU . 2.6 mm? -62.57 132.41 52.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.033 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -95.13 130.69 41.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.275 1.03 . . . . 0.0 109.357 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.91 129.92 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.489 HG23 ' HD2' ' A' ' 107' ' ' ARG . 1.5 pt -97.18 111.55 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 0.0 109.215 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.46 -94.05 1.9 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.987 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -166.92 155.11 9.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.316 1.046 . . . . 0.0 109.325 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -58.35 123.44 13.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.755 2.303 . . . . 0.0 111.831 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.12 111.71 65.26 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 123.916 0.887 . . . . 0.0 109.789 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.08 155.9 63.79 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.229 2.62 . . . . 0.0 113.691 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.86 155.2 41.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 110.914 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.88 84.23 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.344 0.657 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.29 59.28 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.948 0.499 . . . . 0.0 110.899 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 61.29 23.85 14.03 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.285 1.434 . . . . 0.0 112.236 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 t -85.87 -6.51 59.07 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.796 0.438 . . . . 0.0 111.401 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 5.5 ppt_? -161.27 162.54 31.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.583 0.753 . . . . 0.0 109.614 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.56 118.21 32.5 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.599 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 37.8 tt0 -90.27 105.27 17.7 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 69' ' ' ILE . 13.7 mm -88.74 97.69 7.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -81.19 136.84 35.9 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 77.1 m -151.75 -175.5 5.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.068 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.489 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -153.53 160.09 42.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.44 0.696 . . . . 0.0 109.196 165.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 138.49 57.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.544 0.737 . . . . 0.0 110.322 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.62 29.87 5.59 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.851 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 99.16 1.63 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.44 94.74 0.12 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.946 0.898 . . . . 0.0 110.895 -171.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 124.241 1.017 . . . . 0.0 108.58 -173.269 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -74.93 100.27 4.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.132 0.573 . . . . 0.0 111.271 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.9 mt -126.5 -29.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.167 0.987 . . . . 0.0 108.866 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.32 24.63 2.5 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -168.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.482 ' HB2' HD22 ' A' ' 6' ' ' LEU . 37.4 mmt180 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 167.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 5' ' ' ARG . 0.7 OUTLIER -99.09 85.64 3.28 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.752 -170.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -103.58 -7.62 20.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.734 0.814 . . . . 0.0 112.33 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -102.64 -176.92 3.24 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 55.6 mtm180 -133.74 150.78 51.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.579 0.752 . . . . 0.0 109.42 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' THR . 12.4 pt -136.4 157.18 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 31' ' ' ASP . 26.0 m -116.55 124.82 50.82 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.8 mm -72.31 93.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 2.3 tp-100 -71.58 100.17 2.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -83.71 140.55 32.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.603 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB3' ' A' ' 27' ' ' GLU . 42.5 tp -101.6 98.92 9.16 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 110.018 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -83.66 105.91 14.95 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 109.237 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -74.99 90.82 2.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.5 m -89.68 112.31 23.53 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 109.938 -171.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.7 ttp180 -72.65 153.45 41.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.843 0.354 . . . . 0.0 110.431 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 26' ' ' LEU . 19.3 t70 -113.89 164.65 13.48 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.3 5.95 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.853 0.861 . . . . 0.0 112.392 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -101.54 -14.96 17.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.707 0.803 . . . . 0.0 109.033 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.79 33.91 8.09 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.371 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 47.9 mt-10 -102.59 166.95 10.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.613 0.765 . . . . 0.0 110.537 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.2 mm -114.14 105.36 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.708 0.803 . . . . 0.0 109.21 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 20' ' ' ASP . 5.9 mp -98.27 96.05 7.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.849 1.26 . . . . 0.0 107.697 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.668 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.9 mt-10 -79.03 118.66 21.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.512 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -126.75 149.13 49.78 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.753 1.221 . . . . 0.0 110.251 -172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.442 ' CE2' HD13 ' A' ' 15' ' ' LEU . 92.7 m95 -107.62 109.5 21.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.867 0.867 . . . . 0.0 109.49 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.3 140.07 39.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.091 0.957 . . . . 0.0 108.567 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.5 p-10 -71.54 128.99 37.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.28 -119.66 4.56 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.784 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.47 116.59 28.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.448 0.699 . . . . 0.0 109.423 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 26.8 m -90.26 94.53 9.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -103.96 162.83 12.81 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.244 0.545 . . . . 0.0 111.604 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -63.26 126.31 27.0 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.794 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -134.71 165.53 25.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.364 1.066 . . . . 0.0 111.709 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -121.66 98.91 6.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.13 91.63 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.282 0.633 . . . . 0.0 110.125 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -95.54 107.49 19.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.445 0.698 . . . . 0.0 110.34 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.23 130.71 41.45 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 13.8 m -70.21 151.13 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -95.38 -177.32 4.06 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.653 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -61.29 -41.0 96.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.641 0.776 . . . . 0.0 110.778 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.17 -34.4 68.42 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.225 1.01 . . . . 0.0 112.314 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 5.8 mm-40 -62.3 -39.41 92.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.263 0.625 . . . . 0.0 111.169 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.98 67.12 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.512 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.77 -33.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.106 0.962 . . . . 0.0 111.939 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -87.65 -48.55 7.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.513 0.725 . . . . 0.0 110.704 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 15.8 m -84.49 -22.65 30.16 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.86 -102.19 1.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.242 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.24 -5.02 57.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.431 0.692 . . . . 0.0 111.816 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 34.7 tt0 -82.91 -62.64 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.632 0.373 . . . . 0.0 110.465 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 58' ' ' THR . 47.1 mt -110.08 147.94 32.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.493 0.717 . . . . 0.0 109.228 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.97 168.92 18.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.476 1.11 . . . . 0.0 110.252 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.4 116.12 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.81 -9.76 14.21 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 123.072 0.368 . . . . 0.0 112.43 -167.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.623 HG21 HD22 ' A' ' 54' ' ' LEU . 88.2 m -80.56 161.98 24.51 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.299 1.04 . . . . 0.0 109.281 172.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.97 126.41 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.116 0.966 . . . . 0.0 109.117 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -95.46 134.36 38.38 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.18 109.35 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -94.15 127.22 39.84 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 10' ' ' ILE . 49.7 pt -132.83 168.04 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.627 0.371 . . . . 0.0 110.677 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -49.14 131.71 19.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.815 0.446 . . . . 0.0 110.15 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.54 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 69.0 t80 -51.55 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.519 1.528 . . . . 0.0 111.697 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 104.58 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 109.464 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.76 7.73 9.68 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.055 0.942 . . . . 0.0 111.729 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.84 -18.91 21.5 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.189 0.996 . . . . 0.0 111.138 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.615 HG21 HD12 ' A' ' 104' ' ' ILE . 39.2 mm -68.7 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 122.878 0.471 . . . . 0.0 109.897 -177.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -142.33 172.68 12.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.107 0.963 . . . . 0.0 108.587 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -30.1 65.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.082 0.953 . . . . 0.0 112.99 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 p -90.55 23.26 3.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.543 0.737 . . . . 0.0 112.324 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -112.74 162.34 15.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.685 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 99.8 mtt180 -122.88 159.34 28.41 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.61 93.25 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.95 0.9 . . . . 0.0 109.134 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.6 ttpt -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.549 HG23 HD23 ' A' ' 87' ' ' LEU . 83.9 t -67.36 122.03 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 122.917 0.487 . . . . 0.0 110.517 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 44.0 t -82.33 -39.64 22.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.937 0.895 . . . . 0.0 109.932 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.3 p -143.92 137.2 27.65 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.739 0.816 . . . . 0.0 109.887 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.41 -161.6 25.0 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.977 0.798 . . . . 0.0 111.485 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.04 -17.98 40.59 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.186 2.591 . . . . 0.0 112.522 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -116.4 27.5 9.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.866 0.866 . . . . 0.0 110.223 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.14 95.08 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.661 0.785 . . . . 0.0 111.586 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.99 -18.33 5.6 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.072 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -86.85 143.8 27.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.713 0.805 . . . . 0.0 110.201 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.0 p -100.94 117.69 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 0.0 109.316 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.0 mm? -87.63 142.95 27.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 108.318 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -107.69 139.59 42.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.923 0.889 . . . . 0.0 109.047 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.9 mt -81.14 99.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 107' ' ' ARG . 23.6 pt -74.26 94.34 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.945 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.29 12.64 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.595 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -128.35 142.97 46.42 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.267 1.027 . . . . 0.0 109.309 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.54 155.53 69.84 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.025 2.483 . . . . 0.0 112.601 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -116.88 107.41 46.15 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -62.76 141.1 83.85 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -69.03 145.49 53.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.88 67.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.606 1.163 . . . . 0.0 112.357 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.62 54.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.763 0.425 . . . . 0.0 111.586 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 65.42 14.4 9.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.47 1.108 . . . . 0.0 112.67 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.415 HG23 ' HD2' ' A' ' 101' ' ' ARG . 13.5 t -89.8 -2.81 58.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.872 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -168.57 178.04 4.93 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.629 0.772 . . . . 0.0 110.91 171.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.44 121.53 32.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -83.72 112.25 19.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 69' ' ' ILE . 22.1 mm -98.11 142.29 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -117.82 133.76 55.61 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 81.2 m -150.06 161.74 41.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.582 -171.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.408 ' HB2' HD13 ' A' ' 90' ' ' ILE . 56.5 ttp180 -144.95 139.85 27.84 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' LEU . 27.7 tt0 -48.78 143.29 5.42 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.517 1.136 . . . . 0.0 113.397 -168.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.26 53.9 4.45 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.775 -173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.34 69.02 2.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.949 0.899 . . . . 0.0 108.779 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.94 93.56 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.736 1.214 . . . . 0.0 111.284 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 tptt . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -176.134 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.2 mtp . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 62' ' ' TRP . 4.2 m-20 -95.97 122.2 38.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.516 1.126 . . . . 0.0 110.855 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.95 11.38 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.584 0.754 . . . . 0.0 111.349 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.76 57.83 4.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.928 0.775 . . . . 0.0 111.678 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -66.04 142.36 57.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.142 1.377 . . . . 0.0 111.47 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 38' ' ' SER . 6.4 mp -70.49 117.68 12.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.005 0.922 . . . . 0.0 110.301 -172.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -123.62 -29.26 3.76 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.165 0.986 . . . . 0.0 111.548 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -99.89 -172.82 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.341 1.456 . . . . 0.0 110.247 -173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB2' HG22 ' A' ' 79' ' ' THR . 53.4 mtm180 -139.62 146.35 39.66 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 110.409 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.83 149.79 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.419 1.088 . . . . 0.0 109.048 178.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -107.58 126.13 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.18 111.32 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.361 0.665 . . . . 0.0 110.229 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 76.4 mt-30 -95.06 96.7 9.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.513 0.725 . . . . 0.0 109.718 172.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -82.07 150.25 27.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.109 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 27' ' ' GLU . 51.3 tp -89.3 98.31 11.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.8 0.727 . . . . 0.0 109.517 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -85.34 101.59 12.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.611 0.764 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -86.73 86.13 7.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -91.95 126.04 36.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.066 0.946 . . . . 0.0 110.611 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.6 ttp180 -79.19 148.14 32.38 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.693 0.282 . . . . 0.0 110.98 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.43 165.76 12.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.226 1.01 . . . . 0.0 108.887 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.41 -11.09 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 C-N-CA 124.225 1.01 . . . . 0.0 113.239 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -105.0 -7.07 19.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.57 -0.706 . . . . 0.0 109.33 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 50.56 3.67 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.078 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 45.6 mt-10 -108.55 138.38 44.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 108.894 173.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 mm -87.94 99.56 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.89 109.26 17.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.61 0.764 . . . . 0.0 109.776 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.2 mt-10 -80.0 111.3 16.21 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.3 p -132.69 154.27 50.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.043 . . . . 0.0 108.59 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -103.04 105.24 15.51 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 16.5 pt-20 -84.56 139.81 31.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.958 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -84.94 138.32 32.57 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.16 -108.77 2.8 Favored Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -174.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -118.05 142.39 47.45 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.952 0.406 . . . . 0.0 110.465 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 9' ' ' ARG . 16.2 m -96.14 96.69 8.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 108.57 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -105.01 176.28 5.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.154 0.582 . . . . 0.0 111.472 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -71.83 134.91 46.41 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.361 1.064 . . . . 0.0 111.056 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -142.84 168.04 20.66 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.112 0.965 . . . . 0.0 110.829 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 23.1 t -123.15 98.69 6.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.63 90.95 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.27 97.52 11.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.716 0.806 . . . . 0.0 109.495 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.85 106.04 11.58 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 46' ' ' GLU . 3.3 m -74.86 138.19 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.358 0.599 . . . . 0.0 111.645 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.4 m -97.36 -174.01 2.81 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 124.456 1.103 . . . . 0.0 109.757 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 56' ' ' ILE . 13.2 p -53.8 -43.64 69.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.17 0.988 . . . . 0.0 112.764 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.32 -46.38 83.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.079 0.551 . . . . 0.0 111.456 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 53.1 mm-40 -61.96 -43.26 99.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.12 0.568 . . . . 0.0 111.859 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.46 91.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.505 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.1 -31.05 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.636 0.774 . . . . 0.0 110.505 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.0 m -71.05 -25.92 62.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.482 0.713 . . . . 0.0 110.628 172.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 26.8 t -92.24 -10.65 37.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.151 0.981 . . . . 0.0 110.552 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 -80.14 1.73 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.33 12.11 0.55 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.977 0.911 . . . . 0.0 110.757 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 35.7 tt0 -75.65 -55.01 6.06 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 58' ' ' THR . 80.3 mt -86.96 166.82 14.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.986 0.514 . . . . 0.0 109.659 168.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.18 160.73 31.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.097 0.959 . . . . 0.0 109.208 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' SER . 49.6 mt -69.88 104.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.26 3.63 18.99 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.348 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 54' ' ' LEU . 32.2 m -68.44 119.37 12.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.444 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -84.05 97.46 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.371 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -87.99 125.31 34.47 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 75' ' ' ILE . 86.2 mt -128.72 109.71 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 0.0 109.362 -165.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.595 ' HZ3' ' HB3' ' A' ' 2' ' ' ASN . 15.1 m0 -97.13 113.5 25.08 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 123.561 0.744 . . . . 0.0 109.71 -175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' A' ' 66' ' ' ARG . 41.5 pt -120.58 163.35 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -58.77 149.78 25.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.299 0.5 . . . . 0.0 112.057 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.02 124.87 22.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.348 -170.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.571 ' HD3' HD12 ' A' ' 63' ' ' ILE . 10.2 ptm180 -153.46 133.51 13.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.485 0.714 . . . . 0.0 109.759 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -83.64 10.27 9.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.827 0.851 . . . . 0.0 111.061 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -91.25 -27.28 18.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.58 1.152 . . . . 0.0 111.552 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 104' ' ' ILE . 19.0 mm -74.75 137.86 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.923 0.392 . . . . 0.0 110.294 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -137.44 164.73 27.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.025 0.93 . . . . 0.0 108.867 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.77 66.06 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.757 0.823 . . . . 0.0 111.914 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.5 p -86.83 28.78 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.712 0.805 . . . . 0.0 111.636 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -126.63 134.61 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -100.31 148.8 24.27 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.47 HG21 HD13 ' A' ' 61' ' ' ILE . 43.2 mm -110.04 108.79 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.692 0.797 . . . . 0.0 109.328 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -100.43 112.93 25.33 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.27 104.49 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.947 0.499 . . . . 0.0 109.744 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.67 -26.39 63.42 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.576 0.75 . . . . 0.0 111.694 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.8 t -162.95 135.04 5.27 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.38 -154.53 25.92 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.315 -0.714 . . . . 0.0 112.346 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 -20.27 33.47 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.228 2.619 . . . . 0.0 112.31 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 85' ' ' ARG . 84.1 mt -128.23 38.33 4.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.755 0.822 . . . . 0.0 109.995 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.43 97.87 0.15 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.57 -34.93 1.92 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.872 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 75.4 mtt85 -68.57 138.17 54.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.44 0.696 . . . . 0.0 112.195 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.91 86.9 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.643 1.211 . . . . 0.0 108.019 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.61 149.43 43.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.803 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.99 139.21 44.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.513 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.91 105.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HG23 ' A' ' 58' ' ' THR . 19.6 pt -77.83 74.08 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 122.1 0.952 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.72 -141.16 13.79 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -127.16 138.39 32.62 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.76 0.824 . . . . 0.0 109.046 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.22 142.12 79.12 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.568 2.845 . . . . 0.0 112.53 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.79 119.67 29.93 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.52 155.18 59.8 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.589 2.192 . . . . 0.0 112.163 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.65 151.42 46.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.189 0.596 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -41.02 88.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.403 1.081 . . . . 0.0 111.802 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 -3.92 57.18 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.427 0.691 . . . . 0.0 111.891 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 63.61 15.9 9.26 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.905 1.282 . . . . 0.0 113.114 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -82.06 -7.48 59.62 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.951 0.405 . . . . 0.0 111.172 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 4.6 ppt_? -162.7 169.69 19.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.722 0.809 . . . . 0.0 109.11 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.28 131.33 56.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 33.3 tt0 -100.28 114.77 28.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.187 0.518 . . . . 0.0 109.902 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 69' ' ' ILE . 15.4 mm -93.97 136.44 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -109.48 130.64 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.418 ' SG ' HG22 ' A' ' 104' ' ' ILE . 82.7 m -147.36 171.21 15.81 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.891 0.877 . . . . 0.0 108.66 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' HB2' HD13 ' A' ' 90' ' ' ILE . 64.1 ttt180 -158.47 160.52 36.85 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.598 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.0 146.38 54.21 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.641 1.176 . . . . 0.0 110.278 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.05 48.61 3.47 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 51.39 -95.47 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.736 1.615 . . . . 0.0 112.287 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -168.57 26.1 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.976 1.31 . . . . 0.0 108.467 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.777 1.231 . . . . 0.0 109.448 -173.386 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -74.23 122.74 23.31 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 mt -129.5 170.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.124 1.369 . . . . 0.0 107.329 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.67 56.67 2.56 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 123.419 0.533 . . . . 0.0 112.959 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -82.21 -25.26 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.922 1.289 . . . . 0.0 109.833 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt -70.28 97.74 1.28 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.606 0.762 . . . . 0.0 109.531 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -105.55 -33.3 8.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.422 0.689 . . . . 0.0 110.138 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -96.23 -174.13 2.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.594 1.158 . . . . 0.0 110.116 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' THR . 53.8 ttp180 -154.1 123.38 6.5 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -116.18 159.07 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.632 0.773 . . . . 0.0 110.142 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -109.67 146.02 35.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.368 0.667 . . . . 0.0 109.329 168.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -101.26 107.2 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.486 1.114 . . . . 0.0 110.08 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -77.69 95.41 4.61 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 p -80.15 152.08 29.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.505 0.722 . . . . 0.0 109.82 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 27' ' ' GLU . 27.9 tp -92.41 97.59 10.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.323 0.583 . . . . 0.0 110.992 -171.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -76.83 95.19 4.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.095 0.958 . . . . 0.0 109.644 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.4 104.86 14.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.8 m -111.83 116.23 30.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 -169.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -85.96 140.17 30.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 122.607 0.363 . . . . 0.0 110.791 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -99.81 178.39 4.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 109.613 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tt -50.45 -46.68 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.357 1.063 . . . . 0.0 113.298 -172.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -105.85 12.79 30.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.89 23.58 7.37 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -77.94 119.57 21.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.15 87.33 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.66 92.62 0.87 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.685 0.794 . . . . 0.0 109.565 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.593 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.2 mt-10 -79.76 94.17 5.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -101.44 143.86 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.48 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -94.02 93.39 7.83 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.7 112.4 14.49 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.11 103.93 0.33 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.964 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.41 2.07 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.683 -160.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -106.76 146.72 30.51 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.603 0.761 . . . . 0.0 111.254 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.476 HG22 ' HG2' ' A' ' 9' ' ' ARG . 4.6 m -106.76 140.59 39.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.626 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.82 158.18 40.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.432 0.693 . . . . 0.0 110.684 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -61.43 149.04 39.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.106 0.962 . . . . 0.0 112.041 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -155.29 169.47 24.12 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.368 0.667 . . . . 0.0 111.385 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 14.7 t -128.58 91.37 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.95 96.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.407 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -107.52 99.37 8.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.499 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 82' ' ' LEU . 48.7 mtp -73.11 142.03 47.52 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.84 159.71 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.522 0.729 . . . . 0.0 112.518 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.64 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.2 m -93.31 -178.46 4.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.13 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . 34.9 p -72.23 -20.99 61.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.065 0.546 . . . . 0.0 111.56 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 20.6 ptmt -53.56 -41.7 66.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.352 1.061 . . . . 0.0 113.193 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -31.71 49.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.457 0.703 . . . . 0.0 110.868 -172.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.99 85.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.672 0.789 . . . . 0.0 110.357 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.72 -34.67 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -68.85 -49.42 58.51 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.84 0.856 . . . . 0.0 111.304 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 23.7 m -93.64 1.17 56.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.65 -79.01 1.44 Allowed Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.31 -17.67 2.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.02 0.928 . . . . 0.0 111.241 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 33.3 tt0 -57.37 -50.31 73.36 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.293 0.637 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.9 mt -103.0 158.14 16.49 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.899 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.19 153.41 25.68 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.232 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 44' ' ' SER . 31.0 mt -65.4 128.05 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.2 -8.42 18.32 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.213 0.321 . . . . 0.0 112.77 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 40.8 m -68.93 139.49 55.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.308 0.643 . . . . 0.0 109.309 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -124.68 103.24 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -81.64 98.93 8.6 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.67 106.29 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.512 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 9.1 m0 -88.32 113.37 23.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.742 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.96 -171.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.78 0.832 . . . . 0.0 108.899 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -86.94 158.46 19.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.491 0.316 . . . . 0.0 110.456 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 70.1 t80 -60.66 97.44 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.522 1.129 . . . . 0.0 112.039 -172.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -120.77 104.81 10.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 109.501 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -68.92 -0.4 5.52 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.04 -20.57 21.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.603 0.761 . . . . 0.0 110.834 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.49 HG21 HD12 ' A' ' 104' ' ' ILE . 48.0 mm -66.18 128.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -127.45 164.9 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.7 1.2 . . . . 0.0 108.56 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.23 65.4 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.451 0.7 . . . . 0.0 111.22 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.1 p -87.4 40.19 0.91 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.166 0.986 . . . . 0.0 110.877 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -141.72 145.81 35.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.115 0.966 . . . . 0.0 108.861 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -108.8 138.7 44.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 104' ' ' ILE . 22.3 mm -107.33 90.75 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 33.7 ttmt -83.71 115.85 22.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 97.4 t -72.85 99.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 m -71.04 -26.46 63.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 111.566 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -155.49 140.73 17.57 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.942 0.897 . . . . 0.0 108.733 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.65 -154.68 26.08 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.313 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.62 -37.5 21.67 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.704 2.269 . . . . 0.0 111.369 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 87' ' ' LEU . 89.0 mt -103.89 42.12 1.22 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.476 1.11 . . . . 0.0 109.74 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.63 101.48 0.25 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.863 0.865 . . . . 0.0 111.602 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.88 -19.13 11.3 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.412 1.006 . . . . 0.0 112.307 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 82' ' ' LEU . 92.7 mtt180 -83.13 141.16 32.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.478 0.711 . . . . 0.0 111.241 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 51.4 t -103.0 106.99 21.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 124.834 1.254 . . . . 0.0 108.408 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.6 mm? -90.07 128.73 36.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.527 0.731 . . . . 0.0 109.167 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.9 OUTLIER -97.82 119.0 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.282 0.633 . . . . 0.0 110.059 -173.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' CYS . 45.6 mt -56.36 134.31 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.417 0.687 . . . . 0.0 111.26 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' HE ' ' A' ' 107' ' ' ARG . 11.5 pt -112.1 96.34 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.724 175.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.27 -84.76 0.37 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.126 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -170.33 158.83 6.15 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.212 1.005 . . . . 0.0 109.523 -172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 57.8 Cg_endo -69.62 125.07 11.79 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.23 1.953 . . . . 0.0 111.57 171.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -103.93 109.47 62.35 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.063 0.945 . . . . 0.0 109.508 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.29 150.5 53.01 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.693 2.262 . . . . 0.0 111.04 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.73 175.11 7.5 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.3 67.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.385 0.674 . . . . 0.0 112.508 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.89 -13.55 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.369 0.668 . . . . 0.0 112.528 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.52 26.07 15.87 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.391 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 t -82.25 -25.5 34.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.299 0.639 . . . . 0.0 110.012 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -138.83 168.59 19.48 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 15.4 tp -128.54 108.22 10.35 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.95 109.78 18.41 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.549 HG21 HG13 ' A' ' 75' ' ' ILE . 13.1 mm -90.09 102.88 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.684 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.4 pt? -81.12 105.13 12.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.182 0.991 . . . . 0.0 108.362 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 61.5 m -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.921 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.675 ' HE ' HG21 ' A' ' 90' ' ' ILE . 21.4 ttp85 -146.39 140.65 26.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.67 118.92 8.3 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 111.096 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.78 41.84 3.05 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.02 29.06 1.21 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.386 1.474 . . . . 0.0 108.356 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.89 76.81 1.64 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.458 1.503 . . . . 0.0 110.718 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? . . . . . 0 C--O 1.251 1.181 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.24 112.67 21.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.374 0.669 . . . . 0.0 109.537 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 mm -75.89 149.47 6.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.22 59.32 2.33 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 123.376 0.512 . . . . 0.0 112.588 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.59 -36.5 74.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.034 1.333 . . . . 0.0 111.579 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 54.3 mt -69.57 80.01 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.231 0.957 . . . . 0.0 110.574 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -91.25 -26.95 18.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.922 1.289 . . . . 0.0 110.896 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.22 -172.64 2.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.609 1.564 . . . . 0.0 109.719 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HG2' HG22 ' A' ' 34' ' ' THR . 14.6 ttp180 -155.77 138.75 15.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.879 0.872 . . . . 0.0 108.776 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.01 144.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.387 0.675 . . . . 0.0 111.122 -173.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -92.0 120.93 33.1 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.524 1.13 . . . . 0.0 109.902 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.43 95.52 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -73.59 99.26 3.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 109.928 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 p -79.87 146.42 32.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.603 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.5 tp -92.86 106.77 18.68 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.75 0.42 . . . . 0.0 110.333 -172.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -94.69 101.87 13.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.52 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 48.6 mt-30 -77.56 93.95 4.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.58 0.752 . . . . 0.0 109.164 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.2 m -92.78 123.52 36.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.347 1.059 . . . . 0.0 110.404 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -74.59 163.13 28.09 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.031 0.532 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.28 165.0 12.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.465 1.106 . . . . 0.0 108.502 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.2 -15.84 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -95.84 -6.69 38.84 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.1 6.39 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.077 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.08 136.28 53.17 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.132 0.973 . . . . 0.0 108.827 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.35 120.22 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.4 123.9 51.31 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.06 0.944 . . . . 0.0 109.707 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.645 ' HB3' HD11 ' A' ' 15' ' ' LEU . 3.5 mp0 -81.57 116.92 21.56 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.781 0.833 . . . . 0.0 110.118 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 p -130.92 153.04 49.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.109 0.964 . . . . 0.0 108.806 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -110.4 108.86 19.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.503 0.721 . . . . 0.0 109.491 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.03 133.8 35.81 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.7 127.46 31.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.15 -113.75 3.8 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -99.61 124.93 45.28 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.427 0.691 . . . . 0.0 109.847 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 10.1 m -101.04 94.88 6.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -117.04 168.51 10.19 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.206 0.602 . . . . 0.0 111.773 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 35.7 m95 -64.19 136.36 57.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.916 0.886 . . . . 0.0 112.573 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -139.24 165.97 25.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.295 1.038 . . . . 0.0 111.672 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 22.5 t -120.42 92.12 3.7 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 166.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -90.72 98.19 8.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.016 0.926 . . . . 0.0 108.951 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -119.07 116.04 25.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.546 0.738 . . . . 0.0 109.408 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.532 ' HG2' HG22 ' A' ' 59' ' ' VAL . 81.9 mtp -65.9 130.7 44.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.644 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 22.3 m -70.54 146.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 111.021 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t -84.53 174.78 9.74 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.6 p -60.73 -25.92 66.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -26.1 68.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.644 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 16.3 mm-40 -68.2 -41.46 81.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.156 0.582 . . . . 0.0 110.719 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.15 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.907 0.754 . . . . 0.0 110.86 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -64.86 -40.31 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.366 0.666 . . . . 0.0 110.521 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.0 m -66.48 -49.74 65.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.687 0.795 . . . . 0.0 111.943 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 76.6 p -91.42 -19.48 22.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.462 0.705 . . . . 0.0 112.39 -171.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.34 2.22 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.56 -15.04 1.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.426 0.691 . . . . 0.0 112.036 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 24.4 mm-40 -59.82 -43.75 94.36 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.2 0.6 . . . . 0.0 111.297 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.94 149.33 29.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.55 167.46 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.814 0.846 . . . . 0.0 109.644 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 mt -76.28 114.22 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 4.76 59.73 Favored Glycine 0 N--CA 1.467 0.706 0 CA-C-O 119.625 -0.542 . . . . 0.0 112.95 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.525 HG23 HD11 ' A' ' 90' ' ' ILE . 18.3 m -56.54 113.74 1.74 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.293 0.568 . . . . 0.0 109.753 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 41' ' ' MET . 49.3 t -73.18 107.25 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.189 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -90.98 134.02 34.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 80.7 mt -133.35 108.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -168.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 32.5 m0 -91.25 124.3 35.36 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 123.528 0.731 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.35 163.84 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -52.21 149.71 5.16 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.746 0.418 . . . . 0.0 111.627 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -56.83 108.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.017 0.823 . . . . 0.0 109.968 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 46.9 ttt85 -135.96 116.69 14.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -168.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -84.44 9.05 14.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.625 1.17 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 20.9 t70 -92.85 -19.57 21.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.245 1.418 . . . . 0.0 110.495 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 13.2 mm -84.32 139.94 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.483 0.713 . . . . 0.0 109.577 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -130.65 166.48 20.6 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.76 -23.71 66.79 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.411 0.684 . . . . 0.0 111.437 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -85.44 41.93 0.92 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.191 0.996 . . . . 0.0 110.433 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 m -131.72 147.57 52.51 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 123.778 0.831 . . . . 0.0 109.081 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -115.17 120.99 41.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 104' ' ' ILE . 18.2 mm -88.4 91.28 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.32 1.048 . . . . 0.0 109.507 -173.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -91.18 120.18 31.9 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 87' ' ' LEU . 88.7 t -71.38 122.28 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.824 0.345 . . . . 0.0 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -89.44 -30.53 18.25 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 109.583 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 m -143.57 110.51 5.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.065 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.68 -170.08 30.52 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.82 -0.434 . . . . 0.0 113.736 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.26 -29.0 26.98 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.839 2.359 . . . . 0.0 111.735 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.3 mt -98.26 22.14 9.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.656 0.782 . . . . 0.0 111.018 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.14 124.32 19.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.005 0.522 . . . . 0.0 110.715 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.08 34.17 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.111 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -88.88 143.24 27.01 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.439 0.695 . . . . 0.0 110.744 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -105.99 100.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 122.194 0.997 . . . . 0.0 109.54 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -83.24 113.08 20.43 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.953 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -83.8 139.8 32.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 109.094 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 75' ' ' ILE . 63.1 mt -78.53 108.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.525 HD11 HG23 ' A' ' 58' ' ' THR . 18.5 pt -92.16 61.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 122.152 0.977 . . . . 0.0 110.133 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.92 -122.03 1.12 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.426 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -150.88 143.82 16.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.976 0.91 . . . . 0.0 109.139 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 111.97 1.12 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 110.499 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.47 117.43 36.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.128 0.971 . . . . 0.0 108.845 -167.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.56 158.57 49.12 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.574 2.183 . . . . 0.0 112.367 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.1 -174.54 4.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.837 0.455 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.08 -48.01 66.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.487 0.715 . . . . 0.0 111.705 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.97 58.86 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.598 0.759 . . . . 0.0 112.798 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 71.39 14.33 6.44 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -85.05 -1.72 57.16 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.315 1.046 . . . . 0.0 112.236 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -163.41 161.32 24.3 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.812 0.815 . . . . 0.0 110.129 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.74 109.21 21.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -90.67 108.87 20.09 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 0.0 109.666 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 75' ' ' ILE . 9.3 mm -88.45 145.38 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -120.48 132.93 55.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 60.2 m -153.76 175.64 13.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.34 0.656 . . . . 0.0 111.017 -169.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.6 166.62 22.22 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 108.497 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 54.3 mp0 -73.22 156.16 38.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 173.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.63 28.3 16.47 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -172.54 34.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.788 1.235 . . . . 0.0 109.281 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -60.95 -16.71 45.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.969 1.308 . . . . 0.0 112.456 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.505 1.122 . . . . 0.0 110.678 175.35 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -142.64 126.04 16.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.461 0.704 . . . . 0.0 109.412 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 5' ' ' ARG . 63.3 mt -63.16 129.89 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.99 22.34 8.34 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.576 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.667 ' H ' HG22 ' A' ' 3' ' ' ILE . 10.3 mpt_? 59.39 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.071 1.748 . . . . 0.0 113.472 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.91 164.3 26.33 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.085 1.354 . . . . 0.0 111.567 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -129.44 -30.06 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.663 0.785 . . . . 0.0 111.839 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -109.96 -166.91 1.13 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.045 1.738 . . . . 0.0 109.858 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 79' ' ' THR . 25.1 ttm180 -152.78 140.92 20.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.939 0.896 . . . . 0.0 109.166 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.15 156.78 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.804 0.842 . . . . 0.0 110.014 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -103.37 123.14 46.27 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.484 1.114 . . . . 0.0 108.992 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.19 108.95 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -85.83 111.41 20.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.71 0.767 . . . . 0.0 110.308 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -84.75 142.7 29.64 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.782 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.1 tp -97.85 113.88 25.8 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.748 0.819 . . . . 0.0 109.634 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' NZ ' ' HB3' ' A' ' 16' ' ' LYS . 5.6 ttpm? -99.77 113.19 25.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.797 0.839 . . . . 0.0 109.657 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.4 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.3 mt-30 -86.56 103.35 14.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.799 0.84 . . . . 0.0 109.402 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 m -93.9 165.16 12.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -114.1 165.95 12.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.859 0.754 . . . . 0.0 109.835 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -108.72 161.8 14.76 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.52 -14.21 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -103.25 -10.16 18.97 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.66 15.42 20.76 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.238 -0.892 . . . . 0.0 115.32 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.78 145.35 24.65 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.534 1.167 . . . . 0.0 109.485 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.51 122.48 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.312 0.645 . . . . 0.0 111.15 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.84 108.48 21.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.339 1.056 . . . . 0.0 108.565 175.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.4 mt-10 -80.96 107.1 13.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.371 0.669 . . . . 0.0 109.605 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -114.68 146.49 40.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.755 0.822 . . . . 0.0 110.2 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -111.18 106.23 15.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.698 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -106.1 143.86 33.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.78 137.94 48.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.821 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.26 -116.67 3.77 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -99.08 137.35 37.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.1 m -108.82 96.73 6.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.767 0.827 . . . . 0.0 108.855 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.59 175.24 5.57 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.38 0.609 . . . . 0.0 111.276 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -70.69 135.42 48.29 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.477 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.5 173.75 11.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.336 1.054 . . . . 0.0 111.074 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.2 m -130.38 96.25 4.1 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 160.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 61' ' ' ILE . 2.6 p -94.41 102.36 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -173.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -117.27 122.58 44.36 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.779 0.831 . . . . 0.0 109.123 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 82' ' ' LEU . 72.1 mtp -72.22 145.93 47.64 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.1 134.51 30.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -83.45 176.33 9.15 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 123.53 0.732 . . . . 0.0 109.776 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p -60.13 -31.12 69.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -56.56 -49.67 74.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.671 0.788 . . . . 0.0 111.012 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.58 -44.07 91.83 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.845 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.98 -45.68 90.01 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 124.281 0.988 . . . . 0.0 112.438 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.93 -46.85 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.332 0.653 . . . . 0.0 111.217 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.5 m -65.6 -29.09 69.63 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.642 0.777 . . . . 0.0 112.216 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 89.8 p -90.6 -17.42 26.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.521 0.728 . . . . 0.0 111.996 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.02 -79.21 1.72 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.74 12.09 2.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.292 0.637 . . . . 0.0 111.05 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.4 tp10 -77.87 -53.55 7.35 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 58' ' ' THR . 81.1 mt -106.49 147.22 29.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.862 0.865 . . . . 0.0 108.808 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.28 158.75 41.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.1 mt -62.63 120.39 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.64 -11.12 13.99 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 123.383 0.427 . . . . 0.0 112.59 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 54' ' ' LEU . 25.4 m -71.88 140.21 49.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 166.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 38.7 t -122.67 122.28 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.494 0.718 . . . . 0.0 110.482 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -93.81 135.89 34.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 75' ' ' ILE . 66.1 mt -132.6 107.98 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.77 116.02 28.29 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.257 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.23 159.06 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -55.69 136.64 50.58 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 168.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HB3' ' NH1' ' A' ' 64' ' ' ARG . 56.0 t80 -48.17 114.66 0.98 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.568 1.547 . . . . 0.0 113.212 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -138.23 119.61 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.78 0.832 . . . . 0.0 109.231 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -79.84 7.57 8.49 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.8 0.44 . . . . 0.0 110.992 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.34 -22.89 20.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.337 0.655 . . . . 0.0 110.183 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.91 130.81 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.71 162.67 23.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.708 0.803 . . . . 0.0 109.171 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.96 -15.64 63.54 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.302 0.641 . . . . 0.0 112.052 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.2 p -83.16 2.82 33.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.563 0.745 . . . . 0.0 111.649 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -101.31 137.74 39.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -106.17 134.77 48.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 61' ' ' ILE . 30.3 mm -94.07 102.63 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 123.041 0.536 . . . . 0.0 110.077 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.4 ttpt -103.78 112.72 25.8 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.62 120.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.24 0.616 . . . . 0.0 111.594 -173.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -79.45 -31.9 42.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.696 1.199 . . . . 0.0 111.749 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 9' ' ' ARG . 11.7 t -160.51 142.79 12.84 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.14 -160.63 24.42 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.832 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.49 -27.36 46.59 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.911 2.407 . . . . 0.0 112.639 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 41' ' ' MET . 54.9 mt -115.77 31.64 6.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.723 0.809 . . . . 0.0 111.156 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.02 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.494 0.718 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.58 -19.0 4.83 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.082 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HD2' HD22 ' A' ' 82' ' ' LEU . 91.4 mtt-85 -86.51 142.69 28.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.291 0.637 . . . . 0.0 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 4.5 p -107.25 95.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.026 0.917 . . . . 0.0 108.995 172.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 108' ' ' GLU . 1.2 mm? -77.33 128.38 34.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.433 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -99.7 141.5 32.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.744 . . . . 0.0 109.17 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.62 122.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 pt -100.02 86.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.12 -94.18 0.54 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -159.15 145.83 12.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.964 0.905 . . . . 0.0 110.041 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.39 114.89 3.06 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.835 2.357 . . . . 0.0 111.128 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.94 108.76 48.16 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.876 0.87 . . . . 0.0 109.346 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.1 143.93 55.77 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.057 2.505 . . . . 0.0 112.331 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.41 168.9 19.24 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.194 0.452 . . . . 0.0 110.723 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.91 -27.5 65.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.005 0.922 . . . . 0.0 112.877 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.4 -7.25 42.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 62.13 29.78 17.63 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.447 1.099 . . . . 0.0 111.491 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 p -90.55 -17.98 26.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.881 0.873 . . . . 0.0 111.434 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -158.78 171.15 20.61 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.616 0.722 . . . . 0.0 110.78 -168.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.57 113.07 17.58 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.78 96.25 5.56 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.589 HG22 ' SG ' ' A' ' 106' ' ' CYS . 22.8 mm -88.71 97.16 6.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.702 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -79.01 130.51 35.61 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.077 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 104' ' ' ILE . 84.7 m -147.78 173.14 13.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.376 1.07 . . . . 0.0 108.875 -170.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -138.41 153.71 48.88 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 87' ' ' LEU . 38.3 tt0 -44.33 125.73 4.79 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.724 0.81 . . . . 0.0 112.848 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 86' ' ' VAL . . . -89.87 52.0 3.56 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.472 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.54 142.22 48.53 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.109 0.964 . . . . 0.0 108.885 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.44 -28.7 61.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.669 0.388 . . . . 0.0 110.532 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.1 tttm . . . . . 0 C--O 1.249 1.054 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.736 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.31 150.29 35.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.303 1.041 . . . . 0.0 109.016 174.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.13 34.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 124.001 0.921 . . . . 0.0 112.174 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.04 50.29 4.38 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.296 0.474 . . . . 0.0 114.047 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -146.18 170.92 15.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.178 0.991 . . . . 0.0 109.064 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 37' ' ' ALA . 43.7 mt -115.67 117.89 31.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.186 0.594 . . . . 0.0 109.733 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -123.08 -28.63 4.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.388 0.675 . . . . 0.0 111.775 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -101.82 -174.18 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB2' HG22 ' A' ' 79' ' ' THR . 94.2 mtt180 -136.38 142.22 43.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.68 0.792 . . . . 0.0 109.601 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' THR . 49.3 pt -133.71 166.01 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 108.779 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -132.81 134.93 45.32 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 73' ' ' SER . 51.4 mm -81.91 116.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.674 0.609 . . . . 0.0 109.666 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -89.98 104.26 16.84 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.39 139.37 34.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.927 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.4 tp -89.51 98.62 11.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.226 0.467 . . . . 0.0 109.902 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.2 99.31 6.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 110.312 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 51.5 mt-30 -96.56 79.37 3.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -98.58 126.08 44.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.043 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 28.7 ttp180 -76.64 162.32 27.84 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.185 0.994 . . . . 0.0 111.482 -175.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 11.3 t70 -113.65 164.35 13.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.733 0.813 . . . . 0.0 109.835 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.49 -14.62 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.669 0.788 . . . . 0.0 112.859 172.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 p -100.53 -20.15 15.85 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.91 39.97 3.22 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.007 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mm-40 -97.44 146.72 24.93 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.813 0.845 . . . . 0.0 108.921 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.8 100.32 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.38 92.13 7.48 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB3' HD11 ' A' ' 15' ' ' LEU . 38.5 mt-10 -82.63 106.29 14.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.987 0.915 . . . . 0.0 109.046 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -126.05 165.48 18.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.447 1.099 . . . . 0.0 109.474 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.69 102.73 10.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.28 121.59 29.94 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.787 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.51 126.28 26.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.839 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.55 -112.77 3.6 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -120.53 133.72 55.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.143 0.577 . . . . 0.0 109.944 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 33.6 m -85.31 107.45 17.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.53 0.732 . . . . 0.0 109.693 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.1 pt? -108.06 164.53 12.2 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 0.0 110.863 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -75.86 130.4 38.49 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.608 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' HA ' HD22 ' A' ' 6' ' ' LEU . . . -147.24 -176.51 5.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.816 0.846 . . . . 0.0 111.268 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -134.27 104.33 6.12 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.536 HG11 HG23 ' A' ' 77' ' ' VAL . 2.3 p -105.61 114.42 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 109.186 -172.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -136.14 153.62 51.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.167 1.387 . . . . 0.0 109.521 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 82' ' ' LEU . 76.6 mtp -85.17 136.33 33.58 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 58' ' ' THR . 20.2 m -68.45 137.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -97.22 -173.94 2.81 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.86 0.864 . . . . 0.0 110.865 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 p -54.48 -34.44 61.58 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.268 1.027 . . . . 0.0 112.182 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -51.76 -52.62 47.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.856 0.863 . . . . 0.0 110.902 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.42 -41.58 76.16 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.447 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.93 78.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.619 . . . . 0.0 112.353 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.23 -33.75 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.678 0.791 . . . . 0.0 110.795 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 t -71.91 -44.34 63.85 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.331 0.652 . . . . 0.0 111.552 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 73.6 p -104.33 0.28 29.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.29 0.636 . . . . 0.0 112.479 -174.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.77 -70.39 2.93 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.04 -2.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.09 0.556 . . . . 0.0 112.206 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 38.0 tt0 -65.07 -50.94 64.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.108 0.563 . . . . 0.0 110.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.06 60.79 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.47 156.63 26.48 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.82 122.83 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -171.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.38 -13.04 16.04 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.695 0.665 . . . . 0.0 112.031 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 87.3 m -79.65 139.46 37.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.51 HG11 ' HG ' ' A' ' 87' ' ' LEU . 42.8 t -110.67 116.5 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.46 0.704 . . . . 0.0 110.914 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -83.67 128.42 34.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.628 1.171 . . . . 0.0 110.408 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' SG ' ' A' ' 106' ' ' CYS . 51.3 mt -135.19 110.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -98.98 131.69 44.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.109 0.564 . . . . 0.0 110.438 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.29 161.04 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -63.75 151.04 43.19 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 164.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -53.49 118.64 4.03 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.034 0.934 . . . . 0.0 111.157 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 HD13 ' A' ' 35' ' ' LEU . 56.4 ttt180 -136.86 128.08 28.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.75 1.83 40.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.275 1.03 . . . . 0.0 112.457 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.89 -21.76 19.65 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.489 0.716 . . . . 0.0 111.31 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 104' ' ' ILE . 25.5 mm -81.0 131.36 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 110.249 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -131.66 158.65 40.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.092 0.957 . . . . 0.0 109.747 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.99 -25.82 66.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.047 0.939 . . . . 0.0 112.312 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -84.13 8.9 14.08 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.795 0.838 . . . . 0.0 111.758 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 12' ' ' ILE . 22.8 m -111.5 120.02 40.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.607 0.763 . . . . 0.0 109.177 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -83.1 136.88 34.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.78 0.432 . . . . 0.0 110.41 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 61' ' ' ILE . 33.1 mm -96.36 101.8 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 0.0 110.114 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 29.9 ttpt -90.31 120.0 31.08 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.241 0.616 . . . . 0.0 109.982 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.536 HG23 HG11 ' A' ' 39' ' ' VAL . 2.7 p -73.55 115.62 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.347 0.659 . . . . 0.0 110.805 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -81.3 -24.8 36.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.865 0.866 . . . . 0.0 111.814 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 9' ' ' ARG . 10.6 t -168.24 137.86 2.48 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.857 0.863 . . . . 0.0 108.725 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.37 -165.96 29.53 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.462 -174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.15 -9.02 22.93 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 123.388 2.725 . . . . 0.0 112.656 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 41' ' ' MET . 79.9 mt -119.08 6.66 11.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.169 0.988 . . . . 0.0 111.2 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -42.5 115.04 0.65 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.846 1.258 . . . . 0.0 113.58 -165.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.02 25.22 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.48 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -94.77 172.58 8.08 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.207 0.504 . . . . 0.0 110.593 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 42.5 t -124.08 114.08 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.307 0.643 . . . . 0.0 109.645 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.612 HD11 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -90.25 140.84 29.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -103.0 143.71 32.22 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.52 130.61 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 107' ' ' ARG . 29.7 pt -102.5 128.23 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 122.881 0.472 . . . . 0.0 109.82 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.02 -93.34 1.18 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.936 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 12.2 pt20 -161.51 156.35 19.97 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.399 1.08 . . . . 0.0 108.878 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.1 109.87 2.28 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.871 1.714 . . . . 0.0 110.274 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.4 113.31 38.21 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.32 1.048 . . . . 0.0 108.949 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.58 144.55 32.02 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.335 2.023 . . . . 0.0 111.665 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -60.76 149.57 35.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.415 0.686 . . . . 0.0 112.09 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.04 -28.77 65.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.032 0.933 . . . . 0.0 110.978 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.69 -5.46 45.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.591 0.756 . . . . 0.0 111.368 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? 61.31 18.72 9.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.837 1.255 . . . . 0.0 113.377 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -81.28 -10.49 59.57 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.361 0.528 . . . . 0.0 111.28 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -155.6 -179.13 7.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.349 0.595 . . . . 0.0 110.853 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -137.64 112.22 8.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.0 97.78 2.92 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.0 mm -85.31 86.96 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -79.11 136.03 37.02 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.529 ' SG ' HD12 ' A' ' 61' ' ' ILE . 62.9 m -146.41 170.25 17.21 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' HB2' HD13 ' A' ' 90' ' ' ILE . 37.2 ttp180 -142.16 144.49 33.47 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 172.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -41.6 118.95 1.16 Allowed 'General case' 0 C--N 1.362 1.11 0 O-C-N 124.43 1.081 . . . . 0.0 110.998 -177.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.44 51.01 3.32 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.927 -165.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.45 89.9 0.52 Allowed 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.107 0.563 . . . . 0.0 109.656 171.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 112' ' ' LYS . 9.3 pt-20 -71.83 -31.66 66.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 111' ' ' GLU . 24.3 pttm . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.85 0.86 . . . . 0.0 109.223 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -148.6 -168.63 3.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.436 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.8 mm -75.33 89.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.49 50.89 3.59 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.798 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -68.68 138.21 54.77 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.045 0.938 . . . . 0.0 110.298 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.87 81.31 7.16 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.854 0.835 . . . . 0.0 108.783 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.09 -22.55 45.1 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.651 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -103.6 -175.39 2.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.573 1.149 . . . . 0.0 110.283 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 34' ' ' THR . 51.6 mtm180 -141.38 148.25 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 109.399 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -140.79 145.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.891 0.876 . . . . 0.0 108.687 177.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 m -96.23 122.85 39.54 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.551 0.614 . . . . 0.0 109.976 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.7 mm -75.54 103.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.575 0.75 . . . . 0.0 109.892 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -85.55 95.72 9.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.511 0.672 . . . . 0.0 109.882 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -79.09 150.09 31.91 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.7 tp -88.35 105.0 17.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -170.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -89.73 96.61 10.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.037 0.935 . . . . 0.0 109.807 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 45.9 mt-30 -84.4 97.44 9.5 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -106.14 117.7 34.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.614 0.766 . . . . 0.0 109.336 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -72.07 162.48 29.4 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 120.629 0.252 . . . . 0.0 110.506 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.88 163.6 15.32 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.801 0.84 . . . . 0.0 109.361 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.6 -21.38 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.95 0.9 . . . . 0.0 113.018 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -93.85 -13.36 27.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.85 40.31 4.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.157 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.27 137.86 42.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 109.603 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -90.75 96.42 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.96 96.14 8.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 15' ' ' LEU . 49.4 mt-10 -79.97 111.58 16.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -125.58 169.15 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.857 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.443 ' HZ3' ' HA ' ' A' ' 73' ' ' SER . 79.6 m95 -119.97 109.41 15.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.31 115.11 22.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.5 135.79 55.6 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.202 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.57 -119.84 3.14 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.803 -168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -99.8 125.21 45.68 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -170.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 3.7 m -88.04 93.29 9.44 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -110.89 170.41 8.11 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -64.38 120.65 12.64 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.2 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -141.87 176.53 8.86 Favored 'General case' 0 C--O 1.209 -1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 111.979 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 m -135.38 108.41 7.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.579 HG23 HG12 ' A' ' 61' ' ' ILE . 2.0 p -108.16 109.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.958 0.903 . . . . 0.0 110.837 -172.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.05 138.66 49.7 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 0.0 109.044 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.509 ' SD ' HD21 ' A' ' 82' ' ' LEU . 77.1 mtp -75.45 145.34 41.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.32 130.8 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 O-C-N 123.691 0.619 . . . . 0.0 109.68 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 m -87.94 -175.93 5.29 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 123.4 0.68 . . . . 0.0 110.706 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.8 p -59.9 -33.91 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.791 0.837 . . . . 0.0 111.502 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.86 -47.52 67.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.806 0.843 . . . . 0.0 111.106 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.21 -45.22 81.53 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.114 0.884 . . . . 0.0 111.165 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -51.97 66.4 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.922 0.764 . . . . 0.0 111.217 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.23 -38.23 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.141 0.977 . . . . 0.0 111.581 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 t -77.09 -28.57 54.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.99 0.516 . . . . 0.0 111.556 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 50.7 m -94.79 -9.86 33.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 0.0 111.894 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.94 -74.62 2.27 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.25 2.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.767 0.827 . . . . 0.0 111.047 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 1.9 tm-20 -63.95 -61.15 2.46 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.81 142.01 30.1 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.08 151.34 45.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.36 0.664 . . . . 0.0 109.557 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.85 119.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.834 0.854 . . . . 0.0 110.765 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.28 -12.64 16.46 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.281 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.478 HG23 HD11 ' A' ' 90' ' ' ILE . 86.3 m -73.47 154.14 40.06 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 164.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 41' ' ' MET . 22.0 t -132.2 115.41 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -87.45 132.2 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 39' ' ' VAL . 41.8 mt -138.86 109.0 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.781 0.832 . . . . 0.0 109.037 -170.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -95.0 122.97 38.2 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.8 pt -116.62 165.32 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 66' ' ' ARG . 24.8 mmm180 -54.25 140.17 33.72 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 164.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 95' ' ' PRO . 51.8 t80 -54.6 129.51 36.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.007 1.323 . . . . 0.0 111.745 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 64' ' ' ARG . 50.4 mtt85 -150.96 129.32 12.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.788 0.835 . . . . 0.0 110.688 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -81.79 -13.9 57.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.252 1.021 . . . . 0.0 111.02 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.05 -21.47 22.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.765 0.426 . . . . 0.0 110.747 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.08 128.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.663 0.385 . . . . 0.0 110.199 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.686 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 67.2 t30 -140.73 168.09 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.387 1.075 . . . . 0.0 109.235 -177.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.62 -7.66 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.9 p -86.08 19.99 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.345 1.058 . . . . 0.0 112.274 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.443 ' HA ' ' HZ3' ' A' ' 29' ' ' TRP . 72.5 m -130.09 172.77 11.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.609 0.764 . . . . 0.0 110.777 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -119.92 140.66 50.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.899 0.88 . . . . 0.0 108.952 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.523 HG21 HG21 ' A' ' 61' ' ' ILE . 50.1 mm -98.08 105.49 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.601 0.76 . . . . 0.0 109.617 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 88.2 tttt -90.44 131.09 36.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.456 HG23 HD23 ' A' ' 87' ' ' LEU . 67.8 t -83.9 123.09 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.785 0.434 . . . . 0.0 110.579 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -85.64 -38.9 17.87 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.466 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 p -146.76 128.41 15.17 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.32 -169.69 29.62 Favored Glycine 0 N--CA 1.469 0.895 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.244 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.42 -1.24 10.75 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.017 2.478 . . . . 0.0 112.855 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' SD ' ' A' ' 41' ' ' MET . 89.4 mt -130.03 32.98 4.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.004 0.922 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.83 104.95 0.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.59 0.756 . . . . 0.0 111.685 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.32 -18.36 12.14 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.959 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.15 158.31 20.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 110.954 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.8 p -124.96 98.6 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.552 1.168 . . . . 0.0 110.189 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.5 mm? -82.54 148.77 27.88 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.294 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -110.76 141.07 44.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.051 0.94 . . . . 0.0 108.508 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.71 98.69 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 58' ' ' THR . 39.2 pt -80.86 146.57 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.098 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.12 -105.45 2.06 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.755 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -161.8 144.94 9.19 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 123.519 0.728 . . . . 0.0 109.897 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.686 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 62.8 Cg_endo -69.7 125.74 12.53 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.196 1.931 . . . . 0.0 110.678 173.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 111.7 54.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HB3' ' HE1' ' A' ' 65' ' ' TYR . 74.4 Cg_exo -53.83 142.59 62.63 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.205 2.603 . . . . 0.0 113.559 175.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.535 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 18.1 t70 -51.74 156.09 1.51 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.929 0.892 . . . . 0.0 112.639 173.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.16 77.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.326 1.05 . . . . 0.0 112.013 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.97 -6.58 35.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.313 0.645 . . . . 0.0 111.491 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 25.57 15.27 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.783 1.233 . . . . 0.0 112.249 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.9 p -83.28 -4.73 58.72 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.327 0.584 . . . . 0.0 111.334 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 17.3 ptt180 -169.12 -176.46 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.661 1.584 . . . . 0.0 107.894 -168.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.16 118.16 14.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.69 108.51 14.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 mm -100.17 153.15 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -133.63 146.61 51.07 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 170.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 71.3 m -150.21 171.99 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.281 -168.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -160.62 158.19 28.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -44.16 151.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.469 1.108 . . . . 0.0 112.776 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.98 42.57 3.11 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.753 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.96 166.73 10.61 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.785 1.234 . . . . 0.0 108.843 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 64.77 14.47 9.17 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.282 1.033 . . . . 0.0 112.555 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.878 0.871 . . . . 0.0 108.786 -176.129 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -141.3 106.63 5.02 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mt 73.79 -29.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 126.319 1.848 . . . . 0.0 112.086 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.79 55.44 5.01 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 121.926 -0.484 . . . . 0.0 113.053 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -81.6 -16.68 50.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.444 1.098 . . . . 0.0 109.775 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 34.9 mt -91.38 117.84 30.02 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.932 1.293 . . . . 0.0 110.329 -165.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -116.03 1.74 13.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.564 0.746 . . . . 0.0 112.429 -170.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -113.88 -172.59 2.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.939 1.296 . . . . 0.0 109.231 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 50.1 mtm180 -140.57 156.21 46.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.168 0.987 . . . . 0.0 109.234 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.35 135.39 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.3 m -90.02 113.58 25.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.116 0.966 . . . . 0.0 109.654 173.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mm -74.06 105.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.845 1.258 . . . . 0.0 109.982 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.564 HE21 ' HB2' ' A' ' 76' ' ' LYS . 65.9 mt-30 -72.76 102.32 3.33 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 174.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -83.03 133.64 35.08 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.624 -1.625 . . . . 0.0 108.294 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.3 tp -82.04 96.77 7.85 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -80.82 102.23 9.88 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -81.79 100.97 9.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.298 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -92.39 178.95 5.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -130.11 164.95 23.29 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.605 -0.684 . . . . 0.0 109.448 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 18.5 t70 -107.02 160.22 15.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.142 0.977 . . . . 0.0 108.754 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.5 tt -55.57 -15.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -98.71 -2.84 37.23 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.71 53.99 3.6 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.39 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 15.0 pt-20 -130.62 142.35 50.45 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.65 109.96 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 122.884 0.473 . . . . 0.0 110.998 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -96.26 93.0 6.64 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HB3' HD11 ' A' ' 15' ' ' LEU . 48.5 mt-10 -80.86 131.68 35.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.921 0.488 . . . . 0.0 110.302 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.4 p -138.95 159.81 41.26 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.306 1.042 . . . . 0.0 110.137 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -111.62 120.41 41.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.261 0.624 . . . . 0.0 109.886 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.15 164.14 23.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.725 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.07 138.65 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.114 0.884 . . . . 0.0 108.797 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.56 -107.4 2.42 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -110.07 129.4 55.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.91 0.884 . . . . 0.0 109.131 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 21.4 m -106.5 96.16 6.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.646 0.378 . . . . 0.0 110.183 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.74 172.01 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 122.883 0.473 . . . . 0.0 112.254 -174.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -67.19 129.97 41.62 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -144.56 172.55 12.81 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 123.769 0.828 . . . . 0.0 111.423 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 6' ' ' LEU . 72.1 m -128.17 109.68 11.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.507 HG23 HG12 ' A' ' 61' ' ' ILE . 2.9 p -100.86 98.0 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.831 0.852 . . . . 0.0 109.611 -172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -112.4 115.24 28.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.827 0.851 . . . . 0.0 110.748 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 69.7 mtp -62.39 133.81 55.58 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 6.0 m -68.02 153.5 8.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.417 0.448 . . . . 0.0 110.262 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -84.28 171.76 12.44 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.949 0.5 . . . . 0.0 110.458 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -60.18 -27.13 66.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.167 0.587 . . . . 0.0 110.669 173.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -47.85 -46.15 30.9 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.378 1.471 . . . . 0.0 111.897 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 33.9 mm-40 -67.2 -39.76 86.39 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.504 0.502 . . . . 0.0 111.465 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -51.63 57.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.981 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.57 -52.61 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.344 1.058 . . . . 0.0 112.155 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -71.69 -26.47 62.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.439 0.695 . . . . 0.0 112.486 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 43.0 m -92.7 -7.71 45.97 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.912 0.485 . . . . 0.0 111.411 175.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.53 0.72 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 123.494 0.496 . . . . 0.0 111.894 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.71 -5.93 7.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.791 0.836 . . . . 0.0 111.123 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 12.1 tp10 -66.56 -51.46 56.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.488 0.715 . . . . 0.0 110.669 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.83 155.95 19.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.87 0.868 . . . . 0.0 108.982 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.28 177.63 7.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.758 0.823 . . . . 0.0 110.546 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.73 136.68 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.88 43.91 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -170.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.0 m -70.75 145.13 50.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.044 0.937 . . . . 0.0 109.322 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 45.2 t -126.24 129.81 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.424 1.09 . . . . 0.0 109.214 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.3 140.37 37.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.643 HD13 HG21 ' A' ' 75' ' ' ILE . 56.1 mt -137.1 143.37 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -170.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -129.22 127.32 41.04 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 37' ' ' ALA . 42.9 pt -126.95 157.89 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.572 1.149 . . . . 0.0 107.931 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -60.28 145.46 47.44 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.448 . . . . 0.0 110.482 168.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.523 ' HA ' HD13 ' A' ' 102' ' ' LEU . 39.5 t80 -57.09 125.12 21.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.676 0.79 . . . . 0.0 110.242 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 32.7 ttt180 -153.29 122.08 6.43 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 123.613 0.571 . . . . 0.0 110.79 -172.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -71.56 -3.16 19.85 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.174 1.389 . . . . 0.0 112.431 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 4.3 t70 -89.92 -23.35 21.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.353 1.061 . . . . 0.0 110.369 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.447 HD11 ' HD3' ' A' ' 66' ' ' ARG . 20.8 mm -87.65 130.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.527 -175.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.707 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 66.3 t30 -145.3 167.95 21.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 109.594 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.26 65.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.165 0.986 . . . . 0.0 111.947 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.8 p -72.16 0.03 10.75 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.343 1.057 . . . . 0.0 112.334 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.9 t -101.14 161.34 13.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.855 0.862 . . . . 0.0 109.565 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 52.9 mtp180 -113.88 147.48 38.38 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.643 HG21 HD13 ' A' ' 61' ' ' ILE . 49.3 mm -95.6 102.56 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.491 0.316 . . . . 0.0 110.393 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HB2' HE21 ' A' ' 13' ' ' GLN . 58.3 tttm -94.94 102.96 14.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG23 HD23 ' A' ' 87' ' ' LEU . 70.2 t -69.41 124.28 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 120.74 0.305 . . . . 0.0 111.095 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 42.2 t -80.97 -40.11 24.92 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.991 0.917 . . . . 0.0 110.79 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.0 p -146.33 132.64 19.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 108.747 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.0 -170.44 27.91 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 123.517 0.51 . . . . 0.0 112.531 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.03 -17.65 59.85 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.137 2.558 . . . . 0.0 112.059 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 41' ' ' MET . 29.9 mt -114.25 23.94 12.4 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.742 1.217 . . . . 0.0 110.088 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.85 108.48 1.2 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.892 . . . . 0.0 111.487 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.28 -31.42 5.45 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 123.979 0.8 . . . . 0.0 111.938 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.492 HH12 ' HG3' ' A' ' 108' ' ' GLU . 36.3 mtm180 -89.08 170.71 10.41 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.573 0.749 . . . . 0.0 112.761 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 76' ' ' LYS . 37.5 t -122.54 104.88 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.454 1.101 . . . . 0.0 110.106 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 77' ' ' VAL . 2.2 mm? -86.63 140.93 29.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.601 170.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.47 141.95 39.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.404 1.082 . . . . 0.0 109.072 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 106' ' ' CYS . 51.8 mt -81.11 107.14 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -173.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 107' ' ' ARG . 32.0 pt -90.92 41.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.414 0.686 . . . . 0.0 111.302 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.5 -134.97 2.5 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 112.001 -0.439 . . . . 0.0 112.001 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -134.65 136.52 25.62 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.903 1.281 . . . . 0.0 108.708 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.707 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 73.9 Cg_endo -69.62 111.24 2.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.158 1.905 . . . . 0.0 110.765 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 107.66 60.17 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -173.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 51.4 Cg_exo -56.03 150.61 46.41 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.539 2.826 . . . . 0.0 112.882 172.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.8 173.34 9.26 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.81 -32.45 69.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.48 0.712 . . . . 0.0 112.36 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.47 -9.33 44.91 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 62.48 30.09 17.16 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.176 0.99 . . . . 0.0 111.302 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.2 p -101.38 -12.88 18.27 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.824 0.849 . . . . 0.0 112.204 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.66 143.08 3.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -171.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.546 HD23 ' HB2' ' A' ' 93' ' ' PRO . 9.6 mp -101.64 139.57 37.12 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.958 0.903 . . . . 0.0 110.069 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.66 109.99 19.56 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 164.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.5 mm -95.92 104.57 15.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.7 pt? -83.3 137.52 33.95 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 104' ' ' ILE . 73.7 m -149.57 175.05 11.87 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.099 0.96 . . . . 0.0 108.888 -173.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.464 ' HB2' HD13 ' A' ' 90' ' ' ILE . 57.5 ttt180 -156.65 159.97 38.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HG3' HH12 ' A' ' 85' ' ' ARG . 0.4 OUTLIER -61.34 101.0 0.15 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.41 52.49 1.35 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.981 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.55 74.37 0.44 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.264 1.025 . . . . 0.0 111.53 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -76.91 -20.2 56.49 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.587 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 9.3 mptt . . . . . 0 C--O 1.258 1.53 0 C-N-CA 124.651 1.18 . . . . 0.0 108.402 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 121.068 0.461 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -160.49 156.04 25.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.106 1.362 . . . . 0.0 108.05 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG12 ' NH1' ' A' ' 64' ' ' ARG . 2.9 mp -69.74 96.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.58 56.19 4.89 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.254 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -130.06 -61.44 0.98 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.557 0.743 . . . . 0.0 109.146 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 36' ' ' TRP . 8.1 mp -69.18 90.8 0.49 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.395 0.678 . . . . 0.0 111.355 -169.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -121.64 -13.67 8.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.86 1.264 . . . . 0.0 111.366 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.47 -170.74 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.444 1.497 . . . . 0.0 110.09 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.459 ' HB3' HG22 ' A' ' 34' ' ' THR . 46.2 mtm180 -136.5 142.75 43.53 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 109.904 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -136.15 143.5 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.344 1.058 . . . . 0.0 109.155 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -101.83 118.85 37.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.033 0.933 . . . . 0.0 108.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.32 92.14 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 123.95 0.781 . . . . 0.0 109.634 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 35.1 tt0 -83.79 93.77 8.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.904 0.859 . . . . 0.0 109.645 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -80.07 154.09 28.34 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.288 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' GLU . 67.2 tp -83.5 108.77 16.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.181 0.592 . . . . 0.0 109.948 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 45.9 tttp -84.67 94.24 8.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.384 0.674 . . . . 0.0 110.224 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.415 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 42.9 mt-30 -87.45 108.64 19.11 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -130.09 129.37 43.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.782 0.833 . . . . 0.0 109.173 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -73.49 148.47 43.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 122.75 0.42 . . . . 0.0 110.086 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.33 169.28 8.99 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.02 -14.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 p -91.85 -10.84 38.26 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.777 0.798 . . . . 0.0 109.344 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.32 44.29 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.742 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.21 132.59 38.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.0 mm -76.44 94.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.82 109.2 15.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.6 mt-10 -84.11 96.17 8.84 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.82 0.819 . . . . 0.0 109.303 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' HD12 ' A' ' 15' ' ' LEU . 67.1 p -110.92 -177.99 3.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.08 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -128.53 115.5 18.23 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.947 -0.471 . . . . 0.0 110.536 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 16' ' ' LYS . 8.7 pt-20 -97.95 109.89 22.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 13' ' ' GLN . 6.4 p-10 -63.75 135.2 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.9 -112.22 3.23 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 120.089 -0.284 . . . . 0.0 113.127 -163.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -102.66 135.28 44.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.091 0.557 . . . . 0.0 109.68 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.4 m -100.98 99.11 9.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.58 -179.68 3.94 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.192 0.52 . . . . 0.0 110.62 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.562 ' HB2' HD23 ' A' ' 6' ' ' LEU . 27.4 m95 -73.85 146.3 44.23 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.341 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -157.67 166.46 32.76 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.909 0.884 . . . . 0.0 112.824 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 t -110.42 95.92 5.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.586 HG21 HG21 ' A' ' 77' ' ' VAL . 3.5 p -96.7 90.49 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.971 0.891 . . . . 0.0 109.054 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -112.18 127.55 55.98 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.533 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.0 mtp -67.16 137.77 56.52 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.27 159.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.597 0.759 . . . . 0.0 111.857 -173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 m -82.5 168.61 17.23 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.396 0.678 . . . . 0.0 110.345 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.3 p -63.56 -21.56 66.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.513 0.725 . . . . 0.0 111.773 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.28 14.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.694 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.23 -46.25 91.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 111.372 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.36 61.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.61 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.62 -47.39 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.891 0.876 . . . . 0.0 111.896 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -75.69 -32.59 60.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.872 0.869 . . . . 0.0 111.14 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.0 t -74.55 -45.6 44.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.866 0.467 . . . . 0.0 111.285 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.73 -75.86 0.22 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.613 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.81 13.64 0.91 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.011 0.525 . . . . 0.0 112.352 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.76 -63.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.67 149.94 31.08 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.06 20.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.443 0.697 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mt -78.29 156.79 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.965 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.93 -10.2 68.15 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.445 HG23 HD11 ' A' ' 90' ' ' ILE . 86.8 m -65.2 152.21 44.21 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.536 1.134 . . . . 0.0 109.784 171.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 41' ' ' MET . 41.9 t -125.46 125.9 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.954 0.901 . . . . 0.0 109.438 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD3' ' HE1' ' A' ' 62' ' ' TRP . 21.7 ttm-85 -96.97 133.24 41.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 109.265 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 75' ' ' ILE . 67.7 mt -133.21 107.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.536 0.734 . . . . 0.0 109.177 -169.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.413 ' HE1' ' HD3' ' A' ' 60' ' ' ARG . 11.1 m0 -95.35 119.89 34.63 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.621 0.768 . . . . 0.0 110.743 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.21 166.11 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.892 0.877 . . . . 0.0 108.733 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' HD21 ' A' ' 6' ' ' LEU . 31.5 mmm180 -56.72 157.47 5.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.789 0.435 . . . . 0.0 110.612 166.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.85 95.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 28.7 ttt85 -110.16 116.72 32.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.346 -177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -78.71 1.17 23.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.763 1.225 . . . . 0.0 111.679 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -92.51 -19.43 21.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.425 1.09 . . . . 0.0 110.535 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 16.6 mm -79.91 134.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.957 0.503 . . . . 0.0 110.582 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -129.42 166.12 20.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.99 67.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.033 0.533 . . . . 0.0 110.955 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.1 p -82.58 19.43 1.29 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.654 0.781 . . . . 0.0 111.824 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -107.37 142.32 37.36 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.787 0.835 . . . . 0.0 108.842 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -107.58 133.35 52.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 61' ' ' ILE . 37.7 mm -94.49 91.7 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.112 0.482 . . . . 0.0 110.139 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 26.8 ttpp -86.99 106.3 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 99.1 t -78.8 130.35 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.116 0.566 . . . . 0.0 111.281 -169.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.5 m -89.81 -19.67 24.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.977 0.911 . . . . 0.0 113.048 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.6 p -135.0 -177.13 4.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.172 0.589 . . . . 0.0 110.92 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.12 -151.59 51.97 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.956 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.83 -12.89 13.29 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.177 2.585 . . . . 0.0 113.349 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.07 23.35 13.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.577 0.751 . . . . 0.0 110.737 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.7 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.406 0.682 . . . . 0.0 110.734 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.16 6.89 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.727 0.679 . . . . 0.0 112.13 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -71.06 139.36 50.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.059 0.544 . . . . 0.0 110.193 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.2 p -104.89 90.65 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.497 1.142 . . . . 0.0 108.927 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -70.76 149.26 47.07 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.861 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -122.11 137.93 54.64 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.27 95.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -173.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 58' ' ' THR . 25.3 pt -80.63 63.72 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 122.333 1.063 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.18 -118.27 0.82 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.434 ' H ' HD21 ' A' ' 105' ' ' LEU . 9.9 pt20 -162.74 142.43 7.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.64 0.776 . . . . 0.0 109.42 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.84 116.06 3.1 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.989 2.46 . . . . 0.0 110.751 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.94 108.15 38.96 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.809 0.843 . . . . 0.0 109.767 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.05 135.82 19.48 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.359 2.04 . . . . 0.0 110.129 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.0 174.07 9.12 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.57 62.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.652 0.781 . . . . 0.0 113.031 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.45 27.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.492 0.317 . . . . 0.0 111.258 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 62.06 30.49 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.232 1.013 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.1 t -86.13 -16.2 38.68 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.843 0.857 . . . . 0.0 110.933 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -152.12 166.45 31.63 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.675 0.75 . . . . 0.0 110.349 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 107.8 12.84 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -87.09 101.5 13.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.302 0.641 . . . . 0.0 109.448 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.5 mm -83.92 145.72 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.97 0.908 . . . . 0.0 108.788 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.4 pt? -122.78 143.07 50.07 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 72.2 m -151.53 176.09 11.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.705 0.802 . . . . 0.0 110.64 -170.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -161.11 155.35 22.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.373 0.669 . . . . 0.0 109.448 167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.34 144.89 28.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.183 0.993 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.92 35.77 3.7 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.023 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.69 91.89 0.36 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.967 1.307 . . . . 0.0 109.153 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -104.65 0.14 28.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.123 0.969 . . . . 0.0 111.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.056 0.942 . . . . 0.0 111.511 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -83.02 77.47 9.73 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.554 HG13 ' HG2' ' A' ' 5' ' ' ARG . 19.8 pt -97.68 157.6 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.729 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.22 25.65 6.06 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 114.05 0.38 . . . . 0.0 114.05 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.554 ' HG2' HG13 ' A' ' 3' ' ' ILE . 12.2 ptm180 -60.28 143.62 52.37 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.85 0.86 . . . . 0.0 110.683 176.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.3 mm? -70.59 96.05 1.15 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.056 0.847 . . . . 0.0 110.628 -169.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -98.96 -36.92 9.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.785 1.234 . . . . 0.0 112.369 -171.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -96.6 -167.6 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.775 1.23 . . . . 0.0 108.861 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' HB3' HG22 ' A' ' 34' ' ' THR . 49.3 mtm180 -148.91 146.46 27.9 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 0.0 110.418 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.3 151.27 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.841 0.856 . . . . 0.0 109.044 175.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -102.45 122.95 45.33 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.8 116.96 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.792 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -83.36 99.94 10.36 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 p -82.28 141.28 33.06 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.989 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.3 tp -110.27 113.77 26.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.513 0.725 . . . . 0.0 109.386 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -102.35 114.46 28.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.722 0.409 . . . . 0.0 110.212 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 41.8 mt-30 -75.51 90.3 2.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -91.54 110.23 21.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 109.703 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -71.24 158.59 36.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.534 0.334 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.92 164.41 13.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.428 0.691 . . . . 0.0 109.703 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.81 -11.23 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 125.068 1.347 . . . . 0.0 112.982 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 p -104.67 -23.99 13.01 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.84 44.67 1.74 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.94 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -106.41 149.91 26.55 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.33 101.69 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.906 0.483 . . . . 0.0 110.025 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.93 90.96 7.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.991 0.916 . . . . 0.0 108.96 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' HB3' HD11 ' A' ' 15' ' ' LEU . 42.4 mt-10 -79.34 121.04 24.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -137.98 141.85 40.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.587 1.155 . . . . 0.0 109.824 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -101.5 103.55 14.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.078 0.951 . . . . 0.0 109.088 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.44 125.73 34.88 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.247 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.83 113.36 7.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.706 1.202 . . . . 0.0 108.397 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.35 -109.45 2.86 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.319 -157.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -117.09 139.0 51.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.394 0.678 . . . . 0.0 110.215 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.7 m -101.45 98.44 8.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 109.74 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 63' ' ' ILE . 1.3 pt? -106.69 163.73 12.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.952 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -59.49 123.31 16.43 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.113 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.83 176.44 8.7 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.203 1.001 . . . . 0.0 110.933 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -136.94 107.55 6.54 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 77' ' ' VAL . 66.5 t -105.29 131.6 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.65 0.78 . . . . 0.0 109.307 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -151.29 159.58 44.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 167.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.453 ' SD ' HG22 ' A' ' 59' ' ' VAL . 19.8 mmt -67.76 148.22 51.55 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.19 145.23 13.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 O-C-N 123.746 0.654 . . . . 0.0 110.151 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 47.4 t -74.35 163.27 28.0 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.955 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 p -61.21 -31.5 71.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.501 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 16.9 ptpt -62.17 -33.5 74.64 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.469 0.707 . . . . 0.0 111.492 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.75 -50.84 14.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.558 0.743 . . . . 0.0 110.258 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.95 40.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.437 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.2 mt -66.43 -27.32 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.773 0.829 . . . . 0.0 111.982 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -59.24 -49.36 78.14 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.787 0.435 . . . . 0.0 110.572 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 83.9 p -79.78 -12.29 59.79 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.151 0.58 . . . . 0.0 111.564 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -77.5 2.04 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.89 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.103 0.561 . . . . 0.0 111.847 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 32.6 mt-10 -78.36 -69.54 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.94 141.91 31.81 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -139.75 156.91 46.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.96 0.504 . . . . 0.0 110.212 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.59 125.55 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.07 -12.58 12.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -163.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 m -77.77 154.61 31.8 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 156.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG22 ' SD ' ' A' ' 41' ' ' MET . 40.5 t -124.53 128.04 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.841 0.857 . . . . 0.0 111.033 -170.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -98.2 128.86 44.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.335 0.654 . . . . 0.0 109.519 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.619 HD13 HG21 ' A' ' 75' ' ' ILE . 65.7 mt -135.0 143.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.141 0.976 . . . . 0.0 108.494 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 60.1 m95 -134.92 121.67 20.86 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 35' ' ' LEU . 44.6 pt -121.41 168.75 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.414 0.686 . . . . 0.0 109.977 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -47.42 146.75 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.595 0.758 . . . . 0.0 112.748 165.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -67.35 108.95 2.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.358 0.663 . . . . 0.0 110.287 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' HD13 ' A' ' 35' ' ' LEU . 9.9 ptp180 -149.21 125.63 10.91 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.059 0.544 . . . . 0.0 110.327 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -84.09 12.35 6.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.394 1.078 . . . . 0.0 111.408 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.28 -18.31 28.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.405 1.082 . . . . 0.0 110.004 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.417 HG13 HD11 ' A' ' 63' ' ' ILE . 21.6 mm -74.55 138.69 20.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 159.68 34.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.14 -20.67 66.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.594 0.358 . . . . 0.0 111.808 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -92.06 28.23 1.93 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -107.34 161.74 14.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.553 HH21 HG21 ' A' ' 86' ' ' VAL . 51.3 mtp180 -125.04 128.55 48.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.619 HG21 HD13 ' A' ' 61' ' ' ILE . 44.5 mm -88.4 96.52 6.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.721 0.808 . . . . 0.0 109.454 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -94.76 109.39 21.35 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.484 HG23 HD23 ' A' ' 87' ' ' LEU . 61.5 t -74.99 124.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.381 0.672 . . . . 0.0 110.789 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 t -83.52 -25.66 30.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.71 0.804 . . . . 0.0 111.342 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.1 t -163.37 132.53 4.02 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.59 -163.7 30.43 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.93 -14.24 29.36 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.778 2.319 . . . . 0.0 112.028 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.1 mt -123.06 32.28 5.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.285 1.034 . . . . 0.0 110.01 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.73 25.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.45 0.7 . . . . 0.0 110.659 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.62 12.29 72.63 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.588 0.555 . . . . 0.0 113.085 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -119.9 148.18 43.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.348 0.659 . . . . 0.0 109.44 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.553 HG21 HH21 ' A' ' 74' ' ' ARG . 5.1 p -111.17 97.9 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 122.624 1.202 . . . . 0.0 110.93 -173.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD23 HG23 ' A' ' 77' ' ' VAL . 1.8 mm? -86.38 142.43 28.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.387 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -103.59 143.32 32.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.363 1.065 . . . . 0.0 108.763 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.29 129.62 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 pt -113.07 132.73 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.893 0.877 . . . . 0.0 109.27 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.76 -84.38 1.41 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 29.6 pt20 -169.34 158.13 7.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.683 0.793 . . . . 0.0 110.512 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.24 148.87 27.51 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.05 1.833 . . . . 0.0 110.334 159.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.18 125.05 5.08 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 152.55 40.12 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.443 2.096 . . . . 0.0 112.194 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.73 178.02 3.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 122.289 -0.257 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.87 -36.42 83.25 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.767 0.827 . . . . 0.0 112.523 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.76 -13.29 34.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.119 0.568 . . . . 0.0 111.958 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 62.45 34.47 15.43 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.628 1.171 . . . . 0.0 111.408 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -98.33 0.33 45.31 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.747 0.819 . . . . 0.0 110.817 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 5.4 ptp180 -169.51 -177.77 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.95 0.9 . . . . 0.0 109.242 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.07 112.64 16.09 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.91 119.6 17.37 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.547 HG22 ' SG ' ' A' ' 106' ' ' CYS . 25.8 mm -109.8 118.83 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -98.65 133.47 42.95 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.178 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 104' ' ' ILE . 85.3 m -144.98 173.68 11.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.036 -170.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -150.03 162.89 39.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -45.59 143.79 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.044 0.537 . . . . 0.0 111.099 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.22 51.12 4.2 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.136 0.273 . . . . 0.0 113.14 -171.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.23 89.23 3.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.49 71.28 6.06 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.983 0.913 . . . . 0.0 109.26 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--O 1.247 0.932 0 C-N-CA 124.9 1.28 . . . . 0.0 108.617 -175.851 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -68.58 109.61 3.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.229 0.612 . . . . 0.0 109.511 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -85.75 -15.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 177.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.61 37.58 3.47 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.239 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -76.6 -16.6 59.54 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.969 0.508 . . . . 0.0 110.666 172.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.7 104.25 16.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.335 1.054 . . . . 0.0 109.578 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -83.22 -39.55 20.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.061 0.944 . . . . 0.0 112.218 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.63 -171.35 1.82 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.557 1.543 . . . . 0.0 109.905 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -143.85 147.35 33.94 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.616 1.166 . . . . 0.0 110.214 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.04 154.7 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.421 1.089 . . . . 0.0 109.576 177.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -108.56 125.37 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.197 0.999 . . . . 0.0 108.47 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.53 125.92 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 123.395 0.435 . . . . 0.0 110.373 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 19.3 mp0 -88.07 100.28 12.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.096 0.958 . . . . 0.0 108.68 170.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -83.63 143.84 29.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.818 172.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.7 tp -90.7 107.7 19.34 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.672 0.389 . . . . 0.0 110.627 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.53 97.06 8.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.545 0.738 . . . . 0.0 109.375 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.23 90.75 2.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -89.94 161.14 16.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.213 1.005 . . . . 0.0 109.389 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -125.97 154.54 42.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.13 -0.356 . . . . 0.0 110.577 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.8 t70 -104.64 160.06 15.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.78 1.232 . . . . 0.0 108.64 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.31 -11.37 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -108.7 -0.51 20.03 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.682 0.753 . . . . 0.0 109.261 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 28.58 9.09 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.249 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 10.3 mm-40 -92.75 134.78 34.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.1 mm -91.07 118.14 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.83 17.51 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' HD11 ' A' ' 15' ' ' LEU . 1.9 mp0 -78.78 114.94 18.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.8 p -130.22 152.48 49.6 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.128 0.971 . . . . 0.0 108.385 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -106.59 103.86 13.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -87.34 128.71 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.09 145.56 55.2 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -106.93 2.56 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -115.2 135.21 54.42 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.073 0.949 . . . . 0.0 108.683 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.4 m -94.26 95.8 9.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.1 pt? -111.34 169.49 8.76 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.45 0.643 . . . . 0.0 111.447 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -71.12 130.37 41.32 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.739 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.703 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.84 176.72 8.46 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.495 175.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 55.4 m -130.58 98.99 4.82 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.61 102.6 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.497 0.719 . . . . 0.0 109.07 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.15 106.42 14.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.054 0.942 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' HG22 ' A' ' 59' ' ' VAL . 86.6 mmm -60.19 117.94 5.76 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 m -70.63 155.58 7.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 121.118 0.485 . . . . 0.0 110.668 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t -85.22 176.98 8.02 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.458 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.73 -28.73 66.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.055 0.942 . . . . 0.0 111.909 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 20.4 ptmt -49.33 -42.75 42.61 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.798 1.239 . . . . 0.0 113.463 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.52 -41.16 93.45 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.295 0.638 . . . . 0.0 111.052 -176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.19 74.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.758 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.1 mt -60.51 -43.31 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.68 0.792 . . . . 0.0 111.26 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.5 m -69.72 -33.8 72.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.391 0.676 . . . . 0.0 111.994 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 77.8 p -82.09 -30.25 31.34 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.635 0.374 . . . . 0.0 111.046 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.82 -66.03 0.24 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.044 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 15.04 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.299 1.04 . . . . 0.0 110.59 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.1 tt0 -86.13 -53.75 4.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.601 0.76 . . . . 0.0 109.584 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 58' ' ' THR . 94.4 mt -84.53 160.8 20.42 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 167.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.88 154.82 40.48 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.751 0.82 . . . . 0.0 110.153 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.83 108.28 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.52 10.92 20.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.497 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.402 HG21 HD22 ' A' ' 54' ' ' LEU . 37.9 m -64.71 122.18 16.26 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.702 HG22 ' SD ' ' A' ' 41' ' ' MET . 24.8 t -86.95 105.6 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.778 0.831 . . . . 0.0 110.026 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -90.74 133.37 35.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.576 HD13 HG21 ' A' ' 75' ' ' ILE . 79.6 mt -135.79 117.46 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.134 0.974 . . . . 0.0 108.895 -169.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 79.3 m95 -102.73 119.12 38.27 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 122.888 0.475 . . . . 0.0 109.909 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 pt -124.22 155.76 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -59.17 163.64 3.61 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.25 0.477 . . . . 0.0 111.396 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' HA ' HD13 ' A' ' 102' ' ' LEU . 42.5 t80 -55.8 100.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.755 0.822 . . . . 0.0 111.203 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -118.93 106.28 12.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -68.03 -24.08 65.06 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.389 1.076 . . . . 0.0 113.28 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.25 -18.64 23.14 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.624 0.769 . . . . 0.0 112.325 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -67.18 132.63 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -154.17 173.6 15.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -26.39 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.505 0.722 . . . . 0.0 112.329 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.7 p -80.09 9.91 4.99 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.282 1.033 . . . . 0.0 113.341 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.0 p -117.55 156.94 27.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.257 0.623 . . . . 0.0 109.503 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 74.5 mtp180 -112.95 155.0 25.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 171.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.576 HG21 HD13 ' A' ' 61' ' ' ILE . 21.3 mm -116.82 103.21 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.26 0.624 . . . . 0.0 109.864 -177.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.2 ttpt -94.15 109.5 21.28 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 HD23 ' A' ' 87' ' ' LEU . 95.8 t -73.23 126.85 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 O-C-N 123.622 0.576 . . . . 0.0 110.516 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.4 m -79.67 -25.17 41.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.292 1.037 . . . . 0.0 113.287 -171.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -152.53 178.47 9.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.71 -146.64 30.07 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.42 -0.655 . . . . 0.0 113.052 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.64 -22.47 13.69 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.262 2.642 . . . . 0.0 113.289 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.639 HD11 ' SD ' ' A' ' 41' ' ' MET . 92.5 mt -115.71 31.29 6.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.881 0.473 . . . . 0.0 110.927 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.72 94.71 0.31 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.476 0.71 . . . . 0.0 110.895 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.0 -17.81 8.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.739 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -79.23 129.57 34.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.374 0.67 . . . . 0.0 109.722 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -102.36 80.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 122.648 1.214 . . . . 0.0 109.152 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 77' ' ' VAL . 2.0 mm? -65.78 153.52 41.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.184 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -120.43 139.1 53.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 106' ' ' CYS . 62.7 mt -80.78 104.07 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -172.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 107' ' ' ARG . 40.0 pt -83.1 16.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.002 0.921 . . . . 0.0 112.36 -174.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.57 -141.85 3.23 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -128.89 134.81 26.73 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.575 ' HB2' HD23 ' A' ' 102' ' ' LEU . 67.1 Cg_endo -68.36 146.13 67.85 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.905 2.403 . . . . 0.0 111.52 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 120.41 5.01 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 40.3 Cg_endo -66.65 157.43 60.94 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.555 . . . . 0.0 113.743 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.56 179.73 3.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.25 69.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.872 0.869 . . . . 0.0 112.623 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.6 -11.26 29.74 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.36 0.664 . . . . 0.0 112.463 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.2 20.02 8.97 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.958 0.903 . . . . 0.0 111.938 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -74.82 -18.02 60.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.411 0.684 . . . . 0.0 111.842 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.18 153.27 5.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.618 0.767 . . . . 0.0 110.764 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 93' ' ' PRO . 8.1 mp -102.82 133.95 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.131 0.973 . . . . 0.0 109.718 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.37 116.54 23.76 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 12.4 mm -98.95 131.81 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 173.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -106.77 136.83 45.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 89' ' ' ILE . 83.9 m -148.73 172.92 13.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.4 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HB3' HG21 ' A' ' 90' ' ' ILE . 72.3 ttt-85 -163.6 154.38 16.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -74.19 131.17 41.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.92 28.32 7.33 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.27 111.13 0.02 OUTLIER 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.401 1.48 . . . . 0.0 111.734 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.76 83.76 0.07 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.923 -168.166 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.53 147.43 23.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.867 0.467 . . . . 0.0 109.872 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.45 153.5 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 108.775 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.5 49.29 3.82 Favored Glycine 0 C--N 1.348 1.241 0 C-N-CA 123.184 0.421 . . . . 0.0 112.914 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 163.82 12.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.868 0.867 . . . . 0.0 110.594 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -123.29 169.1 11.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.909 0.884 . . . . 0.0 109.968 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -136.13 -28.91 1.03 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.22 0.608 . . . . 0.0 112.438 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' THR . 70.0 m-20 -107.14 -171.26 1.85 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.45 1.5 . . . . 0.0 110.419 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -141.11 147.14 38.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.315 1.046 . . . . 0.0 108.975 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.88 155.61 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.233 0.613 . . . . 0.0 109.791 173.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 m -113.18 124.99 53.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.364 0.666 . . . . 0.0 109.628 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.53 108.86 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.637 1.175 . . . . 0.0 110.596 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.6 mp0 -80.74 98.3 7.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.045 0.926 . . . . 0.0 108.979 172.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 5.0 m -79.8 145.23 32.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.987 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.2 tp -97.38 99.79 11.22 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.92 -0.487 . . . . 0.0 109.817 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -83.44 105.66 14.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.218 0.607 . . . . 0.0 109.876 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 50.3 mt-30 -88.31 89.06 7.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.5 m -94.04 135.12 35.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.099 0.96 . . . . 0.0 110.0 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 4.7 ttp180 -74.47 148.41 41.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . 20.5 t70 -96.58 163.81 12.87 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.12 -11.05 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -99.24 -4.2 32.5 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.446 -0.784 . . . . 0.0 109.643 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.73 44.51 6.79 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.821 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.6 mt-10 -103.37 173.58 6.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.719 0.807 . . . . 0.0 109.736 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.61 103.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.341 0.656 . . . . 0.0 109.308 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 20' ' ' ASP . 8.8 mp -94.61 108.94 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.833 1.253 . . . . 0.0 109.31 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 41.9 mt-10 -79.88 117.0 20.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 p -131.91 157.4 44.08 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.359 1.063 . . . . 0.0 109.422 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -103.83 101.5 11.32 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 6.3 pt-20 -83.37 123.01 29.23 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.32 115.43 10.47 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.66 -119.77 4.32 Favored Glycine 0 N--CA 1.474 1.192 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.876 -160.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.97 159.76 28.61 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.554 0.742 . . . . 0.0 110.478 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 47.0 m -138.07 95.97 3.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 169.79 8.58 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.933 -174.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -67.85 131.42 45.49 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.425 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -140.82 178.28 7.45 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.99 0.916 . . . . 0.0 111.363 176.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -140.73 105.18 4.87 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.84 114.63 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -133.01 124.59 27.97 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.523 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -67.78 134.56 51.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.19 152.3 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.552 0.341 . . . . 0.0 110.203 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t -97.91 -175.43 3.15 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 56' ' ' ILE . 14.2 p -55.93 -30.55 61.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.284 1.033 . . . . 0.0 112.936 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -50.14 -48.17 53.79 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.648 1.179 . . . . 0.0 112.716 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.16 -36.65 72.1 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.05 96.57 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.004 0.815 . . . . 0.0 110.519 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.48 -46.78 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.433 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -71.67 -24.15 61.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.417 0.687 . . . . 0.0 112.399 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 31.8 m -101.84 -5.4 24.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.218 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.07 -90.07 0.79 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.019 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.99 -11.68 10.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 110.803 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 10.0 tp10 -64.43 -59.82 3.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 110.288 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.677 HD22 HG21 ' A' ' 58' ' ' THR . 61.2 mt -93.88 162.07 14.06 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.92 166.19 25.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 110.315 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 44' ' ' SER . 59.6 mt -71.12 111.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.12 -10.38 17.72 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-O 120.218 -0.212 . . . . 0.0 112.626 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.677 HG21 HD22 ' A' ' 54' ' ' LEU . 24.5 m -61.6 137.75 58.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.304 0.642 . . . . 0.0 109.53 169.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 41' ' ' MET . 48.9 t -105.33 127.46 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 109.867 -177.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -109.32 144.32 37.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.41 0.624 . . . . 0.0 109.909 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 75' ' ' ILE . 41.0 mt -135.69 107.35 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -167.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -96.06 114.4 26.11 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.5 pt -116.37 155.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 1.6 tmt_? -55.83 143.98 29.42 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.501 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 57.0 t80 -45.16 124.68 4.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 111.666 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' H ' HD23 ' A' ' 102' ' ' LEU . 5.7 tpm_? -151.26 116.01 5.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.51 0.724 . . . . 0.0 109.54 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HE3' ' HE2' ' A' ' 65' ' ' TYR . 91.0 mttt -84.8 8.59 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.194 0.998 . . . . 0.0 111.577 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.98 -24.11 17.78 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.511 1.124 . . . . 0.0 111.567 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.88 126.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.716 0.406 . . . . 0.0 111.287 -170.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.89 157.96 30.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.84 -13.53 60.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.428 0.691 . . . . 0.0 112.68 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 p -77.05 -24.14 51.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.804 0.441 . . . . 0.0 110.964 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -73.19 155.21 39.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.316 0.647 . . . . 0.0 110.627 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 75.9 mtm180 -113.5 162.81 15.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 172.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.633 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.4 mp -112.17 126.97 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.052 1.341 . . . . 0.0 108.177 171.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -118.86 116.14 25.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.45 110.25 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 123.556 0.535 . . . . 0.0 110.998 -170.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.467 ' H ' ' HA ' ' A' ' 10' ' ' ILE . 31.8 t -70.5 -27.2 64.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.593 1.157 . . . . 0.0 111.265 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' ASP . 12.8 t -166.45 137.96 3.56 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.59 -162.45 30.73 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 119.771 -0.46 . . . . 0.0 112.294 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.33 -14.17 18.45 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.11 2.54 . . . . 0.0 111.765 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -124.81 32.86 5.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.441 1.096 . . . . 0.0 109.162 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.32 102.22 0.21 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.739 0.815 . . . . 0.0 111.507 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.85 0.24 15.09 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 119.859 -0.411 . . . . 0.0 113.147 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -106.64 160.47 15.43 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.582 0.753 . . . . 0.0 110.077 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.25 100.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.947 1.356 . . . . 0.0 111.168 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.93 124.5 34.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.269 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -97.6 142.32 29.55 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.324 1.05 . . . . 0.0 108.334 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.07 117.45 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.26 71.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 121.98 0.895 . . . . 0.0 109.852 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.53 -114.24 0.63 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.174 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.549 ' H ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -166.81 142.79 3.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.73 0.812 . . . . 0.0 109.438 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 102' ' ' LEU . 37.1 Cg_endo -60.28 120.74 8.68 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.791 2.328 . . . . 0.0 112.145 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.93 108.62 55.47 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.336 1.055 . . . . 0.0 108.965 -170.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 153.73 53.62 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.797 2.331 . . . . 0.0 113.082 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 6.8 p-10 -84.33 172.45 11.79 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 0.0 110.462 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.13 75.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.893 0.877 . . . . 0.0 112.249 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.04 -9.35 59.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.931 0.492 . . . . 0.0 111.65 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 25.2 mmt180 60.58 28.64 18.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.132 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -101.16 -5.44 25.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.845 0.858 . . . . 0.0 110.739 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.03 155.58 25.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.312 0.577 . . . . 0.0 110.903 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 93' ' ' PRO . 3.3 mm? -108.83 113.07 25.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -77.07 107.06 9.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.51 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.1 mm -96.55 134.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -111.25 130.6 55.61 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.51 ' SG ' HG22 ' A' ' 104' ' ' ILE . 71.9 m -153.77 176.68 11.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -167.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ptm85 -160.27 163.58 33.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.9 145.49 45.65 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.294 0.371 . . . . 0.0 110.874 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.92 51.38 4.29 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.39 102.58 5.19 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.13 0.972 . . . . 0.0 110.318 -175.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.39 79.27 0.38 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 110.952 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.198 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -71.31 99.17 1.89 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.085 0.554 . . . . 0.0 109.743 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mt 70.81 2.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 125.193 1.397 . . . . 0.0 111.29 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.11 55.15 3.63 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -149.73 154.88 39.24 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.731 1.213 . . . . 0.0 108.474 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 1.7 mm? -77.75 95.76 4.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 -170.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -97.9 -41.96 7.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.401 1.081 . . . . 0.0 111.276 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -102.61 -167.17 1.36 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.295 1.438 . . . . 0.0 110.238 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -146.38 150.8 36.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.857 1.263 . . . . 0.0 109.055 171.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.93 145.36 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.332 0.653 . . . . 0.0 109.698 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 31' ' ' ASP . 3.2 m -90.61 124.6 35.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 167.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.8 mm -71.14 107.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 35.4 tt0 -78.84 95.35 5.36 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.624 1.202 . . . . 0.0 108.26 176.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 27.8 m -81.58 142.54 32.71 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.455 -2.157 . . . . 0.0 109.641 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 27' ' ' GLU . 37.5 tp -98.5 104.49 16.53 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -96.25 123.9 40.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -102.85 102.41 12.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -110.82 121.18 44.7 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.377 1.071 . . . . 0.0 109.164 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -69.11 164.93 21.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.311 0.644 . . . . 0.0 110.979 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -113.51 165.71 12.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.43 3.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 C-N-CA 124.563 1.145 . . . . 0.0 113.616 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.1 p -100.72 -11.76 19.68 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.14 -0.975 . . . . 0.0 109.765 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.7 30.4 15.5 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.859 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -104.82 135.32 46.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.83 0.852 . . . . 0.0 108.908 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.76 112.5 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.101 0.41 . . . . 0.0 110.013 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.06 117.22 30.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -84.52 118.63 24.43 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.422 0.689 . . . . 0.0 109.311 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.1 p -129.82 151.21 50.65 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 0.0 109.933 -175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -110.31 104.17 12.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.679 0.792 . . . . 0.0 110.193 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 10.7 pt-20 -91.57 152.83 20.12 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.857 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.2 p-10 -85.26 131.8 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.7 -113.71 3.86 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -170.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -112.09 135.27 52.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.508 0.723 . . . . 0.0 109.722 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.3 m -98.74 106.64 18.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.474 0.709 . . . . 0.0 110.194 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.623 HD11 HD12 ' A' ' 63' ' ' ILE . 1.1 pt? -111.31 165.29 12.07 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.697 0.76 . . . . 0.0 112.242 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.541 ' HD1' ' HD2' ' A' ' 64' ' ' ARG . 51.6 m95 -56.98 122.45 12.33 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.324 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -133.04 176.64 8.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.238 1.015 . . . . 0.0 111.982 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.2 t -145.78 101.2 3.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 162.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 61' ' ' ILE . 53.1 t -96.29 113.09 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.672 0.789 . . . . 0.0 109.281 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -134.53 130.32 36.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.145 0.578 . . . . 0.0 109.874 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.686 ' SD ' HG22 ' A' ' 59' ' ' VAL . 77.9 mmm -62.74 131.28 48.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.681 . . . . 0.0 109.447 170.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 60' ' ' ARG . 8.0 m -71.13 152.36 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.269 0.356 . . . . 0.0 110.12 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.9 m -77.54 168.65 19.64 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.0 p -61.04 -20.82 63.0 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.447 0.699 . . . . 0.0 111.812 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 14.6 ptmm? -51.32 -35.63 38.96 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.163 1.385 . . . . 0.0 112.413 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -70.73 -41.26 72.09 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.416 0.447 . . . . 0.0 110.558 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.16 93.59 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.664 0.786 . . . . 0.0 110.415 175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.93 -43.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.221 1.008 . . . . 0.0 110.827 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 t -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.977 0.911 . . . . 0.0 111.121 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 81.8 p -89.6 -4.74 57.69 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.392 0.677 . . . . 0.0 111.229 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.37 -68.38 3.32 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.217 0.437 . . . . 0.0 112.064 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.54 16.97 0.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.794 0.838 . . . . 0.0 110.564 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.5 tp10 -79.25 -67.27 0.77 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.82 152.44 40.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.77 27.66 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.626 0.771 . . . . 0.0 109.882 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 mt -73.03 129.61 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.99 -9.55 15.76 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 106' ' ' CYS . 55.1 m -70.66 142.61 51.57 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.717 0.807 . . . . 0.0 109.027 169.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.686 HG22 ' SD ' ' A' ' 41' ' ' MET . 26.9 t -122.07 129.85 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.776 0.831 . . . . 0.0 109.612 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 42' ' ' VAL . 8.5 ttt85 -103.64 126.22 50.64 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 75' ' ' ILE . 30.4 mt -129.95 106.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.898 0.879 . . . . 0.0 108.756 -167.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -97.43 111.99 24.01 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 35' ' ' LEU . 42.8 pt -122.19 153.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.541 ' HD2' ' HD1' ' A' ' 36' ' ' TRP . 5.7 ptm180 -56.35 153.91 9.02 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 120.73 0.3 . . . . 0.0 111.399 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.69 134.35 55.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.366 0.666 . . . . 0.0 110.269 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.412 ' H ' HD23 ' A' ' 102' ' ' LEU . 32.1 ttt180 -158.63 136.28 10.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.716 0.635 . . . . 0.0 110.066 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -83.3 -5.36 59.11 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.742 0.817 . . . . 0.0 112.486 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.49 -19.65 21.03 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.835 0.854 . . . . 0.0 111.204 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.5 mm -69.71 121.56 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.918 0.487 . . . . 0.0 110.259 -172.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.71 162.41 32.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 109.6 -172.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -64.05 -27.34 69.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.708 0.803 . . . . 0.0 112.325 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -74.03 -17.56 60.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 0.0 111.779 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -96.76 105.08 17.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.006 0.922 . . . . 0.0 110.087 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 82.5 mtp180 -72.77 162.47 29.44 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.966 0.412 . . . . 0.0 111.441 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 HD13 ' A' ' 61' ' ' ILE . 44.1 mm -106.23 102.97 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.707 0.803 . . . . 0.0 110.19 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -96.77 112.66 24.32 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.36 119.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.683 0.393 . . . . 0.0 111.605 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -77.7 -25.76 49.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.708 0.803 . . . . 0.0 111.998 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -168.39 135.36 2.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.579 0.751 . . . . 0.0 109.397 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.97 -164.91 28.19 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.616 -0.546 . . . . 0.0 112.228 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.78 -6.52 17.61 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.098 2.532 . . . . 0.0 112.593 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HD11 ' A' ' 87' ' ' LEU . 78.1 mt -130.37 26.92 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.226 1.01 . . . . 0.0 110.019 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 105.73 0.6 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.66 0.784 . . . . 0.0 111.552 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.89 -40.13 2.09 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.87 139.46 41.69 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.528 0.731 . . . . 0.0 110.364 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 t -106.59 110.77 32.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.385 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD13 ' A' ' 82' ' ' LEU . 1.4 mm? -74.65 150.96 39.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.886 0.874 . . . . 0.0 110.365 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.47 ' OD1' ' HA3' ' A' ' 109' ' ' GLY . 9.0 m120 -114.09 135.81 53.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.393 1.077 . . . . 0.0 108.494 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 106' ' ' CYS . 61.8 mt -82.54 121.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -172.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -77.87 121.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.519 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.76 -87.61 0.36 Allowed Glycine 0 C--N 1.345 1.062 0 O-C-N 123.91 0.756 . . . . 0.0 112.735 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 23.2 pt20 -166.37 150.13 6.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.858 1.263 . . . . 0.0 108.951 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.37 157.64 58.58 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.526 2.151 . . . . 0.0 112.159 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.25 109.55 19.61 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.316 0.647 . . . . 0.0 110.142 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.55 133.81 50.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.774 2.316 . . . . 0.0 110.496 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 99' ' ' ARG . 5.1 p-10 -64.95 173.99 2.1 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.707 0.403 . . . . 0.0 111.164 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.29 -35.6 67.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.032 0.933 . . . . 0.0 112.943 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.61 -13.24 40.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 112.105 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 96' ' ' ASP . 3.7 mpt_? 60.88 29.15 18.83 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.429 1.092 . . . . 0.0 110.767 -175.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -93.59 -0.86 56.03 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.985 0.914 . . . . 0.0 110.39 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 8.4 ptp85 -163.57 169.35 18.79 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.737 0.815 . . . . 0.0 110.092 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -110.23 109.23 19.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.83 1.252 . . . . 0.0 107.644 169.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.62 110.86 20.12 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.521 HG22 ' SG ' ' A' ' 106' ' ' CYS . 14.3 mm -98.42 116.17 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -89.27 134.79 33.91 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 104' ' ' ILE . 99.1 m -151.58 -179.38 7.36 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 109.494 -173.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -149.37 152.25 35.46 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 166.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.1 107.19 0.7 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.096 0.474 . . . . 0.0 111.365 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' ' OD1' ' A' ' 88' ' ' ASN . . . -93.46 35.35 4.16 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.565 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.01 35.98 1.64 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.414 1.086 . . . . 0.0 108.616 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.99 -34.25 61.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.498 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.26 175.389 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -83.79 103.85 13.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.23 140.09 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.591 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.14 39.16 2.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.13 0.269 . . . . 0.0 113.545 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -73.44 146.25 45.15 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.982 0.913 . . . . 0.0 109.802 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 31.9 mt -81.55 93.45 6.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.52 -163.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -100.13 -24.99 14.43 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.946 0.898 . . . . 0.0 111.784 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -108.01 -173.31 2.25 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.951 1.3 . . . . 0.0 109.626 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.54 ' HG2' HG22 ' A' ' 34' ' ' THR . 51.0 ttp180 -148.09 131.86 16.98 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -129.99 153.32 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.6 0.76 . . . . 0.0 110.554 -175.332 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -103.04 124.64 48.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.221 1.008 . . . . 0.0 110.091 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.29 116.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 123.623 0.577 . . . . 0.0 109.946 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.693 1.197 . . . . 0.0 109.103 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -80.21 140.33 36.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.534 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 27' ' ' GLU . 33.2 tp -91.99 97.6 11.05 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -88.66 108.26 19.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.849 0.859 . . . . 0.0 109.56 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 48.4 mt-30 -91.58 101.31 13.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -109.58 122.3 47.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.667 0.787 . . . . 0.0 109.398 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -78.53 157.87 28.72 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.734 0.302 . . . . 0.0 110.294 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 22.7 t70 -103.51 168.73 8.97 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.617 0.767 . . . . 0.0 109.189 -172.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.48 -4.59 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 124.413 1.085 . . . . 0.0 112.666 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -110.98 -31.02 7.27 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.57 31.09 1.71 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.184 -1.371 . . . . 0.0 114.623 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 48.3 mm-40 -79.91 144.54 33.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 mm -95.89 101.77 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.6 90.93 6.86 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 44.3 mt-10 -79.68 105.56 11.07 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.9 p -123.93 155.11 38.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.334 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -109.45 96.71 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.48 130.63 35.59 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.21 127.53 32.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.48 -110.4 3.39 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -168.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -105.44 132.45 51.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 9' ' ' ARG . 36.5 m -104.58 95.17 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -108.44 170.1 8.23 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.591 0.71 . . . . 0.0 112.26 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 50.5 m95 -69.93 133.03 46.86 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.665 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -138.49 168.56 19.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.791 0.836 . . . . 0.0 112.175 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.9 t -120.98 94.06 4.22 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 162.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HG12 ' A' ' 61' ' ' ILE . 3.7 p -94.58 90.46 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 122.325 1.06 . . . . 0.0 108.978 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.3 118.51 36.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.444 -172.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.445 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.3 mtp -67.62 141.51 56.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.63 155.03 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.914 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 46' ' ' GLU . 18.0 m -76.13 163.46 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.091 0.556 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -62.43 -35.64 79.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.316 0.647 . . . . 0.0 110.465 176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.25 -28.54 69.42 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.621 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 15.4 mm-40 -71.81 -41.42 68.27 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.371 0.419 . . . . 0.0 110.207 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.23 -52.34 65.7 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 124.184 0.928 . . . . 0.0 111.184 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.29 -48.24 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.272 1.029 . . . . 0.0 111.953 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.26 -30.62 65.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.558 0.743 . . . . 0.0 111.728 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 11.1 t -90.22 -8.59 50.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.587 0.755 . . . . 0.0 110.578 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.42 -102.36 1.18 Allowed Glycine 0 C--N 1.352 1.452 0 O-C-N 123.587 0.555 . . . . 0.0 112.787 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.09 -5.55 17.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.927 0.891 . . . . 0.0 111.789 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 10.3 tp10 -74.55 -75.42 0.16 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.754 0.422 . . . . 0.0 109.973 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 58' ' ' THR . 64.7 mt -83.33 147.73 27.76 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.28 165.53 25.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.203 1.001 . . . . 0.0 109.048 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.13 117.06 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.66 -10.67 14.12 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.526 0.517 . . . . 0.0 112.101 -168.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.687 HG21 HD22 ' A' ' 54' ' ' LEU . 93.7 m -74.53 139.37 43.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 41' ' ' MET . 44.7 t -126.29 132.47 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.592 0.757 . . . . 0.0 110.599 -173.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -99.65 141.06 32.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 50.9 mt -134.57 107.9 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -102.73 112.75 25.67 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 37' ' ' ALA . 39.3 pt -123.93 166.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.147 0.579 . . . . 0.0 109.748 -173.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 21.5 mmt180 -53.07 137.99 32.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.273 0.488 . . . . 0.0 111.415 164.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HE1' ' HE3' ' A' ' 67' ' ' LYS . 28.3 t80 -55.87 116.69 3.1 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.175 0.99 . . . . 0.0 109.167 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HD3' HD11 ' A' ' 69' ' ' ILE . 37.0 ttt180 -140.02 121.06 14.66 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HE3' ' HE1' ' A' ' 65' ' ' TYR . 32.7 mmtp -69.18 -10.1 56.11 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.825 1.25 . . . . 0.0 112.431 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.78 -19.23 22.8 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.619 0.767 . . . . 0.0 110.976 -173.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 66' ' ' ARG . 33.3 mm -69.8 119.93 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -116.88 168.59 10.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.989 0.916 . . . . 0.0 108.961 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.01 -24.67 66.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.786 . . . . 0.0 110.992 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -90.78 13.54 16.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.698 0.799 . . . . 0.0 111.67 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 100.33 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.929 0.892 . . . . 0.0 109.266 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -72.23 165.5 24.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.685 0.755 . . . . 0.0 111.035 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.1 mp -115.6 130.28 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -125.32 113.87 18.16 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 82' ' ' LEU . 62.0 t -68.31 115.9 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.361 0.413 . . . . 0.0 111.626 -169.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.142 0.977 . . . . 0.0 111.813 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' ' 9' ' ' ARG . 10.0 t -166.68 129.05 1.81 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.786 0.835 . . . . 0.0 109.499 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.67 -165.9 31.15 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.46 -0.633 . . . . 0.0 111.952 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.02 -15.01 35.97 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.829 2.352 . . . . 0.0 112.304 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 87' ' ' LEU . 96.7 mt -122.78 35.01 4.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.061 0.945 . . . . 0.0 110.486 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.88 111.83 1.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.044 0.538 . . . . 0.0 110.42 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.82 -17.64 41.73 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.506 0.504 . . . . 0.0 113.229 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -83.96 132.3 34.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.81 0.844 . . . . 0.0 109.611 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.25 101.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 122.078 0.942 . . . . 0.0 110.54 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 HD13 ' A' ' 82' ' ' LEU . 1.2 mm? -81.57 124.41 29.5 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.327 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.7 141.51 32.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.529 1.132 . . . . 0.0 109.036 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 106' ' ' CYS . 39.4 mt -78.19 128.63 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.1 68.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 122.0 0.905 . . . . 0.0 109.605 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.19 -122.88 1.53 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.691 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -140.6 146.5 45.06 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 108.679 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.29 102.11 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.181 1.92 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.74 112.74 34.41 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.908 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.92 137.21 44.12 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.435 2.09 . . . . 0.0 111.667 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.498 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 34.9 t70 -58.73 144.54 43.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.82 0.448 . . . . 0.0 111.494 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.04 63.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.025 0.93 . . . . 0.0 112.103 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.66 -5.18 46.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.202 0.601 . . . . 0.0 111.015 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.01 22.73 12.96 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 124.619 1.168 . . . . 0.0 112.107 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 75.1 p -85.83 -10.44 55.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.142 0.577 . . . . 0.0 110.766 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.498 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 7.8 ptp180 -163.71 -177.53 5.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.737 0.815 . . . . 0.0 110.742 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.58 115.84 18.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -82.29 102.31 11.1 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.547 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.7 mm -98.72 125.98 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.2 pt? -103.6 134.32 47.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 61' ' ' ILE . 70.9 m -152.92 177.88 10.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.738 0.815 . . . . 0.0 110.217 -170.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -143.92 162.33 36.41 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.011 1.325 . . . . 0.0 107.974 169.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.01 122.01 12.67 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.07 44.28 3.1 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.676 0.61 . . . . 0.0 113.807 -171.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 47.76 54.94 9.15 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.882 1.273 . . . . 0.0 113.126 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.05 56.06 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.782 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 123.62 0.768 . . . . 0.0 109.207 169.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -115.18 -32.56 5.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.671 0.788 . . . . 0.0 111.592 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.39 -168.21 1.33 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.999 1.32 . . . . 0.0 109.242 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HB2' HG22 ' A' ' 79' ' ' THR . 50.4 mtm180 -138.55 147.71 43.39 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.472 0.709 . . . . 0.0 110.135 171.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 75' ' ' ILE . 32.9 pt -125.98 153.45 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.644 1.178 . . . . 0.0 109.794 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -115.63 124.17 50.24 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 69' ' ' ILE . 26.5 mm -83.03 111.45 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 124.013 0.82 . . . . 0.0 109.933 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -99.22 95.36 7.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.175 0.988 . . . . 0.0 108.44 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' HG3' ' A' ' 30' ' ' GLU . 5.7 p -82.9 145.29 29.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.199 -1.818 . . . . 0.0 107.622 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' THR . 58.2 tp -96.32 107.87 20.29 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.851 0.751 . . . . 0.0 109.015 -170.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -85.28 104.24 14.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.199 1.0 . . . . 0.0 109.958 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 53.5 mt-30 -100.56 85.47 2.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 108.671 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -94.4 120.65 34.97 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.639 0.776 . . . . 0.0 109.669 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -71.91 170.56 13.48 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 122.849 0.459 . . . . 0.0 110.497 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 15.5 t70 -112.02 161.74 16.14 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.417 0.687 . . . . 0.0 109.564 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -70.86 13.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.486 1.114 . . . . 0.0 112.904 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -140.38 -34.33 0.53 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.97 0.56 Allowed Glycine 0 C--N 1.355 1.591 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.786 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 30.6 mt-10 -114.06 157.3 22.72 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.98 104.98 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.87 89.81 6.87 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 40.3 mt-10 -81.0 118.36 22.4 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.69 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.404 ' O ' HD12 ' A' ' 15' ' ' LEU . 21.5 p -141.77 158.29 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 107.597 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -106.92 101.05 10.51 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 10.0 pt-20 -73.19 94.43 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.44 121.67 13.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.536 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.71 -111.0 2.55 Favored Glycine 0 C--N 1.344 0.972 0 C-N-CA 121.448 -0.406 . . . . 0.0 113.304 -154.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -98.56 130.82 45.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 51.1 m -105.75 97.58 7.38 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.68 171.61 7.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -59.78 124.43 20.13 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.753 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -140.29 170.97 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.696 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 t -133.29 101.44 5.18 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 61' ' ' ILE . 31.7 t -93.91 95.54 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.755 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -119.68 122.29 41.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' VAL . 87.6 mtp -67.93 156.54 36.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.655 0.264 . . . . 0.0 110.4 174.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.15 160.89 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.998 0.919 . . . . 0.0 111.511 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -93.08 178.52 5.72 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 160.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -65.57 -20.26 66.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.476 0.31 . . . . 0.0 110.81 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -60.84 2.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.187 . . . . 0.0 112.417 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.53 -18.37 57.04 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.69 -59.07 2.95 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.158 0.504 . . . . 0.0 109.928 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.2 mt -51.21 -38.59 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.998 1.319 . . . . 0.0 111.6 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -64.96 -46.27 82.24 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.404 0.682 . . . . 0.0 111.335 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 27.3 t -80.42 -4.68 54.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.927 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.55 -87.84 1.13 Allowed Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.63 11.01 1.85 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.414 0.686 . . . . 0.0 111.013 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 44.5 tt0 -76.92 -51.88 10.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 58' ' ' THR . 65.8 mt -91.77 163.42 14.07 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 160.68 37.24 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.3 113.7 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -6.32 20.61 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.42 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 54' ' ' LEU . 42.1 m -55.72 131.46 46.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.198 0.599 . . . . 0.0 110.248 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG22 ' HG2' ' A' ' 41' ' ' MET . 61.8 t -96.23 113.92 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.291 0.637 . . . . 0.0 110.019 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -88.16 143.25 27.16 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.718 HD13 HG21 ' A' ' 75' ' ' ILE . 82.1 mt -139.95 108.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -99.39 116.84 32.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.665 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 10' ' ' ILE . 46.7 pt -128.98 160.28 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -57.3 157.69 6.17 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.724 0.238 . . . . 0.0 110.89 165.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -57.39 112.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.295 0.638 . . . . 0.0 111.395 -171.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HD3' HD11 ' A' ' 69' ' ' ILE . 26.6 ttt85 -139.22 103.7 4.82 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.504 0.722 . . . . 0.0 109.377 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -80.53 11.02 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.495 1.118 . . . . 0.0 112.006 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.02 -24.57 22.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.186 0.994 . . . . 0.0 109.916 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.481 HG21 HD12 ' A' ' 104' ' ' ILE . 20.5 mm -69.55 131.63 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -120.48 161.15 21.75 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.71 -24.56 64.5 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.297 0.639 . . . . 0.0 111.858 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 p -81.33 -7.67 59.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.473 0.709 . . . . 0.0 111.74 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -78.5 157.97 28.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -116.49 148.98 40.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.671 0.788 . . . . 0.0 108.98 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.718 HG21 HD13 ' A' ' 61' ' ' ILE . 45.2 mm -112.48 117.19 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.816 0.446 . . . . 0.0 109.996 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 34.5 ttpt -104.86 125.66 51.12 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -78.32 103.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 110.042 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -67.69 -22.96 65.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.681 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 9' ' ' ARG . 11.7 t -171.5 135.28 0.9 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.887 0.875 . . . . 0.0 109.88 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.95 -159.29 28.09 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.478 -0.624 . . . . 0.0 112.956 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.64 -17.15 29.94 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.109 2.539 . . . . 0.0 112.23 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.72 36.73 4.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.419 1.087 . . . . 0.0 109.454 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.05 98.51 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.781 0.832 . . . . 0.0 111.596 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.83 -20.26 7.27 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.825 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.12 137.15 36.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.931 0.892 . . . . 0.0 110.818 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 12.1 t -104.15 106.91 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.482 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -84.42 156.7 21.67 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.976 173.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -117.52 144.14 45.38 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.0 mt -82.38 123.23 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 58' ' ' THR . 26.2 pt -105.24 139.22 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.578 0.751 . . . . 0.0 109.968 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -108.46 2.53 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.894 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' O ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -153.6 141.07 13.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.568 0.747 . . . . 0.0 109.855 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.62 102.11 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.273 1.982 . . . . 0.0 111.101 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.32 116.49 64.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.062 0.945 . . . . 0.0 109.434 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.87 136.58 33.05 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.628 2.219 . . . . 0.0 112.106 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.5 139.42 31.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.255 0.622 . . . . 0.0 110.775 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.88 80.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.108 0.963 . . . . 0.0 112.247 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.07 -3.46 58.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.221 0.609 . . . . 0.0 111.288 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? 66.51 22.37 10.63 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.438 1.095 . . . . 0.0 111.942 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.1 p -85.57 -13.28 49.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.266 0.626 . . . . 0.0 110.996 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -163.42 -172.15 2.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.928 0.491 . . . . 0.0 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -140.46 124.5 17.45 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -88.1 95.59 10.2 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 21.4 mm -87.06 120.48 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -108.98 142.25 39.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 61' ' ' ILE . 72.2 m -150.93 172.93 14.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.754 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -143.95 158.47 43.68 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.73 127.09 30.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.441 0.463 . . . . 0.0 111.073 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.784 -177.487 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 120.484 0.183 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.18 -14.14 6.59 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.185 0.994 . . . . 0.0 112.319 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -102.15 -179.2 3.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.957 1.303 . . . . 0.0 109.268 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HB3' HG22 ' A' ' 34' ' ' THR . 45.2 mtm180 -135.59 146.86 48.39 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.076 0.55 . . . . 0.0 109.98 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.92 144.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.944 0.898 . . . . 0.0 109.527 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -98.57 127.37 44.47 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.8 mm -80.64 106.97 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.452 0.701 . . . . 0.0 110.678 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' TRP . 27.9 mp0 -79.9 96.59 6.41 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.472 0.653 . . . . 0.0 109.93 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -81.25 136.22 35.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.708 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.8 tp -78.42 98.97 6.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.07 0.462 . . . . 0.0 109.782 -173.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -74.92 93.93 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.027 0.931 . . . . 0.0 110.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.453 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 46.4 mt-30 -91.76 83.65 5.31 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -90.31 125.53 35.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.24 0.616 . . . . 0.0 110.404 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 42.1 ttp180 -78.22 152.06 32.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.671 0.389 . . . . 0.0 110.277 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 31.1 t70 -99.97 164.11 12.14 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.4 -10.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.472 1.109 . . . . 0.0 113.092 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -120.65 -6.45 9.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.455 -0.778 . . . . 0.0 109.496 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.17 48.04 1.64 Allowed Glycine 0 C--N 1.36 1.897 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 165.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 5.1 mp0 -106.14 148.15 28.18 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.53 100.83 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.64 101.25 13.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 0.0 108.65 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.1 mt-10 -85.19 118.79 24.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.501 0.72 . . . . 0.0 110.202 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 15' ' ' LEU . 36.5 p -134.95 174.8 10.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . 85.0 m95 -117.5 107.83 14.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.0 146.43 23.94 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.9 141.39 53.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.911 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.96 -107.0 3.17 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -127.51 148.78 50.32 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.6 m -102.79 97.49 7.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.161 0.584 . . . . 0.0 109.465 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.3 pt? -113.01 171.99 7.21 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.251 0.62 . . . . 0.0 111.941 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -62.65 123.77 19.26 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.937 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.721 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.61 172.03 13.6 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.488 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 t -129.91 99.34 5.07 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.527 HG13 HG12 ' A' ' 61' ' ' ILE . 21.8 t -88.7 92.44 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.4 0.619 . . . . 0.0 109.446 -174.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -96.03 106.07 18.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.741 0.816 . . . . 0.0 110.244 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.46 121.75 19.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG21 ' HB ' ' A' ' 58' ' ' THR . 5.5 m -67.38 135.44 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -91.53 -177.03 4.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.461 0.705 . . . . 0.0 111.36 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 p -61.79 -41.21 97.43 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.495 0.718 . . . . 0.0 111.269 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -54.58 -43.58 72.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.118 0.967 . . . . 0.0 110.693 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.93 -52.23 66.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.648 0.593 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.77 -55.22 21.07 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.821 0.849 . . . . 0.0 112.712 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.034 0.934 . . . . 0.0 111.516 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.7 m -66.25 -41.05 90.52 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.452 0.701 . . . . 0.0 112.161 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 93.9 p -87.52 -5.24 58.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.106 0.562 . . . . 0.0 111.755 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.65 -71.95 1.5 Allowed Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.18 11.35 0.28 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.882 0.873 . . . . 0.0 110.897 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.1 tt0 -80.29 -27.2 38.58 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.087 0.555 . . . . 0.0 110.984 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -115.03 44.67 1.75 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.45 132.11 46.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.87 126.31 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 124.364 1.04 . . . . 0.0 110.85 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.58 -12.42 13.69 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -163.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.45 ' HB ' HG21 ' A' ' 42' ' ' VAL . 31.3 m -82.17 149.32 28.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.07 129.53 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -100.01 135.81 40.88 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 75' ' ' ILE . 71.1 mt -134.46 109.38 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.971 0.908 . . . . 0.0 109.002 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -90.95 116.79 29.02 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 37' ' ' ALA . 43.4 pt -121.32 163.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.67 138.73 58.04 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 164.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 2.6 t80 -53.04 126.58 21.06 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.36 1.064 . . . . 0.0 109.82 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -140.79 134.62 30.47 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.818 0.699 . . . . 0.0 109.252 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -82.16 1.79 34.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 111.581 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.16 -20.78 20.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.874 0.869 . . . . 0.0 111.201 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 104' ' ' ILE . 23.4 mm -72.16 123.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.668 0.387 . . . . 0.0 110.481 -170.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -133.41 170.88 14.83 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 109.138 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.62 65.45 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.294 0.638 . . . . 0.0 111.433 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -94.19 39.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.819 0.848 . . . . 0.0 110.374 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 m -130.47 150.5 51.66 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 78.1 mtm180 -117.16 162.95 17.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 61' ' ' ILE . 32.2 mm -127.58 97.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 HG11 ' A' ' 39' ' ' VAL . 22.9 t -73.68 118.09 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.873 0.469 . . . . 0.0 110.443 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 t -69.07 -36.56 77.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.76 0.824 . . . . 0.0 110.738 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 9' ' ' ARG . 9.0 t -167.51 135.59 2.46 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.897 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.91 -158.33 27.83 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.861 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.76 -29.21 51.1 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.811 2.341 . . . . 0.0 112.062 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 39' ' ' VAL . 66.6 mt -115.86 32.16 6.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 0.0 110.559 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.46 114.2 2.12 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.467 0.707 . . . . 0.0 111.349 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.59 -30.68 6.54 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.683 0.615 . . . . 0.0 112.69 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -72.7 142.64 48.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.405 0.682 . . . . 0.0 110.864 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.57 97.75 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-O 122.494 1.14 . . . . 0.0 109.985 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.9 114.66 21.83 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.701 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.527 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.07 135.56 34.79 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.135 0.974 . . . . 0.0 109.433 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.61 116.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.2 pt -98.88 132.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.294 0.637 . . . . 0.0 109.508 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.98 -120.88 5.58 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -171.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.418 ' O ' HD21 ' A' ' 105' ' ' LEU . 11.3 pt20 -147.25 147.59 29.13 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.056 0.943 . . . . 0.0 108.485 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.89 141.84 96.14 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.87 2.38 . . . . 0.0 112.718 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.86 108.92 53.12 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.65 156.17 62.72 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.356 2.037 . . . . 0.0 112.004 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 27.2 t70 -59.54 154.59 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.442 0.697 . . . . 0.0 112.34 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.21 91.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.927 0.891 . . . . 0.0 111.126 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.43 -8.44 54.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.19 0.596 . . . . 0.0 111.235 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.79 21.05 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.227 1.411 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -79.77 -3.11 46.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 18.6 ptp180 -167.17 -176.1 3.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.068 0.947 . . . . 0.0 109.141 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -132.18 117.27 18.05 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.66 111.8 21.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.56 HG22 ' SG ' ' A' ' 106' ' ' CYS . 21.9 mm -95.26 135.37 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -112.45 128.35 56.3 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 174.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.56 ' SG ' HG22 ' A' ' 104' ' ' ILE . 76.3 m -147.11 175.1 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.605 -168.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -139.64 158.02 44.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -52.53 151.93 3.92 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.015 0.526 . . . . 0.0 111.535 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.816 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.268 -175.485 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -80.01 -43.62 21.62 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.934 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' THR . 53.5 m-20 -104.41 -161.15 0.8 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.688 1.595 . . . . 0.0 110.872 -170.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 53.9 ttt180 -159.0 137.06 10.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.116 0.966 . . . . 0.0 109.557 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -132.42 168.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 124.428 1.091 . . . . 0.0 110.446 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.9 m -115.92 138.91 50.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.798 1.239 . . . . 0.0 108.101 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.12 101.58 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.024 0.53 . . . . 0.0 110.495 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.521 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 19.6 mp0 -75.51 100.97 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.707 0.803 . . . . 0.0 110.265 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.8 p -79.06 147.95 32.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.107 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 27' ' ' GLU . 60.5 tp -98.03 107.63 20.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -99.07 120.57 39.69 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.599 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 89.2 mt-30 -82.57 93.7 7.36 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -92.05 114.36 26.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.582 0.753 . . . . 0.0 109.401 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 23.6 ttp85 -72.72 158.29 35.88 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -110.7 169.84 8.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 109.351 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.6 -8.42 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 124.331 1.052 . . . . 0.0 112.839 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 p -99.25 -9.27 23.87 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.612 0.72 . . . . 0.0 109.084 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.39 19.8 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.339 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 42.5 mt-10 -97.29 140.55 31.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.355 0.662 . . . . 0.0 109.421 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' GLN . 40.0 mm -89.32 101.43 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.45 104.97 17.48 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 42.9 mt-10 -80.19 112.4 17.47 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -128.58 144.52 51.17 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.231 1.013 . . . . 0.0 110.609 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -103.28 100.22 10.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -98.0 135.3 39.9 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.689 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.06 142.98 55.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 -110.19 3.18 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -117.53 141.83 47.89 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 109.545 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 9' ' ' ARG . 11.2 m -101.8 102.5 13.13 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.087 0.955 . . . . 0.0 109.531 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.7 pt? -114.16 171.03 7.85 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.276 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -70.8 132.77 45.81 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.214 1.005 . . . . 0.0 111.945 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.8 -179.47 5.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.375 1.07 . . . . 0.0 110.867 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -139.06 102.29 4.49 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.92 106.27 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.396 1.078 . . . . 0.0 110.064 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -116.52 108.85 16.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 110.53 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 84.2 mtp -68.64 125.53 26.84 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.25 138.05 19.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 C-N-CA 123.766 0.826 . . . . 0.0 111.03 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -97.14 -177.86 3.99 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.66 -35.71 72.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.939 0.896 . . . . 0.0 111.794 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -52.62 -61.21 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.939 0.896 . . . . 0.0 112.233 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.49 -23.99 42.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.676 0.39 . . . . 0.0 111.578 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.38 18.22 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 120.954 0.407 . . . . 0.0 111.383 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.27 -37.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.03 0.932 . . . . 0.0 111.067 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -46.78 87.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.729 0.812 . . . . 0.0 111.115 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 79.4 p -82.38 -13.65 56.51 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.273 0.629 . . . . 0.0 111.348 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.24 -86.89 1.17 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.23 -1.59 5.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.817 0.847 . . . . 0.0 111.153 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.0 tt0 -65.58 -63.07 1.18 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.462 0.705 . . . . 0.0 109.774 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.29 138.15 31.69 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 165.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.2 144.69 51.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.4 mt -62.81 113.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 118.113 0.415 . . . . 0.0 110.398 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.18 -10.75 14.89 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 123.04 0.352 . . . . 0.0 112.898 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -63.81 146.93 53.02 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.8 t -119.63 123.69 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.263 0.625 . . . . 0.0 110.63 -169.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -103.78 130.44 51.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 75' ' ' ILE . 86.4 mt -134.2 113.04 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.393 0.677 . . . . 0.0 109.209 -166.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -102.05 115.27 30.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.619 0.768 . . . . 0.0 109.79 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 47.4 pt -121.32 163.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -60.51 157.08 14.87 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.444 ' N ' ' HA ' ' A' ' 101' ' ' ARG . 70.8 t80 -64.16 101.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.571 -172.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -119.9 118.83 31.77 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.8 -2.69 40.79 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.997 0.919 . . . . 0.0 110.932 -174.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -92.66 -21.12 20.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.288 0.635 . . . . 0.0 110.949 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.04 134.48 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.158 0.583 . . . . 0.0 110.632 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -131.0 171.68 12.94 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.2 67.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.567 0.747 . . . . 0.0 111.076 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.7 p -86.36 45.47 1.24 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.87 1.268 . . . . 0.0 110.554 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.0 m -141.49 122.65 14.72 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.412 1.085 . . . . 0.0 108.213 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -94.56 133.09 38.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 61' ' ' ILE . 22.7 mm -95.99 94.0 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.867 0.867 . . . . 0.0 109.932 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HE2' ' NE2' ' A' ' 13' ' ' GLN . 40.1 ttpt -94.6 111.62 23.38 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 87' ' ' LEU . 49.8 t -70.65 128.75 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 110.477 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -93.23 -29.63 15.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.924 0.89 . . . . 0.0 110.364 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 9' ' ' ARG . 54.4 m -151.93 110.49 3.79 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.467 -166.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.74 29.73 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.556 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -16.18 45.72 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 87' ' ' LEU . 83.6 mt -127.36 34.33 4.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.217 1.007 . . . . 0.0 110.147 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.72 93.48 0.11 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.337 0.655 . . . . 0.0 111.131 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.58 -13.56 4.81 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.792 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.627 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 62.1 ttm-85 -95.55 149.36 21.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.17 0.988 . . . . 0.0 110.563 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.9 p -108.21 101.1 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 122.326 1.06 . . . . 0.0 109.737 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -86.53 131.18 34.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.031 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -103.78 143.66 32.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.434 0.694 . . . . 0.0 109.256 -174.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.52 108.37 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 107' ' ' ARG . 25.7 pt -87.19 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 122.254 1.026 . . . . 0.0 110.559 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.43 -149.07 19.83 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -124.45 141.38 37.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.5 134.66 65.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.329 2.686 . . . . 0.0 112.629 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.51 107.15 49.46 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.318 1.047 . . . . 0.0 109.446 -170.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.22 152.01 72.09 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.672 2.248 . . . . 0.0 111.832 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -81.1 178.19 8.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.388 0.275 . . . . 0.0 110.643 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.24 70.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.102 0.961 . . . . 0.0 112.889 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.21 37.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.016 0.526 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 57.64 33.24 23.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 0.0 110.391 -172.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.0 t -92.15 -7.64 47.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.117 0.967 . . . . 0.0 110.162 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HA ' ' N ' ' A' ' 65' ' ' TYR . 9.1 ptp180 -161.34 167.86 25.01 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.543 0.687 . . . . 0.0 111.384 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.05 109.34 16.33 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.437 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -79.93 107.6 12.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.501 HG22 ' SG ' ' A' ' 106' ' ' CYS . 24.6 mm -97.67 112.44 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -82.37 135.06 35.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.501 ' SG ' HG22 ' A' ' 104' ' ' ILE . 78.7 m -148.99 175.41 11.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.197 0.999 . . . . 0.0 108.755 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 90' ' ' ILE . 61.5 ttt85 -149.95 161.48 42.22 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' ' HD3' ' A' ' 85' ' ' ARG . 1.8 tm-20 -45.45 125.73 5.96 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.795 0.838 . . . . 0.0 110.384 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.06 0 O-C-N 123.552 0.533 . . . . 0.0 113.686 -167.128 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -93.8 -27.51 16.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.03 0.932 . . . . 0.0 112.345 -163.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.85 171.8 8.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.061 0.944 . . . . 0.0 109.026 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HB2' HG22 ' A' ' 79' ' ' THR . 98.2 mtt180 -136.84 138.0 40.32 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 77' ' ' VAL . 47.8 pt -140.97 176.86 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.248 1.019 . . . . 0.0 109.751 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -140.12 136.5 33.61 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.361 0.664 . . . . 0.0 109.406 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.0 mm -73.12 125.89 32.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.268 0.627 . . . . 0.0 109.549 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -97.62 116.53 30.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -89.76 135.57 33.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.096 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' ' 27' ' ' GLU . 2.9 tm? -92.91 99.9 12.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -85.93 107.92 17.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.361 0.664 . . . . 0.0 110.015 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -77.43 110.49 12.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -120.45 121.4 38.41 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -77.01 172.35 13.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.322 0.51 . . . . 0.0 111.209 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.9 t70 -108.12 161.22 15.17 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.8 tt -67.77 -6.26 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 123.792 0.837 . . . . 0.0 113.056 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -105.46 -18.92 13.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.45 54.69 0.93 Allowed Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.737 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 25.9 mt-10 -112.15 147.24 36.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.581 1.152 . . . . 0.0 107.942 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.7 mm -90.07 101.15 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.863 0.756 . . . . 0.0 109.731 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.45 97.85 11.43 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.617 ' HB3' HD21 ' A' ' 15' ' ' LEU . 43.8 mt-10 -83.46 131.75 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.443 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.9 p -132.89 161.4 34.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.109 0.964 . . . . 0.0 109.982 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -118.21 118.59 32.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.485 0.714 . . . . 0.0 109.729 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.89 151.35 25.88 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.105 0.962 . . . . 0.0 109.25 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.83 135.25 38.89 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.36 -110.34 3.06 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -113.28 132.76 55.42 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.0 m -76.45 141.66 41.27 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.97 0.908 . . . . 0.0 108.985 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.88 146.42 27.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.234 0.54 . . . . 0.0 111.682 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -71.06 124.23 23.93 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.437 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -136.81 172.45 12.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.775 0.83 . . . . 0.0 111.288 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -130.84 105.55 7.85 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 61' ' ' ILE . 60.8 t -91.64 91.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 0.0 109.373 -173.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -115.4 119.91 37.81 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.518 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -66.32 152.69 44.45 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.05 149.74 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.894 0.478 . . . . 0.0 111.039 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -88.15 176.61 7.19 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -57.47 -35.96 70.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.078 0.551 . . . . 0.0 110.446 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.05 -39.25 59.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.704 1.202 . . . . 0.0 112.133 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -66.16 -49.74 66.36 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.383 0.427 . . . . 0.0 111.198 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.5 97.66 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.981 0.801 . . . . 0.0 110.8 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.5 mt -63.22 -43.83 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.645 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 t -75.76 -13.66 60.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.428 0.691 . . . . 0.0 111.781 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 45.6 m -111.18 -2.38 15.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.676 0.79 . . . . 0.0 111.736 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.13 -74.5 1.85 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.6 5.33 0.8 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.884 0.874 . . . . 0.0 111.21 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 35.8 tt0 -70.73 -68.54 0.42 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.126 0.571 . . . . 0.0 110.342 -177.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.16 142.5 45.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 164.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.67 153.18 39.73 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.53 0.732 . . . . 0.0 109.539 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.85 115.39 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.07 -5.54 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.766 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 90' ' ' ILE . 98.6 m -70.49 119.39 14.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 41' ' ' MET . 51.0 t -84.68 118.1 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -98.75 143.33 29.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 75' ' ' ILE . 66.5 mt -138.54 109.97 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -97.56 115.55 28.07 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 ' HB2' ' A' ' 37' ' ' ALA . 49.4 pt -121.2 158.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -56.33 140.76 44.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.191 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -49.32 118.8 2.91 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.615 1.166 . . . . 0.0 111.629 -171.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -143.34 117.76 9.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.154 0.582 . . . . 0.0 109.967 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.42 2.59 27.93 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.597 1.159 . . . . 0.0 112.204 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.36 -17.32 24.82 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.852 0.861 . . . . 0.0 110.998 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.6 HG21 HD12 ' A' ' 104' ' ' ILE . 26.9 mm -67.52 138.98 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.039 0.536 . . . . 0.0 110.31 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -145.7 169.63 18.1 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.081 0.952 . . . . 0.0 108.709 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . . . -63.6 -26.97 68.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.088 0.555 . . . . 0.0 112.037 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.5 p -97.9 48.01 1.01 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.16 0.981 . . . . 0.0 110.656 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -131.29 156.53 45.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -126.76 159.25 34.32 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.289 0.566 . . . . 0.0 109.989 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.604 HG21 HD13 ' A' ' 61' ' ' ILE . 48.4 mm -112.41 98.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.053 . . . . 0.0 109.224 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -90.45 113.57 25.54 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.525 ' HA ' HG22 ' A' ' 10' ' ' ILE . 64.9 t -77.0 112.23 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 110.629 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.7 t -72.8 -30.02 63.74 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.969 0.907 . . . . 0.0 111.227 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 9' ' ' ARG . 15.0 t -165.71 139.55 4.51 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.978 0.911 . . . . 0.0 109.285 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.7 -163.4 30.38 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-O 118.95 -0.917 . . . . 0.0 111.67 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.74 -25.91 28.21 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.377 2.051 . . . . 0.0 111.452 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -114.5 33.93 5.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.195 0.998 . . . . 0.0 109.724 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.3 109.16 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.702 0.801 . . . . 0.0 111.452 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.37 -21.32 10.02 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.415 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -80.62 165.87 21.63 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.387 0.675 . . . . 0.0 111.153 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.17 102.05 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 122.351 1.072 . . . . 0.0 109.414 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 120.86 24.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.674 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -82.75 134.76 35.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.223 1.009 . . . . 0.0 108.288 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' A' ' 106' ' ' CYS . 66.1 mt -82.19 95.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -172.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 58' ' ' THR . 21.7 pt -80.53 62.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 122.3 1.048 . . . . 0.0 111.14 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.54 -158.85 27.83 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 92.5 mt-30 -126.59 145.44 53.22 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 109.365 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 134.47 57.88 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 113.504 -173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -106.56 108.92 62.7 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.1 142.7 56.95 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.668 2.246 . . . . 0.0 112.269 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.24 150.56 48.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 111.374 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.99 70.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.529 1.132 . . . . 0.0 112.369 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.66 -8.97 45.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.878 0.471 . . . . 0.0 110.973 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 62.54 20.28 11.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.705 1.202 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.8 t -89.41 -0.17 57.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.344 0.258 . . . . 0.0 110.813 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.64 -174.89 2.94 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 123.65 0.78 . . . . 0.0 109.949 171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.26 124.62 26.21 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.62 117.33 28.42 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 HG21 ' A' ' 69' ' ' ILE . 15.3 mm -108.76 140.55 26.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -112.14 128.97 56.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' A' ' 89' ' ' ILE . 56.2 m -150.74 -178.96 6.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -171.09 175.68 4.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.34 1.056 . . . . 0.0 108.642 163.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -57.67 172.04 0.41 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.691 0.796 . . . . 0.0 111.066 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.097 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -176.45 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.707 0.289 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -117.09 -44.17 2.81 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.398 1.079 . . . . 0.0 110.284 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -101.07 -175.48 2.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.049 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -131.94 147.73 52.48 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.79 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' THR . 13.7 pt -138.97 145.29 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.622 1.169 . . . . 0.0 109.266 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -108.62 137.95 45.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 109.021 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.06 114.15 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.889 0.476 . . . . 0.0 110.284 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.584 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.1 mp0 -89.79 103.79 16.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 p -79.41 159.03 27.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.481 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.5 tp -114.84 110.28 19.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.082 0.553 . . . . 0.0 109.997 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -93.99 101.94 14.01 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.952 0.901 . . . . 0.0 109.417 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -79.81 125.42 29.67 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -137.11 150.55 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 108.718 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 37.9 ttp180 -99.33 166.24 11.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.55 0.34 . . . . 0.0 110.121 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 8.7 t70 -110.59 162.89 14.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.642 1.177 . . . . 0.0 108.592 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tt -59.25 -12.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 125.013 1.325 . . . . 0.0 113.805 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -112.52 -34.61 5.8 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.49 48.04 0.15 Allowed Glycine 0 C--N 1.354 1.559 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.708 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.506 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 23.7 mm-40 -96.12 154.21 17.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.423 0.689 . . . . 0.0 109.258 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -107.05 102.93 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.81 101.72 13.06 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.575 1.15 . . . . 0.0 109.106 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -88.2 107.39 18.76 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -116.14 144.6 43.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.638 0.775 . . . . 0.0 110.231 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.42 ' CZ3' ' HG3' ' A' ' 74' ' ' ARG . 85.4 m95 -114.22 113.62 24.88 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.133 0.973 . . . . 0.0 109.424 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.02 123.82 47.34 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.36 128.88 38.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.267 1.427 . . . . 0.0 109.364 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.47 -126.4 3.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -165.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.91 135.03 43.01 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.918 0.887 . . . . 0.0 110.717 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 16.6 m -99.1 105.77 17.9 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.369 0.668 . . . . 0.0 110.85 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -108.82 170.72 7.86 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.588 0.708 . . . . 0.0 111.721 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -71.81 127.54 32.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.279 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -138.74 176.35 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.306 1.043 . . . . 0.0 111.106 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -136.7 110.29 8.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.022 0.929 . . . . 0.0 108.511 162.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.87 106.28 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.392 0.677 . . . . 0.0 110.538 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -112.91 103.92 11.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.009 0.923 . . . . 0.0 109.48 173.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.536 ' SD ' HD21 ' A' ' 82' ' ' LEU . 92.5 mtp -66.53 130.52 43.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.04 142.51 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.015 0.436 . . . . 0.0 110.737 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -98.22 -173.02 2.47 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 124.03 0.932 . . . . 0.0 110.457 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -53.42 -29.92 37.64 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.264 1.025 . . . . 0.0 112.839 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -49.99 -51.12 44.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.63 0.772 . . . . 0.0 112.053 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -67.12 -40.43 86.83 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.653 0.596 . . . . 0.0 111.634 -174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.79 72.18 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.293 0.637 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.68 -42.45 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.832 0.853 . . . . 0.0 111.403 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.4 t -68.77 -30.25 68.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.216 0.607 . . . . 0.0 111.383 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 97.1 p -91.84 -9.34 43.75 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.417 0.687 . . . . 0.0 111.163 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.5 -72.09 2.8 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.37 10.19 0.5 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.704 0.802 . . . . 0.0 110.88 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 47.3 mt-10 -78.45 -30.91 47.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.91 0.484 . . . . 0.0 111.084 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.56 170.34 8.25 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.074 0.95 . . . . 0.0 109.252 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.07 149.54 35.25 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.803 0.841 . . . . 0.0 109.682 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mt -63.23 144.6 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.53 0.732 . . . . 0.0 110.364 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.98 -12.03 70.58 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.135 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.511 HG23 HD11 ' A' ' 90' ' ' ILE . 47.1 m -61.05 116.7 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.223 0.609 . . . . 0.0 109.358 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.554 HG11 ' HG ' ' A' ' 87' ' ' LEU . 46.4 t -76.69 103.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.883 -171.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -92.58 137.44 32.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -141.4 109.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.824 0.85 . . . . 0.0 108.777 -167.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -92.65 124.11 36.43 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.35 0.66 . . . . 0.0 109.579 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.9 pt -130.25 167.39 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.623 0.769 . . . . 0.0 110.16 -175.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -53.25 151.08 5.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.735 0.647 . . . . 0.0 111.451 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.466 ' HE1' ' HD2' ' A' ' 99' ' ' ARG . 61.5 t80 -60.38 107.91 0.73 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -129.64 119.16 23.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.3 -2.89 30.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.927 1.291 . . . . 0.0 112.31 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.05 -21.31 19.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.885 0.874 . . . . 0.0 111.396 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 HD12 ' A' ' 104' ' ' ILE . 29.0 mm -72.62 132.21 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.65 0.38 . . . . 0.0 110.554 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.529 HD22 ' H ' ' A' ' 72' ' ' THR . 5.0 t30 -143.18 161.88 37.08 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.01 -27.78 68.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.3 0.64 . . . . 0.0 111.897 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.529 ' H ' HD22 ' A' ' 70' ' ' ASN . 35.3 p -79.2 14.32 1.53 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.183 0.993 . . . . 0.0 112.364 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -111.42 167.65 10.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.505 0.722 . . . . 0.0 109.077 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 51.0 mtm180 -122.46 150.28 42.72 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 mm -113.17 99.92 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.498 1.119 . . . . 0.0 109.019 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.3 ttpt -89.44 120.28 30.63 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.072 -0.393 . . . . 0.0 110.172 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 87' ' ' LEU . 53.4 t -76.79 120.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.966 0.412 . . . . 0.0 109.902 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.0 m -84.81 -29.94 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.343 1.057 . . . . 0.0 111.522 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.9 p -141.27 126.77 18.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.85 0.86 . . . . 0.0 109.556 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.92 -158.19 25.08 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.503 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.62 -13.38 29.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.246 2.631 . . . . 0.0 112.441 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.536 HD21 ' SD ' ' A' ' 41' ' ' MET . 70.9 mt -120.77 25.77 9.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.838 . . . . 0.0 110.149 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.34 112.48 2.44 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.342 0.657 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.01 2.54 51.86 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.501 0.501 . . . . 0.0 113.175 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -105.53 139.55 39.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.574 0.75 . . . . 0.0 109.475 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -104.93 102.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 122.313 1.054 . . . . 0.0 109.722 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' HG11 ' A' ' 59' ' ' VAL . 1.5 mm? -82.73 133.14 35.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.198 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -100.44 143.6 30.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.195 0.598 . . . . 0.0 109.561 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.3 mt -80.48 143.62 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 HG23 ' A' ' 58' ' ' THR . 2.2 pt -122.19 104.38 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.813 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.3 -105.98 2.48 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.847 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.1 150.17 29.05 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.684 0.794 . . . . 0.0 109.884 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HB2' HD23 ' A' ' 102' ' ' LEU . 33.6 Cg_endo -64.02 123.64 12.23 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 121.903 1.736 . . . . 0.0 111.008 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -89.14 113.8 57.68 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -76.55 129.13 10.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.17 1.913 . . . . 0.0 110.699 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.671 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 21.9 t70 -52.69 150.37 5.24 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.342 1.057 . . . . 0.0 112.198 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.76 -43.92 77.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.926 0.891 . . . . 0.0 112.001 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.57 0.12 56.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.549 0.739 . . . . 0.0 111.251 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 38.7 mmt180 61.88 26.04 15.72 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.088 1.355 . . . . 0.0 112.138 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.8 p -79.79 -12.2 59.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 96' ' ' ASP . 13.3 ptp180 -165.67 175.9 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 93' ' ' PRO . 6.5 mp -122.69 121.81 37.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.944 0.898 . . . . 0.0 108.766 165.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.33 102.99 12.36 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 69' ' ' ILE . 8.6 mm -87.26 142.88 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -123.61 138.05 54.62 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.09 176.44 10.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.073 -167.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 159.24 42.8 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -45.79 122.76 3.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.405 ' HA3' ' ND2' ' A' ' 88' ' ' ASN . . . . . . . . 0 C--N 1.344 0.976 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.142 -172.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 64' ' ' ARG . 27.2 mt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.884 0.373 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -97.56 -21.2 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.504 0.721 . . . . 0.0 111.468 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.3 -174.68 2.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.145 0.978 . . . . 0.0 110.052 -173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -139.01 150.92 46.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.385 0.674 . . . . 0.0 110.077 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 34' ' ' THR . 44.6 pt -139.33 168.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.178 . . . . 0.0 109.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -128.81 138.91 52.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.677 0.791 . . . . 0.0 109.013 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -89.71 92.35 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.359 0.6 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -71.66 99.13 2.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.82 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 p -84.27 139.45 32.32 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.57 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 28' ' ' THR . 64.1 tp -78.18 105.58 9.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.144 0.577 . . . . 0.0 109.737 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -90.51 117.95 29.6 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.804 0.841 . . . . 0.0 111.087 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.98 94.34 5.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -90.92 111.49 22.95 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.346 0.659 . . . . 0.0 109.576 -173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.7 ttt-85 -87.79 152.85 21.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.052 0.453 . . . . 0.0 111.443 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -107.65 164.04 12.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.963 0.905 . . . . 0.0 108.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.4 tt -72.2 -1.26 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 C-N-CA 124.121 0.969 . . . . 0.0 113.239 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -98.45 -14.24 20.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.981 0.896 . . . . 0.0 109.33 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.97 40.98 5.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.805 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 46.5 mt-10 -96.79 149.58 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.622 0.769 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -108.49 107.4 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.47 103.79 15.77 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.2 mt-10 -80.38 126.5 31.25 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 109.631 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.433 ' O ' HD12 ' A' ' 15' ' ' LEU . 37.7 p -139.53 -176.17 4.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.599 1.56 . . . . 0.0 108.469 -168.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -128.05 115.09 17.93 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.906 -0.496 . . . . 0.0 109.665 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.62 145.34 26.95 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.79 136.81 37.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.966 0.507 . . . . 0.0 109.634 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.86 -109.45 3.34 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -108.11 134.38 51.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 88.3 m -97.96 102.91 14.79 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.04 168.75 9.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.576 0.751 . . . . 0.0 112.264 -173.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.0 122.26 19.01 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.359 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.96 13.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.442 0.697 . . . . 0.0 112.368 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 2.1 m -131.74 94.61 3.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.384 1.074 . . . . 0.0 108.226 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 77' ' ' VAL . 2.8 p -91.2 94.27 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.698 0.761 . . . . 0.0 109.67 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -113.6 119.85 38.91 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.724 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.539 ' SD ' HD21 ' A' ' 82' ' ' LEU . 54.1 mtp -76.62 150.63 36.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.937 0.495 . . . . 0.0 109.737 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -83.7 136.41 22.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.146 0.579 . . . . 0.0 109.576 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 39.5 t -90.3 -178.85 5.48 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.964 0.906 . . . . 0.0 109.535 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -60.53 -33.57 72.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.423 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 18.4 ptpt -53.93 -40.24 66.56 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.619 1.167 . . . . 0.0 111.461 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -70.28 -43.37 70.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.012 0.925 . . . . 0.0 110.44 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.39 -32.12 72.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.895 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.8 mt -73.16 -45.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.249 0.62 . . . . 0.0 110.553 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.3 m -63.45 -36.95 85.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.78 0.832 . . . . 0.0 111.856 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.7 p -86.51 -48.37 8.44 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.034 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.22 -64.68 0.31 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.98 -5.57 0.79 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.872 0.869 . . . . 0.0 111.568 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.0 tt0 -71.98 -68.94 0.42 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.006 0.522 . . . . 0.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -77.09 119.52 20.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.91 39.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.98 117.97 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.08 -11.17 14.88 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 116.856 -0.156 . . . . 0.0 113.048 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 90' ' ' ILE . 89.1 m -68.29 146.91 52.87 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.93 116.41 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.271 0.628 . . . . 0.0 110.096 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -87.63 126.39 34.92 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 75' ' ' ILE . 44.8 mt -123.48 104.95 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 11.9 m0 -90.56 117.91 29.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.723 0.809 . . . . 0.0 109.722 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 pt -130.29 161.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 108.324 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HG3' HD11 ' A' ' 6' ' ' LEU . 64.1 mtm180 -60.92 141.13 57.48 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.883 0.765 . . . . 0.0 110.826 167.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.24 130.99 36.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.052 1.341 . . . . 0.0 111.135 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.41 147.15 25.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.19 0.596 . . . . 0.0 111.238 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -83.2 1.02 42.78 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.603 1.161 . . . . 0.0 111.884 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.67 -26.78 19.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.877 0.471 . . . . 0.0 111.216 -165.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 104' ' ' ILE . 6.3 mm -75.65 132.03 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.73 167.37 16.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.91 63.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.082 0.553 . . . . 0.0 111.635 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.1 p -84.95 3.11 39.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.791 0.836 . . . . 0.0 111.547 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 m -93.95 159.79 15.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.57 0.748 . . . . 0.0 109.646 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -132.12 165.0 25.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 0.0 109.01 170.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.646 HG21 HD13 ' A' ' 61' ' ' ILE . 43.7 mm -115.97 99.22 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.487 0.715 . . . . 0.0 110.621 -173.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -91.93 110.11 21.46 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 39' ' ' VAL . 95.7 t -72.84 117.94 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.678 0.791 . . . . 0.0 111.106 -172.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.3 m -77.44 -21.73 52.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.358 1.063 . . . . 0.0 112.158 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -167.71 132.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.729 0.811 . . . . 0.0 109.34 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.44 -163.72 30.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.928 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.42 -16.07 17.37 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.134 2.556 . . . . 0.0 112.102 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 87' ' ' LEU . 82.7 mt -119.26 28.93 7.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.341 1.056 . . . . 0.0 109.795 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.81 115.23 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.425 0.69 . . . . 0.0 110.542 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.63 38.96 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.811 0.694 . . . . 0.0 112.946 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -107.68 143.82 35.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.862 0.865 . . . . 0.0 109.853 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.12 88.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 122.481 1.134 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 82' ' ' LEU . 2.6 mm? -62.57 132.41 52.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.033 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -95.13 130.69 41.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.275 1.03 . . . . 0.0 109.357 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.91 129.92 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.489 HG23 ' HD2' ' A' ' 107' ' ' ARG . 1.5 pt -97.18 111.55 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 0.0 109.215 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.46 -94.05 1.9 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.987 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -166.92 155.11 9.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.316 1.046 . . . . 0.0 109.325 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -58.35 123.44 13.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.755 2.303 . . . . 0.0 111.831 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.12 111.71 65.26 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 123.916 0.887 . . . . 0.0 109.789 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.08 155.9 63.79 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.229 2.62 . . . . 0.0 113.691 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.86 155.2 41.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 110.914 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.88 84.23 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.344 0.657 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.29 59.28 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.948 0.499 . . . . 0.0 110.899 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 61.29 23.85 14.03 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.285 1.434 . . . . 0.0 112.236 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 t -85.87 -6.51 59.07 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.796 0.438 . . . . 0.0 111.401 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.599 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 5.5 ppt_? -161.27 162.54 31.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.583 0.753 . . . . 0.0 109.614 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.56 118.21 32.5 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.599 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 37.8 tt0 -90.27 105.27 17.7 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 69' ' ' ILE . 13.7 mm -88.74 97.69 7.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -81.19 136.84 35.9 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 77.1 m -151.75 -175.5 5.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.068 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.489 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -153.53 160.09 42.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.44 0.696 . . . . 0.0 109.196 165.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 138.49 57.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.544 0.737 . . . . 0.0 110.322 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.073 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.851 -171.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -103.58 -7.62 20.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.734 0.814 . . . . 0.0 112.33 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -102.64 -176.92 3.24 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 55.6 mtm180 -133.74 150.78 51.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.579 0.752 . . . . 0.0 109.42 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' THR . 12.4 pt -136.4 157.18 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 31' ' ' ASP . 26.0 m -116.55 124.82 50.82 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.8 mm -72.31 93.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 2.3 tp-100 -71.58 100.17 2.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -83.71 140.55 32.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.603 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB3' ' A' ' 27' ' ' GLU . 42.5 tp -101.6 98.92 9.16 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 110.018 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -83.66 105.91 14.95 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 109.237 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -74.99 90.82 2.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.5 m -89.68 112.31 23.53 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 109.938 -171.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.7 ttp180 -72.65 153.45 41.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.843 0.354 . . . . 0.0 110.431 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 26' ' ' LEU . 19.3 t70 -113.89 164.65 13.48 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.3 5.95 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.853 0.861 . . . . 0.0 112.392 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -101.54 -14.96 17.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.707 0.803 . . . . 0.0 109.033 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.79 33.91 8.09 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.371 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 47.9 mt-10 -102.59 166.95 10.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.613 0.765 . . . . 0.0 110.537 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.2 mm -114.14 105.36 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.708 0.803 . . . . 0.0 109.21 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 20' ' ' ASP . 5.9 mp -98.27 96.05 7.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.849 1.26 . . . . 0.0 107.697 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.668 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.9 mt-10 -79.03 118.66 21.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.512 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -126.75 149.13 49.78 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.753 1.221 . . . . 0.0 110.251 -172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.442 ' CE2' HD13 ' A' ' 15' ' ' LEU . 92.7 m95 -107.62 109.5 21.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.867 0.867 . . . . 0.0 109.49 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.3 140.07 39.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.091 0.957 . . . . 0.0 108.567 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.5 p-10 -71.54 128.99 37.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.28 -119.66 4.56 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.784 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.47 116.59 28.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.448 0.699 . . . . 0.0 109.423 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 26.8 m -90.26 94.53 9.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -103.96 162.83 12.81 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.244 0.545 . . . . 0.0 111.604 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -63.26 126.31 27.0 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.794 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -134.71 165.53 25.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.364 1.066 . . . . 0.0 111.709 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -121.66 98.91 6.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.13 91.63 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.282 0.633 . . . . 0.0 110.125 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -95.54 107.49 19.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.445 0.698 . . . . 0.0 110.34 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.23 130.71 41.45 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 13.8 m -70.21 151.13 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -95.38 -177.32 4.06 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.653 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -61.29 -41.0 96.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.641 0.776 . . . . 0.0 110.778 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.17 -34.4 68.42 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.225 1.01 . . . . 0.0 112.314 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 5.8 mm-40 -62.3 -39.41 92.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.263 0.625 . . . . 0.0 111.169 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.98 67.12 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.512 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.77 -33.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.106 0.962 . . . . 0.0 111.939 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -87.65 -48.55 7.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.513 0.725 . . . . 0.0 110.704 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 15.8 m -84.49 -22.65 30.16 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.86 -102.19 1.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.242 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.24 -5.02 57.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.431 0.692 . . . . 0.0 111.816 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 34.7 tt0 -82.91 -62.64 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.632 0.373 . . . . 0.0 110.465 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 58' ' ' THR . 47.1 mt -110.08 147.94 32.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.493 0.717 . . . . 0.0 109.228 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.97 168.92 18.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.476 1.11 . . . . 0.0 110.252 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.4 116.12 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.81 -9.76 14.21 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 123.072 0.368 . . . . 0.0 112.43 -167.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.623 HG21 HD22 ' A' ' 54' ' ' LEU . 88.2 m -80.56 161.98 24.51 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.299 1.04 . . . . 0.0 109.281 172.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.97 126.41 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.116 0.966 . . . . 0.0 109.117 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -95.46 134.36 38.38 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.18 109.35 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -94.15 127.22 39.84 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 10' ' ' ILE . 49.7 pt -132.83 168.04 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.627 0.371 . . . . 0.0 110.677 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -49.14 131.71 19.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.815 0.446 . . . . 0.0 110.15 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.54 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 69.0 t80 -51.55 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.519 1.528 . . . . 0.0 111.697 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 104.58 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 109.464 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.76 7.73 9.68 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.055 0.942 . . . . 0.0 111.729 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.84 -18.91 21.5 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.189 0.996 . . . . 0.0 111.138 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.615 HG21 HD12 ' A' ' 104' ' ' ILE . 39.2 mm -68.7 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 122.878 0.471 . . . . 0.0 109.897 -177.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -142.33 172.68 12.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.107 0.963 . . . . 0.0 108.587 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -30.1 65.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.082 0.953 . . . . 0.0 112.99 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 p -90.55 23.26 3.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.543 0.737 . . . . 0.0 112.324 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -112.74 162.34 15.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.685 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 99.8 mtt180 -122.88 159.34 28.41 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.61 93.25 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.95 0.9 . . . . 0.0 109.134 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.6 ttpt -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.549 HG23 HD23 ' A' ' 87' ' ' LEU . 83.9 t -67.36 122.03 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 122.917 0.487 . . . . 0.0 110.517 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 44.0 t -82.33 -39.64 22.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.937 0.895 . . . . 0.0 109.932 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.3 p -143.92 137.2 27.65 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.739 0.816 . . . . 0.0 109.887 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.41 -161.6 25.0 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.977 0.798 . . . . 0.0 111.485 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.04 -17.98 40.59 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.186 2.591 . . . . 0.0 112.522 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -116.4 27.5 9.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.866 0.866 . . . . 0.0 110.223 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.14 95.08 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.661 0.785 . . . . 0.0 111.586 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.99 -18.33 5.6 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.072 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -86.85 143.8 27.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.713 0.805 . . . . 0.0 110.201 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.0 p -100.94 117.69 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 0.0 109.316 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.0 mm? -87.63 142.95 27.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 108.318 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -107.69 139.59 42.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.923 0.889 . . . . 0.0 109.047 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.9 mt -81.14 99.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 107' ' ' ARG . 23.6 pt -74.26 94.34 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.945 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.29 12.64 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.595 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -128.35 142.97 46.42 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.267 1.027 . . . . 0.0 109.309 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.54 155.53 69.84 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.025 2.483 . . . . 0.0 112.601 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -116.88 107.41 46.15 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -62.76 141.1 83.85 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -69.03 145.49 53.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.88 67.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.606 1.163 . . . . 0.0 112.357 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.62 54.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.763 0.425 . . . . 0.0 111.586 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 65.42 14.4 9.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.47 1.108 . . . . 0.0 112.67 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.415 HG23 ' HD2' ' A' ' 101' ' ' ARG . 13.5 t -89.8 -2.81 58.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.872 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -168.57 178.04 4.93 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.629 0.772 . . . . 0.0 110.91 171.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.44 121.53 32.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -83.72 112.25 19.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 69' ' ' ILE . 22.1 mm -98.11 142.29 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -117.82 133.76 55.61 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 81.2 m -150.06 161.74 41.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.582 -171.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.408 ' HB2' HD13 ' A' ' 90' ' ' ILE . 56.5 ttp180 -144.95 139.85 27.84 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' LEU . 27.7 tt0 -48.78 143.29 5.42 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.517 1.136 . . . . 0.0 113.397 -168.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.018 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.775 -173.124 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 38' ' ' SER . 6.4 mp . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -123.62 -29.26 3.76 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.165 0.986 . . . . 0.0 111.548 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -99.89 -172.82 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.341 1.456 . . . . 0.0 110.247 -173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB2' HG22 ' A' ' 79' ' ' THR . 53.4 mtm180 -139.62 146.35 39.66 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 110.409 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.83 149.79 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.419 1.088 . . . . 0.0 109.048 178.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -107.58 126.13 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.18 111.32 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.361 0.665 . . . . 0.0 110.229 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 76.4 mt-30 -95.06 96.7 9.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.513 0.725 . . . . 0.0 109.718 172.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -82.07 150.25 27.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.109 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 27' ' ' GLU . 51.3 tp -89.3 98.31 11.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.8 0.727 . . . . 0.0 109.517 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -85.34 101.59 12.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.611 0.764 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -86.73 86.13 7.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -91.95 126.04 36.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.066 0.946 . . . . 0.0 110.611 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.6 ttp180 -79.19 148.14 32.38 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.693 0.282 . . . . 0.0 110.98 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.43 165.76 12.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.226 1.01 . . . . 0.0 108.887 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.41 -11.09 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 C-N-CA 124.225 1.01 . . . . 0.0 113.239 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -105.0 -7.07 19.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.57 -0.706 . . . . 0.0 109.33 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 50.56 3.67 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.078 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 45.6 mt-10 -108.55 138.38 44.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 108.894 173.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 mm -87.94 99.56 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.89 109.26 17.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.61 0.764 . . . . 0.0 109.776 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.2 mt-10 -80.0 111.3 16.21 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.3 p -132.69 154.27 50.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.043 . . . . 0.0 108.59 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -103.04 105.24 15.51 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 16.5 pt-20 -84.56 139.81 31.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.958 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -84.94 138.32 32.57 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.16 -108.77 2.8 Favored Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -174.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -118.05 142.39 47.45 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.952 0.406 . . . . 0.0 110.465 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 9' ' ' ARG . 16.2 m -96.14 96.69 8.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 108.57 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -105.01 176.28 5.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.154 0.582 . . . . 0.0 111.472 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -71.83 134.91 46.41 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.361 1.064 . . . . 0.0 111.056 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -142.84 168.04 20.66 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.112 0.965 . . . . 0.0 110.829 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 23.1 t -123.15 98.69 6.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.63 90.95 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.27 97.52 11.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.716 0.806 . . . . 0.0 109.495 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.85 106.04 11.58 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 46' ' ' GLU . 3.3 m -74.86 138.19 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.358 0.599 . . . . 0.0 111.645 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.4 m -97.36 -174.01 2.81 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 124.456 1.103 . . . . 0.0 109.757 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 56' ' ' ILE . 13.2 p -53.8 -43.64 69.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.17 0.988 . . . . 0.0 112.764 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.32 -46.38 83.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.079 0.551 . . . . 0.0 111.456 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 53.1 mm-40 -61.96 -43.26 99.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.12 0.568 . . . . 0.0 111.859 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.46 91.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.505 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.1 -31.05 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.636 0.774 . . . . 0.0 110.505 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.0 m -71.05 -25.92 62.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.482 0.713 . . . . 0.0 110.628 172.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 26.8 t -92.24 -10.65 37.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.151 0.981 . . . . 0.0 110.552 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 -80.14 1.73 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.33 12.11 0.55 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.977 0.911 . . . . 0.0 110.757 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 35.7 tt0 -75.65 -55.01 6.06 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 58' ' ' THR . 80.3 mt -86.96 166.82 14.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.986 0.514 . . . . 0.0 109.659 168.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.18 160.73 31.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.097 0.959 . . . . 0.0 109.208 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' SER . 49.6 mt -69.88 104.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.26 3.63 18.99 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.348 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 54' ' ' LEU . 32.2 m -68.44 119.37 12.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.444 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -84.05 97.46 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.371 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -87.99 125.31 34.47 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 75' ' ' ILE . 86.2 mt -128.72 109.71 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 0.0 109.362 -165.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -97.13 113.5 25.08 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 123.561 0.744 . . . . 0.0 109.71 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' A' ' 66' ' ' ARG . 41.5 pt -120.58 163.35 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -58.77 149.78 25.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.299 0.5 . . . . 0.0 112.057 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.02 124.87 22.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.348 -170.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.571 ' HD3' HD12 ' A' ' 63' ' ' ILE . 10.2 ptm180 -153.46 133.51 13.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.485 0.714 . . . . 0.0 109.759 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -83.64 10.27 9.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.827 0.851 . . . . 0.0 111.061 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -91.25 -27.28 18.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.58 1.152 . . . . 0.0 111.552 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 104' ' ' ILE . 19.0 mm -74.75 137.86 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.923 0.392 . . . . 0.0 110.294 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -137.44 164.73 27.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.025 0.93 . . . . 0.0 108.867 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.77 66.06 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.757 0.823 . . . . 0.0 111.914 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.5 p -86.83 28.78 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.712 0.805 . . . . 0.0 111.636 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -126.63 134.61 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -100.31 148.8 24.27 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.47 HG21 HD13 ' A' ' 61' ' ' ILE . 43.2 mm -110.04 108.79 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.692 0.797 . . . . 0.0 109.328 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -100.43 112.93 25.33 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.27 104.49 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.947 0.499 . . . . 0.0 109.744 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.67 -26.39 63.42 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.576 0.75 . . . . 0.0 111.694 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.8 t -162.95 135.04 5.27 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.38 -154.53 25.92 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.315 -0.714 . . . . 0.0 112.346 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 -20.27 33.47 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.228 2.619 . . . . 0.0 112.31 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 85' ' ' ARG . 84.1 mt -128.23 38.33 4.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.755 0.822 . . . . 0.0 109.995 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.43 97.87 0.15 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.57 -34.93 1.92 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.872 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 75.4 mtt85 -68.57 138.17 54.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.44 0.696 . . . . 0.0 112.195 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.91 86.9 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.643 1.211 . . . . 0.0 108.019 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.61 149.43 43.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.803 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -108.99 139.21 44.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.513 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.91 105.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HG23 ' A' ' 58' ' ' THR . 19.6 pt -77.83 74.08 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 122.1 0.952 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.72 -141.16 13.79 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -127.16 138.39 32.62 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.76 0.824 . . . . 0.0 109.046 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.22 142.12 79.12 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.568 2.845 . . . . 0.0 112.53 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.79 119.67 29.93 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.52 155.18 59.8 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.589 2.192 . . . . 0.0 112.163 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.65 151.42 46.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.189 0.596 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -41.02 88.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.403 1.081 . . . . 0.0 111.802 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 -3.92 57.18 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.427 0.691 . . . . 0.0 111.891 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 63.61 15.9 9.26 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.905 1.282 . . . . 0.0 113.114 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -82.06 -7.48 59.62 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.951 0.405 . . . . 0.0 111.172 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 4.6 ppt_? -162.7 169.69 19.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.722 0.809 . . . . 0.0 109.11 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.28 131.33 56.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 33.3 tt0 -100.28 114.77 28.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.187 0.518 . . . . 0.0 109.902 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 69' ' ' ILE . 15.4 mm -93.97 136.44 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -109.48 130.64 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.418 ' SG ' HG22 ' A' ' 104' ' ' ILE . 82.7 m -147.36 171.21 15.81 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.891 0.877 . . . . 0.0 108.66 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.447 ' HB2' HD13 ' A' ' 90' ' ' ILE . 64.1 ttt180 -158.47 160.52 36.85 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.598 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.0 146.38 54.21 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.641 1.176 . . . . 0.0 110.278 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 170.51 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -105.55 -33.3 8.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.422 0.689 . . . . 0.0 110.138 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -96.23 -174.13 2.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.594 1.158 . . . . 0.0 110.116 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' THR . 53.8 ttp180 -154.1 123.38 6.5 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -116.18 159.07 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.632 0.773 . . . . 0.0 110.142 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -109.67 146.02 35.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.368 0.667 . . . . 0.0 109.329 168.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -101.26 107.2 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.486 1.114 . . . . 0.0 110.08 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -77.69 95.41 4.61 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 p -80.15 152.08 29.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.505 0.722 . . . . 0.0 109.82 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 27' ' ' GLU . 27.9 tp -92.41 97.59 10.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.323 0.583 . . . . 0.0 110.992 -171.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -76.83 95.19 4.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.095 0.958 . . . . 0.0 109.644 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.4 104.86 14.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.8 m -111.83 116.23 30.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 -169.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -85.96 140.17 30.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 122.607 0.363 . . . . 0.0 110.791 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -99.81 178.39 4.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 109.613 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tt -50.45 -46.68 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.357 1.063 . . . . 0.0 113.298 -172.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -105.85 12.79 30.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.89 23.58 7.37 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -77.94 119.57 21.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.15 87.33 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.66 92.62 0.87 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.685 0.794 . . . . 0.0 109.565 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.593 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.2 mt-10 -79.76 94.17 5.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -101.44 143.86 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.48 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -94.02 93.39 7.83 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.7 112.4 14.49 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.11 103.93 0.33 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.964 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.41 2.07 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.683 -160.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -106.76 146.72 30.51 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.603 0.761 . . . . 0.0 111.254 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.476 HG22 ' HG2' ' A' ' 9' ' ' ARG . 4.6 m -106.76 140.59 39.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.626 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.82 158.18 40.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.432 0.693 . . . . 0.0 110.684 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -61.43 149.04 39.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.106 0.962 . . . . 0.0 112.041 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -155.29 169.47 24.12 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.368 0.667 . . . . 0.0 111.385 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 14.7 t -128.58 91.37 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.95 96.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.407 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -107.52 99.37 8.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.499 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 82' ' ' LEU . 48.7 mtp -73.11 142.03 47.52 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.84 159.71 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.522 0.729 . . . . 0.0 112.518 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.64 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.2 m -93.31 -178.46 4.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.13 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . 34.9 p -72.23 -20.99 61.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.065 0.546 . . . . 0.0 111.56 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 20.6 ptmt -53.56 -41.7 66.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.352 1.061 . . . . 0.0 113.193 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -31.71 49.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.457 0.703 . . . . 0.0 110.868 -172.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.99 85.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.672 0.789 . . . . 0.0 110.357 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.72 -34.67 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -68.85 -49.42 58.51 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.84 0.856 . . . . 0.0 111.304 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 23.7 m -93.64 1.17 56.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.65 -79.01 1.44 Allowed Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.31 -17.67 2.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.02 0.928 . . . . 0.0 111.241 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 33.3 tt0 -57.37 -50.31 73.36 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.293 0.637 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.9 mt -103.0 158.14 16.49 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.899 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.19 153.41 25.68 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.232 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 44' ' ' SER . 31.0 mt -65.4 128.05 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.2 -8.42 18.32 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.213 0.321 . . . . 0.0 112.77 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 40.8 m -68.93 139.49 55.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.308 0.643 . . . . 0.0 109.309 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -124.68 103.24 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -81.64 98.93 8.6 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.67 106.29 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.512 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 9.1 m0 -88.32 113.37 23.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.742 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.96 -171.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.78 0.832 . . . . 0.0 108.899 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -86.94 158.46 19.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.491 0.316 . . . . 0.0 110.456 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 70.1 t80 -60.66 97.44 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.522 1.129 . . . . 0.0 112.039 -172.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -120.77 104.81 10.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 109.501 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -68.92 -0.4 5.52 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.04 -20.57 21.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.603 0.761 . . . . 0.0 110.834 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.49 HG21 HD12 ' A' ' 104' ' ' ILE . 48.0 mm -66.18 128.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.45 164.9 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.7 1.2 . . . . 0.0 108.56 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.23 65.4 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.451 0.7 . . . . 0.0 111.22 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.1 p -87.4 40.19 0.91 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.166 0.986 . . . . 0.0 110.877 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -141.72 145.81 35.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.115 0.966 . . . . 0.0 108.861 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -108.8 138.7 44.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 104' ' ' ILE . 22.3 mm -107.33 90.75 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 33.7 ttmt -83.71 115.85 22.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 97.4 t -72.85 99.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 m -71.04 -26.46 63.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 111.566 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -155.49 140.73 17.57 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.942 0.897 . . . . 0.0 108.733 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.65 -154.68 26.08 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.313 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.62 -37.5 21.67 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.704 2.269 . . . . 0.0 111.369 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 87' ' ' LEU . 89.0 mt -103.89 42.12 1.22 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.476 1.11 . . . . 0.0 109.74 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.63 101.48 0.25 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.863 0.865 . . . . 0.0 111.602 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.88 -19.13 11.3 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.412 1.006 . . . . 0.0 112.307 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 82' ' ' LEU . 92.7 mtt180 -83.13 141.16 32.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.478 0.711 . . . . 0.0 111.241 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 51.4 t -103.0 106.99 21.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 124.834 1.254 . . . . 0.0 108.408 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.6 mm? -90.07 128.73 36.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.527 0.731 . . . . 0.0 109.167 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.9 OUTLIER -97.82 119.0 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.282 0.633 . . . . 0.0 110.059 -173.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' CYS . 45.6 mt -56.36 134.31 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.417 0.687 . . . . 0.0 111.26 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' HE ' ' A' ' 107' ' ' ARG . 11.5 pt -112.1 96.34 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.724 175.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.27 -84.76 0.37 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.126 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -170.33 158.83 6.15 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.212 1.005 . . . . 0.0 109.523 -172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 57.8 Cg_endo -69.62 125.07 11.79 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.23 1.953 . . . . 0.0 111.57 171.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -103.93 109.47 62.35 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.063 0.945 . . . . 0.0 109.508 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.29 150.5 53.01 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.693 2.262 . . . . 0.0 111.04 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.73 175.11 7.5 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.3 67.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.385 0.674 . . . . 0.0 112.508 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.89 -13.55 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.369 0.668 . . . . 0.0 112.528 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.52 26.07 15.87 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.391 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 t -82.25 -25.5 34.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.299 0.639 . . . . 0.0 110.012 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -138.83 168.59 19.48 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 15.4 tp -128.54 108.22 10.35 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.95 109.78 18.41 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.549 HG21 HG13 ' A' ' 75' ' ' ILE . 13.1 mm -90.09 102.88 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.684 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.4 pt? -81.12 105.13 12.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.182 0.991 . . . . 0.0 108.362 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 61.5 m -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.921 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.675 ' HE ' HG21 ' A' ' 90' ' ' ILE . 21.4 ttp85 -146.39 140.65 26.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.67 118.92 8.3 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 111.096 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.431 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 176.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 54.3 mt . . . . . 0 CA--C 1.552 1.03 0 CA-C-O 121.786 0.803 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -91.25 -26.95 18.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.922 1.289 . . . . 0.0 110.896 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.22 -172.64 2.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.609 1.564 . . . . 0.0 109.719 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HG2' HG22 ' A' ' 34' ' ' THR . 14.6 ttp180 -155.77 138.75 15.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.879 0.872 . . . . 0.0 108.776 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.01 144.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.387 0.675 . . . . 0.0 111.122 -173.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -92.0 120.93 33.1 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.524 1.13 . . . . 0.0 109.902 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.43 95.52 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -73.59 99.26 3.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 109.928 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 p -79.87 146.42 32.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.603 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.5 tp -92.86 106.77 18.68 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.75 0.42 . . . . 0.0 110.333 -172.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -94.69 101.87 13.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.52 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 48.6 mt-30 -77.56 93.95 4.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.58 0.752 . . . . 0.0 109.164 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.2 m -92.78 123.52 36.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.347 1.059 . . . . 0.0 110.404 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -74.59 163.13 28.09 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.031 0.532 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.28 165.0 12.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.465 1.106 . . . . 0.0 108.502 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.2 -15.84 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -95.84 -6.69 38.84 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.1 6.39 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.077 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.08 136.28 53.17 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.132 0.973 . . . . 0.0 108.827 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.35 120.22 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.4 123.9 51.31 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.06 0.944 . . . . 0.0 109.707 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.645 ' HB3' HD11 ' A' ' 15' ' ' LEU . 3.5 mp0 -81.57 116.92 21.56 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.781 0.833 . . . . 0.0 110.118 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 p -130.92 153.04 49.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.109 0.964 . . . . 0.0 108.806 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -110.4 108.86 19.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.503 0.721 . . . . 0.0 109.491 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.03 133.8 35.81 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.7 127.46 31.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.15 -113.75 3.8 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -99.61 124.93 45.28 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.427 0.691 . . . . 0.0 109.847 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 10.1 m -101.04 94.88 6.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -117.04 168.51 10.19 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.206 0.602 . . . . 0.0 111.773 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 35.7 m95 -64.19 136.36 57.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.916 0.886 . . . . 0.0 112.573 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -139.24 165.97 25.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.295 1.038 . . . . 0.0 111.672 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 22.5 t -120.42 92.12 3.7 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 166.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -90.72 98.19 8.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.016 0.926 . . . . 0.0 108.951 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -119.07 116.04 25.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.546 0.738 . . . . 0.0 109.408 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.532 ' HG2' HG22 ' A' ' 59' ' ' VAL . 81.9 mtp -65.9 130.7 44.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.644 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 22.3 m -70.54 146.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 111.021 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t -84.53 174.78 9.74 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.6 p -60.73 -25.92 66.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -26.1 68.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.644 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 16.3 mm-40 -68.2 -41.46 81.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.156 0.582 . . . . 0.0 110.719 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.15 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.907 0.754 . . . . 0.0 110.86 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -64.86 -40.31 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.366 0.666 . . . . 0.0 110.521 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.0 m -66.48 -49.74 65.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.687 0.795 . . . . 0.0 111.943 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 76.6 p -91.42 -19.48 22.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.462 0.705 . . . . 0.0 112.39 -171.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.34 2.22 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.56 -15.04 1.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.426 0.691 . . . . 0.0 112.036 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 24.4 mm-40 -59.82 -43.75 94.36 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.2 0.6 . . . . 0.0 111.297 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.94 149.33 29.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.55 167.46 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.814 0.846 . . . . 0.0 109.644 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 mt -76.28 114.22 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 4.76 59.73 Favored Glycine 0 N--CA 1.467 0.706 0 CA-C-O 119.625 -0.542 . . . . 0.0 112.95 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.525 HG23 HD11 ' A' ' 90' ' ' ILE . 18.3 m -56.54 113.74 1.74 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.293 0.568 . . . . 0.0 109.753 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 41' ' ' MET . 49.3 t -73.18 107.25 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.189 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -90.98 134.02 34.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 80.7 mt -133.35 108.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -168.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 32.5 m0 -91.25 124.3 35.36 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 123.528 0.731 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.35 163.84 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -52.21 149.71 5.16 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.746 0.418 . . . . 0.0 111.627 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -56.83 108.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.017 0.823 . . . . 0.0 109.968 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 46.9 ttt85 -135.96 116.69 14.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -168.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -84.44 9.05 14.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.625 1.17 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 20.9 t70 -92.85 -19.57 21.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.245 1.418 . . . . 0.0 110.495 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 13.2 mm -84.32 139.94 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.483 0.713 . . . . 0.0 109.577 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -130.65 166.48 20.6 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.76 -23.71 66.79 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.411 0.684 . . . . 0.0 111.437 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -85.44 41.93 0.92 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.191 0.996 . . . . 0.0 110.433 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 m -131.72 147.57 52.51 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 123.778 0.831 . . . . 0.0 109.081 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -115.17 120.99 41.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 104' ' ' ILE . 18.2 mm -88.4 91.28 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.32 1.048 . . . . 0.0 109.507 -173.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -91.18 120.18 31.9 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 87' ' ' LEU . 88.7 t -71.38 122.28 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.824 0.345 . . . . 0.0 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -89.44 -30.53 18.25 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 109.583 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 m -143.57 110.51 5.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.065 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.68 -170.08 30.52 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.82 -0.434 . . . . 0.0 113.736 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.26 -29.0 26.98 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.839 2.359 . . . . 0.0 111.735 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.3 mt -98.26 22.14 9.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.656 0.782 . . . . 0.0 111.018 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.14 124.32 19.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.005 0.522 . . . . 0.0 110.715 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.08 34.17 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.111 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -88.88 143.24 27.01 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.439 0.695 . . . . 0.0 110.744 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -105.99 100.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 122.194 0.997 . . . . 0.0 109.54 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -83.24 113.08 20.43 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.953 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.8 139.8 32.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 109.094 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 75' ' ' ILE . 63.1 mt -78.53 108.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.525 HD11 HG23 ' A' ' 58' ' ' THR . 18.5 pt -92.16 61.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 122.152 0.977 . . . . 0.0 110.133 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.92 -122.03 1.12 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.426 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -150.88 143.82 16.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.976 0.91 . . . . 0.0 109.139 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 111.97 1.12 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 110.499 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.47 117.43 36.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.128 0.971 . . . . 0.0 108.845 -167.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.56 158.57 49.12 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.574 2.183 . . . . 0.0 112.367 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.1 -174.54 4.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.837 0.455 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.08 -48.01 66.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.487 0.715 . . . . 0.0 111.705 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.97 58.86 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.598 0.759 . . . . 0.0 112.798 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 71.39 14.33 6.44 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -85.05 -1.72 57.16 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.315 1.046 . . . . 0.0 112.236 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -163.41 161.32 24.3 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.812 0.815 . . . . 0.0 110.129 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.74 109.21 21.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -90.67 108.87 20.09 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 0.0 109.666 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 75' ' ' ILE . 9.3 mm -88.45 145.38 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -120.48 132.93 55.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 60.2 m -153.76 175.64 13.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.34 0.656 . . . . 0.0 111.017 -169.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.6 166.62 22.22 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 108.497 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -73.22 156.16 38.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.697 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 167.4 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.551 0.983 0 CA-C-O 120.591 0.234 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -129.44 -30.06 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.663 0.785 . . . . 0.0 111.839 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -109.96 -166.91 1.13 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.045 1.738 . . . . 0.0 109.858 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 79' ' ' THR . 25.1 ttm180 -152.78 140.92 20.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.939 0.896 . . . . 0.0 109.166 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.15 156.78 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.804 0.842 . . . . 0.0 110.014 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -103.37 123.14 46.27 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.484 1.114 . . . . 0.0 108.992 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.19 108.95 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -85.83 111.41 20.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.71 0.767 . . . . 0.0 110.308 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -84.75 142.7 29.64 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.782 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.1 tp -97.85 113.88 25.8 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.748 0.819 . . . . 0.0 109.634 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' NZ ' ' HB3' ' A' ' 16' ' ' LYS . 5.6 ttpm? -99.77 113.19 25.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.797 0.839 . . . . 0.0 109.657 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.4 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.3 mt-30 -86.56 103.35 14.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.799 0.84 . . . . 0.0 109.402 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 m -93.9 165.16 12.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -114.1 165.95 12.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.859 0.754 . . . . 0.0 109.835 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -108.72 161.8 14.76 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.52 -14.21 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -103.25 -10.16 18.97 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.66 15.42 20.76 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.238 -0.892 . . . . 0.0 115.32 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.78 145.35 24.65 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.534 1.167 . . . . 0.0 109.485 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.51 122.48 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.312 0.645 . . . . 0.0 111.15 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.84 108.48 21.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.339 1.056 . . . . 0.0 108.565 175.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.4 mt-10 -80.96 107.1 13.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.371 0.669 . . . . 0.0 109.605 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -114.68 146.49 40.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.755 0.822 . . . . 0.0 110.2 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -111.18 106.23 15.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.698 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -106.1 143.86 33.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.78 137.94 48.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.821 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.26 -116.67 3.77 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -99.08 137.35 37.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.1 m -108.82 96.73 6.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.767 0.827 . . . . 0.0 108.855 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.59 175.24 5.57 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.38 0.609 . . . . 0.0 111.276 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -70.69 135.42 48.29 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.477 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.5 173.75 11.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.336 1.054 . . . . 0.0 111.074 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.2 m -130.38 96.25 4.1 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 160.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 61' ' ' ILE . 2.6 p -94.41 102.36 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -173.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.27 122.58 44.36 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.779 0.831 . . . . 0.0 109.123 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 82' ' ' LEU . 72.1 mtp -72.22 145.93 47.64 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.1 134.51 30.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -83.45 176.33 9.15 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 123.53 0.732 . . . . 0.0 109.776 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p -60.13 -31.12 69.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -56.56 -49.67 74.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.671 0.788 . . . . 0.0 111.012 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.58 -44.07 91.83 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.845 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.98 -45.68 90.01 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 124.281 0.988 . . . . 0.0 112.438 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.93 -46.85 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.332 0.653 . . . . 0.0 111.217 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.5 m -65.6 -29.09 69.63 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.642 0.777 . . . . 0.0 112.216 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 89.8 p -90.6 -17.42 26.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.521 0.728 . . . . 0.0 111.996 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.02 -79.21 1.72 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.74 12.09 2.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.292 0.637 . . . . 0.0 111.05 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.4 tp10 -77.87 -53.55 7.35 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 58' ' ' THR . 81.1 mt -106.49 147.22 29.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.862 0.865 . . . . 0.0 108.808 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.28 158.75 41.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.1 mt -62.63 120.39 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.64 -11.12 13.99 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 123.383 0.427 . . . . 0.0 112.59 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 54' ' ' LEU . 25.4 m -71.88 140.21 49.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 166.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 38.7 t -122.67 122.28 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.494 0.718 . . . . 0.0 110.482 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -93.81 135.89 34.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 75' ' ' ILE . 66.1 mt -132.6 107.98 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.77 116.02 28.29 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.257 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.23 159.06 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -55.69 136.64 50.58 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 168.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HB3' ' NH1' ' A' ' 64' ' ' ARG . 56.0 t80 -48.17 114.66 0.98 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.568 1.547 . . . . 0.0 113.212 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -138.23 119.61 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.78 0.832 . . . . 0.0 109.231 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -79.84 7.57 8.49 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.8 0.44 . . . . 0.0 110.992 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.34 -22.89 20.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.337 0.655 . . . . 0.0 110.183 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.91 130.81 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.71 162.67 23.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.708 0.803 . . . . 0.0 109.171 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.96 -15.64 63.54 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.302 0.641 . . . . 0.0 112.052 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.2 p -83.16 2.82 33.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.563 0.745 . . . . 0.0 111.649 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -101.31 137.74 39.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -106.17 134.77 48.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 61' ' ' ILE . 30.3 mm -94.07 102.63 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 123.041 0.536 . . . . 0.0 110.077 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.4 ttpt -103.78 112.72 25.8 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.62 120.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.24 0.616 . . . . 0.0 111.594 -173.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -79.45 -31.9 42.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.696 1.199 . . . . 0.0 111.749 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 9' ' ' ARG . 11.7 t -160.51 142.79 12.84 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.14 -160.63 24.42 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.832 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.49 -27.36 46.59 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.911 2.407 . . . . 0.0 112.639 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 41' ' ' MET . 54.9 mt -115.77 31.64 6.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.723 0.809 . . . . 0.0 111.156 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.02 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.494 0.718 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.58 -19.0 4.83 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.082 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HD2' HD22 ' A' ' 82' ' ' LEU . 91.4 mtt-85 -86.51 142.69 28.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.291 0.637 . . . . 0.0 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 4.5 p -107.25 95.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.026 0.917 . . . . 0.0 108.995 172.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 108' ' ' GLU . 1.2 mm? -77.33 128.38 34.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.433 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -99.7 141.5 32.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.744 . . . . 0.0 109.17 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.62 122.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 pt -100.02 86.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.12 -94.18 0.54 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -159.15 145.83 12.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.964 0.905 . . . . 0.0 110.041 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.39 114.89 3.06 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.835 2.357 . . . . 0.0 111.128 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.94 108.76 48.16 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.876 0.87 . . . . 0.0 109.346 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.1 143.93 55.77 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.057 2.505 . . . . 0.0 112.331 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.41 168.9 19.24 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.194 0.452 . . . . 0.0 110.723 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.91 -27.5 65.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.005 0.922 . . . . 0.0 112.877 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.4 -7.25 42.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 62.13 29.78 17.63 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.447 1.099 . . . . 0.0 111.491 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 p -90.55 -17.98 26.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.881 0.873 . . . . 0.0 111.434 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -158.78 171.15 20.61 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.616 0.722 . . . . 0.0 110.78 -168.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.57 113.07 17.58 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.78 96.25 5.56 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.589 HG22 ' SG ' ' A' ' 106' ' ' CYS . 22.8 mm -88.71 97.16 6.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.702 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -79.01 130.51 35.61 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 104' ' ' ILE . 84.7 m -147.78 173.14 13.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.376 1.07 . . . . 0.0 108.875 -170.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -138.41 153.71 48.88 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 87' ' ' LEU . 38.3 tt0 -44.33 125.73 4.79 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.724 0.81 . . . . 0.0 112.848 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 86' ' ' VAL . . . . . . . . 0 C--N 1.347 1.187 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.472 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 37' ' ' ALA . 43.7 mt . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -123.08 -28.63 4.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.388 0.675 . . . . 0.0 111.775 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -101.82 -174.18 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB2' HG22 ' A' ' 79' ' ' THR . 94.2 mtt180 -136.38 142.22 43.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.68 0.792 . . . . 0.0 109.601 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' THR . 49.3 pt -133.71 166.01 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 108.779 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -132.81 134.93 45.32 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 73' ' ' SER . 51.4 mm -81.91 116.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.674 0.609 . . . . 0.0 109.666 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -89.98 104.26 16.84 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.39 139.37 34.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.927 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.4 tp -89.51 98.62 11.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.226 0.467 . . . . 0.0 109.902 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.2 99.31 6.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 110.312 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 51.5 mt-30 -96.56 79.37 3.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -98.58 126.08 44.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.043 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 28.7 ttp180 -76.64 162.32 27.84 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.185 0.994 . . . . 0.0 111.482 -175.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 11.3 t70 -113.65 164.35 13.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.733 0.813 . . . . 0.0 109.835 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.49 -14.62 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.669 0.788 . . . . 0.0 112.859 172.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 p -100.53 -20.15 15.85 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.91 39.97 3.22 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.007 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mm-40 -97.44 146.72 24.93 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.813 0.845 . . . . 0.0 108.921 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.8 100.32 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.38 92.13 7.48 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB3' HD11 ' A' ' 15' ' ' LEU . 38.5 mt-10 -82.63 106.29 14.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.987 0.915 . . . . 0.0 109.046 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -126.05 165.48 18.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.447 1.099 . . . . 0.0 109.474 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.69 102.73 10.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.28 121.59 29.94 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.787 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.51 126.28 26.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.839 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.55 -112.77 3.6 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -120.53 133.72 55.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.143 0.577 . . . . 0.0 109.944 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 33.6 m -85.31 107.45 17.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.53 0.732 . . . . 0.0 109.693 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.1 pt? -108.06 164.53 12.2 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 0.0 110.863 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -75.86 130.4 38.49 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.608 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.456 ' HA ' HD22 ' A' ' 6' ' ' LEU . . . -147.24 -176.51 5.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.816 0.846 . . . . 0.0 111.268 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -134.27 104.33 6.12 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.536 HG11 HG23 ' A' ' 77' ' ' VAL . 2.3 p -105.61 114.42 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 109.186 -172.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -136.14 153.62 51.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.167 1.387 . . . . 0.0 109.521 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 82' ' ' LEU . 76.6 mtp -85.17 136.33 33.58 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 58' ' ' THR . 20.2 m -68.45 137.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -97.22 -173.94 2.81 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.86 0.864 . . . . 0.0 110.865 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 p -54.48 -34.44 61.58 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.268 1.027 . . . . 0.0 112.182 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -51.76 -52.62 47.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.856 0.863 . . . . 0.0 110.902 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.42 -41.58 76.16 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.447 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.93 78.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.619 . . . . 0.0 112.353 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.23 -33.75 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.678 0.791 . . . . 0.0 110.795 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 t -71.91 -44.34 63.85 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.331 0.652 . . . . 0.0 111.552 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 73.6 p -104.33 0.28 29.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.29 0.636 . . . . 0.0 112.479 -174.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.77 -70.39 2.93 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.04 -2.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.09 0.556 . . . . 0.0 112.206 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 38.0 tt0 -65.07 -50.94 64.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.108 0.563 . . . . 0.0 110.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.06 60.79 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.47 156.63 26.48 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.82 122.83 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -171.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.38 -13.04 16.04 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.695 0.665 . . . . 0.0 112.031 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 87.3 m -79.65 139.46 37.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.51 HG11 ' HG ' ' A' ' 87' ' ' LEU . 42.8 t -110.67 116.5 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.46 0.704 . . . . 0.0 110.914 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -83.67 128.42 34.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.628 1.171 . . . . 0.0 110.408 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' SG ' ' A' ' 106' ' ' CYS . 51.3 mt -135.19 110.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -98.98 131.69 44.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.109 0.564 . . . . 0.0 110.438 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.29 161.04 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -63.75 151.04 43.19 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 164.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -53.49 118.64 4.03 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.034 0.934 . . . . 0.0 111.157 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 HD13 ' A' ' 35' ' ' LEU . 56.4 ttt180 -136.86 128.08 28.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.75 1.83 40.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.275 1.03 . . . . 0.0 112.457 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.89 -21.76 19.65 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.489 0.716 . . . . 0.0 111.31 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 104' ' ' ILE . 25.5 mm -81.0 131.36 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 110.249 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -131.66 158.65 40.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.092 0.957 . . . . 0.0 109.747 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.99 -25.82 66.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.047 0.939 . . . . 0.0 112.312 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -84.13 8.9 14.08 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.795 0.838 . . . . 0.0 111.758 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 12' ' ' ILE . 22.8 m -111.5 120.02 40.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.607 0.763 . . . . 0.0 109.177 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -83.1 136.88 34.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.78 0.432 . . . . 0.0 110.41 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 61' ' ' ILE . 33.1 mm -96.36 101.8 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 0.0 110.114 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 29.9 ttpt -90.31 120.0 31.08 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.241 0.616 . . . . 0.0 109.982 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.536 HG23 HG11 ' A' ' 39' ' ' VAL . 2.7 p -73.55 115.62 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.347 0.659 . . . . 0.0 110.805 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -81.3 -24.8 36.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.865 0.866 . . . . 0.0 111.814 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 9' ' ' ARG . 10.6 t -168.24 137.86 2.48 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.857 0.863 . . . . 0.0 108.725 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.37 -165.96 29.53 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.462 -174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.15 -9.02 22.93 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 123.388 2.725 . . . . 0.0 112.656 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 41' ' ' MET . 79.9 mt -119.08 6.66 11.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.169 0.988 . . . . 0.0 111.2 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -42.5 115.04 0.65 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.846 1.258 . . . . 0.0 113.58 -165.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.02 25.22 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.48 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -94.77 172.58 8.08 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.207 0.504 . . . . 0.0 110.593 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 42.5 t -124.08 114.08 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.307 0.643 . . . . 0.0 109.645 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.612 HD11 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -90.25 140.84 29.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.0 143.71 32.22 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.52 130.61 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 107' ' ' ARG . 29.7 pt -102.5 128.23 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 122.881 0.472 . . . . 0.0 109.82 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.02 -93.34 1.18 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.936 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 12.2 pt20 -161.51 156.35 19.97 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.399 1.08 . . . . 0.0 108.878 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.1 109.87 2.28 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.871 1.714 . . . . 0.0 110.274 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.4 113.31 38.21 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.32 1.048 . . . . 0.0 108.949 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.58 144.55 32.02 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.335 2.023 . . . . 0.0 111.665 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -60.76 149.57 35.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.415 0.686 . . . . 0.0 112.09 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.04 -28.77 65.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.032 0.933 . . . . 0.0 110.978 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.69 -5.46 45.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.591 0.756 . . . . 0.0 111.368 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? 61.31 18.72 9.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.837 1.255 . . . . 0.0 113.377 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -81.28 -10.49 59.57 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.361 0.528 . . . . 0.0 111.28 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -155.6 -179.13 7.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.349 0.595 . . . . 0.0 110.853 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -137.64 112.22 8.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.0 97.78 2.92 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.0 mm -85.31 86.96 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -79.11 136.03 37.02 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.529 ' SG ' HD12 ' A' ' 61' ' ' ILE . 62.9 m -146.41 170.25 17.21 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' HB2' HD13 ' A' ' 90' ' ' ILE . 37.2 ttp180 -142.16 144.49 33.47 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 172.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -41.6 118.95 1.16 Allowed 'General case' 0 C--N 1.362 1.11 0 O-C-N 124.43 1.081 . . . . 0.0 110.998 -177.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.214 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.927 -165.352 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.241 0.639 0 CA-C-O 121.854 0.835 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.09 -22.55 45.1 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.651 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -103.6 -175.39 2.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.573 1.149 . . . . 0.0 110.283 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 34' ' ' THR . 51.6 mtm180 -141.38 148.25 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 109.399 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -140.79 145.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.891 0.876 . . . . 0.0 108.687 177.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 m -96.23 122.85 39.54 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.551 0.614 . . . . 0.0 109.976 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.7 mm -75.54 103.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.575 0.75 . . . . 0.0 109.892 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 76' ' ' LYS . 78.5 mt-30 -85.55 95.72 9.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.511 0.672 . . . . 0.0 109.882 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -79.09 150.09 31.91 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.7 tp -88.35 105.0 17.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -170.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -89.73 96.61 10.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.037 0.935 . . . . 0.0 109.807 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 45.9 mt-30 -84.4 97.44 9.5 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -106.14 117.7 34.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.614 0.766 . . . . 0.0 109.336 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -72.07 162.48 29.4 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 120.629 0.252 . . . . 0.0 110.506 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.88 163.6 15.32 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.801 0.84 . . . . 0.0 109.361 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.6 -21.38 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.95 0.9 . . . . 0.0 113.018 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -93.85 -13.36 27.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.85 40.31 4.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.157 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.27 137.86 42.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 109.603 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -90.75 96.42 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.96 96.14 8.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 15' ' ' LEU . 49.4 mt-10 -79.97 111.58 16.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -125.58 169.15 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.857 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.443 ' HZ3' ' HA ' ' A' ' 73' ' ' SER . 79.6 m95 -119.97 109.41 15.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.31 115.11 22.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.5 135.79 55.6 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.202 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.57 -119.84 3.14 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.803 -168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -99.8 125.21 45.68 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -170.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 3.7 m -88.04 93.29 9.44 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -110.89 170.41 8.11 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -64.38 120.65 12.64 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.2 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -141.87 176.53 8.86 Favored 'General case' 0 C--O 1.209 -1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 111.979 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 m -135.38 108.41 7.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.579 HG23 HG12 ' A' ' 61' ' ' ILE . 2.0 p -108.16 109.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.958 0.903 . . . . 0.0 110.837 -172.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.05 138.66 49.7 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 0.0 109.044 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.509 ' SD ' HD21 ' A' ' 82' ' ' LEU . 77.1 mtp -75.45 145.34 41.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.32 130.8 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 O-C-N 123.691 0.619 . . . . 0.0 109.68 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 m -87.94 -175.93 5.29 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 123.4 0.68 . . . . 0.0 110.706 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.8 p -59.9 -33.91 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.791 0.837 . . . . 0.0 111.502 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.86 -47.52 67.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.806 0.843 . . . . 0.0 111.106 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.21 -45.22 81.53 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.114 0.884 . . . . 0.0 111.165 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -51.97 66.4 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.922 0.764 . . . . 0.0 111.217 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.23 -38.23 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.141 0.977 . . . . 0.0 111.581 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 t -77.09 -28.57 54.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.99 0.516 . . . . 0.0 111.556 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 50.7 m -94.79 -9.86 33.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 0.0 111.894 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.94 -74.62 2.27 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.25 2.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.767 0.827 . . . . 0.0 111.047 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 1.9 tm-20 -63.95 -61.15 2.46 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.81 142.01 30.1 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.08 151.34 45.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.36 0.664 . . . . 0.0 109.557 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.85 119.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.834 0.854 . . . . 0.0 110.765 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.28 -12.64 16.46 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.281 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.478 HG23 HD11 ' A' ' 90' ' ' ILE . 86.3 m -73.47 154.14 40.06 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 164.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 41' ' ' MET . 22.0 t -132.2 115.41 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -87.45 132.2 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 39' ' ' VAL . 41.8 mt -138.86 109.0 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.781 0.832 . . . . 0.0 109.037 -170.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -95.0 122.97 38.2 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.8 pt -116.62 165.32 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 66' ' ' ARG . 24.8 mmm180 -54.25 140.17 33.72 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 164.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 95' ' ' PRO . 51.8 t80 -54.6 129.51 36.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.007 1.323 . . . . 0.0 111.745 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 64' ' ' ARG . 50.4 mtt85 -150.96 129.32 12.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.788 0.835 . . . . 0.0 110.688 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -81.79 -13.9 57.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.252 1.021 . . . . 0.0 111.02 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.05 -21.47 22.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.765 0.426 . . . . 0.0 110.747 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.08 128.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.663 0.385 . . . . 0.0 110.199 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.686 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 67.2 t30 -140.73 168.09 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.387 1.075 . . . . 0.0 109.235 -177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.62 -7.66 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.9 p -86.08 19.99 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.345 1.058 . . . . 0.0 112.274 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.443 ' HA ' ' HZ3' ' A' ' 29' ' ' TRP . 72.5 m -130.09 172.77 11.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.609 0.764 . . . . 0.0 110.777 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -119.92 140.66 50.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.899 0.88 . . . . 0.0 108.952 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.523 HG21 HG21 ' A' ' 61' ' ' ILE . 50.1 mm -98.08 105.49 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.601 0.76 . . . . 0.0 109.617 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 88.2 tttt -90.44 131.09 36.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.456 HG23 HD23 ' A' ' 87' ' ' LEU . 67.8 t -83.9 123.09 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.785 0.434 . . . . 0.0 110.579 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -85.64 -38.9 17.87 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.466 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 p -146.76 128.41 15.17 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.32 -169.69 29.62 Favored Glycine 0 N--CA 1.469 0.895 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.244 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.42 -1.24 10.75 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.017 2.478 . . . . 0.0 112.855 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' SD ' ' A' ' 41' ' ' MET . 89.4 mt -130.03 32.98 4.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.004 0.922 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.83 104.95 0.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.59 0.756 . . . . 0.0 111.685 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.32 -18.36 12.14 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.959 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.15 158.31 20.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 110.954 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.8 p -124.96 98.6 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.552 1.168 . . . . 0.0 110.189 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.5 mm? -82.54 148.77 27.88 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.294 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -110.76 141.07 44.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.051 0.94 . . . . 0.0 108.508 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.71 98.69 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 58' ' ' THR . 39.2 pt -80.86 146.57 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.098 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.12 -105.45 2.06 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.755 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -161.8 144.94 9.19 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 123.519 0.728 . . . . 0.0 109.897 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.686 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 62.8 Cg_endo -69.7 125.74 12.53 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.196 1.931 . . . . 0.0 110.678 173.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 111.7 54.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HB3' ' HE1' ' A' ' 65' ' ' TYR . 74.4 Cg_exo -53.83 142.59 62.63 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.205 2.603 . . . . 0.0 113.559 175.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.535 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 18.1 t70 -51.74 156.09 1.51 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.929 0.892 . . . . 0.0 112.639 173.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.16 77.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.326 1.05 . . . . 0.0 112.013 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.97 -6.58 35.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.313 0.645 . . . . 0.0 111.491 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 25.57 15.27 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.783 1.233 . . . . 0.0 112.249 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.9 p -83.28 -4.73 58.72 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.327 0.584 . . . . 0.0 111.334 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 17.3 ptt180 -169.12 -176.46 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.661 1.584 . . . . 0.0 107.894 -168.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.16 118.16 14.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.69 108.51 14.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 mm -100.17 153.15 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -133.63 146.61 51.07 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 170.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 71.3 m -150.21 171.99 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.281 -168.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -160.62 158.19 28.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -44.16 151.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.469 1.108 . . . . 0.0 112.776 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.899 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.753 -175.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 34.9 mt . . . . . 0 C--O 1.239 0.509 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -116.03 1.74 13.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.564 0.746 . . . . 0.0 112.429 -170.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -113.88 -172.59 2.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.939 1.296 . . . . 0.0 109.231 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 50.1 mtm180 -140.57 156.21 46.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.168 0.987 . . . . 0.0 109.234 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.35 135.39 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.3 m -90.02 113.58 25.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.116 0.966 . . . . 0.0 109.654 173.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mm -74.06 105.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.845 1.258 . . . . 0.0 109.982 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.564 HE21 ' HB2' ' A' ' 76' ' ' LYS . 65.9 mt-30 -72.76 102.32 3.33 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 174.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -83.03 133.64 35.08 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.624 -1.625 . . . . 0.0 108.294 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.3 tp -82.04 96.77 7.85 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -80.82 102.23 9.88 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -81.79 100.97 9.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.298 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -92.39 178.95 5.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -130.11 164.95 23.29 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.605 -0.684 . . . . 0.0 109.448 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 18.5 t70 -107.02 160.22 15.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.142 0.977 . . . . 0.0 108.754 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.5 tt -55.57 -15.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -98.71 -2.84 37.23 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.71 53.99 3.6 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.39 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 15.0 pt-20 -130.62 142.35 50.45 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.65 109.96 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 122.884 0.473 . . . . 0.0 110.998 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -96.26 93.0 6.64 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HB3' HD11 ' A' ' 15' ' ' LEU . 48.5 mt-10 -80.86 131.68 35.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.921 0.488 . . . . 0.0 110.302 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.4 p -138.95 159.81 41.26 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.306 1.042 . . . . 0.0 110.137 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -111.62 120.41 41.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.261 0.624 . . . . 0.0 109.886 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.15 164.14 23.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.725 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.07 138.65 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.114 0.884 . . . . 0.0 108.797 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.56 -107.4 2.42 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -110.07 129.4 55.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.91 0.884 . . . . 0.0 109.131 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 21.4 m -106.5 96.16 6.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.646 0.378 . . . . 0.0 110.183 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.74 172.01 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 122.883 0.473 . . . . 0.0 112.254 -174.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -67.19 129.97 41.62 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -144.56 172.55 12.81 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 123.769 0.828 . . . . 0.0 111.423 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 6' ' ' LEU . 72.1 m -128.17 109.68 11.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.507 HG23 HG12 ' A' ' 61' ' ' ILE . 2.9 p -100.86 98.0 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.831 0.852 . . . . 0.0 109.611 -172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -112.4 115.24 28.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.827 0.851 . . . . 0.0 110.748 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 69.7 mtp -62.39 133.81 55.58 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 6.0 m -68.02 153.5 8.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.417 0.448 . . . . 0.0 110.262 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -84.28 171.76 12.44 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.949 0.5 . . . . 0.0 110.458 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -60.18 -27.13 66.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.167 0.587 . . . . 0.0 110.669 173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -47.85 -46.15 30.9 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.378 1.471 . . . . 0.0 111.897 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 33.9 mm-40 -67.2 -39.76 86.39 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.504 0.502 . . . . 0.0 111.465 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -51.63 57.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.981 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.57 -52.61 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.344 1.058 . . . . 0.0 112.155 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -71.69 -26.47 62.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.439 0.695 . . . . 0.0 112.486 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 43.0 m -92.7 -7.71 45.97 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.912 0.485 . . . . 0.0 111.411 175.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.53 0.72 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 123.494 0.496 . . . . 0.0 111.894 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.71 -5.93 7.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.791 0.836 . . . . 0.0 111.123 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 12.1 tp10 -66.56 -51.46 56.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.488 0.715 . . . . 0.0 110.669 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.83 155.95 19.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.87 0.868 . . . . 0.0 108.982 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.28 177.63 7.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.758 0.823 . . . . 0.0 110.546 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.73 136.68 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.88 43.91 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -170.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.0 m -70.75 145.13 50.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.044 0.937 . . . . 0.0 109.322 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 45.2 t -126.24 129.81 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.424 1.09 . . . . 0.0 109.214 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.3 140.37 37.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.643 HD13 HG21 ' A' ' 75' ' ' ILE . 56.1 mt -137.1 143.37 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -170.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -129.22 127.32 41.04 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 37' ' ' ALA . 42.9 pt -126.95 157.89 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.572 1.149 . . . . 0.0 107.931 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -60.28 145.46 47.44 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.448 . . . . 0.0 110.482 168.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.523 ' HA ' HD13 ' A' ' 102' ' ' LEU . 39.5 t80 -57.09 125.12 21.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.676 0.79 . . . . 0.0 110.242 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 32.7 ttt180 -153.29 122.08 6.43 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 123.613 0.571 . . . . 0.0 110.79 -172.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -71.56 -3.16 19.85 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.174 1.389 . . . . 0.0 112.431 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 4.3 t70 -89.92 -23.35 21.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.353 1.061 . . . . 0.0 110.369 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.447 HD11 ' HD3' ' A' ' 66' ' ' ARG . 20.8 mm -87.65 130.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.527 -175.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.707 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 66.3 t30 -145.3 167.95 21.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 109.594 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.26 65.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.165 0.986 . . . . 0.0 111.947 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.8 p -72.16 0.03 10.75 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.343 1.057 . . . . 0.0 112.334 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.9 t -101.14 161.34 13.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.855 0.862 . . . . 0.0 109.565 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 52.9 mtp180 -113.88 147.48 38.38 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.643 HG21 HD13 ' A' ' 61' ' ' ILE . 49.3 mm -95.6 102.56 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.491 0.316 . . . . 0.0 110.393 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HB2' HE21 ' A' ' 13' ' ' GLN . 58.3 tttm -94.94 102.96 14.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG23 HD23 ' A' ' 87' ' ' LEU . 70.2 t -69.41 124.28 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 120.74 0.305 . . . . 0.0 111.095 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 42.2 t -80.97 -40.11 24.92 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.991 0.917 . . . . 0.0 110.79 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.0 p -146.33 132.64 19.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 108.747 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.0 -170.44 27.91 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 123.517 0.51 . . . . 0.0 112.531 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.03 -17.65 59.85 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.137 2.558 . . . . 0.0 112.059 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 41' ' ' MET . 29.9 mt -114.25 23.94 12.4 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.742 1.217 . . . . 0.0 110.088 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.85 108.48 1.2 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.892 . . . . 0.0 111.487 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.28 -31.42 5.45 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 123.979 0.8 . . . . 0.0 111.938 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.492 HH12 ' HG3' ' A' ' 108' ' ' GLU . 36.3 mtm180 -89.08 170.71 10.41 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.573 0.749 . . . . 0.0 112.761 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 76' ' ' LYS . 37.5 t -122.54 104.88 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.454 1.101 . . . . 0.0 110.106 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 77' ' ' VAL . 2.2 mm? -86.63 140.93 29.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.601 170.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.47 141.95 39.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.404 1.082 . . . . 0.0 109.072 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 106' ' ' CYS . 51.8 mt -81.11 107.14 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -173.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 107' ' ' ARG . 32.0 pt -90.92 41.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.414 0.686 . . . . 0.0 111.302 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.5 -134.97 2.5 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 112.001 -0.439 . . . . 0.0 112.001 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -134.65 136.52 25.62 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.903 1.281 . . . . 0.0 108.708 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.707 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 73.9 Cg_endo -69.62 111.24 2.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.158 1.905 . . . . 0.0 110.765 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 107.66 60.17 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -173.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 51.4 Cg_exo -56.03 150.61 46.41 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.539 2.826 . . . . 0.0 112.882 172.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.8 173.34 9.26 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.81 -32.45 69.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.48 0.712 . . . . 0.0 112.36 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.47 -9.33 44.91 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 62.48 30.09 17.16 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.176 0.99 . . . . 0.0 111.302 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.2 p -101.38 -12.88 18.27 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.824 0.849 . . . . 0.0 112.204 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.66 143.08 3.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -171.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.546 HD23 ' HB2' ' A' ' 93' ' ' PRO . 9.6 mp -101.64 139.57 37.12 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.958 0.903 . . . . 0.0 110.069 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.66 109.99 19.56 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 164.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.5 mm -95.92 104.57 15.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.7 pt? -83.3 137.52 33.95 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 104' ' ' ILE . 73.7 m -149.57 175.05 11.87 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.099 0.96 . . . . 0.0 108.888 -173.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.464 ' HB2' HD13 ' A' ' 90' ' ' ILE . 57.5 ttt180 -156.65 159.97 38.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HG3' HH12 ' A' ' 85' ' ' ARG . 0.4 OUTLIER -61.34 101.0 0.15 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.037 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.981 -165.663 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 36' ' ' TRP . 8.1 mp . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.407 0.622 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -121.64 -13.67 8.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.86 1.264 . . . . 0.0 111.366 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.47 -170.74 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.444 1.497 . . . . 0.0 110.09 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.459 ' HB3' HG22 ' A' ' 34' ' ' THR . 46.2 mtm180 -136.5 142.75 43.53 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 109.904 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -136.15 143.5 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.344 1.058 . . . . 0.0 109.155 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -101.83 118.85 37.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.033 0.933 . . . . 0.0 108.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.32 92.14 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 123.95 0.781 . . . . 0.0 109.634 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 35.1 tt0 -83.79 93.77 8.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.904 0.859 . . . . 0.0 109.645 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -80.07 154.09 28.34 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.288 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' GLU . 67.2 tp -83.5 108.77 16.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.181 0.592 . . . . 0.0 109.948 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 45.9 tttp -84.67 94.24 8.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.384 0.674 . . . . 0.0 110.224 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.415 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 42.8 mt-30 -87.45 108.64 19.11 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -130.09 129.37 43.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.782 0.833 . . . . 0.0 109.173 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -73.49 148.47 43.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 122.75 0.42 . . . . 0.0 110.086 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.33 169.28 8.99 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.02 -14.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 p -91.85 -10.84 38.26 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.777 0.798 . . . . 0.0 109.344 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.32 44.29 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.742 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.21 132.59 38.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.0 mm -76.44 94.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.82 109.2 15.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.6 mt-10 -84.11 96.17 8.84 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.82 0.819 . . . . 0.0 109.303 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' HD12 ' A' ' 15' ' ' LEU . 67.1 p -110.92 -177.99 3.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.08 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -128.53 115.5 18.23 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.947 -0.471 . . . . 0.0 110.536 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 16' ' ' LYS . 8.7 pt-20 -97.95 109.89 22.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 13' ' ' GLN . 6.4 p-10 -63.75 135.2 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.9 -112.22 3.23 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 120.089 -0.284 . . . . 0.0 113.127 -163.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -102.66 135.28 44.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.091 0.557 . . . . 0.0 109.68 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.4 m -100.98 99.11 9.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.58 -179.68 3.94 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.192 0.52 . . . . 0.0 110.62 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.562 ' HB2' HD23 ' A' ' 6' ' ' LEU . 27.4 m95 -73.85 146.3 44.23 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.341 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -157.67 166.46 32.76 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.909 0.884 . . . . 0.0 112.824 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 t -110.42 95.92 5.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.586 HG21 HG21 ' A' ' 77' ' ' VAL . 3.5 p -96.7 90.49 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.971 0.891 . . . . 0.0 109.054 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.18 127.55 55.98 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.533 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.0 mtp -67.16 137.77 56.52 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.27 159.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.597 0.759 . . . . 0.0 111.857 -173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 m -82.5 168.61 17.23 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.396 0.678 . . . . 0.0 110.345 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.3 p -63.56 -21.56 66.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.513 0.725 . . . . 0.0 111.773 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.28 14.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.694 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.23 -46.25 91.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 111.372 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.36 61.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.61 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.62 -47.39 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.891 0.876 . . . . 0.0 111.896 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -75.69 -32.59 60.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.872 0.869 . . . . 0.0 111.14 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.0 t -74.55 -45.6 44.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.866 0.467 . . . . 0.0 111.285 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.73 -75.86 0.22 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.613 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.81 13.64 0.91 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.011 0.525 . . . . 0.0 112.352 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.76 -63.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.67 149.94 31.08 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.06 20.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.443 0.697 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mt -78.29 156.79 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.965 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.93 -10.2 68.15 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.445 HG23 HD11 ' A' ' 90' ' ' ILE . 86.8 m -65.2 152.21 44.21 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.536 1.134 . . . . 0.0 109.784 171.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 41' ' ' MET . 41.9 t -125.46 125.9 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.954 0.901 . . . . 0.0 109.438 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD3' ' HE1' ' A' ' 62' ' ' TRP . 21.7 ttm-85 -96.97 133.24 41.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 109.265 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 75' ' ' ILE . 67.7 mt -133.21 107.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.536 0.734 . . . . 0.0 109.177 -169.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.413 ' HE1' ' HD3' ' A' ' 60' ' ' ARG . 11.1 m0 -95.35 119.89 34.63 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.621 0.768 . . . . 0.0 110.743 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.21 166.11 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.892 0.877 . . . . 0.0 108.733 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' HD21 ' A' ' 6' ' ' LEU . 31.5 mmm180 -56.72 157.47 5.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.789 0.435 . . . . 0.0 110.612 166.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.85 95.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 28.7 ttt85 -110.16 116.72 32.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.346 -177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -78.71 1.17 23.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.763 1.225 . . . . 0.0 111.679 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -92.51 -19.43 21.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.425 1.09 . . . . 0.0 110.535 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 16.6 mm -79.91 134.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.957 0.503 . . . . 0.0 110.582 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -129.42 166.12 20.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.99 67.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.033 0.533 . . . . 0.0 110.955 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.1 p -82.58 19.43 1.29 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.654 0.781 . . . . 0.0 111.824 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -107.37 142.32 37.36 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.787 0.835 . . . . 0.0 108.842 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -107.58 133.35 52.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 61' ' ' ILE . 37.7 mm -94.49 91.7 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.112 0.482 . . . . 0.0 110.139 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 26.8 ttpp -86.99 106.3 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 99.1 t -78.8 130.35 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.116 0.566 . . . . 0.0 111.281 -169.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.5 m -89.81 -19.67 24.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.977 0.911 . . . . 0.0 113.048 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.6 p -135.0 -177.13 4.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.172 0.589 . . . . 0.0 110.92 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.12 -151.59 51.97 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.956 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.83 -12.89 13.29 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.177 2.585 . . . . 0.0 113.349 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.07 23.35 13.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.577 0.751 . . . . 0.0 110.737 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.7 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.406 0.682 . . . . 0.0 110.734 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.16 6.89 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.727 0.679 . . . . 0.0 112.13 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -71.06 139.36 50.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.059 0.544 . . . . 0.0 110.193 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.2 p -104.89 90.65 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.497 1.142 . . . . 0.0 108.927 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -70.76 149.26 47.07 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.861 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -122.11 137.93 54.64 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.27 95.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -173.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 58' ' ' THR . 25.3 pt -80.63 63.72 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 122.333 1.063 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.18 -118.27 0.82 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.434 ' H ' HD21 ' A' ' 105' ' ' LEU . 9.9 pt20 -162.74 142.43 7.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.64 0.776 . . . . 0.0 109.42 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.84 116.06 3.1 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.989 2.46 . . . . 0.0 110.751 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.94 108.15 38.96 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.809 0.843 . . . . 0.0 109.767 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.05 135.82 19.48 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.359 2.04 . . . . 0.0 110.129 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.0 174.07 9.12 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.57 62.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.652 0.781 . . . . 0.0 113.031 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.45 27.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.492 0.317 . . . . 0.0 111.258 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 62.06 30.49 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.232 1.013 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.1 t -86.13 -16.2 38.68 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.843 0.857 . . . . 0.0 110.933 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -152.12 166.45 31.63 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.675 0.75 . . . . 0.0 110.349 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 107.8 12.84 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -87.09 101.5 13.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.302 0.641 . . . . 0.0 109.448 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.5 mm -83.92 145.72 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.97 0.908 . . . . 0.0 108.788 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.4 pt? -122.78 143.07 50.07 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 72.2 m -151.53 176.09 11.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.705 0.802 . . . . 0.0 110.64 -170.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -161.11 155.35 22.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.373 0.669 . . . . 0.0 109.448 167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.34 144.89 28.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.183 0.993 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.04 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.023 173.411 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 121.403 0.62 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -98.96 -36.92 9.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.785 1.234 . . . . 0.0 112.369 -171.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -96.6 -167.6 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.775 1.23 . . . . 0.0 108.861 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' HB3' HG22 ' A' ' 34' ' ' THR . 49.3 mtm180 -148.91 146.46 27.9 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 0.0 110.418 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.3 151.27 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.841 0.856 . . . . 0.0 109.044 175.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -102.45 122.95 45.33 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.8 116.96 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.792 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -83.36 99.94 10.36 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 p -82.28 141.28 33.06 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.989 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.3 tp -110.27 113.77 26.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.513 0.725 . . . . 0.0 109.386 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -102.35 114.46 28.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.722 0.409 . . . . 0.0 110.212 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 41.8 mt-30 -75.51 90.3 2.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -91.54 110.23 21.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 109.703 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -71.24 158.59 36.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.534 0.334 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.92 164.41 13.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.428 0.691 . . . . 0.0 109.703 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.81 -11.23 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 125.068 1.347 . . . . 0.0 112.982 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 p -104.67 -23.99 13.01 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.84 44.67 1.74 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.94 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -106.41 149.91 26.55 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.33 101.69 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.906 0.483 . . . . 0.0 110.025 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.93 90.96 7.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.991 0.916 . . . . 0.0 108.96 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.588 ' HB3' HD11 ' A' ' 15' ' ' LEU . 42.4 mt-10 -79.34 121.04 24.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -137.98 141.85 40.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.587 1.155 . . . . 0.0 109.824 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -101.5 103.55 14.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.078 0.951 . . . . 0.0 109.088 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.44 125.73 34.88 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.247 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.83 113.36 7.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.706 1.202 . . . . 0.0 108.397 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.35 -109.45 2.86 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.319 -157.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -117.09 139.0 51.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.394 0.678 . . . . 0.0 110.215 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.7 m -101.45 98.44 8.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 109.74 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 63' ' ' ILE . 1.3 pt? -106.69 163.73 12.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.952 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -59.49 123.31 16.43 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.113 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.83 176.44 8.7 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.203 1.001 . . . . 0.0 110.933 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -136.94 107.55 6.54 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 77' ' ' VAL . 66.5 t -105.29 131.6 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.65 0.78 . . . . 0.0 109.307 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.4 HD22 ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -151.29 159.58 44.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 167.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.453 ' SD ' HG22 ' A' ' 59' ' ' VAL . 19.8 mmt -67.76 148.22 51.55 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.19 145.23 13.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 O-C-N 123.746 0.654 . . . . 0.0 110.151 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 47.4 t -74.35 163.27 28.0 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.955 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 p -61.21 -31.5 71.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.501 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 16.9 ptpt -62.17 -33.5 74.64 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.469 0.707 . . . . 0.0 111.492 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.75 -50.84 14.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.558 0.743 . . . . 0.0 110.258 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.95 40.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.437 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.2 mt -66.43 -27.32 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.773 0.829 . . . . 0.0 111.982 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -59.24 -49.36 78.14 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.787 0.435 . . . . 0.0 110.572 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 83.9 p -79.78 -12.29 59.79 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.151 0.58 . . . . 0.0 111.564 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -77.5 2.04 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.89 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.103 0.561 . . . . 0.0 111.847 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 32.6 mt-10 -78.36 -69.54 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.94 141.91 31.81 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -139.75 156.91 46.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.96 0.504 . . . . 0.0 110.212 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.59 125.55 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.07 -12.58 12.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -163.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 m -77.77 154.61 31.8 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 156.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG22 ' SD ' ' A' ' 41' ' ' MET . 40.5 t -124.53 128.04 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.841 0.857 . . . . 0.0 111.033 -170.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -98.2 128.86 44.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.335 0.654 . . . . 0.0 109.519 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.619 HD13 HG21 ' A' ' 75' ' ' ILE . 65.7 mt -135.0 143.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.141 0.976 . . . . 0.0 108.494 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 60.1 m95 -134.92 121.67 20.86 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 35' ' ' LEU . 44.6 pt -121.41 168.75 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.414 0.686 . . . . 0.0 109.977 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -47.42 146.75 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.595 0.758 . . . . 0.0 112.748 165.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -67.35 108.95 2.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.358 0.663 . . . . 0.0 110.287 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' HD13 ' A' ' 35' ' ' LEU . 9.9 ptp180 -149.21 125.63 10.91 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.059 0.544 . . . . 0.0 110.327 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -84.09 12.35 6.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.394 1.078 . . . . 0.0 111.408 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.28 -18.31 28.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.405 1.082 . . . . 0.0 110.004 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.417 HG13 HD11 ' A' ' 63' ' ' ILE . 21.6 mm -74.55 138.69 20.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 159.68 34.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.14 -20.67 66.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.594 0.358 . . . . 0.0 111.808 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -92.06 28.23 1.93 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -107.34 161.74 14.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.553 HH21 HG21 ' A' ' 86' ' ' VAL . 51.3 mtp180 -125.04 128.55 48.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.619 HG21 HD13 ' A' ' 61' ' ' ILE . 44.5 mm -88.4 96.52 6.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.721 0.808 . . . . 0.0 109.454 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -94.76 109.39 21.35 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.484 HG23 HD23 ' A' ' 87' ' ' LEU . 61.5 t -74.99 124.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.381 0.672 . . . . 0.0 110.789 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 t -83.52 -25.66 30.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.71 0.804 . . . . 0.0 111.342 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.1 t -163.37 132.53 4.02 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.59 -163.7 30.43 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.93 -14.24 29.36 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.778 2.319 . . . . 0.0 112.028 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.1 mt -123.06 32.28 5.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.285 1.034 . . . . 0.0 110.01 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.73 25.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.45 0.7 . . . . 0.0 110.659 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.62 12.29 72.63 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.588 0.555 . . . . 0.0 113.085 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -119.9 148.18 43.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.348 0.659 . . . . 0.0 109.44 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.553 HG21 HH21 ' A' ' 74' ' ' ARG . 5.1 p -111.17 97.9 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 122.624 1.202 . . . . 0.0 110.93 -173.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD23 HG23 ' A' ' 77' ' ' VAL . 1.8 mm? -86.38 142.43 28.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.387 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.59 143.32 32.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.363 1.065 . . . . 0.0 108.763 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.29 129.62 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 pt -113.07 132.73 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.893 0.877 . . . . 0.0 109.27 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.76 -84.38 1.41 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 29.6 pt20 -169.34 158.13 7.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.683 0.793 . . . . 0.0 110.512 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.24 148.87 27.51 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.05 1.833 . . . . 0.0 110.334 159.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.18 125.05 5.08 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 152.55 40.12 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.443 2.096 . . . . 0.0 112.194 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.73 178.02 3.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 122.289 -0.257 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.87 -36.42 83.25 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.767 0.827 . . . . 0.0 112.523 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.76 -13.29 34.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.119 0.568 . . . . 0.0 111.958 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 62.45 34.47 15.43 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.628 1.171 . . . . 0.0 111.408 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -98.33 0.33 45.31 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.747 0.819 . . . . 0.0 110.817 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 5.4 ptp180 -169.51 -177.77 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.95 0.9 . . . . 0.0 109.242 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.07 112.64 16.09 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.91 119.6 17.37 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.547 HG22 ' SG ' ' A' ' 106' ' ' CYS . 25.8 mm -109.8 118.83 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -98.65 133.47 42.95 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 104' ' ' ILE . 85.3 m -144.98 173.68 11.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.036 -170.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -150.03 162.89 39.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -45.59 143.79 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.044 0.537 . . . . 0.0 111.099 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.255 0 O-C-N 123.136 0.273 . . . . 0.0 113.14 -171.014 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -83.22 -39.55 20.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.061 0.944 . . . . 0.0 112.218 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.63 -171.35 1.82 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.557 1.543 . . . . 0.0 109.905 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -143.85 147.35 33.94 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.616 1.166 . . . . 0.0 110.214 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.04 154.7 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.421 1.089 . . . . 0.0 109.576 177.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -108.56 125.37 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.197 0.999 . . . . 0.0 108.47 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.53 125.92 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 123.395 0.435 . . . . 0.0 110.373 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 19.3 mp0 -88.07 100.28 12.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.096 0.958 . . . . 0.0 108.68 170.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -83.63 143.84 29.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.818 172.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.7 tp -90.7 107.7 19.34 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.672 0.389 . . . . 0.0 110.627 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.53 97.06 8.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.545 0.738 . . . . 0.0 109.375 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.23 90.75 2.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -89.94 161.14 16.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.213 1.005 . . . . 0.0 109.389 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -125.97 154.54 42.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.13 -0.356 . . . . 0.0 110.577 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.8 t70 -104.64 160.06 15.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.78 1.232 . . . . 0.0 108.64 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.31 -11.37 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -108.7 -0.51 20.03 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.682 0.753 . . . . 0.0 109.261 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 28.58 9.09 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.249 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 10.3 mm-40 -92.75 134.78 34.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.1 mm -91.07 118.14 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.83 17.51 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' HD11 ' A' ' 15' ' ' LEU . 1.9 mp0 -78.78 114.94 18.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.8 p -130.22 152.48 49.6 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.128 0.971 . . . . 0.0 108.385 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -106.59 103.86 13.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -87.34 128.71 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.09 145.56 55.2 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -106.93 2.56 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -115.2 135.21 54.42 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.073 0.949 . . . . 0.0 108.683 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.4 m -94.26 95.8 9.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.1 pt? -111.34 169.49 8.76 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.45 0.643 . . . . 0.0 111.447 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -71.12 130.37 41.32 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.739 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.703 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.84 176.72 8.46 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.495 175.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 55.4 m -130.58 98.99 4.82 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.61 102.6 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.497 0.719 . . . . 0.0 109.07 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.15 106.42 14.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.054 0.942 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' HG22 ' A' ' 59' ' ' VAL . 86.6 mmm -60.19 117.94 5.76 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 m -70.63 155.58 7.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 121.118 0.485 . . . . 0.0 110.668 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t -85.22 176.98 8.02 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.458 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.73 -28.73 66.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.055 0.942 . . . . 0.0 111.909 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 20.4 ptmt -49.33 -42.75 42.61 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.798 1.239 . . . . 0.0 113.463 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.52 -41.16 93.45 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.295 0.638 . . . . 0.0 111.052 -176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.19 74.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.758 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.1 mt -60.51 -43.31 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.68 0.792 . . . . 0.0 111.26 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.5 m -69.72 -33.8 72.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.391 0.676 . . . . 0.0 111.994 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 77.8 p -82.09 -30.25 31.34 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.635 0.374 . . . . 0.0 111.046 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.82 -66.03 0.24 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.044 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 15.04 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.299 1.04 . . . . 0.0 110.59 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.1 tt0 -86.13 -53.75 4.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.601 0.76 . . . . 0.0 109.584 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 58' ' ' THR . 94.4 mt -84.53 160.8 20.42 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 167.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.88 154.82 40.48 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.751 0.82 . . . . 0.0 110.153 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.83 108.28 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.52 10.92 20.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.497 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.402 HG21 HD22 ' A' ' 54' ' ' LEU . 37.9 m -64.71 122.18 16.26 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.702 HG22 ' SD ' ' A' ' 41' ' ' MET . 24.8 t -86.95 105.6 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.778 0.831 . . . . 0.0 110.026 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -90.74 133.37 35.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.576 HD13 HG21 ' A' ' 75' ' ' ILE . 79.6 mt -135.79 117.46 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.134 0.974 . . . . 0.0 108.895 -169.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 79.3 m95 -102.73 119.12 38.27 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 122.888 0.475 . . . . 0.0 109.909 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 pt -124.22 155.76 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -59.17 163.64 3.61 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.25 0.477 . . . . 0.0 111.396 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.494 ' HA ' HD13 ' A' ' 102' ' ' LEU . 42.5 t80 -55.8 100.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.755 0.822 . . . . 0.0 111.203 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -118.93 106.28 12.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -68.03 -24.08 65.06 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.389 1.076 . . . . 0.0 113.28 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.25 -18.64 23.14 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.624 0.769 . . . . 0.0 112.325 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -67.18 132.63 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -154.17 173.6 15.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -26.39 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.505 0.722 . . . . 0.0 112.329 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.7 p -80.09 9.91 4.99 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.282 1.033 . . . . 0.0 113.341 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.0 p -117.55 156.94 27.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.257 0.623 . . . . 0.0 109.503 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 74.5 mtp180 -112.95 155.0 25.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 171.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.576 HG21 HD13 ' A' ' 61' ' ' ILE . 21.3 mm -116.82 103.21 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.26 0.624 . . . . 0.0 109.864 -177.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.2 ttpt -94.15 109.5 21.28 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 HD23 ' A' ' 87' ' ' LEU . 95.8 t -73.23 126.85 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 O-C-N 123.622 0.576 . . . . 0.0 110.516 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.4 m -79.67 -25.17 41.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.292 1.037 . . . . 0.0 113.287 -171.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -152.53 178.47 9.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.71 -146.64 30.07 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.42 -0.655 . . . . 0.0 113.052 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.64 -22.47 13.69 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.262 2.642 . . . . 0.0 113.289 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.639 HD11 ' SD ' ' A' ' 41' ' ' MET . 92.5 mt -115.71 31.29 6.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.881 0.473 . . . . 0.0 110.927 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.72 94.71 0.31 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.476 0.71 . . . . 0.0 110.895 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.0 -17.81 8.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.739 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -79.23 129.57 34.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.374 0.67 . . . . 0.0 109.722 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -102.36 80.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 122.648 1.214 . . . . 0.0 109.152 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 77' ' ' VAL . 2.0 mm? -65.78 153.52 41.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.184 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -120.43 139.1 53.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 106' ' ' CYS . 62.7 mt -80.78 104.07 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -172.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 107' ' ' ARG . 40.0 pt -83.1 16.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.002 0.921 . . . . 0.0 112.36 -174.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.57 -141.85 3.23 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -128.89 134.81 26.73 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.575 ' HB2' HD23 ' A' ' 102' ' ' LEU . 67.1 Cg_endo -68.36 146.13 67.85 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.905 2.403 . . . . 0.0 111.52 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 120.41 5.01 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 40.3 Cg_endo -66.65 157.43 60.94 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.555 . . . . 0.0 113.743 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.56 179.73 3.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.25 69.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.872 0.869 . . . . 0.0 112.623 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.6 -11.26 29.74 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.36 0.664 . . . . 0.0 112.463 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.2 20.02 8.97 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.958 0.903 . . . . 0.0 111.938 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -74.82 -18.02 60.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.411 0.684 . . . . 0.0 111.842 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.18 153.27 5.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.618 0.767 . . . . 0.0 110.764 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 93' ' ' PRO . 8.1 mp -102.82 133.95 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.131 0.973 . . . . 0.0 109.718 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.37 116.54 23.76 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 12.4 mm -98.95 131.81 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 173.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -106.77 136.83 45.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 89' ' ' ILE . 83.9 m -148.73 172.92 13.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.4 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HB3' HG21 ' A' ' 90' ' ' ILE . 72.3 ttt-85 -163.6 154.38 16.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -74.19 131.17 41.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 179.725 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -136.13 -28.91 1.03 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.22 0.608 . . . . 0.0 112.438 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' THR . 70.0 m-20 -107.14 -171.26 1.85 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.45 1.5 . . . . 0.0 110.419 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -141.11 147.14 38.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.315 1.046 . . . . 0.0 108.975 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.88 155.61 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.233 0.613 . . . . 0.0 109.791 173.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 m -113.18 124.99 53.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.364 0.666 . . . . 0.0 109.628 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.53 108.86 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.637 1.175 . . . . 0.0 110.596 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.6 mp0 -80.74 98.3 7.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.045 0.926 . . . . 0.0 108.979 172.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 5.0 m -79.8 145.23 32.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.987 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.2 tp -97.38 99.79 11.22 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.92 -0.487 . . . . 0.0 109.817 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -83.44 105.66 14.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.218 0.607 . . . . 0.0 109.876 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 50.3 mt-30 -88.31 89.06 7.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.5 m -94.04 135.12 35.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.099 0.96 . . . . 0.0 110.0 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 4.7 ttp180 -74.47 148.41 41.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . 20.5 t70 -96.58 163.81 12.87 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.12 -11.05 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -99.24 -4.2 32.5 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.446 -0.784 . . . . 0.0 109.643 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.73 44.51 6.79 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.821 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.6 mt-10 -103.37 173.58 6.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.719 0.807 . . . . 0.0 109.736 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.61 103.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.341 0.656 . . . . 0.0 109.308 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 20' ' ' ASP . 8.8 mp -94.61 108.94 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.833 1.253 . . . . 0.0 109.31 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 41.9 mt-10 -79.88 117.0 20.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 p -131.91 157.4 44.08 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.359 1.063 . . . . 0.0 109.422 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -103.83 101.5 11.32 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 6.3 pt-20 -83.37 123.01 29.23 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.32 115.43 10.47 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.66 -119.77 4.32 Favored Glycine 0 N--CA 1.474 1.192 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.876 -160.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.97 159.76 28.61 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.554 0.742 . . . . 0.0 110.478 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 47.0 m -138.07 95.97 3.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 169.79 8.58 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.933 -174.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -67.85 131.42 45.49 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.425 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -140.82 178.28 7.45 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.99 0.916 . . . . 0.0 111.363 176.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -140.73 105.18 4.87 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.84 114.63 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -133.01 124.59 27.97 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.523 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -67.78 134.56 51.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.19 152.3 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.552 0.341 . . . . 0.0 110.203 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t -97.91 -175.43 3.15 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 56' ' ' ILE . 14.2 p -55.93 -30.55 61.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.284 1.033 . . . . 0.0 112.936 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -50.14 -48.17 53.79 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.648 1.179 . . . . 0.0 112.716 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.16 -36.65 72.1 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.05 96.57 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.004 0.815 . . . . 0.0 110.519 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.48 -46.78 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.433 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -71.67 -24.15 61.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.417 0.687 . . . . 0.0 112.399 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 31.8 m -101.84 -5.4 24.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.218 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.07 -90.07 0.79 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.019 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.99 -11.68 10.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 110.803 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 10.0 tp10 -64.43 -59.82 3.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 110.288 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.677 HD22 HG21 ' A' ' 58' ' ' THR . 61.2 mt -93.88 162.07 14.06 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.92 166.19 25.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 110.315 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 44' ' ' SER . 59.6 mt -71.12 111.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.12 -10.38 17.72 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-O 120.218 -0.212 . . . . 0.0 112.626 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.677 HG21 HD22 ' A' ' 54' ' ' LEU . 24.5 m -61.6 137.75 58.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.304 0.642 . . . . 0.0 109.53 169.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 41' ' ' MET . 48.9 t -105.33 127.46 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 109.867 -177.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -109.32 144.32 37.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.41 0.624 . . . . 0.0 109.909 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 75' ' ' ILE . 41.0 mt -135.69 107.35 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -167.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -96.06 114.4 26.11 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.5 pt -116.37 155.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 1.6 tmt_? -55.83 143.98 29.42 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.501 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 57.0 t80 -45.16 124.68 4.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 111.666 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.477 ' H ' HD23 ' A' ' 102' ' ' LEU . 5.7 tpm_? -151.26 116.01 5.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.51 0.724 . . . . 0.0 109.54 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HE3' ' HE2' ' A' ' 65' ' ' TYR . 91.0 mttt -84.8 8.59 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.194 0.998 . . . . 0.0 111.577 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.98 -24.11 17.78 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.511 1.124 . . . . 0.0 111.567 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.88 126.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.716 0.406 . . . . 0.0 111.287 -170.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.89 157.96 30.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.84 -13.53 60.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.428 0.691 . . . . 0.0 112.68 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 p -77.05 -24.14 51.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.804 0.441 . . . . 0.0 110.964 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -73.19 155.21 39.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.316 0.647 . . . . 0.0 110.627 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 75.9 mtm180 -113.5 162.81 15.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 172.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.633 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.4 mp -112.17 126.97 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.052 1.341 . . . . 0.0 108.177 171.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -118.86 116.14 25.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.45 110.25 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 123.556 0.535 . . . . 0.0 110.998 -170.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.467 ' H ' ' HA ' ' A' ' 10' ' ' ILE . 31.8 t -70.5 -27.2 64.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.593 1.157 . . . . 0.0 111.265 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' ASP . 12.8 t -166.45 137.96 3.56 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.59 -162.45 30.73 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 119.771 -0.46 . . . . 0.0 112.294 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.33 -14.17 18.45 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.11 2.54 . . . . 0.0 111.765 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -124.81 32.86 5.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.441 1.096 . . . . 0.0 109.162 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.32 102.22 0.21 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.739 0.815 . . . . 0.0 111.507 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.85 0.24 15.09 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 119.859 -0.411 . . . . 0.0 113.147 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -106.64 160.47 15.43 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.582 0.753 . . . . 0.0 110.077 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.25 100.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.947 1.356 . . . . 0.0 111.168 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.93 124.5 34.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.269 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -97.6 142.32 29.55 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.324 1.05 . . . . 0.0 108.334 177.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.07 117.45 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.26 71.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 121.98 0.895 . . . . 0.0 109.852 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.53 -114.24 0.63 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.174 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.549 ' H ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -166.81 142.79 3.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.73 0.812 . . . . 0.0 109.438 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 102' ' ' LEU . 37.1 Cg_endo -60.28 120.74 8.68 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.791 2.328 . . . . 0.0 112.145 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.93 108.62 55.47 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.336 1.055 . . . . 0.0 108.965 -170.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 153.73 53.62 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.797 2.331 . . . . 0.0 113.082 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 6.8 p-10 -84.33 172.45 11.79 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 0.0 110.462 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.13 75.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.893 0.877 . . . . 0.0 112.249 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.04 -9.35 59.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.931 0.492 . . . . 0.0 111.65 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 25.2 mmt180 60.58 28.64 18.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.132 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -101.16 -5.44 25.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.845 0.858 . . . . 0.0 110.739 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.03 155.58 25.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.312 0.577 . . . . 0.0 110.903 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 93' ' ' PRO . 3.3 mm? -108.83 113.07 25.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -77.07 107.06 9.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.51 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.1 mm -96.55 134.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -111.25 130.6 55.61 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.51 ' SG ' HG22 ' A' ' 104' ' ' ILE . 71.9 m -153.77 176.68 11.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -167.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ptm85 -160.27 163.58 33.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.9 145.49 45.65 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.294 0.371 . . . . 0.0 110.874 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.262 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.496 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 1.7 mm? . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -97.9 -41.96 7.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.401 1.081 . . . . 0.0 111.276 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -102.61 -167.17 1.36 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.295 1.438 . . . . 0.0 110.238 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -146.38 150.8 36.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.857 1.263 . . . . 0.0 109.055 171.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.93 145.36 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.332 0.653 . . . . 0.0 109.698 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 31' ' ' ASP . 3.2 m -90.61 124.6 35.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 167.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.8 mm -71.14 107.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 35.4 tt0 -78.84 95.35 5.36 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.624 1.202 . . . . 0.0 108.26 176.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 27.8 m -81.58 142.54 32.71 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.455 -2.157 . . . . 0.0 109.641 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 27' ' ' GLU . 37.5 tp -98.5 104.49 16.53 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -96.25 123.9 40.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -102.85 102.41 12.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -110.82 121.18 44.7 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.377 1.071 . . . . 0.0 109.164 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -69.11 164.93 21.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.311 0.644 . . . . 0.0 110.979 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -113.51 165.71 12.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.43 3.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 C-N-CA 124.563 1.145 . . . . 0.0 113.616 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.1 p -100.72 -11.76 19.68 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.14 -0.975 . . . . 0.0 109.765 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.7 30.4 15.5 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.859 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -104.82 135.32 46.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.83 0.852 . . . . 0.0 108.908 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.76 112.5 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.101 0.41 . . . . 0.0 110.013 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.06 117.22 30.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -84.52 118.63 24.43 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.422 0.689 . . . . 0.0 109.311 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.1 p -129.82 151.21 50.65 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 0.0 109.933 -175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -110.31 104.17 12.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.679 0.792 . . . . 0.0 110.193 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 10.7 pt-20 -91.57 152.83 20.12 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.857 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.2 p-10 -85.26 131.8 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.7 -113.71 3.86 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -170.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -112.09 135.27 52.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.508 0.723 . . . . 0.0 109.722 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.3 m -98.74 106.64 18.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.474 0.709 . . . . 0.0 110.194 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.623 HD11 HD12 ' A' ' 63' ' ' ILE . 1.1 pt? -111.31 165.29 12.07 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.697 0.76 . . . . 0.0 112.242 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.541 ' HD1' ' HD2' ' A' ' 64' ' ' ARG . 51.6 m95 -56.98 122.45 12.33 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.324 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -133.04 176.64 8.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.238 1.015 . . . . 0.0 111.982 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.2 t -145.78 101.2 3.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 162.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 61' ' ' ILE . 53.1 t -96.29 113.09 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.672 0.789 . . . . 0.0 109.281 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -134.53 130.32 36.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.145 0.578 . . . . 0.0 109.874 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.686 ' SD ' HG22 ' A' ' 59' ' ' VAL . 77.9 mmm -62.74 131.28 48.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.681 . . . . 0.0 109.447 170.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 60' ' ' ARG . 8.0 m -71.13 152.36 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.269 0.356 . . . . 0.0 110.12 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.9 m -77.54 168.65 19.64 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.0 p -61.04 -20.82 63.0 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.447 0.699 . . . . 0.0 111.812 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 14.6 ptmm? -51.32 -35.63 38.96 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.163 1.385 . . . . 0.0 112.413 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -70.73 -41.26 72.09 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.416 0.447 . . . . 0.0 110.558 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.16 93.59 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.664 0.786 . . . . 0.0 110.415 175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.93 -43.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.221 1.008 . . . . 0.0 110.827 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 t -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.977 0.911 . . . . 0.0 111.121 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 81.8 p -89.6 -4.74 57.69 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.392 0.677 . . . . 0.0 111.229 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.37 -68.38 3.32 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.217 0.437 . . . . 0.0 112.064 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.54 16.97 0.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.794 0.838 . . . . 0.0 110.564 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.5 tp10 -79.25 -67.27 0.77 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.82 152.44 40.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.77 27.66 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.626 0.771 . . . . 0.0 109.882 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 mt -73.03 129.61 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.99 -9.55 15.76 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 106' ' ' CYS . 55.1 m -70.66 142.61 51.57 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.717 0.807 . . . . 0.0 109.027 169.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.686 HG22 ' SD ' ' A' ' 41' ' ' MET . 26.9 t -122.07 129.85 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.776 0.831 . . . . 0.0 109.612 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 42' ' ' VAL . 8.5 ttt85 -103.64 126.22 50.64 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 75' ' ' ILE . 30.4 mt -129.95 106.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.898 0.879 . . . . 0.0 108.756 -167.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -97.43 111.99 24.01 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 35' ' ' LEU . 42.8 pt -122.19 153.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.541 ' HD2' ' HD1' ' A' ' 36' ' ' TRP . 5.7 ptm180 -56.35 153.91 9.02 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 120.73 0.3 . . . . 0.0 111.399 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.69 134.35 55.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.366 0.666 . . . . 0.0 110.269 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.412 ' H ' HD23 ' A' ' 102' ' ' LEU . 32.1 ttt180 -158.63 136.28 10.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.716 0.635 . . . . 0.0 110.066 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -83.3 -5.36 59.11 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.742 0.817 . . . . 0.0 112.486 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.49 -19.65 21.03 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.835 0.854 . . . . 0.0 111.204 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.5 mm -69.71 121.56 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.918 0.487 . . . . 0.0 110.259 -172.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.71 162.41 32.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 109.6 -172.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -64.05 -27.34 69.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.708 0.803 . . . . 0.0 112.325 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -74.03 -17.56 60.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 0.0 111.779 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -96.76 105.08 17.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.006 0.922 . . . . 0.0 110.087 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 82.5 mtp180 -72.77 162.47 29.44 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.966 0.412 . . . . 0.0 111.441 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 HD13 ' A' ' 61' ' ' ILE . 44.1 mm -106.23 102.97 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.707 0.803 . . . . 0.0 110.19 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -96.77 112.66 24.32 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.36 119.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.683 0.393 . . . . 0.0 111.605 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -77.7 -25.76 49.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.708 0.803 . . . . 0.0 111.998 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -168.39 135.36 2.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.579 0.751 . . . . 0.0 109.397 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.97 -164.91 28.19 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.616 -0.546 . . . . 0.0 112.228 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.78 -6.52 17.61 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.098 2.532 . . . . 0.0 112.593 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HD11 ' A' ' 87' ' ' LEU . 78.1 mt -130.37 26.92 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.226 1.01 . . . . 0.0 110.019 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 105.73 0.6 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.66 0.784 . . . . 0.0 111.552 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.89 -40.13 2.09 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.87 139.46 41.69 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.528 0.731 . . . . 0.0 110.364 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 t -106.59 110.77 32.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.385 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD13 ' A' ' 82' ' ' LEU . 1.4 mm? -74.65 150.96 39.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.886 0.874 . . . . 0.0 110.365 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.47 ' OD1' ' HA3' ' A' ' 109' ' ' GLY . 9.0 m120 -114.09 135.81 53.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.393 1.077 . . . . 0.0 108.494 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 106' ' ' CYS . 61.8 mt -82.54 121.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -172.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -77.87 121.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.76 -87.61 0.36 Allowed Glycine 0 C--N 1.345 1.062 0 O-C-N 123.91 0.756 . . . . 0.0 112.735 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 23.2 pt20 -166.37 150.13 6.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.858 1.263 . . . . 0.0 108.951 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.37 157.64 58.58 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.526 2.151 . . . . 0.0 112.159 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.25 109.55 19.61 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.316 0.647 . . . . 0.0 110.142 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.55 133.81 50.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.774 2.316 . . . . 0.0 110.496 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 99' ' ' ARG . 5.1 p-10 -64.95 173.99 2.1 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.707 0.403 . . . . 0.0 111.164 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.29 -35.6 67.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.032 0.933 . . . . 0.0 112.943 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.61 -13.24 40.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 112.105 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 96' ' ' ASP . 3.7 mpt_? 60.88 29.15 18.83 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.429 1.092 . . . . 0.0 110.767 -175.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -93.59 -0.86 56.03 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.985 0.914 . . . . 0.0 110.39 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 8.4 ptp85 -163.57 169.35 18.79 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.737 0.815 . . . . 0.0 110.092 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -110.23 109.23 19.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.83 1.252 . . . . 0.0 107.644 169.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.62 110.86 20.12 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.521 HG22 ' SG ' ' A' ' 106' ' ' CYS . 14.3 mm -98.42 116.17 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -89.27 134.79 33.91 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 104' ' ' ILE . 99.1 m -151.58 -179.38 7.36 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 109.494 -173.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -149.37 152.25 35.46 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 166.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.1 107.19 0.7 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.096 0.474 . . . . 0.0 111.365 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' ' OD1' ' A' ' 88' ' ' ASN . . . . . . . . 0 C--N 1.348 1.206 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.565 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 31.9 mt . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 120.999 0.428 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -100.13 -24.99 14.43 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.946 0.898 . . . . 0.0 111.784 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -108.01 -173.31 2.25 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.951 1.3 . . . . 0.0 109.626 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.54 ' HG2' HG22 ' A' ' 34' ' ' THR . 51.0 ttp180 -148.09 131.86 16.98 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -129.99 153.32 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.6 0.76 . . . . 0.0 110.554 -175.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -103.04 124.64 48.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.221 1.008 . . . . 0.0 110.091 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.29 116.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 123.623 0.577 . . . . 0.0 109.946 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.693 1.197 . . . . 0.0 109.103 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -80.21 140.33 36.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.534 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 27' ' ' GLU . 33.2 tp -91.99 97.6 11.05 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -88.66 108.26 19.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.849 0.859 . . . . 0.0 109.56 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 48.4 mt-30 -91.58 101.31 13.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -109.58 122.3 47.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.667 0.787 . . . . 0.0 109.398 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -78.53 157.87 28.72 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.734 0.302 . . . . 0.0 110.294 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 22.7 t70 -103.51 168.73 8.97 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.617 0.767 . . . . 0.0 109.189 -172.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.48 -4.59 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 124.413 1.085 . . . . 0.0 112.666 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -110.98 -31.02 7.27 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.57 31.09 1.71 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.184 -1.371 . . . . 0.0 114.623 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 48.3 mm-40 -79.91 144.54 33.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 mm -95.89 101.77 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.6 90.93 6.86 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 44.3 mt-10 -79.68 105.56 11.07 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.9 p -123.93 155.11 38.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.334 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -109.45 96.71 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.48 130.63 35.59 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.21 127.53 32.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.48 -110.4 3.39 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -168.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 35' ' ' LEU . 86.4 t60 -105.44 132.45 51.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 9' ' ' ARG . 36.5 m -104.58 95.17 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -108.44 170.1 8.23 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.591 0.71 . . . . 0.0 112.26 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 50.5 m95 -69.93 133.03 46.86 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.665 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -138.49 168.56 19.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.791 0.836 . . . . 0.0 112.175 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.9 t -120.98 94.06 4.22 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 162.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HG12 ' A' ' 61' ' ' ILE . 3.7 p -94.58 90.46 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 122.325 1.06 . . . . 0.0 108.978 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.3 118.51 36.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.444 -172.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.445 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.3 mtp -67.62 141.51 56.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.63 155.03 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.914 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 46' ' ' GLU . 18.0 m -76.13 163.46 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.091 0.556 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -62.43 -35.64 79.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.316 0.647 . . . . 0.0 110.465 176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.25 -28.54 69.42 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.621 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 15.4 mm-40 -71.81 -41.42 68.27 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.371 0.419 . . . . 0.0 110.207 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.23 -52.34 65.7 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 124.184 0.928 . . . . 0.0 111.184 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.29 -48.24 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.272 1.029 . . . . 0.0 111.953 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.26 -30.62 65.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.558 0.743 . . . . 0.0 111.728 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 11.1 t -90.22 -8.59 50.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.587 0.755 . . . . 0.0 110.578 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.42 -102.36 1.18 Allowed Glycine 0 C--N 1.352 1.452 0 O-C-N 123.587 0.555 . . . . 0.0 112.787 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.09 -5.55 17.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.927 0.891 . . . . 0.0 111.789 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 10.3 tp10 -74.55 -75.42 0.16 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.754 0.422 . . . . 0.0 109.973 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 58' ' ' THR . 64.7 mt -83.33 147.73 27.76 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.28 165.53 25.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.203 1.001 . . . . 0.0 109.048 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.13 117.06 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.66 -10.67 14.12 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.526 0.517 . . . . 0.0 112.101 -168.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.687 HG21 HD22 ' A' ' 54' ' ' LEU . 93.7 m -74.53 139.37 43.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 41' ' ' MET . 44.7 t -126.29 132.47 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.592 0.757 . . . . 0.0 110.599 -173.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -99.65 141.06 32.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 50.9 mt -134.57 107.9 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -102.73 112.75 25.67 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 37' ' ' ALA . 39.3 pt -123.93 166.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.147 0.579 . . . . 0.0 109.748 -173.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 21.5 mmt180 -53.07 137.99 32.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.273 0.488 . . . . 0.0 111.415 164.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HE1' ' HE3' ' A' ' 67' ' ' LYS . 28.3 t80 -55.87 116.69 3.1 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.175 0.99 . . . . 0.0 109.167 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HD3' HD11 ' A' ' 69' ' ' ILE . 37.0 ttt180 -140.02 121.06 14.66 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HE3' ' HE1' ' A' ' 65' ' ' TYR . 32.7 mmtp -69.18 -10.1 56.11 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.825 1.25 . . . . 0.0 112.431 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.78 -19.23 22.8 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.619 0.767 . . . . 0.0 110.976 -173.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 66' ' ' ARG . 33.3 mm -69.8 119.93 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -116.88 168.59 10.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.989 0.916 . . . . 0.0 108.961 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.01 -24.67 66.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.786 . . . . 0.0 110.992 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -90.78 13.54 16.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.698 0.799 . . . . 0.0 111.67 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 100.33 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.929 0.892 . . . . 0.0 109.266 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HD2' ' ND2' ' A' ' 88' ' ' ASN . 49.1 mtm180 -72.23 165.5 24.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.685 0.755 . . . . 0.0 111.035 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.1 mp -115.6 130.28 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -125.32 113.87 18.16 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 82' ' ' LEU . 62.0 t -68.31 115.9 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.361 0.413 . . . . 0.0 111.626 -169.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.142 0.977 . . . . 0.0 111.813 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' ' 9' ' ' ARG . 10.0 t -166.68 129.05 1.81 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.786 0.835 . . . . 0.0 109.499 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.67 -165.9 31.15 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.46 -0.633 . . . . 0.0 111.952 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.02 -15.01 35.97 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.829 2.352 . . . . 0.0 112.304 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 87' ' ' LEU . 96.7 mt -122.78 35.01 4.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.061 0.945 . . . . 0.0 110.486 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.88 111.83 1.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.044 0.538 . . . . 0.0 110.42 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.82 -17.64 41.73 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.506 0.504 . . . . 0.0 113.229 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -83.96 132.3 34.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.81 0.844 . . . . 0.0 109.611 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.25 101.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 122.078 0.942 . . . . 0.0 110.54 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 HD13 ' A' ' 82' ' ' LEU . 1.2 mm? -81.57 124.41 29.5 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.327 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.436 ' ND2' ' HD2' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -99.7 141.51 32.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.529 1.132 . . . . 0.0 109.036 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 106' ' ' CYS . 39.4 mt -78.19 128.63 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.1 68.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 122.0 0.905 . . . . 0.0 109.605 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.19 -122.88 1.53 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.691 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -140.6 146.5 45.06 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 108.679 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.29 102.11 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.181 1.92 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.74 112.74 34.41 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.908 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.92 137.21 44.12 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.435 2.09 . . . . 0.0 111.667 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.498 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 34.9 t70 -58.73 144.54 43.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.82 0.448 . . . . 0.0 111.494 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.04 63.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.025 0.93 . . . . 0.0 112.103 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.66 -5.18 46.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.202 0.601 . . . . 0.0 111.015 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.01 22.73 12.96 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 124.619 1.168 . . . . 0.0 112.107 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 75.1 p -85.83 -10.44 55.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.142 0.577 . . . . 0.0 110.766 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.498 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 7.8 ptp180 -163.71 -177.53 5.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.737 0.815 . . . . 0.0 110.742 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.58 115.84 18.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -82.29 102.31 11.1 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.547 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.7 mm -98.72 125.98 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.2 pt? -103.6 134.32 47.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 61' ' ' ILE . 70.9 m -152.92 177.88 10.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.738 0.815 . . . . 0.0 110.217 -170.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -143.92 162.33 36.41 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.011 1.325 . . . . 0.0 107.974 169.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.01 122.01 12.67 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA3' ' ND2' ' A' ' 88' ' ' ASN . . . . . . . . 0 C--N 1.34 0.775 0 O-C-N 123.676 0.61 . . . . 0.0 113.807 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -64.83 105.62 1.04 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.896 0.379 . . . . 0.0 110.355 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 mm -73.16 -10.43 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 124.217 1.007 . . . . 0.0 111.213 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.22 51.55 3.6 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 123.33 0.49 . . . . 0.0 113.009 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.86 170.29 16.47 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 123.811 0.844 . . . . 0.0 109.729 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.1 mm? -77.07 113.75 15.13 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.482 0.713 . . . . 0.0 109.731 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -115.18 -32.56 5.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.671 0.788 . . . . 0.0 111.592 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.39 -168.21 1.33 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.999 1.32 . . . . 0.0 109.242 -170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.457 ' HB2' HG22 ' A' ' 79' ' ' THR . 50.4 mtm180 -138.55 147.71 43.39 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.472 0.709 . . . . 0.0 110.135 171.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 75' ' ' ILE . 32.9 pt -125.98 153.45 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.644 1.178 . . . . 0.0 109.794 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 m -115.63 124.17 50.24 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 69' ' ' ILE . 26.5 mm -83.03 111.45 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 124.013 0.82 . . . . 0.0 109.933 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -99.22 95.36 7.03 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.175 0.988 . . . . 0.0 108.44 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' HG3' ' A' ' 30' ' ' GLU . 5.7 p -82.9 145.29 29.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.199 -1.818 . . . . 0.0 107.622 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' THR . 58.2 tp -96.32 107.87 20.29 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.851 0.751 . . . . 0.0 109.015 -170.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -85.28 104.24 14.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.199 1.0 . . . . 0.0 109.958 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 53.5 mt-30 -100.56 85.47 2.95 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 108.671 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -94.4 120.65 34.97 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.639 0.776 . . . . 0.0 109.669 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -71.91 170.56 13.48 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 122.849 0.459 . . . . 0.0 110.497 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 15.5 t70 -112.02 161.74 16.14 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.417 0.687 . . . . 0.0 109.564 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -70.86 13.32 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 124.486 1.114 . . . . 0.0 112.904 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -140.38 -34.33 0.53 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 116.27 74.97 0.56 Allowed Glycine 0 C--N 1.355 1.591 0 CA-C-N 114.074 -1.421 . . . . 0.0 114.786 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 30.6 mt-10 -114.06 157.3 22.72 Favored 'General case' 0 C--O 1.242 0.711 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 159.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.98 104.98 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.87 89.81 6.87 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 40.3 mt-10 -81.0 118.36 22.4 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.69 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.404 ' O ' HD12 ' A' ' 15' ' ' LEU . 21.5 p -141.77 158.29 43.98 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 107.597 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -106.92 101.05 10.51 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HG3' ' OG1' ' A' ' 14' ' ' THR . 10.0 pt-20 -73.19 94.43 1.96 Allowed 'General case' 0 C--O 1.245 0.844 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.44 121.67 13.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 112.901 -1.954 . . . . 0.0 108.536 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.71 -111.0 2.55 Favored Glycine 0 C--N 1.344 0.972 0 C-N-CA 121.448 -0.406 . . . . 0.0 113.304 -154.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -98.56 130.82 45.12 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -172.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 51.1 m -105.75 97.58 7.38 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.68 171.61 7.23 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -59.78 124.43 20.13 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 113.212 -1.813 . . . . 0.0 111.753 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -140.29 170.97 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.696 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 t -133.29 101.44 5.18 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 164.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 61' ' ' ILE . 31.7 t -93.91 95.54 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.755 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.411 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -119.68 122.29 41.15 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -176.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.505 ' HG2' HG22 ' A' ' 59' ' ' VAL . 87.6 mtp -67.93 156.54 36.99 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.655 0.264 . . . . 0.0 110.4 174.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.15 160.89 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.998 0.919 . . . . 0.0 111.511 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -93.08 178.52 5.72 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 160.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -65.57 -20.26 66.25 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.476 0.31 . . . . 0.0 110.81 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -60.84 2.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.187 . . . . 0.0 112.417 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.53 -18.37 57.04 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.69 -59.07 2.95 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.158 0.504 . . . . 0.0 109.928 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.2 mt -51.21 -38.59 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.998 1.319 . . . . 0.0 111.6 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.6 t -64.96 -46.27 82.24 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.404 0.682 . . . . 0.0 111.335 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.42 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 27.3 t -80.42 -4.68 54.59 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.927 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.55 -87.84 1.13 Allowed Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.63 11.01 1.85 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.414 0.686 . . . . 0.0 111.013 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 44.5 tt0 -76.92 -51.88 10.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 58' ' ' THR . 65.8 mt -91.77 163.42 14.07 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 165.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.47 160.68 37.24 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.787 0.835 . . . . 0.0 110.085 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.2 mt -68.3 113.7 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -6.32 20.61 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-O 119.83 -0.428 . . . . 0.0 113.42 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 54' ' ' LEU . 42.1 m -55.72 131.46 46.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.198 0.599 . . . . 0.0 110.248 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG22 ' HG2' ' A' ' 41' ' ' MET . 61.8 t -96.23 113.92 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.291 0.637 . . . . 0.0 110.019 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -88.16 143.25 27.16 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.718 HD13 HG21 ' A' ' 75' ' ' ILE . 82.1 mt -139.95 108.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -99.39 116.84 32.48 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.665 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 10' ' ' ILE . 46.7 pt -128.98 160.28 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -57.3 157.69 6.17 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.724 0.238 . . . . 0.0 110.89 165.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -57.39 112.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.295 0.638 . . . . 0.0 111.395 -171.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HD3' HD11 ' A' ' 69' ' ' ILE . 26.6 ttt85 -139.22 103.7 4.82 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.504 0.722 . . . . 0.0 109.377 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -80.53 11.02 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.495 1.118 . . . . 0.0 112.006 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -89.02 -24.57 22.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.186 0.994 . . . . 0.0 109.916 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.481 HG21 HD12 ' A' ' 104' ' ' ILE . 20.5 mm -69.55 131.63 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -120.48 161.15 21.75 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.71 -24.56 64.5 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.297 0.639 . . . . 0.0 111.858 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.1 p -81.33 -7.67 59.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.473 0.709 . . . . 0.0 111.74 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.0 m -78.5 157.97 28.73 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -116.49 148.98 40.26 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.671 0.788 . . . . 0.0 108.98 171.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.718 HG21 HD13 ' A' ' 61' ' ' ILE . 45.2 mm -112.48 117.19 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 122.816 0.446 . . . . 0.0 109.996 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 34.5 ttpt -104.86 125.66 51.12 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.6 t -78.32 103.59 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 110.042 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -67.69 -22.96 65.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.681 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.457 HG22 ' HB2' ' A' ' 9' ' ' ARG . 11.7 t -171.5 135.28 0.9 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.887 0.875 . . . . 0.0 109.88 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.95 -159.29 28.09 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.478 -0.624 . . . . 0.0 112.956 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.64 -17.15 29.94 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.109 2.539 . . . . 0.0 112.23 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.72 36.73 4.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.419 1.087 . . . . 0.0 109.454 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.05 98.51 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.781 0.832 . . . . 0.0 111.596 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.83 -20.26 7.27 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.825 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -80.12 137.15 36.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.931 0.892 . . . . 0.0 110.818 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 12.1 t -104.15 106.91 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.482 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.7 OUTLIER -84.42 156.7 21.67 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.976 173.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -117.52 144.14 45.38 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.0 mt -82.38 123.23 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 58' ' ' THR . 26.2 pt -105.24 139.22 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 123.578 0.751 . . . . 0.0 109.968 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.07 -108.46 2.53 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.894 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' O ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -153.6 141.07 13.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.568 0.747 . . . . 0.0 109.855 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.62 102.11 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.273 1.982 . . . . 0.0 111.101 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.32 116.49 64.67 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.062 0.945 . . . . 0.0 109.434 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.87 136.58 33.05 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.628 2.219 . . . . 0.0 112.106 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.5 139.42 31.15 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.255 0.622 . . . . 0.0 110.775 172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.88 80.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.108 0.963 . . . . 0.0 112.247 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -86.07 -3.46 58.95 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.221 0.609 . . . . 0.0 111.288 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? 66.51 22.37 10.63 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.438 1.095 . . . . 0.0 111.942 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.1 p -85.57 -13.28 49.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.266 0.626 . . . . 0.0 110.996 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -163.42 -172.15 2.84 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.928 0.491 . . . . 0.0 110.773 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -140.46 124.5 17.45 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -178.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -88.1 95.59 10.2 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.55 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 21.4 mm -87.06 120.48 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -108.98 142.25 39.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 61' ' ' ILE . 72.2 m -150.93 172.93 14.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.754 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -143.95 158.47 43.68 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 167.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.73 127.09 30.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.441 0.463 . . . . 0.0 111.073 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.05 54.86 4.3 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.784 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.3 96.33 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 0.0 111.641 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.95 -1.9 56.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.887 0.875 . . . . 0.0 111.889 -173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm . . . . . 0 C--O 1.25 1.093 0 C-N-CA 123.171 0.589 . . . . 0.0 109.763 179.001 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -140.01 141.92 36.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.079 0.952 . . . . 0.0 109.324 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -30.28 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.854 0.862 . . . . 0.0 112.354 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.63 49.99 1.42 Allowed Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -72.06 138.77 48.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.978 0.911 . . . . 0.0 110.858 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 mt -81.14 105.33 12.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.807 0.443 . . . . 0.0 110.895 -168.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -125.18 -14.14 6.59 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.185 0.994 . . . . 0.0 112.319 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -102.15 -179.2 3.92 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.957 1.303 . . . . 0.0 109.268 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HB3' HG22 ' A' ' 34' ' ' THR . 45.2 mtm180 -135.59 146.86 48.39 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.076 0.55 . . . . 0.0 109.98 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -138.92 144.16 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.944 0.898 . . . . 0.0 109.527 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.5 m -98.57 127.37 44.47 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.8 mm -80.64 106.97 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.452 0.701 . . . . 0.0 110.678 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' TRP . 27.9 mp0 -79.9 96.59 6.41 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.472 0.653 . . . . 0.0 109.93 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 p -81.25 136.22 35.79 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.708 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.8 tp -78.42 98.97 6.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.07 0.462 . . . . 0.0 109.782 -173.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -74.92 93.93 2.74 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.027 0.931 . . . . 0.0 110.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.453 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 46.4 mt-30 -91.76 83.65 5.31 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -90.31 125.53 35.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.24 0.616 . . . . 0.0 110.404 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 42.1 ttp180 -78.22 152.06 32.8 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.671 0.389 . . . . 0.0 110.277 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 31.1 t70 -99.97 164.11 12.14 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.1 tt -61.4 -10.28 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.472 1.109 . . . . 0.0 113.092 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -120.65 -6.45 9.69 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.455 -0.778 . . . . 0.0 109.496 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.17 48.04 1.64 Allowed Glycine 0 C--N 1.36 1.897 0 N-CA-C 115.284 0.874 . . . . 0.0 115.284 165.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 5.1 mp0 -106.14 148.15 28.18 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.53 100.83 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.64 101.25 13.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.022 0.929 . . . . 0.0 108.65 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.1 mt-10 -85.19 118.79 24.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.501 0.72 . . . . 0.0 110.202 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.461 ' O ' HD12 ' A' ' 15' ' ' LEU . 36.5 p -134.95 174.8 10.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.865 1.266 . . . . 0.0 108.388 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . 85.0 m95 -117.5 107.83 14.77 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.0 146.43 23.94 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.9 141.39 53.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.911 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.96 -107.0 3.17 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -127.51 148.78 50.32 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.6 m -102.79 97.49 7.64 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.161 0.584 . . . . 0.0 109.465 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.3 pt? -113.01 171.99 7.21 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.251 0.62 . . . . 0.0 111.941 -174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -62.65 123.77 19.26 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.937 175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.721 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.61 172.03 13.6 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.488 173.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 t -129.91 99.34 5.07 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.527 HG13 HG12 ' A' ' 61' ' ' ILE . 21.8 t -88.7 92.44 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.4 0.619 . . . . 0.0 109.446 -174.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -96.03 106.07 18.19 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.741 0.816 . . . . 0.0 110.244 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.46 121.75 19.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG21 ' HB ' ' A' ' 58' ' ' THR . 5.5 m -67.38 135.44 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 121.07 0.462 . . . . 0.0 111.22 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -91.53 -177.03 4.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.461 0.705 . . . . 0.0 111.36 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 p -61.79 -41.21 97.43 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.495 0.718 . . . . 0.0 111.269 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -54.58 -43.58 72.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.118 0.967 . . . . 0.0 110.693 176.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.93 -52.23 66.32 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.648 0.593 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.77 -55.22 21.07 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.821 0.849 . . . . 0.0 112.712 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.034 0.934 . . . . 0.0 111.516 -176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.7 m -66.25 -41.05 90.52 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.452 0.701 . . . . 0.0 112.161 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 93.9 p -87.52 -5.24 58.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.106 0.562 . . . . 0.0 111.755 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.65 -71.95 1.5 Allowed Glycine 0 C--N 1.347 1.141 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.18 11.35 0.28 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.882 0.873 . . . . 0.0 110.897 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.1 tt0 -80.29 -27.2 38.58 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.087 0.555 . . . . 0.0 110.984 -175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.7 mt -115.03 44.67 1.75 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.45 132.11 46.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.1 mt -54.87 126.31 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 124.364 1.04 . . . . 0.0 110.85 -165.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.58 -12.42 13.69 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -163.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.45 ' HB ' HG21 ' A' ' 42' ' ' VAL . 31.3 m -82.17 149.32 28.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.07 129.53 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -100.01 135.81 40.88 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 75' ' ' ILE . 71.1 mt -134.46 109.38 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.971 0.908 . . . . 0.0 109.002 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 30.0 m95 -90.95 116.79 29.02 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 37' ' ' ALA . 43.4 pt -121.32 163.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -60.67 138.73 58.04 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 164.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 2.6 t80 -53.04 126.58 21.06 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.36 1.064 . . . . 0.0 109.82 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -140.79 134.62 30.47 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.818 0.699 . . . . 0.0 109.252 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -82.16 1.79 34.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 111.581 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.16 -20.78 20.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.874 0.869 . . . . 0.0 111.201 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 104' ' ' ILE . 23.4 mm -72.16 123.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.668 0.387 . . . . 0.0 110.481 -170.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -133.41 170.88 14.83 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.129 0.972 . . . . 0.0 109.138 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.62 65.45 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.294 0.638 . . . . 0.0 111.433 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 p -94.19 39.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.819 0.848 . . . . 0.0 110.374 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.2 m -130.47 150.5 51.66 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 78.1 mtm180 -117.16 162.95 17.03 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 167.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.531 HG21 HG21 ' A' ' 61' ' ' ILE . 32.2 mm -127.58 97.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 HG11 ' A' ' 39' ' ' VAL . 22.9 t -73.68 118.09 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.873 0.469 . . . . 0.0 110.443 -174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.0 t -69.07 -36.56 77.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.76 0.824 . . . . 0.0 110.738 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.419 HG22 ' HB2' ' A' ' 9' ' ' ARG . 9.0 t -167.51 135.59 2.46 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.897 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.91 -158.33 27.83 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.861 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.76 -29.21 51.1 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.811 2.341 . . . . 0.0 112.062 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD12 HG12 ' A' ' 39' ' ' VAL . 66.6 mt -115.86 32.16 6.26 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.64 0.776 . . . . 0.0 110.559 -175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.46 114.2 2.12 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.467 0.707 . . . . 0.0 111.349 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.59 -30.68 6.54 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.683 0.615 . . . . 0.0 112.69 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -72.7 142.64 48.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.405 0.682 . . . . 0.0 110.864 -176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.57 97.75 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-O 122.494 1.14 . . . . 0.0 109.985 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -83.9 114.66 21.83 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.701 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.527 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.07 135.56 34.79 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.135 0.974 . . . . 0.0 109.433 -178.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.61 116.44 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.2 pt -98.88 132.24 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.294 0.637 . . . . 0.0 109.508 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.98 -120.88 5.58 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -171.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.418 ' O ' HD21 ' A' ' 105' ' ' LEU . 11.3 pt20 -147.25 147.59 29.13 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.056 0.943 . . . . 0.0 108.485 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.89 141.84 96.14 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.87 2.38 . . . . 0.0 112.718 -179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.86 108.92 53.12 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.65 156.17 62.72 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.356 2.037 . . . . 0.0 112.004 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 27.2 t70 -59.54 154.59 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.442 0.697 . . . . 0.0 112.34 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.0 -43.21 91.48 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.927 0.891 . . . . 0.0 111.126 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.43 -8.44 54.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.19 0.596 . . . . 0.0 111.235 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.79 21.05 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.227 1.411 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.9 p -79.77 -3.11 46.21 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 18.6 ptp180 -167.17 -176.1 3.2 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.068 0.947 . . . . 0.0 109.141 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -132.18 117.27 18.05 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.66 111.8 21.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.56 HG22 ' SG ' ' A' ' 106' ' ' CYS . 21.9 mm -95.26 135.37 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.578 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -112.45 128.35 56.3 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 174.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.56 ' SG ' HG22 ' A' ' 104' ' ' ILE . 76.3 m -147.11 175.1 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.605 -168.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -139.64 158.02 44.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -52.53 151.93 3.92 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.015 0.526 . . . . 0.0 111.535 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 43.64 3.26 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.268 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.42 80.02 4.83 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.12 -11.82 61.13 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.085 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 C-N-CA 124.629 1.171 . . . . 0.0 108.157 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -93.22 106.22 18.21 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.466 0.706 . . . . 0.0 109.365 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.5 mt -87.02 72.19 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.757 0.823 . . . . 0.0 110.962 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.79 53.41 0.61 Allowed Glycine 0 N--CA 1.467 0.748 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.69 166.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.15 132.15 27.99 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.59 0.756 . . . . 0.0 110.82 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -76.02 89.84 3.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.732 0.645 . . . . 0.0 109.336 -173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -80.01 -43.62 21.62 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.934 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' THR . 53.5 m-20 -104.41 -161.15 0.8 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.688 1.595 . . . . 0.0 110.872 -170.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 53.9 ttt180 -159.0 137.06 10.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.116 0.966 . . . . 0.0 109.557 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -132.42 168.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 124.428 1.091 . . . . 0.0 110.446 -177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.9 m -115.92 138.91 50.74 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.798 1.239 . . . . 0.0 108.101 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.1 mm -97.12 101.58 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.024 0.53 . . . . 0.0 110.495 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.521 ' NE2' ' HE2' ' A' ' 76' ' ' LYS . 19.6 mp0 -75.51 100.97 4.7 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.707 0.803 . . . . 0.0 110.265 173.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.8 p -79.06 147.95 32.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.107 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 27' ' ' GLU . 60.5 tp -98.03 107.63 20.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -99.07 120.57 39.69 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.599 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 89.2 mt-30 -82.57 93.7 7.36 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.6 m -92.05 114.36 26.88 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.582 0.753 . . . . 0.0 109.401 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 23.6 ttp85 -72.72 158.29 35.88 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -110.7 169.84 8.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.252 0.621 . . . . 0.0 109.351 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.6 -8.42 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 C-N-CA 124.331 1.052 . . . . 0.0 112.839 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 p -99.25 -9.27 23.87 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-O 121.612 0.72 . . . . 0.0 109.084 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.39 19.8 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.754 -1.112 . . . . 0.0 113.339 176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 42.5 mt-10 -97.29 140.55 31.59 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.355 0.662 . . . . 0.0 109.421 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' GLN . 40.0 mm -89.32 101.43 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.365 0.666 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.45 104.97 17.48 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 42.9 mt-10 -80.19 112.4 17.47 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.7 p -128.58 144.52 51.17 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.231 1.013 . . . . 0.0 110.609 -173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -103.28 100.22 10.1 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.178 0.991 . . . . 0.0 109.206 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -98.0 135.3 39.9 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.689 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.06 142.98 55.69 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 -110.19 3.18 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -117.53 141.83 47.89 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.438 0.695 . . . . 0.0 109.545 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 9' ' ' ARG . 11.2 m -101.8 102.5 13.13 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.087 0.955 . . . . 0.0 109.531 -175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.473 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.7 pt? -114.16 171.03 7.85 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.276 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -70.8 132.77 45.81 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.214 1.005 . . . . 0.0 111.945 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -135.8 -179.47 5.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.375 1.07 . . . . 0.0 110.867 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -139.06 102.29 4.49 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 164.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.92 106.27 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.396 1.078 . . . . 0.0 110.064 -172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -116.52 108.85 16.5 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.929 1.292 . . . . 0.0 110.53 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 84.2 mtp -68.64 125.53 26.84 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.25 138.05 19.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 C-N-CA 123.766 0.826 . . . . 0.0 111.03 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -97.14 -177.86 3.99 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.66 -35.71 72.99 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.939 0.896 . . . . 0.0 111.794 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -52.62 -61.21 2.43 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.939 0.896 . . . . 0.0 112.233 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.49 -23.99 42.6 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.676 0.39 . . . . 0.0 111.578 -174.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.38 18.22 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 120.954 0.407 . . . . 0.0 111.383 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.27 -37.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.03 0.932 . . . . 0.0 111.067 175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -46.78 87.38 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.729 0.812 . . . . 0.0 111.115 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 79.4 p -82.38 -13.65 56.51 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.273 0.629 . . . . 0.0 111.348 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.24 -86.89 1.17 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.23 -1.59 5.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.817 0.847 . . . . 0.0 111.153 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.0 tt0 -65.58 -63.07 1.18 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.462 0.705 . . . . 0.0 109.774 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.29 138.15 31.69 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 165.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.2 144.69 51.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.4 mt -62.81 113.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 118.113 0.415 . . . . 0.0 110.398 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.18 -10.75 14.89 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 123.04 0.352 . . . . 0.0 112.898 -172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 m -63.81 146.93 53.02 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 48.8 t -119.63 123.69 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.263 0.625 . . . . 0.0 110.63 -169.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -103.78 130.44 51.32 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 75' ' ' ILE . 86.4 mt -134.2 113.04 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.393 0.677 . . . . 0.0 109.209 -166.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -102.05 115.27 30.18 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.619 0.768 . . . . 0.0 109.79 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 101' ' ' ARG . 47.4 pt -121.32 163.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -60.51 157.08 14.87 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.444 ' N ' ' HA ' ' A' ' 101' ' ' ARG . 70.8 t80 -64.16 101.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.571 -172.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -119.9 118.83 31.77 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.8 -2.69 40.79 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.997 0.919 . . . . 0.0 110.932 -174.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -92.66 -21.12 20.2 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.288 0.635 . . . . 0.0 110.949 -173.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.04 134.48 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.158 0.583 . . . . 0.0 110.632 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -131.0 171.68 12.94 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.2 67.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.567 0.747 . . . . 0.0 111.076 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 73.7 p -86.36 45.47 1.24 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.87 1.268 . . . . 0.0 110.554 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.0 m -141.49 122.65 14.72 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.412 1.085 . . . . 0.0 108.213 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -94.56 133.09 38.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 61' ' ' ILE . 22.7 mm -95.99 94.0 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 123.867 0.867 . . . . 0.0 109.932 -176.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HE2' ' NE2' ' A' ' 13' ' ' GLN . 40.1 ttpt -94.6 111.62 23.38 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 87' ' ' LEU . 49.8 t -70.65 128.75 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.237 0.615 . . . . 0.0 110.477 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.9 m -93.23 -29.63 15.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.924 0.89 . . . . 0.0 110.364 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 9' ' ' ARG . 54.4 m -151.93 110.49 3.79 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.467 -166.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.74 29.73 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.78 -0.456 . . . . 0.0 113.556 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.75 -16.18 45.72 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 87' ' ' LEU . 83.6 mt -127.36 34.33 4.72 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.217 1.007 . . . . 0.0 110.147 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.72 93.48 0.11 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.337 0.655 . . . . 0.0 111.131 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.58 -13.56 4.81 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.792 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.627 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 62.1 ttm-85 -95.55 149.36 21.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.17 0.988 . . . . 0.0 110.563 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.9 p -108.21 101.1 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 122.326 1.06 . . . . 0.0 109.737 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -86.53 131.18 34.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.031 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -103.78 143.66 32.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.434 0.694 . . . . 0.0 109.256 -174.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.52 108.37 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 107' ' ' ARG . 25.7 pt -87.19 59.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 122.254 1.026 . . . . 0.0 110.559 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.43 -149.07 19.83 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -124.45 141.38 37.49 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.5 134.66 65.73 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.329 2.686 . . . . 0.0 112.629 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.51 107.15 49.46 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.318 1.047 . . . . 0.0 109.446 -170.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.22 152.01 72.09 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.672 2.248 . . . . 0.0 111.832 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -81.1 178.19 8.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.388 0.275 . . . . 0.0 110.643 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.33 -30.24 70.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.102 0.961 . . . . 0.0 112.889 -175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.21 37.25 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.016 0.526 . . . . 0.0 111.59 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 57.64 33.24 23.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 0.0 110.391 -172.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.0 t -92.15 -7.64 47.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.117 0.967 . . . . 0.0 110.162 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HA ' ' N ' ' A' ' 65' ' ' TYR . 9.1 ptp180 -161.34 167.86 25.01 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.543 0.687 . . . . 0.0 111.384 -175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.05 109.34 16.33 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.437 174.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -79.93 107.6 12.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.501 HG22 ' SG ' ' A' ' 106' ' ' CYS . 24.6 mm -97.67 112.44 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -82.37 135.06 35.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 170.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.501 ' SG ' HG22 ' A' ' 104' ' ' ILE . 78.7 m -148.99 175.41 11.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.197 0.999 . . . . 0.0 108.755 -176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 90' ' ' ILE . 61.5 ttt85 -149.95 161.48 42.22 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.627 ' HG2' ' HD3' ' A' ' 85' ' ' ARG . 1.8 tm-20 -45.45 125.73 5.96 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.795 0.838 . . . . 0.0 110.384 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.32 36.73 3.44 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.552 0.533 . . . . 0.0 113.686 -167.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.32 39.12 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.715 1.206 . . . . 0.0 112.451 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -77.23 89.3 3.69 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.788 0.835 . . . . 0.0 110.573 -172.569 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -72.6 115.86 12.37 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.363 0.665 . . . . 0.0 109.981 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -75.07 -25.77 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.047 0.539 . . . . 0.0 110.014 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.38 30.3 1.92 Allowed Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 114.181 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.467 ' HB2' HD22 ' A' ' 6' ' ' LEU . 60.3 mtp180 -71.23 -48.6 50.31 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 161.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 5' ' ' ARG . 2.5 mm? -92.38 98.94 11.8 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.499 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -93.8 -27.51 16.42 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.03 0.932 . . . . 0.0 112.345 -163.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.85 171.8 8.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.061 0.944 . . . . 0.0 109.026 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HB2' HG22 ' A' ' 79' ' ' THR . 98.2 mtt180 -136.84 138.0 40.32 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 77' ' ' VAL . 47.8 pt -140.97 176.86 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.248 1.019 . . . . 0.0 109.751 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.9 m -140.12 136.5 33.61 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.361 0.664 . . . . 0.0 109.406 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.0 mm -73.12 125.89 32.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 123.268 0.627 . . . . 0.0 109.549 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -97.62 116.53 30.0 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 169.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -89.76 135.57 33.54 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.096 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' A' ' 27' ' ' GLU . 2.9 tm? -92.91 99.9 12.46 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -85.93 107.92 17.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.361 0.664 . . . . 0.0 110.015 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -77.43 110.49 12.24 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.8 m -120.45 121.4 38.41 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 107.67 -1.234 . . . . 0.0 107.67 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -77.01 172.35 13.34 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 118.322 0.51 . . . . 0.0 111.209 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.9 t70 -108.12 161.22 15.17 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.8 tt -67.77 -6.26 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 123.792 0.837 . . . . 0.0 113.056 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -105.46 -18.92 13.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.45 54.69 0.93 Allowed Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.737 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 25.9 mt-10 -112.15 147.24 36.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.581 1.152 . . . . 0.0 107.942 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.7 mm -90.07 101.15 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.863 0.756 . . . . 0.0 109.731 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.45 97.85 11.43 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.617 ' HB3' HD21 ' A' ' 15' ' ' LEU . 43.8 mt-10 -83.46 131.75 35.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.443 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.9 p -132.89 161.4 34.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.109 0.964 . . . . 0.0 109.982 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -118.21 118.59 32.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.485 0.714 . . . . 0.0 109.729 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -107.89 151.35 25.88 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.105 0.962 . . . . 0.0 109.25 174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.83 135.25 38.89 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.36 -110.34 3.06 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -113.28 132.76 55.42 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.0 m -76.45 141.66 41.27 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.97 0.908 . . . . 0.0 108.985 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.88 146.42 27.08 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.234 0.54 . . . . 0.0 111.682 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -71.06 124.23 23.93 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.437 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -136.81 172.45 12.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.775 0.83 . . . . 0.0 111.288 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -130.84 105.55 7.85 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 162.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 61' ' ' ILE . 60.8 t -91.64 91.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 0.0 109.373 -173.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -115.4 119.91 37.81 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -176.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.518 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -66.32 152.69 44.45 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -70.05 149.74 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.894 0.478 . . . . 0.0 111.039 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 t -88.15 176.61 7.19 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.9 m -57.47 -35.96 70.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.078 0.551 . . . . 0.0 110.446 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -52.05 -39.25 59.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.704 1.202 . . . . 0.0 112.133 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -66.16 -49.74 66.36 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.383 0.427 . . . . 0.0 111.198 -177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.5 97.66 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.981 0.801 . . . . 0.0 110.8 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.5 mt -63.22 -43.83 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.645 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 t -75.76 -13.66 60.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.428 0.691 . . . . 0.0 111.781 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 45.6 m -111.18 -2.38 15.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.676 0.79 . . . . 0.0 111.736 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.13 -74.5 1.85 Allowed Glycine 0 C--N 1.351 1.411 0 N-CA-C 112.023 -0.431 . . . . 0.0 112.023 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.6 5.33 0.8 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.884 0.874 . . . . 0.0 111.21 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 35.8 tt0 -70.73 -68.54 0.42 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.126 0.571 . . . . 0.0 110.342 -177.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.16 142.5 45.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 164.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.67 153.18 39.73 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.53 0.732 . . . . 0.0 109.539 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.85 115.39 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.07 -5.54 17.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.766 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 90' ' ' ILE . 98.6 m -70.49 119.39 14.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 41' ' ' MET . 51.0 t -84.68 118.1 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -98.75 143.33 29.22 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 75' ' ' ILE . 66.5 mt -138.54 109.97 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -97.56 115.55 28.07 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 ' HB2' ' A' ' 37' ' ' ALA . 49.4 pt -121.2 158.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -56.33 140.76 44.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.191 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -49.32 118.8 2.91 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.615 1.166 . . . . 0.0 111.629 -171.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -143.34 117.76 9.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.154 0.582 . . . . 0.0 109.967 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -81.42 2.59 27.93 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.597 1.159 . . . . 0.0 112.204 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.36 -17.32 24.82 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.852 0.861 . . . . 0.0 110.998 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.6 HG21 HD12 ' A' ' 104' ' ' ILE . 26.9 mm -67.52 138.98 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.039 0.536 . . . . 0.0 110.31 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -145.7 169.63 18.1 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.081 0.952 . . . . 0.0 108.709 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 92' ' ' GLN . . . -63.6 -26.97 68.93 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.088 0.555 . . . . 0.0 112.037 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.5 p -97.9 48.01 1.01 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 122.16 0.981 . . . . 0.0 110.656 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.9 m -131.29 156.53 45.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 168.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -126.76 159.25 34.32 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.289 0.566 . . . . 0.0 109.989 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.604 HG21 HD13 ' A' ' 61' ' ' ILE . 48.4 mm -112.41 98.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.331 1.053 . . . . 0.0 109.224 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -90.45 113.57 25.54 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.525 ' HA ' HG22 ' A' ' 10' ' ' ILE . 64.9 t -77.0 112.23 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.539 0.736 . . . . 0.0 110.629 -173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.7 t -72.8 -30.02 63.74 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.969 0.907 . . . . 0.0 111.227 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.539 HG22 ' HB2' ' A' ' 9' ' ' ARG . 15.0 t -165.71 139.55 4.51 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.978 0.911 . . . . 0.0 109.285 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.7 -163.4 30.38 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-O 118.95 -0.917 . . . . 0.0 111.67 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.74 -25.91 28.21 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.377 2.051 . . . . 0.0 111.452 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.7 mt -114.5 33.93 5.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.195 0.998 . . . . 0.0 109.724 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.3 109.16 1.06 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.702 0.801 . . . . 0.0 111.452 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.37 -21.32 10.02 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.415 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -80.62 165.87 21.63 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.387 0.675 . . . . 0.0 111.153 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.17 102.05 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 122.351 1.072 . . . . 0.0 109.414 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 120.86 24.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.674 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -82.75 134.76 35.12 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.223 1.009 . . . . 0.0 108.288 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' A' ' 106' ' ' CYS . 66.1 mt -82.19 95.8 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -172.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.554 HD11 HG23 ' A' ' 58' ' ' THR . 21.7 pt -80.53 62.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-O 122.3 1.048 . . . . 0.0 111.14 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.54 -158.85 27.83 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 71' ' ' ALA . 92.5 mt-30 -126.59 145.44 53.22 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.372 0.669 . . . . 0.0 109.365 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -59.66 134.47 57.88 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 113.504 -173.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -106.56 108.92 62.7 Favored Pre-proline 0 N--CA 1.48 1.045 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.1 142.7 56.95 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.668 2.246 . . . . 0.0 112.269 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.24 150.56 48.62 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 111.374 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.26 -29.99 70.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.529 1.132 . . . . 0.0 112.369 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.66 -8.97 45.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.878 0.471 . . . . 0.0 110.973 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 62.54 20.28 11.85 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.705 1.202 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.8 t -89.41 -0.17 57.29 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 122.344 0.258 . . . . 0.0 110.813 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.64 -174.89 2.94 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 123.65 0.78 . . . . 0.0 109.949 171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.26 124.62 26.21 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.62 117.33 28.42 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.6 HD12 HG21 ' A' ' 69' ' ' ILE . 15.3 mm -108.76 140.55 26.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.65 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -112.14 128.97 56.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' A' ' 89' ' ' ILE . 56.2 m -150.74 -178.96 6.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 -173.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -171.09 175.68 4.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.34 1.056 . . . . 0.0 108.642 163.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -57.67 172.04 0.41 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.691 0.796 . . . . 0.0 111.066 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.23 44.17 3.31 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.9 83.71 7.67 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 124.368 1.067 . . . . 0.0 110.092 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.59 3.36 52.8 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.053 176.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.434 1.093 . . . . 0.0 109.783 -177.529 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -72.64 156.81 38.58 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 122.547 0.339 . . . . 0.0 110.113 175.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 mt -91.65 46.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.07 30.37 7.74 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.433 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.97 -81.8 0.64 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.434 0.694 . . . . 0.0 109.569 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 140.53 38.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.682 . . . . 0.0 110.407 -173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -117.09 -44.17 2.81 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.398 1.079 . . . . 0.0 110.284 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -101.07 -175.48 2.88 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.049 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -131.94 147.73 52.48 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.79 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' THR . 13.7 pt -138.97 145.29 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.622 1.169 . . . . 0.0 109.266 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 m -108.62 137.95 45.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 109.021 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.06 114.15 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.889 0.476 . . . . 0.0 110.284 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.584 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.1 mp0 -89.79 103.79 16.41 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 p -79.41 159.03 27.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.481 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.602 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.5 tp -114.84 110.28 19.45 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.082 0.553 . . . . 0.0 109.997 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -93.99 101.94 14.01 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.952 0.901 . . . . 0.0 109.417 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -79.81 125.42 29.67 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 172.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.8 m -137.11 150.55 48.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 108.718 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 37.9 ttp180 -99.33 166.24 11.29 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 122.55 0.34 . . . . 0.0 110.121 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 8.7 t70 -110.59 162.89 14.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.642 1.177 . . . . 0.0 108.592 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.9 tt -59.25 -12.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 125.013 1.325 . . . . 0.0 113.805 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -112.52 -34.61 5.8 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.49 48.04 0.15 Allowed Glycine 0 C--N 1.354 1.559 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.708 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.506 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 23.7 mm-40 -96.12 154.21 17.37 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.423 0.689 . . . . 0.0 109.258 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 51.2 mm -107.05 102.93 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.81 101.72 13.06 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 124.575 1.15 . . . . 0.0 109.106 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -88.2 107.39 18.76 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -116.14 144.6 43.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.638 0.775 . . . . 0.0 110.231 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.42 ' CZ3' ' HG3' ' A' ' 74' ' ' ARG . 85.4 m95 -114.22 113.62 24.88 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.133 0.973 . . . . 0.0 109.424 -173.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.02 123.82 47.34 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.36 128.88 38.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.267 1.427 . . . . 0.0 109.364 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.47 -126.4 3.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 114.251 0.461 . . . . 0.0 114.251 -165.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -100.91 135.03 43.01 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.918 0.887 . . . . 0.0 110.717 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 16.6 m -99.1 105.77 17.9 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.369 0.668 . . . . 0.0 110.85 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -108.82 170.72 7.86 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.588 0.708 . . . . 0.0 111.721 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -71.81 127.54 32.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.279 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 63' ' ' ILE . . . -138.74 176.35 8.77 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.306 1.043 . . . . 0.0 111.106 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.8 m -136.7 110.29 8.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.022 0.929 . . . . 0.0 108.511 162.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.87 106.28 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.392 0.677 . . . . 0.0 110.538 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.7 OUTLIER -112.91 103.92 11.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.009 0.923 . . . . 0.0 109.48 173.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.536 ' SD ' HD21 ' A' ' 82' ' ' LEU . 92.5 mtp -66.53 130.52 43.47 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 169.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.04 142.51 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.015 0.436 . . . . 0.0 110.737 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.0 m -98.22 -173.02 2.47 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 124.03 0.932 . . . . 0.0 110.457 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -53.42 -29.92 37.64 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.264 1.025 . . . . 0.0 112.839 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -49.99 -51.12 44.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.63 0.772 . . . . 0.0 112.053 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -67.12 -40.43 86.83 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.653 0.596 . . . . 0.0 111.634 -174.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.2 -48.79 72.18 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.293 0.637 . . . . 0.0 110.692 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.68 -42.45 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.832 0.853 . . . . 0.0 111.403 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.4 t -68.77 -30.25 68.8 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.216 0.607 . . . . 0.0 111.383 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 97.1 p -91.84 -9.34 43.75 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.417 0.687 . . . . 0.0 111.163 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.5 -72.09 2.8 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.37 10.19 0.5 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.704 0.802 . . . . 0.0 110.88 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 47.3 mt-10 -78.45 -30.91 47.75 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.91 0.484 . . . . 0.0 111.084 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.56 170.34 8.25 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.074 0.95 . . . . 0.0 109.252 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -145.07 149.54 35.25 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.803 0.841 . . . . 0.0 109.682 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.7 mt -63.23 144.6 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.53 0.732 . . . . 0.0 110.364 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.98 -12.03 70.58 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.135 176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.511 HG23 HD11 ' A' ' 90' ' ' ILE . 47.1 m -61.05 116.7 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.223 0.609 . . . . 0.0 109.358 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.554 HG11 ' HG ' ' A' ' 87' ' ' LEU . 46.4 t -76.69 103.32 3.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.883 -171.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -92.58 137.44 32.36 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.3 mt -141.4 109.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.824 0.85 . . . . 0.0 108.777 -167.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -92.65 124.11 36.43 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.35 0.66 . . . . 0.0 109.579 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.9 pt -130.25 167.39 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.623 0.769 . . . . 0.0 110.16 -175.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -53.25 151.08 5.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.735 0.647 . . . . 0.0 111.451 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.466 ' HE1' ' HD2' ' A' ' 99' ' ' ARG . 61.5 t80 -60.38 107.91 0.73 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -129.64 119.16 23.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -75.3 -2.89 30.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.927 1.291 . . . . 0.0 112.31 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.05 -21.31 19.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.885 0.874 . . . . 0.0 111.396 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.446 HG21 HD12 ' A' ' 104' ' ' ILE . 29.0 mm -72.62 132.21 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.65 0.38 . . . . 0.0 110.554 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.529 HD22 ' H ' ' A' ' 72' ' ' THR . 5.0 t30 -143.18 161.88 37.08 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.01 -27.78 68.56 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.3 0.64 . . . . 0.0 111.897 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.529 ' H ' HD22 ' A' ' 70' ' ' ASN . 35.3 p -79.2 14.32 1.53 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.183 0.993 . . . . 0.0 112.364 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.3 m -111.42 167.65 10.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.505 0.722 . . . . 0.0 109.077 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 51.0 mtm180 -122.46 150.28 42.72 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.2 mm -113.17 99.92 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.498 1.119 . . . . 0.0 109.019 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.3 ttpt -89.44 120.28 30.63 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 122.072 -0.393 . . . . 0.0 110.172 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.492 HG23 HD23 ' A' ' 87' ' ' LEU . 53.4 t -76.79 120.04 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.966 0.412 . . . . 0.0 109.902 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.0 m -84.81 -29.94 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.343 1.057 . . . . 0.0 111.522 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.9 p -141.27 126.77 18.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.85 0.86 . . . . 0.0 109.556 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.92 -158.19 25.08 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.503 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.62 -13.38 29.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.246 2.631 . . . . 0.0 112.441 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.536 HD21 ' SD ' ' A' ' 41' ' ' MET . 70.9 mt -120.77 25.77 9.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.838 . . . . 0.0 110.149 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.34 112.48 2.44 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.342 0.657 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.01 2.54 51.86 Favored Glycine 0 C--N 1.345 1.073 0 O-C-N 123.501 0.501 . . . . 0.0 113.175 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -105.53 139.55 39.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.574 0.75 . . . . 0.0 109.475 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -104.93 102.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 122.313 1.054 . . . . 0.0 109.722 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' HG11 ' A' ' 59' ' ' VAL . 1.5 mm? -82.73 133.14 35.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.198 -174.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.8 OUTLIER -100.44 143.6 30.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.195 0.598 . . . . 0.0 109.561 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.3 mt -80.48 143.62 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.511 HD11 HG23 ' A' ' 58' ' ' THR . 2.2 pt -122.19 104.38 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.813 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.3 -105.98 2.48 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.847 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -150.1 150.17 29.05 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.684 0.794 . . . . 0.0 109.884 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HB2' HD23 ' A' ' 102' ' ' LEU . 33.6 Cg_endo -64.02 123.64 12.23 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 121.903 1.736 . . . . 0.0 111.008 167.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -89.14 113.8 57.68 Favored Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -76.55 129.13 10.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.17 1.913 . . . . 0.0 110.699 171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.671 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 21.9 t70 -52.69 150.37 5.24 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.342 1.057 . . . . 0.0 112.198 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.76 -43.92 77.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.926 0.891 . . . . 0.0 112.001 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.57 0.12 56.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.549 0.739 . . . . 0.0 111.251 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 38.7 mmt180 61.88 26.04 15.72 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.088 1.355 . . . . 0.0 112.138 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 82.8 p -79.79 -12.2 59.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.671 ' HG2' ' HB2' ' A' ' 96' ' ' ASP . 13.3 ptp180 -165.67 175.9 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 93' ' ' PRO . 6.5 mp -122.69 121.81 37.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.944 0.898 . . . . 0.0 108.766 165.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.33 102.99 12.36 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 168.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 69' ' ' ILE . 8.6 mm -87.26 142.88 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -123.61 138.05 54.62 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.9 m -150.09 176.44 10.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.073 -167.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.58 159.24 42.8 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -45.79 122.76 3.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 173.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.405 ' HA3' ' ND2' ' A' ' 88' ' ' ASN . . . -88.97 50.63 3.72 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.223 -0.899 . . . . 0.0 113.142 -172.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.06 119.87 22.81 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -67.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.059 0.849 . . . . 0.0 108.864 177.552 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 120.329 0.109 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -91.07 108.36 19.82 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG13 ' HG2' ' A' ' 64' ' ' ARG . 40.2 mm -89.04 87.06 2.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 169.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.94 51.44 4.57 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.859 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -126.53 -37.61 2.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.672 1.189 . . . . 0.0 109.891 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 64' ' ' ARG . 27.2 mt -72.29 84.27 1.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.497 -163.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -97.56 -21.2 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.504 0.721 . . . . 0.0 111.468 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -114.3 -174.68 2.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.145 0.978 . . . . 0.0 110.052 -173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -139.01 150.92 46.38 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.385 0.674 . . . . 0.0 110.077 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 34' ' ' THR . 44.6 pt -139.33 168.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.644 1.178 . . . . 0.0 109.544 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -128.81 138.91 52.33 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.677 0.791 . . . . 0.0 109.013 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 36.3 mm -89.71 92.35 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.359 0.6 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -71.66 99.13 2.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.82 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 p -84.27 139.45 32.32 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.57 175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 28' ' ' THR . 64.1 tp -78.18 105.58 9.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.144 0.577 . . . . 0.0 109.737 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -90.51 117.95 29.6 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.804 0.841 . . . . 0.0 111.087 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -79.98 94.34 5.89 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.2 m -90.92 111.49 22.95 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.346 0.659 . . . . 0.0 109.576 -173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.7 ttt-85 -87.79 152.85 21.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.052 0.453 . . . . 0.0 111.443 -173.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -107.65 164.04 12.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.963 0.905 . . . . 0.0 108.781 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.4 tt -72.2 -1.26 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.472 0 C-N-CA 124.121 0.969 . . . . 0.0 113.239 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -98.45 -14.24 20.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.981 0.896 . . . . 0.0 109.33 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.97 40.98 5.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.805 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 46.5 mt-10 -96.79 149.58 21.68 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.622 0.769 . . . . 0.0 109.254 173.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -108.49 107.4 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -98.47 103.79 15.77 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.2 mt-10 -80.38 126.5 31.25 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.227 0.537 . . . . 0.0 109.631 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.433 ' O ' HD12 ' A' ' 15' ' ' LEU . 37.7 p -139.53 -176.17 4.45 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.599 1.56 . . . . 0.0 108.469 -168.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -128.05 115.09 17.93 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.906 -0.496 . . . . 0.0 109.665 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.62 145.34 26.95 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.79 136.81 37.47 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.966 0.507 . . . . 0.0 109.634 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.86 -109.45 3.34 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -108.11 134.38 51.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 88.3 m -97.96 102.91 14.79 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -111.04 168.75 9.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.576 0.751 . . . . 0.0 112.264 -173.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 m95 -70.0 122.26 19.01 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.359 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.42 171.96 13.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.442 0.697 . . . . 0.0 112.368 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 2.1 m -131.74 94.61 3.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.384 1.074 . . . . 0.0 108.226 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 77' ' ' VAL . 2.8 p -91.2 94.27 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 121.698 0.761 . . . . 0.0 109.67 -175.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -113.6 119.85 38.91 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.724 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.539 ' SD ' HD21 ' A' ' 82' ' ' LEU . 54.1 mtp -76.62 150.63 36.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.937 0.495 . . . . 0.0 109.737 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -83.7 136.41 22.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.146 0.579 . . . . 0.0 109.576 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 39.5 t -90.3 -178.85 5.48 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.964 0.906 . . . . 0.0 109.535 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -60.53 -33.57 72.84 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.993 0.917 . . . . 0.0 111.423 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 18.4 ptpt -53.93 -40.24 66.56 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.619 1.167 . . . . 0.0 111.461 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -70.28 -43.37 70.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.012 0.925 . . . . 0.0 110.44 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.39 -32.12 72.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.895 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.8 mt -73.16 -45.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.249 0.62 . . . . 0.0 110.553 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.3 m -63.45 -36.95 85.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.78 0.832 . . . . 0.0 111.856 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 78.7 p -86.51 -48.37 8.44 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.034 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.22 -64.68 0.31 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.98 -5.57 0.79 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.872 0.869 . . . . 0.0 111.568 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 36.0 tt0 -71.98 -68.94 0.42 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.006 0.522 . . . . 0.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -77.09 119.52 20.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.91 39.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.98 117.97 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.08 -11.17 14.88 Favored Glycine 0 N--CA 1.477 1.404 0 CA-C-N 116.856 -0.156 . . . . 0.0 113.048 -169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 90' ' ' ILE . 89.1 m -68.29 146.91 52.87 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 164.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.93 116.41 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.271 0.628 . . . . 0.0 110.096 -171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -87.63 126.39 34.92 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 75' ' ' ILE . 44.8 mt -123.48 104.95 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 11.9 m0 -90.56 117.91 29.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.723 0.809 . . . . 0.0 109.722 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 pt -130.29 161.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 108.324 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.523 ' HG2' HG13 ' A' ' 3' ' ' ILE . 64.1 mtm180 -60.92 141.13 57.48 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.883 0.765 . . . . 0.0 110.826 167.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -53.24 130.99 36.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.052 1.341 . . . . 0.0 111.135 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -153.41 147.15 25.21 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.19 0.596 . . . . 0.0 111.238 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -83.2 1.02 42.78 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.603 1.161 . . . . 0.0 111.884 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.67 -26.78 19.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.877 0.471 . . . . 0.0 111.216 -165.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 104' ' ' ILE . 6.3 mm -75.65 132.03 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.73 167.37 16.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.91 63.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.082 0.553 . . . . 0.0 111.635 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.1 p -84.95 3.11 39.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.791 0.836 . . . . 0.0 111.547 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 m -93.95 159.79 15.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.57 0.748 . . . . 0.0 109.646 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -132.12 165.0 25.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.918 0.887 . . . . 0.0 109.01 170.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.646 HG21 HD13 ' A' ' 61' ' ' ILE . 43.7 mm -115.97 99.22 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.487 0.715 . . . . 0.0 110.621 -173.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -91.93 110.11 21.46 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 39' ' ' VAL . 95.7 t -72.84 117.94 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.678 0.791 . . . . 0.0 111.106 -172.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.3 m -77.44 -21.73 52.56 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.358 1.063 . . . . 0.0 112.158 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -167.71 132.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.729 0.811 . . . . 0.0 109.34 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.44 -163.72 30.38 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.928 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.42 -16.07 17.37 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.134 2.556 . . . . 0.0 112.102 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.664 HD13 HD11 ' A' ' 87' ' ' LEU . 82.7 mt -119.26 28.93 7.93 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.341 1.056 . . . . 0.0 109.795 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.81 115.23 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.425 0.69 . . . . 0.0 110.542 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.83 -0.63 38.96 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.811 0.694 . . . . 0.0 112.946 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -107.68 143.82 35.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.862 0.865 . . . . 0.0 109.853 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.12 88.54 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 CA-C-O 122.481 1.134 . . . . 0.0 110.182 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 82' ' ' LEU . 2.6 mm? -62.57 132.41 52.33 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.033 -175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -95.13 130.69 41.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.275 1.03 . . . . 0.0 109.357 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -76.91 129.92 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 110.0 -0.371 . . . . 0.0 110.0 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.489 HG23 ' HD2' ' A' ' 107' ' ' ARG . 1.5 pt -97.18 111.55 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 0.0 109.215 174.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.46 -94.05 1.9 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.987 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -166.92 155.11 9.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.316 1.046 . . . . 0.0 109.325 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -58.35 123.44 13.63 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.755 2.303 . . . . 0.0 111.831 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.12 111.71 65.26 Favored Pre-proline 0 N--CA 1.487 1.394 0 C-N-CA 123.916 0.887 . . . . 0.0 109.789 -172.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.08 155.9 63.79 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.229 2.62 . . . . 0.0 113.691 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.86 155.2 41.09 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 110.914 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.19 -36.88 84.23 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.344 0.657 . . . . 0.0 112.07 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.2 -6.29 59.28 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.948 0.499 . . . . 0.0 110.899 172.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 61.29 23.85 14.03 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.285 1.434 . . . . 0.0 112.236 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 t -85.87 -6.51 59.07 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 122.796 0.438 . . . . 0.0 111.401 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 5.5 ppt_? -161.27 162.54 31.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.583 0.753 . . . . 0.0 109.614 -176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD12 HD13 ' A' ' 104' ' ' ILE . 0.1 OUTLIER -115.56 118.21 32.5 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.599 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 37.8 tt0 -90.27 105.27 17.7 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 69' ' ' ILE . 13.7 mm -88.74 97.69 7.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.6 pt? -81.19 136.84 35.9 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 77.1 m -151.75 -175.5 5.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.068 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.489 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -153.53 160.09 42.4 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.44 0.696 . . . . 0.0 109.196 165.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.76 138.49 57.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.544 0.737 . . . . 0.0 110.322 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.62 29.87 5.59 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.851 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 99.16 1.63 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 166.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.44 94.74 0.12 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.946 0.898 . . . . 0.0 110.895 -171.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 124.241 1.017 . . . . 0.0 108.58 -173.269 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -74.93 100.27 4.07 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.132 0.573 . . . . 0.0 111.271 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.9 mt -126.5 -29.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.167 0.987 . . . . 0.0 108.866 171.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.32 24.63 2.5 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -168.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.482 ' HB2' HD22 ' A' ' 6' ' ' LEU . 37.4 mmt180 -74.5 -43.03 57.82 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 167.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 5' ' ' ARG . 0.7 OUTLIER -99.09 85.64 3.28 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.752 -170.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -103.58 -7.62 20.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.734 0.814 . . . . 0.0 112.33 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -102.64 -176.92 3.24 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 55.6 mtm180 -133.74 150.78 51.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.579 0.752 . . . . 0.0 109.42 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' THR . 12.4 pt -136.4 157.18 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 172.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.468 HG21 ' HB2' ' A' ' 31' ' ' ASP . 26.0 m -116.55 124.82 50.82 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.8 mm -72.31 93.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 2.3 tp-100 -71.58 100.17 2.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -83.71 140.55 32.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.188 -1.824 . . . . 0.0 110.603 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB3' ' A' ' 27' ' ' GLU . 42.5 tp -101.6 98.92 9.16 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 110.018 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -83.66 105.91 14.95 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.8 0.84 . . . . 0.0 109.237 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -74.99 90.82 2.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.5 m -89.68 112.31 23.53 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.597 0.759 . . . . 0.0 109.938 -171.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.7 ttp180 -72.65 153.45 41.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.843 0.354 . . . . 0.0 110.431 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB2' HD13 ' A' ' 26' ' ' LEU . 19.3 t70 -113.89 164.65 13.48 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 tt -75.3 5.95 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.853 0.861 . . . . 0.0 112.392 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -101.54 -14.96 17.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.707 0.803 . . . . 0.0 109.033 170.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.79 33.91 8.09 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.371 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 47.9 mt-10 -102.59 166.95 10.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.613 0.765 . . . . 0.0 110.537 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.2 mm -114.14 105.36 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.708 0.803 . . . . 0.0 109.21 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD13 ' HB2' ' A' ' 20' ' ' ASP . 5.9 mp -98.27 96.05 7.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.849 1.26 . . . . 0.0 107.697 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.668 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.9 mt-10 -79.03 118.66 21.22 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.512 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -126.75 149.13 49.78 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.753 1.221 . . . . 0.0 110.251 -172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.442 ' CE2' HD13 ' A' ' 15' ' ' LEU . 92.7 m95 -107.62 109.5 21.14 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.867 0.867 . . . . 0.0 109.49 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.3 140.07 39.82 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.091 0.957 . . . . 0.0 108.567 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.5 p-10 -71.54 128.99 37.62 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.28 -119.66 4.56 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 113.784 -169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -90.47 116.59 28.52 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.448 0.699 . . . . 0.0 109.423 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 26.8 m -90.26 94.53 9.79 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.5 pt? -103.96 162.83 12.81 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.244 0.545 . . . . 0.0 111.604 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -63.26 126.31 27.0 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.794 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -134.71 165.53 25.04 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.364 1.066 . . . . 0.0 111.709 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.3 t -121.66 98.91 6.18 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 167.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.13 91.63 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.282 0.633 . . . . 0.0 110.125 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -95.54 107.49 19.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.445 0.698 . . . . 0.0 110.34 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.23 130.71 41.45 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 13.8 m -70.21 151.13 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -168.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -95.38 -177.32 4.06 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.107 -0.952 . . . . 0.0 109.653 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -61.29 -41.0 96.22 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.641 0.776 . . . . 0.0 110.778 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -57.17 -34.4 68.42 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.225 1.01 . . . . 0.0 112.314 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 5.8 mm-40 -62.3 -39.41 92.89 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.263 0.625 . . . . 0.0 111.169 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.98 67.12 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.512 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.77 -33.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.106 0.962 . . . . 0.0 111.939 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -87.65 -48.55 7.8 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.513 0.725 . . . . 0.0 110.704 -173.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 15.8 m -84.49 -22.65 30.16 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.86 -102.19 1.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.242 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -89.24 -5.02 57.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.431 0.692 . . . . 0.0 111.816 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 34.7 tt0 -82.91 -62.64 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.632 0.373 . . . . 0.0 110.465 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 58' ' ' THR . 47.1 mt -110.08 147.94 32.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.493 0.717 . . . . 0.0 109.228 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -138.97 168.92 18.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.476 1.11 . . . . 0.0 110.252 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.4 116.12 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.81 -9.76 14.21 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 123.072 0.368 . . . . 0.0 112.43 -167.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.623 HG21 HD22 ' A' ' 54' ' ' LEU . 88.2 m -80.56 161.98 24.51 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.299 1.04 . . . . 0.0 109.281 172.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.97 126.41 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.116 0.966 . . . . 0.0 109.117 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.7 ttm-85 -95.46 134.36 38.38 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -136.18 109.35 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -167.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -94.15 127.22 39.84 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 10' ' ' ILE . 49.7 pt -132.83 168.04 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.627 0.371 . . . . 0.0 110.677 -173.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -49.14 131.71 19.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.815 0.446 . . . . 0.0 110.15 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.54 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 69.0 t80 -51.55 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.519 1.528 . . . . 0.0 111.697 -170.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.65 104.58 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.627 0.771 . . . . 0.0 109.464 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.76 7.73 9.68 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.055 0.942 . . . . 0.0 111.729 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -93.84 -18.91 21.5 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.189 0.996 . . . . 0.0 111.138 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.615 HG21 HD12 ' A' ' 104' ' ' ILE . 39.2 mm -68.7 129.94 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 122.878 0.471 . . . . 0.0 109.897 -177.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -142.33 172.68 12.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.107 0.963 . . . . 0.0 108.587 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.06 -30.1 65.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.082 0.953 . . . . 0.0 112.99 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.4 p -90.55 23.26 3.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.543 0.737 . . . . 0.0 112.324 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -112.74 162.34 15.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 165.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.685 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 99.8 mtt180 -122.88 159.34 28.41 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.61 93.25 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.95 0.9 . . . . 0.0 109.134 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 38.6 ttpt -90.12 110.32 21.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.549 HG23 HD23 ' A' ' 87' ' ' LEU . 83.9 t -67.36 122.03 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 122.917 0.487 . . . . 0.0 110.517 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 44.0 t -82.33 -39.64 22.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.937 0.895 . . . . 0.0 109.932 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.3 p -143.92 137.2 27.65 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.739 0.816 . . . . 0.0 109.887 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.41 -161.6 25.0 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 123.977 0.798 . . . . 0.0 111.485 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.04 -17.98 40.59 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.186 2.591 . . . . 0.0 112.522 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.7 mt -116.4 27.5 9.17 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.866 0.866 . . . . 0.0 110.223 -177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.14 95.08 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.661 0.785 . . . . 0.0 111.586 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.99 -18.33 5.6 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.072 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -86.85 143.8 27.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.713 0.805 . . . . 0.0 110.201 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 14.0 p -100.94 117.69 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.543 0.687 . . . . 0.0 109.316 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.0 mm? -87.63 142.95 27.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.228 1.011 . . . . 0.0 108.318 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -107.69 139.59 42.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.923 0.889 . . . . 0.0 109.047 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.9 mt -81.14 99.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.701 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 107' ' ' ARG . 23.6 pt -74.26 94.34 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.945 176.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.07 -136.29 12.64 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.595 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -128.35 142.97 46.42 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 124.267 1.027 . . . . 0.0 109.309 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.54 155.53 69.84 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.025 2.483 . . . . 0.0 112.601 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -116.88 107.41 46.15 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -62.76 141.1 83.85 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.678 2.252 . . . . 0.0 112.275 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -69.03 145.49 53.48 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.11 -27.88 67.7 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.606 1.163 . . . . 0.0 112.357 -175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.37 -11.62 54.1 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.763 0.425 . . . . 0.0 111.586 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? 65.42 14.4 9.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.47 1.108 . . . . 0.0 112.67 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.415 HG23 ' HD2' ' A' ' 101' ' ' ARG . 13.5 t -89.8 -2.81 58.31 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.117 0.567 . . . . 0.0 110.872 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.2 OUTLIER -168.57 178.04 4.93 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.629 0.772 . . . . 0.0 110.91 171.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.44 121.53 32.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -178.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -83.72 112.25 19.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 69' ' ' ILE . 22.1 mm -98.11 142.29 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -117.82 133.76 55.61 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.611 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 81.2 m -150.06 161.74 41.77 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.407 -1.27 . . . . 0.0 108.582 -171.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.408 ' HB2' HD13 ' A' ' 90' ' ' ILE . 56.5 ttp180 -144.95 139.85 27.84 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HA ' HD13 ' A' ' 87' ' ' LEU . 27.7 tt0 -48.78 143.29 5.42 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.517 1.136 . . . . 0.0 113.397 -168.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.26 53.9 4.45 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.775 -173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.34 69.02 2.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.949 0.899 . . . . 0.0 108.779 170.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.94 93.56 0.02 OUTLIER 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.736 1.214 . . . . 0.0 111.284 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 tptt . . . . . 0 C--O 1.248 1.024 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -176.134 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.2 mtp . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 62' ' ' TRP . 4.2 m-20 -95.97 122.2 38.54 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.516 1.126 . . . . 0.0 110.855 -169.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 pp -104.95 11.38 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.584 0.754 . . . . 0.0 111.349 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.76 57.83 4.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.928 0.775 . . . . 0.0 111.678 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -66.04 142.36 57.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.142 1.377 . . . . 0.0 111.47 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.457 ' HA ' ' HB2' ' A' ' 38' ' ' SER . 6.4 mp -70.49 117.68 12.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.005 0.922 . . . . 0.0 110.301 -172.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -123.62 -29.26 3.76 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.165 0.986 . . . . 0.0 111.548 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -99.89 -172.82 2.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.341 1.456 . . . . 0.0 110.247 -173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.513 ' HB2' HG22 ' A' ' 79' ' ' THR . 53.4 mtm180 -139.62 146.35 39.66 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 110.409 170.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.83 149.79 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 124.419 1.088 . . . . 0.0 109.048 178.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 m -107.58 126.13 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.18 111.32 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.361 0.665 . . . . 0.0 110.229 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 76.4 mt-30 -95.06 96.7 9.42 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.513 0.725 . . . . 0.0 109.718 172.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -82.07 150.25 27.64 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.109 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 27' ' ' GLU . 51.3 tp -89.3 98.31 11.69 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.8 0.727 . . . . 0.0 109.517 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -85.34 101.59 12.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.611 0.764 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -86.73 86.13 7.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.75 0.82 . . . . 0.0 109.293 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 85.7 m -91.95 126.04 36.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.066 0.946 . . . . 0.0 110.611 -173.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 40.6 ttp180 -79.19 148.14 32.38 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.693 0.282 . . . . 0.0 110.98 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.43 165.76 12.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.226 1.01 . . . . 0.0 108.887 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.7 tt -63.41 -11.09 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.477 0 C-N-CA 124.225 1.01 . . . . 0.0 113.239 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -105.0 -7.07 19.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.57 -0.706 . . . . 0.0 109.33 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.9 50.56 3.67 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.078 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 45.6 mt-10 -108.55 138.38 44.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 108.894 173.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.5 mm -87.94 99.56 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -83.89 109.26 17.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.61 0.764 . . . . 0.0 109.776 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.2 mt-10 -80.0 111.3 16.21 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.3 p -132.69 154.27 50.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.043 . . . . 0.0 108.59 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -103.04 105.24 15.51 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 16.5 pt-20 -84.56 139.81 31.85 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.958 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -84.94 138.32 32.57 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.16 -108.77 2.8 Favored Glycine 0 C--O 1.241 0.576 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -174.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -118.05 142.39 47.45 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.952 0.406 . . . . 0.0 110.465 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.506 HG22 ' HB3' ' A' ' 9' ' ' ARG . 16.2 m -96.14 96.69 8.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.272 1.029 . . . . 0.0 108.57 175.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.2 pt? -105.01 176.28 5.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.154 0.582 . . . . 0.0 111.472 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -71.83 134.91 46.41 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.361 1.064 . . . . 0.0 111.056 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -142.84 168.04 20.66 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 124.112 0.965 . . . . 0.0 110.829 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 23.1 t -123.15 98.69 6.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.63 90.95 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -91.27 97.52 11.17 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.716 0.806 . . . . 0.0 109.495 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -79.85 106.04 11.58 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 46' ' ' GLU . 3.3 m -74.86 138.19 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.358 0.599 . . . . 0.0 111.645 -167.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.4 m -97.36 -174.01 2.81 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 124.456 1.103 . . . . 0.0 109.757 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' HG12 ' A' ' 56' ' ' ILE . 13.2 p -53.8 -43.64 69.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.17 0.988 . . . . 0.0 112.764 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.32 -46.38 83.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.079 0.551 . . . . 0.0 111.456 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 53.1 mm-40 -61.96 -43.26 99.21 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.12 0.568 . . . . 0.0 111.859 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.46 91.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.598 0.759 . . . . 0.0 111.505 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 75.5 mt -76.1 -31.05 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.636 0.774 . . . . 0.0 110.505 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.0 m -71.05 -25.92 62.85 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.482 0.713 . . . . 0.0 110.628 172.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 26.8 t -92.24 -10.65 37.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.151 0.981 . . . . 0.0 110.552 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 -80.14 1.73 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.33 12.11 0.55 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.977 0.911 . . . . 0.0 110.757 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.449 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 35.7 tt0 -75.65 -55.01 6.06 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 58' ' ' THR . 80.3 mt -86.96 166.82 14.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.986 0.514 . . . . 0.0 109.659 168.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.18 160.73 31.99 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.097 0.959 . . . . 0.0 109.208 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 44' ' ' SER . 49.6 mt -69.88 104.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.26 3.63 18.99 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.348 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.62 HG21 HD22 ' A' ' 54' ' ' LEU . 32.2 m -68.44 119.37 12.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.049 0.452 . . . . 0.0 110.444 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -84.05 97.46 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.332 0.653 . . . . 0.0 109.371 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -87.99 125.31 34.47 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 75' ' ' ILE . 86.2 mt -128.72 109.71 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 0.0 109.362 -165.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.595 ' HZ3' ' HB3' ' A' ' 2' ' ' ASN . 15.1 m0 -97.13 113.5 25.08 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 123.561 0.744 . . . . 0.0 109.71 -175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' A' ' 66' ' ' ARG . 41.5 pt -120.58 163.35 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -58.77 149.78 25.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.299 0.5 . . . . 0.0 112.057 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -63.02 124.87 22.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.348 -170.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.571 ' HD3' HD12 ' A' ' 63' ' ' ILE . 10.2 ptm180 -153.46 133.51 13.29 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.485 0.714 . . . . 0.0 109.759 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -83.64 10.27 9.63 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.827 0.851 . . . . 0.0 111.061 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -91.25 -27.28 18.54 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.58 1.152 . . . . 0.0 111.552 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 104' ' ' ILE . 19.0 mm -74.75 137.86 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.923 0.392 . . . . 0.0 110.294 -173.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -137.44 164.73 27.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.025 0.93 . . . . 0.0 108.867 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.08 -22.77 66.06 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.757 0.823 . . . . 0.0 111.914 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.5 p -86.83 28.78 0.86 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.712 0.805 . . . . 0.0 111.636 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 t -126.63 134.61 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -100.31 148.8 24.27 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.47 HG21 HD13 ' A' ' 61' ' ' ILE . 43.2 mm -110.04 108.79 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.692 0.797 . . . . 0.0 109.328 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -100.43 112.93 25.33 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.9 t -68.27 104.49 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.947 0.499 . . . . 0.0 109.744 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.67 -26.39 63.42 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.576 0.75 . . . . 0.0 111.694 -176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.8 t -162.95 135.04 5.27 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.38 -154.53 25.92 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.315 -0.714 . . . . 0.0 112.346 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.09 -20.27 33.47 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.228 2.619 . . . . 0.0 112.31 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 85' ' ' ARG . 84.1 mt -128.23 38.33 4.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.755 0.822 . . . . 0.0 109.995 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.43 97.87 0.15 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.57 -34.93 1.92 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.872 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HD2' ' HB3' ' A' ' 82' ' ' LEU . 75.4 mtt85 -68.57 138.17 54.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.44 0.696 . . . . 0.0 112.195 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 p -108.91 86.9 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 122.643 1.211 . . . . 0.0 108.019 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.61 149.43 43.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 114.066 -1.424 . . . . 0.0 110.803 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -108.99 139.21 44.17 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.513 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -76.91 105.89 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HG23 ' A' ' 58' ' ' THR . 19.6 pt -77.83 74.08 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 122.1 0.952 . . . . 0.0 110.472 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.72 -141.16 13.79 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -127.16 138.39 32.62 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.76 0.824 . . . . 0.0 109.046 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -55.22 142.12 79.12 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.568 2.845 . . . . 0.0 112.53 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.79 119.67 29.93 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.52 155.18 59.8 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.589 2.192 . . . . 0.0 112.163 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.65 151.42 46.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.189 0.596 . . . . 0.0 110.574 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -41.02 88.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.403 1.081 . . . . 0.0 111.802 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 -3.92 57.18 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.427 0.691 . . . . 0.0 111.891 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 63.61 15.9 9.26 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.905 1.282 . . . . 0.0 113.114 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.1 t -82.06 -7.48 59.62 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 120.951 0.405 . . . . 0.0 111.172 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.416 ' NH1' ' HB2' ' A' ' 103' ' ' GLU . 4.6 ppt_? -162.7 169.69 19.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.722 0.809 . . . . 0.0 109.11 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.28 131.33 56.54 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HB2' ' NH1' ' A' ' 101' ' ' ARG . 33.3 tt0 -100.28 114.77 28.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.187 0.518 . . . . 0.0 109.902 177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 69' ' ' ILE . 15.4 mm -93.97 136.44 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.657 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -109.48 130.64 55.49 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.418 ' SG ' HG22 ' A' ' 104' ' ' ILE . 82.7 m -147.36 171.21 15.81 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.891 0.877 . . . . 0.0 108.66 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' HB2' HD13 ' A' ' 90' ' ' ILE . 64.1 ttt180 -158.47 160.52 36.85 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.598 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -64.0 146.38 54.21 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.641 1.176 . . . . 0.0 110.278 173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.05 48.61 3.47 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 51.39 -95.47 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.736 1.615 . . . . 0.0 112.287 -175.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -168.57 26.1 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.976 1.31 . . . . 0.0 108.467 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.777 1.231 . . . . 0.0 109.448 -173.386 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 ttm . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -74.23 122.74 23.31 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 mt -129.5 170.75 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.124 1.369 . . . . 0.0 107.329 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.67 56.67 2.56 Favored Glycine 0 C--N 1.351 1.387 0 C-N-CA 123.419 0.533 . . . . 0.0 112.959 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -82.21 -25.26 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.922 1.289 . . . . 0.0 109.833 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 mt -70.28 97.74 1.28 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.606 0.762 . . . . 0.0 109.531 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -105.55 -33.3 8.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.422 0.689 . . . . 0.0 110.138 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -96.23 -174.13 2.99 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.594 1.158 . . . . 0.0 110.116 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HG2' HG22 ' A' ' 34' ' ' THR . 53.8 ttp180 -154.1 123.38 6.5 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -116.18 159.07 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.632 0.773 . . . . 0.0 110.142 -178.037 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -109.67 146.02 35.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.368 0.667 . . . . 0.0 109.329 168.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -101.26 107.2 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.486 1.114 . . . . 0.0 110.08 -175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -77.69 95.41 4.61 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 p -80.15 152.08 29.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.505 0.722 . . . . 0.0 109.82 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 27' ' ' GLU . 27.9 tp -92.41 97.59 10.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.323 0.583 . . . . 0.0 110.992 -171.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -76.83 95.19 4.01 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.095 0.958 . . . . 0.0 109.644 173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.4 104.86 14.78 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.8 m -111.83 116.23 30.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 -169.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -85.96 140.17 30.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 122.607 0.363 . . . . 0.0 110.791 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -99.81 178.39 4.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 109.613 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.7 tt -50.45 -46.68 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.357 1.063 . . . . 0.0 113.298 -172.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -105.85 12.79 30.34 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.89 23.58 7.37 Favored Glycine 0 C--N 1.356 1.682 0 N-CA-C 115.17 0.828 . . . . 0.0 115.17 165.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -77.94 119.57 21.58 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.1 mm -88.15 87.33 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.66 92.62 0.87 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.685 0.794 . . . . 0.0 109.565 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.593 ' HB3' HD11 ' A' ' 15' ' ' LEU . 50.2 mt-10 -79.76 94.17 5.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -101.44 143.86 30.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.48 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -94.02 93.39 7.83 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.7 112.4 14.49 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.11 103.93 0.33 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.964 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.89 -109.41 2.07 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.451 -0.795 . . . . 0.0 113.683 -160.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -106.76 146.72 30.51 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.603 0.761 . . . . 0.0 111.254 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.476 HG22 ' HG2' ' A' ' 9' ' ' ARG . 4.6 m -106.76 140.59 39.36 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.626 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -153.82 158.18 40.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.432 0.693 . . . . 0.0 110.684 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -61.43 149.04 39.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.106 0.962 . . . . 0.0 112.041 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -155.29 169.47 24.12 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.368 0.667 . . . . 0.0 111.385 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 14.7 t -128.58 91.37 3.22 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -76.95 96.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.407 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -107.52 99.37 8.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.499 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.473 ' SD ' HD21 ' A' ' 82' ' ' LEU . 48.7 mtp -73.11 142.03 47.52 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.84 159.71 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.522 0.729 . . . . 0.0 112.518 -171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.64 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.2 m -93.31 -178.46 4.76 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.13 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . 34.9 p -72.23 -20.99 61.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.065 0.546 . . . . 0.0 111.56 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 20.6 ptmt -53.56 -41.7 66.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.352 1.061 . . . . 0.0 113.193 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 -31.71 49.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.457 0.703 . . . . 0.0 110.868 -172.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.87 -46.99 85.27 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.672 0.789 . . . . 0.0 110.357 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.3 mt -68.72 -34.67 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -68.85 -49.42 58.51 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.84 0.856 . . . . 0.0 111.304 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 23.7 m -93.64 1.17 56.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.65 -79.01 1.44 Allowed Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.24 -0.344 . . . . 0.0 112.24 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.31 -17.67 2.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.02 0.928 . . . . 0.0 111.241 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 33.3 tt0 -57.37 -50.31 73.36 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.293 0.637 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.9 mt -103.0 158.14 16.49 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.899 171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.19 153.41 25.68 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.232 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 44' ' ' SER . 31.0 mt -65.4 128.05 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.2 -8.42 18.32 Favored Glycine 0 N--CA 1.474 1.17 0 O-C-N 123.213 0.321 . . . . 0.0 112.77 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 90' ' ' ILE . 40.8 m -68.93 139.49 55.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.308 0.643 . . . . 0.0 109.309 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.9 t -124.68 103.24 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -81.64 98.93 8.6 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -98.67 106.29 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.512 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 9.1 m0 -88.32 113.37 23.85 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.742 -174.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.2 pt -112.96 -171.34 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.78 0.832 . . . . 0.0 108.899 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.1 mtt180 -86.94 158.46 19.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.491 0.316 . . . . 0.0 110.456 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 70.1 t80 -60.66 97.44 0.05 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.522 1.129 . . . . 0.0 112.039 -172.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 ttm180 -120.77 104.81 10.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.633 0.773 . . . . 0.0 109.501 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -68.92 -0.4 5.52 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -92.04 -20.57 21.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.603 0.761 . . . . 0.0 110.834 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.49 HG21 HD12 ' A' ' 104' ' ' ILE . 48.0 mm -66.18 128.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.45 164.9 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.7 1.2 . . . . 0.0 108.56 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.23 65.4 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.451 0.7 . . . . 0.0 111.22 173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.1 p -87.4 40.19 0.91 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.166 0.986 . . . . 0.0 110.877 174.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -141.72 145.81 35.3 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.115 0.966 . . . . 0.0 108.861 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -108.8 138.7 44.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 104' ' ' ILE . 22.3 mm -107.33 90.75 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 33.7 ttmt -83.71 115.85 22.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.687 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 97.4 t -72.85 99.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.9 m -71.04 -26.46 63.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 111.566 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.4 t -155.49 140.73 17.57 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.942 0.897 . . . . 0.0 108.733 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.65 -154.68 26.08 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-O 119.371 -0.683 . . . . 0.0 113.313 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.62 -37.5 21.67 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.704 2.269 . . . . 0.0 111.369 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.601 HD13 HD11 ' A' ' 87' ' ' LEU . 89.0 mt -103.89 42.12 1.22 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.476 1.11 . . . . 0.0 109.74 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.63 101.48 0.25 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.863 0.865 . . . . 0.0 111.602 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.88 -19.13 11.3 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.412 1.006 . . . . 0.0 112.307 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 82' ' ' LEU . 92.7 mtt180 -83.13 141.16 32.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.478 0.711 . . . . 0.0 111.241 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 51.4 t -103.0 106.99 21.07 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 124.834 1.254 . . . . 0.0 108.408 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.6 mm? -90.07 128.73 36.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.527 0.731 . . . . 0.0 109.167 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.9 OUTLIER -97.82 119.0 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.282 0.633 . . . . 0.0 110.059 -173.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 106' ' ' CYS . 45.6 mt -56.36 134.31 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.417 0.687 . . . . 0.0 111.26 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.675 HG21 ' HE ' ' A' ' 107' ' ' ARG . 11.5 pt -112.1 96.34 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.505 0.722 . . . . 0.0 109.724 175.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.27 -84.76 0.37 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.126 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -170.33 158.83 6.15 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.212 1.005 . . . . 0.0 109.523 -172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.463 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 57.8 Cg_endo -69.62 125.07 11.79 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.23 1.953 . . . . 0.0 111.57 171.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -103.93 109.47 62.35 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.063 0.945 . . . . 0.0 109.508 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.29 150.5 53.01 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.693 2.262 . . . . 0.0 111.04 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.73 175.11 7.5 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.3 67.13 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.385 0.674 . . . . 0.0 112.508 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.89 -13.55 31.09 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.369 0.668 . . . . 0.0 112.528 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.52 26.07 15.87 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.391 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 t -82.25 -25.5 34.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.299 0.639 . . . . 0.0 110.012 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -138.83 168.59 19.48 Favored 'General case' 0 C--O 1.251 1.152 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 65' ' ' TYR . 15.4 tp -128.54 108.22 10.35 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.95 109.78 18.41 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.549 HG21 HG13 ' A' ' 75' ' ' ILE . 13.1 mm -90.09 102.88 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.684 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.4 pt? -81.12 105.13 12.09 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.182 0.991 . . . . 0.0 108.362 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 61.5 m -110.57 179.99 3.92 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.921 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.675 ' HE ' HG21 ' A' ' 90' ' ' ILE . 21.4 ttp85 -146.39 140.65 26.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -62.67 118.92 8.3 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.751 0.657 . . . . 0.0 111.096 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.78 41.84 3.05 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.607 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -145.02 29.06 1.21 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.386 1.474 . . . . 0.0 108.356 174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -73.89 76.81 1.64 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.458 1.503 . . . . 0.0 110.718 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? . . . . . 0 C--O 1.251 1.181 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.714 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -86.24 112.67 21.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.374 0.669 . . . . 0.0 109.537 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 mm -75.89 149.47 6.77 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.22 59.32 2.33 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 123.376 0.512 . . . . 0.0 112.588 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -58.59 -36.5 74.09 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.034 1.333 . . . . 0.0 111.579 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 54.3 mt -69.57 80.01 0.41 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 124.231 0.957 . . . . 0.0 110.574 -175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -91.25 -26.95 18.75 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.922 1.289 . . . . 0.0 110.896 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -106.22 -172.64 2.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.609 1.564 . . . . 0.0 109.719 -174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HG2' HG22 ' A' ' 34' ' ' THR . 14.6 ttp180 -155.77 138.75 15.4 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.879 0.872 . . . . 0.0 108.776 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.752 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -134.01 144.93 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.387 0.675 . . . . 0.0 111.122 -173.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -92.0 120.93 33.1 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.524 1.13 . . . . 0.0 109.902 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.43 95.52 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -73.59 99.26 3.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.039 0.447 . . . . 0.0 109.928 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 p -79.87 146.42 32.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.603 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.645 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.5 tp -92.86 106.77 18.68 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 122.75 0.42 . . . . 0.0 110.333 -172.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -94.69 101.87 13.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.52 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 48.6 mt-30 -77.56 93.95 4.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.58 0.752 . . . . 0.0 109.164 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.2 m -92.78 123.52 36.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.347 1.059 . . . . 0.0 110.404 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -74.59 163.13 28.09 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.031 0.532 . . . . 0.0 110.96 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -110.28 165.0 12.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.465 1.106 . . . . 0.0 108.502 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.2 -15.84 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 p -95.84 -6.69 38.84 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.1 6.39 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.077 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -116.08 136.28 53.17 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.132 0.973 . . . . 0.0 108.827 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mm -91.35 120.22 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.4 123.9 51.31 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.06 0.944 . . . . 0.0 109.707 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.645 ' HB3' HD11 ' A' ' 15' ' ' LEU . 3.5 mp0 -81.57 116.92 21.56 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.781 0.833 . . . . 0.0 110.118 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 p -130.92 153.04 49.59 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.109 0.964 . . . . 0.0 108.806 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -110.4 108.86 19.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.503 0.721 . . . . 0.0 109.491 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -93.03 133.8 35.81 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -64.7 127.46 31.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.15 -113.75 3.8 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -99.61 124.93 45.28 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.427 0.691 . . . . 0.0 109.847 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 10.1 m -101.04 94.88 6.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -117.04 168.51 10.19 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.206 0.602 . . . . 0.0 111.773 -174.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 35.7 m95 -64.19 136.36 57.14 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.916 0.886 . . . . 0.0 112.573 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -139.24 165.97 25.78 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.295 1.038 . . . . 0.0 111.672 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 62' ' ' TRP . 22.5 t -120.42 92.12 3.7 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 166.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.7 t -90.72 98.19 8.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.016 0.926 . . . . 0.0 108.951 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -119.07 116.04 25.55 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.546 0.738 . . . . 0.0 109.408 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.532 ' HG2' HG22 ' A' ' 59' ' ' VAL . 81.9 mtp -65.9 130.7 44.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.644 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 22.3 m -70.54 146.0 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 120.826 0.346 . . . . 0.0 111.021 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 t -84.53 174.78 9.74 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 42.6 p -60.73 -25.92 66.8 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -26.1 68.25 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.644 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 16.3 mm-40 -68.2 -41.46 81.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.156 0.582 . . . . 0.0 110.719 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.15 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.907 0.754 . . . . 0.0 110.86 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.3 mt -64.86 -40.31 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.366 0.666 . . . . 0.0 110.521 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.0 m -66.48 -49.74 65.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.687 0.795 . . . . 0.0 111.943 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 76.6 p -91.42 -19.48 22.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.462 0.705 . . . . 0.0 112.39 -171.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -69.34 2.22 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.56 -15.04 1.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.426 0.691 . . . . 0.0 112.036 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 24.4 mm-40 -59.82 -43.75 94.36 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.2 0.6 . . . . 0.0 111.297 -177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.4 mt -108.94 149.33 29.35 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -121.55 167.46 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.814 0.846 . . . . 0.0 109.644 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 mt -76.28 114.22 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.17 4.76 59.73 Favored Glycine 0 N--CA 1.467 0.706 0 CA-C-O 119.625 -0.542 . . . . 0.0 112.95 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.525 HG23 HD11 ' A' ' 90' ' ' ILE . 18.3 m -56.54 113.74 1.74 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.293 0.568 . . . . 0.0 109.753 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 41' ' ' MET . 49.3 t -73.18 107.25 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.189 -169.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -90.98 134.02 34.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 80.7 mt -133.35 108.39 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -168.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 32.5 m0 -91.25 124.3 35.36 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 123.528 0.731 . . . . 0.0 110.0 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 pt -131.35 163.84 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -52.21 149.71 5.16 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.746 0.418 . . . . 0.0 111.627 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -56.83 108.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.017 0.823 . . . . 0.0 109.968 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 46.9 ttt85 -135.96 116.69 14.01 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -168.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -84.44 9.05 14.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.625 1.17 . . . . 0.0 111.739 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 20.9 t70 -92.85 -19.57 21.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.245 1.418 . . . . 0.0 110.495 -175.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 13.2 mm -84.32 139.94 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.483 0.713 . . . . 0.0 109.577 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -130.65 166.48 20.6 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.76 -23.71 66.79 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.411 0.684 . . . . 0.0 111.437 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.9 p -85.44 41.93 0.92 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.191 0.996 . . . . 0.0 110.433 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 m -131.72 147.57 52.51 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 123.778 0.831 . . . . 0.0 109.081 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 51.0 mtm180 -115.17 120.99 41.61 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 104' ' ' ILE . 18.2 mm -88.4 91.28 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.32 1.048 . . . . 0.0 109.507 -173.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -91.18 120.18 31.9 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 87' ' ' LEU . 88.7 t -71.38 122.28 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.824 0.345 . . . . 0.0 110.147 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -89.44 -30.53 18.25 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.477 1.111 . . . . 0.0 109.583 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.0 m -143.57 110.51 5.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.065 -165.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 150.68 -170.08 30.52 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.82 -0.434 . . . . 0.0 113.736 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.26 -29.0 26.98 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.839 2.359 . . . . 0.0 111.735 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.3 mt -98.26 22.14 9.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.656 0.782 . . . . 0.0 111.018 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.14 124.32 19.89 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.005 0.522 . . . . 0.0 110.715 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.19 -21.08 34.17 Favored Glycine 0 N--CA 1.468 0.823 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.111 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -88.88 143.24 27.01 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.439 0.695 . . . . 0.0 110.744 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -105.99 100.44 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 122.194 0.997 . . . . 0.0 109.54 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.554 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -83.24 113.08 20.43 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.953 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.7 OUTLIER -83.8 139.8 32.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 109.094 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 75' ' ' ILE . 63.1 mt -78.53 108.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.525 HD11 HG23 ' A' ' 58' ' ' THR . 18.5 pt -92.16 61.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-O 122.152 0.977 . . . . 0.0 110.133 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.92 -122.03 1.12 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.426 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -150.88 143.82 16.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.976 0.91 . . . . 0.0 109.139 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.69 111.97 1.12 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.564 2.176 . . . . 0.0 110.499 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.47 117.43 36.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.128 0.971 . . . . 0.0 108.845 -167.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.56 158.57 49.12 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.574 2.183 . . . . 0.0 112.367 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -79.1 -174.54 4.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.837 0.455 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.08 -48.01 66.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.487 0.715 . . . . 0.0 111.705 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.57 -7.97 58.86 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.598 0.759 . . . . 0.0 112.798 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 71.39 14.33 6.44 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.3 t -85.05 -1.72 57.16 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.315 1.046 . . . . 0.0 112.236 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -163.41 161.32 24.3 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.812 0.815 . . . . 0.0 110.129 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.74 109.21 21.08 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -90.67 108.87 20.09 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.455 0.645 . . . . 0.0 109.666 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 75' ' ' ILE . 9.3 mm -88.45 145.38 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.1 pt? -120.48 132.93 55.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 60.2 m -153.76 175.64 13.06 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.34 0.656 . . . . 0.0 111.017 -169.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.6 166.62 22.22 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.927 1.291 . . . . 0.0 108.497 169.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 54.3 mp0 -73.22 156.16 38.83 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 173.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.63 28.3 16.47 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -172.54 34.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.788 1.235 . . . . 0.0 109.281 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -60.95 -16.71 45.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.969 1.308 . . . . 0.0 112.456 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.505 1.122 . . . . 0.0 110.678 175.35 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -142.64 126.04 16.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.461 0.704 . . . . 0.0 109.412 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.667 HG22 ' H ' ' A' ' 5' ' ' ARG . 63.3 mt -63.16 129.89 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.99 22.34 8.34 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-O 119.131 -0.816 . . . . 0.0 113.576 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.667 ' H ' HG22 ' A' ' 3' ' ' ILE . 10.3 mpt_? 59.39 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.071 1.748 . . . . 0.0 113.472 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.91 164.3 26.33 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.085 1.354 . . . . 0.0 111.567 -172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -129.44 -30.06 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.663 0.785 . . . . 0.0 111.839 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -109.96 -166.91 1.13 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.045 1.738 . . . . 0.0 109.858 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 79' ' ' THR . 25.1 ttm180 -152.78 140.92 20.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.939 0.896 . . . . 0.0 109.166 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.15 156.78 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.804 0.842 . . . . 0.0 110.014 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -103.37 123.14 46.27 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.484 1.114 . . . . 0.0 108.992 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.19 108.95 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -85.83 111.41 20.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.71 0.767 . . . . 0.0 110.308 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.9 p -84.75 142.7 29.64 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.782 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.1 tp -97.85 113.88 25.8 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.748 0.819 . . . . 0.0 109.634 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' NZ ' ' HB3' ' A' ' 16' ' ' LYS . 5.6 ttpm? -99.77 113.19 25.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.797 0.839 . . . . 0.0 109.657 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.4 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.3 mt-30 -86.56 103.35 14.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.799 0.84 . . . . 0.0 109.402 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.3 m -93.9 165.16 12.8 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -114.1 165.95 12.12 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.859 0.754 . . . . 0.0 109.835 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -108.72 161.8 14.76 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.52 -14.21 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 p -103.25 -10.16 18.97 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.661 -0.649 . . . . 0.0 109.255 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.66 15.42 20.76 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.238 -0.892 . . . . 0.0 115.32 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -93.78 145.35 24.65 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.534 1.167 . . . . 0.0 109.485 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.51 122.48 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.312 0.645 . . . . 0.0 111.15 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mp -96.84 108.48 21.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.339 1.056 . . . . 0.0 108.565 175.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HB3' HD11 ' A' ' 15' ' ' LEU . 44.4 mt-10 -80.96 107.1 13.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.371 0.669 . . . . 0.0 109.605 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -114.68 146.49 40.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.755 0.822 . . . . 0.0 110.2 -175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -111.18 106.23 15.18 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.698 -171.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -106.1 143.86 33.63 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -71.78 137.94 48.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.821 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.26 -116.67 3.77 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -99.08 137.35 37.73 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.1 m -108.82 96.73 6.53 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.767 0.827 . . . . 0.0 108.855 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.59 175.24 5.57 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.38 0.609 . . . . 0.0 111.276 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -70.69 135.42 48.29 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.477 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.5 173.75 11.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.336 1.054 . . . . 0.0 111.074 172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.2 m -130.38 96.25 4.1 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 160.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.571 HG23 HG12 ' A' ' 61' ' ' ILE . 2.6 p -94.41 102.36 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -173.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.27 122.58 44.36 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.779 0.831 . . . . 0.0 109.123 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 82' ' ' LEU . 72.1 mtp -72.22 145.93 47.64 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 m -68.1 134.51 30.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 t -83.45 176.33 9.15 Favored 'General case' 0 C--O 1.248 0.986 0 C-N-CA 123.53 0.732 . . . . 0.0 109.776 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 p -60.13 -31.12 69.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -56.56 -49.67 74.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.671 0.788 . . . . 0.0 111.012 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.58 -44.07 91.83 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.845 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.98 -45.68 90.01 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 124.281 0.988 . . . . 0.0 112.438 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.93 -46.85 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.332 0.653 . . . . 0.0 111.217 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.5 m -65.6 -29.09 69.63 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.642 0.777 . . . . 0.0 112.216 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 89.8 p -90.6 -17.42 26.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.521 0.728 . . . . 0.0 111.996 -178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.02 -79.21 1.72 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.74 12.09 2.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.292 0.637 . . . . 0.0 111.05 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.4 tp10 -77.87 -53.55 7.35 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.531 HD22 HG21 ' A' ' 58' ' ' THR . 81.1 mt -106.49 147.22 29.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.862 0.865 . . . . 0.0 108.808 173.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.28 158.75 41.02 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 174.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.1 mt -62.63 120.39 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.64 -11.12 13.99 Favored Glycine 0 N--CA 1.477 1.399 0 O-C-N 123.383 0.427 . . . . 0.0 112.59 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.531 HG21 HD22 ' A' ' 54' ' ' LEU . 25.4 m -71.88 140.21 49.17 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 166.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 38.7 t -122.67 122.28 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.494 0.718 . . . . 0.0 110.482 -176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -93.81 135.89 34.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 75' ' ' ILE . 66.1 mt -132.6 107.98 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -95.77 116.02 28.29 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.257 -175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.3 pt -122.23 159.06 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -55.69 136.64 50.58 Favored 'General case' 0 CA--C 1.562 1.434 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 168.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.415 ' HB3' ' NH1' ' A' ' 64' ' ' ARG . 56.0 t80 -48.17 114.66 0.98 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.568 1.547 . . . . 0.0 113.212 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -138.23 119.61 14.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.78 0.832 . . . . 0.0 109.231 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -79.84 7.57 8.49 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.8 0.44 . . . . 0.0 110.992 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -91.34 -22.89 20.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.337 0.655 . . . . 0.0 110.183 -177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -68.91 130.81 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.71 162.67 23.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.708 0.803 . . . . 0.0 109.171 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.96 -15.64 63.54 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.302 0.641 . . . . 0.0 112.052 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.2 p -83.16 2.82 33.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.563 0.745 . . . . 0.0 111.649 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 m -101.31 137.74 39.24 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -106.17 134.77 48.77 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.633 HG21 HG21 ' A' ' 61' ' ' ILE . 30.3 mm -94.07 102.63 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 123.041 0.536 . . . . 0.0 110.077 -175.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.4 ttpt -103.78 112.72 25.8 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.62 120.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.24 0.616 . . . . 0.0 111.594 -173.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -79.45 -31.9 42.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.696 1.199 . . . . 0.0 111.749 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 9' ' ' ARG . 11.7 t -160.51 142.79 12.84 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.14 -160.63 24.42 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 119.006 -0.886 . . . . 0.0 111.832 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.49 -27.36 46.59 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.911 2.407 . . . . 0.0 112.639 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 41' ' ' MET . 54.9 mt -115.77 31.64 6.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.723 0.809 . . . . 0.0 111.156 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.02 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.494 0.718 . . . . 0.0 111.476 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.58 -19.0 4.83 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.082 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HD2' HD22 ' A' ' 82' ' ' LEU . 91.4 mtt-85 -86.51 142.69 28.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.291 0.637 . . . . 0.0 111.159 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' O ' ' HA3' ' A' ' 109' ' ' GLY . 4.5 p -107.25 95.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.026 0.917 . . . . 0.0 108.995 172.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 108' ' ' GLU . 1.2 mm? -77.33 128.38 34.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.433 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -99.7 141.5 32.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.744 . . . . 0.0 109.17 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.62 122.78 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.4 pt -100.02 86.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.12 -94.18 0.54 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -159.15 145.83 12.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 123.964 0.905 . . . . 0.0 110.041 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -65.39 114.89 3.06 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.835 2.357 . . . . 0.0 111.128 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.94 108.76 48.16 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.876 0.87 . . . . 0.0 109.346 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -69.1 143.93 55.77 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.057 2.505 . . . . 0.0 112.331 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.41 168.9 19.24 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.194 0.452 . . . . 0.0 110.723 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.91 -27.5 65.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.005 0.922 . . . . 0.0 112.877 -174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.4 -7.25 42.12 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 62.13 29.78 17.63 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.447 1.099 . . . . 0.0 111.491 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.6 p -90.55 -17.98 26.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.881 0.873 . . . . 0.0 111.434 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -158.78 171.15 20.61 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.616 0.722 . . . . 0.0 110.78 -168.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.57 113.07 17.58 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -78.78 96.25 5.56 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.589 HG22 ' SG ' ' A' ' 106' ' ' CYS . 22.8 mm -88.71 97.16 6.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.702 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -79.01 130.51 35.61 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.077 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 104' ' ' ILE . 84.7 m -147.78 173.14 13.08 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.376 1.07 . . . . 0.0 108.875 -170.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -138.41 153.71 48.88 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 87' ' ' LEU . 38.3 tt0 -44.33 125.73 4.79 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.724 0.81 . . . . 0.0 112.848 173.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 86' ' ' VAL . . . -89.87 52.0 3.56 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.472 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.54 142.22 48.53 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.109 0.964 . . . . 0.0 108.885 174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -74.44 -28.7 61.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.669 0.388 . . . . 0.0 110.532 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.1 tttm . . . . . 0 C--O 1.249 1.054 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.736 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.31 150.29 35.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.303 1.041 . . . . 0.0 109.016 174.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.7 pt -81.13 34.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 C-N-CA 124.001 0.921 . . . . 0.0 112.174 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.04 50.29 4.38 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.296 0.474 . . . . 0.0 114.047 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -146.18 170.92 15.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.178 0.991 . . . . 0.0 109.064 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 37' ' ' ALA . 43.7 mt -115.67 117.89 31.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.186 0.594 . . . . 0.0 109.733 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -123.08 -28.63 4.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.388 0.675 . . . . 0.0 111.775 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -101.82 -174.18 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.525 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.446 ' HB2' HG22 ' A' ' 79' ' ' THR . 94.2 mtt180 -136.38 142.22 43.74 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.68 0.792 . . . . 0.0 109.601 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 34' ' ' THR . 49.3 pt -133.71 166.01 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.898 1.279 . . . . 0.0 108.779 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m -132.81 134.93 45.32 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 73' ' ' SER . 51.4 mm -81.91 116.46 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.674 0.609 . . . . 0.0 109.666 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -89.98 104.26 16.84 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.39 139.37 34.09 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.927 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.4 tp -89.51 98.62 11.87 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.226 0.467 . . . . 0.0 109.902 -174.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -79.2 99.31 6.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 110.312 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 51.5 mt-30 -96.56 79.37 3.03 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.1 m -98.58 126.08 44.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.043 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 28.7 ttp180 -76.64 162.32 27.84 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.185 0.994 . . . . 0.0 111.482 -175.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 11.3 t70 -113.65 164.35 13.8 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.733 0.813 . . . . 0.0 109.835 -173.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.2 tt -63.49 -14.62 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.669 0.788 . . . . 0.0 112.859 172.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 p -100.53 -20.15 15.85 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.91 39.97 3.22 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 114.373 -1.285 . . . . 0.0 113.007 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 28.6 mm-40 -97.44 146.72 24.93 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.813 0.845 . . . . 0.0 108.921 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.8 100.32 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.38 92.13 7.48 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB3' HD11 ' A' ' 15' ' ' LEU . 38.5 mt-10 -82.63 106.29 14.36 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.987 0.915 . . . . 0.0 109.046 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -126.05 165.48 18.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.447 1.099 . . . . 0.0 109.474 -172.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.69 102.73 10.3 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.362 0.601 . . . . 0.0 109.74 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.28 121.59 29.94 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.787 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.51 126.28 26.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.839 173.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.55 -112.77 3.6 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 -170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -120.53 133.72 55.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.143 0.577 . . . . 0.0 109.944 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 33.6 m -85.31 107.45 17.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.53 0.732 . . . . 0.0 109.693 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.1 pt? -108.06 164.53 12.2 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 0.0 110.863 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -75.86 130.4 38.49 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.608 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' HA ' HD22 ' A' ' 6' ' ' LEU . . . -147.24 -176.51 5.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.816 0.846 . . . . 0.0 111.268 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.9 m -134.27 104.33 6.12 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 162.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.536 HG11 HG23 ' A' ' 77' ' ' VAL . 2.3 p -105.61 114.42 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.962 0.905 . . . . 0.0 109.186 -172.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -136.14 153.62 51.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.167 1.387 . . . . 0.0 109.521 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 82' ' ' LEU . 76.6 mtp -85.17 136.33 33.58 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 169.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 58' ' ' THR . 20.2 m -68.45 137.45 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 m -97.22 -173.94 2.81 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 123.86 0.864 . . . . 0.0 110.865 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.5 p -54.48 -34.44 61.58 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.268 1.027 . . . . 0.0 112.182 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -51.76 -52.62 47.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.856 0.863 . . . . 0.0 110.902 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.42 -41.58 76.16 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.447 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.93 78.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.619 . . . . 0.0 112.353 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -69.23 -33.75 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.678 0.791 . . . . 0.0 110.795 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 t -71.91 -44.34 63.85 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.331 0.652 . . . . 0.0 111.552 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 73.6 p -104.33 0.28 29.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.29 0.636 . . . . 0.0 112.479 -174.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.77 -70.39 2.93 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.04 -2.53 0.46 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.09 0.556 . . . . 0.0 112.206 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 38.0 tt0 -65.07 -50.94 64.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.108 0.563 . . . . 0.0 110.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.4 mt -111.06 60.79 0.61 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.47 156.63 26.48 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -62.82 122.83 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -171.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.38 -13.04 16.04 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.695 0.665 . . . . 0.0 112.031 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 87.3 m -79.65 139.46 37.4 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 168.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.51 HG11 ' HG ' ' A' ' 87' ' ' LEU . 42.8 t -110.67 116.5 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.46 0.704 . . . . 0.0 110.914 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -83.67 128.42 34.51 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.628 1.171 . . . . 0.0 110.408 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.529 HD12 ' SG ' ' A' ' 106' ' ' CYS . 51.3 mt -135.19 110.02 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -98.98 131.69 44.85 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.109 0.564 . . . . 0.0 110.438 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.1 pt -130.29 161.04 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -63.75 151.04 43.19 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 164.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -53.49 118.64 4.03 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.034 0.934 . . . . 0.0 111.157 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.45 HH11 HD13 ' A' ' 35' ' ' LEU . 56.4 ttt180 -136.86 128.08 28.03 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -83.75 1.83 40.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.275 1.03 . . . . 0.0 112.457 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.89 -21.76 19.65 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.489 0.716 . . . . 0.0 111.31 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 104' ' ' ILE . 25.5 mm -81.0 131.36 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.85 0.357 . . . . 0.0 110.249 -170.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -131.66 158.65 40.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.092 0.957 . . . . 0.0 109.747 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.99 -25.82 66.5 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.047 0.939 . . . . 0.0 112.312 -177.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -84.13 8.9 14.08 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.795 0.838 . . . . 0.0 111.758 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 12' ' ' ILE . 22.8 m -111.5 120.02 40.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.607 0.763 . . . . 0.0 109.177 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -83.1 136.88 34.31 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.78 0.432 . . . . 0.0 110.41 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 61' ' ' ILE . 33.1 mm -96.36 101.8 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 0.0 110.114 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 29.9 ttpt -90.31 120.0 31.08 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.241 0.616 . . . . 0.0 109.982 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.536 HG23 HG11 ' A' ' 39' ' ' VAL . 2.7 p -73.55 115.62 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 123.347 0.659 . . . . 0.0 110.805 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -81.3 -24.8 36.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.865 0.866 . . . . 0.0 111.814 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 9' ' ' ARG . 10.6 t -168.24 137.86 2.48 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 123.857 0.863 . . . . 0.0 108.725 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.37 -165.96 29.53 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.462 -174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.15 -9.02 22.93 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 123.388 2.725 . . . . 0.0 112.656 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 41' ' ' MET . 79.9 mt -119.08 6.66 11.29 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.169 0.988 . . . . 0.0 111.2 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -42.5 115.04 0.65 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.846 1.258 . . . . 0.0 113.58 -165.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.84 -11.02 25.22 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.48 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -94.77 172.58 8.08 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.207 0.504 . . . . 0.0 110.593 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 42.5 t -124.08 114.08 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.307 0.643 . . . . 0.0 109.645 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.612 HD11 HD13 ' A' ' 82' ' ' LEU . 0.5 OUTLIER -90.25 140.84 29.29 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.0 143.71 32.22 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -77.52 130.61 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 107' ' ' ARG . 29.7 pt -102.5 128.23 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 122.881 0.472 . . . . 0.0 109.82 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.02 -93.34 1.18 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.936 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 12.2 pt20 -161.51 156.35 19.97 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.399 1.08 . . . . 0.0 108.878 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.1 109.87 2.28 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.871 1.714 . . . . 0.0 110.274 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.4 113.31 38.21 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.32 1.048 . . . . 0.0 108.949 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.58 144.55 32.02 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.335 2.023 . . . . 0.0 111.665 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -60.76 149.57 35.21 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.415 0.686 . . . . 0.0 112.09 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.04 -28.77 65.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.032 0.933 . . . . 0.0 110.978 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.69 -5.46 45.47 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.591 0.756 . . . . 0.0 111.368 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? 61.31 18.72 9.5 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.837 1.255 . . . . 0.0 113.377 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -81.28 -10.49 59.57 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.361 0.528 . . . . 0.0 111.28 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -155.6 -179.13 7.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.349 0.595 . . . . 0.0 110.853 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -137.64 112.22 8.78 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 175.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.0 97.78 2.92 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.0 mm -85.31 86.96 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -79.11 136.03 37.02 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.529 ' SG ' HD12 ' A' ' 61' ' ' ILE . 62.9 m -146.41 170.25 17.21 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -172.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' HB2' HD13 ' A' ' 90' ' ' ILE . 37.2 ttp180 -142.16 144.49 33.47 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 172.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -41.6 118.95 1.16 Allowed 'General case' 0 C--N 1.362 1.11 0 O-C-N 124.43 1.081 . . . . 0.0 110.998 -177.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.44 51.01 3.32 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.927 -165.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.45 89.9 0.52 Allowed 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.107 0.563 . . . . 0.0 109.656 171.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.538 ' HG3' ' HG2' ' A' ' 112' ' ' LYS . 9.3 pt-20 -71.83 -31.66 66.75 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.657 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HG2' ' HG3' ' A' ' 111' ' ' GLU . 24.3 pttm . . . . . 0 C--O 1.254 1.291 0 C-N-CA 123.85 0.86 . . . . 0.0 109.223 -175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -148.6 -168.63 3.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.436 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.8 mm -75.33 89.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.49 50.89 3.59 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.798 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -68.68 138.21 54.77 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.045 0.938 . . . . 0.0 110.298 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.87 81.31 7.16 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.854 0.835 . . . . 0.0 108.783 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.09 -22.55 45.1 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.651 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -103.6 -175.39 2.79 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.573 1.149 . . . . 0.0 110.283 -175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 34' ' ' THR . 51.6 mtm180 -141.38 148.25 39.33 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.801 1.241 . . . . 0.0 109.399 172.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -140.79 145.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.891 0.876 . . . . 0.0 108.687 177.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 m -96.23 122.85 39.54 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.551 0.614 . . . . 0.0 109.976 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.7 mm -75.54 103.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.575 0.75 . . . . 0.0 109.892 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.433 ' NE2' ' HB2' ' A' ' 76' ' ' LYS . 78.5 mt-30 -85.55 95.72 9.41 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.511 0.672 . . . . 0.0 109.882 176.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.4 p -79.09 150.09 31.91 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 27' ' ' GLU . 49.7 tp -88.35 105.0 17.28 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.259 0.623 . . . . 0.0 111.148 -170.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -89.73 96.61 10.77 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.037 0.935 . . . . 0.0 109.807 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 45.9 mt-30 -84.4 97.44 9.5 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -106.14 117.7 34.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.614 0.766 . . . . 0.0 109.336 -170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -72.07 162.48 29.4 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 120.629 0.252 . . . . 0.0 110.506 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -114.88 163.6 15.32 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.801 0.84 . . . . 0.0 109.361 -177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.6 -21.38 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.95 0.9 . . . . 0.0 113.018 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -93.85 -13.36 27.34 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.85 40.31 4.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.157 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -105.27 137.86 42.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.097 0.959 . . . . 0.0 109.603 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -90.75 96.42 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mp -83.96 96.14 8.75 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.599 ' HB3' HD11 ' A' ' 15' ' ' LEU . 49.4 mt-10 -79.97 111.58 16.45 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 65.5 p -125.58 169.15 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.398 -1.274 . . . . 0.0 107.857 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.443 ' HZ3' ' HA ' ' A' ' 73' ' ' SER . 79.6 m95 -119.97 109.41 15.49 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -173.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -84.31 115.11 22.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.5 135.79 55.6 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.202 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.57 -119.84 3.14 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.803 -168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -99.8 125.21 45.68 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -170.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 3.7 m -88.04 93.29 9.44 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -110.89 170.41 8.11 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -64.38 120.65 12.64 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.2 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -141.87 176.53 8.86 Favored 'General case' 0 C--O 1.209 -1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 111.979 177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 m -135.38 108.41 7.65 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 162.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.579 HG23 HG12 ' A' ' 61' ' ' ILE . 2.0 p -108.16 109.44 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.958 0.903 . . . . 0.0 110.837 -172.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.05 138.66 49.7 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.764 0.826 . . . . 0.0 109.044 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.509 ' SD ' HD21 ' A' ' 82' ' ' LEU . 77.1 mtp -75.45 145.34 41.55 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.8 m -72.32 130.8 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 O-C-N 123.691 0.619 . . . . 0.0 109.68 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 m -87.94 -175.93 5.29 Favored 'General case' 0 C--O 1.246 0.917 0 C-N-CA 123.4 0.68 . . . . 0.0 110.706 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.8 p -59.9 -33.91 72.47 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.791 0.837 . . . . 0.0 111.502 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.86 -47.52 67.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.806 0.843 . . . . 0.0 111.106 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.21 -45.22 81.53 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.114 0.884 . . . . 0.0 111.165 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.53 -51.97 66.4 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.922 0.764 . . . . 0.0 111.217 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.23 -38.23 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.141 0.977 . . . . 0.0 111.581 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 t -77.09 -28.57 54.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.99 0.516 . . . . 0.0 111.556 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 50.7 m -94.79 -9.86 33.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 0.0 111.894 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.94 -74.62 2.27 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.25 2.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.767 0.827 . . . . 0.0 111.047 175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 1.9 tm-20 -63.95 -61.15 2.46 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.6 mt -97.81 142.01 30.1 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 165.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.08 151.34 45.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.36 0.664 . . . . 0.0 109.557 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.85 119.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.834 0.854 . . . . 0.0 110.765 -175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.28 -12.64 16.46 Favored Glycine 0 N--CA 1.475 1.244 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.281 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.478 HG23 HD11 ' A' ' 90' ' ' ILE . 86.3 m -73.47 154.14 40.06 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 164.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 41' ' ' MET . 22.0 t -132.2 115.41 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -172.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.2 ttm-85 -87.45 132.2 34.08 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.579 HG12 HG23 ' A' ' 39' ' ' VAL . 41.8 mt -138.86 109.0 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.781 0.832 . . . . 0.0 109.037 -170.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -95.0 122.97 38.2 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.8 pt -116.62 165.32 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' A' ' 66' ' ' ARG . 24.8 mmm180 -54.25 140.17 33.72 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 111.388 0.144 . . . . 0.0 111.388 164.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HE1' ' HB3' ' A' ' 95' ' ' PRO . 51.8 t80 -54.6 129.51 36.68 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.007 1.323 . . . . 0.0 111.745 -172.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' NH1' ' HB2' ' A' ' 64' ' ' ARG . 50.4 mtt85 -150.96 129.32 12.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.788 0.835 . . . . 0.0 110.688 -177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -81.79 -13.9 57.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.252 1.021 . . . . 0.0 111.02 172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -90.05 -21.47 22.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.765 0.426 . . . . 0.0 110.747 -173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.08 128.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.663 0.385 . . . . 0.0 110.199 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.686 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 67.2 t30 -140.73 168.09 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.387 1.075 . . . . 0.0 109.235 -177.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.62 -7.66 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.947 0.899 . . . . 0.0 112.98 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.9 p -86.08 19.99 2.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.345 1.058 . . . . 0.0 112.274 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.443 ' HA ' ' HZ3' ' A' ' 29' ' ' TRP . 72.5 m -130.09 172.77 11.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.609 0.764 . . . . 0.0 110.777 173.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -119.92 140.66 50.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.899 0.88 . . . . 0.0 108.952 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.523 HG21 HG21 ' A' ' 61' ' ' ILE . 50.1 mm -98.08 105.49 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.601 0.76 . . . . 0.0 109.617 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 88.2 tttt -90.44 131.09 36.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.456 HG23 HD23 ' A' ' 87' ' ' LEU . 67.8 t -83.9 123.09 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 122.785 0.434 . . . . 0.0 110.579 -178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -85.64 -38.9 17.87 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.466 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 p -146.76 128.41 15.17 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.32 -169.69 29.62 Favored Glycine 0 N--CA 1.469 0.895 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.244 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.42 -1.24 10.75 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.017 2.478 . . . . 0.0 112.855 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.509 HD21 ' SD ' ' A' ' 41' ' ' MET . 89.4 mt -130.03 32.98 4.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.004 0.922 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.83 104.95 0.4 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.59 0.756 . . . . 0.0 111.685 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.32 -18.36 12.14 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.959 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.15 158.31 20.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 110.954 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 3.8 p -124.96 98.6 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 122.552 1.168 . . . . 0.0 110.189 -174.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 106' ' ' CYS . 2.5 mm? -82.54 148.77 27.88 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.294 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -110.76 141.07 44.56 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.051 0.94 . . . . 0.0 108.508 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.71 98.69 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -172.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 58' ' ' THR . 39.2 pt -80.86 146.57 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.098 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.12 -105.45 2.06 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.755 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -161.8 144.94 9.19 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 123.519 0.728 . . . . 0.0 109.897 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.686 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 62.8 Cg_endo -69.7 125.74 12.53 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.196 1.931 . . . . 0.0 110.678 173.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 111.7 54.41 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HB3' ' HE1' ' A' ' 65' ' ' TYR . 74.4 Cg_exo -53.83 142.59 62.63 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.205 2.603 . . . . 0.0 113.559 175.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.535 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 18.1 t70 -51.74 156.09 1.51 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.929 0.892 . . . . 0.0 112.639 173.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.16 77.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.326 1.05 . . . . 0.0 112.013 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -96.97 -6.58 35.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.313 0.645 . . . . 0.0 111.491 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.34 25.57 15.27 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.783 1.233 . . . . 0.0 112.249 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.9 p -83.28 -4.73 58.72 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.327 0.584 . . . . 0.0 111.334 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 17.3 ptt180 -169.12 -176.46 2.6 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.661 1.584 . . . . 0.0 107.894 -168.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.16 118.16 14.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -80.69 108.51 14.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 mm -100.17 153.15 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -133.63 146.61 51.07 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 170.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 71.3 m -150.21 171.99 16.04 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.281 -168.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -160.62 158.19 28.51 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -44.16 151.71 0.22 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.469 1.108 . . . . 0.0 112.776 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.98 42.57 3.11 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.753 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.96 166.73 10.61 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.785 1.234 . . . . 0.0 108.843 172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 64.77 14.47 9.17 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.282 1.033 . . . . 0.0 112.555 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.878 0.871 . . . . 0.0 108.786 -176.129 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -141.3 106.63 5.02 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.3 mt 73.79 -29.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 126.319 1.848 . . . . 0.0 112.086 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.79 55.44 5.01 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 121.926 -0.484 . . . . 0.0 113.053 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -81.6 -16.68 50.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.444 1.098 . . . . 0.0 109.775 170.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' HA ' ' OG ' ' A' ' 38' ' ' SER . 34.9 mt -91.38 117.84 30.02 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.932 1.293 . . . . 0.0 110.329 -165.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -116.03 1.74 13.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.564 0.746 . . . . 0.0 112.429 -170.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -113.88 -172.59 2.11 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.939 1.296 . . . . 0.0 109.231 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 50.1 mtm180 -140.57 156.21 46.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.168 0.987 . . . . 0.0 109.234 171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.35 135.39 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.3 m -90.02 113.58 25.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.116 0.966 . . . . 0.0 109.654 173.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.1 mm -74.06 105.39 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.845 1.258 . . . . 0.0 109.982 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.564 HE21 ' HB2' ' A' ' 76' ' ' LYS . 65.9 mt-30 -72.76 102.32 3.33 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-O 121.593 0.711 . . . . 0.0 109.565 174.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -83.03 133.64 35.08 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.624 -1.625 . . . . 0.0 108.294 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.3 tp -82.04 96.77 7.85 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -80.82 102.23 9.88 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -81.79 100.97 9.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.264 -1.334 . . . . 0.0 108.298 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -92.39 178.95 5.68 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -130.11 164.95 23.29 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.605 -0.684 . . . . 0.0 109.448 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 18.5 t70 -107.02 160.22 15.71 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.142 0.977 . . . . 0.0 108.754 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.5 tt -55.57 -15.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.4 p -98.71 -2.84 37.23 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.535 -0.728 . . . . 0.0 109.963 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.71 53.99 3.6 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.39 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 20' ' ' ASP . 15.0 pt-20 -130.62 142.35 50.45 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.65 109.96 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 122.884 0.473 . . . . 0.0 110.998 -175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.5 mt -96.26 93.0 6.64 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HB3' HD11 ' A' ' 15' ' ' LEU . 48.5 mt-10 -80.86 131.68 35.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.921 0.488 . . . . 0.0 110.302 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.4 p -138.95 159.81 41.26 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.306 1.042 . . . . 0.0 110.137 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -111.62 120.41 41.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.261 0.624 . . . . 0.0 109.886 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -128.15 164.14 23.13 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.725 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.07 138.65 46.01 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.114 0.884 . . . . 0.0 108.797 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.56 -107.4 2.42 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 -174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -110.07 129.4 55.69 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.91 0.884 . . . . 0.0 109.131 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 21.4 m -106.5 96.16 6.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.646 0.378 . . . . 0.0 110.183 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.74 172.01 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 122.883 0.473 . . . . 0.0 112.254 -174.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.3 m95 -67.19 129.97 41.62 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.156 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -144.56 172.55 12.81 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 123.769 0.828 . . . . 0.0 111.423 174.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.476 ' OG ' ' HA ' ' A' ' 6' ' ' LEU . 72.1 m -128.17 109.68 11.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.507 HG23 HG12 ' A' ' 61' ' ' ILE . 2.9 p -100.86 98.0 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.831 0.852 . . . . 0.0 109.611 -172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -112.4 115.24 28.39 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.827 0.851 . . . . 0.0 110.748 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 69.7 mtp -62.39 133.81 55.58 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.645 ' HB ' ' HG3' ' A' ' 46' ' ' GLU . 6.0 m -68.02 153.5 8.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.417 0.448 . . . . 0.0 110.262 -176.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.3 m -84.28 171.76 12.44 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.949 0.5 . . . . 0.0 110.458 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.2 p -60.18 -27.13 66.87 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.167 0.587 . . . . 0.0 110.669 173.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -47.85 -46.15 30.9 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.378 1.471 . . . . 0.0 111.897 173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.645 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 33.9 mm-40 -67.2 -39.76 86.39 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.504 0.502 . . . . 0.0 111.465 -176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -51.63 57.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.981 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.57 -52.61 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.344 1.058 . . . . 0.0 112.155 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -71.69 -26.47 62.52 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.439 0.695 . . . . 0.0 112.486 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 43.0 m -92.7 -7.71 45.97 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.912 0.485 . . . . 0.0 111.411 175.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.53 0.72 Allowed Glycine 0 C--N 1.35 1.32 0 O-C-N 123.494 0.496 . . . . 0.0 111.894 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.71 -5.93 7.49 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.791 0.836 . . . . 0.0 111.123 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 12.1 tp10 -66.56 -51.46 56.28 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.488 0.715 . . . . 0.0 110.669 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.5 mt -107.83 155.95 19.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.87 0.868 . . . . 0.0 108.982 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.28 177.63 7.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.758 0.823 . . . . 0.0 110.546 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.2 mt -85.73 136.68 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.18 -10.88 43.91 Favored Glycine 0 N--CA 1.471 0.967 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -170.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.0 m -70.75 145.13 50.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.044 0.937 . . . . 0.0 109.322 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 41' ' ' MET . 45.2 t -126.24 129.81 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.424 1.09 . . . . 0.0 109.214 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -103.3 140.37 37.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.643 HD13 HG21 ' A' ' 75' ' ' ILE . 56.1 mt -137.1 143.37 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -170.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -129.22 127.32 41.04 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 37' ' ' ALA . 42.9 pt -126.95 157.89 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.572 1.149 . . . . 0.0 107.931 -177.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -60.28 145.46 47.44 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.448 . . . . 0.0 110.482 168.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.523 ' HA ' HD13 ' A' ' 102' ' ' LEU . 39.5 t80 -57.09 125.12 21.24 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.676 0.79 . . . . 0.0 110.242 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' HG2' ' HB3' ' A' ' 68' ' ' ASP . 32.7 ttt180 -153.29 122.08 6.43 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 123.613 0.571 . . . . 0.0 110.79 -172.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -71.56 -3.16 19.85 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.174 1.389 . . . . 0.0 112.431 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 66' ' ' ARG . 4.3 t70 -89.92 -23.35 21.61 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.353 1.061 . . . . 0.0 110.369 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.447 HD11 ' HD3' ' A' ' 66' ' ' ARG . 20.8 mm -87.65 130.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.527 -175.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.707 ' HA ' ' HG3' ' A' ' 93' ' ' PRO . 66.3 t30 -145.3 167.95 21.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 109.594 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -24.26 65.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.165 0.986 . . . . 0.0 111.947 174.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.8 p -72.16 0.03 10.75 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.343 1.057 . . . . 0.0 112.334 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.9 t -101.14 161.34 13.68 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.855 0.862 . . . . 0.0 109.565 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 52.9 mtp180 -113.88 147.48 38.38 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 169.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.643 HG21 HD13 ' A' ' 61' ' ' ILE . 49.3 mm -95.6 102.56 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 122.491 0.316 . . . . 0.0 110.393 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HB2' HE21 ' A' ' 13' ' ' GLN . 58.3 tttm -94.94 102.96 14.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 169.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG23 HD23 ' A' ' 87' ' ' LEU . 70.2 t -69.41 124.28 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 120.74 0.305 . . . . 0.0 111.095 -170.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 9' ' ' ARG . 42.2 t -80.97 -40.11 24.92 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.991 0.917 . . . . 0.0 110.79 -176.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.0 p -146.33 132.64 19.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 108.747 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.0 -170.44 27.91 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 123.517 0.51 . . . . 0.0 112.531 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -65.03 -17.65 59.85 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.137 2.558 . . . . 0.0 112.059 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 41' ' ' MET . 29.9 mt -114.25 23.94 12.4 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.742 1.217 . . . . 0.0 110.088 -176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.85 108.48 1.2 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.892 . . . . 0.0 111.487 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.28 -31.42 5.45 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 123.979 0.8 . . . . 0.0 111.938 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.492 HH12 ' HG3' ' A' ' 108' ' ' GLU . 36.3 mtm180 -89.08 170.71 10.41 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.573 0.749 . . . . 0.0 112.761 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 76' ' ' LYS . 37.5 t -122.54 104.88 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.454 1.101 . . . . 0.0 110.106 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 77' ' ' VAL . 2.2 mm? -86.63 140.93 29.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.601 170.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.47 141.95 39.58 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.404 1.082 . . . . 0.0 109.072 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.403 HG12 ' SG ' ' A' ' 106' ' ' CYS . 51.8 mt -81.11 107.14 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -173.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 107' ' ' ARG . 32.0 pt -90.92 41.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.414 0.686 . . . . 0.0 111.302 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.5 -134.97 2.5 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 112.001 -0.439 . . . . 0.0 112.001 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -134.65 136.52 25.62 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 124.903 1.281 . . . . 0.0 108.708 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.707 ' HG3' ' HA ' ' A' ' 70' ' ' ASN . 73.9 Cg_endo -69.62 111.24 2.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.158 1.905 . . . . 0.0 110.765 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 107.66 60.17 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -173.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 51.4 Cg_exo -56.03 150.61 46.41 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.539 2.826 . . . . 0.0 112.882 172.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -72.8 173.34 9.26 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.222 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.81 -32.45 69.38 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.48 0.712 . . . . 0.0 112.36 -178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.47 -9.33 44.91 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? 62.48 30.09 17.16 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.176 0.99 . . . . 0.0 111.302 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.2 p -101.38 -12.88 18.27 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.824 0.849 . . . . 0.0 112.204 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.66 143.08 3.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -171.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.546 HD23 ' HB2' ' A' ' 93' ' ' PRO . 9.6 mp -101.64 139.57 37.12 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.958 0.903 . . . . 0.0 110.069 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -86.66 109.99 19.56 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 164.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 27.5 mm -95.92 104.57 15.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.7 pt? -83.3 137.52 33.95 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.444 ' SG ' HG22 ' A' ' 104' ' ' ILE . 73.7 m -149.57 175.05 11.87 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.099 0.96 . . . . 0.0 108.888 -173.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.464 ' HB2' HD13 ' A' ' 90' ' ' ILE . 57.5 ttt180 -156.65 159.97 38.93 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 171.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.492 ' HG3' HH12 ' A' ' 85' ' ' ARG . 0.4 OUTLIER -61.34 101.0 0.15 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.41 52.49 1.35 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.981 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.55 74.37 0.44 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.264 1.025 . . . . 0.0 111.53 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -76.91 -20.2 56.49 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.587 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 9.3 mptt . . . . . 0 C--O 1.258 1.53 0 C-N-CA 124.651 1.18 . . . . 0.0 108.402 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 121.068 0.461 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -160.49 156.04 25.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.106 1.362 . . . . 0.0 108.05 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG12 ' NH1' ' A' ' 64' ' ' ARG . 2.9 mp -69.74 96.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.58 56.19 4.89 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.254 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -130.06 -61.44 0.98 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.557 0.743 . . . . 0.0 109.146 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 36' ' ' TRP . 8.1 mp -69.18 90.8 0.49 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.395 0.678 . . . . 0.0 111.355 -169.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -121.64 -13.67 8.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.86 1.264 . . . . 0.0 111.366 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.47 -170.74 1.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.444 1.497 . . . . 0.0 110.09 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.459 ' HB3' HG22 ' A' ' 34' ' ' THR . 46.2 mtm180 -136.5 142.75 43.53 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 109.904 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -136.15 143.5 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.344 1.058 . . . . 0.0 109.155 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 m -101.83 118.85 37.78 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.033 0.933 . . . . 0.0 108.869 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.4 mm -81.32 92.14 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 123.95 0.781 . . . . 0.0 109.634 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 35.1 tt0 -83.79 93.77 8.04 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.904 0.859 . . . . 0.0 109.645 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 p -80.07 154.09 28.34 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.288 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' GLU . 67.2 tp -83.5 108.77 16.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.181 0.592 . . . . 0.0 109.948 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HB2' ' HG2' ' A' ' 30' ' ' GLU . 45.9 tttp -84.67 94.24 8.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.384 0.674 . . . . 0.0 110.224 176.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.415 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 42.8 mt-30 -87.45 108.64 19.11 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 174.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -130.09 129.37 43.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.782 0.833 . . . . 0.0 109.173 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -73.49 148.47 43.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 122.75 0.42 . . . . 0.0 110.086 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.33 169.28 8.99 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.02 -14.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 p -91.85 -10.84 38.26 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 121.777 0.798 . . . . 0.0 109.344 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.32 44.29 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.742 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.21 132.59 38.61 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.0 mm -76.44 94.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.4 mt -81.82 109.2 15.99 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 15' ' ' LEU . 45.6 mt-10 -84.11 96.17 8.84 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.82 0.819 . . . . 0.0 109.303 178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' HD12 ' A' ' 15' ' ' LEU . 67.1 p -110.92 -177.99 3.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.08 -177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -128.53 115.5 18.23 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.947 -0.471 . . . . 0.0 110.536 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 16' ' ' LYS . 8.7 pt-20 -97.95 109.89 22.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 171.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 13' ' ' GLN . 6.4 p-10 -63.75 135.2 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.9 -112.22 3.23 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-O 120.089 -0.284 . . . . 0.0 113.127 -163.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -102.66 135.28 44.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.091 0.557 . . . . 0.0 109.68 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.4 m -100.98 99.11 9.53 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.58 -179.68 3.94 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.192 0.52 . . . . 0.0 110.62 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.562 ' HB2' HD23 ' A' ' 6' ' ' LEU . 27.4 m95 -73.85 146.3 44.23 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.341 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -157.67 166.46 32.76 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.909 0.884 . . . . 0.0 112.824 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 t -110.42 95.92 5.88 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.586 HG21 HG21 ' A' ' 77' ' ' VAL . 3.5 p -96.7 90.49 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 121.971 0.891 . . . . 0.0 109.054 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.18 127.55 55.98 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.533 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.0 mtp -67.16 137.77 56.52 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.27 159.79 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.597 0.759 . . . . 0.0 111.857 -173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 m -82.5 168.61 17.23 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.396 0.678 . . . . 0.0 110.345 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.3 p -63.56 -21.56 66.41 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.513 0.725 . . . . 0.0 111.773 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.28 14.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.211 1.405 . . . . 0.0 112.694 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.23 -46.25 91.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.189 0.596 . . . . 0.0 111.372 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.1 -46.36 61.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.61 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.62 -47.39 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.891 0.876 . . . . 0.0 111.896 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -75.69 -32.59 60.17 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.872 0.869 . . . . 0.0 111.14 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.0 t -74.55 -45.6 44.45 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.866 0.467 . . . . 0.0 111.285 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.73 -75.86 0.22 Allowed Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.613 -174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.81 13.64 0.91 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.011 0.525 . . . . 0.0 112.352 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.76 -63.96 1.08 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.8 mt -79.67 149.94 31.08 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.35 168.06 20.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.443 0.697 . . . . 0.0 110.199 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mt -78.29 156.79 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.965 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.93 -10.2 68.15 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 112.231 -0.347 . . . . 0.0 112.231 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.445 HG23 HD11 ' A' ' 90' ' ' ILE . 86.8 m -65.2 152.21 44.21 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.536 1.134 . . . . 0.0 109.784 171.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 41' ' ' MET . 41.9 t -125.46 125.9 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.954 0.901 . . . . 0.0 109.438 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD3' ' HE1' ' A' ' 62' ' ' TRP . 21.7 ttm-85 -96.97 133.24 41.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 109.265 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 75' ' ' ILE . 67.7 mt -133.21 107.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.536 0.734 . . . . 0.0 109.177 -169.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.413 ' HE1' ' HD3' ' A' ' 60' ' ' ARG . 11.1 m0 -95.35 119.89 34.63 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.621 0.768 . . . . 0.0 110.743 -178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 pt -127.21 166.11 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.892 0.877 . . . . 0.0 108.733 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' HD21 ' A' ' 6' ' ' LEU . 31.5 mmm180 -56.72 157.47 5.41 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.789 0.435 . . . . 0.0 110.612 166.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.85 95.1 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD3' HD11 ' A' ' 69' ' ' ILE . 28.7 ttt85 -110.16 116.72 32.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.346 -177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -78.71 1.17 23.91 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.763 1.225 . . . . 0.0 111.679 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -92.51 -19.43 21.98 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.425 1.09 . . . . 0.0 110.535 -172.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.474 HD11 ' HD3' ' A' ' 66' ' ' ARG . 16.6 mm -79.91 134.91 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.957 0.503 . . . . 0.0 110.582 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -129.42 166.12 20.22 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -22.99 67.09 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.033 0.533 . . . . 0.0 110.955 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.1 p -82.58 19.43 1.29 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.654 0.781 . . . . 0.0 111.824 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -107.37 142.32 37.36 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.787 0.835 . . . . 0.0 108.842 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -107.58 133.35 52.16 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 61' ' ' ILE . 37.7 mm -94.49 91.7 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 121.112 0.482 . . . . 0.0 110.139 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 26.8 ttpp -86.99 106.3 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG23 HD23 ' A' ' 87' ' ' LEU . 99.1 t -78.8 130.35 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.116 0.566 . . . . 0.0 111.281 -169.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.5 m -89.81 -19.67 24.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.977 0.911 . . . . 0.0 113.048 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.6 p -135.0 -177.13 4.49 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.172 0.589 . . . . 0.0 110.92 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.12 -151.59 51.97 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.956 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -79.83 -12.89 13.29 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.177 2.585 . . . . 0.0 113.349 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.07 23.35 13.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.577 0.751 . . . . 0.0 110.737 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.7 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.406 0.682 . . . . 0.0 110.734 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.33 -30.16 6.89 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.727 0.679 . . . . 0.0 112.13 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -71.06 139.36 50.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.059 0.544 . . . . 0.0 110.193 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.2 p -104.89 90.65 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-O 122.497 1.142 . . . . 0.0 108.927 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.633 HD23 HG23 ' A' ' 77' ' ' VAL . 2.1 mm? -70.76 149.26 47.07 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 113.743 -1.571 . . . . 0.0 108.861 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -122.11 137.93 54.64 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -78.27 95.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -173.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.445 HD11 HG23 ' A' ' 58' ' ' THR . 25.3 pt -80.63 63.72 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 122.333 1.063 . . . . 0.0 110.544 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.18 -118.27 0.82 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.434 ' H ' HD21 ' A' ' 105' ' ' LEU . 9.9 pt20 -162.74 142.43 7.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 123.64 0.776 . . . . 0.0 109.42 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.84 116.06 3.1 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.989 2.46 . . . . 0.0 110.751 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -95.94 108.15 38.96 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.809 0.843 . . . . 0.0 109.767 -170.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.05 135.82 19.48 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.359 2.04 . . . . 0.0 110.129 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.0 174.07 9.12 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 120.802 0.334 . . . . 0.0 110.369 -176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.57 62.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.652 0.781 . . . . 0.0 113.031 -173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.45 27.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.492 0.317 . . . . 0.0 111.258 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 62.06 30.49 17.9 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.232 1.013 . . . . 0.0 111.087 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.1 t -86.13 -16.2 38.68 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.843 0.857 . . . . 0.0 110.933 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.0 ptp85 -152.12 166.45 31.63 Favored 'General case' 0 C--O 1.249 1.058 0 CA-C-O 121.675 0.75 . . . . 0.0 110.349 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 107.8 12.84 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -87.09 101.5 13.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.302 0.641 . . . . 0.0 109.448 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.512 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 13.5 mm -83.92 145.72 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.97 0.908 . . . . 0.0 108.788 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.4 pt? -122.78 143.07 50.07 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 72.2 m -151.53 176.09 11.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.705 0.802 . . . . 0.0 110.64 -170.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -161.11 155.35 22.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.373 0.669 . . . . 0.0 109.448 167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.34 144.89 28.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.183 0.993 . . . . 0.0 111.731 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.92 35.77 3.7 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.023 173.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.69 91.89 0.36 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.967 1.307 . . . . 0.0 109.153 -177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -104.65 0.14 28.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.123 0.969 . . . . 0.0 111.064 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.288 0 C-N-CA 124.056 0.942 . . . . 0.0 111.511 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -83.02 77.47 9.73 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.554 HG13 ' HG2' ' A' ' 5' ' ' ARG . 19.8 pt -97.68 157.6 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.729 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.22 25.65 6.06 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 114.05 0.38 . . . . 0.0 114.05 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.554 ' HG2' HG13 ' A' ' 3' ' ' ILE . 12.2 ptm180 -60.28 143.62 52.37 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.85 0.86 . . . . 0.0 110.683 176.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' H ' HD22 ' A' ' 6' ' ' LEU . 1.3 mm? -70.59 96.05 1.15 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.056 0.847 . . . . 0.0 110.628 -169.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -98.96 -36.92 9.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.785 1.234 . . . . 0.0 112.369 -171.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -96.6 -167.6 1.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.775 1.23 . . . . 0.0 108.861 -176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' HB3' HG22 ' A' ' 34' ' ' THR . 49.3 mtm180 -148.91 146.46 27.9 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 0.0 110.418 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.3 151.27 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.841 0.856 . . . . 0.0 109.044 175.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -102.45 122.95 45.33 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.8 116.96 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.792 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -83.36 99.94 10.36 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 p -82.28 141.28 33.06 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.989 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 27' ' ' GLU . 54.3 tp -110.27 113.77 26.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.513 0.725 . . . . 0.0 109.386 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -102.35 114.46 28.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.722 0.409 . . . . 0.0 110.212 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 41.8 mt-30 -75.51 90.3 2.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 170.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.6 m -91.54 110.23 21.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 109.703 -174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -71.24 158.59 36.13 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.534 0.334 . . . . 0.0 110.721 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.92 164.41 13.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.428 0.691 . . . . 0.0 109.703 -176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.0 tt -61.81 -11.23 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 125.068 1.347 . . . . 0.0 112.982 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.3 p -104.67 -23.99 13.01 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.84 44.67 1.74 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.94 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -106.41 149.91 26.55 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.33 101.69 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.906 0.483 . . . . 0.0 110.025 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.93 90.96 7.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.991 0.916 . . . . 0.0 108.96 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.588 ' HB3' HD11 ' A' ' 15' ' ' LEU . 42.4 mt-10 -79.34 121.04 24.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -137.98 141.85 40.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.587 1.155 . . . . 0.0 109.824 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -101.5 103.55 14.43 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.078 0.951 . . . . 0.0 109.088 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.44 125.73 34.88 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.247 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.83 113.36 7.0 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.706 1.202 . . . . 0.0 108.397 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.35 -109.45 2.86 Favored Glycine 0 N--CA 1.469 0.855 0 CA-C-O 119.858 -0.412 . . . . 0.0 113.319 -157.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -117.09 139.0 51.26 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.394 0.678 . . . . 0.0 110.215 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 11.7 m -101.45 98.44 8.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 109.74 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 63' ' ' ILE . 1.3 pt? -106.69 163.73 12.67 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.064 0.459 . . . . 0.0 111.952 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -59.49 123.31 16.43 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 114.131 -1.395 . . . . 0.0 111.113 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.613 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.83 176.44 8.7 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.203 1.001 . . . . 0.0 110.933 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -136.94 107.55 6.54 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 163.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 77' ' ' VAL . 66.5 t -105.29 131.6 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.65 0.78 . . . . 0.0 109.307 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.4 HD22 ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -151.29 159.58 44.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 167.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.453 ' SD ' HG22 ' A' ' 59' ' ' VAL . 19.8 mmt -67.76 148.22 51.55 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.0 m -63.19 145.23 13.8 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 O-C-N 123.746 0.654 . . . . 0.0 110.151 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 47.4 t -74.35 163.27 28.0 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.955 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.1 p -61.21 -31.5 71.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.501 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 16.9 ptpt -62.17 -33.5 74.64 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.469 0.707 . . . . 0.0 111.492 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.75 -50.84 14.09 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.558 0.743 . . . . 0.0 110.258 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.95 40.81 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.437 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 74.2 mt -66.43 -27.32 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.773 0.829 . . . . 0.0 111.982 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -59.24 -49.36 78.14 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.787 0.435 . . . . 0.0 110.572 174.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 53' ' ' GLU . 83.9 p -79.78 -12.29 59.79 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.151 0.58 . . . . 0.0 111.564 177.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -77.5 2.04 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.89 2.1 3.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.103 0.561 . . . . 0.0 111.847 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 50' ' ' SER . 32.6 mt-10 -78.36 -69.54 0.55 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 41.6 mt -82.94 141.91 31.81 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 169.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -139.75 156.91 46.52 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.96 0.504 . . . . 0.0 110.212 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.59 125.55 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 118.07 -12.58 12.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -163.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.1 m -77.77 154.61 31.8 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 156.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG22 ' SD ' ' A' ' 41' ' ' MET . 40.5 t -124.53 128.04 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.841 0.857 . . . . 0.0 111.033 -170.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -98.2 128.86 44.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.335 0.654 . . . . 0.0 109.519 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.619 HD13 HG21 ' A' ' 75' ' ' ILE . 65.7 mt -135.0 143.04 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.141 0.976 . . . . 0.0 108.494 -174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 101' ' ' ARG . 60.1 m95 -134.92 121.67 20.86 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 35' ' ' LEU . 44.6 pt -121.41 168.75 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.414 0.686 . . . . 0.0 109.977 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -47.42 146.75 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.595 0.758 . . . . 0.0 112.748 165.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -67.35 108.95 2.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.358 0.663 . . . . 0.0 110.287 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' HD13 ' A' ' 35' ' ' LEU . 9.9 ptp180 -149.21 125.63 10.91 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.059 0.544 . . . . 0.0 110.327 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -84.09 12.35 6.54 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.394 1.078 . . . . 0.0 111.408 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.28 -18.31 28.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.405 1.082 . . . . 0.0 110.004 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.417 HG13 HD11 ' A' ' 63' ' ' ILE . 21.6 mm -74.55 138.69 20.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.81 159.68 34.98 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -66.14 -20.67 66.22 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.594 0.358 . . . . 0.0 111.808 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.5 p -92.06 28.23 1.93 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.608 0.763 . . . . 0.0 111.217 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -107.34 161.74 14.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.553 HH21 HG21 ' A' ' 86' ' ' VAL . 51.3 mtp180 -125.04 128.55 48.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.619 HG21 HD13 ' A' ' 61' ' ' ILE . 44.5 mm -88.4 96.52 6.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 123.721 0.808 . . . . 0.0 109.454 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -94.76 109.39 21.35 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.484 HG23 HD23 ' A' ' 87' ' ' LEU . 61.5 t -74.99 124.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.381 0.672 . . . . 0.0 110.789 -170.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 t -83.52 -25.66 30.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.71 0.804 . . . . 0.0 111.342 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 9' ' ' ARG . 14.1 t -163.37 132.53 4.02 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.59 -163.7 30.43 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.93 -14.24 29.36 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.778 2.319 . . . . 0.0 112.028 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.1 mt -123.06 32.28 5.74 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.285 1.034 . . . . 0.0 110.01 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 125.73 25.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.45 0.7 . . . . 0.0 110.659 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.62 12.29 72.63 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.588 0.555 . . . . 0.0 113.085 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -119.9 148.18 43.81 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.348 0.659 . . . . 0.0 109.44 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.553 HG21 HH21 ' A' ' 74' ' ' ARG . 5.1 p -111.17 97.9 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 122.624 1.202 . . . . 0.0 110.93 -173.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD23 HG23 ' A' ' 77' ' ' VAL . 1.8 mm? -86.38 142.43 28.46 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.387 177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.59 143.32 32.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.363 1.065 . . . . 0.0 108.763 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.7 mt -80.29 129.62 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.1 pt -113.07 132.73 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.893 0.877 . . . . 0.0 109.27 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.76 -84.38 1.41 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 29.6 pt20 -169.34 158.13 7.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.683 0.793 . . . . 0.0 110.512 -174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.24 148.87 27.51 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.05 1.833 . . . . 0.0 110.334 159.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.18 125.05 5.08 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 152.55 40.12 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.443 2.096 . . . . 0.0 112.194 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.73 178.02 3.84 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 122.289 -0.257 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.87 -36.42 83.25 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.767 0.827 . . . . 0.0 112.523 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.76 -13.29 34.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.119 0.568 . . . . 0.0 111.958 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 62.45 34.47 15.43 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.628 1.171 . . . . 0.0 111.408 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 t -98.33 0.33 45.31 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.747 0.819 . . . . 0.0 110.817 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 5.4 ptp180 -169.51 -177.77 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.95 0.9 . . . . 0.0 109.242 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.07 112.64 16.09 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.91 119.6 17.37 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.547 HG22 ' SG ' ' A' ' 106' ' ' CYS . 25.8 mm -109.8 118.83 57.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' H ' HD23 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -98.65 133.47 42.95 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.547 ' SG ' HG22 ' A' ' 104' ' ' ILE . 85.3 m -144.98 173.68 11.67 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.036 -170.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -150.03 162.89 39.51 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -45.59 143.79 1.82 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.044 0.537 . . . . 0.0 111.099 168.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.22 51.12 4.2 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.136 0.273 . . . . 0.0 113.14 -171.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.23 89.23 3.68 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.49 71.28 6.06 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.983 0.913 . . . . 0.0 109.26 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--O 1.247 0.932 0 C-N-CA 124.9 1.28 . . . . 0.0 108.617 -175.851 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -68.58 109.61 3.84 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.229 0.612 . . . . 0.0 109.511 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -85.75 -15.16 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 177.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.61 37.58 3.47 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.239 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -76.6 -16.6 59.54 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.969 0.508 . . . . 0.0 110.666 172.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.7 104.25 16.73 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.335 1.054 . . . . 0.0 109.578 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -83.22 -39.55 20.79 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.061 0.944 . . . . 0.0 112.218 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -109.63 -171.35 1.82 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.557 1.543 . . . . 0.0 109.905 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 -143.85 147.35 33.94 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.616 1.166 . . . . 0.0 110.214 174.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -133.04 154.7 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.421 1.089 . . . . 0.0 109.576 177.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 m -108.56 125.37 51.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.197 0.999 . . . . 0.0 108.47 169.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.1 mm -82.53 125.92 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 123.395 0.435 . . . . 0.0 110.373 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 19.3 mp0 -88.07 100.28 12.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.096 0.958 . . . . 0.0 108.68 170.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 p -83.63 143.84 29.83 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.818 172.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 27' ' ' GLU . 57.7 tp -90.7 107.7 19.34 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.672 0.389 . . . . 0.0 110.627 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -83.53 97.06 8.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.545 0.738 . . . . 0.0 109.375 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.23 90.75 2.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 171.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -89.94 161.14 16.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.213 1.005 . . . . 0.0 109.389 -172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -125.97 154.54 42.73 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 122.13 -0.356 . . . . 0.0 110.577 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 16.8 t70 -104.64 160.06 15.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.78 1.232 . . . . 0.0 108.64 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.31 -11.37 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.388 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 p -108.7 -0.51 20.03 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.682 0.753 . . . . 0.0 109.261 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.2 28.58 9.09 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.249 169.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 10.3 mm-40 -92.75 134.78 34.71 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.1 mm -91.07 118.14 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.12 106.83 17.51 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' HD11 ' A' ' 15' ' ' LEU . 1.9 mp0 -78.78 114.94 18.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.8 p -130.22 152.48 49.6 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.128 0.971 . . . . 0.0 108.385 -175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -106.59 103.86 13.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -87.34 128.71 35.18 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -67.09 145.56 55.2 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -106.93 2.56 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 111.409 -0.677 . . . . 0.0 111.409 -171.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -115.2 135.21 54.42 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.073 0.949 . . . . 0.0 108.683 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 18.4 m -94.26 95.8 9.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.1 pt? -111.34 169.49 8.76 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.45 0.643 . . . . 0.0 111.447 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -71.12 130.37 41.32 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.739 -177.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.703 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -136.84 176.72 8.46 Favored 'General case' 0 C--O 1.211 -0.929 0 CA-C-N 114.346 -1.297 . . . . 0.0 111.495 175.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 62' ' ' TRP . 55.4 m -130.58 98.99 4.82 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 163.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.61 102.6 13.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.497 0.719 . . . . 0.0 109.07 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.15 106.42 14.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.054 0.942 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.702 ' SD ' HG22 ' A' ' 59' ' ' VAL . 86.6 mmm -60.19 117.94 5.76 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 m -70.63 155.58 7.53 Favored 'Isoleucine or valine' 0 C--O 1.245 0.842 0 CA-C-O 121.118 0.485 . . . . 0.0 110.668 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 45' ' ' LYS . 23.0 t -85.22 176.98 8.02 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.458 174.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.9 m -58.73 -28.73 66.13 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.055 0.942 . . . . 0.0 111.909 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 43' ' ' SER . 20.4 ptmt -49.33 -42.75 42.61 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.798 1.239 . . . . 0.0 113.463 -177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.52 -41.16 93.45 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.295 0.638 . . . . 0.0 111.052 -176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.19 74.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.758 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 79.1 mt -60.51 -43.31 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.68 0.792 . . . . 0.0 111.26 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.5 m -69.72 -33.8 72.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.391 0.676 . . . . 0.0 111.994 -176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 77.8 p -82.09 -30.25 31.34 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.635 0.374 . . . . 0.0 111.046 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.82 -66.03 0.24 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.044 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 15.04 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.299 1.04 . . . . 0.0 110.59 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 40.1 tt0 -86.13 -53.75 4.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.601 0.76 . . . . 0.0 109.584 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 58' ' ' THR . 94.4 mt -84.53 160.8 20.42 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 167.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.88 154.82 40.48 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.751 0.82 . . . . 0.0 110.153 -175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 44.4 mt -71.83 108.28 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.52 10.92 20.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.497 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.402 HG21 HD22 ' A' ' 54' ' ' LEU . 37.9 m -64.71 122.18 16.26 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.702 HG22 ' SD ' ' A' ' 41' ' ' MET . 24.8 t -86.95 105.6 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.778 0.831 . . . . 0.0 110.026 -178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -90.74 133.37 35.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.576 HD13 HG21 ' A' ' 75' ' ' ILE . 79.6 mt -135.79 117.46 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.134 0.974 . . . . 0.0 108.895 -169.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 79.3 m95 -102.73 119.12 38.27 Favored 'General case' 0 C--O 1.209 -1.037 0 C-N-CA 122.888 0.475 . . . . 0.0 109.909 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 pt -124.22 155.76 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -59.17 163.64 3.61 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 118.25 0.477 . . . . 0.0 111.396 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' HA ' HD13 ' A' ' 102' ' ' LEU . 42.5 t80 -55.8 100.57 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.755 0.822 . . . . 0.0 111.203 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -118.93 106.28 12.31 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -68.03 -24.08 65.06 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.389 1.076 . . . . 0.0 113.28 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.25 -18.64 23.14 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.624 0.769 . . . . 0.0 112.325 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.3 mm -67.18 132.63 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -154.17 173.6 15.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -26.39 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.505 0.722 . . . . 0.0 112.329 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.7 p -80.09 9.91 4.99 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.282 1.033 . . . . 0.0 113.341 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.0 p -117.55 156.94 27.21 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.257 0.623 . . . . 0.0 109.503 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 74.5 mtp180 -112.95 155.0 25.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 171.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.576 HG21 HD13 ' A' ' 61' ' ' ILE . 21.3 mm -116.82 103.21 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.26 0.624 . . . . 0.0 109.864 -177.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 39.2 ttpt -94.15 109.5 21.28 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.556 HG23 HD23 ' A' ' 87' ' ' LEU . 95.8 t -73.23 126.85 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 O-C-N 123.622 0.576 . . . . 0.0 110.516 -175.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.4 m -79.67 -25.17 41.35 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.292 1.037 . . . . 0.0 113.287 -171.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -152.53 178.47 9.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.43 -171.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.71 -146.64 30.07 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.42 -0.655 . . . . 0.0 113.052 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.64 -22.47 13.69 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.262 2.642 . . . . 0.0 113.289 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.639 HD11 ' SD ' ' A' ' 41' ' ' MET . 92.5 mt -115.71 31.29 6.8 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.881 0.473 . . . . 0.0 110.927 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.72 94.71 0.31 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.476 0.71 . . . . 0.0 110.895 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.0 -17.81 8.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.739 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -79.23 129.57 34.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.374 0.67 . . . . 0.0 109.722 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 7.5 p -102.36 80.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 122.648 1.214 . . . . 0.0 109.152 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.556 HD23 HG23 ' A' ' 77' ' ' VAL . 2.0 mm? -65.78 153.52 41.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.184 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -120.43 139.1 53.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' A' ' 106' ' ' CYS . 62.7 mt -80.78 104.07 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -172.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 107' ' ' ARG . 40.0 pt -83.1 16.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.002 0.921 . . . . 0.0 112.36 -174.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.57 -141.85 3.23 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -128.89 134.81 26.73 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.575 ' HB2' HD23 ' A' ' 102' ' ' LEU . 67.1 Cg_endo -68.36 146.13 67.85 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.905 2.403 . . . . 0.0 111.52 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.9 120.41 5.01 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 40.3 Cg_endo -66.65 157.43 60.94 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.132 2.555 . . . . 0.0 113.743 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -73.56 179.73 3.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.252 1.021 . . . . 0.0 111.162 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.25 69.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.872 0.869 . . . . 0.0 112.623 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.6 -11.26 29.74 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.36 0.664 . . . . 0.0 112.463 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? 68.2 20.02 8.97 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.958 0.903 . . . . 0.0 111.938 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -74.82 -18.02 60.52 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.411 0.684 . . . . 0.0 111.842 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.18 153.27 5.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.618 0.767 . . . . 0.0 110.764 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.575 HD23 ' HB2' ' A' ' 93' ' ' PRO . 8.1 mp -102.82 133.95 47.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.131 0.973 . . . . 0.0 109.718 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.37 116.54 23.76 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 12.4 mm -98.95 131.81 45.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 173.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.3 pt? -106.77 136.83 45.91 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 89' ' ' ILE . 83.9 m -148.73 172.92 13.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.4 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' HB3' HG21 ' A' ' 90' ' ' ILE . 72.3 ttt-85 -163.6 154.38 16.07 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -74.19 131.17 41.0 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.92 28.32 7.33 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.076 -0.41 . . . . 0.0 112.076 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.27 111.13 0.02 OUTLIER 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.401 1.48 . . . . 0.0 111.734 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.76 83.76 0.07 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.729 -0.653 . . . . 0.0 109.923 -168.166 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptm . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -90.53 147.43 23.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.867 0.467 . . . . 0.0 109.872 176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.45 153.5 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.042 0.937 . . . . 0.0 108.775 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.5 49.29 3.82 Favored Glycine 0 C--N 1.348 1.241 0 C-N-CA 123.184 0.421 . . . . 0.0 112.914 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 163.82 12.94 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.868 0.867 . . . . 0.0 110.594 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -123.29 169.1 11.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.909 0.884 . . . . 0.0 109.968 -174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -136.13 -28.91 1.03 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.22 0.608 . . . . 0.0 112.438 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' THR . 70.0 m-20 -107.14 -171.26 1.85 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.45 1.5 . . . . 0.0 110.419 -172.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -141.11 147.14 38.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.315 1.046 . . . . 0.0 108.975 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.88 155.61 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.233 0.613 . . . . 0.0 109.791 173.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.6 m -113.18 124.99 53.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.364 0.666 . . . . 0.0 109.628 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.53 108.86 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.637 1.175 . . . . 0.0 110.596 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 74' ' ' ARG . 27.6 mp0 -80.74 98.3 7.69 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.045 0.926 . . . . 0.0 108.979 172.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 5.0 m -79.8 145.23 32.92 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.14 -1.845 . . . . 0.0 107.987 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 27' ' ' GLU . 50.2 tp -97.38 99.79 11.22 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.92 -0.487 . . . . 0.0 109.817 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -83.44 105.66 14.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.218 0.607 . . . . 0.0 109.876 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 50.3 mt-30 -88.31 89.06 7.84 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.5 m -94.04 135.12 35.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.099 0.96 . . . . 0.0 110.0 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 4.7 ttp180 -74.47 148.41 41.06 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB2' HD13 ' A' ' 26' ' ' LEU . 20.5 t70 -96.58 163.81 12.87 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.12 -11.05 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -99.24 -4.2 32.5 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.446 -0.784 . . . . 0.0 109.643 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.73 44.51 6.79 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.821 177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.6 mt-10 -103.37 173.58 6.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.719 0.807 . . . . 0.0 109.736 174.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.61 103.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.341 0.656 . . . . 0.0 109.308 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 20' ' ' ASP . 8.8 mp -94.61 108.94 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.833 1.253 . . . . 0.0 109.31 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 41.9 mt-10 -79.88 117.0 20.34 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 p -131.91 157.4 44.08 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.359 1.063 . . . . 0.0 109.422 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -103.83 101.5 11.32 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 6.3 pt-20 -83.37 123.01 29.23 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.32 115.43 10.47 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.66 -119.77 4.32 Favored Glycine 0 N--CA 1.474 1.192 0 CA-C-O 120.086 -0.286 . . . . 0.0 112.876 -160.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -77.97 159.76 28.61 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.554 0.742 . . . . 0.0 110.478 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 47.0 m -138.07 95.97 3.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.69 169.79 8.58 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.933 -174.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -67.85 131.42 45.49 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.425 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -140.82 178.28 7.45 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.99 0.916 . . . . 0.0 111.363 176.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.4 m -140.73 105.18 4.87 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.84 114.63 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -133.01 124.59 27.97 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.523 ' HG2' HG22 ' A' ' 59' ' ' VAL . 73.3 mtp -67.78 134.56 51.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.19 152.3 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.552 0.341 . . . . 0.0 110.203 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t -97.91 -175.43 3.15 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 56' ' ' ILE . 14.2 p -55.93 -30.55 61.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.284 1.033 . . . . 0.0 112.936 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -50.14 -48.17 53.79 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.648 1.179 . . . . 0.0 112.716 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.16 -36.65 72.1 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 -176.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.05 96.57 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.004 0.815 . . . . 0.0 110.519 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.48 -46.78 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.433 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -71.67 -24.15 61.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.417 0.687 . . . . 0.0 112.399 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 31.8 m -101.84 -5.4 24.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.153 0.581 . . . . 0.0 111.218 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.07 -90.07 0.79 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.019 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.99 -11.68 10.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.79 0.836 . . . . 0.0 110.803 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 50' ' ' SER . 10.0 tp10 -64.43 -59.82 3.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 110.288 -174.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.677 HD22 HG21 ' A' ' 58' ' ' THR . 61.2 mt -93.88 162.07 14.06 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -140.92 166.19 25.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.609 0.764 . . . . 0.0 110.315 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 44' ' ' SER . 59.6 mt -71.12 111.92 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.12 -10.38 17.72 Favored Glycine 0 N--CA 1.475 1.282 0 CA-C-O 120.218 -0.212 . . . . 0.0 112.626 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.677 HG21 HD22 ' A' ' 54' ' ' LEU . 24.5 m -61.6 137.75 58.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.304 0.642 . . . . 0.0 109.53 169.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 41' ' ' MET . 48.9 t -105.33 127.46 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.24 0.616 . . . . 0.0 109.867 -177.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -109.32 144.32 37.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.41 0.624 . . . . 0.0 109.909 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 75' ' ' ILE . 41.0 mt -135.69 107.35 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -167.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -96.06 114.4 26.11 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 37' ' ' ALA . 44.5 pt -116.37 155.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 65' ' ' TYR . 1.6 tmt_? -55.83 143.98 29.42 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 167.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.501 ' N ' ' HD3' ' A' ' 64' ' ' ARG . 57.0 t80 -45.16 124.68 4.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.577 1.151 . . . . 0.0 111.666 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' H ' HD23 ' A' ' 102' ' ' LEU . 5.7 tpm_? -151.26 116.01 5.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.51 0.724 . . . . 0.0 109.54 -170.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HE3' ' HE2' ' A' ' 65' ' ' TYR . 91.0 mttt -84.8 8.59 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.194 0.998 . . . . 0.0 111.577 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -93.98 -24.11 17.78 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.511 1.124 . . . . 0.0 111.567 -173.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.0 mm -74.88 126.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 122.716 0.406 . . . . 0.0 111.287 -170.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.89 157.96 30.03 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.84 -13.53 60.94 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.428 0.691 . . . . 0.0 112.68 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.4 p -77.05 -24.14 51.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.804 0.441 . . . . 0.0 110.964 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -73.19 155.21 39.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.316 0.647 . . . . 0.0 110.627 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 75.9 mtm180 -113.5 162.81 15.7 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.389 0.676 . . . . 0.0 109.405 172.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.633 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.4 mp -112.17 126.97 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.052 1.341 . . . . 0.0 108.177 171.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -118.86 116.14 25.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.9 t -66.45 110.25 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 123.556 0.535 . . . . 0.0 110.998 -170.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.467 ' H ' ' HA ' ' A' ' 10' ' ' ILE . 31.8 t -70.5 -27.2 64.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.593 1.157 . . . . 0.0 111.265 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' ASP . 12.8 t -166.45 137.96 3.56 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.59 -162.45 30.73 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-O 119.771 -0.46 . . . . 0.0 112.294 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.33 -14.17 18.45 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.11 2.54 . . . . 0.0 111.765 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -124.81 32.86 5.34 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.441 1.096 . . . . 0.0 109.162 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.32 102.22 0.21 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.739 0.815 . . . . 0.0 111.507 -176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.85 0.24 15.09 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-O 119.859 -0.411 . . . . 0.0 113.147 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -106.64 160.47 15.43 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.582 0.753 . . . . 0.0 110.077 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.25 100.76 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.947 1.356 . . . . 0.0 111.168 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.93 124.5 34.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 113.679 -1.601 . . . . 0.0 110.269 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 88' ' ' ASN . 0.5 OUTLIER -97.6 142.32 29.55 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.324 1.05 . . . . 0.0 108.334 177.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.07 117.45 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.26 71.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-O 121.98 0.895 . . . . 0.0 109.852 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.53 -114.24 0.63 Allowed Glycine 0 C--N 1.335 0.476 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.174 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.549 ' H ' HD21 ' A' ' 105' ' ' LEU . 12.5 pt20 -166.81 142.79 3.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.73 0.812 . . . . 0.0 109.438 -176.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 102' ' ' LEU . 37.1 Cg_endo -60.28 120.74 8.68 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.791 2.328 . . . . 0.0 112.145 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -111.93 108.62 55.47 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.336 1.055 . . . . 0.0 108.965 -170.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 153.73 53.62 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.797 2.331 . . . . 0.0 113.082 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 6.8 p-10 -84.33 172.45 11.79 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 0.0 110.462 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.03 -33.13 75.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.893 0.877 . . . . 0.0 112.249 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.04 -9.35 59.3 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.931 0.492 . . . . 0.0 111.65 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 25.2 mmt180 60.58 28.64 18.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.132 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.1 t -101.16 -5.44 25.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.845 0.858 . . . . 0.0 110.739 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -160.03 155.58 25.55 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.312 0.577 . . . . 0.0 110.903 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.539 HD12 ' HB2' ' A' ' 93' ' ' PRO . 3.3 mm? -108.83 113.07 25.68 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -77.07 107.06 9.17 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.51 HG22 ' SG ' ' A' ' 106' ' ' CYS . 20.1 mm -96.55 134.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.9 pt? -111.25 130.6 55.61 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.51 ' SG ' HG22 ' A' ' 104' ' ' ILE . 71.9 m -153.77 176.68 11.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -167.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ptm85 -160.27 163.58 33.31 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -59.9 145.49 45.65 Favored 'General case' 0 C--O 1.244 0.804 0 O-C-N 123.294 0.371 . . . . 0.0 110.874 176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.92 51.38 4.29 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.39 102.58 5.19 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.13 0.972 . . . . 0.0 110.318 -175.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.39 79.27 0.38 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.094 0.958 . . . . 0.0 110.952 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.198 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -71.31 99.17 1.89 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.085 0.554 . . . . 0.0 109.743 -176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.1 mt 70.81 2.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 125.193 1.397 . . . . 0.0 111.29 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.11 55.15 3.63 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -149.73 154.88 39.24 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.731 1.213 . . . . 0.0 108.474 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 1.7 mm? -77.75 95.76 4.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 -170.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -97.9 -41.96 7.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.401 1.081 . . . . 0.0 111.276 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -102.61 -167.17 1.36 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.295 1.438 . . . . 0.0 110.238 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -146.38 150.8 36.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.857 1.263 . . . . 0.0 109.055 171.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -137.93 145.36 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.332 0.653 . . . . 0.0 109.698 174.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 31' ' ' ASP . 3.2 m -90.61 124.6 35.18 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 167.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.8 mm -71.14 107.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 35.4 tt0 -78.84 95.35 5.36 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.624 1.202 . . . . 0.0 108.26 176.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 30' ' ' GLU . 27.8 m -81.58 142.54 32.71 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.455 -2.157 . . . . 0.0 109.641 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 27' ' ' GLU . 37.5 tp -98.5 104.49 16.53 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -96.25 123.9 40.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 52.5 mt-30 -102.85 102.41 12.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -110.82 121.18 44.7 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.377 1.071 . . . . 0.0 109.164 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -69.11 164.93 21.42 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.311 0.644 . . . . 0.0 110.979 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -113.51 165.71 12.22 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.0 tt -68.43 3.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 C-N-CA 124.563 1.145 . . . . 0.0 113.616 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.1 p -100.72 -11.76 19.68 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.14 -0.975 . . . . 0.0 109.765 170.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.7 30.4 15.5 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.758 -1.11 . . . . 0.0 112.859 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -104.82 135.32 46.41 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.83 0.852 . . . . 0.0 108.908 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.76 112.5 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.101 0.41 . . . . 0.0 110.013 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.6 mp -96.06 117.22 30.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 15' ' ' LEU . 47.5 mt-10 -84.52 118.63 24.43 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.422 0.689 . . . . 0.0 109.311 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.1 p -129.82 151.21 50.65 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 0.0 109.933 -175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -110.31 104.17 12.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.679 0.792 . . . . 0.0 110.193 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HG3' ' HB ' ' A' ' 14' ' ' THR . 10.7 pt-20 -91.57 152.83 20.12 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.857 177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' THR . 5.2 p-10 -85.26 131.8 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.7 -113.71 3.86 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -170.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -112.09 135.27 52.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.508 0.723 . . . . 0.0 109.722 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 28.3 m -98.74 106.64 18.93 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.474 0.709 . . . . 0.0 110.194 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.623 HD11 HD12 ' A' ' 63' ' ' ILE . 1.1 pt? -111.31 165.29 12.07 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.697 0.76 . . . . 0.0 112.242 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.541 ' HD1' ' HD2' ' A' ' 64' ' ' ARG . 51.6 m95 -56.98 122.45 12.33 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.17 -1.832 . . . . 0.0 111.324 175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.656 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -133.04 176.64 8.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.238 1.015 . . . . 0.0 111.982 -176.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.2 t -145.78 101.2 3.52 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 162.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 61' ' ' ILE . 53.1 t -96.29 113.09 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.672 0.789 . . . . 0.0 109.281 -172.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -134.53 130.32 36.43 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.145 0.578 . . . . 0.0 109.874 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.686 ' SD ' HG22 ' A' ' 59' ' ' VAL . 77.9 mmm -62.74 131.28 48.35 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.404 0.681 . . . . 0.0 109.447 170.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 60' ' ' ARG . 8.0 m -71.13 152.36 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.269 0.356 . . . . 0.0 110.12 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 45' ' ' LYS . 19.9 m -77.54 168.65 19.64 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.065 171.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.0 p -61.04 -20.82 63.0 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.447 0.699 . . . . 0.0 111.812 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 14.6 ptmm? -51.32 -35.63 38.96 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.163 1.385 . . . . 0.0 112.413 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -70.73 -41.26 72.09 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.416 0.447 . . . . 0.0 110.558 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.16 93.59 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.664 0.786 . . . . 0.0 110.415 175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.93 -43.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.221 1.008 . . . . 0.0 110.827 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.8 t -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.977 0.911 . . . . 0.0 111.121 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.594 ' HB2' ' HB3' ' A' ' 53' ' ' GLU . 81.8 p -89.6 -4.74 57.69 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.392 0.677 . . . . 0.0 111.229 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.37 -68.38 3.32 Favored Glycine 0 C--N 1.352 1.463 0 C-N-CA 123.217 0.437 . . . . 0.0 112.064 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.54 16.97 0.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.794 0.838 . . . . 0.0 110.564 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 50' ' ' SER . 10.5 tp10 -79.25 -67.27 0.77 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.82 152.44 40.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -122.99 159.77 27.66 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.626 0.771 . . . . 0.0 109.882 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.0 mt -73.03 129.61 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.99 -9.55 15.76 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 106' ' ' CYS . 55.1 m -70.66 142.61 51.57 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.717 0.807 . . . . 0.0 109.027 169.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.686 HG22 ' SD ' ' A' ' 41' ' ' MET . 26.9 t -122.07 129.85 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.776 0.831 . . . . 0.0 109.612 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 42' ' ' VAL . 8.5 ttt85 -103.64 126.22 50.64 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.615 HD13 HG21 ' A' ' 75' ' ' ILE . 30.4 mt -129.95 106.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.898 0.879 . . . . 0.0 108.756 -167.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -97.43 111.99 24.01 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -173.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.623 HD12 HD11 ' A' ' 35' ' ' LEU . 42.8 pt -122.19 153.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.541 ' HD2' ' HD1' ' A' ' 36' ' ' TRP . 5.7 ptm180 -56.35 153.91 9.02 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-O 120.73 0.3 . . . . 0.0 111.399 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -63.69 134.35 55.23 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.366 0.666 . . . . 0.0 110.269 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.412 ' H ' HD23 ' A' ' 102' ' ' LEU . 32.1 ttt180 -158.63 136.28 10.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.716 0.635 . . . . 0.0 110.066 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -83.3 -5.36 59.11 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.742 0.817 . . . . 0.0 112.486 -172.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -93.49 -19.65 21.03 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.835 0.854 . . . . 0.0 111.204 -172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.5 mm -69.71 121.56 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 122.918 0.487 . . . . 0.0 110.259 -172.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -135.71 162.41 32.82 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.8 0.84 . . . . 0.0 109.6 -172.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 92' ' ' GLN . . . -64.05 -27.34 69.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.708 0.803 . . . . 0.0 112.325 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.1 p -74.03 -17.56 60.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.185 0.594 . . . . 0.0 111.779 177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -96.76 105.08 17.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.006 0.922 . . . . 0.0 110.087 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HB2' ' HB3' ' A' ' 13' ' ' GLN . 82.5 mtp180 -72.77 162.47 29.44 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.966 0.412 . . . . 0.0 111.441 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.615 HG21 HD13 ' A' ' 61' ' ' ILE . 44.1 mm -106.23 102.97 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 123.707 0.803 . . . . 0.0 110.19 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -96.77 112.66 24.32 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.36 119.48 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 122.683 0.393 . . . . 0.0 111.605 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 m -77.7 -25.76 49.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.708 0.803 . . . . 0.0 111.998 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -168.39 135.36 2.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.579 0.751 . . . . 0.0 109.397 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.97 -164.91 28.19 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-O 119.616 -0.546 . . . . 0.0 112.228 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.78 -6.52 17.61 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.098 2.532 . . . . 0.0 112.593 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HD11 ' A' ' 87' ' ' LEU . 78.1 mt -130.37 26.92 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.226 1.01 . . . . 0.0 110.019 -178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 105.73 0.6 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.66 0.784 . . . . 0.0 111.552 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.89 -40.13 2.09 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -175.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.87 139.46 41.69 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 123.528 0.731 . . . . 0.0 110.364 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 t -106.59 110.77 32.75 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.385 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD13 ' A' ' 82' ' ' LEU . 1.4 mm? -74.65 150.96 39.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.886 0.874 . . . . 0.0 110.365 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.47 ' OD1' ' HA3' ' A' ' 109' ' ' GLY . 9.0 m120 -114.09 135.81 53.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.393 1.077 . . . . 0.0 108.494 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 106' ' ' CYS . 61.8 mt -82.54 121.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -172.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.44 HG23 ' HD2' ' A' ' 107' ' ' ARG . 0.3 OUTLIER -77.87 121.21 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.76 -87.61 0.36 Allowed Glycine 0 C--N 1.345 1.062 0 O-C-N 123.91 0.756 . . . . 0.0 112.735 -176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 71' ' ' ALA . 23.2 pt20 -166.37 150.13 6.77 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 124.858 1.263 . . . . 0.0 108.951 -175.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.37 157.64 58.58 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.526 2.151 . . . . 0.0 112.159 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -128.25 109.55 19.61 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 123.316 0.647 . . . . 0.0 110.142 -170.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.55 133.81 50.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.774 2.316 . . . . 0.0 110.496 166.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 99' ' ' ARG . 5.1 p-10 -64.95 173.99 2.1 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.707 0.403 . . . . 0.0 111.164 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.29 -35.6 67.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.032 0.933 . . . . 0.0 112.943 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.61 -13.24 40.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.102 0.561 . . . . 0.0 112.105 -178.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 96' ' ' ASP . 3.7 mpt_? 60.88 29.15 18.83 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.429 1.092 . . . . 0.0 110.767 -175.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -93.59 -0.86 56.03 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.985 0.914 . . . . 0.0 110.39 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 8.4 ptp85 -163.57 169.35 18.79 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.737 0.815 . . . . 0.0 110.092 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -110.23 109.23 19.63 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.83 1.252 . . . . 0.0 107.644 169.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -86.62 110.86 20.12 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.521 HG22 ' SG ' ' A' ' 106' ' ' CYS . 14.3 mm -98.42 116.17 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 105' ' ' LEU . 1.5 pt? -89.27 134.79 33.91 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.521 ' SG ' HG22 ' A' ' 104' ' ' ILE . 99.1 m -151.58 -179.38 7.36 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 109.494 -173.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -149.37 152.25 35.46 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 166.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.1 107.19 0.7 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.096 0.474 . . . . 0.0 111.365 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' ' OD1' ' A' ' 88' ' ' ASN . . . -93.46 35.35 4.16 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.565 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.01 35.98 1.64 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.414 1.086 . . . . 0.0 108.616 172.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.99 -34.25 61.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.498 -166.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.462 -0.78 . . . . 0.0 109.26 175.389 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -83.79 103.85 13.41 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.23 140.09 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.591 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.14 39.16 2.43 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.13 0.269 . . . . 0.0 113.545 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -73.44 146.25 45.15 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 123.982 0.913 . . . . 0.0 109.802 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 31.9 mt -81.55 93.45 6.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.52 -163.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -100.13 -24.99 14.43 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.946 0.898 . . . . 0.0 111.784 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -108.01 -173.31 2.25 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.951 1.3 . . . . 0.0 109.626 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.54 ' HG2' HG22 ' A' ' 34' ' ' THR . 51.0 ttp180 -148.09 131.86 16.98 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -129.99 153.32 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.6 0.76 . . . . 0.0 110.554 -175.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -103.04 124.64 48.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.221 1.008 . . . . 0.0 110.091 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.29 116.31 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 123.623 0.577 . . . . 0.0 109.946 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.693 1.197 . . . . 0.0 109.103 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -80.21 140.33 36.34 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.534 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 27' ' ' GLU . 33.2 tp -91.99 97.6 11.05 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 -173.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -88.66 108.26 19.36 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.849 0.859 . . . . 0.0 109.56 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.572 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 48.4 mt-30 -91.58 101.31 13.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.1 m -109.58 122.3 47.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.667 0.787 . . . . 0.0 109.398 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -78.53 157.87 28.72 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-O 120.734 0.302 . . . . 0.0 110.294 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 24' ' ' GLU . 22.7 t70 -103.51 168.73 8.97 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.617 0.767 . . . . 0.0 109.189 -172.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.3 tt -67.48 -4.59 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 124.413 1.085 . . . . 0.0 112.666 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -110.98 -31.02 7.27 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.57 31.09 1.71 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.184 -1.371 . . . . 0.0 114.623 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' H ' ' HB3' ' A' ' 20' ' ' ASP . 48.3 mm-40 -79.91 144.54 33.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.4 mm -95.89 101.77 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.6 90.93 6.86 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 17' ' ' GLN . 44.3 mt-10 -79.68 105.56 11.07 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.9 p -123.93 155.11 38.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.334 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -109.45 96.71 6.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -79.48 130.63 35.59 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.481 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.21 127.53 32.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.48 -110.4 3.39 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -168.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 35' ' ' LEU . 86.4 t60 -105.44 132.45 51.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 9' ' ' ARG . 36.5 m -104.58 95.17 5.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.4 pt? -108.44 170.1 8.23 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.591 0.71 . . . . 0.0 112.26 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' LEU . 50.5 m95 -69.93 133.03 46.86 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.665 177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HD12 ' A' ' 10' ' ' ILE . . . -138.49 168.56 19.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.791 0.836 . . . . 0.0 112.175 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.9 t -120.98 94.06 4.22 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 162.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.564 HG23 HG12 ' A' ' 61' ' ' ILE . 3.7 p -94.58 90.46 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 122.325 1.06 . . . . 0.0 108.978 -174.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.3 118.51 36.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.444 -172.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.445 ' HG2' HG22 ' A' ' 59' ' ' VAL . 72.3 mtp -67.62 141.51 56.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -66.63 155.03 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.914 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 46' ' ' GLU . 18.0 m -76.13 163.46 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.091 0.556 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -62.43 -35.64 79.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.316 0.647 . . . . 0.0 110.465 176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -65.25 -28.54 69.42 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.621 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 43' ' ' SER . 15.4 mm-40 -71.81 -41.42 68.27 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.371 0.419 . . . . 0.0 110.207 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.23 -52.34 65.7 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 124.184 0.928 . . . . 0.0 111.184 172.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 78.6 mt -57.29 -48.24 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.272 1.029 . . . . 0.0 111.953 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -72.26 -30.62 65.03 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.558 0.743 . . . . 0.0 111.728 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 53' ' ' GLU . 11.1 t -90.22 -8.59 50.7 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.587 0.755 . . . . 0.0 110.578 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.42 -102.36 1.18 Allowed Glycine 0 C--N 1.352 1.452 0 O-C-N 123.587 0.555 . . . . 0.0 112.787 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.09 -5.55 17.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.927 0.891 . . . . 0.0 111.789 -176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' HB3' ' OG ' ' A' ' 50' ' ' SER . 10.3 tp10 -74.55 -75.42 0.16 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.754 0.422 . . . . 0.0 109.973 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 58' ' ' THR . 64.7 mt -83.33 147.73 27.76 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.28 165.53 25.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.203 1.001 . . . . 0.0 109.048 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.13 117.06 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.66 -10.67 14.12 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.526 0.517 . . . . 0.0 112.101 -168.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.687 HG21 HD22 ' A' ' 54' ' ' LEU . 93.7 m -74.53 139.37 43.74 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 166.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 41' ' ' MET . 44.7 t -126.29 132.47 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.592 0.757 . . . . 0.0 110.599 -173.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -99.65 141.06 32.94 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 50.9 mt -134.57 107.9 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -172.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -102.73 112.75 25.67 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 37' ' ' ALA . 39.3 pt -123.93 166.65 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.147 0.579 . . . . 0.0 109.748 -173.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 21.5 mmt180 -53.07 137.99 32.05 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.273 0.488 . . . . 0.0 111.415 164.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HE1' ' HE3' ' A' ' 67' ' ' LYS . 28.3 t80 -55.87 116.69 3.1 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 124.175 0.99 . . . . 0.0 109.167 176.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HD3' HD11 ' A' ' 69' ' ' ILE . 37.0 ttt180 -140.02 121.06 14.66 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HE3' ' HE1' ' A' ' 65' ' ' TYR . 32.7 mmtp -69.18 -10.1 56.11 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.825 1.25 . . . . 0.0 112.431 -177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.78 -19.23 22.8 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.619 0.767 . . . . 0.0 110.976 -173.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.415 HD11 ' HD3' ' A' ' 66' ' ' ARG . 33.3 mm -69.8 119.93 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -116.88 168.59 10.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.989 0.916 . . . . 0.0 108.961 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.01 -24.67 66.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.666 0.786 . . . . 0.0 110.992 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 68.8 p -90.78 13.54 16.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.698 0.799 . . . . 0.0 111.67 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 m -111.64 100.33 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.929 0.892 . . . . 0.0 109.266 176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HD2' ' ND2' ' A' ' 88' ' ' ASN . 49.1 mtm180 -72.23 165.5 24.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.685 0.755 . . . . 0.0 111.035 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' HB ' ' A' ' 10' ' ' ILE . 2.1 mp -115.6 130.28 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -125.32 113.87 18.16 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 168.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 82' ' ' LEU . 62.0 t -68.31 115.9 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 123.361 0.413 . . . . 0.0 111.626 -169.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -75.78 -22.74 56.13 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.142 0.977 . . . . 0.0 111.813 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.512 HG22 ' HB3' ' A' ' 9' ' ' ARG . 10.0 t -166.68 129.05 1.81 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.786 0.835 . . . . 0.0 109.499 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.67 -165.9 31.15 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.46 -0.633 . . . . 0.0 111.952 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.02 -15.01 35.97 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.829 2.352 . . . . 0.0 112.304 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 87' ' ' LEU . 96.7 mt -122.78 35.01 4.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.061 0.945 . . . . 0.0 110.486 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.88 111.83 1.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.044 0.538 . . . . 0.0 110.42 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 105.82 -17.64 41.73 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.506 0.504 . . . . 0.0 113.229 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 mmm-85 -83.96 132.3 34.77 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.81 0.844 . . . . 0.0 109.611 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 p -99.25 101.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 CA-C-O 122.078 0.942 . . . . 0.0 110.54 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.484 HD11 HD13 ' A' ' 82' ' ' LEU . 1.2 mm? -81.57 124.41 29.5 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.327 176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.436 ' ND2' ' HD2' ' A' ' 74' ' ' ARG . 0.8 OUTLIER -99.7 141.51 32.41 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.529 1.132 . . . . 0.0 109.036 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG12 ' SG ' ' A' ' 106' ' ' CYS . 39.4 mt -78.19 128.63 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -109.1 68.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 122.0 0.905 . . . . 0.0 109.605 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.19 -122.88 1.53 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.691 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -140.6 146.5 45.06 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.004 0.922 . . . . 0.0 108.679 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.29 102.11 0.38 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.181 1.92 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.74 112.74 34.41 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.908 -174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.92 137.21 44.12 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.435 2.09 . . . . 0.0 111.667 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.498 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 34.9 t70 -58.73 144.54 43.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 122.82 0.448 . . . . 0.0 111.494 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.04 63.06 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.025 0.93 . . . . 0.0 112.103 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.66 -5.18 46.2 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.202 0.601 . . . . 0.0 111.015 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.01 22.73 12.96 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 124.619 1.168 . . . . 0.0 112.107 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 75.1 p -85.83 -10.44 55.4 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.142 0.577 . . . . 0.0 110.766 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.498 ' HG3' ' HB2' ' A' ' 96' ' ' ASP . 7.8 ptp180 -163.71 -177.53 5.22 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.737 0.815 . . . . 0.0 110.742 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.58 115.84 18.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -82.29 102.31 11.1 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.718 0.807 . . . . 0.0 109.547 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 61' ' ' ILE . 15.7 mm -98.72 125.98 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.564 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.2 pt? -103.6 134.32 47.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 61' ' ' ILE . 70.9 m -152.92 177.88 10.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.738 0.815 . . . . 0.0 110.217 -170.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -143.92 162.33 36.41 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.011 1.325 . . . . 0.0 107.974 169.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.01 122.01 12.67 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA3' ' ND2' ' A' ' 88' ' ' ASN . . . -89.07 44.28 3.1 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.676 0.61 . . . . 0.0 113.807 -171.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 47.76 54.94 9.15 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.882 1.273 . . . . 0.0 113.126 172.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -21.05 56.06 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.782 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 123.62 0.768 . . . . 0.0 109.207 169.6 . . . . . . . . 0 0 . 1 stop_ save_